0001193125-15-179221.txt : 20150508 0001193125-15-179221.hdr.sgml : 20150508 20150508141919 ACCESSION NUMBER: 0001193125-15-179221 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20150331 FILED AS OF DATE: 20150508 DATE AS OF CHANGE: 20150508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Imprivata Inc CENTRAL INDEX KEY: 0001328015 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36516 FILM NUMBER: 15845898 BUSINESS ADDRESS: STREET 1: 10 MAGUIRE RD, BUILDING 1 STREET 2: SUITE 125 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-2700 MAIL ADDRESS: STREET 1: 10 MAGUIRE RD, BUILDING 1 STREET 2: SUITE 125 CITY: LEXINGTON STATE: MA ZIP: 02421 10-Q 1 d899224d10q.htm FORM 10-Q Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

Or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 001-36516

 

 

IMPRIVATA, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   04-3560178

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

10 Maguire Road

Lexington, Massachusetts 02421

(Address of principal executive offices, including zip code)

(781) 674-2700

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨ .

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No    ¨ .

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   x  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes  ¨    No  x

As of May 1, 2015, there were 24,082,957 shares of the registrant’s common stock outstanding.

 

 

 


Table of Contents

Table of Contents

 

PART I

Item 1.

   Financial Statements (Unaudited)    4
   Condensed Consolidated Balance Sheets as of March 31, 2015 and December 31, 2014    4
   Condensed Consolidated Statements of Operations for the three months ended March 31, 2015 and 2014    5
   Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2015 and 2014    6
   Condensed Consolidated Statement of Stockholders’ Equity as of March 31, 2015    7
   Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2015 and 2014    8
   Notes to Condensed Consolidated Financial Statements (Unaudited)    9

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    17
   Overview    17
   Critical Accounting Estimates    19
   Results of Operations    20
   Liquidity and Capital Resources    25

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    26

Item 4.

   Controls and Procedures    27
PART II

Item 1.

   Legal Proceedings    28

Item 1A.

   Risk Factors    28

Item 2.

   Unregistered Sales of Equity Securities and Use of Proceeds    44

Item 3.

   Defaults Upon Senior Securities    44

Item 4.

   Mine Safety Disclosures    44

Item 5.

   Other Information    44

Item 6.

   Exhibits    44

 

2


Table of Contents

Special note regarding forward-looking statements and industry data

This Quarterly Report on Form 10-Q, including the information incorporated by reference herein, contains, in addition to historical information, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

These forward-looking statements are based on our current expectations, assumptions, estimates and projections regarding our business and industry, and we do not undertake an obligation to update our forward-looking statements to reflect future events or circumstances. We may, in some cases, use words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would,” or the negative of these words or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:

 

    the size and growth of the potential markets for our products and our ability to serve those markets;

 

    the rate and degree of market acceptance of our products;

 

    the accuracy of our estimates regarding expenses, revenues and capital requirements;

 

    regulatory developments in the United States and foreign countries;

 

    the success of our sales and marketing capabilities;

 

    the success of competing products that are or become available;

 

    our ability to obtain additional financing if needed;

 

    our ability to obtain and maintain intellectual property protection for our proprietary assets; and

 

    the loss of key technology or management personnel.

Any forward-looking statements in this Quarterly Report on Form 10-Q reflect our current views with respect to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under “Part II, Item 1A. Risk factors” and elsewhere in this Quarterly Report on Form 10-Q. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

 

3


Table of Contents

PART 1

 

Item 1. Financial Statements.

Imprivata, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

     March 31,     December 31,  

(in thousands, except share amounts)

   2015     2014  

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 75,377      $ 78,524   

Accounts receivable, net of allowances

     19,073        25,335   

Prepaid expenses and other current assets

     4,693        3,516   
  

 

 

   

 

 

 

Total current assets

  99,143      107,375   

Property and equipment, net

  7,286      7,640   

Goodwill

  1,560      1,560   

Intangible assets, net

  1,407      1,499   

Other assets

  98      105   
  

 

 

   

 

 

 

Total assets

$ 109,494    $ 118,179   
  

 

 

   

 

 

 

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$ 2,929    $ 2,498   

Accrued expenses and other current liabilities

  6,632      10,565   

Current portion of capital lease obligations and long-term debt

  571      625   

Current portion of other long-term liabilities

  196      288   

Current portion of deferred revenue

  33,102      33,120   

Current portion of contingent purchase price liability

  236      152   
  

 

 

   

 

 

 

Total current liabilities

  43,666      47,248   

Deferred revenue, net of current portion

  4,004      4,021   

Capital lease obligations, long-term debt and royalty obligations, net of current portion

  490      619   

Other long-term liabilities, net of current portion

  1,634      1,535   

Contingent purchase price liability, net of current portion

  417      480   
  

 

 

   

 

 

 

Total liabilities

  50,211      53,903   

Commitments and contingencies (Note 7)

Stockholders’ equity:

Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized; none issued at March 31, 2015 and December 31, 2014

  —        —     

Common stock, $0.001 par value, 250,000,000 shares authorized at March 31, 2015 and December 31, 2014; 23,979,778 and 23,742,467 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively

  24      24   

Additional paid-in capital

  173,654      171,903   

Accumulated other comprehensive loss

  (145   (100

Accumulated deficit

  (114,250   (107,551
  

 

 

   

 

 

 

Total stockholders’ equity

  59,283      64,276   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

$ 109,494    $ 118,179   
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements. 

 

4


Table of Contents

Imprivata, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

 

     Three Months Ended March 31,  

(in thousands, except per share data)

   2015     2014  

Revenue

    

Product

   $ 12,913      $ 9,274   

Maintenance and services

     12,723        10,166   
  

 

 

   

 

 

 

Total revenue

  25,636      19,440   
  

 

 

   

 

 

 

Cost of revenue

Product

  3,423      2,160   

Maintenance and services

  4,927      4,193   
  

 

 

   

 

 

 

Total cost of revenue

  8,350      6,353   
  

 

 

   

 

 

 

Gross profit

  17,286      13,087   

Operating expenses

Research and development

  6,872      6,536   

Sales and marketing

  12,018      10,419   

General and administrative

  4,580      3,013   
  

 

 

   

 

 

 

Total operating expenses

  23,470      19,968   
  

 

 

   

 

 

 

Loss from operations

  (6,184   (6,881

Other income (expense)

Foreign currency exchange loss

  (462   (131

Interest and other income (expense), net

  (16   (29
  

 

 

   

 

 

 

Loss before income taxes

  (6,662   (7,041

Income taxes

  37      26   
  

 

 

   

 

 

 

Net loss

  (6,699   (7,067

Accretion of redeemable convertible preferred stock

  —        (1,238
  

 

 

   

 

 

 

Net loss attributable to common stockholders

$ (6,699 $ (8,305
  

 

 

   

 

 

 

Net loss per share attributable to common stockholders

Basic and diluted

$ (0.28 $ (2.29
  

 

 

   

 

 

 

Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders

Basic and diluted

  23,868      3,627   
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5


Table of Contents

Imprivata, Inc.

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited)

 

     Three Months Ended March 31,  

(in thousands)

   2015     2014  

Net loss

   $ (6,699   $ (7,067

Other comprehensive loss:

    

Foreign currency translation adjustments

     (45     144   
  

 

 

   

 

 

 

Comprehensive loss

$ (6,744 $ (6,923
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6


Table of Contents

Imprivata, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

     Shares      Common
stock

par value
$ 0.001
    Additional
paid-in
capital
     Accumulated
other
comprehensive
income (loss)
    Accumulated
deficit
    Total  

(in thousands)

      Amount           

Balance- January 1, 2015

     23,742       $ 24      $ 171,903       $ (100   $ (107,551   $ 64,276   

Exercise of common stock options

     178         —          367           —          367   

Stock-based compensation expense

          701             701   

Employee stock purchase plan

     59         1        683             684   

Common stock grants

     1         (1     —               (1

Net loss

               (6,699     (6,699

Other comprehensive income (loss)

             (45       (45
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Balance- March 31, 2015

  23,980    $ 24    $ 173,654    $ (145 $ (114,250 $ 59,283   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

7


Table of Contents

Imprivata, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

     Three Months Ended March 31,  

(in thousands)

   2015     2014  

Cash flows from operating activities:

    

Net loss

   $ (6,699   $ (7,067

Adjustments to reconcile net loss to net cash used in operating activities:

    

Depreciation and amortization expense

     780        695   

Stock-based compensation

     701        298   

Loss on disposal of fixed assets

     14        12   

Change in value of contingent purchase price liability

     21        45   

Changes in operating assets and liabilities:

    

Accounts receivable

     6,262        6,264   

Prepaid expenses and other current assets

     (857     (330

Deferred revenue

     (35     (410

Accounts payable

     412        (1,783

Accrued expenses and other current liabilities

     (4,145     (3,367

Other liabilities

     5        (62
  

 

 

   

 

 

 

Net cash used in operating activities

  (3,541   (5,705
  

 

 

   

 

 

 

Cash flows from investing activities:

Purchases of property and equipment

  (371   (655
  

 

 

   

 

 

 

Net cash used in investing activities

  (371   (655
  

 

 

   

 

 

 

Cash flows from financing activities:

Deferred offering costs

  —        (1,154

Repayments for capital lease obligations, long-term debt and other

  (180   (220

Proceeds from employee stock purchase plan

  684      —     

Proceeds from exercise of stock options

  330      294   
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

  834      (1,080
  

 

 

   

 

 

 

Effect of exchange rates on cash and cash equivalents

  (69   84   
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

  (3,147   (7,356

Cash and cash equivalents, beginning of period

  78,524      13,284   
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

$ 75,377    $ 5,928   
  

 

 

   

 

 

 

Supplemental disclosures of non-cash investing and financing activities:

Equipment purchases under capital leases

$ —      $ 507   
  

 

 

   

 

 

 

Property and equipment purchases included in accounts payable and accrued expenses

$ 99    $ 19   
  

 

 

   

 

 

 

Accretion of preferred stock

$ —      $ 1,238   
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

8


Table of Contents

Imprivata, Inc.

Notes to condensed consolidated financial statements

(Unaudited)

1. Organization and business

(a) Description of business

Imprivata, Inc. (the “Company”) is a leading provider of healthcare IT security solutions that provide authentication management, fast access to patient information, and secure communications technologies to the healthcare industry. The Company’s flagship product Imprivata OneSign, is an integrated enterprise single sign-on, authentication management and workflow automation platform that addresses multiple security and productivity challenges faced by hospitals and other healthcare organizations. By enabling fast, secure access to healthcare information technology systems, the Company believes that its solutions save clinicians significant time to focus on patient care, increase their productivity and satisfaction, and help healthcare organizations comply with privacy and security regulations.

The Company was incorporated in the State of Delaware in May 2001.

On June 30, 2014, the Company completed its initial public offering (“IPO”) and is listed on the New York Stock Exchange (“NYSE”) under the ticker symbol “IMPR.”

(b) Basis of presentation and principles of consolidation

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company is subject to a number of risks. Principal among these risks are dependence on key individuals, competition from substitute products and larger companies, the successful development and marketing of its products, and recruitment of key personnel.

Management believes the Company has sufficient cash and availability under its letter of credit to sustain operations through at least the next 12 months.

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited. All intercompany balances and transactions have been eliminated in consolidation.

(c) Use of estimates

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP applicable to interim periods, under the rules and regulations of the United States Securities and Exchange Commission (“SEC”), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended December 31, 2014. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for the fair presentation of interim information have been included. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015, for any other interim period or for any other future year.

The consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements at that date, but does not include all of the disclosures required by U.S. GAAP. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s 2014 Annual Report on Form 10-K filed with the SEC on March 11, 2015.

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited, as well as two branch offices. All intercompany balances and transactions have been eliminated in consolidation. In the first quarter of 2014, the Company completed the closure of its UK branch office. In the first quarter of 2015, the Company closed its Netherlands branch office.

(d) Foreign currency

The foreign subsidiaries and branches use the local currency as the functional currency. The Company translates the assets and liabilities of its foreign operations into U.S. dollars based on the rates of exchange in effect as of the balance sheet date. Revenues and expenses are translated into U.S. dollars using average exchange rates for each period. The resulting adjustments from the translation process are included in accumulated other comprehensive (loss) income in the accompanying consolidated balance sheets.

 

9


Table of Contents

Certain transactions of the Company are settled in foreign currency, and are thus translated to U.S. dollars at the rate of exchange in effect at the end of each month. Gains (losses) resulting from the translation are included in foreign exchange gains (losses) in the accompanying consolidated statements of operations.

(e) Subsequent event

On April 30, 2015, the Company announced the acquisition of HT Systems, the market leading provider of palm-vein based biometric patient identification systems, to enter into the emerging patient identification market. The acquisition of HT Systems and its PatientSecure biometric patient identification technology supports Imprivata’s long-term vision to be the leading provider of healthcare IT security solutions that increase provider productivity, enable patient engagement, and improve patient safety. Under the terms of the transaction, the Company paid approximately $19.1 million in cash at closing, of which $2 million was deposited into an escrow fund to secure certain obligations of the selling members of HT Systems to indemnify us and to pay us the amount of any shortfall in HT System’s working capital as of the closing date. Additionally, The Company will pay up to $1.9 million in retention-based payments two years from closing plus up to $5.0 million based on achieving certain sales targets over the two-year period following the transaction. The Company is required to allocate the purchase price to the estimated fair value of the tangible and identifiable intangible assets acquired and liabilities assumed. The excess of the purchase price over those fair values is recorded as goodwill. The Company is in the process of finalizing the valuation of the assets acquired and liabilities assumed.

2. Summary of significant accounting policies

The Company has not made any significant changes in the application of its significant accounting policies as described in Note 2 of its audited consolidated financial statements for the year ended December 31, 2014 included in its 2014 Annual Report on Form 10-K filed with the SEC on March 11, 2015. See Note 2 in the 2014 Annual Report on Form 10-K for information about these critical accounting policies as well as a description of the “Summary of significant accounting policies.”

Recent accounting guidance

Accounting standards or updates not yet effective

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers” (Topic 606) (ASU 2014-09). ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. On April 1, 2015, the FASB voted to propose a delay in the effective date of this ASU for reporting periods beginning after December 15, 2017, with early adoption permitted as of the original effective date of periods beginning after December 15, 2016. This new guidance is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017; unless the early adoption provision is elected. Entities have the option of using either a full retrospective or a modified approach to adopt the guidance. This update could impact the timing and amounts of revenue recognized. The Company is currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of operations upon adoption.

3. Fair value measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

(a) Fair value hierarchy

The accounting guidance for fair value measurement requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows:

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

10


Table of Contents

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

(b) Assets and liabilities measured at fair value on a recurring basis

The Company’s cash equivalents primarily consist of money market funds recorded at cost, which approximates fair value measured based on quoted prices for assets traded in active markets. The contingent consideration liability is recorded at fair value determined using a probability weighted discounted cash flow model primarily based upon future revenue projections.

The following table sets forth the Company’s assets and liabilities which are measured at fair value on a recurring basis by level within the fair value hierarchy:

 

     Fair value measurements at March 31, 2015  

(in thousands)

   Level 1      Level 2      Level 3      Total
carrying value
 

Assets

           

Cash equivalents:

           

Money market funds

   $ 30,187             $ 30,187   

Certificates of deposit

        97            97   

Liabilities

           

Contingent consideration

           653         653   

 

     Fair value measurements at December 31, 2014  

(in thousands)

   Level 1      Level 2      Level 3      Total
carrying value
 

Assets

           

Cash equivalents:

           

Money market funds

   $ 33,184             $ 33,184   

Certificates of deposit

        97            97   

Liabilities

           

Contingent consideration

           632         632   

(c) Assets and liabilities measured on a non-recurring basis

There were no fair value measurements on a non-recurring basis as of March 31, 2015 and December 31, 2014.

(d) Level 3 fair value measurements

The contingent liability associated with the acquisition of Validus is based on an earn-out capped at $9.8 million, to be paid based on revenue generated using the purchased intellectual property.

The Company re-measures the fair value of the contingent liability at each balance sheet date based on the present value of forecasted revenues through December 31, 2016. The changes in the fair value are primarily due to the difference in actual revenue earned to date versus the initial projections and revisions to the timing and amount of forecasted future revenues.

The resulting forecasted revenues were then discounted using a rate that reflects the uncertainty surrounding the expected outcomes, which the Company believes is appropriate and representative of a market participant assumption.

 

11


Table of Contents

The following table presents a reconciliation of the contingent liability measured at fair value using significant unobservable inputs, and the revaluation amount recorded in the Company’s consolidated statements of operations as a result of the change in fair value:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Beginning balance

   $ 632       $ 1,008   

Revaluation recognized in general and administrative expenses in the corresponding statements of operations

     21         (376
  

 

 

    

 

 

 

Ending balance

$ 653    $ 632   
  

 

 

    

 

 

 

This following table presents the significant unobservable inputs used in the valuation of the contingent liability:

 

     March 31,
2015
    December 31,
2014
 

Discount Rate

     17     17

(e) Other financial instruments

The carrying amounts reflected in the consolidated balance sheets for cash and cash equivalents (which are comprised primarily of deposit accounts), accounts receivable, prepaid expenses, other current assets, accounts payable, and accrued expenses approximate fair value due to their short-term maturities.

4. Accrued expenses and other current liabilities

The following table presents the details of the Company’s accrued expenses and other current liabilities:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Accrued payroll and related

   $ 2,883       $ 7,839   

Accrued taxes (1)

     906         1,144   

Other accrued expenses

     2,843         1,582   
  

 

 

    

 

 

 
$ 6,632    $ 10,565   
  

 

 

    

 

 

 

 

(1) Accrued taxes consist of accruals for foreign and state taxes, sales and use taxes, value added taxes due in foreign jurisdictions and franchise taxes.

5. Warranty obligations

The Company maintains an allowance for warranty obligations that may be incurred under its limited warranty. Factors that affect the Company’s allowance for warranty obligations include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and the cost per claim to satisfy the Company’s warranty obligation.

The following table presents the details of the Company’s allowance for warranty obligations:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Beginning balance

   $ 40       $ 93   

Provision for estimated claims

     —           5   

Adjustment to estimate

     —           (51

Settlement of claims

     —           (7
  

 

 

    

 

 

 

Ending balance

$ 40    $ 40   
  

 

 

    

 

 

 

The warranty obligations are included in accrued expenses and other current liabilities in the consolidated balance sheets presented.

 

12


Table of Contents

6. Debt

Bank credit facility

The Company has a revolving credit facility with a bank pursuant to a Loan and Security Agreement dated January 30, 2009 (the “Revolving Credit Facility”). In February 2014, the Company modified the revolving credit agreement that had expired in October 2013 and extended the maturity date to February 2015. In February 2015, the Company amended its revolving credit facility to extend the maturity through April 2015. In April 2015, the Company further amended its revolving credit facility to extend the maturity through April 2016 and increase the borrowing limit from $10.0 million to $15.0 million based primarily on accounts receivable, and is subject to certain financial covenants requiring the Company to maintain minimum levels of liquidity. Outstanding borrowings accrue interest at the Wall Street Journal published prime rate plus 0.75%. Substantially all of the assets of the Company are pledged as collateral.

At March 31, 2015 and December 31, 2014, there was no outstanding balance under the revolving credit facility.

7. Commitments and contingencies

(a) Operating lease obligations

On January 16, 2015, the Company amended its lease agreement for its corporate headquarters in Lexington, Massachusetts to lease approximately 21,000 of additional square footage. The amendment increased the total square footage leased to approximately 93,000 and extended the term through December 2021. The additional rent expense is approximately $7.9 million and the landlord has agreed to contribute approximately $735,000 towards leasehold improvements.

(b) Litigation

The Company is not presently a party to any litigation that it believes might have a material adverse effect on its business operations or financial statements.

(c) Indemnifications

As permitted under Delaware law, the Company’s Certificate of Incorporation and By Laws provide that the Company indemnify its stockholders, officers, directors, and partners, and each person controlling the stock held for certain events or occurrences that happen by reason of the relationship with or position held at the Company. The Company’s agreements with customers generally require the Company to indemnify the customer against claims in which the Company’s products infringe third-party patents, copyrights, or trademarks, and indemnify against product liability matters.

As of March 31, 2015 and December 31, 2014, the Company had not experienced any material losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.

 

13


Table of Contents

8. Accumulated other comprehensive loss

The following table presents the changes in accumulated other comprehensive loss before taxes, as the tax effect is not material to the consolidated financial statements:

 

(in thousands)

   Foreign
Currency
Translation
Adjustments
     Affected line item in the
statement where net
income is presented

Balance at January 1, 2014

     (145   

Other comprehensive loss

     (100   

Amounts reclassified from accumulated other comprehensive income: Closure of foreign branch

     145       Other income (expense)
  

 

 

    

Net current-period other comprehensive loss

  45   
  

 

 

    

Balance at December 31, 2014

  (100

Other comprehensive loss

  (11

Amounts reclassified from accumulated other comprehensive income:

Closure of foreign branch

  (34 Other income (expense)
  

 

 

    

Net current-period other comprehensive loss

  (45
  

 

 

    

Balance at March 31, 2015

$ (145
  

 

 

    

9. Stock award plans and stock based compensation

(a) Equity incentive plan

In May 2014, the Company’s 2014 Stock Option and Incentive Plan (“2014 Plan”), was adopted by the Company’s board of directors and approved by its stockholders and became effective in June 2014. The 2014 Plan replaces the Amended and Restated 2002 Stock Option and Incentive Plan (“2002 Plan”) as the Company’s board of directors has determined not to make additional awards under the 2002 Plan. The 2014 Plan allows the compensation committee to make equity-based incentive awards to the Company’s officers, employees, directors and other key persons (including consultants).

Stock options expire no later than 10 years from the date of grant and generally vest over a period of four years. At the discretion of the Board of Directors, certain option grants may be immediately exercisable but subject to a right to repurchase, at cost, pursuant to the vesting schedule of the individual grant.

During the three months ended March 31, 2015, the Company granted 1,446,050 options to purchase common stock at a weighted average exercise price of $13.55.

At March 31, 2015, there were 2,122,083 shares available for future grant under the 2014 Plan.

(b) Employee stock purchase plan

In May 2014, the Company’s board of directors adopted and its stockholders approved the Employee Stock Purchase Plan (“ESPP”). Each employee who is a participant in the ESPP may purchase shares by authorizing payroll deductions of his or her base compensation during an offering period. Unless the participating employee has previously withdrawn from the offering, his or her accumulated payroll deductions will be used to purchase ordinary shares on the last business day of the offering period at a price equal to 85% of the fair market value of the common stock on the first business day or the last business day of the offering period, whichever is lower. All offering periods will be for six months and begin on March 1st and September 1st of each year.

At February 27, 2015, the Company issued 58,793 shares of common stock at a purchase price of $11.64.

At March 31, 2015, there were 627,033 shares available for future grant under the ESPP.

(c) Early exercise of stock options

The Company issues stock option agreements to Company executives and members of the Board of Directors, which may permit options to be exercised at any time. The Company may also include an early exercise provision for incentive stock option agreements at its discretion. The unvested shares of common stock exercised are subject to the Company’s right to repurchase at the original exercise price upon termination of employment or other relationship.

 

14


Table of Contents

At March 31, 2015 and December 31, 2014, a total of 35,000 and 40,202 shares of unvested stock options exercised were subject to repurchase at an aggregate price of $162,400 and $184,000, respectively. These amounts are recorded as accrued and other current liabilities in the Company’s consolidated balance sheets and will be reclassified to equity as the Company’s repurchase right lapses.

During the three months ended March 31, 2015 and 2014, 5,202 and 5,626 stock options associated with the early exercise vested, respectively.

(d) Valuation of share-based compensation

The Company utilizes the Black-Scholes option-pricing model to estimate the fair value of stock options awarded to employees and rights to acquire stock under the ESPP, which requires several key assumptions to be made.

Weighted average assumptions used to apply this model were as follows:

 

     Three Months ended March 31,  
     2015     2014  

Risk-free interest rate(1)

     1.77     1.87

Expected life (years)(2)

     6.02        6.04   

Expected dividend yield(3)

     —       —  

Expected volatility of underlying stock(4)

     47     54

The assumptions used to estimate the fair value of the rights to acquire stock under the ESPP during the offering beginning on March 1, 2015 were as follows:

 

Risk-free interest rate(1)

     0.07

Expected life (years)(2)

     0.50   

Expected dividend yield(3)

     —  

Expected volatility of underlying stock(4)

     55

 

(1) Risk-free interest rate—the yield on zero-coupon U.S. Treasury securities with maturities similar to the expected term of the award being valued is used as the risk-free interest rate.
(2) Expected term—the expected term for stock options granted based on a review of the period that the Company’s stock option awards are expected to be outstanding and is calculated using the simplified method, which represents the average of the contractual term of the options and the weighted-average vesting period of the options. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate the expected term.
(3) Expected dividend yield—the expected dividend yield was not considered in the option pricing formula since the Company has not declared dividends and does not expect to pay dividends in the foreseeable future.
(4) Expected volatility—the Company is responsible for estimating volatility. The Company has limited trading history as a public company and does not have relevant historical data to develop its volatility assumptions. Therefore, the Company used a weighted average of its volatility and analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March 31, 2015. The Company analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March 31, 2014.

(e) Summary of share-based compensation expense

The Company uses the straight-line attribution method to recognize expense for stock-based awards such that the expense associated with awards is evenly recognized throughout the period.

 

15


Table of Contents

Stock-based compensation included in costs and operating expenses related to the awards of stock options and the employee stock purchase plan are as follows:

 

     Three Months ended March 31,  

(in thousands)

   2015      2014  

Cost of maintenance and professional services

   $ 60       $ 23   

Research and development

     223         92   

Sales and marketing

     216         89   

General and administrative

     202         94   
  

 

 

    

 

 

 

Total

$ 701    $ 298   
  

 

 

    

 

 

 

10. Income taxes

We operate in several tax jurisdictions and are subject to taxes in each country or jurisdiction in which we conduct business. Earnings from our activities outside of the United States are subject to local country income tax and may be subject to U.S. income tax. To date, we have incurred cumulative net losses and maintain a full valuation allowance on our net deferred tax assets. Therefore, we have not recorded any U.S. federal tax provisions and our effective tax rate differs from statutory rates. Our tax expense to date primarily relates to foreign income taxes, mainly from our international operations, and to a lesser extent state income tax provisions.

As of December 31, 2014, the Company’s valuation allowance related to income taxes was approximately $27.5 million. The Company is in a three year cumulative loss position in the United States. As a result, the Company maintains a 100% valuation allowance to reduce the carrying value of the related deferred tax assets to zero. The Company will continue to maintain a full valuation allowance for those tax assets until sustainable future levels of profitability are evident.

As of March 31, 2015 and December 31, 2014, the Company had no uncertain positions or unrecorded liabilities for uncertain tax positions.

11. Computation of net loss per share

The Company calculates basic and diluted net loss per common share by dividing the net loss adjusted for the accretion on the redeemable convertible preferred stock by the weighted average number of common shares outstanding during the period. The Company has excluded all potentially dilutive shares, which include redeemable convertible preferred stock, warrant for common stock, common stock subject to repurchase and outstanding common stock options, from the weighted average number of common shares outstanding as their inclusion in the computation for all periods would be anti-dilutive due to net losses. The Company’s redeemable convertible preferred stock are participating securities as defined under the authoritative guidance, but are excluded from the earnings per share calculation as they do not have an obligation to share or fund in the Company’s net losses.

The components of net loss per share are as follows:

 

     Three Months Ended March 31,  

(in thousands, except per share data)

   2015      2014  

Numerator:

     

Net loss

   $ (6,699    $ (7,067

Accretion of preferred stock

     —           (1,238
  

 

 

    

 

 

 

Net loss attributable to common stockholders

  (6,699   (8,305
  

 

 

    

 

 

 

Denominator:

Weighted average common shares outstanding used in computing basic and diluted net loss per common share

  23,868      3,627   
  

 

 

    

 

 

 

Net loss per share, basic and diluted

$ (0.28 $ (2.29
  

 

 

    

 

 

 

 

16


Table of Contents

The following common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders because they had an antidilutive impact:

 

     Three Months Ended March 31,  

(in thousands)

   2015      2014  

Options to purchase common stock

     4,951         3,605   

Common stock subject to repurchase

     35         57   

Warrants

     —           120   

Convertible preferred stock

     —           13,971   
  

 

 

    

 

 

 

Total

  4,986      17,753   
  

 

 

    

 

 

 

12. Concentration of risk and off-balance sheet risk

Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains substantially all of its cash and cash equivalents in institutional money market mutual funds. The fund provides daily liquidity and invests in a portfolio of short-term money market instruments. To manage accounts receivable credit risk, the Company continuously evaluates the creditworthiness of its customers and reseller and maintains allowances for potential credit losses.

No customers or resellers accounted for 10% or more of revenues for the three months ended March 31, 2015 and 2014, respectively.

No customers or resellers accounted for 10% or more of accounts receivable at March 31, 2015 and December 31, 2014, respectively.

The Company does not have any off-balance sheet arrangements and did not have any such arrangements during the three months ended March 31, 2015 and the year ended December 31, 2014.

 

Item 2. Management’s discussion and analysis of financial condition and results of operations

You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report, and in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2014 filed on March 11, 2015 with the SEC. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should review the “Part II, Item 1A. Risk factors” section of this Quarterly Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. We do not undertake, and specifically disclaim, any obligation to update any forward-looking statements to reflect the occurrence of events or circumstances after the date of such statements except as required by law.

Overview

We are a leading provider of healthcare IT security solutions that provide authentication management, fast access to patient information, and secure communications technologies to the healthcare industry. Our authentication management, single sign-on and secure communications solutions help simplify clinical workflows while addressing multiple security and productivity challenges faced by hospitals and other healthcare organizations. By enabling fast, secure access to healthcare information technology systems, we believe our solutions save clinicians significant time to focus on patient care, increase their productivity and satisfaction, and help healthcare organizations comply with complex privacy and security regulations. Our solutions can be installed on workstations and other application access point throughout a healthcare organization and once deployed become a critical part of the customer’s security, access and communications infrastructure. As a result, we believe that Imprivata OneSign is one of the most widely-used technology solutions by our customers’ physicians, nurses, and other clinicians.

 

17


Table of Contents

As a result of the widespread adoption of healthcare information technology systems and increasing privacy and security regulations, demand for our solutions has grown, which has driven growth in our revenue. Our revenue growth is derived from both sales to new customers as well as add-on sales to our existing customer base. Consistent with our healthcare focused strategy, our healthcare customers, including large integrated healthcare systems, academic medical centers and small- and medium-sized independent healthcare facilities, accounted for the growth in sales to new customers. Many of our customers continue to add licensed users and purchase additional products and services from us after the initial sale.

Many other industries face security and productivity challenges similar to those in healthcare. Although healthcare is our primary focus, we sell to non-healthcare organizations, including financial services, the public sector and other industries. Sales to non-healthcare customers decreased during the three months ended March 31, 2015 due to our focus on the healthcare industry, however, we believe the composition of non-healthcare customers may vary on a quarterly basis and is not indicative of any trend.

We have focused on growing our business to pursue the significant market opportunity we see for our products and services, and we plan to continue to invest in building for growth. As a result, we expect to incur significant operating costs relating to our research and development initiatives for our new and existing solutions and products, and for expansion of our sales and marketing operations as we add additional sales personnel, increase our marketing efforts and expand into new geographical markets. We also expect to increase our general and administrative expenses as a result of becoming a public company.

Initial Public Offering

On June 30, 2014, we completed our IPO, in which we sold 5,750,000 shares of common stock, including 750,000 shares sold pursuant to the underwriters’ option to purchase additional shares, at an offering price of $15.00 per share. All outstanding shares of redeemable convertible preferred stock converted to 13,970,934 shares of common stock at the closing of the IPO. Our shares are traded on the NYSE under the symbol “IMPR.” We received proceeds from the IPO of $80.2 million, net of underwriting discounts and commissions, but before offering expenses of approximately $3.4 million. These offering expenses have been recorded as a reduction of the proceeds received.

Acquisition of HT Systems

On April 30, 2015, we announced the acquisition of HT Systems, the market leading provider of palm-vein based biometric patient identification systems, to enter into the emerging patient identification market. The acquisition of HT Systems and its PatientSecure® biometric patient identification technology supports our long-term vision to be the leading provider of healthcare IT security solutions that increase provider productivity, enable patient engagement, and improve patient safety. Under the terms of the transaction, we paid approximately $19.1 million in cash at closing, of which $2 million was deposited into an escrow fund to secure certain obligations of the selling members of HT Systems to indemnify us and to pay us the amount of any shortfall in HT System’s working capital as of the closing date. Additionally, we will pay up to $1.9 million in retention-based payments two years from closing plus up to $5.0 million based on achieving certain sales targets over the two-year period following the transaction. We are required to allocate the purchase price to the estimated fair value of the tangible and identifiable intangible assets acquired and liabilities assumed. The excess of the purchase price over those fair values is recorded as goodwill. We are in the process of finalizing the valuation of the assets acquired and liabilities assumed.

Adjusted EBITDA

We believe that the presentation of Adjusted EBITDA, a non-GAAP financial measure, provides investors with additional information about our financial results. Adjusted EBITDA is an important supplemental measure used by our board of directors and management to evaluate our operating performance from period to period on a consistent basis and as a measure for planning and forecasting overall expectations and for evaluating actual results against such expectations.

We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization adjusted for foreign currency gains (losses), stock based-compensation and the impact of the fair value revaluation on our contingent liability.

Adjusted EBITDA is not in accordance with, or an alternative to, measures prepared in accordance with U.S. GAAP. In addition, this non-GAAP measure is not based on any comprehensive set of accounting rules or principles. As a non-GAAP measure, Adjusted EBITDA has limitations in that it does not reflect all of the amounts associated with our results of operations as determined in accordance with U.S. GAAP. In particular:

 

    Adjusted EBITDA does not reflect the amounts we paid in taxes or other components of our tax provision;

 

    Adjusted EBITDA does not include depreciation expense from fixed assets or amortization expense from acquired intangible assets;

 

    Adjusted EBITDA does not reflect other (expense) income which include interest income we earn on cash and cash equivalents; interest expense, or the cash requirements necessary to service interest or principal payments, on our debt and capital leases; and the gains or losses on foreign currency transactions;

 

    Adjusted EBITDA does not include the impact of stock-based compensation;

 

18


Table of Contents
    Adjusted EBITDA does not include the change in value of our contingent liability related to the acquisition of assets from Validus Medical Systems, as described in the Notes to consolidated financial statements;

 

    Adjusted EBITDA does not include the transaction costs associated with business acquisitions; and

 

    Others may calculate Adjusted EBITDA differently than we do and these calculations may not be comparable to our Adjusted EBITDA metric. Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including net income (loss) and our financial results presented in accordance with U.S. GAAP.

The following table provides a reconciliation of net loss to Adjusted EBITDA for each of the periods indicated:

 

     Three Months Ended
March 31,
 

(in thousands, except per share amounts)

   2015      2014  

GAAP net loss

   $ (6,699    $ (7,067

Adjustments to reconcile to Adjusted EBITDA:

     

Income tax expense

     37         26   

Depreciation and amortization

     780         695   

Other expense (income), net

     478         160   

Stock-based compensation

     701         298   

Change in fair value of contingent liability

     21         45   

Transaction costs associated with business acquisitions

     163         —     
  

 

 

    

 

 

 

Adjusted EBITDA

$ (4,519 $ (5,843
  

 

 

    

 

 

 

Backlog

Our backlog consists of the total future value of our committed customer purchases, whether billed or unbilled. Backlog includes products, software maintenance and professional services which we have billed or been paid for in advance, and are included in deferred revenue on our balance sheet, as well as committed customer purchases where we have not invoiced or fulfilled the order as of the last day of the applicable period and which are not reflected on our balance sheet. We generally complete the unfulfilled committed customer product purchases by shipment in the next fiscal quarter and recognize revenue upon such shipment. We recognize any maintenance and services revenue related to unfulfilled committed customer purchases in subsequent periods in accordance with our revenue recognition policies. As of March 31, 2015 and December 31, 2014, we had backlog of $40.7 million and $39.3 million, respectively. Of the $40.7 million in backlog as of March 31, 2015, approximately $33.0 million, which includes approximately $22.1 million of maintenance, is expected to be recognized as revenue during the year ended December 31, 2015. Additionally, $5.8 million of maintenance revenue is expected to be recognized over the five year period subsequent to the year ended December 31, 2015. Revenue in any period is a function of new purchases during the period, the timing of fulfillment of customer orders, maintenance renewals and revenue recognized from backlog. Therefore, backlog viewed in isolation may not be indicative of future performance. Our presentation of backlog may differ from that of other companies in our industry.

Critical accounting estimates

Our financial statements are prepared in conformity with U.S. GAAP. We will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. To the extent that there are material differences between our estimates and our actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. See Note 2 of our audited consolidated financial statements for the year ended December 31, 2014 included in our Annual Report on Form 10-K filed with the SEC on March 11, 2015 for information about these critical accounting policies as well as a description of the “Summary of significant accounting policies.”

Recent accounting guidance

Accounting standards or updates not yet effective

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers” (Topic 606) (ASU 2014-09). ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for

 

19


Table of Contents

revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. On April 1, 2015, the FASB voted to propose a delay in the effective date of this ASU for reporting periods beginning after December 15, 2017, with early adoption permitted as of the original effective date of periods beginning after December 15, 2016. This new guidance is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017; unless the early adoption provision is elected. Entities have the option of using either a full retrospective or a modified approach to adopt the guidance. This update could impact the timing and amounts of revenue recognized. The Company is currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of operations upon adoption.

Results of operations

The following table sets forth our consolidated statements of operations data for each of the periods presented.

 

     Three Months Ended March 31,  

(in thousands, except per share data)

   2015      2014  

Revenue

     

Product

   $ 12,913       $ 9,274   

Maintenance and services

     12,723         10,166   
  

 

 

    

 

 

 

Total revenue

  25,636      19,440   

Cost of revenue

Product

  3,423      2,160   

Maintenance and services

  4,927      4,193   
  

 

 

    

 

 

 

Total cost of revenue

  8,350      6,353   
  

 

 

    

 

 

 

Gross profit

  17,286      13,087   

Operating expenses

Research and development

  6,872      6,536   

Sales and marketing

  12,018      10,419   

General and administrative

  4,580      3,013   
  

 

 

    

 

 

 

Total operating expenses

  23,470      19,968   
  

 

 

    

 

 

 

Loss from operations

  (6,184   (6,881

Other income (expense)

Foreign currency exchange loss

  (462   (131

Interest and other income expense (net)

  (16   (29
  

 

 

    

 

 

 

Loss before income taxes

  (6,662   (7,041

Income taxes

  37      26   
  

 

 

    

 

 

 

Net loss

$ (6,699 $ (7,067
  

 

 

    

 

 

 

Revenue

Product revenue is generally recognized upon shipment of the software license key or hardware. Software maintenance revenue is recognized ratably over the maintenance period. Revenue from our professional service arrangements is recognized as the services are performed. Training revenue is recognized when the training is completed. See our audited consolidated financial statements for the year ended December 31, 2014 included in our Annual Report on Form 10-K filed with the SEC for “Summary of significant accounting policies—Revenue recognition” for more information.

The following table sets forth our revenues for each of the periods presented.

 

20


Table of Contents
     Three Months Ended
March 31,
    Period-to-Period  
     2015     2014     Change  

(dollars in thousands)

   Amount     Amount     $      %  

Revenue

         

Product revenue

   $ 12,913      $ 9,274      $ 3,639         39.2

Percentage of revenue

     50.4     47.7     

Maintenance and service revenue

     12,723        10,166      $ 2,557         25.2

Percentage of revenue

     49.6     52.3     
  

 

 

   

 

 

   

 

 

    

Total Revenue

$ 25,636    $ 19,440    $ 6,196      31.9
  

 

 

   

 

 

   

 

 

    

Product revenue

We derive our product revenue from the sales of both software and hardware. We derive substantially all of our software revenue from the sale of perpetual licenses for our Imprivata OneSign solution. Our license sales are generally priced on a per user basis, but are sometimes licensed on an enterprise-wide basis with an unlimited number of users. From time to time, we also derive software revenue from licenses sold on a term license basis. The software is delivered pre-loaded on a hardware server or as a software only solution that provides the same functionality as the software delivered on the pre-loaded server. Hardware sales also include the sale of devices such as proximity card and fingerprint readers.

Comparison of three months ended March 31, 2015 and 2014

Product revenue increased by $3.6 million, or 39%, during the three months ended March 31, 2015, as compared to the three months ended March 31, 2014. The increase was driven primarily by an increase of $2.2 million in sales of additional products into our existing customer base, $2.3 million of which relate to healthcare customers. This increase was offset by a $150,000 decrease in sales to non-healthcare customers. Sales to new customers increased by approximately $1.5 million over the same period. Sales to new healthcare customers increased by $1.8 million during the three months ended March 31, 2015 as compared to the three months ended March 31, 2014, which was offset by a $300,000 decrease in sales to new non-healthcare customers. Although our sales to non-healthcare customers decreased during the three months ended March 31, 2015 due to our focus on the healthcare industry, we believe the composition of non-healthcare customers may vary on a quarterly basis and is not indicative of any trend.

Maintenance and service revenue

Maintenance and services revenue is generated from maintenance and technical support associated with our software as well as professional services, which include implementation and training. Maintenance is typically invoiced annually in advance, recorded as deferred revenue and recognized ratably over the maintenance period. Professional services revenue consists primarily of fees associated with the implementation of our software and training services, and represented 12% of our revenues for the three months ended March 31, 2015 and March 31, 2014. Our professional service arrangements are generally billed on a time and materials basis and revenue is recognized as the services are performed. Training is generally billed as a fixed fee and revenue is recognized when the training is completed.

Comparison of three months ended March 31, 2015 and 2014

Maintenance and service revenue increased by $2.6 million, or 25%, during the three months ended March 31, 2015, as compared to the three months ended March 31, 2014. The increase was driven by increased maintenance revenue of $1.8 million resulting from our larger installed base of users. In addition, professional services increased by $750,000 over the same period due to the increased sales of our products, which resulted in new professional services related to implementation and training.

 

21


Table of Contents

Cost of revenue

The following table sets forth our cost of revenues for each of the periods presented.

 

     Three Months
ended March 31,
    Period-to-Period  
     2015     2014     Change  

(dollars in thousands)

   Amount     Amount     $ / #      %  

Cost of revenue

         

Product

   $ 3,423      $ 2,160      $ 1,263         58.5

Product gross margin

     73.5     76.7     

Maintenance and services

     4,927        4,193      $ 734         17.5

Maintenance and service gross margin

     61.3     58.8     
  

 

 

   

 

 

   

 

 

    

Total cost of revenue

$ 8,350    $ 6,353    $ 1,997      31.4
  

 

 

   

 

 

   

 

 

    

Total gross margin

  67.4   67.3

Headcount

  99      75      24      32.0

Cost of product revenue

Cost of product consists primarily of costs of physical appliances and proximity card and fingerprint readers. Additional product costs include third party software license costs, duties and freight and amortization expense related to intangible assets acquired.

Comparison of three months ended March 31, 2015 and 2014

Cost of product revenue increased by $1.3 million, or 59%, during the three months ended March 31, 2015, as compared to the three months ended March 31, 2014. The increase was primarily attributable to the increase in sales of proximity card and fingerprint devices. Product gross margin decreased due to unfavorable changes in the mix between higher-margin software and device sales. Device sales have lower margins than software sales and device sales increased as a percentage of total product revenue during the three months ended March 31, 2015 as compared to the three months ended March 31, 2014 which resulted in the decrease in product gross margin. Device revenues as a percentage of total product revenues can fluctuate and, as a result, we expect product gross margins to vary depending on the mix of device revenues to total product revenues.

Cost of maintenance and service revenue

Cost of maintenance and services consists primarily of costs related to our support and professional services personnel, including employee wages and benefits, bonuses, stock compensation and travel expense. These costs also include depreciation and overhead related to facilities and information technology used to provide these services.

Comparison of three months ended March 31, 2015 and 2014

Cost of maintenance and services revenue increased by $734,000, or 18%, during the three months ended March 31, 2015, as compared to the three months ended March 31, 2014. The increase was primarily attributable to $887,000 in payroll-related costs as a result of our increased investment in our support and service personnel. In addition, the increase in employees hired also caused an increase in travel-related costs of $166,000. These increases were partially offset by a $299,000 decrease in consulting expense as we used fewer third party consultants for support and services due to our increased headcount during the three months ended March 31, 2014.

Operating expenses

Our operating expenses consist primarily of personnel costs, including salaries, commissions, bonuses, share-based compensation and related benefits and taxes, costs related to the design and development of new products and enhancement of existing products, marketing programs, consulting, travel, and depreciation expenses. Personnel costs are our largest expense, representing $14.7 million, or 63% of our total operating expenses for the three months ended March 31, 2015 and $12.2 million, or 61% of our total operating expenses for the three months ended March 31, 2014. We allocate overhead such as our information technology expenses, including personal costs, and facility expenses based on headcount. Due to our headcount growth, we have increased the leased square footage for our corporate headquarters in Lexington, Massachusetts and our capital expenditures for leasehold improvements and information technology equipment.

The following table sets forth our operating expenses.

 

22


Table of Contents
     Three Months ended
March 31,
    Period-to-Period  
     2015     2014     Change  

(dollars in thousands)

   Amount     Amount     $ / #      %  

Operating expenses

         

Research and development

   $ 6,872      $ 6,536      $ 336         5.1

Percentage of revenue

     26.8     33.6     

Sales and marketing

     12,018        10,419        1,599         15.3

Percentage of revenue

     46.9     53.6     

General and administrative

     4,580        3,013        1,567         52.0

Percentage of revenue

     17.9     15.5     
  

 

 

   

 

 

   

 

 

    

Total operating expenses

$ 23,470    $ 19,968    $ 3,502      17.5
  

 

 

   

 

 

   

 

 

    

Percentage of revenue

  91.6   102.7

Headcount

Research and development

  103      89      14      15.7

Sales and marketing

  146      125      21      16.8

General and administrative

  41      32      9      28.1

Information technology

  14      13      1      7.7
  

 

 

   

 

 

   

 

 

    
  304      259      45      17.4
  

 

 

   

 

 

   

 

 

    

Research and development

Research and development expenses consist of costs for our research and development personnel, including salaries, benefits, bonuses and stock-based compensation, the cost of certain third-party contractors, including off-shore development, travel expense and allocated overhead. Research and development costs are expensed as they are incurred.

We intend to continue to develop additional products and functionality for our existing solutions as well as develop new solutions for the healthcare market and expect research and development costs to continue to increase in absolute dollars, although they may fluctuate as a percentage of revenue.

Comparison of three months ended March 31, 2015 and 2014

Research and development expenses increased by $336,000, or 5%, during the three months ended March 31, 2015, as compared to the three months ended March 31, 2014. The increase was driven by increased payroll and related costs of $637,000 for the three months ended March 31, 2015, as compared to the three months ended March 31, 2014. The increase in payroll and related costs was primarily due to our increase in employees during the three months ended March 31, 2015, as compared to the same period in 2014. Consulting expenses for our third-party developers located in Ukraine and Argentina decreased by $201,000 and outsourced data services decreased by $99,000 due to the timing of our development efforts for our existing and new solutions.

Sales and marketing

Sales and marketing expenses consist of costs for our sales and marketing personnel, including salaries, benefits, bonuses, stock-based compensation and sales commissions, costs of marketing and promotional events, corporate communications, online marketing, product marketing and management and other brand-building activities, travel expense and allocated overhead. Sales commissions are generally earned and recorded as expense when the customer order has been received, which may precede recognition of the associated revenue. We expect sales and marketing expenses to increase in absolute dollars as we expand our business both domestically and internationally, although they may fluctuate as a percentage of revenue.

Comparison of three months ended March 31, 2015 and 2014

Sales and marketing expenses increased by $1.6 million, or 15%, during the three months ended March 31, 2015 as compared to the three months ended March 31, 2014. The increase was attributable to an increase in spending on sales related costs of $788,000 and marketing and business-development related costs of $812,000 as we continued to invest in building our brand as well as our sales force. The increase in sales-related costs was due to an increase in payroll-related expenses, including commissions, of $633,000 due to our increased headcount and an increase of $240,000 related to the Company’s sales events. These increases were partially offset by a decrease in travel expense of $90,000. The marketing increases were due primarily to an increase of $874,000 in payroll and related expenses. The increase in payroll and related expenses was partially offset by a $159,000 decrease in hiring expenses.

 

23


Table of Contents

General and administrative

General and administrative expenses consist primarily of costs for administrative, finance, legal and human resource personnel, including salaries, benefits, bonuses and stock-based compensation, professional fees, insurance premiums, other corporate expenses and allocated overhead. General and administrative expenses also include the re-valuing of our contingent liability associated with any earn-out we may be required to pay in connection with the Validus acquisition. We measure the liability at each balance sheet date based on revenue earned to date from the acquired Validus product (now our Imprivata Cortext solution) and our projections of revenues from sales of Imprivata Cortext. We expect our general and administrative expenses to continue to increase in absolute dollars as a result of being a public company, although they may fluctuate as a percentage of revenue. We expect additional general and administrative expenses to include increased personnel costs, insurance costs, costs required to comply with the regulatory requirements of the SEC, as well as costs associated with enhancing our internal controls and accounting systems.

Comparison of three months ended March 31, 2015 and 2014

General and administrative expenses increased by $1.6 million, or 52%, during the three months ended March 31, 2015 as compared to the three months ended March 31, 2014. The increase was driven by $419,000 in headcount and related expenses as a result of our increased headcount. In addition, we incurred an increase of $426,000 for professional fees and consulting services, primarily due to increased cost as a result of our becoming a public company and transaction costs related to our acquisition of HT Systems, $165,000 for increases in insurance expense as a result of changes in our insurance coverage due to our becoming a public company and $571,000 for corporate events. These increases were partially offset by a decrease of $128,000 in facilities related expenses.

Other income (expense)

Other income (expense) primarily consists of foreign exchange gains (losses), interest income and interest expense. Foreign exchange gains (losses) relate to transactions denominated in currencies other than the functional currency. Interest income represents interest received on our cash and cash equivalents. Interest expense is associated with our capital leases and term loans.

 

     Three Months ended March 31,     Period-to-Period  
     2015     2014     Change  

(dollars in thousands)

   Amount     Amount     $      %  

Foreign currency exchange gain (loss)

   $ (462   $ (131   $ (331      252.7

Percentage of revenue

     -1.8     -0.7     

Interest and other income (expense), net

     (16     (29     13         (44.8 %) 

Percentage of revenue

     -0.1     -0.1     
  

 

 

   

 

 

   

 

 

    

Total other income (expense)

$ (478 $ (160 $ (318   198.8
  

 

 

   

 

 

   

 

 

    

Comparison of three months ended March 31, 2015 and 2014

Other expenses increased by $318,000 during the three months ended March 31, 2015 as compared to three months ended March 31, 2014. The increase was primarily driven by foreign exchange losses due to the strengthening of the U.S. dollar against the Euro and Pound Sterling. We have cash and accounts receivable denominated in the Euro and Pound Sterling as a result of our European operations.

Income tax expense

 

     Three Months ended March 31,     Period-to-Period  
     2015     2014     Change  

(dollars in thousands)

   Amount     Amount     $      %  

Income taxes

   $ 37      $ 26      $ 11         42.3

Percentage of revenue

     0.1     0.1     

 

24


Table of Contents

Comparison of three months ended March 31, 2015 and 2014

We operate in several tax jurisdictions and are subject to taxes in each country or jurisdiction in which we conduct business. Earnings from our activities outside of the United States are subject to local country income tax and may be subject to U.S. income tax. To date, we have incurred cumulative net losses and maintain a full valuation allowance on our net deferred tax assets. Therefore, we have not recorded any U.S. federal tax provisions and our effective tax rate differs from statutory rates. Our tax expense to date primarily relates to foreign income taxes, mainly from our international operations, and to a lesser extent state income tax provisions.

Liquidity and capital resources

Resources

To date, we have financed our operations primarily through the sale of equity securities, including private placements of preferred stock, and net cash proceeds from our IPO, as well as cash from operating activities.

Cash and cash equivalents

As of March 31, 2015, we had $75.4 million of cash and cash equivalents, of which $633,000 was held in our foreign subsidiaries. Our cash is invested in money market funds or in cash deposit accounts, and is held for working capital purposes. We do not enter into investments for trading or speculative purposes.

On June 30, 2014, we completed our IPO, in which we sold 5,750,000 shares of common stock, including 750,000 shares sold pursuant to the underwriters’ option to purchase additional shares, at an offering price of $15.00 per share. We received proceeds from the IPO of $80.2 million, net of underwriting discounts and commissions, but before offering expenses of approximately $3.4 million. As of December 31, 2014, all expenses incurred in connection with the IPO have been paid.

On April 30, 2015, we used approximately $19.1 million in cash as a result of our acquisition of HT Systems.

We believe our cash and cash equivalents, $15.0 million revolving credit agreement and cash flows from operations will be sufficient to meet our working capital and capital expenditure requirements for at least 12 months.

Our net cash flows from operating, investing and financing activities for the years indicated in the table below were as follows:

 

     Three Months Ended March 31,  

(in thousands)

   2015      2014  

Net cash used in operating activities

   $ (3,541    $ (5,705

Net cash used in investing activities

     (371      (655

Net cash provided by (used in) financing activities

     834         (1,080

Effect of exchange rates on cash and cash equivalents

     (69      84   
  

 

 

    

 

 

 

Net decrease in cash and cash equivalents

$ (3,147 $ (7,356
  

 

 

    

 

 

 

Net cash used in operating activities

Cash provided by operating activities consists of significant components of the statement of operations adjusted for changes in various working capital items including accounts receivable, prepaid expenses, accounts payable, and deferred revenue. Cash provided by operating activities is influenced by the investment we make in personnel and infrastructure costs necessary to support the anticipated growth of the business, the increase in the sales of software licenses and renewal of software maintenance contracts as well as the timing of customer payments.

Our cash used in operating activities during the three months ended March 31, 2015 was primarily due to a net loss of $6.7 million adjusted for $1.5 million of non-cash expenses that included $780,000 of depreciation and amortization, $701,000 in stock-based compensation, a loss on disposal of fixed assets of $14,000 and a decrease of $21,000 due to the reduction to the fair value of the contingent purchase price liability. Net decrease in working capital amounted to $1.6 million attributable to decreases in accounts receivable of $6.3 million and an increase in accounts payable of $412,000. These increases were partially offset by a decrease in accrued expenses of $4.1 million, an increase in prepaid expenses and other current assets of $857,000 and a decrease in deferred revenue of $35,000.

 

25


Table of Contents

Net cash used in investing activities

Our primary investing activities have consisted of capital expenditures to purchase computer equipment and furniture and fixtures as well as leasehold improvements to our company headquarters necessary to support the expansion of our infrastructure and workforce. As our business grows, we expect our capital expenditures and our investment activity to continue to increase.

For the three months ended March 31, 2015, cash used in investing activities consisted of purchases of $371,000 of property and equipment, which was primarily driven by the increase in leasehold improvements, computer equipment and furnishings for our corporate headquarters, as well as increases in computer equipment for our increased headcount.

Net cash provided by financing activities

Our primary financing activities have consisted of proceeds from the exercise of stock options as well as proceeds from and payments on equipment debt obligations entered into to finance equipment leases and purchased software costs.

For the three months ended March 31, 2015, cash provided by financing activities primarily consisted of $684,000 proceeds from the closing of the first offering period of the Company’s employee stock purchase plan and $330,000 of proceeds from the exercise of stock options, partially offset by $180,000 in payments in connection with our debt, capital leases and royalty obligations.

Requirements

Capital expenditures

We have made capital expenditures primarily for leasehold improvements and furniture and fixtures related to the expansion of our corporate headquarters, as well as information technology equipment to support our increased headcount, product enhancement and development and our overall growth. Our capital expenditures totaled $371,000 and $655,000 for the three months ended March 31, 2015 and 2014 respectively.

We expect our 2015 capital expenditures be consistent with previous periods presented, primarily related to, equipment to support product development, facility expansions and other general purposes to support our growth.

Contractual obligations and commitments

During the three months ended March 31, 2015, we amended our lease agreement for our corporate headquarters to lease approximately 21,000 of additional square footage. The amendment increased the total square footage leased to approximately 93,000 and extended the term through December 2021. The additional rent expense is approximately $7.9 million over the extended term and the landlord has agreed to contribute approximately $735,000 towards leasehold improvements.

There have been no other significant changes in contractual obligations from those disclosed in the audited consolidated financial statements for the year ended December 31, 2014 included in our Annual Report on Form 10-K filed with the SEC.

Off-balance sheet arrangements

During the periods presented, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

 

Item 3. Quantitative and qualitative disclosures about market risk

We have operations both within the United States and internationally which expose us to market risk. These risks are primarily the result of fluctuation in foreign exchange rates and interest rates, as well as risks relating to changes in the general economic conditions in the countries where we conduct business. We do not use derivative instruments to mitigate the impact of our market risk exposures.

Foreign currency exchange risk

We have foreign currency risks related to our cash, accounts receivable, revenue and operating expenses denominated in currencies other than the U.S. dollar.

We maintain foreign cash accounts denominated in the Euro and British Pound Sterling, to fund our foreign operations and collect foreign accounts receivables. We invoice our customers in the currencies of the countries in which the customer is located. At March 31, 2015, our foreign accounts receivable balances were primarily denominated in the Euro, British Pound Sterling and the Australian Dollar.

 

26


Table of Contents

Our customer contracts are generally denominated in the currencies of the countries in which the customer is located which exposes us to risk associated with sales made in foreign currencies. Our historical revenue has been denominated in U.S. dollars, the Euro and British Pound Sterling. The functional currency for our foreign operations is denominated in the local currency and as a result operating expenses related to our foreign locations are impacted by fluctuations in foreign currency exchange rates. Increases and decreases in our foreign denominated revenue due to fluctuations in foreign currency exchange rates are somewhat offset by the currency fluctuations in our operating expenses that are denominated in foreign currencies

If the foreign currency exchange rates fluctuated by 10% as of March 31, 2015, our foreign currency exchange gain or loss would have fluctuated by $528,000.

Interest rate risk

At March 31, 2015, we had cash and cash equivalents of $75.4 million. We maintain substantially all of our cash equivalents in an institutional money market mutual fund. The fund provides daily liquidity and invests in a portfolio of short-term money market instruments issued by the U.S. government. We do not enter into investments for trading or speculative purposes. Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates.

At March 31, 2015, we had a 2.5 year term loan with a fixed interest rate of 6.5%, associated with the purchase of licenses and associated maintenance with an outstanding balance of $199,000. Changes in interest rates would not have a significant impact on our outstanding borrowing.

 

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Our management, with the participation of our Chief Executive Officer, our principal executive officer, and our Chief Financial Officer, our principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2015, the end of the period covered by this Quarterly Report on Form 10-Q. Based upon such evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such date.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

27


Table of Contents

PART II

 

Item 1. Legal Proceedings

From time to time, we may be involved in lawsuits, claims, investigations and proceedings, consisting of intellectual property, commercial, employment and other matters which arise in the ordinary course of business. We are not currently involved in any material legal proceedings.

 

Item 1A. Risk Factors

These are risks and uncertainties that could cause actual results to differ materially from the results contemplated by the forward-looking statements contained in this Quarterly Report on Form 10-Q. Because of the these factors, as well as other variables affecting our operating results, past financial performance should not be considered as a reliable indicator of future performance and investors should not use historical trends to anticipate results or trends in future periods. These risks are not the only ones facing us. Please also see “SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS” earlier in this Quarterly Report on Form 10-Q. The following discussion highlights certain risks which may affect future operating results. These are the risks and uncertainties we believe are most important for our existing and potential stockholders to consider. Additional risks and uncertainties not presently known to us, which we currently deem immaterial or which are similar to those faced by other companies in our industry or business in general, may also impair our business operations. If any of the following risks or uncertainties actually occurs, our business, financial condition and operating results would likely suffer.

Risks related to our business and industry

We have a history of losses, we expect to continue to incur losses and we may not be profitable in the future.

We incurred a $6.7 million net loss for the three months ended March 31, 2015. As of March 31, 2015, we had an accumulated deficit of $114.3 million and we expect to continue to incur operating and net losses for the foreseeable future. Our ability to be profitable in the future depends upon continued demand for our authentication and access management solutions. In addition, our profitability will be affected by, among other things, our ability to develop and commercialize new solutions, and products for those solutions, and enhance existing solutions and products. Further market adoption of our solutions, including increased penetration within our existing customers, depends upon our ability to improve clinical workflows related to the utilization of healthcare information technology systems and increase clinician productivity. We expect to incur significant operating costs relating to our research and development initiatives for our new and existing solutions and products, and for our expansion of our sales and marketing operations as we add additional sales personnel and increase our marketing efforts. Furthermore, we may incur significant losses in the future for a number of reasons, including the other risks described in this Quarterly Report on Form 10-Q, and we may encounter unforeseen expenses, difficulties, complications, delays and other unknown events. As a result, we cannot assure you that we will be able achieve or sustain profitability in the future.

We depend on sales of our Imprivata OneSign solution in the healthcare industry for a substantial portion of our revenue, and any decrease in its sales would have a material adverse effect on our business, financial condition and results of operations.

A substantial portion of our revenue has been derived from sales of our Imprivata OneSign solution to the healthcare industry. We anticipate that sales of our Imprivata OneSign solution to the healthcare industry will represent a significant portion of our revenue for the foreseeable future. Any decrease in revenue from sales of this solution would have a material adverse effect on our business. Healthcare organizations are currently facing significant budget constraints, increasing demands resulting from a growing number of patients, and impediments to obtaining third-party reimbursements and patient payments for their services. Although healthcare organizations are currently allocating funds for capital and infrastructure improvements to benefit from governmental initiatives, they may not choose to prioritize or implement access or authentication management solutions as part of those efforts at this time, or at all, due to financial and resource constraints. Even if clinicians determine that our Imprivata OneSign solution provides benefits over their existing authentication and access management solutions, their healthcare organizations may not have, or may not be willing to spend, the resources necessary to purchase, install and maintain information technology systems, adopt our Imprivata OneSign solution, add licensed users in other departments or purchase additional products and services from us.

In addition, our healthcare customers have been experiencing consolidation in response to developments generally affecting the healthcare industry. As a result, we may lose existing or potential healthcare customers for our solutions. If our existing customers combine with other healthcare organizations that are not our customers, they may reduce or discontinue their purchases of our solutions. In addition, the combined organizations may have greater leverage in negotiating terms with us, and we may be forced to accept terms that are less favorable to us.

 

28


Table of Contents

We do not anticipate that sales of our solutions in non-healthcare industries will represent a significant portion of our revenue for the foreseeable future. As a result, decreased revenue from sales of our Imprivata OneSign solution in the healthcare industry would have a material adverse effect on our business, financial condition and results of operations.

We may not be able to attract new customers and retain and increase sales to our existing customers, which could have a material adverse effect on our business, financial condition and results of operations.

Our success and growth strategy depends in part upon the purchase of our Imprivata OneSign solution by new customers. Our sales and marketing efforts seek to demonstrate to potential new customers that our solutions streamline clinician workflow and increase productivity, enhance the value of existing investments in healthcare information technology, and help ensure compliance with complex privacy and security regulations. If we are not able to persuade new customers that our solutions provide these benefits, or if we fail to generate sufficient sales leads through our marketing programs, then we will not be able to attract new customers, which would have a material adverse effect on our business, financial condition and results of operations.

In most cases, our customers initially license our solutions for a limited number of departments within a healthcare organization. After the initial sale, our customers frequently add licensed users in other departments, functional groups and sites and buy additional products and services over time. Factors that may affect our ability to retain and increase sales to our existing customers include the quality of our customer service, training and technology, as well as our ability to successfully develop and introduce new solutions and products. Additionally, our customers may stop using our Imprivata OneSign solution or may not renew agreements for services, including software maintenance, for reasons entirely out of our control, such as a reduction in their budgets. If our efforts to satisfy our existing customers are not successful, we may not be able to retain them or sell additional functionality to them, which could have a material adverse effect on our business, financial condition and results of operations.

If we fail to successfully develop and introduce new solutions and products for existing solutions, our business, financial condition and results of operations could be adversely affected.

Our success depends, in part, upon our ability to anticipate industry evolution and introduce or acquire new solutions and products to keep pace with technological developments and market requirements both within our industry and in related industries. However, we may not be able to develop, introduce, acquire and integrate new solutions and products in response to our customers’ changing requirements in a timely manner or on a cost-effective basis, or that sufficiently differentiate us from competing solutions such that customers choose to purchase our solutions. For example, healthcare organizations may shift their existing information technology infrastructure from on-site services to cloud-based services, which may not be compatible with our solutions, requiring us to develop new products or to re-engineer our existing products. In addition, healthcare organizations may adopt mobile applications more quickly than we have anticipated, requiring us to accelerate the development of a mobile version of our authentication and access management solutions. If any of our competitors’ implements new technologies before we are able to implement them or better anticipates the innovation opportunities in related industries, those competitors may be able to provide more effective or more cost-effective solutions than ours. In addition, we may experience technical problems and additional costs as we introduce new solutions, deploy future iterations of our solutions and integrate new solutions with existing customer systems and workflows. If any of these problems were to arise, our business, financial condition and results of operations could be adversely affected.

Developments in the healthcare industry or regulatory environment could adversely affect our business.

Our growth strategy is focused on the healthcare industry and a substantial portion of our revenue is derived from the healthcare industry. This industry is highly regulated and is subject to changing political, legislative, regulatory and other influences. Developments generally affecting the healthcare industry, including new regulations or new interpretations of existing regulations, such as reductions in funding, changes in pricing for healthcare services or impediments to third-party reimbursement for healthcare costs, may cause deterioration in the financial or business condition of our customers and cause them to reduce their spending on information technology. As a result, these developments could adversely affect our business.

In March 2010, comprehensive healthcare reform legislation was enacted in the United States through the Patient Protection and Affordable Health Care for America Act and the Health Care and Education Reconciliation Act. This law is expected to increase health insurance coverage through individual and employer mandates, subsidies offered to lower income individuals, tax credits available to smaller employers and broadening of Medicaid eligibility, and to affect third-party reimbursement levels for healthcare organizations. We cannot predict what effect federal healthcare reform or any future legislation or regulation, or healthcare initiatives, if any, implemented at the state level, will have on us or our healthcare customers.

 

29


Table of Contents

In addition, our healthcare customers’ expectations regarding pending or potential industry developments may also affect their budgeting processes and spending plans with respect to our authentication and access management solutions. The healthcare industry has changed significantly in recent years and we expect that significant changes will continue to occur. However, the timing and impact of developments in the healthcare industry are difficult to predict. We cannot assure you that the markets for our solutions will continue to exist at current levels or that we will have adequate technical, financial and marketing resources to react to changes in those markets.

Seasonal variations in the purchasing patterns of our customers may lead to fluctuations in our operating results and financial condition.

We have experienced and expect to continue to experience seasonal variations in the timing of customers’ purchases of our solutions. Many customers make purchasing decisions based on their fiscal year budgets, which typically coincide with the calendar year and result in increased purchasing in the fourth quarter of the year. Because many of our expenses remain relatively fixed throughout the year, the seasonality of our business requires us to manage our working capital carefully over the course of the year. If we fail to manage our working capital effectively or do not accurately predict customer demand in the fourth quarter of the year, our operating results and financial condition may fluctuate.

Our sales cycles for new customers can be lengthy and unpredictable, which may cause our revenue and operating results to fluctuate significantly.

Our sales cycles for new customers can be lengthy and unpredictable. Our sales efforts involve educating our customers about the use and benefits of our authentication and access management solutions, including demonstrating the potential of our solutions in streamlining clinician workflow and increasing productivity. Customers may undertake a significant evaluation process, involving not only our solutions but also the customer’s existing healthcare information technology infrastructure. This assessment can result in a lengthy and unpredictable sales cycle. In addition, purchases of our solutions are frequently subject to budget constraints, multiple approvals, and unplanned administrative, processing and other delays. We spend substantial time, effort and money in our sales efforts without any assurance that our efforts will produce any sales. In addition, cancellation of any implementation after it has begun might result in lost time, effort, and expenses invested in the cancelled implementation process and lost opportunity for implementing paying customers in that same period of time. These factors may contribute to significant fluctuations in our revenue and operating results.

Our revenue and operating results have fluctuated, and are likely to continue to fluctuate, which may make our quarterly results difficult to predict, cause us to miss analyst expectations and cause the price of our common stock to decline.

Our revenue and operating results may be difficult to predict, even in the near term, and are likely to fluctuate as a result of a variety of factors, many of which are outside of our control. Comparisons of our revenue and operating results on a period-to-period basis may not be meaningful. You should not rely on our past results as an indication of our future performance. Each of the following factors, among others, could cause our revenue and operating results to fluctuate from quarter to quarter:

 

    the financial health of our healthcare customers and budgetary constraints on their ability to purchase authentication and access management solutions;

 

    changes in the regulatory environment affecting our healthcare customers, including impediments to their ability to obtain third-party reimbursement for their services;

 

    our ability to develop and introduce new solutions and products and enhance existing solutions that achieve market acceptance;

 

    the procurement and deployment cycles of our healthcare customers and the length of our sales cycles;

 

    our ability to forecast demand and manage lead times for the manufacture of hardware used in our solutions;

 

    the mix of our product and service revenue and pricing, including discounts by us or our competitors; and

 

    the timing of when orders are fulfilled and revenue is recognized.

The resulting variability and unpredictability could result in our failure to meet our operating plan or the expectations of investors or analysts for any period. If we fail to meet such expectations for these or other reasons, the market price of our common stock may decline.

If we are unable to maintain successful relationships with our channel partners and technology alliance partners, our ability to market, sell and distribute our solutions will be limited and our business, financial condition and results of operations could be adversely affected.

In addition to our direct sales force, we rely on our sales partners, consisting of our channel partners and technology alliance partners, to sell our solutions. We derive a substantial portion of our revenue from sales of our products and services through our sales partners, and we expect that sales through sales partners will continue to be a significant percentage of our revenue. For the three months ended March 31, 2015 and 2014, 8% and 9%, respectively, of our total revenues were derived from our largest sales partner.

 

30


Table of Contents

Our agreements with our sales partners are generally non-exclusive, meaning our sales partners may offer their customers products and services from several different companies, including products and services that compete with ours. We depend on channel partners to supplement our direct sales organization within the United States and internationally. If our channel partners do not effectively market and sell our products and services, choose to use greater efforts to market and sell their own products and services or those of our competitors, or fail to meet the needs of our customers, our ability to grow our business and sell our products and services may be adversely affected. Our channel partners may cease marketing our products and services with limited or no notice and with little or no penalty, and they have no obligation to renew their agreements with us on commercially reasonable terms, or at all. The loss of a substantial number of our channel partners, our possible inability to replace them, or the failure to recruit additional channel partners could materially and adversely affect our results of operations. New channel partners require extensive training and may take several months or more to achieve productivity for us. Our channel partner structure could also subject us to lawsuits or reputational harm if, for example, a channel partner misrepresents the functionality of our platform to customers or violates applicable laws or our corporate policies applicable to the partner. We work with our technology alliance partners to design go-to-market strategies that combine our solutions with products or services provided by our technology alliance partners. The loss of a technology alliance partner may mean that certain of our solutions that were designed to interoperate with the products or services provided by the technology alliance partner may no longer function as intended and require substantial re-engineering or the development of new solutions and products.

Our ability to generate revenue in the future will depend in part on our success in maintaining effective working relationships with our sales partners, in expanding our indirect sales channel, in training our channel partners to independently sell and deploy our solutions and in continuing to integrate our solutions with the products and services offered by our technology alliance partners. If we are unable to maintain our relationships with these sales partners, our business, financial condition and results of operations could be adversely affected.

We depend on sole source suppliers and a contract manufacturer for hardware components of our Imprivata OneSign solution. If we are unable to source our components from them or effectively forecast our customer demand to properly manage our inventory, our business and operating results could be adversely affected.

We depend on sole source suppliers for hardware components of our Imprivata OneSign solution. We rely upon Cross Match Technologies, Inc. (formerly DigitalPersona, Inc.) as the only provider of our fingerprint readers. Although we currently purchase all of our proximity cards from RF IDeas, Inc., we believe alternative sources are available. In addition, we depend on a contract manufacturer to produce certain other hardware components for our solutions. Our agreements with RF IDeas, Inc. and our contract manufacturer renew automatically on an annual basis. These agreements do not contain supply commitments. We purchase our fingerprint readers from Avnet on a purchase order basis, and do not have the benefit of a long-term supply agreement or supply commitments. As a result, we cannot assure you that our suppliers and contract manufacturer will be able to meet our requirements, which could adversely affect our business and operating results.

Any of these suppliers or contract manufacturer could cease production of our components, experience capacity constraints, material shortages, work stoppages, financial difficulties, cost increases or other reductions or disruptions in output, cease operations or be acquired by, or enter into exclusive arrangements with, a competitor. These suppliers and contract manufacturer typically rely on purchase orders rather than long-term contracts with their suppliers. As a result, even if available, an affected supplier or contract manufacturer may not be able to secure sufficient materials at reasonable prices or of acceptable quality to build our components in a timely manner, forcing us to seek components from alternative sources, which may not have the required specifications, or be available in time to meet demand or on commercially reasonable terms, if at all.

We also place orders with our suppliers and contract manufacturer for our inventory based on forecasts of customer demand. Our forecasts are based on multiple assumptions, each of which may introduce errors into our estimates affecting our ability to meet our customers’ demands for our solutions or manage our inventory effectively. We may also be forced to redesign our solutions if a component becomes unavailable in order to incorporate a component from an alternative source, which may increase the cost of providing our solutions. Any of these circumstances could cause interruptions or delays in the delivery of our solutions to our customers, and could adversely affect our business and operating results.

Our use of third-party off-shore development providers could have a material adverse effect on our business, financial condition and results of operations.

Since 2006, we have relied upon a third-party development provider in Lviv, Ukraine to assist with software development, quality assurance, testing and automation to reduce costs and to meet our customers’ needs in a timely manner. These services are performed pursuant to statements of work under a master services agreement. The development provider may terminate its agreement with us without cause with 60 days’ notice, unless a statement of work is in progress. While they have been dependable in the past, we have less control over the development provider’s performance than if it was comprised of our employees or if the development provider was located in the United States. As a result, we are subject to the risk that the development provider will not perform as anticipated. Furthermore, in recent periods, Ukraine has experienced civil unrest and political and economic uncertainties. The evolving economic,

 

31


Table of Contents

political and social developments in the Ukraine may materially and adversely affect the operations of the development provider in ways beyond their control and may constrain our ability to assert or defend our contractual or other legal rights relating to our relationship with the development provider and its handling of our intellectual property. Since June of 2014, we have also relied upon a third-party developer in Buenos Aires, Argentina to assist with software development, quality assurance, testing and automation to reduce costs and to meet our customers’ needs in a timely manner. These services are performed pursuant to statements of work under a master services agreement. The development provider may terminate its agreement with us without cause with 30 days’ notice, unless a statement of work is in progress. We have less control over the development provider’s performance than if it was comprised of our employees or if the development provider was located in the United States. If we are unable to rely upon either of these development provider for the reasons stated above or for other reasons, we may be required to shift development projects to our employees or to another independent contractor. As a result, we may face increased costs and delays in our ability to introduce new solutions or products or provide services. These risks could have a material adverse effect on our business, financial condition and results of operations.

If we are not able to manage our growth effectively, or if our business does not grow as we expect, our operating results will be adversely affected.

We have experienced significant revenue growth in recent periods. For example, our revenue increased from $22.0 million for the year ended December 31, 2009, to $97.0 million for the year ended December 31, 2014. During this period, we significantly expanded our operations and increased the number of our employees from 105 at December 31, 2008 to 403 at March 31, 2015. Our rapid growth has placed, and will continue to place, a significant strain on our management systems, infrastructure and other resources. We plan to hire additional direct sales and marketing personnel domestically and internationally, increase our investment in research and development and acquire complementary businesses, technologies or assets. Our future operating results depend to a large extent on our ability to successfully implement these plans and manage our anticipated expansion. To do so successfully we must, among other things:

 

    manage our expenses in line with our operating plans and current business environment;

 

    maintain and enhance our operational, financial and management controls, reporting systems and procedures;

 

    develop and deliver new solutions and enhancements to existing solutions efficiently and reliably;

 

    manage operations in multiple locations and time zones; and

 

    integrate acquired businesses, technologies or assets.

We expect to incur costs associated with the investments made to support our growth before the anticipated benefits or the returns are realized, if at all. If we are unable to manage our growth effectively, we may not be able to take advantage of market opportunities or develop new solutions or enhancements to existing solutions. We may also fail to satisfy customer requirements, maintain quality, execute our business plan or respond to competitive pressures, which could adversely affect our operating results.

Changes in renewal rates in our software maintenance contracts may not be immediately reflected in our operating results.

We generally recognize revenue from our software maintenance contracts ratably over the contract term. A portion of the maintenance revenue we report in each quarter is derived from the recognition of deferred revenue relating to software maintenance contracts entered into during previous quarters. In each of the years ended December 31, 2014, 2013, 2012, 2011 and the three months ended March 31, 2015, we retained greater than 90% of the aggregate dollar amount of our software maintenance contracts up for renewal. Consequently, a decline in renewed software maintenance by our customers in any one quarter may not be immediately reflected in our revenue for that quarter. Such a decline, however, will adversely affect our revenue in future quarters. Accordingly, the effect of significant downturns in our rate of renewals may not be fully reflected in our operating results until future periods.

We primarily operate in the rapidly evolving and highly competitive healthcare market, and if we fail to effectively respond to competitive pressures, our business, financial condition and operating results could be adversely affected.

The market for authentication and access management solutions within the healthcare market is highly fragmented, consisting of a significant number of vendors that is rapidly changing. Competition in our market is primarily based on:

 

    brand awareness and reputation;

 

    breadth of our solutions set and ease of implementation, use and management;

 

    breadth of product distribution;

 

    strategic relationships and ability to integrate with software and device vendors; and

 

    product innovation and ability to meet customer needs.

 

32


Table of Contents

We believe our primary competitor in the healthcare industry is Caradigm USA LLC, a joint venture of General Electric Company and Microsoft Corporation. We expect competition to intensify in the future with existing competitors and market entrants. Our competitors in the healthcare market for authentication and access management solutions include large, multinational companies with significantly more resources to dedicate to product development and sales and marketing. These companies may have existing relationships within healthcare organizations, which may enhance their ability to gain a foothold in our market. Customers may prefer to purchase a more highly integrated or bundled solution from a single provider or an existing supplier rather than a separate supplier, regardless of performance or features. Increased competition may result in additional pricing pressure, reduced profit margins, higher sales and marketing expenses, lower revenue and the loss of market share, which could adversely affect our business, financial condition and operating results.

The market for secure communications in the healthcare market in which our Cortext solution competes is also highly fragmented, consisting of an increasing number of vendors that is rapidly changing. We believe our primary competitor in secure communications in the healthcare market is TigerText, and we expect competition to intensify in the future with existing competitors and market entrants. As in the healthcare market for authentication and access management solutions, competitors in the healthcare market for secure communications include large, multinational companies with significantly more resources to dedicate to product development and sales and marketing.

Industry consolidation or new market entrants may result in increased competitive pressure, which could result in the loss of customers or a reduction in revenue.

Some of our competitors have made or may make acquisitions or may enter into partnerships or other strategic relationships to offer more comprehensive services than they individually had offered or achieve greater economies of scale. We expect these trends to continue as companies attempt to strengthen or maintain their market positions. For example, potential entrants not currently considered to be our competitors, such as providers of electronic health record systems, may enter our market by acquiring or developing their own access or authentication management solutions. In addition, providers of authentication and access management solutions, such as CA, Inc., International Business Machines Corporation, Oracle Corporation and Novell, Inc., may enter the healthcare market. Such potential entrants, if they enter the healthcare market for authentication and access management solutions, may have competitive advantages over us, such as greater name recognition, longer operating histories, more varied services and larger marketing budgets, as well as greater financial, technical and other resources. The companies resulting from combinations or that expand or vertically integrate their business to include the authentication and access management market that we address may create more compelling service offerings and may offer greater pricing flexibility than we can or may engage in business practices that make it more difficult for us to compete effectively, including on the basis of price, sales and marketing programs, technology or service functionality. These pressures could result in a substantial loss of our customers, which may have a material adverse effect on our business, financial condition and operating results.

Our success depends upon our ability to attract, integrate and retain key personnel, and our failure to do so could adversely affect our ability to grow our business.

Our success depends, in part, on the services of our senior management and other key personnel, and our ability to continue to attract, integrate and retain highly skilled personnel, particularly in engineering, sales and marketing. Competition for highly skilled personnel is intense. If we fail to attract, integrate and retain key personnel, our ability to grow our business could be adversely affected.

The members of our senior management and other key personnel are at-will employees, and may terminate their employment at any time without notice. If they terminate their employment, we may not be able to find qualified individuals to replace them on a timely basis or at all and our senior management may need to divert their attention from other aspects of our business. Former employees may also become employees of a competitor. We may also have to pay additional compensation to attract and retain key personnel. We also anticipate hiring additional engineering, marketing and sales, and services personnel to grow our business. Often, significant amounts of time and resources are required to recruit and train these personnel. We may incur significant costs to attract, integrate and retain them, and we may lose them to a competitor or another company before we realize the benefit of our investments in them.

If we do not achieve the anticipated strategic or financial benefits from our acquisitions, or if we cannot successfully integrate them, our business and operating results could be adversely affected.

We have acquired, and in the future may acquire, complementary businesses, technologies or assets that we believe to be strategic. We may not achieve the anticipated strategic or financial benefits, or be successful in integrating any acquired businesses, technologies or assets. If we cannot effectively integrate newly-acquired technologies and solutions and successfully market and sell these new product offerings, we may not achieve market acceptance for, or significant revenue from, these new product offerings.

 

33


Table of Contents

Integrating newly-acquired businesses, technologies and assets could strain our resources, could be expensive and time consuming, and might not be successful. If we acquire or invest in additional businesses, technologies or assets, we will be further exposed, to a number of risks, including that we may:

 

    experience technical issues as we integrate acquired businesses, technologies or assets into our existing solutions;

 

    encounter difficulties leveraging our existing sales and marketing organizations, and sales channels, to increase our revenue from acquired businesses, technologies or assets;

 

    find that the acquisition does not further our business strategy, that we overpaid for the acquisition or that the economic conditions underlying our acquisition decision have changed;

 

    have difficulty retaining the key personnel of acquired businesses;

 

    suffer disruption to our ongoing business and diversion of our management’s attention as a result of the negotiation of any acquisition as well as related transition or integration issues and the challenges of managing geographically or culturally diverse enterprises; and

 

    experience unforeseen and significant problems or liabilities associated with quality, technology and legal contingencies relating to the acquisition, such as intellectual property or employment matters.

In addition, from time to time we may enter into negotiations for acquisitions that are not ultimately consummated. These negotiations could result in significant diversion of management time, as well as substantial out-of-pocket costs. If we were to proceed with one or more significant acquisitions in which the consideration included cash, we could be required to use a substantial portion of our available cash. To the extent we issue shares of capital stock or other rights to purchase capital stock, including options and warrants, the ownership of existing stockholders would be diluted. In addition, acquisitions may result in the incurrence of debt, contingent liabilities, write-offs or other unanticipated costs, events or circumstances, any of which adversely affect our business and operating results.

The software and hardware contained in the Imprivata OneSign solution is complex and may contain undetected errors that could have a material adverse effect on our business, financial condition and operating results.

Our Imprivata OneSign solution incorporates complex technology, is used in a variety of healthcare settings and must interoperate with many different types of complex devices and information technology systems. While we test our solutions for defects and errors prior to release, we or our customers may not discover a defect or error until after we have deployed our solutions and our customers have commenced general use of the solution. If we cannot successfully integrate our authentication and access management solutions with health information systems as needed or if any hardware or software of these health information systems contains any defect or error, then our solutions may not perform as designed, or may exhibit a defect or error.

Any defects or errors in, or which are attributed to, our solutions, could result in:

 

    delayed market acceptance of our affected solutions;

 

    loss of customers or inability to attract new customers;

 

    diversion of engineering or other resources for remedying the defect or error;

 

    damage to our brand and reputation;

 

    increased service and warranty costs;

 

    legal actions by our customers or third parties, including product liability claims; and

 

    penalties imposed by regulatory authorities.

Our solutions are utilized by clinicians in the course of providing patient care. It is possible that our healthcare customers may allege we are responsible for harm to patients or clinicians due to defects in, the malfunction of, the characteristics of, or the use of, our solutions. Although our customer agreements contain disclaimers of liability that are intended to reduce or eliminate our potential liability, we could be required to spend significant amounts of management time and resources to defend ourselves against product liability, tort, warranty or other claims. If any such claims were to prevail, we could be forced to pay damages or stop distributing our solutions. Even if potential claims do not result in liability to us, investigating and defending against these claims could be expensive and time consuming and could divert management’s attention away from our business. We maintain general liability insurance coverage, including coverage for errors and omissions; however, this coverage may not be sufficient to cover large claims against us or otherwise continue to be available on acceptable terms. Further, the insurer could attempt to disclaim coverage as to any particular claim. Such circumstances could have a material adverse effect on our business, financial condition and results of operations.

 

34


Table of Contents

Our international operations subject us, and may increasingly subject us in the future, to operational, financial, economic and political risks abroad, which could have a material adverse effect on our business, financial condition and results of operations.

Although we currently derive a relatively small portion of our revenue from customers outside of the United States, a key element of our growth strategy is to expand internationally. Our international expansion efforts might not be successful in creating demand for our products and services or in effectively selling our solutions in the international markets we enter. In addition, we will face risks in doing business internationally that could adversely affect our business, including:

 

    difficulties integrating our solutions with information technology systems and processes with which we do not have experience;

 

    political and economic instability in, or foreign conflicts that involve or affect, the countries where we operate and sell our solution;

 

    difficulties in staffing and managing personnel and channel partners;

 

    the need to comply with a wide variety of foreign laws and regulations, including privacy and security regulations, requirements for export controls for encryption technology, employment laws, changes in tax laws and tax audits by government agencies;

 

    competitors who are more familiar with local markets;

 

    challenges associated with delivering services, training and documentation in foreign languages;

 

    difficulties in collecting accounts receivable and longer accounts receivable payment cycles; and

 

    limited or unfavorable intellectual property protection in some countries.

In addition, as we continue to expand our international operations, we have become more exposed to the effects of fluctuations in currency exchange rates. We incur expenses for employee compensation and other operating expenses at our international locations and accept payment from customers in the local currency. Since we conduct business in currencies other than the U.S. dollar but report our operating results in U.S. dollars, we have exposure to fluctuations in currency exchange rates. We do not currently hedge against the risks associated with currency fluctuations but may do so in the future.

Any of these factors could harm our existing international business and operations, and have a material adverse effect on our business, financial condition and results of operations.

Risks posed by sales to foreign government-operated healthcare organizations could have a material adverse effect on our revenues and operating results.

We expect to continue to derive a substantial portion of our international revenues from foreign government-operated healthcare organizations. Sales to governmental entities present risks in addition to those involved in sales to commercial customers, including potential disruption due to changes in appropriation and spending patterns, delays in budget approvals and exposure to penalties in the event of violations of the Foreign Corrupt Practices Act. General political and economic conditions, which we cannot accurately predict, directly and indirectly may affect the quantity and allocation of expenditures by governmental entities. In addition, obtaining government contracts may involve long purchase and payment cycles, competitive bidding, qualification requirements, delays or changes in funding, budgetary constraints, political agendas, extensive specification development and price negotiations and milestone requirements. In general, each governmental entity also maintains its own rules and regulations with which we must comply and which can vary significantly among departments. These factors may result in cutbacks or re-allocations in the budget or losses of government sales, which could have a material adverse effect on our revenues and operating results.

If we fail to offer services that are satisfactory to our customers, our ability to sell our solutions will be adversely affected.

Our ability to sell our Imprivata OneSign solution is dependent upon our ability to provide high-quality services and support. Our services team assists our customers with their clinical workflow design, authentication and access management solution configuration, training and project management during the pre-deployment and deployment stages. Once our solutions are deployed within a customer’s facility, the customer typically depends on our services team to help resolve technical issues, assist in optimizing the use of our solutions and facilitate adoption of new functionality. A substantial proportion of our Imprivata OneSign customers in the United States rely on our Imprivata OneSign solution as a means to access their electronic health record, or EHR, systems that they implement to meet regulatory standards for adoption, or “meaningful use,” of EHR technologies. If our solutions do not adequately facilitate our customers’ attainment of meaningful use requirements as defined by the relevant regulatory authorities and interpreted by our customers, or if deployment of our solutions is unsatisfactory, we may incur significant costs to attain and sustain customer satisfaction. As we hire new services personnel, we may inadvertently hire underperforming people who will have to be replaced, or fail to effectively train such employees. If we do not effectively assist our customers in deploying our solutions, succeed in helping our customers resolve technical and other post-deployment issues, or provide effective ongoing services, our ability to expand the use of our solutions with existing customers and to sell our solutions to new customers will be harmed. In addition, the failure of channel partners to provide high-quality services in markets outside of the United States could adversely affect sales of our solutions internationally.

 

35


Table of Contents

We face potential liability related to the privacy and security of protected health information accessed or collected through our solutions.

Our Imprivata OneSign solution customers in the ordinary course of their business handle, access or store protected health information, or PHI. In the United States, the manner in which these customers manage PHI is subject to the Health Insurance Portability and Accountability Act of 1996, or HIPAA, the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH Act, health data privacy, security and breach notification regulations issued pursuant to these statutes, and state privacy, security and breach notification laws and regulations applicable to such health information. These customers rely on our Imprivata OneSign solution as a tool to facilitate their compliance with applicable health data privacy and security standards. Specifically, HIPAA-covered health care providers are required to implement technical data security safeguards, certain of which are supported by Imprivata OneSign. The failure of our Imprivata OneSign solution to perform an essential function for which it was designed could result in a breach of our obligations under our customer contracts, which could result in monetary damages, adverse publicity, and have an adverse impact on our business.

We may also directly handle, access or store PHI in connection with our commercial solutions, such as our Imprivata Cortext solution, which is a secure, cloud-based communication platform that provides healthcare organizations and healthcare providers with secure SMS texting and messaging capabilities. Although we are transmitting and storing PHI in encrypted format for such customers, and do not, in the ordinary course of our business, require access to such PHI, we are deemed to be a “business associate” of such customers and as such are directly subject to certain HIPAA and HITECH Act requirements as well as contractual obligations that may be imposed by our customers pursuant to their HIPAA and HITECH Act requirements. These statutes, regulations and contractual obligations impose numerous requirements regarding the use and disclosure of PHI. Our failure to effectively implement the required or addressable health data privacy and security safeguards and breach notification procedures, our failure to accurately anticipate the application or interpretation of these statutes, regulations and contractual obligations as we develop our solutions or an allegation that defects in our products have resulted in noncompliance by our customers could result in a breach of our contractual obligations to our customers, create material civil and/or criminal liability for us, which could result in adverse publicity and have a material adverse effect on our business.

In addition to complying with applicable U.S. law, the use and disclosure of PHI is subject to regulation in other jurisdictions in which we do business or expect to do business in the future. Those jurisdictions may attempt to apply such laws extraterritorially or through treaties or other arrangements with U.S. governmental entities. We might unintentionally violate such laws, such laws may be modified and new laws may be enacted in the future which may increase the chance that we violate them. Any such developments, or developments stemming from enactment or modification of other laws, or the failure by us to comply with their requirements or to accurately anticipate the application or interpretation of these laws, could discourage us from offering certain of our solutions, such as Imprivata Cortext, to customers outside of the United States, and could create material liability to us, result in adverse publicity and adversely affect our business. A finding that we have failed to comply with applicable laws and regulations regarding the collection, use and disclosure of PHI could create liability for us, result in adverse publicity and materially adversely affect our business.

In addition, the costs of compliance with, and the other burdens imposed by, these and other laws or regulatory actions may prevent us from selling our solutions or increase the costs associated with selling our solutions, and may affect our ability to invest in or jointly develop solutions in the United States and in foreign jurisdictions. Further, we cannot assure you that our privacy and security policies and practices will be found sufficient to protect us from liability or adverse publicity relating to the privacy and security of PHI.

Fluctuating economic conditions could have a material adverse effect on our business, financial condition and results of operations.

Our revenue depends significantly on general economic conditions and the demand for authentication and access management solutions in the healthcare market. Our healthcare customers may experience declining revenues from the decreased utilization of healthcare services and diminishing margins due to impediments in obtaining third-party reimbursement and patient payments. These factors may result in constrained spending on authentication and access management solutions. General economic weakness may also lead to longer collection cycles for payments due from our customers, an increase in customer bad debt, restructuring initiatives and associated expenses, and impairment of investments. Uncertainty about future economic conditions also makes it difficult to forecast operating results and to make decisions about future investments. Such factors could make it difficult to accurately forecast our sales and operating results and could adversely affect our ability to provide accurate forecasts to our suppliers and contract manufacturer and manage our supplier and contract manufacturer relationships and other expenses. Economic weakness faced by us or our customers, failure of our customers and markets to recover from such weakness, customer financial difficulties, and reductions in spending on authentication and access management technologies could have a material adverse effect on demand for our solutions and consequently on our business, financial condition and results of operations.

 

36


Table of Contents

The market size estimates we have provided publicly may prove to be inaccurate and may not be indicative of our future growth.

The healthcare industry is in the early stages of market acceptance of authentication and access management solutions. Because of rapid and significant technological changes, it is difficult to predict the size of the market and the rate at which the market for our products and services will grow or be accepted. While the estimates of the total available market we have provided publicly are made in good faith and are based on assumptions and estimates we believe to be reasonable, these estimates may not prove to be accurate. This is particularly the case with respect to estimating the size of the international component of the market.

Our Imprivata Cortext solution uses a third-party data service provider for web hosting services. Any operational delay or failure of our Cortext solution could expose us to litigation, harm our relationships with customers and have a material adverse effect on our brand and our business.

Our Imprivata Cortext solution utilizes a cloud-based third-party data service provider for web hosting services. We exercise limited control over this third-party data service provider, which increases our vulnerability with respect to the technology and information services it provides. In addition, if we are unable to renew the agreement with the third-party data service provider on commercially reasonable terms, we may be required to transfer our services to new data service providers and we may incur significant costs and possible service interruption in connection with doing so. Our Cortext solution provides communication and information to assist healthcare organizations. Any operational delay or failure of our Cortext solution might result in the disruption of patient care and could harm our relationships with customers, expose us to litigation or have a material adverse effect on our brand and our business.

We anticipate that sales of our Imprivata Confirm ID solution will be driven primarily by legislation requiring that prescriptions be sent electronically. Failure or delay in the enactment of such laws could cause sales of our Imprivata Confirm ID to be adversely affected.

Our Imprivata Confirm ID solution simplifies healthcare providers’ compliance with laws requiring electronic prescribing of controlled substances (“EPCS”), and helps healthcare providers address workflow inefficiencies and the potential for fraud associated with paper-based prescriptions. Consequently, we anticipate that sales of Imprivata Confirm ID will be driven primarily by the adoption of state and federal mandates requiring that prescriptions be sent electronically. For example, New York’s I-STOP (Internet System for Tracking Over-Prescribing) law mandates that all patient medications be prescribed electronically. The deadline for prescribers to comply with I-STOP is March 27, 2016. If other states fail to enact legislation requiring that prescriptions be sent electronically or if existing requirements for electronic prescriptions are scaled-back, our ability to sell Imprivata Confirm ID solution may be adversely affected.

The mix of revenue from sales of our subscription-based products and our perpetual software products may result in revenue fluctuations, which may make our quarterly results difficult to predict, cause us to miss analyst expectations, and cause the price of our common stock to decline.

The timing of revenue recognition for our products licensed on a perpetual basis will differ in the event our customers elect to purchase both perpetual and subscription-based products together. Revenue for our perpetual software products is generally recognized upon shipment. If our perpetual software products are sold in a multiple element arrangement with subscription-based products, the revenue associated with the perpetual license will likely be recognized over the period of the subscription to the extent we are unable to determine the vendor specific objective evidence of fair value of undelivered software products. As a result, our revenue and operating results may be difficult to predict, and are likely to fluctuate based on factors, many of which are outside of our control. The resulting variability and unpredictability could result in our failure to meet the expectations of investors or analysts for any period, which could cause the price of our common stock to decline.

If we are required to collect sales and use or similar foreign taxes in additional jurisdictions, we might be subject to liability for past sales and our future sales may decrease.

We might lose sales or incur significant expenses if states or foreign jurisdictions successfully impose broader guidelines on state sales and use or similar foreign taxes. A successful assertion by one or more states or foreign jurisdictions requiring us to collect sales or other taxes on the licensing of our software or sale of our services could result in substantial tax liabilities for past transactions and otherwise harm our business. Each state or foreign jurisdiction has different rules and regulations governing sales and use or similar foreign taxes, and these rules and regulations are subject to varying complex interpretations that change over time. We review these rules and regulations periodically and, when we believe we are subject to sales and use or similar foreign taxes in a particular state or foreign jurisdiction, engage tax authorities in order to determine how to comply with their rules and regulations. We cannot assure you that we will not be subject to sales and use or similar taxes or related penalties for past sales in states or foreign jurisdictions where we currently believe no such taxes are required.

Vendors of products and services, like us, are typically held responsible by taxing authorities for the collection and payment of any applicable sales and similar taxes. If one or more taxing authorities determines that taxes should have, but have not, been paid with respect to our services, we might be liable for past taxes in addition to taxes going forward. Liability for past taxes might also include substantial interest and penalty charges. Our customer contracts typically provide that our customers must pay all applicable sales and similar taxes. Nevertheless, our customers might be reluctant to pay back taxes and might refuse responsibility for interest or penalties associated with those taxes. If we are required to collect and pay back taxes and the associated interest and penalties, and if our clients fail or refuse to reimburse us for all or a portion of these amounts, we will incur unplanned expenses that may be substantial.

 

37


Table of Contents

Moreover, imposition of such taxes on us going forward will effectively increase the cost of our products and services to our customers and might adversely affect our ability to retain existing customers or to gain new customers in the areas in which such taxes are imposed.

Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations.

In general, under Section 382 of the Internal Revenue Code of 1986, as amended, or the Code, a corporation that undergoes an “ownership change” is subject to limitations on its ability to utilize its pre-change net operating losses, or NOLs, to offset future taxable income. If we undergo an ownership change, our ability to utilize NOLs could be further limited by Section 382 of the Code. Future changes in our stock ownership, some of which are outside of our control, could result in an ownership change under Section 382 of the Code. Furthermore, our ability to utilize NOLs of companies that we may acquire in the future may be subject to limitations. There is also a risk that due to regulatory changes, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could expire or otherwise be unavailable to offset future income tax liabilities. For these reasons, we may not be able to utilize a material portion of the NOLs reflected on our balance sheet, even if we attain profitability.

Our business is subject to the risks of earthquakes, fire, floods and other natural catastrophic events, and to interruption by man-made problems such as power disruptions or terrorism.

A significant natural disaster, such as an earthquake, fire or a flood, occurring at our headquarters, our other facilities or where our contract manufacturer or its suppliers are located, could harm our business, operating results and financial condition. In addition, acts of terrorism could cause disruptions in our business, the businesses of our customers and suppliers, or the economy as a whole. We also rely on information technology systems to communicate among our workforce located worldwide, and in particular, our senior management, general and administrative, and research and development activities that are coordinated with our corporate headquarters in the Boston, Massachusetts area and Santa Cruz, California and San Francisco, California offices. Any disruption to our internal communications, whether caused by a natural disaster or by man-made problems, such as power disruptions, in the Boston, Massachusetts area and Santa Cruz, California and San Francisco, California offices could delay our research and development efforts, cause delays or cancellations of customer orders or delay deployment of our solutions, which could have a material adverse effect on our business, operating results and financial condition.

Our loan agreement contains operating and financial covenants that may restrict our business and financing activities.

We are party to a loan and security agreement relating to a revolving line of credit facility with Silicon Valley Bank. Borrowings under this loan and security agreement are secured by substantially all of our assets. Our loan and security agreement restricts our ability to:

 

    incur additional indebtedness;

 

    redeem subordinated indebtedness;

 

    create liens on our assets;

 

    enter into transactions with affiliates;

 

    make investments;

 

    sell assets;

 

    make material changes in our business or management;

 

    pay dividends, other than dividends paid solely in shares of our common stock, or make distributions on and, in certain cases, repurchase our stock; or

 

    consolidate or merge with other entities.

In addition, our revolving line of credit requires us to maintain specified adjusted quick ratio tests. The operating and financial restrictions and covenants in the loan and security agreement governing our revolving line of credit, as well as any future financing agreements that we may enter into, may restrict our ability to finance our operations, engage in business activities or expand or fully pursue our business strategies. Our ability to comply with these covenants may be affected by events beyond our control, and we may not be able to meet those covenants. A breach of any of these covenants could result in a default under the loan and security agreement, which could cause all of the outstanding indebtedness under the facility to become immediately due and payable and terminate all commitments to extend further credit.

If we are unable to generate sufficient cash available to repay our debt obligations when they become due and payable, either when they mature or in the event of a default, we may not be able to obtain additional debt or equity financing on favorable terms, if at all, which may negatively impact our ability to continue as a going concern.

 

38


Table of Contents

Risks related to our intellectual property

If we are unable to protect our intellectual property rights, our competitive position could be harmed or we could be required to incur significant expenses to enforce our rights.

Our success depends, in part, on our ability to protect our proprietary technology. We seek to protect our proprietary technology through patent, copyright, trade secret and trademark laws in the United States and similar laws in other countries. We also seek to protect our proprietary technology through licensing agreements, nondisclosure agreements and other contractual provisions. These protections may not be available in all cases or may be inadequate to prevent our competitors from copying, reverse engineering or otherwise obtaining and using our technology, proprietary rights or solutions in an unauthorized manner. The laws of some foreign countries may not be as protective of intellectual property rights as those in the United States, and mechanisms for enforcement of intellectual property rights may be inadequate. In addition, third parties may seek to challenge, invalidate or circumvent our patents, trademarks, copyrights and trade secrets, or applications for any of the foregoing. Our competitors may independently develop technologies that are substantially equivalent, or superior, to our technology or design around our proprietary rights. In each case, our ability to compete could be significantly impaired.

To prevent unauthorized use of our intellectual property rights, it may be necessary to prosecute actions for infringement or misappropriation of our proprietary rights. Any such action could result in significant costs and diversion of our resources and management’s attention, and there can be no assurance that we will be successful in such action. Furthermore, many of our current and potential competitors have the ability to dedicate substantially greater resources to enforce their intellectual property rights than we do. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing or misappropriating our intellectual property. While we plan to continue to seek to protect our intellectual property with, among other things, patent protection, there can be no assurance that:

 

    current or future U.S. or foreign patent applications will be approved;

 

    our issued patents will adequately protect our intellectual property and not be held invalid or unenforceable if challenged by third parties;

 

    we will succeed in protecting our technology adequately in all key jurisdictions in which we or our competitors operate; and

 

    others will not design around any patents that may be issued to us.

Our failure to obtain patents sufficiently broad to cover our technology and possible workarounds, or the invalidation of our patents, or our inability adequately to protect our intellectual property, may weaken our competitive position and harm our business and operating results. We might be required to spend significant resources to monitor and protect our intellectual property rights. We may initiate claims or litigation against third parties for infringement of our proprietary rights or to establish the validity of our proprietary rights. Any litigation, whether or not it is resolved in our favor, could result in significant expense to us and divert the efforts of our technical and management personnel, which may harm our business, operating results and financial condition.

Agreements we have with our employees, consultants and independent contractors may not afford adequate protection for our trade secrets, confidential information and other proprietary information.

In addition to patent protection, we also rely on copyright and trademark protection, trade secrets, know-how, continuing technological innovation and licensing opportunities. In an effort to maintain the confidentiality and ownership of our trade secrets and proprietary information, we require our employees, consultants and independent contractors to execute confidentiality and proprietary information agreements. However, these agreements may not provide us with adequate protection against improper use or disclosure of confidential information and available remedies in the event of unauthorized use or disclosure may not be adequate. The failure by employees, consultants or independent contractors to maintain the secrecy of our confidential information may compromise or prevent our ability to maintain trade secrets or obtain needed or meaningful patent protection. In some situations, our confidentiality and proprietary information agreements may conflict with, or be subject to, the rights of third parties with whom our employees, consultants or independent contractors have prior employment or consulting relationships. Although we require our employees, consultants and independent contractors to maintain the confidentiality of all proprietary information of their previous employers, these individuals, or we, may be subject to allegations of trade secret misappropriation or other similar claims as a result of their prior affiliations. Finally, others may independently develop substantially equivalent proprietary information and techniques or gain access to our trade secrets. Our failure or inability to protect our proprietary information and techniques may inhibit or limit our ability to compete effectively, or exclude certain competitors from the market.

We may not be able to obtain or maintain necessary licenses of third-party technology on commercially reasonable terms, or at all, which could delay product sales and development and have a material adverse effect on product quality and our ability to compete.

We have incorporated third-party licensed technology into certain of our solutions. We anticipate that we are also likely to need to license additional technology from third parties in connection with the development of new solutions or enhancements in the future.

 

39


Table of Contents

Third-party licenses may not be available to us on commercially reasonable terms, or at all. The inability to retain any third-party licenses required in our current solutions or to obtain any new third-party licenses to develop new solutions and products could require us to obtain substitute technology of lower quality or performance standards or at greater cost, and delay or prevent us from introducing these solutions or products, any of which could have a material adverse effect on product quality and our ability to compete.

Claims of intellectual property infringement could harm our business.

Vigorous protection and pursuit of intellectual property rights has resulted in protracted and expensive litigation for many companies in our industry. Although claims of this kind have not materially affected our business to date, there can be no assurance such claims will not arise in the future. Any claims or proceedings against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time, result in the diversion of significant operational resources, or require us to enter into royalty or licensing agreements, any of which could harm our business and operating results.

Intellectual property lawsuits are subject to inherent uncertainties due to the complexity of the technical issues involved, and we cannot be certain that we will be successful in defending ourselves against intellectual property claims. In addition, we may not be able to effectively utilize our intellectual property portfolio to assert defenses or counterclaims in response to patent infringement claims or litigation brought against us by third parties. Further, litigation may involve patent holding companies or other adverse patent owners who have no relevant products and against whom our potential patents may provide little or no deterrence.

Many potential litigants have the capability to dedicate substantially greater resources to enforce their intellectual property rights and to defend claims that may be brought against them. Furthermore, a successful claimant could secure a judgment that requires us to pay substantial damages or prevents us from distributing certain solutions or performing certain services. We might also be required to seek a license and pay royalties for the use of such intellectual property, which may not be available on commercially acceptable terms or at all. Alternatively, we may be required to develop non-infringing technology, which could require significant effort and expense and may ultimately not be successful.

Our use of open source and non-commercial software components could impose risks and limitations on our ability to commercialize our solutions.

Our solutions contain software modules licensed under open source and other types of non-commercial licenses. We also may incorporate open source and other licensed software into our solutions in the future. Use and distribution of such software may entail greater risks than use of third-party commercial software, as licenses of these types generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. Some of these licenses require the release of our proprietary source code to the public if we combine our proprietary software with open source software in certain manners. This could allow competitors to create similar products with lower development effort and time and ultimately result in a loss of sales for us.

The terms of many open source and other non-commercial licenses have not been interpreted by U.S. courts, and there is a risk that such licenses could be construed in a manner that could impose unanticipated conditions or restrictions on our ability to commercialize our solutions. In such event, in order to continue offering our solutions, we could be required to seek licenses from alternative licensors, which may not be available on a commercially reasonable basis or at all, to re-engineer our solutions or to discontinue the sale of our solutions in the event we cannot obtain a license or re-engineer our solutions on a timely basis, any of which could harm our business and operating results. In addition, if an owner of licensed software were to allege that we had not complied with the conditions of the corresponding license agreement, we could incur significant legal costs defending ourselves against such allegations. In the event such claims were successful, we could be subject to significant damages, be required to disclose our source code, or be enjoined from the distribution of our solutions.

Risks related to our common stock

We do not currently intend to pay dividends on our common stock and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock.

We have never declared or paid any cash dividends on our common stock and do not currently intend to do so for the foreseeable future. We currently intend to invest our future earnings, if any, to fund our growth. Therefore, you are not likely to receive any dividends on your common stock for the foreseeable future, and the success of an investment in shares of our common stock will depend upon future appreciation in its value, if any. There is no guarantee that shares of our common stock will appreciate in value or even maintain the price at which our stockholders purchased their shares.

 

40


Table of Contents

Market volatility may affect our common stock price and the value of your investment:

The market price of shares of our common stock could be subject to wide fluctuations as a result of many risks listed in this section, and others beyond our control, including:

 

    our operating performance and the operating performance of similar companies;

 

    the overall performance of the equity markets;

 

    announcements by us or our competitors of new products, commercial relationships or acquisitions;

 

    threatened or actual litigation;

 

    changes in laws or regulations relating to the healthcare industry;

 

    any major change in our board of directors or management;

 

    publication of research reports or news stories about us, our competitors, or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts;

 

    large volumes of sales of our shares of common stock by existing stockholders; and

 

    general political and economic conditions.

In addition, the stock market in general, and the market for healthcare information technology companies in particular, has at times experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies.

Securities class action litigation has often been instituted against companies following periods of volatility in the overall market and in the market price of a company’s securities. This litigation, if instituted against us, could result in substantial costs, divert our management’s attention and resources, and harm our business, operating results and financial condition.

Future sales of shares of our common stock by existing stockholders could depress the market price of our common stock.

There are 24,014,778 shares of our common stock outstanding, based on the number of shares outstanding as of March 31, 2015. An aggregate of 2,122,083 shares of our common stock are reserved for future issuance under our stock option plans, and 627,033 shares of our common stock are reserved for future issuance under our ESPP. These shares can be freely sold in the public market upon issuance. If a large number of these shares are sold in the public market, the sales could reduce the trading price of our common stock.

The concentration of our capital stock ownership with insiders will likely limit your ability to influence corporate matters.

Our executive officers, directors, current 5% or greater stockholders and entities affiliated with any of them, together beneficially own 63.9% of our common stock outstanding, based on the number of shares outstanding as of March 31, 2015. These stockholders, if they act together, will have significant influence over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, and may take actions that may not be in the best interests of our other stockholders. This concentration of ownership could also limit stockholders’ ability to influence corporate matters. Accordingly, corporate actions might be taken even if other stockholders oppose them, or may not be taken even if other stockholders view them as in the best interests of our stockholders. This concentration of ownership may have the effect of delaying or preventing a change of control of our company, may make the approval of certain transactions difficult or impossible without the support of these stockholders and might adversely affect the market price of our common stock.

We are an “emerging growth company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.

We are an “emerging growth company.” We will remain an emerging growth company until the earliest of: the end of the fiscal year in which the market value of our common stock that is held by non-affiliates exceeds $700 million as of June 30 of that fiscal year, the end of the fiscal year in which we have total annual gross revenue of $1 billion or more during such fiscal year, the date on which we issue more than $1 billion in non-convertible debt securities in a three-year period, or the last day of the fiscal year following the fifth anniversary of this offering.

Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.

 

41


Table of Contents

We are taking advantage of exemptions from various other requirements that are available to emerging growth companies, including, but not limited to, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved, and exemptions from the requirements of auditor attestation reports on the effectiveness of our internal control over financial reporting. We cannot predict whether investors will find our common stock less attractive to the extent we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.

We are subject to financial and other reporting and corporate governance requirements that may be difficult for us to satisfy. Corporate governance and public disclosure regulations may result in additional expenses and continuing uncertainty.

As a public company, we are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, and the rules and regulations of the New York Stock Exchange, which will impose significant compliance obligations upon us, particularly after we are no longer an emerging growth company. These obligations will require a commitment of additional resources and divert our senior management’s time and attention from our day-to-day operations. We may not be successful in complying with these obligations, and compliance with these obligations will be time-consuming and expensive.

The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing the costly process of implementing and testing our systems to report our results as a public company, to continue to manage our growth and to implement internal controls. We are and will continue to be required to implement and maintain various other control and business systems related to our equity, finance, treasury, information technology, other recordkeeping systems and other operations. As a result of this implementation and maintenance, management’s attention may be diverted from other business concerns, which could adversely affect our business.

In addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.

If securities or industry analysts do not publish research or reports about our business, or publish inaccurate or unfavorable research or reports about our business, our stock price and trading volume could decline.

The trading market for our common stock will, to some extent, depend on the research and reports that securities or industry analysts publish about us and our business. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade our common stock or change their opinion of our common stock, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline.

Our charter documents and Delaware law could discourage, delay or prevent a change of control of our company or change in our management that stockholders consider favorable and cause our stock price to decline.

Certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws and Delaware law could discourage, delay or prevent a change of control of our company or change in our management that the stockholders of our company consider favorable. These provisions:

 

    authorize the issuance of “blank check” preferred stock that our board of directors could issue to increase the number of outstanding shares and to discourage a takeover attempt;

 

    prohibit stockholder action by written consent, requiring all stockholder actions to be taken at a meeting of stockholders;

 

    establish advance notice procedures for nominating candidates to our board of directors or proposing matters that can be acted upon by stockholders at stockholder meetings;

 

    limit the ability of our stockholders to call special meetings of stockholders;

 

42


Table of Contents
    prohibit stockholders from cumulating their votes for the election of directors;

 

    permit newly-created directorships resulting from an increase in the authorized number of directors or vacancies on our board of directors to be filled only by majority vote of our remaining directors, even if less than a quorum is then in office;

 

    provide that our board of directors is expressly authorized to make, alter or repeal our amended and restated bylaws;

 

    establish a classified board of directors so that not all members of our board are elected at one time;

 

    provide that our directors may be removed only for “cause” and only with the approval of the holders of at least 75% of our outstanding stock; and

 

    require super-majority voting to amend certain provisions in our amended and restated certificate of incorporation and amended and restated bylaws.

Section 203 of the Delaware General Corporation Law, which will apply to us, may also discourage, delay or prevent a change of control of our company.

We may not be able to obtain capital when desired on favorable terms, if at all, or without dilution to our stockholders.

We may need additional financing to execute on our current or future business strategies, including to:

 

    hire additional personnel;

 

    develop new or enhance existing products and services;

 

    expand our operating infrastructure;

 

    acquire businesses or technologies; or

 

    otherwise respond to competitive pressures.

If we incur additional funds through debt financing, a substantial portion of our operating cash flow may be dedicated to the payment of principal and interest on such indebtedness, thus limiting funds available for our business activities. We cannot assure you that additional financing will be available on terms favorable to us, or at all. If adequate funds are not available or are not available on acceptable terms when we desire them, our ability to fund our operations, take advantage of unanticipated opportunities, develop or enhance our products and services, or otherwise respond to competitive pressures would be significantly limited. If we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our stockholders could be significantly diluted, and these newly-issued securities may have rights, preferences or privileges senior to those of existing stockholders.

 

43


Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Recent Sales of unregistered securities

None.

Use of proceeds

On June 30, 2014, we closed our IPO of 5,750,000 shares of common stock, including 750,000 shares of common stock sold pursuant to the underwriters’ option to purchase additional shares, at a public offering price of $15.00 per share, for aggregate gross proceeds to us of $86.3 million. All of the shares issued and sold in the IPO were registered under the Securities Act of 1933 pursuant to a registration statement on Form S-1 (File No.333-194921), which was declared effective by the SEC on June 24, 2014. Following the sale of the shares in connection with the closing of our IPO, the offering terminated. The managing underwriters for the offering were J.P. Morgan and Piper Jaffray.

The net offering proceeds to us, after deducting underwriting discounts totaling approximately $6.0 million and offering expenses totaling approximately $3.4 million, were approximately $76.8 million. No offering expenses were paid directly or indirectly to any of our directors or officers (or their associates) or persons owning ten percent or more of any class of our equity securities or to any other affiliates. At December 31, 2014, all expenses incurred in connection with the offering have been paid.

During the three months ended March 31, 2015, we used $1.4 million of our offering proceeds for working capital purposes. There has been no material change in the use of proceeds from our IPO as described in our prospectus filed with the SEC pursuant to Rule 424(b)(4).

 

Item 3. Defaults Upon Senior Securities.

None.

 

Item 4. Mine Safety Disclosures.

Not Applicable.

 

Item 5. Other Information.

On April 27, 2015, the Company amended its revolving credit facility to extend the maturity through April 2016 and increase the borrowing limit from $10.0 million to $15.0 million, which is based primarily on accounts receivable. The revolving credit facility is subject to certain financial covenants requiring the Company to maintain minimum levels of liquidity. The foregoing is only a summary of the material terms of the Loan Modification Agreement, does not purport to be a complete description of the rights and obligations of the parties thereunder, and is qualified in its entirety by reference to the Loan Modification Agreement. The Loan Modification Agreement is filed as Exhibit 10.9 to this Quarterly Report on Form 10-Q.

 

Item 6. Exhibits.

The exhibits filed as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index, which is incorporated herein by reference.

 

44


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

IMPRIVATA, INC.
DATED: May 8, 2015 By:

/s/ Jeff Kalowski

Chief Financial Officer
Principal Financial Officer and Duly Authorized
Signatory

 

45


Table of Contents

Exhibit Index

 

Exhibit

No

  

Description

  3.1    Amended and Restated Certificate of Incorporation of the Company, effective June 30, 2014 (incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 1 to Registration Statement on Form S-1, filed on June 11, 2014).
  3.2    Amended and Restated Bylaws of the Company, effective June 30, 2014 (incorporated by reference to Exhibit 3.4 to the Company’s Amendment No. 1 to Registration Statement on Form S-1, filed on June 11, 2014).
  4.1    Form of Common Stock Certificate of the Company (incorporated by reference to Exhibit 4.1 to the Company’s Amendment No. 1 to Registration Statement on Form S-1, filed on June 11, 2014.
10.7*    Eighth Amendment to the Office Lease Agreement by and between the Registrant and Normandy Lexington Acquisition, LLC on January16, 2015.
10.8*    Fifth Loan Modification Agreement to the Loan and Security Agreement by and between the Registrant and Silicon Valley Bank on February 19, 2015.
10.9*    Sixth Loan Modification Agreement to the Loan and Security Agreement by and between the Registrant and Silicon Valley Bank on April 27, 2015.
31.1*    Certification of Chief Executive Officer, pursuant to Rule 13a-14(a) or 15(d)-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*    Certification of Chief Financial Officer, pursuant to Rule 13a-14(a) or 15(d)-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**    Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101*    The following materials from the Company’s Form 10-Q for the three months ended March 31, 2015, formatted in eXtensible Business Reporting Language (XBRL): (i) Consolidated Statements of Operations, (ii) Consolidated Statements of Comprehensive Loss, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements (Unaudited).

 

* Filed herewith
** The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.
*** Users of this data are advised that, pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under these sections.

 

46

EX-10.7 2 d899224dex107.htm EX-10.7 EX-10.7

Exhibit 10.7

EIGHTH AMENDMENT

THIS EIGHTH AMENDMENT(the “Eighth Amendment”) is made and entered into as of the 16th day of January 2015 (the “Execution Date”), by and between NORMANDY LEXINGTON ACQUISITION, LLC, a Delaware limited liability company (“Landlord”), and IMPRIVATA, INC., a Delaware corporation (“Tenant”).

RECITALS

A. Landlord and Tenant are parties to that certain office lease agreement dated April 24, 2007, which lease has been previously amended by a First Amendment dated as of January 14, 2009, a Second Amendment to Lease dated as of April 16, 2010 (“Second Amendment”), a Third Amendment to Lease dated as of March 2, 2012, a related Right of First Offer Letter dated October 29, 2012 (“Right of First Offer Letter”), a Fourth Amendment dated as of December 28, 2012 (“Fourth Amendment”), a Fifth Amendment dated August 12, 2013 (“Fifth Amendment”), a Sixth Amendment to Lease dated as of January 14, 2014 (“Sixth Amendment”) and a Seventh Amendment dated April 19, 2014 (collectively, the “Lease”). Pursuant to the Lease, Landlord has leased to Tenant space currently containing approximately: (i) 29,887 rentable square feet located on the third (3rd) floor, (ii) 19,863 rentable square feet located on the second (2nd) floor, and (iii) 22,268 rentable square feet on the first (1st) floor of the Building 1 portion of the building (collectively, the “Original Premises”) located at 10 Maguire Road, Lexington, Massachusetts (the “Building”). The Original Premises contain, in the aggregate, 72,018 rentable square feet.

B. Tenant has requested that additional premises containing approximately 20,999 rentable square feet of space, comprising: (i) 8,872 rentable square feet on the second (2nd) floor of the Building, as shown on Exhibit A, Eighth Amendment – Sheet 1 attached hereto (“Expansion Premises A”), and (ii) 12,127 rentable square feet on the second (2nd) floor of the Building as shown on Exhibit A, Eighth Amendment – Sheet 2, attached hereto (“Expansion Premises B”), (hereinafter sometimes collectively referred to as the “8th Amendment Expansion Premises”) be added to the Original Premises, and that the Lease be appropriately amended. Landlord is willing to do the same on the following terms and conditions.

C. The Lease by its terms shall expire on September 30, 2019 (“Prior Termination Date”), and the parties desire to extend the Term of the Lease, all on the following terms and conditions.

NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant agree as follows:

 

I. Expansion and Commencement Date.

Effective as of the Expansion Premises A Commencement Date (defined below), the Original Premises shall be increased from 72,018 rentable square feet on the first (1st), second (2nd) and third (3rd) floors of the Building to 80,890 rentable square feet on the first (1st), second (2nd) and third (3rd) floors of the Building by the addition of Expansion Premises A, and effective as of the Expansion Premises B Commencement Date (defined below), the Original Premises, as previously increased by the addition thereto of Expansion Premises A, shall be further increased from 80,890 rentable square feet on the first (1st), second (2nd) and third (3rd) floors of the Building to 93,017 rentable square


feet on the first (1st), second (2nd) and third (3rd) floors of the Building by the addition of Expansion Premises B. From and after the Expansion Premises A Commencement Date, references in the Lease to the Premises shall be deemed to refer to the Original Premises and Expansion Premises A, collectively, and from and after the Expansion Premises B Commencement Date, references in the Lease to the Premises shall be deemed to refer to the Original Premises, Expansion Premises A, and Expansion Premises B, collectively. The 8th Amendment Expansion Premises are subject to all the terms and conditions of the Lease except as expressly modified herein, except that Tenant shall not be entitled to receive any allowances, abatements, or other financial concessions granted with respect to the Original Premises unless such concessions are expressly provided for herein with respect to the 8th Amendment Expansion Premises.

 

  A. The “Expansion Premises A Commencement Date” shall be the date that Landlord delivers Expansion Premises A to Tenant in accordance with the terms of this Eighth Amendment, which is scheduled for October 1, 2015. The Expansion Premises A Commencement Date shall be delayed to the extent that Landlord fails to deliver possession of Expansion Premises A for any reason, including but not limited to, holding over by the current occupant thereof. Any such delay in the Expansion Premises A Commencement Date shall not subject Landlord to any liability for any loss or damage resulting therefrom; provided, however, that Landlord shall diligently use commercially reasonable efforts to deliver possession of Expansion Premises A to Tenant as soon thereafter as possible. Notwithstanding the foregoing, in the event that Landlord does not deliver the Expansion Premises A to Tenant by December 1, 2015 (the “Target Expansion Premises A Delivery Date”), then Tenant shall be entitled to an abatement of Base Rent with respect to Expansion Premises A in an amount equal to the product of (i) $607.67 multiplied by (ii) the number of days that elapse after December 1, 2015, until the date on which the Expansion Premises A has been delivered to Sublessee in the condition required by this Eighth Amendment. If the Expansion Premises A Commencement Date is delayed, the Extended Termination Date (as hereinafter defined) shall not be similarly extended.

 

  B. The “Expansion Premises B Commencement Date” shall be September 1, 2016.

 

  C. The “Expansion Premises A Rent Commencement Date” shall be three (3) months after the Expansion Premises A Commencement Date.

 

  D. The “Expansion Premises B Rent Commencement Date” shall be January 1, 2017.

 

II. Base Rent.

 

  A. Original Premises Through Prior Termination Date. The Base Rent, Additional Rent and all other charges under the Lease with respect to the Original Premises shall be payable as provided therein through and including the Prior Termination Date.

 

2


  B. Original Premises From and After Extension Date. As of the Extension Date (as defined hereafter), the schedule of Base Rent payable with respect to the Original Premises (72,018 square feet) during the Extended Term (as defined hereafter) is the following:

 

Time Period

   Annual Rate Per
Rentable Square Foot
     Annual Base
Rent
     Monthly Base Rent  

10/1/19-12/31/19:

   $ 28.00       $ 2,016,504.00    $ 168,042.00   

1/1/20-12/31/20:

   $ 29.00       $ 2,088,522.00       $ 174,043.50   

1/1/21-12/31/21:

   $ 30.00       $ 2,160,540.00       $ 180,045.00   

 

* annualized

All such Base Rent shall be payable by Tenant in accordance with the terms of the Lease.

 

  C. 8th Amendment Expansion Premises From 8th Amendment Expansion Premises Commencement Date Through Extended Termination Date. In addition to Tenant’s obligation to pay Base Rent for the Original Premises, Tenant shall pay Base Rent for the 8th Amendment Expansion Premises as follows:

 

  I. Expansion Premises A (8,872 square feet):

 

Time Period

   Annual Rate Per
Rentable Square
Foot
     Annual Base
Rent
     Monthly Base Rent  

Expansion Premises A Commencement Date – Expansion Premises A Rent Commencement Date:

   $ -0-       $ -0-       $ -0-   

Expansion Premises A Rent Commencement Date-12/31/16:

   $ 25.00       $ 221,800.00       $ 18,483.33   

1/1/17-12/31/17:

   $ 26.00       $ 230,672.00       $ 19,222.67   

1/1/18-12/31/18:

   $ 27.00       $ 239,544.00       $ 19,962.00   

1/1/19-12/31/19:

   $ 28.00       $ 248,416.00       $ 20,701.33   

1/1/20-12/31/20:

   $ 29.00       $ 257,288.00       $ 21,440.67   

1/1/21-12/31/21:

   $ 30.00       $ 266,160.00       $ 22,180.00   

 

  II. Expansion Premises B (12,127 square feet):

 

Time Period

   Annual Rate Per
Rentable Square
Foot
     Annual Base
Rent
     Monthly Base Rent  

9/1/16-12/31/16:

   $ -0-       $ -0-       $ -0-   

1/1/17-12/31/17:

   $ 26.00       $ 315,302.00       $ 26,275.17   

1/1/18-12/31/18:

   $ 27.00       $ 327,429.00       $ 27,285.75   

1/1/19-12/31/19:

   $ 28.00       $ 339,556.00       $ 28,296.33   

1/1/20-12/31/20:

   $ 29.00       $ 351,683.00       $ 29,306.92   

1/1/21-12/31/21:

   $ 30.00       $ 363,810.00       $ 30,317.50   

 

3


III. Tenant’s Pro Rata Share With Respect to 8th Amendment Expansion Premises.

 

  A. For the period commencing with the Expansion Premises A Commencement Date, and ending on the Extended Termination Date, Tenant’s Pro Rata Share for Expansion Premises A shall be 3.11% (i.e., 8,872 rentable square feet of Expansion Premises A divided by 285,133 rentable square feet of the Building).

 

  B. For the period commencing with the Expansion Premises B Commencement Date, and ending on the Extended Termination Date, Tenant’s Pro Rata Share for Expansion Premises B shall be 4.25% (i.e., 12,127 rentable square feet of Expansion Premises B divided by 285,133 rentable square feet of the Building).

 

IV. Expenses and Taxes.

 

  A. Original Premises during the Extended Term. For the period commencing with the Extension Date, and ending on the Extended Termination Date, Tenant shall pay for Tenant’s Pro Rata Share of Expenses and Taxes applicable to the Original Premises in accordance with the terms of the Lease.

 

  B. Expansion Premises A Commencement Date Through Extended Termination Date. For the period commencing with the Expansion Premises A Commencement Date, and ending on the Extended Termination Date, Tenant shall pay for Tenant’s Pro Rata Share of Expenses and Taxes applicable to Expansion Premises A in accordance with the terms of the Lease, provided, however, during such period:

 

  (i) the Base Year for the computation of Tenant’s Pro Rata Share of Expenses applicable to Expansion Premises A shall be calendar year 2015; and

 

  (ii) the Base Year for the computation of Tenant’s Pro Rata Share of Taxes applicable to Expansion Premises A shall be fiscal year 2016 (i.e., July 1, 2015, through June 30, 2016).

 

  C. Expansion Premises B Commencement Date Through Extended Termination Date. For the period commencing with the Expansion Premises B Commencement Date, and ending on the Extended Termination Date, Tenant shall pay for Tenant’s Pro Rata Share of Expenses and Taxes applicable to Expansion Premises B in accordance with the terms of the Lease, provided, however, during such period:

 

  (i) the Base Year for the computation of Tenant’s Pro Rata Share of Expenses applicable to Expansion Premises B shall be calendar year 2015; and

 

  (ii) the Base Year for the computation of Tenant’s Pro Rata Share of Taxes applicable to Expansion Premises B shall be fiscal year 2016 (i.e., July 1, 2015, through June 30, 2016).

 

4


V. Condition of 8th Amendment Expansion Premises. Landlord shall deliver the 8th Amendment Expansion Premises to Tenant on the Expansion Premises A Commencement Date, and the Expansion Premises B Commencement Date, respectively, in broom-clean condition, free of all personal property, debris and free of any occupants, but otherwise in its “as is” condition as of each such date, subject, however, to the following provisions of this Section V. Tenant agrees to accept the 8th Amendment Expansion Premises “as is” without any agreements, representations, understandings or obligations on the part of Landlord to perform any alterations, repairs or improvements, except as may be expressly provided otherwise in this Eighth Amendment. Notwithstanding the foregoing, Landlord agrees that the Building systems serving the 8th Amendment Expansion Premises will be in good working order at the time Landlord delivers each of Expansion Premises A and Expansion Premises B to Tenant hereunder. Landlord further agrees that Expansion Premises B shall be separately demised at Landlord’s sole cost and expense prior to the Expansion B Commencement Date. In addition, if the electricity serving the 8th Amendment Expansion Premises is not separately metered or submetered, Landlord shall, it its sole cost and expense, prior to the Expansion B Commencement Date, cause the electric service to the 8th Amendment Expansion Premises either (i) to be separately metered or submetered or (ii) to be connected to the meter or submeter servicing the Original Premises.

 

VI. Electricity with Respect to 8th Amendment Expansion Premises. Tenant shall pay, as Additional Rent, for all electricity consumed in the 8th Amendment Expansion Premises in accordance with the terms and conditions set forth in Section 7 of the Lease.

 

VII. Responsibility for Improvements to Additional Expansion Premises. Tenant may perform improvements to the 8th Amendment Expansion Premises in accordance with the Work Letter attached hereto as Exhibit B, Eighth Amendment, and Tenant shall be entitled to the 8th Amendment Expansion Allowance (as defined in Exhibit B, Eighth Amendment) in connection with work in the 8th Amendment Expansion Premises only, as more fully described in Exhibit B, Eighth Amendment.

 

VIII. Extension.

The Term of the Lease is hereby extended for a period commencing on October 1, 2019, and terminating on December 31, 2021 (“Extended Termination Date”), unless sooner terminated in accordance with the terms of the Lease. That portion of the Term commencing the day immediately following the Prior Termination Date (“Extension Date”) and ending on the Extended Termination Date shall be referred to herein as the “Extended Term”.

 

5


IX. Extension Options. The Extension Option set forth in Section V of the Third Amendment, as amended by Section IX of the Fourth Amendment and Section VIII of the Fifth Amendment, shall apply to both the Original Premises and the 8th Amendment Expansion Premises (and may be exercised only with respect to the entirety of both such spaces); provided, however, that Section IX of the Fourth Amendment shall be modified as follows:

 

  i) “Section V.A. is deleted and the following is substituted in its place:

Grant of Option: Conditions. Tenant shall have the right to extend the Term (the “Extension Option”) for one (1) additional period of five (5) years, commencing on January 1, 2022, and ending on December 31, 2026 (the “Fifth Extended Term”), if:”

 

  ii) Section V.A.(i) is deleted and the following is substituted in its place:

“(i) Landlord received notice of exercise (“Initial Extension Notice”) not later than January 1, 2021, and not earlier than October 1, 2020.”

 

  iii) The first (1st) sentence of Section V.B.(i) is deleted and the following is substituted in its place:

“(i) The initial Base Rent rate per rentable square foot during the Fifth Extended Term shall equal the Prevailing Market rate (hereinafter defined) per rentable square foot for the Premises.”

 

X. Right of First Offer. Tenant shall continue to have the Right of First Offer set forth in Section VII of the Third Amendment, except that Section VII of the Third Amendment shall be modified as follows:

 

  i) The first (1st) sentence of Section VII.A. of the Third Amendment is deleted and the following is substituted in its place:

“Tenant shall have the following ongoing right of first offer (the “Right of First Offer”) with respect to: (i) 11,385 square feet on the first (1st) floor of Building 2, as shown on Exhibit C, Eighth Amendment – Sheet 1, attached hereto, and (ii) 19,725 square feet on the third (3rd) floor of Building 2, as shown on Exhibit C, Eighth Amendment – Sheet 2, attached hereto (the “Offering Space”).

 

XI. Letter of Credit

The parties hereby acknowledge that Landlord is currently holding a Security Deposit in the form of a Letter of Credit in the amount of One Hundred Twenty Thousand Four Hundred Seventeen and 27/100 Dollars ($120,417.27) pursuant to Section 6 of the Lease, as modified by Section 2.01 of the First Amendment, Section VI of the Second Amendment, Section VIII of the Third Amendment, Section III of the Fourth Amendment, and Section X of the Fifth Amendment. No additional Security Deposit shall be required with respect to the 8th Amendment Expansion Premises, and Landlord shall continue to hold the current Security Deposit/Letter of Credit in accordance with the terms of the Lease.

 

XII. Inapplicable and Deleted Lease Provisions.

 

  A. Exhibit C to the Lease and Schedule I to Exhibit C to the Lease (Work Letter); Section IV of the Second Amendment (Abatement of Rent); Exhibit B of the Fourth Amendment (Work Letter); Exhibit B of the Fifth Amendment (Work Letter), and Exhibit B to the Sixth Amendment shall have no applicability with respect to this Eighth Amendment.

 

  B. Section IX of the Sixth Amendment (Termination Option) is hereby deleted and is of no further force or effect.

 

6


XIII. Miscellaneous.

 

  A. This Eighth Amendment and the Lease set forth the entire agreement between the parties with respect to the matters set forth herein. There have been no additional oral or written representations or agreements. Under no circumstances shall Tenant be entitled to any Rent abatement, improvement allowance, leasehold improvements, or other work to the Premises, or any similar economic incentives that may have been provided Tenant in connection with entering into the Lease, unless specifically set forth in this Eighth Amendment.

 

  B. Except as herein modified or amended, the provisions, conditions and terms of the Lease shall remain unchanged and in full force and effect.

 

  C. In the case of any inconsistency between the provisions of the Lease and this Eighth Amendment, the provisions of this Eighth Amendment shall govern and control.

 

  D. Submission of this Eighth Amendment by Landlord is not an offer to enter into this Eighth Amendment but rather is a solicitation for such an offer by Tenant. Landlord shall not be bound by this Eighth Amendment until Landlord has executed and delivered the same to Tenant.

 

  E. The capitalized terms used in this Eighth Amendment shall have the same definitions as set forth in the Lease to the extent that such capitalized terms are defined therein and not redefined in this Eighth Amendment.

 

  F. Tenant hereby represents to Landlord that Tenant has dealt with no broker in connection with this Eighth Amendment, other than T3 Realty Advisors (“Tenant’s Broker”) and TW/Richards Barry Joyce & Partners, LLC (“Landlord’s Broker”) (collectively, the “Brokers”). Tenant agrees to indemnify and hold Landlord, its trustees, members, principals, beneficiaries, partners, officers, directors, employees, mortgagee(s) and agents, and the respective principals and members of any such agents harmless from all claims of any brokers, other than the Brokers, claiming to have represented Tenant in connection with this Eighth Amendment. Landlord hereby represents to Tenant that Landlord has dealt with no broker, other than the Brokers, in connection with this Eighth Amendment. Landlord agrees to indemnify and hold Tenant, its trustees, members, principals, beneficiaries, partners, officers, directors, employees, and agents, and the respective principals and members of any such agents harmless from all claims of any brokers claiming to have represented Landlord in connection with this Eighth Amendment. Landlord shall be responsible for any commission payable to the Brokers by reason of this Eighth Amendment.

 

  G. Each signatory of this Eighth Amendment represents hereby that he or she has the authority to execute and deliver the same on behalf of the party hereto for which such signatory is acting.

 

7


IN WITNESS WHEREOF, Landlord and Tenant have duly executed this Sixth Amendment as of the day and year first above written.

 

LANDLORD:

NORMANDY LEXINGTON ACQUISITION, LLC,

a Delaware limited liability company

By: LOGO
 

 

Name: Joseph Adamo
Title: Vice President
TENANT:

IMPRIVATA, INC.,

a Delaware corporation

By: LOGO
 

 

Name: Jeff Kalowski
Title: CFO

 

8


EXHIBIT A, EIGHTH AMENDMENT – SHEET 1

EXPANSION PREMISES A

 

LOGO

 

Exhibit A-1, Eighth Amendment


EXHIBIT A, EIGHTH AMENDMENT – SHEET 2

EXPANSION PREMISES B

 

LOGO

 

Exhibit A-2, Eighth Amendment


EXHIBIT B, EIGHTH AMENDMENT

WORK LETTER

This Exhibit is attached to and made a part of the Eighth Amendment by and between NORMANDY LEXINGTON ACQUISITION, LLC, a Delaware limited liability company (“Landlord”), and IMPRIVATA, INC., a Delaware corporation (“Tenant”), for space in the Building located at 10 Maguire Road, Lexington, Massachusetts.

As used in this Workletter, the “Premises” shall be deemed to mean the 8th Amendment Expansion Premises, as defined in the attached Eighth Amendment.

8th Amendment Expansion Premises Alterations and 8th Amendment Expansion Premises Allowance:

 

  A. From and after the Expansion Premises A Commencement Date, Tenant shall have the right to perform alterations and improvements in Expansion Premises A and from and after the Expansion Premises B Commencement Date, Tenant shall have the right to perform alterations and improvements in Expansion Premises B. All such alterations and improvements are referred to herein as the “8th Amendment Expansion Premises Alterations”. Notwithstanding the foregoing, Tenant and its contractors shall not have the right to perform 8th Amendment Expansion Premises in the 8th Amendment Expansion Premises unless and until Tenant has complied with all of the terms and conditions of Section 9 of the Lease, including, without limitation, approval by Landlord of the final plans for the 8th Amendment Expansion Premises Alterations and the contractors to be retained by Tenant to perform such 8th Amendment Expansion Premises Alterations. Landlord’s consent is solely for the benefit of Landlord, and neither Tenant nor any third party shall have the right to rely on Landlord’s consent, or its approval of Tenant’s plans, for any purpose whatsoever. Landlord shall execute any documents reasonably required to obtain such permits or governmental approvals, and shall otherwise reasonably cooperate with Tenant’s efforts to obtain the same at no out of pocket expense to Landlord. Tenant shall be responsible for all elements of the design of Tenant’s plans (including, without limitation, compliance with law, functionality of design, the structural integrity of the design, the configuration of the 8th Amendment Expansion Premises and the placement of Tenant’s furniture, appliances and equipment), and Landlord’s approval of Tenant’s plans shall in no event relieve Tenant of the responsibility for such design. Landlord’s approval of the contractors to perform the 8th Amendment Expansion Premises Alterations shall not be unreasonably withheld, delayed or conditioned. The parties agree that Landlord’s approval of the general contractor to perform the 8th Amendment Expansion Premises Alterations shall not be considered to be unreasonably withheld if any such general contractor (i) does not have trade references reasonably acceptable to Landlord, (ii) does not maintain insurance as required pursuant to the terms of this Lease, (iii) does not have the ability to be bonded for the work in an amount of no less than 150% of the total estimated cost of the 8th Amendment Expansion Premises Alterations, (iv) does not provide current financial statements reasonably acceptable to Landlord, or (v) is not licensed as a contractor in the Commonwealth of Massachusetts. Tenant acknowledges the foregoing is not intended to be an exclusive list of the reasons why Landlord may reasonably withhold its consent to a general contractor. Landlord hereby approves Avison Young (“AY”) as Tenant’s general contractor.

 

Exhibit B-1, Eighth Amendment


  B.

Provided Tenant is not in default (after the expiration of any applicable grace or cure period), Landlord agrees to contribute Seven Hundred Thirty-Four Thousand Nine Hundred Sixty-Five and 00/100 Dollars ($734,965.00) (i.e., $35.00 per square foot of the 8th Amendment Expansion Premises) (the “8th Amendment Expansion Premises Allowance”) toward the cost of performing the 8th Amendment Expansion Premises Alterations in preparation of Tenant’s occupancy of the 8th Amendment Expansion Premises. The 8th Amendment Expansion Premises Allowance may only be used for the cost of preparing design and construction documents and mechanical and electrical plans and hard costs in connection with the 8th Amendment Expansion Premises Alterations. The 8th Amendment Expansion Premises Allowance, less a 10% (or 5%, if such percentage is the retainage amount required in Tenant’s construction contracts) retainage (which retainage shall be payable as part of the final draw), shall be paid to Tenant or, at Landlord’s option, to the order of the general contractor that performs the 8th Amendment Expansion Premises Alterations, in periodic disbursements within thirty (30) days after receipt of the following documentation: (i) an application for payment and sworn statement of contractor substantially in the form of AIA Document G-702 covering all work for which disbursement is to be made to a date specified therein; (ii) a certification from an AIA architect substantially in the form of the Architect’s Certificate for Payment which is located on AIA Document G702, Application and Certificate of Payment; (iii) Contractor’s, subcontractor’s and material supplier’s waivers of liens which shall cover all 8th Amendment Expansion Premises Alterations for which disbursement is being requested and all other statements and forms required for compliance with the mechanics’ lien laws of the Commonwealth of Massachusetts, together with all such invoices, contracts, or other supporting data as Landlord or Landlord’s Mortgagee may reasonably require; (iv) a cost breakdown for each trade or subcontractor performing the 8th Amendment Expansion Premises Alterations; (v) plans and specifications for the 8th Amendment Expansion Premises Alterations, together with a certificate from an AIA architect that such plans and specifications comply in all material respects with all laws affecting the Building, Property and 8th Amendment Expansion Premises; (vi) copies of all construction contracts for the 8th Amendment Expansion Premises Alterations, together with copies of all change orders, if any; and (vii) a request to disburse from Tenant containing an approval by Tenant of the work done and a good faith estimate of the cost to complete the 8th Amendment Expansion Premises Alterations. Upon completion of the 8th Amendment Expansion Premises Alterations, and prior to final disbursement of the 8th Amendment Expansion Premises Allowance, Tenant shall furnish Landlord with: (1) general contractor and architect’s completion affidavits, (2) full and final waivers of lien, (3) receipted bills covering all labor and materials expended and used, (4) as-built plans of the 8th Amendment Expansion Premises Alterations, and (5) the certification of Tenant and its architect that the 8th Amendment Expansion Premises Alterations have been installed in a good and workmanlike manner in accordance with the approved plans, and in accordance with applicable laws, codes and ordinances. In no event shall Landlord be required to disburse the 8th Amendment Expansion Premises Allowance more than one time per month. If the 8th Amendment Expansion Premises Alterations

 

Exhibit B-2, Eighth Amendment


  exceed the 8th Amendment Expansion Premises Allowance, Tenant shall be entitled to the 8th Amendment Expansion Premises Allowance in accordance with the terms hereof, but each individual disbursement of the 8th Amendment Expansion Premises Allowance shall be disbursed in the proportion that the 8th Amendment Expansion Premises Allowance bears to the total cost for the 8th Amendment Expansion Premises Alterations, less the 10% (or lesser amount, as set forth above) retainage referenced above. Notwithstanding anything herein to the contrary, Landlord shall not be obligated to disburse any portion of the 8th Amendment Expansion Premises Alterations during the continuance of an uncured default under the Lease, and Landlord’s obligation to disburse shall only resume when and if such default is cured.

 

  C. In no event shall the 8th Amendment Expansion Premises Allowance be used for the purchase of equipment, furniture or other items of personal property of Tenant. If Tenant does not submit a request for payment of the entire 8th Amendment Expansion Premises Allowance to Landlord in accordance with the provisions contained in this Exhibit B, Eighth Amendment, by the date that is eighteen (18) months after the Expansion Premises B Commencement Date, any unused amount shall accrue to the sole benefit of Landlord, it being understood that Tenant shall not be entitled to any credit, abatement or other concession in connection therewith. Notwithstanding the foregoing, provided that Tenant has commenced construction of the 8th Amendment Expansion Premises Alterations before March 1, 2018, and is diligently pursuing the completion thereof, Tenant may elect to extend the foregoing deadline until September 1, 2018, by giving Landlord notice of such election before March 1, 2018. Tenant shall be responsible for all applicable state sales or use taxes, if any, payable in connection with the 8th Amendment Expansion Premises Alterations and/or 8th Amendment Expansion Premises Allowance. Landlord shall be entitled to deduct from the 8th Amendment Expansion Premises Allowance a construction management fee for Landlord’s oversight of the 8th Amendment Expansion Premises Alterations in an amount equal to 5% of the total cost of the 8th Amendment Expansion Premises Alterations; provided however that such fee shall be waived if Tenant employs AY, or any successor general contractor used by Landlord, as its general contractor.

 

  D. Except as otherwise set forth in this Eighth Amendment, Tenant agrees to accept the 8th Amendment Expansion Premises in their “as-is” condition and configuration, it being agreed that Landlord shall not be required to perform any work or, except as provided above with respect to the 8th Amendment Expansion Premises Allowance, incur any costs in connection with the construction or demolition of any improvements in the 8th Amendment Expansion Premises.

 

  E. This Exhibit B, Eighth Amendment shall not be deemed applicable to any additional space added to the Premises at any time or from time to time, whether by any options under the Lease or otherwise, or to any portion of the original Premises or any additions to the Premises in the event of a renewal or extension of the original Term of the Lease, whether by any options under the Lease or otherwise, unless expressly so provided in the Lease or any amendment or supplement to the Lease.

 

Exhibit B-3, Eighth Amendment


EXHIBIT C, EIGHTH AMENDMENT – SHEET 1

OFFERING SPACE

 

LOGO

 

Exhibit C-1, Eighth Amendment


EXHIBIT C, EIGHTH AMENDMENT – SHEET 2

OFFERING SPACE

 

LOGO

 

Exhibit C-2, Eighth Amendment

EX-10.8 3 d899224dex108.htm EX-10.8 EX-10.8

Exhibit 10.8

FIFTH LOAN MODIFICATION AGREEMENT

This Fifth Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of February 19, 2015, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and IMPRIVATA, INC., a Delaware corporation, with its chief executive office located at 10 Maguire Road, Lexington, Massachusetts 02421 (“Borrower”).

1. DESCRIPTION OF EXISTING INDEBTEDNESS AND OBLIGATIONS. Among other indebtedness and obligations which may be owing by Borrower to Bank, Borrower is indebted to Bank pursuant to a loan arrangement dated as of January 30, 2009, evidenced by, among other documents, a certain Loan and Security Agreement dated as of January 30, 2009, between Borrower and Bank, as amended by a First Loan Modification and Reinstatement Agreement dated as of April 26, 2010, as further amended by a Second Loan Modification Agreement dated as of May 24, 2011, and as further amended by a certain Third Loan Modification and Reinstatement Agreement dated as of December 12, 2012, and as further modified by a certain Fourth Loan Modification and Reinstatement Agreement dated as of February 27, 2014 (the “Fourth Loan Modification”) (as amended, the “Loan Agreement”). Capitalized terms used but not otherwise defined herein shall have the same meaning as in the Loan Agreement.

2. DESCRIPTION OF COLLATERAL. Repayment of the Obligations is secured by the Collateral as described in the Loan Agreement (together with any other collateral security granted to Bank, the “Security Documents”). Hereinafter, the Security Documents, together with all other documents evidencing or securing the Obligations shall be referred to as the “Existing Loan Documents”.

3. DESCRIPTION OF CHANGE IN TERMS.

 

  A. Modifications to Loan Agreement.

 

  1 The Loan Agreement shall be amended by deleting the following text, appearing in Section 6.2(a):

“(i) as soon as available, but no later than thirty (30) days after the last day of each month, a company prepared consolidated balance sheet and income statement covering Borrower’s and each of its Subsidiary’s operations for such month certified by a Responsible Officer and in a form reasonably acceptable to Bank;”

and inserting in lieu thereof the following:

“(i) (1) as soon as available, but no later than thirty (30) days after the last day of each month, a company prepared consolidated balance sheet and income statement covering Borrower’s and each of its Subsidiary’s operations for such month certified by a Responsible Officer and in a form reasonably acceptable to Bank; provided, however, Borrower shall not be required to deliver the financial statements described in this subsection (i) with respect to a particular month if no Advance was outstanding or requested at any time during the period commencing on the first day of such month through and including the date that is thirty (30) days after the last day of such month, and (2) for any calendar quarter for which the financial statements described in this subsection (i) were not required to be delivered for any month in such quarter, Borrower shall deliver to Bank, as soon as available, but no later than forty-five (45) days after the last day of such quarter, a company prepared consolidated balance sheet and income statement covering Borrower’s and each of its Subsidiary’s operations for such quarter certified by a Responsible Officer and in a form reasonably acceptable to Bank;”

 

1


  2 The Loan Agreement shall be amended by deleting the following text, appearing in Section 6.2 thereof:

“(b) Within thirty (30) days after the last day of each month, deliver to Bank a duly completed Borrowing Base Certificate signed by a Responsible Officer, with aged listings of accounts receivable and accounts payable (by invoice date).

(c) Within thirty (30) days after the last day of each month, deliver to Bank with the monthly financial statements, a duly completed Compliance Certificate signed by a Responsible Officer setting forth calculations showing compliance with the financial covenants set forth in this Agreement.”

and inserting in lieu thereof the following:

“(b) (i) Within thirty (30) days after the last day of each month, deliver to Bank a duly completed Borrowing Base Certificate signed by a Responsible Officer, with aged listings of accounts receivable and accounts payable (by invoice date); provided, however, Borrower shall not be required to deliver the materials described in this subsection (b) for any month for which no Advance was outstanding or requested at any time during the period commencing on the first day of such month through and including the date that is thirty (30) days after the last day of such month and (ii) together with each request for an Advance if at such time there are no Advances outstanding.

(c) (i) Within thirty (30) days after the last day of each month, deliver to Bank with the monthly financial statements, a duly completed Compliance Certificate signed by a Responsible Officer setting forth calculations showing compliance with the financial covenants set forth in this Agreement; provided, however, Borrower shall not be required to deliver a Compliance Certificate with respect to a particular month if no Advance was outstanding or requested at any time during the period commencing on the first day of such month through and including the date that is thirty (30) days after the last day of such month and (ii) for any calendar quarter for which a Compliance Certificate was not required to be delivered for any month in such quarter, Borrower shall deliver to Bank, within forty-five (45) days after the last day of such quarter, a Compliance Certificate signed by a Responsible Officer setting forth calculations showing compliance with the financial covenants set forth in this Agreement.”

 

  3 The Loan Agreement shall be amended by deleting the following text, appearing in Section 6.7 thereof:

6.7 Financial Covenants. Borrower shall maintain at all times, to be tested as of the last day of each month, unless otherwise noted, on a consolidated basis with respect to Borrower and its Subsidiaries:”

and inserting in lieu thereof the following:

 

2


6.7 Financial Covenant — Adjusted Quick Ratio. Borrower shall maintain at all times, to be tested as of the last day of each month, on a consolidated basis with respect to Borrower and its Subsidiaries an Adjusted Quick Ratio of at least 1.25 to 1.0. Notwithstanding the foregoing, with respect to the first and second months in any calendar quarter, Borrower shall not be required to comply with the financial covenant set forth in this Section 6.7 for any such month to the extent that no Advance was outstanding or requested (i) during such month and (ii) after such month up to and including the date on which Bank receives the applicable financial reporting evidencing Borrower’s Adjusted Quick Ratio for such calendar quarter.”

 

  4 The Loan Agreement shall be amended by deleting the following definition, appearing in Section 13.1 thereof:

Revolving Line Maturity Date is February 26, 2015.”

and inserting in lieu thereof the following:

Revolving Line Maturity Date is April 27, 2015.”

 

  5 The Loan Agreement shall be amended by deleting the Compliance Certificate attached thereto as Exhibit D and inserting in lieu thereof the Compliance Certificate attached hereto as Schedule 1.

4. FEES AND EXPENSES. Borrower shall reimburse Bank for all legal fees and expenses incurred in connection with this amendment to the Existing Loan Documents.

5. RATIFICATION OF PERFECTION CERTIFICATE. Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in a certain Perfection Certificate dated as of December 12, 2012, and acknowledges, confirms and agrees that the disclosures and information Borrower provided to Bank in such Perfection Certificate have not changed, as of the date hereof except as set forth on Schedule 3 to the Fourth Loan Modification.

6. CONSISTENT CHANGES. The Existing Loan Documents are hereby amended wherever necessary to reflect the changes described above.

7. RATIFICATION OF LOAN DOCUMENTS. Borrower hereby ratifies, confirms, and reaffirms all terms and conditions of all security or other collateral granted to the Bank, and confirms that the indebtedness secured thereby includes, without limitation, the Obligations.

8. NO DEFENSES OF BORROWER. Borrower hereby acknowledges and agrees that Borrower has no offsets, defenses, claims, or counterclaims against Bank with respect to the Obligations, or otherwise, and that if Borrower now has, or ever did have, any offsets, defenses, claims, or counterclaims against Bank, whether known or unknown, at law or in equity, all of them are hereby expressly WAIVED and Borrower hereby RELEASES Bank from any liability thereunder.

9. CONTINUING VALIDITY. Borrower understands and agrees that in modifying the existing Obligations, Bank is relying upon Borrower’s representations, warranties, and agreements, as set forth in the Existing Loan Documents. Except as expressly modified pursuant to this Loan Modification Agreement, the terms of the Existing Loan Documents remain unchanged and in full force and effect. Bank’s agreement to modifications to the existing Obligations pursuant to this Loan Modification Agreement in no way shall obligate Bank to make any future modifications to the Obligations. Nothing in this Loan Modification Agreement shall constitute a satisfaction of the Obligations. It is the intention of Bank and Borrower to retain as liable parties all makers of Existing Loan

 

3


Documents, unless the party is expressly released by Bank in writing. No maker will be released by virtue of this Loan Modification Agreement.

10. COUNTERSIGNATURE. This Loan Modification Agreement shall become effective only when it shall have been executed by Borrower and Bank.

[The remainder of this page is intentionally left blank]

 

4


This Loan Modification Agreement is executed as a sealed instrument under the laws of the Commonwealth of Massachusetts as of the date first written above.

 

BORROWER: BANK:
IMPRIVATA, INC. SILICON VALLEY BANK
By:

/s/ Jeff Kalowski

By:

/s/ Kristy Vlahos

Name: Jeff Kalowski Name: Kristy Vlahos
Title: CFO Title: Director


Schedule 1

EXHIBIT D - COMPLIANCE CERTIFICATE

 

TO:        SILICON VALLEY BANK      Date:                                     
FROM:  IMPRIVATA, INC.     

The undersigned authorized officer of IMPRIVATA, INC. (“Borrower”) certifies that under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, the “Agreement”), (1) Borrower is in compliance for the period ending                     with all required covenants except as noted below, (2) there are no Events of Default, (3) all representations and warranties in the Agreement are true and correct in all material respects on this date except as noted below; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date, (4) Borrower, and each of its Subsidiaries, has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section 5.9 of the Agreement, and (5) no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Bank. Attached are the required documents supporting the certification. The undersigned certifies that these are prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes. The undersigned acknowledges that no borrowings may be requested at any time or date of determination that Borrower is not in compliance with any of the terms of the Agreement, and that compliance is determined not just at the date this certificate is delivered. Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.

Please indicate compliance status by circling Yes/No under “Complies” column.

 

Reporting Covenant

  

Required

   Complies
Monthly financial statements with    Monthly within 30 days (waived for    Yes    No
Compliance Certificate    any month for which no Advance was   
   outstanding or requested during the   
   period commencing on the first day of   
   such month through and including the   
   date that is 30 days from the end of   
   such month); within 45 days of the end   
   of each quarter in which the monthly   
   financial statements and compliance   
   certificates were not required to be   
   delivered for any month in such quarter   
Annual financial statement (CPA Audited)    FYE within 210 days    Yes    No
10-Q, 10-K and 8-K    Within 5 days after filing with SEC    Yes    No
Borrowing Base Certificate (with A/R & A/P Agings and a    Monthly within 30 days at all times    Yes    No
deferred revenue report)    when any Advance is outstanding or   
   requested and together with each   
   request for an Advance if at such time   
   there are no Advances outstanding   
Operating Budgets and Projections    FYE within 30 days    Yes    No


Financial Covenant

   Required      Actual      Complies  

Maintain at all times, to be tested on a monthly basis (provided that, for the first and second months in each calendar quarter, testing shall be waived if there are no Obligations outstanding during any such months through and including the date on which Bank receives the applicable financial reporting):

        

Adjusted Quick Ratio

     1.25:1.0         :1.0         Yes No   

The following financial covenant analysis and information set forth in Schedule 1 attached hereto are true and accurate as of the date of this Certificate.

The following are the exceptions with respect to the certification above: (If no exceptions exist, state “No exceptions to note.”)

 

IMPRIVATA, INC.     BANK USE ONLY
    Received by:                                                                                
By:                                                                                                        AUTHORIZED SIGNER
Name:                                                                                                  
Title:                                                                                                     Date:                                                                                                
    Verified:                                                                                         
    AUTHORIZED SIGNER
   
    Date:                                                                                                
    Compliance Status:             Yes         No
EX-10.9 4 d899224dex109.htm EX-10.9 EX-10.9

Exhibit 10.9

SIXTH LOAN MODIFICATION AGREEMENT

This Sixth Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of April 28, 2015, and, with respect to the modification of the definition of Revolving Line Maturity Date only, is effective as of April 27, 2015, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and IMPRIVATA, INC., a Delaware corporation, with its chief executive office located at 10 Maguire Road, Lexington, Massachusetts 02421 (“Borrower”).

1. DESCRIPTION OF EXISTING INDEBTEDNESS AND OBLIGATIONS. Among other indebtedness and obligations which may be owing by Borrower to Bank, Borrower is indebted to Bank pursuant to a loan arrangement dated as of January 30, 2009, evidenced by, among other documents, a certain Loan and Security Agreement dated as of January 30, 2009, between Borrower and Bank, as amended by a First Loan Modification and Reinstatement Agreement dated as of April 26, 2010, as further amended by a Second Loan Modification Agreement dated as of May 24, 2011, and as further amended by a certain Third Loan Modification and Reinstatement Agreement dated as of December 12, 2012, as further modified by a certain Fourth Loan Modification and Reinstatement Agreement dated as of February 27, 2014 (the “Fourth Loan Modification”), and as further amended by a certain Fifth Loan Modification Agreement dated as of February 19, 2015 (as amended, the “Loan Agreement”). Capitalized terms used but not otherwise defined herein shall have the same meaning as in the Loan Agreement.

2. DESCRIPTION OF COLLATERAL. Repayment of the Obligations is secured by the Collateral as described in the Loan Agreement (together with any other collateral security granted to Bank, the “Security Documents”). Hereinafter, the Security Documents, together with all other documents evidencing or securing the Obligations shall be referred to as the “Existing Loan Documents”.

3. DESCRIPTION OF CHANGE IN TERMS.

 

  A. Modifications to Loan Agreement.

 

  1 The Loan Agreement shall be amended by deleting the following definitions, appearing in Section 13.1 thereof:

“ “Revolving Line” is an Advance or Advances in an amount equal to Ten Million Dollars ($10,000,000.00).”

“ “Revolving Line Maturity Date” is April 27, 2015.”

and inserting in lieu thereof the following:

“ “Revolving Line” is an Advance or Advances in an amount equal to Fifteen Million Dollars ($15,000,000.00).”

“ “Revolving Line Maturity Date” is April 25, 2016.”

 

  2 The Loan Agreement shall be amended by deleting the Borrowing Base Certificate attached thereto as Exhibit C and inserting in lieu thereof the Borrowing Base Certificate attached hereto as Schedule 1.

4. FEES AND EXPENSES. Borrower shall pay to Bank a modification fee equal to Sixty Thousand Dollars ($60,000.00), which fee shall be due on the date hereof and shall be deemed fully earned as of the date hereof.

 

1


Borrower shall also reimburse Bank for all legal fees and expenses incurred in connection with this amendment to the Existing Loan Documents.

5. RATIFICATION OF PERFECTION CERTIFICATE. Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in a certain Perfection Certificate dated as of December 12, 2012, and acknowledges, confirms and agrees that the disclosures and information Borrower provided to Bank in such Perfection Certificate have not changed, as of the date hereof except as set forth on Schedule 3 to the Fourth Loan Modification.

6. CONSISTENT CHANGES. The Existing Loan Documents are hereby amended wherever necessary to reflect the changes described above.

7. RATIFICATION OF LOAN DOCUMENTS. Borrower hereby ratifies, confirms, and reaffirms all terms and conditions of all security or other collateral granted to the Bank, and confirms that the indebtedness secured thereby includes, without limitation, the Obligations.

8. NO DEFENSES OF BORROWER. Borrower hereby acknowledges and agrees that Borrower has no offsets, defenses, claims, or counterclaims against Bank with respect to the Obligations, or otherwise, and that if Borrower now has, or ever did have, any offsets, defenses, claims, or counterclaims against Bank, whether known or unknown, at law or in equity, all of them are hereby expressly WAIVED and Borrower hereby RELEASES Bank from any liability thereunder.

9. CONTINUING VALIDITY. Borrower understands and agrees that in modifying the existing Obligations, Bank is relying upon Borrower’s representations, warranties, and agreements, as set forth in the Existing Loan Documents. Except as expressly modified pursuant to this Loan Modification Agreement, the terms of the Existing Loan Documents remain unchanged and in full force and effect. Bank’s agreement to modifications to the existing Obligations pursuant to this Loan Modification Agreement in no way shall obligate Bank to make any future modifications to the Obligations. Nothing in this Loan Modification Agreement shall constitute a satisfaction of the Obligations. It is the intention of Bank and Borrower to retain as liable parties all makers of Existing Loan Documents, unless the party is expressly released by Bank in writing. No maker will be released by virtue of this Loan Modification Agreement.

10. COUNTERSIGNATURE. This Loan Modification Agreement shall become effective only when it shall have been executed by Borrower and Bank.

[The remainder of this page is intentionally left blank]

 

2


This Loan Modification Agreement is executed as a sealed instrument under the laws of the Commonwealth of Massachusetts as of the date first written above.

 

BORROWER: BANK:
IMPRIVATA, INC. SILICON VALLEY BANK
By:

/s/ Jeff Kalowski

By:

/s/ Kristy Vlahos

Name: Jeff Kalowski Name: Kristy Vlahos
Title: CFO Title: Director


Schedule 1

EXHIBIT C - BORROWING BASE CERTIFICATE

Borrower: Imprivata, Inc.

Lender: Silicon Valley Bank

Commitment Amount: $15,000,000.00

 

ACCOUNTS RECEIVABLE
1. Accounts Receivable (invoiced) Book Value as of $                      
2. Additions (please explain on reverse) $                      
3. TOTAL ACCOUNTS RECEIVABLE $                      
ACCOUNTS RECEIVABLE DEDUCTIONS (without duplication)
4. Amounts over 90 days due $                      
5. Balance of 50% over 90 day accounts $                      
6. Foreign Accounts $                      
7. Foreign Invoiced Accounts not approved by Bank $                      
8. Contra/Customer Deposit Accounts $                      
9. Intercompany/Employee Accounts $                      
10. Credit balances over 90 days $                      
11. Concentration Limits $                      
12. U.S. Governmental Accounts $                      
13. Promotion or Demo Accounts; Guaranteed Sale or Consignment Sale Accounts $                      
14. Accounts with Progress/Milestone/Pre-billings; Contract Accounts $                      
15. Accounts for Retainage Billings $                      
16. Trust Accounts $                      
17. Bill and Hold Accounts $                      
18. Unbilled Accounts $                      
19. Non-Trade Accounts $                      
20. Accounts with Extended Term Invoices $                      
21. Accounts subject to Chargebacks $                      
22. Disputed Accounts $                      
23. Other (please explain on reverse) $                      
24. TOTAL ACCOUNTS RECEIVABLE DEDUCTIONS $                      
25. Eligible Accounts (#3 minus #24) $                      
26. ELIGIBLE AMOUNT OF ACCOUNTS (80% of #25) $                      
BALANCES
27. Maximum Loan Amount $15,000,000.00
28. Total Funds Available (Lesser of #27 or #26) $                      
29. Present balance owing on Line of Credit $                      
30. RESERVE POSITION (#28 minus #29) $                      

[Continued on following page.]


The undersigned represents and warrants that the information in this Borrowing Base Certificate is true, complete and correct, and that the information in this Borrowing Base Certificate complies with the representations and warranties in the Loan and Security Agreement between the undersigned and Silicon Valley Bank.

 

BANK USE ONLY
COMMENTS: Received by:                                                                                
AUTHORIZED SIGNER
Date:                                                                                                
By:                                                                                                    Verified:                                                                                         
Authorized Signer AUTHORIZED SIGNER
Date:                                                                                                 Date:                                                                                                
Compliance Status:             Yes         No
EX-31.1 5 d899224dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT

TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Omar Hussain, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Imprivata, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting

 

Date: May 8, 2015

/s/ Omar Hussain

Omar Hussain
President and Chief Executive Officer
EX-31.2 6 d899224dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT

TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jeff Kalowski, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Imprivata, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 8, 2015

/s/ Jeff Kalowski

Jeff Kalowski
Chief Financial Officer
(Principal Financial Officer)
EX-32.1 7 d899224dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Imprivata, Inc. (the “Company”) for the period ended March 31, 2015 as filed with the United States Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his or her knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 8, 2015
By:

/s/ Omar Hussain

Omar Hussain
President and Chief Executive Officer
(Principal Executive Officer)
Date: May 8, 2015
By:

/s/ Jeff Kalowski

Jeff Kalowski
Chief Financial Officer
(Principal Financial Officer)
EX-101.INS 8 impr-20150331.xml XBRL INSTANCE DOCUMENT 93000 13284000 1008000 -145000 23742467 23742467 250000000 0.001 20000000 40202 0.001 0 288000 27500000 4021000 47248000 1144000 619000 24000 -100000 2498000 -107551000 171903000 7839000 10565000 64276000 1535000 1582000 625000 118179000 152000 40000 33120000 53903000 480000 78524000 1560000 7640000 3516000 118179000 0 25335000 1499000 105000 107375000 0 97000 33184000 632000 632000 0 97000 33184000 0 632000 -100000 -107551000 23742000 24000 171903000 -100000 735000 93000 21000 11.64 10000000 15000000 2000000 24082957 5928000 23979778 23979778 250000000 0.001 20000000 35000 0.001 0 196000 4004000 43666000 906000 490000 24000 -145000 2929000 -114250000 173654000 2883000 6632000 59283000 1634000 2843000 571000 109494000 236000 40000 33102000 50211000 417000 75377000 1560000 7286000 4693000 109494000 19073000 1407000 98000 99143000 0 2 97000 30187000 653000 653000 2122083 627033 0 97000 30187000 0 653000 -145000 -114250000 23980000 24000 173654000 -145000 9800000 7900000 2015-01-16 58793 2016-04-30 19100000 1900000 5000000 P2Y P2Y 0.85 -51000 7000 P3Y 5000 184000 1.00 0.17 376000 45000 -100000 -145000 0 -5705000 0.00 P6Y15D 0.0187 3627000 -2.29 0.54 17753000 1154000 13087000 9274000 19440000 330000 -7041000 -6881000 -131000 -6923000 -12000 220000 655000 -8305000 -7067000 -6264000 10166000 144000 507000 19000 84000 -410000 19968000 6536000 10419000 45000 6353000 -7356000 4193000 26000 -3367000 1238000 2160000 695000 -1080000 -655000 294000 3013000 -1783000 298000 -62000 -29000 13971000 57000 120000 3605000 5626 94000 92000 23000 89000 0 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>7. Commitments and contingencies</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(a) Operating lease obligations</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On January&#xA0;16, 2015, the Company amended its lease agreement for its corporate headquarters in Lexington, Massachusetts to lease approximately 21,000 of additional square footage. The amendment increased the total square footage leased to approximately 93,000 and extended the term through December 2021. The additional rent expense is approximately $7.9 million and the landlord has agreed to contribute approximately $735,000 towards leasehold improvements.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(b) Litigation</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company is not presently a party to any litigation that it believes might have a material adverse effect on its business operations or financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(c) Indemnifications</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> As permitted under Delaware law, the Company&#x2019;s Certificate of Incorporation and By Laws provide that the Company indemnify its stockholders, officers, directors, and partners, and each person controlling the stock held for certain events or occurrences that happen by reason of the relationship with or position held at the Company. The Company&#x2019;s agreements with customers generally require the Company to indemnify the customer against claims in which the Company&#x2019;s products infringe third-party patents, copyrights, or trademarks, and indemnify against product liability matters.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> As of March&#xA0;31, 2015 and December&#xA0;31, 2014, the Company had not experienced any material losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>6. Debt</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Bank credit facility</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company has a revolving credit facility with a bank pursuant to a Loan and Security Agreement dated January&#xA0;30, 2009 (the &#x201C;Revolving Credit Facility&#x201D;). In February 2014, the Company modified the revolving credit agreement that had expired in October 2013 and extended the maturity date to February 2015. In February 2015, the Company amended its revolving credit facility to extend the maturity through April 2015. In April 2015, the Company further amended its revolving credit facility to extend the maturity through April 2016 and increase the borrowing limit from $10.0 million to $15.0 million based primarily on accounts receivable, and is subject to certain financial covenants requiring the Company to maintain minimum levels of liquidity. Outstanding borrowings accrue interest at the Wall Street Journal published prime rate plus 0.75%. Substantially all of the assets of the Company are pledged as collateral.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> At March&#xA0;31, 2015 and December&#xA0;31, 2014, there was no outstanding balance under the revolving credit facility.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>11. Computation of net loss per share</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company calculates basic and diluted net loss per common share by dividing the net loss adjusted for the accretion on the redeemable convertible preferred stock by the weighted average number of common shares outstanding during the period. The Company has excluded all potentially dilutive shares, which include redeemable convertible preferred stock, warrant for common stock, common stock subject to repurchase and outstanding common stock options, from the weighted average number of common shares outstanding as their inclusion in the computation for all periods would be anti-dilutive due to net losses. The Company&#x2019;s redeemable convertible preferred stock are participating securities as defined under the authoritative guidance, but are excluded from the earnings per share calculation as they do not have an obligation to share or fund in the Company&#x2019;s net losses.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The components of net loss per share are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"> <b>Three&#xA0;Months&#xA0;Ended&#xA0;March&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 125.65pt"> <b>(in thousands, except per share data)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Numerator:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Net loss</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(6,699</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,067</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Accretion of preferred stock</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(1,238</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net loss attributable to common stockholders</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(6,699</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(8,305</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Denominator:</p> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Weighted average common shares outstanding used in computing basic and diluted net loss per common share</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">23,868</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">3,627</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net loss per share, basic and diluted</p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.28</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2.29</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders because they had an antidilutive impact:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="77%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"> <b>Three&#xA0;Months&#xA0;Ended&#xA0;March&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Options to purchase common stock</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">4,951</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">3,605</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Common stock subject to repurchase</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">35</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">57</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Warrants</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">120</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Convertible preferred stock</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">13,971</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Total</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">4,986</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">17,753</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table presents a reconciliation of the contingent liability measured at fair value using significant unobservable inputs, and the revaluation amount recorded in the Company&#x2019;s consolidated statements of operations as a result of the change in fair value:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Beginning balance</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,008</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Revaluation recognized in general and administrative expenses in the corresponding statements of operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">21</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(376</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Ending balance</p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">653</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table sets forth the Company&#x2019;s assets and liabilities which are measured at fair value on a recurring basis by level within the fair value hierarchy:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="65%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center"> <b>Fair&#xA0;value&#xA0;measurements&#xA0;at&#xA0;March&#xA0;31,&#xA0;2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 1</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;2</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;3</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b><br /> <b>carrying&#xA0;value</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Cash equivalents:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Money market funds</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">30,187</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">30,187</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Certificates of deposit</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">97</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">97</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Contingent consideration</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">653</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">653</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="65%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center"><b>Fair value measurements at December&#xA0;31, 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 1</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;2</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;3</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b><br /> <b>carrying&#xA0;value</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Cash equivalents:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Money market funds</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">33,184</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">33,184</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Certificates of deposit</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">97</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">97</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Contingent consideration</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Weighted average assumptions used to apply this model were as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"> <b>Three&#xA0;Months&#xA0;ended&#xA0;March&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Risk-free interest rate(1)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1.77</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1.87</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected life (years)(2)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">6.02</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">6.04</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected dividend yield(3)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">&#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">&#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected volatility of underlying stock(4)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">47</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">54</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The assumptions used to estimate the fair value of the rights to acquire stock under the ESPP during the offering beginning on March&#xA0;1, 2015 were as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="92%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Risk-free interest rate(1)</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">0.07</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected life (years)(2)</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">0.50</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected dividend yield(3)</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">&#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected volatility of underlying stock(4)</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">55</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1)</td> <td valign="top" align="left"><u>Risk-free interest rate</u>&#x2014;the yield on zero-coupon U.S. Treasury securities with maturities similar to the expected term of the award being valued is used as the risk-free interest rate.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(2)</td> <td valign="top" align="left"><u>Expected term</u>&#x2014;the expected term for stock options granted based on a review of the period that the Company&#x2019;s stock option awards are expected to be outstanding and is calculated using the simplified method, which represents the average of the contractual term of the options and the weighted-average vesting period of the options. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate the expected term.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(3)</td> <td valign="top" align="left"><u>Expected dividend yield</u>&#x2014;the expected dividend yield was not considered in the option pricing formula since the Company has not declared dividends and does not expect to pay dividends in the foreseeable future.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(4)</td> <td valign="top" align="left"><u>Expected volatility</u>&#x2014;the Company is responsible for estimating volatility. The Company has limited trading history as a public company and does not have relevant historical data to develop its volatility assumptions. Therefore, the Company used a weighted average of its volatility and analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March&#xA0;31, 2015. The Company analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March&#xA0;31, 2014.</td> </tr> </table> </div> 10-Q Delaware Imprivata Inc IMPR <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders because they had an antidilutive impact:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="77%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"> <b>Three&#xA0;Months&#xA0;Ended&#xA0;March&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Options to purchase common stock</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">4,951</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">3,605</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Common stock subject to repurchase</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">35</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">57</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Warrants</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">120</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Convertible preferred stock</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">13,971</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Total</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">4,986</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">17,753</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> Non-accelerated Filer <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> This following table presents the significant unobservable inputs used in the valuation of the contingent liability:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="11%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="11%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Discount Rate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> </div> -3541000 P10Y 0.00 P6Y7D <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>4. Accrued expenses and other current liabilities</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table presents the details of the Company&#x2019;s accrued expenses and other current liabilities:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="75%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Accrued payroll and related</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,883</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,839</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Accrued taxes<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">&#xA0;(1)</sup></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,144</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other accrued expenses</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">2,843</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,582</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"></td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,565</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1)</td> <td valign="top" align="left">Accrued taxes consist of accruals for foreign and state taxes, sales and use taxes, value added taxes due in foreign jurisdictions and franchise taxes.</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table presents the details of the Company&#x2019;s accrued expenses and other current liabilities:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="75%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Accrued payroll and related</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,883</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,839</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Accrued taxes<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">&#xA0;(1)</sup></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,144</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Other accrued expenses</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">2,843</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1,582</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"></td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,565</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1)</td> <td valign="top" align="left">Accrued taxes consist of accruals for foreign and state taxes, sales and use taxes, value added taxes due in foreign jurisdictions and franchise taxes.</td> </tr> </table> </div> 0.0177 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(c) Use of estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP applicable to interim periods, under the rules and regulations of the United States Securities and Exchange Commission (&#x201C;SEC&#x201D;), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended December&#xA0;31, 2014. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for the fair presentation of interim information have been included. Operating results for the three months ended March&#xA0;31, 2015 are not necessarily indicative of the results that may be expected for the year ending December&#xA0;31, 2015, for any other interim period or for any other future year.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The consolidated balance sheet at December&#xA0;31, 2014 has been derived from the audited financial statements at that date, but does not include all of the disclosures required by U.S. GAAP. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s 2014 Annual Report on Form&#xA0;10-K filed with the SEC on March&#xA0;11, 2015.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited, as well as two branch offices. All intercompany balances and transactions have been eliminated in consolidation. In the first quarter of 2014, the Company completed the closure of its UK branch office. In the first quarter of 2015, the Company closed its Netherlands branch office.</p> </div> 23868000 2015-03-31 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table presents the changes in accumulated other comprehensive loss before taxes, as the tax effect is not material to the consolidated financial statements:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="65%"></td> <td valign="bottom" width="13%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="13%"></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Foreign<br /> Currency<br /> Translation<br /> Adjustments</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"> <b>Affected&#xA0;line&#xA0;item&#xA0;in&#xA0;the<br /> statement where net<br /> income is presented</b></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> <b>Balance at January&#xA0;1, 2014</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(145</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Other comprehensive loss</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Amounts reclassified from accumulated other comprehensive income: Closure of foreign branch</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">145</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center"> Other&#xA0;income&#xA0;(expense)</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Net current-period other comprehensive loss</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">45</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> <b>Balance at December&#xA0;31, 2014</b></p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Other comprehensive loss</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(11</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Amounts reclassified from accumulated other comprehensive income:</p> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Closure of foreign branch</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(34</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom" align="center"> Other&#xA0;income&#xA0;(expense)</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Net current-period other comprehensive loss</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(45</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> <b>Balance at March&#xA0;31, 2015</b></p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(145</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Stock-based compensation included in costs and operating expenses related to the awards of stock options and the employee stock purchase plan are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"> <b>Three&#xA0;Months&#xA0;ended&#xA0;March&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Cost of maintenance and professional services</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">60</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">23</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Research and development</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">223</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">92</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Sales and marketing</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">216</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">89</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> General and administrative</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">202</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">94</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Total</p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">701</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">298</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <br class="Apple-interchange-newline" /></div> false --12-31 2015 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(d) Foreign currency</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The foreign subsidiaries and branches use the local currency as the functional currency. The Company translates the assets and liabilities of its foreign operations into U.S. dollars based on the rates of exchange in effect as of the balance sheet date. Revenues and expenses are translated into U.S. dollars using average exchange rates for each period. The resulting adjustments from the translation process are included in accumulated other comprehensive (loss) income in the accompanying consolidated balance sheets.</p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Certain transactions of the Company are settled in foreign currency, and are thus translated to U.S. dollars at the rate of exchange in effect at the end of each month. Gains (losses) resulting from the translation are included in foreign exchange gains (losses) in the accompanying consolidated statements of operations.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>10. Income taxes</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> We operate in several tax jurisdictions and are subject to taxes in each country or jurisdiction in which we conduct business. Earnings from our activities outside of the United States are subject to local country income tax and may be subject to U.S. income tax. To date, we have incurred cumulative net losses and maintain a full valuation allowance on our net deferred tax assets. Therefore, we have not recorded any U.S. federal tax provisions and our effective tax rate differs from statutory rates. Our tax expense to date primarily relates to foreign income taxes, mainly from our international operations, and to a lesser extent state income tax provisions.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> As of December&#xA0;31, 2014, the Company&#x2019;s valuation allowance related to income taxes was approximately $27.5 million. The Company is in a three year cumulative loss position in the United States. As a result, the Company maintains a 100% valuation allowance to reduce the carrying value of the related deferred tax assets to zero. The Company will continue to maintain a full valuation allowance for those tax assets until sustainable future levels of profitability are evident.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> As of March&#xA0;31, 2015 and December&#xA0;31, 2014, the Company had no uncertain positions or unrecorded liabilities for uncertain tax positions.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>1. Organization and business</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(a) Description of business</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Imprivata, Inc. (the &#x201C;Company&#x201D;) is a leading provider of healthcare IT security solutions that provide authentication management, fast access to patient information, and secure communications technologies to the healthcare industry. The Company&#x2019;s flagship product Imprivata OneSign, is an integrated enterprise single sign-on, authentication management and workflow automation platform that addresses multiple security and productivity challenges faced by hospitals and other healthcare organizations. By enabling fast, secure access to healthcare information technology systems, the Company believes that its solutions save clinicians significant time to focus on patient care, increase their productivity and satisfaction, and help healthcare organizations comply with privacy and security regulations.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company was incorporated in the State of Delaware in May&#xA0;2001.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On June&#xA0;30, 2014, the Company completed its initial public offering (&#x201C;IPO&#x201D;) and is listed on the New York Stock Exchange (&#x201C;NYSE&#x201D;) under the ticker symbol &#x201C;IMPR.&#x201D;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(b) Basis of presentation and principles of consolidation</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201C;U.S. GAAP&#x201D;). The Company is subject to a number of risks. Principal among these risks are dependence on key individuals, competition from substitute products and larger companies, the successful development and marketing of its products, and recruitment of key personnel.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Management believes the Company has sufficient cash and availability under its letter of credit to sustain operations through at least the next 12&#xA0;months.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(c) Use of estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP applicable to interim periods, under the rules and regulations of the United States Securities and Exchange Commission (&#x201C;SEC&#x201D;), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended December&#xA0;31, 2014. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for the fair presentation of interim information have been included. Operating results for the three months ended March&#xA0;31, 2015 are not necessarily indicative of the results that may be expected for the year ending December&#xA0;31, 2015, for any other interim period or for any other future year.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The consolidated balance sheet at December&#xA0;31, 2014 has been derived from the audited financial statements at that date, but does not include all of the disclosures required by U.S. GAAP. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s 2014 Annual Report on Form 10-K filed with the SEC on March&#xA0;11, 2015.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited, as well as two branch offices. All intercompany balances and transactions have been eliminated in consolidation. In the first quarter of 2014, the Company completed the closure of its UK branch office. In the first quarter of 2015, the Company closed its Netherlands branch office.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(d) Foreign currency</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The foreign subsidiaries and branches use the local currency as the functional currency. The Company translates the assets and liabilities of its foreign operations into U.S. dollars based on the rates of exchange in effect as of the balance sheet date. Revenues and expenses are translated into U.S. dollars using average exchange rates for each period. The resulting adjustments from the translation process are included in accumulated other comprehensive (loss) income in the accompanying consolidated balance sheets.</p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Certain transactions of the Company are settled in foreign currency, and are thus translated to U.S. dollars at the rate of exchange in effect at the end of each month. Gains (losses) resulting from the translation are included in foreign exchange gains (losses) in the accompanying consolidated statements of operations.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(e) Subsequent event</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On April&#xA0;30, 2015, the Company announced the acquisition of HT Systems, the market leading provider of palm-vein based biometric patient identification systems, to enter into the emerging patient identification market. The acquisition of HT Systems and its PatientSecure biometric patient identification technology supports Imprivata&#x2019;s long-term vision to be the leading provider of healthcare IT security solutions that increase provider productivity, enable patient engagement, and improve patient safety. Under the terms of the transaction, the Company paid approximately $19.1 million in cash at closing, of which $2 million was deposited into an escrow fund to secure certain obligations of the selling members of HT Systems to indemnify us and to pay us the amount of any shortfall in HT System&#x2019;s working capital as of the closing date. Additionally, The Company will pay up to $1.9 million in retention-based payments two years from closing plus up to $5.0 million based on achieving certain sales targets over the two-year period following the transaction. The Company is required to allocate the purchase price to the estimated fair value of the tangible and identifiable intangible assets acquired and liabilities assumed. The excess of the purchase price over those fair values is recorded as goodwill. The Company is in the process of finalizing the valuation of the assets acquired and liabilities assumed.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>5. Warranty obligations</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company maintains an allowance for warranty obligations that may be incurred under its limited warranty. Factors that affect the Company&#x2019;s allowance for warranty obligations include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and the cost per claim to satisfy the Company&#x2019;s warranty obligation.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table presents the details of the Company&#x2019;s allowance for warranty obligations:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Beginning balance</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">40</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">93</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Provision for estimated claims</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">5</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Adjustment to estimate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(51</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Settlement of claims</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(7</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Ending balance</p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">40</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">40</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The warranty obligations are included in accrued expenses and other current liabilities in the consolidated balance sheets presented.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The components of net loss per share are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"> <b>Three&#xA0;Months&#xA0;Ended&#xA0;March&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 125.65pt"> <b>(in thousands, except per share data)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Numerator:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Net loss</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(6,699</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,067</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Accretion of preferred stock</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(1,238</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net loss attributable to common stockholders</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(6,699</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(&#xA0;8,305</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Denominator:</p> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Weighted average common shares outstanding used in computing basic and diluted net loss per common share</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">23,868</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">3,627</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Net loss per share, basic and diluted</p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.28</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2.29</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <br class="Apple-interchange-newline" /></div> P4Y <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>2. Summary of significant accounting policies</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company has not made any significant changes in the application of its significant accounting policies as described in Note 2 of its audited consolidated financial statements for the year ended December&#xA0;31, 2014 included in its 2014 Annual Report on Form 10-K filed with the SEC on March&#xA0;11, 2015. See Note 2 in the 2014 Annual Report on Form 10-K for information about these critical accounting policies as well as a description of the &#x201C;Summary of significant accounting policies.&#x201D;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Recent accounting guidance</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <i>Accounting standards or updates not yet effective</i></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In May 2014, the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) issued ASU No.&#xA0;2014-09, &#x201C;Revenue from Contracts with Customers&#x201D; (Topic 606) (ASU 2014-09). ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. On April&#xA0;1, 2015, the FASB voted to propose a delay in the effective date of this ASU for reporting periods beginning after December&#xA0;15, 2017, with early adoption permitted as of the original effective date of periods beginning after December&#xA0;15, 2016. This new guidance is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December&#xA0;15, 2017; unless the early adoption provision is elected. .Entities have the option of using either a full retrospective or a modified approach to adopt the guidance. This update could impact the timing and amounts of revenue recognized. The Company is currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of operations upon adoption.</p> </div> 0001328015 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>9.&#xA0;Stock award plans and stock based compensation</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(a) Equity incentive plan</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In May 2014, the Company&#x2019;s 2014 Stock Option and Incentive Plan (&#x201C;2014 Plan&#x201D;), was adopted by the Company&#x2019;s board of directors and approved by its stockholders and became effective in June 2014. The 2014 Plan replaces the Amended and Restated 2002 Stock Option and Incentive Plan (&#x201C;2002 Plan&#x201D;) as the Company&#x2019;s board of directors has determined not to make additional awards under the 2002 Plan. The 2014 Plan allows the compensation committee to make equity-based incentive awards to the Company&#x2019;s officers, employees, directors and other key persons (including consultants).</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Stock options expire no later than 10 years from the date of grant and generally vest over a period of four years. At the discretion of the Board of Directors, certain option grants may be immediately exercisable but subject to a right to repurchase, at cost, pursuant to the vesting schedule of the individual grant.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> During the three months ended March&#xA0;31, 2015, the Company granted 1,446,050 options to purchase common stock at a weighted average exercise price of $13.55.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> At March&#xA0;31, 2015, there were 2,122,083 shares available for future grant under the 2014 Plan.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(b) Employee stock purchase plan</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In May 2014, the Company&#x2019;s board of directors adopted and its stockholders approved the Employee Stock Purchase Plan (&#x201C;ESPP&#x201D;). Each employee who is a participant in the ESPP may purchase shares by authorizing payroll deductions of his or her base compensation during an offering period. Unless the participating employee has previously withdrawn from the offering, his or her accumulated payroll deductions will be used to purchase ordinary shares on the last business day of the offering period at a price equal to 85% of the fair market value of the common stock on the first business day or the last business day of the offering period, whichever is lower. All offering periods will be for six months and begin on March&#xA0;1<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">st</sup>&#xA0;and September&#xA0;1<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">st</sup>&#xA0;of each year.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> At February&#xA0;27, 2015, the Company issued 58,793 shares of common stock at a purchase price of $11.64.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> At March&#xA0;31, 2015, there were 627,033 shares available for future grant under the ESPP.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(c) Early exercise of stock options</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company issues stock option agreements to Company executives and members of the Board of Directors, which may permit options to be exercised at any time. The Company may also include an early exercise provision for incentive stock option agreements at its discretion. The unvested shares of common stock exercised are subject to the Company&#x2019;s right to repurchase at the original exercise price upon termination of employment or other relationship.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> At March&#xA0;31, 2015 and December&#xA0;31, 2014, a total of 35,000 and 40,202 shares of unvested stock options exercised were subject to repurchase at an aggregate price of $162,400 and $184,000, respectively. These amounts are recorded as accrued and other current liabilities in the Company&#x2019;s consolidated balance sheets and will be reclassified to equity as the Company&#x2019;s repurchase right lapses.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> During the three months ended March&#xA0;31, 2015 and 2014, 5,202 and 5,626 stock options associated with the early exercise vested, respectively.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(d) Valuation of share-based compensation</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company utilizes the Black-Scholes option-pricing model to estimate the fair value of stock options awarded to employees and rights to acquire stock under the ESPP, which requires several key assumptions to be made.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Weighted average assumptions used to apply this model were as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"> <b>Three&#xA0;Months&#xA0;ended&#xA0;March&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Risk-free interest rate(1)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1.77</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">1.87</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected life (years)(2)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">6.02</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">6.04</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected dividend yield(3)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">&#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">&#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected volatility of underlying stock(4)</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">47</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">54</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The assumptions used to estimate the fair value of the rights to acquire stock under the ESPP during the offering beginning on March&#xA0;1, 2015 were as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="92%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Risk-free interest rate(1)</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">0.07</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected life (years)(2)</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">0.50</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected dividend yield(3)</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">&#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Expected volatility of underlying stock(4)</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">55</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(1)</td> <td valign="top" align="left"><u>Risk-free interest rate</u>&#x2014;the yield on zero-coupon U.S. Treasury securities with maturities similar to the expected term of the award being valued is used as the risk-free interest rate.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(2)</td> <td valign="top" align="left"><u>Expected term</u>&#x2014;the expected term for stock options granted based on a review of the period that the Company&#x2019;s stock option awards are expected to be outstanding and is calculated using the simplified method, which represents the average of the contractual term of the options and the weighted-average vesting period of the options. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate the expected term.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(3)</td> <td valign="top" align="left"><u>Expected dividend yield</u>&#x2014;the expected dividend yield was not considered in the option pricing formula since the Company has not declared dividends and does not expect to pay dividends in the foreseeable future.</td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left">(4)</td> <td valign="top" align="left"><u>Expected volatility</u>&#x2014;the Company is responsible for estimating volatility. The Company has limited trading history as a public company and does not have relevant historical data to develop its volatility assumptions. Therefore, the Company used a weighted average of its volatility and analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March&#xA0;31, 2015. The Company analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March&#xA0;31, 2014.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(e) Summary of share-based compensation expense</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company uses the straight-line attribution method to recognize expense for stock-based awards such that the expense associated with awards is evenly recognized throughout the period.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Stock-based compensation included in costs and operating expenses related to the awards of stock options and the employee stock purchase plan are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"> <b>Three&#xA0;Months&#xA0;ended&#xA0;March&#xA0;31,</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Cost of maintenance and professional services</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">60</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">23</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Research and development</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">223</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">92</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Sales and marketing</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">216</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">89</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> General and administrative</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">202</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">94</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Total</p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">701</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">298</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <br class="Apple-interchange-newline" /></div> -0.28 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>3.&#xA0;Fair value measurements</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(a) Fair value hierarchy</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The accounting guidance for fair value measurement requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <i>Level 1</i>&#xA0;applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <i>Level 2</i>&#xA0;applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <i>Level 3</i>&#xA0;applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(b) Assets and liabilities measured at fair value on a recurring basis</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company&#x2019;s cash equivalents primarily consist of money market funds recorded at cost, which approximates fair value measured based on quoted prices for assets traded in active markets. The contingent consideration liability is recorded at fair value determined using a probability weighted discounted cash flow model primarily based upon future revenue projections.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table sets forth the Company&#x2019;s assets and liabilities which are measured at fair value on a recurring basis by level within the fair value hierarchy:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="65%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center"> <b>Fair&#xA0;value&#xA0;measurements&#xA0;at&#xA0;March&#xA0;31,&#xA0;2015</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 1</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;2</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;3</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b><br /> <b>carrying&#xA0;value</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Cash equivalents:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Money market funds</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">30,187</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">30,187</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Certificates of deposit</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">97</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">97</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Contingent consideration</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">653</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">653</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="65%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center"><b>Fair value measurements at December&#xA0;31, 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level 1</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;2</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Level&#xA0;3</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Total</b><br /> <b>carrying&#xA0;value</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Assets</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Cash equivalents:</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Money market funds</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">33,184</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">33,184</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Certificates of deposit</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">97</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">97</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Liabilities</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Contingent consideration</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(c) Assets and liabilities measured on a non-recurring basis</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> There were no fair value measurements on a non-recurring basis as of March&#xA0;31, 2015 and December&#xA0;31, 2014.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(d) Level 3 fair value measurements</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The contingent liability associated with the acquisition of Validus is based on an earn-out capped at $9.8 million, to be paid based on revenue generated using the purchased intellectual property.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company re-measures the fair value of the contingent liability at each balance sheet date based on the present value of forecasted revenues through December&#xA0;31, 2016. The changes in the fair value are primarily due to the difference in actual revenue earned to date versus the initial projections and revisions to the timing and amount of forecasted future revenues.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The resulting forecasted revenues were then discounted using a rate that reflects the uncertainty surrounding the expected outcomes, which the Company believes is appropriate and representative of a market participant assumption.</p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table presents a reconciliation of the contingent liability measured at fair value using significant unobservable inputs, and the revaluation amount recorded in the Company&#x2019;s consolidated statements of operations as a result of the change in fair value:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,</b><br /> <b>2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,</b><br /> <b>2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Beginning balance</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,008</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Revaluation recognized in general and administrative expenses in the corresponding statements of operations</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">21</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(376</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Ending balance</p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">653</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">632</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> This following table presents the significant unobservable inputs used in the valuation of the contingent liability:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="11%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="11%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Discount Rate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">%&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(e) Other financial instruments</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The carrying amounts reflected in the consolidated balance sheets for cash and cash equivalents (which are comprised primarily of deposit accounts), accounts receivable, prepaid expenses, other current assets, accounts payable, and accrued expenses approximate fair value due to their short-term maturities.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Recent accounting guidance</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <i>Accounting standards or updates not yet effective</i></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In May 2014, the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) issued ASU No.&#xA0;2014-09, &#x201C;Revenue from Contracts with Customers&#x201D; (Topic 606) (ASU 2014-09). ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. On April&#xA0;1, 2015, the FASB voted to propose a delay in the effective date of this ASU for reporting periods beginning after December&#xA0;15, 2017, with early adoption permitted as of the original effective date of periods beginning after December&#xA0;15, 2016. This new guidance is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December&#xA0;15, 2017; unless the early adoption provision is elected. .Entities have the option of using either a full retrospective or a modified approach to adopt the guidance. This update could impact the timing and amounts of revenue recognized. The Company is currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of operations upon adoption.</p> </div> <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table presents the details of the Company&#x2019;s allowance for warranty obligations:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>March&#xA0;31,<br /> 2015</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>December&#xA0;31,<br /> 2014</b></td> <td valign="bottom">&#xA0;</td> </tr> <tr style="FONT-SIZE: 1pt"> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Beginning balance</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">40</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">$</td> <td valign="bottom" align="right">93</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Provision for estimated claims</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">5</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Adjustment to estimate</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(51</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Settlement of claims</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;</td> <td valign="bottom" nowrap="nowrap" align="right"> &#x2014;&#xA0;&#xA0;</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(7</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> Ending balance</p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">40</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">40</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <br class="Apple-interchange-newline" /> </div> 0.47 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(e) Subsequent event</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On April&#xA0;30, 2015, the Company announced the acquisition of HT Systems, the market leading provider of palm-vein based biometric patient identification systems, to enter into the emerging patient identification market. The acquisition of HT Systems and its PatientSecure biometric patient identification technology supports Imprivata&#x2019;s long-term vision to be the leading provider of healthcare IT security solutions that increase provider productivity, enable patient engagement, and improve patient safety. Under the terms of the transaction, the Company paid approximately $19.1 million in cash at closing, of which $2 million was deposited into an escrow fund to secure certain obligations of the selling members of HT Systems to indemnify us and to pay us the amount of any shortfall in HT System&#x2019;s working capital as of the closing date. Additionally, The Company will pay up to $1.9 million in retention-based payments two years from closing plus up to $5.0 million based on achieving certain sales targets over the two-year period following the transaction. The Company is required to allocate the purchase price to the estimated fair value of the tangible and identifiable intangible assets acquired and liabilities assumed. The excess of the purchase price over those fair values is recorded as goodwill. The Company is in the process of finalizing the valuation of the assets acquired and liabilities assumed.</p> </div> Q1 4986000 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>8. Accumulated other comprehensive loss</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The following table presents the changes in accumulated other comprehensive loss before taxes, as the tax effect is not material to the consolidated financial statements:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="65%"></td> <td valign="bottom" width="13%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="13%"></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'"> <td valign="bottom" nowrap="nowrap"> <p style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 48.6pt"> <b>(in thousands)</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"><b>Foreign<br /> Currency<br /> Translation<br /> Adjustments</b></td> <td valign="bottom">&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"> <b>Affected&#xA0;line&#xA0;item&#xA0;in&#xA0;the<br /> statement where net<br /> income is presented</b></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> <b>Balance at January&#xA0;1, 2014</b></p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(145</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Other comprehensive loss</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Amounts reclassified from accumulated other comprehensive income: Closure of foreign branch</p> </td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">145</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom" align="center"> Other&#xA0;income&#xA0;(expense)</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Net current-period other comprehensive loss</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">45</td> <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> <b>Balance at December&#xA0;31, 2014</b></p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Other comprehensive loss</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(11</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Amounts reclassified from accumulated other comprehensive income:</p> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Closure of foreign branch</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(34</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom" align="center"> Other&#xA0;income&#xA0;(expense)</td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#CCEEFF"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"> Net current-period other comprehensive loss</p> </td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom" align="right">(45</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> <td valign="top"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"> <b>Balance at March&#xA0;31, 2015</b></p> </td> <td valign="bottom"></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(145</td> <td valign="bottom" nowrap="nowrap">)&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> </tr> </table> </div> 1000 17286000 12913000 25636000 -45000 857000 -6662000 684000 367000 -6184000 -462000 -6744000 -14000 180000 371000 -6699000 -6699000 -6262000 701000 12723000 -45000 99000 -69000 -35000 23470000 6872000 12018000 21000 8350000 -3147000 4927000 37000 -4145000 0 3423000 780000 834000 -371000 330000 684000 4580000 412000 701000 5000 -16000 <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(b) Basis of presentation and principles of consolidation</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201C;U.S. GAAP&#x201D;). The Company is subject to a number of risks. Principal among these risks are dependence on key individuals, competition from substitute products and larger companies, the successful development and marketing of its products, and recruitment of key personnel.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Management believes the Company has sufficient cash and availability under its letter of credit to sustain operations through at least the next 12&#xA0;months.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited. All intercompany balances and transactions have been eliminated in consolidation.</p> </div> 2001-05 162400 P12M <div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>12. Concentration of risk and off-balance sheet risk</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains substantially all of its cash and cash equivalents in institutional money market mutual funds. The fund provides daily liquidity and invests in a portfolio of short-term money market instruments. To manage accounts receivable credit risk, the Company continuously evaluates the creditworthiness of its customers and reseller and maintains allowances for potential credit losses.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> No customers or resellers accounted for 10% or more of revenues for the three months ended March&#xA0;31, 2015 and 2014, respectively.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> No customers or resellers accounted for 10% or more of accounts receivable at March&#xA0;31, 2015 and December&#xA0;31, 2014, respectively.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company does not have any off-balance sheet arrangements and did not have any such arrangements during the three months ended March&#xA0;31, 2015 and the year ended December&#xA0;31, 2014.</p> </div> 35000 4951000 0.17 -21000 5202 1446050 13.55 0.00 P6M 0.0007 0.55 202000 223000 60000 216000 2015-02-28 0.0075 Prime rate plus 0.75% 2015-02-28 2015-04-30 -45000 -6699000 59000 1000 178000 1000 1000 683000 367000 701000 -45000 -11000 34000 0 0 0001328015 us-gaap:AccountsReceivableMember 2015-01-01 2015-03-31 0001328015 us-gaap:SalesRevenueNetMember 2015-01-01 2015-03-31 0001328015 us-gaap:AccumulatedTranslationAdjustmentMember 2015-01-01 2015-03-31 0001328015 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-03-31 0001328015 us-gaap:CommonStockMember 2015-01-01 2015-03-31 0001328015 us-gaap:RetainedEarningsMember 2015-01-01 2015-03-31 0001328015 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-03-31 0001328015 us-gaap:RevolvingCreditFacilityMember 2015-01-01 2015-03-31 0001328015 impr:SalesAndMarketingMember 2015-01-01 2015-03-31 0001328015 impr:CostOfMaintenanceMember 2015-01-01 2015-03-31 0001328015 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-01 2015-03-31 0001328015 us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-03-31 0001328015 impr:EmployeeStockPurchasePlanMember 2015-01-01 2015-03-31 0001328015 impr:StockOptionAndIncentivePlanMember 2015-01-01 2015-03-31 0001328015 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-03-31 0001328015 us-gaap:FairValueInputsLevel3Member 2015-01-01 2015-03-31 0001328015 us-gaap:StockOptionMember 2015-01-01 2015-03-31 0001328015 us-gaap:EquityUnitPurchaseAgreementsMember 2015-01-01 2015-03-31 0001328015 2015-01-01 2015-03-31 0001328015 us-gaap:SalesRevenueNetMember 2014-01-01 2014-03-31 0001328015 impr:SalesAndMarketingMember 2014-01-01 2014-03-31 0001328015 impr:CostOfMaintenanceMember 2014-01-01 2014-03-31 0001328015 us-gaap:ResearchAndDevelopmentExpenseMember 2014-01-01 2014-03-31 0001328015 us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-03-31 0001328015 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-03-31 0001328015 us-gaap:StockOptionMember 2014-01-01 2014-03-31 0001328015 us-gaap:WarrantMember 2014-01-01 2014-03-31 0001328015 us-gaap:EquityUnitPurchaseAgreementsMember 2014-01-01 2014-03-31 0001328015 us-gaap:ConvertiblePreferredStockMember 2014-01-01 2014-03-31 0001328015 2014-01-01 2014-03-31 0001328015 us-gaap:AccountsReceivableMember 2014-01-01 2014-12-31 0001328015 us-gaap:AccumulatedTranslationAdjustmentMember 2014-01-01 2014-12-31 0001328015 us-gaap:FairValueInputsLevel3Member 2014-01-01 2014-12-31 0001328015 2014-01-01 2014-12-31 0001328015 2014-05-01 2014-05-31 0001328015 impr:HtSystemsMemberus-gaap:SubsequentEventMember 2015-04-30 2015-04-30 0001328015 us-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember 2015-04-30 2015-04-30 0001328015 impr:EmployeeStockPurchasePlanMember 2015-02-27 2015-02-27 0001328015 2015-01-16 2015-01-16 0001328015 impr:ValidusMember 2015-03-31 0001328015 us-gaap:AccumulatedTranslationAdjustmentMember 2015-03-31 0001328015 us-gaap:AdditionalPaidInCapitalMember 2015-03-31 0001328015 us-gaap:CommonStockMember 2015-03-31 0001328015 us-gaap:RetainedEarningsMember 2015-03-31 0001328015 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-03-31 0001328015 us-gaap:FairValueMeasurementsRecurringMember 2015-03-31 0001328015 us-gaap:FairValueMeasurementsNonrecurringMember 2015-03-31 0001328015 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember 2015-03-31 0001328015 us-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember 2015-03-31 0001328015 us-gaap:RevolvingCreditFacilityMember 2015-03-31 0001328015 impr:EmployeeStockPurchasePlanMember 2015-03-31 0001328015 impr:StockOptionAndIncentivePlanMember 2015-03-31 0001328015 us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember 2015-03-31 0001328015 us-gaap:FairValueInputsLevel3Member 2015-03-31 0001328015 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2015-03-31 0001328015 us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2015-03-31 0001328015 2015-03-31 0001328015 2014-03-31 0001328015 2015-05-01 0001328015 impr:HtSystemsMemberus-gaap:SubsequentEventMember 2015-04-30 0001328015 us-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember 2015-04-30 0001328015 impr:EmployeeStockPurchasePlanMember 2015-02-27 0001328015 stpr:MA 2015-01-16 0001328015 2015-01-16 0001328015 us-gaap:AccumulatedTranslationAdjustmentMember 2014-12-31 0001328015 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001328015 us-gaap:CommonStockMember 2014-12-31 0001328015 us-gaap:RetainedEarningsMember 2014-12-31 0001328015 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0001328015 us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001328015 us-gaap:FairValueMeasurementsNonrecurringMember 2014-12-31 0001328015 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001328015 us-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001328015 us-gaap:RevolvingCreditFacilityMember 2014-12-31 0001328015 us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001328015 us-gaap:FairValueInputsLevel3Member 2014-12-31 0001328015 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001328015 us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001328015 2014-12-31 0001328015 us-gaap:AccumulatedTranslationAdjustmentMember 2013-12-31 0001328015 us-gaap:FairValueInputsLevel3Member 2013-12-31 0001328015 2013-12-31 iso4217:USD shares iso4217:USD shares utr:sqft impr:Branches pure impr:Customer EX-101.SCH 9 impr-20150331.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - Condensed Consolidated Statements of Operations link:calculationLink link:presentationLink link:definitionLink 106 - Statement - Condensed Consolidated Statements of Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 107 - Statement - Condensed Consolidated Statements of Stockholders Equity link:calculationLink link:presentationLink link:definitionLink 108 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Organization and Business link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Accrued Expenses and Other Current Liabilities link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Warranty Obligations link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Debt link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Accumulated Other Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Stock Award Plans and Stock Based Compensation link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Computation of Net Loss Per Share link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Concentration of Risk and Off-Balance Sheet Risk link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Organization and Business (Policies) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Warranty Obligations (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Stock Award Plans and Stock Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Computation of Net Loss Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Organization and Business - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Fair Value Measurements - Reconciliation of Contingent Liability Measured at Fair Value (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Fair Value Measurements - Significant Unobservable Inputs Used in Valuation of Contingent Liability (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Warranty Obligations - Summary of Allowance for Warranty Obligations (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Debt - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Changes in Accumulated Other Comprehensive Loss Before Taxes (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Stock Award Plans and Stock Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Stock Award Plans and Stock Based Compensation - Schedule of Estimated Weighted-Average Assumptions Used in Calculation of Fair Value of Options Granted and Rights to Acquire Stock Under ESPP (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Stock Award Plans and Stock Based Compensation - Schedule of Stock-Based Compensation Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Computation of Net Loss Per Share - Summary of Components of Net Loss per Share (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Computation of Net Loss Per Share - Summary of Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Concentration of Risk and Off-Balance Sheet Risk - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 10 impr-20150331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 impr-20150331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 impr-20150331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 impr-20150331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 14 g899224ex10_7pg008a.jpg GRAPHIC begin 644 g899224ex10_7pg008a.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X0/2:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C4M8S`R,2`W.2XQ-30Y,3$L(#(P,3,O,3`O,CDM M,3$Z-#7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN"UD M969A=6QT(CY+34)47T,T-30M,C`Q-3`Q,38Q-#4W,34\+W)D9CIL:3X@/"]R M9&8Z06QT/B`\+V1C.G1I=&QE/B`\+W)D9CI$97-C&UP;65T83X@/#]X<&%C:V5T(&5N9#TB"\T8C0'6'?K_^X`#D%D;V)E`&3``````?_;`(0``0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@(" M`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@`8`$L M`P$1``(1`0,1`?_$`)```0`!!`,!`0`````````````(`0('"0,$!08*`0$! M`0$!`````````````````0(#!!````8"`0(#`PH$!0,%`````0(#!`4&``<( M$1(A,1-Q%`E!46&!D:$B4A46P=%"(['A,B078C,8\9)#4R41`0$``@,``@,! M`0`````````!$0(A,1)!46%Q(A.Q_]H`#`,!``(1`Q$`/P#]_&`P&`P&`P&` MP&`P&`P&`P&`P+1*4?,H#[0#"YJWTD_RA]_\\F(OK93T4_R_>/\`/&(>]CT4 M_P`OWC_/&(>]CT4_R_>/\\8A[V5!),OCVA]8B/\`B.,0];+^TOY0^P,J9JN$ M0WY3\D+5JV3U]IO2-3B]CK-*Q5*W"E2/:-J;'=,2G?1])K" M:Q0`I?35D70@W0,*G<`!@ZT<<.?$(R-L:I\WIB];$ADDIY+3LOK?7=4U#;9, M!;NY*E!*-HIU/PM>=*IG09.53*/$D>TJBY3G4<%"9_'7<3+?VE->;<:1WZ*M M;X(CB9KXN4W:M:L\P?Y]<8B^]E@M@^0P_6'7^ M(8PO^E`;A_4;K]`!T^_QQ@N_T[``!0Z`'0`^3*Y]]JX#`\V5F8B":*/YN5C8 M=BD!C*O95\UCVB92AU,91R[511(!0\1$1\`P,#RO+WBC!B8LOR7T+'F(9,BA M7.VZ&04S*^\>F4X?KPB0QO=%.@#T'\`X&1Z9MW5&QRJ&U[L[7UZ!($#+?LZY MURS"B#DG>W]8(:2>BEZY/$G=T[@\L#(>`P&`P&`P&`P.N\>-(]HZ?OW3=BQ8 MMUWCUZ\72;-&;1LD99RZ=.5C$1;MVZ)#'._ZN^NV MG[@QO%3C[+-U%:?C&\@C'+3E=620E46"[]HT"29I'6(*;IOZC5P0P'24.4>N M!E?`P+LSH&4`<#/6`P&!T9.3CH6-D)F8?LXJ)B63J2E).0*L.\>>RCV5H]LG>/_#%5^$9%6B%9 MNHC>/)6"14,66G:I/+*H.]1ZQDED2I1S]!$9F6:&55*+=)5,2AX^P-"P_$2] M<5MB:J>A+_`$ZV7>=NT+8J!MV5LC6,!R\MLRYD2O8#8E@;ND#G M67,0%A[`*"?:8-IV`P-F(/IN%V:9R@4`#J&Q-RX0:-UW;I9-NV:HJ.7"ZI@(D MB@@055E5#CT`J::9!$1'P``P(*_#5KR\'Q"H4BH[4=MK[9-H[0AS*)`EZ=@>>UYV M9-V#7_("'DM)JMBA#:2A+-,\=[&FHH@DFNVE-MU&E["LDNW[R*=3)J1IU"K] M"B@*("H&#X:C0^IY5O+[C^%9L&^3$JR41G;S7=DPW-,2MQ[`>&4:[6LR5R!4 MP%`WI),!44*'0@J&\!"46I.0_P`/6]+KT&NM-2ZVLJ:)TGVJ=FZQB],6M%"+ M%%+TCT^\5ZN'>H-!4*!/=RKIAVCVC^`W0,W7CAGQ*VDT)^ZM`:GD16])RA-0 MM5BZS/?]CL079VJI)PM@2`J!OP&2=%Z!T$/DP,1N-!\@>.L"X?\`%G9UBVS' M,Y)H[+HCDK=75CA58033*DS$43:[B-=7JKRQQ=L_TXLHZDXQ`K0Y%"?W_42# M-7'+DY1^1<-.$BV4M2=E421&O[8T[<4B,;[K*SI"8%(N<9%_M/8YT4OJL9)J M*C-\V.11,P")B%"2.`P&`P&`P-7>U)PO-B]6[731^Y;\)M$KO76_K='/G44U MW_L2KE6?O-(0Z',M>]_&:`Y!^AQTU MRO'K3\"#MNB<(PNT;6\80'JB=,QVBCLI#>`X$]HN,CX6,CH:)9MXZ*B6#2,C M(]HF5%JPCV#=-JR9MD2`!$F[5LD4A"AX%*4`#`BGRY9L)9MQR@)`P$),\L=* M&0$Y3F2.XK3NH>.FZ;MIRE1URCHOD/# MQC`U0DY:MD,PD+17XMXF;]6I4#("HNI(KKH(+(-%!`HCT+@9;^%S-4"0X6:; MCJ9;("TSD;722&T#Q$@5Y(L=GW!V[N%R)8T5$6KUI+.IJ:64'U4BE.3H*1E$ M@*<0RQSBOS_7_%_:BT"H4EQNT0AJ>A)F;K.O5O&UWS:@5PWI()JCZ;![/^]J MG,'IIHMSG/\`A*("'V/'^]Z'>5""U1IG:.O+RCJ.LP=&7BZ?;8&>>1+.HQ<= M`I"\:13YRLBD0B2115$OIBM[M[_\`JS#W+WC_ M`.CWKWCT/6_Z>[N^C`]8JZ8_*)?:'\0ZADRU=+'+W!X>(>/EXAX^SY\K.*QE MM#2NHMUPBE=VYK6D[&AE"`0&5OKD7.`W[5`5*=DN];*NF"I%/$#H'3.`B/0? M'`A:?@%+:G[GO#+D)L/CF*9%UB4&;4=[CU`]>"5\1`J]-O$PNXCF_HOQ3,9L MZ!1,J#<4NST1*H'&ERPY.:+31;T@&.!B%#Q=M0M7W_`!]9YQ\$+Q3[GOC5T?Z* M)ZY+`M"[JUX`IR-BT9LR.:BG(,95\R`58XFA0>E:0[KP3\>RMML>1TK&'NLRGWBSBDP]X5:HF<]`0$AA"W?7(RQ7_4FB M-?:'>.:QNSFC!P#BCJN`3/,:JUE*UYA:=F[6DFCIL0HC1*B],W9=Y4?>IETU M(EX]0`/"Y(Z]U]I'BCK?AKJY%Q76VZK-6N.U(CD'#Q5W)I69P\GMA3%H?LNL MVLTF(!A*.)V01$C@3O3G]1(R@'*&/(.%:\D.9=%80KB)CN*'`RM-92C1,6\_ MLV'6TOL7>-1M* M%AIFNY.;K3Q^#60CT9&W1:,<#:!C@?M$%W:DF_F6;=%1-,Q3*+]/,I@`+>(^ MI?\`BK4:"\D=RO>TJQVQ=:_JN0?23"H:FL-+GI` MC!)\W4LV[MEQ5KKNDJR24BIN/E$6K627]90C=,RPKN4S^*:"H8&4^9-GN--X MUZQXY4F1,TW;R3<4OC=6'1G)7S^#92T&BVVK?%@1!9XZ8U"CLGZB[Q`!%LX< M(*]0\.H>]S,UDPHOPWM^ZKU:P)!0U*XW66OUR.CP4;>A`UBM&]Y0#W-(RBB[ MR)8+>J80ZKJ*&%0WXC&P/)J^D%*;L7BUR"T3$-X]I?:G6]=\CHRH)1:5>O6O M5M6OY/7^P)=!%VUBUY/7]MC6C=K(MB*NU(^651#O1'H4,"2#^&FD&@HI+L6416ZN59LFN[0F$F5@,4Z8=ITQF4%@$@H]V! MY>TX_A_Q_P"7'$77N@*Q7Z'NZ`V1$5>T1.NH`K*'::OV9'SK!W";'F6WIM#2 MK]TY*\B6CE1=YVBHJ!"D,F<0W(RZEYZ48P\6V)^=P_D M%V[1$OTF.`8&%]C\JN.NJ*:POMVW#1&-:F0<%K;B-GF=C?V]PV,":K&EPM=/ M*R]OD"K&*F*,<@X4`Y@`0#K@8=U#SOUOLW7VT]VV.M672V@==S!8>(V[MQ>% MK<3?E6BSB/G',!#HOWLLDUC)I(C)$3E,=\Z4]%$HKD51('Q[?GC:]FF]3BSQ M(WGO:#*Y2`FP;*6%T)K.6C5E!03E*K9=G*-I>S("L4W@A%E`$R&.)@**?>%H M3'Q3K:*Y&M,X9Z=CY)),W_'O_$__``)J;_C3]1_6?V/^ MQ:]^VOUOW'],_7?TOW#W;]=]P_M>^]/>NS_Y,#-V8>@ZB/F/T?5\V!WTS=4R MB(_)XB/T"(>/V9J=..T_IQF<``]`#N`/EZ]/L\!QE9I<\N/VYL#05(:2J M=TB'\@OU7,M&$<'4-U,J<0`H$11XI\E>6^J=PV5D]XF/69N7KAW8J7%2[^6T M=J6S;TK5?D7DY>JFK?XIU(U-/;-5B"/Y*"<(@_5?M07:E$JQB$#UN;%_^([N MBT0/%Z`8T^)L+R&:;(V9KSC`^L4_;J91WSX8JKDV-LB_/J#5I1I.R2;D4XY@ M+1)R+,3.#'1[2F#X38<-R]HEI:<87;J=3TQ`5HW(F>XZH[>E9/9-\T/#R:<# M>==MMG0A5IQH9XK77C]G5H1T=JT;NE6P.W:0$(4-B-6D-%L1E"E)X[1Z=M M$2-.AHF->*I'[F-<1629&.^61!(.U7M5[-KNI=F_$F3O5ANFQM';;:*ZO?,R MR$/5;-Q>U')$I&TZU4Z7#2*]?CM<79J$LXB&Y4DTT&<2SM:2EJVO8];\;C*:N7M$HVA64'L+DJS]]L]Z*W+)MY.TJ57CY#"*#)H M19=![,HJBF+<%E4@Q/IVT.*AOK?7".AU(9JSS&Y*!6[4RED#Q-?@>(^M-)TD MDW:)^5AT2(,F^PIA\]9M2)%5?+.)A1(ZG4@*IAE/B=^P^6$E0J_4Y*?LFE^/ MTNON6Z3B2$5#05LY&W^Q2MB@M>RR$?$-6%E3U/27H)/`;B"!%'B:;@%%O2.D M&Z81`/,0#VCTP+3'*4.HC[.GCU]F%DM<7O!>O^D>GM#K]F3+7BOF[M/JUVDW M"QM"`JZK]6L$VW0,;L]5>*B7;Y),3=B@%`ZB`!U[3=.OD/EC*76Q&W@C6BTS MAWQUC@D/UAW,ZPKU[F98Z@+'DK#LI(^PK$\,L4I!6%6S4_-RK@C6.BHN.0.Y>O7;A00*FB@@F)A^ M4?(`$1`,L9LQ<-+'#VE4_E/S6Y14FJK#_\`Y:3U$Z;=E(+`<#KB)B$2SO:PVOXG^AJK-II.H?5W M%/;&V*>CZ:95&-XN%[KNMY>556[!67*%21.W23[@(05U#]!,(=`GG;:W%7.K M6:G3B9EH6V5^9K4PB3M[U8N>CG,7()E%1-5/N.T='`.XI@ZCX@(>&!IITSR' MW-2M:Q?P[=?5M9WS0U4I*:C)8)MN^-0Z%I*NHL4:7RE,1B]'F([]. MBTBBK(3H>[B1-#IW!Z_`#6FM-"[BYXVJ3L2"4?IZ+K.NW'NBCR[7^WJOW#A583%2211`"D13`0@MIR!WGRNVC5*-JVL1&O MY?65^/RFVSMB^^O.1%KV98[/,*ZQOSZ*9S)9FX12U4@FC>LQYC,D%6*3QR8Z M;5RCWA.+DIH*FL(AG011FN:O,O9[YQKRMV3>IG5UK#EQ9MD*:S9"WU MQKVLTRJQ0R16T7$'?@J+`BJPF>-U50^/N_&2N:P'5^B:K2FO-SEBVJ53CF5Q MY/SDE<-1:;I<>:*@U)H^MD'KF$KU?@FL<1=NT!FF]<$.4QWKMPLFVF8K=[2HP44]KDWLH[UYL.1UQ!HH%@]4TZH:Z;3* MS=&,226.6MFN%?5#BKQU.UUEQ1TW/H+!7W[_7:* MU3=[HL<"X:(1ML6>>[*F@G+PB_H"X56('>"9RAM8`H``````%``*````4`#H M```>0`&!7`8#`8#`8'1%%0/Z>OL$,SBNWK5=[N;IUZAUZ>7\.OEC">XX/'R^ M[(VPOO3?VM..U.3N.R)9PW+)2+:`J=9A6+J;>N""/J*N72AC=P_..3E M?X^V&/B!0UO_`/'M]M/7];JEEV'QUM54Y>0;-2B(!ZBW4IDU`(JG>4OGX1%XT.],O_-W<.U]H054MM^V[1)J! MKDXN16YSNH3:?H+C3S>B5MHM)62XC.(3S@Z;&*2=>F^7.F!>XPB,662Y9KUK MQ7?;KM-FY3[V8775VZKK9T9+4C>J6E>$V#HW3,?4UZC6Z"]D2M739C-VZ.DW MTO98T"+-T))^"8=%FPGQE9KF9K[Q+X;/#5,&QCZB<'<^ZF;S[M*^;%C%+ZNN M507TGLAO"VJ,87R6E%W"JKI>117,N=8X&ZD'MQFKYU^W%R\2C^.O#?94%H&C MUJFS]HBZQIC74%3XN+JY"67:$[$ZPKBC`D>T3!:0B`L@KH=P&/WI=1,`=Q@3 M*;>9UVS38]60=&XI6G2M*BHV(KUD6;2/D)M&.9I3#^/8'648L7LF1$KUTS9*.5#))'.8B8J&$H`(CDS6_.KJ M5ZL5JHL%(JIUV!JT6L^>2:T;7(>.@X]62D%17?R"K.+;-6RCY\L/>LL)145- MXF$1QE9).GN9%,!@=5\Q:2;%[&R"!'3"1:.F#YLJ4#)N&;U!1LZ04*/@8BR" MIBB'S#E2S,PU?:<5YG\0J2ST0;C,3DEK:A?K$-IO8.L]MU&!LPT9";E5ZG7] ME5_9CN"!A*Q,$X;-2.(U1PV*B@4@$,8HF&]NR]>RQP:U?D7K*(,\D65(E' MP-W(5V]0KMPH:OS/8)$551;N?]N?O22FVD[B/FSJOO#?^QM#\X>#EKUZ+AQJ M2U:GO-4VXK)UQ8L`[LS6?6KSSW""LKZOW&M6YDY92K<$V[EFY:=@*'*8P`RS MCZ?2V:$^*IL^-3HDC*<5M#0-@?,V=FVEJNP['M6QZW6_5!29/3(NT0K>'_<# MUH44$%U%$S-SJ>H0Y#%`Y63S697/`7C6I!U%BPK=GK]OI,FZGH/QU*]0J2,>[V-6HQ*T0&MK?;746F4CD5;!>+:K'1C6R7^W/`[I.V6 MMW&LV:3Z6?*B/0`(5)LEVHHE(D0I0F6II/E=4M1T:E76[;!@XQP%HOK\\A,/ MI!^ZDB,E'*;(LDA74'9U"5]G-N(YNN_3;=A7:S=`5.XK=`J;)XC("+"/;/Y" M5:QT>UE)8K(DK)-V39%_)DCB*I1Y)!XFD5R](P37.5$%#&!(IS`7H`CC-7QJ MA1S2T%O+="NG[)Q_NU*HU_UU+;#8A/W9E(/$:_#;0H$E192Y5DD<@Y,I>$G]/ZYBM-:KU]JFON73N(U_48.JM'SY59=] M)#$L46SF5>K.%7"QWDHZ(=PKU.;H=00`>F3+4UF.>V2DE#]X`(B8##T$!\?K M#YNF)4VUF'&4>M*]4:M#-EG]GV%? M)H%TZIK^GQC9)9>2LUI?H^@V3*7M)^)102I)G,7.':[23A'7C?QZO3FT?^3_ M`"K<-++R1L;%9&M5-!8C^C\9JA('7$-=:R3(,3(?KTX8#.W[M,Q"*` MW+_7B.4Q'5?,T)1F]C7I?69R31R MP>)B(]%&KQ$[9<@B`@/0R2@A@LF,->/P]=:T-KH2A,;%2*;+;7XX6W;F@OWG M(U>,?VVO):[V9:(F.C8>U2+5S-(L#UT[)4@H+D3$JO0I2^)R%>/6Y2*@YBHA_&(.W8"4?3;HG4ZD[.\H9%YJ7UMK'B9R,NSIFI(%C]2 MV^/9L$E/14?RMBB5ZS#,RJE(J*?O,Q,($Z@41Z&\/')\M6\2/JN..N5=02]MZ=,SY& MS`8#`8#`8#`8'Q=;UY3:?/72R5>$2A)38-@4A!=& MAFD\^9(IIO'C=!)P^!%,7!U3)D$*DDC[3(I@,!@,"OAT\>O7Y/FP?\4#Q^7I M](X'(0A1_P!1P#Z`\_O\,K-M^([)`1)X@8O7RZB8.O\`EEX8MVO%:,[89D"OM9\-HR,K-.B%TF[F+E.1FR*^ULEGN M1C$<*I+/M::TE(R/8@JEZC1[-/#D$JA0')6M)FIQ9EV,!@<@I*`/3M$?I#RR MX9]1!?B@\EFF]N?]'=D:ECH+D?6K?$%:F`0(38NE=>2[XAB`BD!%E73#UU?$ MWP1#,NH!C!Y&$/8(X3$1+YKK["A-(.-FZJJ1 MKQL+2UNJ&U(>MM445)F9@*U--PV)"P*AT'"Z,I/:Y=RK$/=R^]*HN%$4NIE. M@ZE8WUDY1?D]O0_Q$]CZ>H>FEI"6XT:WGJUN?D=;WD5*Q,9.VRN+(S^K]"1Z MK]HV1G9-G;6:,M8TT!5:(-V:"8JB<_8:L29N(VJF,)QZCY_PS+M)B86Y%,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,#F25$H@`C^'R\?D^D/HRRL[:Y_;NYIQ,!@, M!@,"#?!M*0=Z\W!;99)$LE>^6')V?<+('`R;I"(VM.42*."0'.+8&T-3F[<" M&'NZ(]P^)NN2NFB:.9=#`8'80./42^8=HCT^;I\V6,;R8R@MQ@4(MRL^(@JD M8JJ1=M:3;"JF8%$@<-N/M(*X;BH3J3UVYC`"A.O<01#N`.H9IR3S$`'S`!]H M`.#((`(=!`!#YNF%S5@>DGU`!*41\_'Q^\>N3B+_`%LZIB-T4P2;II)$[S'$ MB)"$)W&ZB8W0@`7N,(]1'Y<5K267-<69=#`8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`[R:A3@`?U`'B`_+T^4,U*X[:V<_#ERLF`P&`'Z//`A%QJE'](V[R6XW M60S5NY@M@2._=5B5-DS":U'O>7D[%(>YM6Y4U'`T[;"<]'NU1)U3*LT[A_N% M$TLRUKMYOX3/%%0/Z>OL$/\`UR8KIZU6"0X>93?8.%S`"''^DWV#@S'`NX09 MH+NW:R;9JT16,G(W?4 M^Q]]2,2YB#NITZ=0#Z>GC]_7SR9K?C50RQS``=>GAX]/#K[<9)K(X\C1@,! M@5`HCU$`\`#J(_,&#*F`P&`P&`P&`P&`P&`P&`P&`P&`P&!4!$H@(>8#UP=O M1`>H`/S@`_;XYMY[QPK@,!@,"(/*G3E[LYJ-O312C1+D/H9Q,25)BY-W[E7M MFU"P)LDM@:;M:YA]%M&W:/C43,7I@[XR7:M7!3%("O<&2./O(2C9F,DH<55W8G23;@<2YO7PG17*S!U*O0-4KL>C%U^L0T97X*,;`)6\=#PS M)&/C6*`=1$$FK-N0A>HB/0,8)M9T]GT4_P`OWC_/)B+ZV=54.BA@`.@>'3V= M`R5TUN8X\C1@,"X@=3E#YS!]G7Q^[*EXCOB4!*)0```0$/#PZ=<(" M`B`^8>&8=S`J4HF'H4.HY4MDF:O%)0/Z1^KH/^&,5/6JGIG\NPWV#_CY8POJ M?:GIG_(;_P!HXP>I]J"4P>93![0$,&8=!^8?L'(N8I@,!@,!@,!@,!@,!@5` M!,(`'B(^`8+QR]$`Z``?,`!]@=,V\]YN5HG^\M(W#_A'D,S8)1KRYQL2G+5+9\(TZ MF9U'=M+3=1J5Y@FYO!H[*X;2\6(]S5R4@"B8N*I$[DY%4^/AV^YN-;Z=DG,M M)14A8^.5KB]@5Q!HT(W/'6-Y7+LI0+I$L)@5CD!L@E++MS(B*A^ABX1T9[87 M(;<=,1C=(:YLN@YR<>KL9+8O(*`KX.:-#$%R0\U7-;0MHG'=NLSI--,S)O(* M,8]`5@.Y.5E+);K9)GL>S-H6UP25V!L^W..\7-B MMTX*:9W!D_4,FR9I`FQC6O1!LDFF'00SM@,#A53[P`0_U!]X?-DL;UVQWTZ8 ME,`]!`0'V9'3,.TWY1^PU^$,!@,!@4$`'S`!]N!8*28^90^KP_PZ9,1KUM]K!;D'R[@]@^'W@(XPONK M/=A^0X?9_F.,+_HM%N?YRC]8_P`0R87W%HHJ!_3U]@A_/&*OO53T5/R_>7^> M,4]:GHJ?E^\/YXQ3UJN!`X^?0/K_`)=<83W%WNYOS!]^,'N'NX_F#I[!Q@]Q 8S)I%)X^9OG'^`?)ED8VVM_3ERLF`P/_9 ` end GRAPHIC 15 g899224ex10_7pg008b.jpg GRAPHIC begin 644 g899224ex10_7pg008b.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X0/2:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C4M8S`R,2`W.2XQ-30Y,3$L(#(P,3,O,3`O,CDM M,3$Z-#7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN"UD M969A=6QT(CY+34)47T,T-30M,C`Q-3`Q,38Q-#4W,34\+W)D9CIL:3X@/"]R M9&8Z06QT/B`\+V1C.G1I=&QE/B`\+W)D9CI$97-C&UP;65T83X@/#]X<&%C:V5T(&5N9#TB"\T8C0'6'?K_^X`#D%D;V)E`&3``````?_;`(0``0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@(" M`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@`3`#( M`P$1``(1`0,1`?_$`'D``0`#``("`P`````````````'"`D$!@(%`0,*`0$` M````````````````````$```!@(!`P,#`04&!P$````!`@,$!08`!P@1$A,A M%!46%PD8,4$B(R91,C,D-!GP87&!H=%#)1$!`````````````````````/_: M``P#`0`"$0,1`#\`_?Q@,!@,!_WZ?\?\\#XZ#_:/_C_U@?.`P&!#6V^0>F]& M-&BVS[["5V0E3HHUZK)G7F;U;';IR1DUCZ=0X-&2N%MD'+Q4J9$8YDY/W#Z@ M``(@&1O*7\B7+%M+4N@Z)TU&:AM.W)U*K:D@]V))R6]]B'D'Q8]*X16I(N0% MKK&DQB:GF4DK2J8YU"BF1F84G'B#8O35!(Y6R!EDTBJ'(50Q@P),#_KUP&`P&`P&`P&` MP&`P&`P&`P&!ZR8FH>O1KF8GY:,@XAGXA=RLP_:QD:U!==)L@+E\]50;(>9R ML1,G<8.XYRE#U$`P/8E,4Y2G(8IR'*!B'*(&*8I@ZE,4P=0,4P#U`0_;@>6` MP*T;TY[VI26O\P=%O6-0T*.NDE%6+."H$`#J:,#XJ1@3 M/O/*6S1#18RX'E70.U MZ%JY&6)X3BV2"1D6QB&16$Q#'*8/"Y4;0?X_:0ML>"J-FW?R7V+--J1KZQ7= MZEL;?>VMDV,[EO7H!"R3)V;B(J\T#A('$'C!LG7UD MV-R!Y,VNM;$Y);E/65IAS7X-)I6M5UROQ;]O&:[HCET=U("PCU)QVFX<@H3W M103`0.)3K+!?;`8'K)J;AJW$25@L4M&0,%#,G$E+S4R^:QD3%Q[1,RSI](R+ MU5!HR9MDBB9110Y2$*`B(@&!6#COS&UARDMNRH73L5=+!3-:.6,8YW"O"(L- M8VR?<]QGD%2Y9R_)+3;R*1[55U/9)M_$H0Y5#$42,H%LL!@,!@,!@,!@,!@, M!@,"/-LZKH^[M;W#4^R85&PTB]0R\)/Q2_0OE;J'37;N6RO0PMI"-?().6JP M!W(.42*%]2A@9,TO?=V_&7;:MQKY2R4W=.+DGTCN/_*-2/=NY"K,@*=1'6&W M6[%)<%%:Z1(Y6KYN!U",`3.*8MB'!D%VM@\]./=2>1E:I,Y*[^V18(Q"4K6L M>/\`%*[0M,FV?,/DHMQ(N8$ZM;J#"29F!9-S,OF")D.Y4HF(0P@$<&H_.KDB MF)]BWF+X5:V=&2;N=>Z?>QFQ=[3L6IZ/_E=S/&Z-9UX\<(F`&_P4<]H!2#BMJ.^[KV@KSMY,5=>L7F4B7%?XWZ MDV,7:)$(NVR_&.+FIA;5_&'5"SMN[;[!Y1ST$\B MU=C;VGVBB(P%50739,!4!99,H"S,])F1(FFK*SDHX5=.#%*5,%%!*F4B92$*$J8#`8#`8#`8#`8#`8 M'%2;'2U`B)%B^X$>Y3O.?J8/3M#TP.5@4PW M5S>UIJ^V+:GHT#;^0>_`*F!-,Z;C2V"L/HOESL&MZAUM(HG?0W'W2\;%6I[$SZ#9^G7Y^\[? MLL<9]-2\"_.W>>TA&T&]'W#QCL.T*=I^(AG^W](O(") MY.<64E4(NO[ZI18Y<*%R0T!:9PHOZ_=+37NTSZ,=K#$O9E%?"RC8UDF*BRZ@@!E%5 M#>A$TDRG565,5-,ICF*40S3TU0K/SPV-7^66^JU(U_05->B]XFZ!L::Q"S7C M4%1IR(VA#*J>T=SLXBXQT%]%A,/KQM"^2GUGNO;$ZJHZL>S-B/40&6FWKEP)ET(E!PHH2/ M9`/C:(&'H`J'5.<+28#`8#`XC]^QBF3N2DWK2.CF#=9V^?OW*+-DR:-R&57= M.W3@Z:#=N@F43'.NNYI/5U?PQ\#MB'2[S1^Q-:*]2M)!A,,2E759HB) MT^IE$B^+N*B&C6`P&`P(XVOMS7&CJ/+[&VK;8FF4^%(7WU-,QO3`S[<.JH]VYV1QP\R.PX**02.MM#CC-OVA]G4^12*V7.K])W*ML>9M*VJUT/(M(*=H(I(3;2' MVG`NA)![%I4HV5(0&K]$T@@94"LU451[#AGWJO:4E^1;?(K4O'6NLI_9]E" M/G5&(9N9^]W^Q*E_R=:HM/BR+S5DFGJHE3*1%/Q)"6SN5LVD]))DIDS(*:]T1%/0%N/;%Z@ISMM M&.VW:U3(=.2=/D%P`PF2`3GZA?NHTNH4"`852BU:O4ZLQ2)&\;7ZQ#Q\%#,4 M2%*0I&T=&-VS1$.TH=>A`$?WX'9NG[OW8%7^2_#_`$;RL@F<=M&L'+8X,06I MVR:NZ&N[(HSY,XJMWM9M30@ND2(KCY/:N`<,CJ`!CHB3O-V4C+ MUN-F8LKJW3K`IUM1\:47114(UK44HX78VK8R*1B%=6)VFHNFLF`-C%`A%,#1 MK`8#`X[IJW?-G#-X@DY:.T%6SILN0JJ#ANNF9%=!9,X"11)9(XE,40Z"`],# M\Y&E*)4=V[B+!0K8U<1TI5;/#>R`[,\ER-7>RMD-11416G4DFE9>&!);Q" M)U,"[6A.&6M=*3BVQYR8M>[=]2C0K6>WQMZ4-:+VJ@9("JQ=7*N`Q5#K8',I MXV$4B@4$U!(HHJ`!T"WN!`'*K4+[?G&_=NF8M^2+E=CZXL]8B7RI2&00EGT< MK\7[@#B4I6JC\B9%3=>I4S"(>H!@4ZT5^1#1U.UW6-<\H913B[N;7-=A:?=: M7MF/EJW$O):O,TX5:5H=L?,BP%SKTF5B5T@HS<*G317)WATZ',$FS7Y/>#$6 MT!:,W_6[T_5,9-G7]9QEDV-9'RX=@%1;0E/AI9Z!U#*%`IE`3()AZ=V!U5'F MWNO:Z!@XP<+-PVQFX1\T;?\`>Z\=Q]UX[1()QW[RT8:>J+U5O[S6'$>M*5]ZK&BJ#IPP<[IN@/+N@^$ M2$1,NP;-"&3`_0@>00P+":1X9\GB@N)7:%R=/;YM&7>J(* MMW3QY?+8O*SZ*CU-<_F3:JMVY^\?Y8=<"T6`P&`P&`P(BVMH+26\H_XS<&JJ M'L9L5L+1NI;*S%2LC'H&6*X,2)EUVPRT0(KE`_O7]N!"U+XLV73EO M@9#2N_MC5[5K9\/U!HS8QS;@HXPG@:MV\7K^;L\DUV!KL8]-N/MR)R[Z/3[N MGM!*':(0OJ^.7Y`?D"WGM>>=-Y&D\18Z+T'JBON"BL2+V5;:]"W/:5[;$3,5 MJE(FC)9M"E.H55-.V:WKCDM<;7?>7LY:JY`VRHW3D':DK['5_P!PFD[*E7:,V9QM"K4C M$O$Q;N`3CA<(N$5"&,!N\,#31))-%--%%,B2*1"))))$*FFFFF4"D33(4`*0 MA"@```````8'G@,!@>CGJQ6K4U38V>O0=C9(K`X19ST2PF&J3@I1*5=-O(-W M"1%@*80`P`!N@_MP.-`TRGU7R_3%4K5;\XB9?X&"BX?S&$I2B97X]JW\@B4A M0ZCU]`#^S`[+@,!@,!@,!@,!@,!@9P:<0Q)A".'^]&OSK(]``Z90T?P&`P&`P&!GO MP4B%M8V7EWQV;MV[2I:?Y$R,WKEDV*H5")HFZZQ";6802)EU%':Z43-S\@4# MJ";U.)"&$A"E(&A&`P&`P&`P&`P&`P&`P&`P&`P&!#6\=#:XY#4Y*F;&C7RR M$;+LK-5K#`R;N`M]&N$458(6XTNQL#$?05DACKF,@N3N(/42J$43,8@A4DVT MN7/%N37BMS4:?Y9:9Z'H.V[IX_XNF!FM:_\`:0^80^VOWP][\<]]O^DS]5'P'O\`XT?<>/[;?TG]5>SZ M^Y_^O=W>]]>_`Z8__3S[%+[@_P"]3]K_`("(^1^LOO#]!?&=4^WY_P"G/ZR\ M7^+Y>[_+>/N\/\KPX$AU/_:;^:8?>?[M_4WP\-\?^N']0WM?C?;#[+VGW7_H M#P^U\?=XOY';V=O[\#8O3?V.^CF7Z?\`[6_07A1]A]I/I7Z6\/\`-\'@^D?_ D`,SIU[^G3UZ]W[^N!+.`P&`P&`P&`P&`P&`P&`P&`P&`P/_9 ` end GRAPHIC 16 g899224ex10_7pg009.jpg GRAPHIC begin 644 g899224ex10_7pg009.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X0/2:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C4M8S`R,2`W.2XQ-30Y,3$L(#(P,3,O,3`O,CDM M,3$Z-#7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN"UD M969A=6QT(CY+34)47T,T-30M,C`Q-3`Q,38Q-#4W,34\+W)D9CIL:3X@/"]R M9&8Z06QT/B`\+V1C.G1I=&QE/B`\+W)D9CI$97-C&UP;65T83X@/#]X<&%C:V5T(&5N9#TB"\T8C0'6'?K_^X`#D%D;V)E`&3``````?_;`(0``0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@(" M`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@"<`(L M`P$1``(1`0,1`?_$`*\``0`"`@(#`0$````````````("08'!0H!`P0""P$! M`````````````````````!````8"`0,"`@,�T(#`L)`0(#!`4&``<($1() M$Q0A%3$B%D%1<1<866&!D;$R([9WE]=X&3E")+34E=76-[(2C1%1F:&1Z=(:!$!```````````` M`````````/_:``P#`0`"$0,1`#\`[_&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P'7K M]'QP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/`@`@(#\0$.@_@ M'`BBV1?QW*Q4C.RW8C.?JKR2FJJN=F_J"B47"P$9$R+5LTG%GD`B#H5OZY>, M$O>/2J(H',4IQ,$KNOP_^%T_^-T_6P/.`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P(V1]*NS3DK-7O\`KH]/DJF$.LHX7C%&B*2+6(.P;115"KR[ M98\RV=J/$4Q;MU`%!0PJ&``*$D.OU>OZ/7_XV!^\!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@:O3>6$FR'3)I[5:KKP)WDL<\P1Z]:6,OL4&J#*- M4$Z\>S%DAU.1/HBH=0R@E`YA,(;-Z!V?2/3N_1_[OZ.O3]CU^'7[V!^\!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@1FITE.%Y#[9A6=+BPK2OR>7 MFKXC<(QQ))3RE)I+&"@7%-">EIJ/%Y'MWBIEC,XEJ8C=,Y".#J*+G"2?13T> MWN+ZG;V=W0>WN_8]W3Z?T<#W8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8`?H'H/0?N#]/3]'`TK$7",5W3;J,QK==/+Q]<@YZQVF$F&*\XU9.$A1K MK.\Q?RQD\8N)!4ST(I,KE_U:-55C^V*HD54-S=?VONZ_]]U^YTZ]>OWNG3`] MF`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`']#XC@1-JZM$/R@O_2H MNH&_K)()_:M2->*HWV'84JF"\%O*"JJW8MZT$@T9G0.1`JZQ#&1%0Q''8$K> MS]J[.XW_`'/=]WZ>GZGW/P8'MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P/`_0/X!P,<-58%6P,+2>-;A/QC639-9("`#D&TS\O\`F"2BO3O5*M\K M0^D?AZ88&2=/U^O^[U_7P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!2;J3R-\UN05+N6R- M%<%Z1LBBTUS*1R\JTY$KP+^9L$*R;/Y>H5R&LNK8E[.6>'!V5LX!`#1POTU6 MZ+Q8Q0[@V.\Y8^4)E6$K0IXR(!3.:5FBO/& M/$L$X::/"F,\Y8:_B/?J,G+0S]_$#)UHH2L,X8JJ`T=I?M*RX!\>TIAP/G1Y MF^0YK(7%I+^*^SN$JC&1;PRL'R7UJX3FUG")SODJNZ@D*PIRR/R M\`9*K`':F4#'[C_#X?3@<4GS*Y\*'(3^:GV`3O,!>Y7E%I$B9>OPZG-[8>TH M?='H/3`]ZG,+GRFT:/!\5MX.#L[D@-DN4^D3O6WM3)E$SQO[0/0(X]3JD/<; MO`IA^'3`^7\LSGQ^:EV'_I0:1_M?`^A7F+SY12:JCXJ[TH#I)14$T>4VD5%F MX)KJM_3>)^U+Z"IQ2[REZFZIF*;[O3`^<>9O/@`$?YJ38@]/N!R@TCU_2_K? M`]R_,?GPW641'Q4WU84C=HJMN4FD54%/@`]R2GM2]Y/C]/0,#T_EF<^/S4NP M_P#2@TC_`&O@/RS.?'YJ78?^E!I'^U\!^69SX_-2[#_TH-(_VO@/RS.?'YJ7 M8?\`I0:1_M?`?EF<^/S4NP_]*#2/]KX&LMM^3+E/H:FNMB;A\:E[H=%8NVK! M_:'O(77L['1[R0]1*,1?H4VK6:6:$DWQ2-$5CM@;@Z72(HHF!P-@7$1,@26B MHR53)Z9)*/92!$P4*KZ9'C9-R4GJD`"*=H*=.X/@/TA@J8H=W;U,`29OUK1HE'M M]U79GD$:E6IJQJL$ETVRCQ.&CG$@9J1RJ4Z3H@/3I@:O\U>/5FWI,<=(RTS9=G0EDE::Z;2-(N4 M55W-OA84MBD:M$7F2A&M/F[$W@A,[%DT>K./;IG/V=I#"`2MP&`P&`P&`P&! M3WX.Q_\`8?5_0W]OD`_0_P#MPY'X?IC@7"8#`8#`8#`8#`8#`8#`8#`8#`8# M`8%8?F%)('X%[2)%%,:0-8-:E;E*JV1$W6_U\%R^J\;/&I0%KW]>](X"'P#H M(@(!8G1FK5C2J>R8H(M6+.K5]JS:MTP20;-6\2T2;H()!\$T442`4I?N%``P M,IP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.O'/)E M4_UBBEF,F4XH\3DG6V!(5E!V&)@:TW@JXW9%;QCR:;,F,X_E MUSJ/9)=@B5J1^LHD4RA2$-@5R>8URFIR=\4T:+=9,_Y3(/C2*J!OE_I!>=+( M>S%REZBXNA,/?Z8$_8?6ZX&<:.UWM8_D!O5KL+C>U0BHSD)NEPW9/Z%!6W2^ MQ*:XU[6DX29B+'$S));3]D7&69HR;]5D>+L:<2T:D4(^0!@,!@,!@,! M@>!^Y^'_`'AP*@_"'[;\B5?V?N/0_'UO'I[KTO6];[7J>[_^1_:_1]YZGI?U M7I=O=];K@6^X#`8#`8#`8#`8#`8#`8#`8#`8#`8%6?F7],?'_MHJYNQ'[0ZN M[S=Q2=`_&-6A#ZQI&(*'4X!]+E+\)OV!@LIJ`B-5K77Z?L]"?JC&-NO]27[O MZ`?@P,CP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!X' MZ!_`.!0041_]X6^GZ>(_0?T0^3D'H/Z>!`%Z?6RD76-D;^K;S MU^=B6T;#R5M0N7 M]8S?G%XI%B>Z[R;G'M]DO[9UU/M/2B?[4N*2X)_LOK=2&`2=0^'7J`?'I$NB MUO,;<'M`:PRLZ5I+ZY+M5P8!G()RN>+D;W4=8SK%A+OF2$X\8M M'T@P8*1Z)V*;0V!V)BCU`!'_`+/C@>!^D/P_[PX%2'A4CDHKA> MNR0?(228;PW`\]VV[?2]24GD)5=K]158OJQJ[TS93ZW7U43=0*/4H!;A@,!@ M:U@5-O#LW8"5F;:\)ITD13CZN=0:]B-L5><40E`OR-Z;OB!748ULZ3:#%&8" M*ATE%/7Z&*&!LK`8#`U1N]QNUKK*PK<=8_6LIN$KFMEJK+;SRQL->*-5;5") M6Q6>=5)):P$4:TP\BJQ*W*/J2!$"*=$C''`VO@,!@: MOL6OH;3_`!G2%E8>QU4?W'VG?TC[-I*^[O"'1+V23WM9&ZF]0?HP-QX#`8#` MIJ<^33?T)3KI?B<'KGM^G5KD;N30;*8TA;'-@L"B^M+L_AF4W.Z^&HRS6J2J]9K3^(:4NOP4=,).XER$FV]9R5H9'ZCA43@4`L%[O\`O3?J M8%7OF-0F`\?^Y)V(,W-]DI+7MEDX]VF0R,O$M+W7V+MB)Q1641.F>0(Y(9/M M,)VX%$P%,;J$Y=&;.UWMC7D58=97*"O5?B3J4]Y.5Q\G)19;#52)1<[')/T. MK9V9@]2$@J(F.BH'0Q#F*("(;?P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&!X'Z!_`/ZV!0.7_:%@_DD?\`$Q,"['<=Q9:\U-LJ^R!% ME&=+HMIM2Y6\4WG'';`0KR4*+>&=2$2VE5RG:@)&ZCIL18P`454P'O*&A>%. M]Y;D#J-"Y66*U57[44\3BIQG#VV$V1O ME[LASO"??!?:`5S&:VKFNBZMA:O%T2'BZ?)SC%TNU=-!D5SH,URS!O2<-G07 M;@/;T+\?P]/A\?T_T<#]X#`8#`8#`]#IPBS;K.W!_3;M457"ZG:8_8B@D=54 M_80ICF[2%$>@`(C]P,"J7PJ!$JK$0<("]=.=M6P$7:@ M.")BB52:K45+V6K15RCHGYA8;[5W;IZ6O3;1=44FYT4Q7 M*05._J4`S707)2N[^?;*@V-!VGK.U:FG*_`W.G[:KL-7;$Q66MNI]AS\C-7N9:.$XPI?3;)N"G!=9%(2F*%BGA<&\ M2G".-N^PF\J%@VCN#R)K2#9H@T;$;SK[UUDS)(I(*% M'O2*"1B"(1<\QFA=M[DW7QQ@N/%-=.MSWS66W*W'6Z"W%*:QFB1%!LFNKBHQ MD4!D8.OR8.8$^YLF;`J5NOCD\IE'UK)VNPQ&PXM.B-;K M=+O:2`\33`@"B7N#='&_66 MM]O1M.4V;3+*$O6>=B''2Z4#;?(2R;:H^UJ?;U[1,V:/5ILY.D"`LO'&E),7 M<;8&9P2D7K4RJGK"%*8[# MUA/'L=1D7\U%MI):&GZ\Y+)5V6>04VQ=PUGBX6D+WO&?NZ]MW!Q]N^MK`+V;8*-8 MV'HY=I["W'2&58501(@$0R@TUER`670("+5LV#T>/+<.P+OR4=A;I.8>5>OP<5MK95:^6:T^=V:57>UZ-9-V3-XN@R9(M9)LLQ_;/; M$4,%P>`P&`P&`P/E>NT(]HY?NC^FU9-UW;E3M,;TT&R*BRQ^TH"8W:F01Z`` MB.!5EX7E&RO`>A'045%138F[W#ENX47]PS.^VW;G[5!=DY.*L6=6,=(+^W$B M?U5@4[>J@F,%J^`P&`P&`P&`P&`P&`P&!U#/)SS(Y!\>N9/,76FH-SN=7PU^ MC^/4\\9P\&\-;GTTRUU2FCN1IUWCD0<4UVC$1Z17H++%2?,RBBF'J&'N"S3P M@7BQ;8USREVS>+M^,^^7+D,R;6'9(PQZX>VM:UJ/745!KF@!CX_*BPLKCR/5[AL1L0YFRRJA]!-#DD3%05*FV*W/LCB6251=/;C==BVA\F"ZAE7"S)W+6U=>/?+G M-U,Y1$CCX?L_IZAN+@=2:QK;2]KUW1XE&O4NB\B^3M6J<`V6=+M86OQ&][VV MC8MLJ]7V;;+K3*_8HM/7+2:UFO&MMDIS^PU2U2'+0%YAY'Q:-I0<27N$ M%G"R2+8J!UE#`1,PX%87CIW=IOBIPAY#;8GY':5DI.M-OFG;G8;AKQM&[RFH M^\MJ&6JSMQ]'8MOC;T=2LV>+=-W[5VU*E%_UOZ"B[8YU@BKR&Y]0Q3HDT7D_9Y.:8/4F3NPBQ:DAB0D<];M0=F8*KBHYP+I%HP+^ M/O6#TRBKER]N.X3NI!TW3;2,D9IM.UQ;1W*)ID(/OPC(]!(X&ZF("12=>A0P M+6,!@,#T$L0.I>X`[@^(8'OP M&`P&`P&`P&`P.I%Y$.*B7(GGMRLD%]K\8=6*1#;CK!Q,GOO>1=9S@'7UI6I" MQOZG66RSC[0LVD0HB1PI(MB(&.L4C17UB+"F%C_@QJT)4-*\E(2NRD5(0\?R MFMLUBN\M.1^KX"R[-DXBDJ3S MVJ7B9CT/=HO'OLVDLZCH$ZZR)53D2/U(!AZEZAM+?V\-[#S?T^PX[5S@H%E(Q+Z=CGD0NVC'NH$C)'36<`]1D#F#T@1 M**@;%5Y(^0KW#84/<]H!5O>`MS'T[[H3=4O;^U].`%'M`/4[^\0']CT^[@ M:XV[SNY@:7J9K5L7Q_)TV$=+/HII87'*G6UC9,IA.NSL^S!]&UFI2^?!JS:6V("ZTB/=!/`314.5L\<$)W].[J`@ M`2@P&`P&`P&`P&`P&`P&`P&`P&`P&!^%%4T4SK+*$222(91150Y2)IID*)SJ M'.80*0A"`(B(CT``ZX%=>Y_)-I"D6"%HFH+'JW>NP)9@M./6[;?FJ=>:YJ%> M1.=(DC<-I668=0[5_+.4E$&$;'-Y.065)W+)-VX@XP-F:FY]\3]JT.$NY=XZ MLH[B3!ZVDZ=?ME4*NVNM341(.HF:AY1@YL7I+^RDV2I$GC4Z[%\B!'#955!1 M,Y@V4GRSXK*G322Y,X06,D3L`1`PG[2&"YKE-.TRK<<]QVO86KDMU4^L4.=L4YJ MQ:#8V).[(0C89!&&&)D64DR5%5RW(8%3MU?;=GK`41(&!4]KCE3J':GCHY36 M[CIK>D<"(ZO61UJJ)D[1`(0\!'3MAB*8C7;M84=<55=W#R+U.UMV:+A9J_38 M+D254560*)0"MY*;L5BW7XAI>W[8JV[;4]Y9[) M-!QK_7"U<:L&CI),D6+-P5J0`$KDX'])$.W^LH5%,RIQ$")E, M6$25_7))-G.24HWJ\5'MG4G(-6RR8()-2)D`JA0#L!8#`8#`8#`Q^V!UJUD# MX_&`F0^`B`__`%:Z^@0Z"`X%8/A.=+/?'1IITOZ?K+3^V!/Z*"#9/J3:5N2+ MVH-DT4$_J)AU[2AU'J(]1$1$+7L!@,#5E=TOK>J;4V1NFOUX([9&W(NDP^P9 M\DC*K!8&.O&%=S]0/:*/<31S&?L%:<#/ZZN,'?*HZ^:5F3B)4$&=EKK555#UO M0=)%,BL11%0Y#!MG`8#`TCN#COJG>\GK"7V7!R,P^T]?(W9-#4C[-9:Z2.M< M49,[1T_1KTM&(SK$#HD,=H]*NU.)`[B#\>H;NP,!L&JM8VR34F;1KFA62752 M105E9^G5V9DE$&Y>Q!%1_(QSET=)`GP(43="A\`Z8'-UJH52FLUH^HUFNU9@ MX<"[78UN$C()FNZ%--$7*S:+;-457`HI$)WF*)NTH!UZ`&!D>!!5CXV.&2%Q ML%XF-.,;O+6&PV2UJQ^R)^S[#JD+8[A;F]YM,S4Z;;YF7JU2D+!96B2SM6.: M-S.$TP1.)D>I!#(='\".,W'38Q]J:HJ5C@[<%1DJ"Q/([$OUEA(2DR<\G9%* MI7:U8K%)P-?K[*73%1FT9MT4&0'.5`I"J'`P3)P*GO-52FUBX!;0N!967A;! MJ*9I^P:K(PSL[-P62^+OEH=TL M:-\NG+EJQ$2^W0D$',B\3#L*!P7>M=@Q*"XBIU$!*W2Z%$`$!$!,(?@WB[Y< M>V2*3R[@LL*ZYFCL[11L)4@;)(LPV*1=!=(X'%10SA0J@&*`$()1$X>C M^:YYA?G>^5O]RY#^-'`?S7/,+\[WRM_N7(?QHX#^:YYA?G>^5O\`87YWOE;_87YWOE;_87YWOE;_/BW?J;">1L2TD48 MSTG`M6HD`3B'IG2ZIF"!'%'A/H>L3ECJ^_%&U==36^]DZMU%R@L=,UQ?=:W. MP0;R`KTIIO8.O-I0-OJ-'ODG,1JDO5W_`%(O)I/'K9-WWHF;*!Z^6.O^+FBI M;7<+KGCY2]HZUT!N2]ZTO-EG:]5H_;_)#>\-J;8-PMXJJA%U^%E=+\>[#(PA MYQFFU3B'3X0C$4`;M"`L$*=9T2#YJ\BM)Z*C:Y3]"SETGI&$>W6N:XTM'R\6 MPJ\+<+@X4<476D-14$Y1^ZKC045G9/7;B7J1T9JN")P[$QO'GY'>YGV>6_97 M:(C\Q[M1PX"4ONU`+[#MM@!W>P[1'U>O[=U_J>F!Z7/CS\DH.%P9^6[8@LP6 M5]J+O4<9[H6W>;T!<^C;01]P*73O[/J]W7I\,#T_S>GDM_.VWS^"1C_A=@/Y MO3R6_G;;Y_!(Q_PNP'\WIY+?SMM\_@D8_P"%V`_F]/);^=MOG\$C'_"[`?S> MGDM_.VWS^"1C_A=@1QY,ZC\@/#BH5?;5V\FFQ=AU]2[I02]:;4*/KA'SQM3[ MC=8QF_?#)SJAXN;D*!^@?P#^M@4):Q`! M_P!8(Y'_```1#BM7NT1`!$!&O:1#J`C]`B`]/P8$T^3/)W7>P^,O..#U%M&1 M@K+I+6=UKUMV'&P=I3A:AT,*?M>E2=A7D-6T2TOII35K(D_6:*Y8T2*L7)]FV:V M=.#VL_="X]^L^CUI[UF:+A7H0"A$*9J^U(+D[X:Z%LG6U(U5>&FT+Q>)K7NN M:IKBDTR!,XVU`O)!6)C-93=FK[Q5U"U8'*KPSTKET<>BK9NNH M9!G'-XALYL&TQ2C6H@+=J"6S+2W."0@FD`@LJB90?JA]8X_AP+4L!@,!@,!@ M,!@,!@,!@,!@,!@,!@,"M+S#?T;?*+_T:IO^5&C8%A]5_P#-BN?^08?_`(/; MX'/8#`8#`I]\6[@J^Q>>A"M6K;VG(YZU,=LFB910%7IO=^F) MR@0HI)$#MZ@)C!<%@,!@,!@,!@,!@>.H?1U#K@>`&0?&6.'891J1(?BH& M!`#A)N^YW[5FNM04"-J([KWWO/9_(C>31RW0MU+T/I!+;#DL\N]1>)J+NYS9 MB,($%5DG215CNGCE\;M08"8P<+S3XH0MNV_KK7_,"9^4<*&#K=S+6Z_!PLU[Q6N3SM$6F M?-#3]7TJ#L<;5Z#O[?%+K+^:DCR+=_`UBG;-BV1$%U8ILLY=M6Z*2:ZHN5NY M=-01`O`P&`P&`P&!5-Y=W+=EH+43QV(@T9\F]>.W8@BHX$&K:G;&7 M<"#=%-59P((D-]0A#'/]``(B`8%K.`P./E9:+@8R1FYR2CX:&B&3J2EI>5>- MXZ,C(YDB=R\?R+]XHBT9,FC=,RBJJARIID*)C"``(X&LX3?VC+-2"[*KFX]8 M3NO#RT77PO$1>JS(U0D[.2$?$Q$*K/M)):,0EI&3EVK=%L=0JQUG"9`+U.4! M"F[5_P#M!'(_^2M7OW/Z0P,%X8V>G[%D?+3*1,'5%"O;%:B6B"Y,MF-(UI,2 MSRU;@>*K[:CDK'9YBJQ#"/7;L7X,XR,CA;-B+]II-1\L`8WJ2DVNW>)[DE5: MEH[7.S+NXV]'ND]1:!?T9[J6V-8JWZUG88E.E-17"1L%NK1J>V;+R))UZ2<= MB1PDJEZ'I`(1LB&;W\LOQ!/;#I?7N@K5,6?*AIRQ(?,48^':`Y67<@].X(/KI(JE%,H=JX=@4,UN=:_+=JB-\CX8+*_I(6 M2&&W,JX"B*0S[NM^]^VF!F<96V,=6KY:8RNV>XIHVE*!B1;P4C5O93"!W3U@@F*D@Z!9SWGL M8I,YV,:HY1!$7*PD1!=5)+J*BJ93!"S^>&XO_P#-WRV_T6-L?WEP'\\-Q?\` M^;SEM_HL[8_O+@9-'^6?B>^7D$5XOD?%D9+%20PHCY? MT"=H=?7(@?ZP="C\>@8/@VS?FBG=OVJTE M"JI(FC'7'?>[>2*LL!#(HF8+:^([!58JA1(7L[C`8.@#U#`YAOY8>'CMJD^: M2&\73)=$KA!XVXP1=%RCK4Z*J!R?$#E,)1#X@/3`QL?,IP*`A5 M!O\`L8"'$Y2''0>[@(U7C['HW<4!*ID39(`BLYC)*EMW3<% MT>TY>I>T2F`2B("`B'TI>:7Q\KN5&3?:-T>BV56CH'RR#1RX9#JK<7O8M)V@JN M4TLT+03.6()=A2'$Q>A3JIAU'N#`T/X@Y^)O4AS:V/5G82E-N/)!VZK\N":K M4SL@IR\P9%Q'O"(2<:\1C9]FHH@Y1263]<"F*!@,`!=)@89L2N6*W4>T5FI7 MF7UG99R'=Q\+?X&,@IJ9J;]P3M1FHZ*LS"4@'[IH/Q*FZ;JI#U^(=>@@&6-D ME$6S=%9<[I5)!))5RH4A%'"B:92G7.1,I4R'6,`F$"@!0$?@'3`]^!KMW4[@ MOM2%NS?94@YJT2,Q$OXR^+68[/[4M)&%C63AD5D1<62 MR;KU!(50G4X;$P&!KC6M4O%2:6UO>=G/]HKS5_MEFK+V0K$!6%J?3)MZ1S7] M=I$KR:2,XUJ*/>BE).2@\=$,'J_$H8&Q\#`=A5Z\6*,AVU!V#^+F497"I3,M M*C58BW%FZE$S35Y:J89A,*)(Q_VMA4U699!$P.6!U`62`QB]HAGV`P->+5J^ M*;38VU'92J&M&]'=P+S485&!42D+FM-(OFE^&]''[2-3,XS4[P6$ M0.7H(;#P(=<\>.LARBXV6O5E?CX5[<5)^C66G.9J>DJF6*E:Y;X=]+/(NVPT M;+RU6FG=-^:,6SYNV6.B9X/4@E$V!3WXZN`L7M#2$MMO7W+GE9HR0N6R]H0] M@JVH=JT_V2;+7^Q[;1ZDA+6)&GKR-G59U^%3!-ZLK6SR%\][-6;!'NHF=KT]M2K2L-,1;U(R#R/DHYY1U6SMHY1.)3D.40 M$!P(U-?&%I[B/R:X?;5H6\MMSVV[-R)>1LTMLRP52U.[?`/M;[7LMT?J19H. M,D%I%\RCDHQ:124,9L5Z+@P&<&(?`O[P&!KMG7]A);4G+.[V"W=ZM>TB!AH3 M5X5.-;NX6[,IF:=SUT4NQ'`RTDWFX9TR:$C3I%0;&:&5*83*B`!L3`^9XFY6 M:.DF;DK-VJV73:O#(%=%:N3I&*@Y,V,=,K@J"H@82"8H'Z=.H=>N!A6K8*^U MG7M1@=H7MMLW8,7#MVMMOS.KL*4UM4R03BXE6]4BW#J/@DENX`*@DHP&[5!,QS%`R[APH4B9 M0^LL*1?-@5AN\BX.-E=A.8V[MHU)Q/G,]KK47DZ47)6[WN-VAK!CM&F:0\86[ M*=J**V#8]1/-Z+:CH>R=F6"SZ5L.QJ99Z:RN-NGV$W2M4UBPH(&DV,Q6695F MKD'+T1%PZ%$?:E"/](B=:P?*7PJ1VHM@(;*H":&QG$1/DB(F'>QSJ0MQ1[:.C/;H`T73?Q"2ZRA4^T3+!ICPTR M="=[SY6#+;IU#M;9"LRLUU^K2WDFI*RFOVMFF)&W7N*A[$Q2=5:%LR\Q7T%F M$6K\M33CVI13!0G><.Q%@,!@,!@,#'K=W?96R]O3N^037;U^CN^6.NG7I\>G M7`K)\*X1A?'AIX(8[U2+"?VK[0\B1)-Z8OXSK6*_N"("*)1!T*@%[?Z@"]?C MUP+5\#3\96MO-=T6RVR>T8V5TM*4VN0U5T\GKZ.83%5NK%^\7L-U6V8C-K2% M@C9Z/500)%+,$2M%$C*%6,!NT`W!@:NN4-MI_?M4R5(NM7KVN85_:5=OUB8J MJTW/W>/>09&]09U6>))LTJFM#S_5R[5.BZ]RAT2`I1^M@;1P&`P/BDA?_+G_ M`,J]M\T]DZ^6>][_`&?S#T#^S]UZ?[9[;W';ZG;];MZ]/C@:)XI?E'_DYZ@_ M*]^POY3'V-8?CF_%GZGV#^VGJ+^^^S/J?6^7^CZ?T?5]3N[?J],"0>!';1B_ M)A:S[V3WZRUZUJ#;:LLEQZ7IBC@\W(:C$#JQ3J^D475:I6,IU"I=J14OJ)]3 ME[A[A".WE>^'`/?@A]/_`.%GW?C_`(Z=<]/P8'P;QXA:5X[36HH) M_P`D9G;D!)2^UZ;9[8QAW>O*A&7)B[;)UFV5MR5%XT]RV.F)5!%51,_>4I3` M(?K['^5W_GSX0?P%;C_C9P'V/\KO_/EP@_@*W'_&S@<8K5/+N!Y$$=P\#%$D MD$S1!U=2[M0/(.A3,*J$DF6]."PSOU(;U%&783ZX=P_4P.5CZQY6DV M[\DCMW@RLX6-Z;!9'3N[!*R22=]Y'9B!LUL5==ZS*!3HF`2(&,/:HIV@80]X M(>6)`G0LCX]9$YUWRACN(WD;&^W1.]7%@V3!!^_!T";#T^]0WIF!3J7H?IZA M@A+Y'VOD)><(=]-]WR'#%CKAQ#T]O8E-7M=W&N)?<;-I3:/-%O;<_;P3!)%\ MJDLY6726[4"'*4G<8%"!UU^:UEJ]NJ''"U5P+)/-(#2VN-4V?9+J^RDW3Y[9 MFL-;U=CL:L5ZD3L*TD8*9IY7T4G)R+-VYC)`RJ0A_7!E1`)K>-.>U7QFV3;: MUR[VK1=5P*8IIV>L2_(*5KDM%V%D[H.PJ.[DM75ZN+LYYU)#$-3$F$)TI#12 MZS%RBJ0ZB)0WI'[P\?\`LGR0V7D+,[914EKNUNN1-;WE5 MX35.HZ-6VB6N6EI*TJL%&'1^G"M!! M,RSY%0&9`W!PHY?:0U_R2V1NZG5&R3=&3X^:@@N6&Q!V,RV=):]O4KN?8)+G MNBYWEZM\YVO4GBDE%K'?Q+8!8PXI@9HU39BW2"R?Q+SE6MT5S`NE-FV5@K]I MY87>7CI6(>&<0\BQ?LV4K'RC5`.U-%Q)L)-)510Q"+JIF2]3]B4`"WG`8#`8 M#`8#`8#`8#`8#`8'@?N?3]/W/P#@=7WC9R(D^/FT=A[SW+K:=AMQU=ML+5^X M^-7'71-"U?#UJK!L*C.]8;6V_8R;'BJG)&FE+F#>L+OFI)-^9](&156:)@I@ M2Z?><#BVPH]7W:>A\AC)VJ=M&NV=858PK.!3"K1K.T/+`WFGMK;:JF7ZX.BL MP38RCF;06**"S9(HE$X:@Y-V/DII/=]+YQ:NX_;$Y!3.Z*O4['&ZUV3QN2M5 MFXX1;6BRD*GJYELNC6.?M.KYA=]85'1VT7`"B^<.'@2C];HE@8'7?-1S/78Z M@O5LX1P$#IG;6Q(.B0VS_G-X"N.UWES;TV7292QHE9DUDV3\'"2"3L$?<+MS ME3!0"'Z!V8P^C],?]P1P/.`P&`P&!4WY@58E'1&BS3`-Q0/R^TPBS]PB98H3 M2\7=T8(R92D4$CDLP=`4C_`$U.AA$`#J`6R8#`_)A$.G3[X!^'`ZSNH=V[=U MANZ(U/J[F#MC\F^6Y/VJ"BK?9N#4C:-..)>W[CF'=@UJZY(6^\N;*[.\N,HO M6DIDQ3)!(K$,B?T@`Y0WIK,#C_K`O)($C%(H/%.`!,YR"H0IQKND>PQTRG3, MYM1NJ[3AZ9:94[5`2@NY)'P3]V9N MB)@$H*K%1[2B/PZC@5E^#\_J>-S2*@`)04FMKJ`4?I+W[4MYN@_HAUP+:/RMV;BM6^:7'E3F4WV&_TVXXX;03:,=>2=S82);W^,.G&@WKPE)G(*559) MQ))!,P]YTP4.3N+TZ&*&L?'/8>).6KRC0I52&!N8X&],.O>(A*/S&4B5V%C@7"*B?U M1##^,'!GQI\D-04K9*VM;QK:S65W-5^:UG9>3^TUK#7;I6+1*4JQ5Y$Y-A-U M)E!&S0RZ+-R1!,7B78<$R"?L`*[K3I?A%RQO,-QMX%U3;NMMLNMK/JM8=M[D MM.]U*-`UVET^W6R[)1[!Y=)A!U:17K`LFT9(MVB[HGJK)G133]P4+J_%S`:P MIZG-2CZ75E5-8T3EH^IE;^;3\O9S^[K>H-5Q5M68S4W*S3][$O+HVD5FAS.5 M"F;J$$O0O0`"UW`8#`KB\M#95?@)O(R3QPT!!YJ5RJ"!4#`[11W3KOO8K^ND MJ)6SGN^N*?8H'3ZI@P,0YG?Y^_BD_?$Y/_Y$FV!:43]B'Z?ZXX'ZP&`P&`P* MV?+XHDCXY.32RS8CU!&!HZR[)03@F\12VK1%%6:ADC%5*FZ3**9A*(&`#?`0 M'I@5$ZV\PVON*M:#2NQM$2VU$8J0?V^@66H;`&[5UMK?89R6VHU>,M>V*M4K M996-,CI$L.UD#-#(.63!#TUW`%]8X3KXP;[;;+XFFV$FW<+/;K6-?UN.MDK.+^HT;+*D=-HU%J"153*BX`H<:%9)(`FR4$YA$1[A#>*8;VVYFGG3UC3HFFA8U&4/#`I8+PUKXI5Z8O:HD]!](Q[=DS=^B0R3= M$G0@!;1@,!@,!@,!@,!@,!@,!@,#P(]/OC^#`Z__`"!?TYYQC\LN[J@\I-NC M;1R5T]%L+C6Y.)?)S,?0X+BQ&*Q+NVQZ3Q$\1!V)T_`I0572:+*.3=A3F4`0 MZZ=PKV]8_6MLH-AD]2FI5&@;"R&PMGS`*;8XRD&UZV79Z1M()EUE=+I./*`R M.X=5(#V2<_K\THX<(BKZ870\KZ5S]XH\`)NG+W>DN..H4_0#2T6IAM39TGON MOS,TRU[`;&JU"E'S5I&_8&SW;WA@;.UU"I1LBNDFFDAV-R!5?J#F#R!V_=N, MO'&U;5=J:$C]X:+@([5C6N52IME(=ILS6[QHT'["56%9*)Q$M!)N62JBI73< MP+""AC.%O6#OMA]'Z8_KC@>J@80`C5@HY!98X?$B9# @6PX#`_"@@4O<(@`%'J(B/0``` M$1$1^X`8'6MK0N#;%@&C=WS/1\:R/+&NO];RK)33*^OY+=)N2#MLG&3112;[ MW#CPKNY8B3))R"IO=)>[4/V&;E(&Z-7_`.T$_<]I#`R+AKOO8M0W7 MR-N_)KD='5C2M@Y"/M&Z-U#>HRLP]O2N]CNUG-32.XR#K24I2HI>NQ`Q\.R7 MD':#U-NN^,FEMAJ$BE0 MJ[=-LDHH5X"4XT.*AP*@4K@@BH`#UP*7.1VZ=;\A_,7XZIS3>QZOL6FUQI,0 M[B4@9EHO#,+5!S^QCVJ,([4%),\M[1BT`$RB87'1($N[O+W!M7B!:]%[J\G? M(SD0R=:QKMI@X2T%6@KH^LL)O*J,:K7:IK&U/W,*SG9/4X5!FXK+I9W*+>WG M&A7Z:*I005*80V!X7XW7\I^55LJA,M<5^/MVS&#,E)UQ;96994PD5(6TBC"2 M@).TV=6+6EBG1D"/C'(:4,Z4.3HW(B0@7G8#`8#`8#`UANUR9GIG;;LI"JF: MZROSDJ9T@6(H9"IRZH$,B/0%2G$O02C^R#X8%?\`X8H%:K^/G4E=<2,-+KP] MBVJS5E*Z_)*P3XX;-M2HKQ4BF1,CQH/J=`.!0#J`A]S`M/P/P*B93=ICD`WP M^J)B@;ZW7M^`CU^MVCT^_P!,#J[^=C2.V-]@A-'S1<1Y;D/O;A@M5K1=QL]NE;!J\]5JE-E+JXJE7;OXZ9FMT,V44.F=6S?(&WT9Q&ZUA]C2]' M9SD@=Q#WM\^C+E-52.LOV'>(%LT=%3+N%]\V=G$2BS72<%.=,P'P.,X(:AVM MN_DU5=E(ZU0"D,!@XO9?+GRL2+2*#3WC03JTBFZ5&:4V5NS7-SCW;#L(9!*,;5>U4MTQ M>E?6U'OYY98`*Q+2/(.8EE8/YLQ MFU8]*8K->E2-G3Z._K7WC0[TZ"J8?$ATAZ]!'M`+GP,S/@BU:E&4ZV3*$09" M5QLJJ@)05#1'-+QGT/1? M`)]R5AMM[BL%H-6-12KNHV1KKC[+)J;$F:E&S*"R<+08B<;)1Y)]04#%=E.5 M0A`.)@[@$++/*[*U2_\``ZT56O[AKIY%S.\=JB_J#&Q4-^U:R,CM2G,SO)5$ M2FL3%XT`YU%2^]01(@S,8Q"E*JI@=?W7W$-UIS;W%NZ!:7DJ]B>0G'E'8+*= MKU9K"$':;#L^BQS2G4>5C=JW%3:+9NL\U#_?' M]<<#S@,!@,!@5*^75&(EM=\0JI+**]EH\@7&1@#=$5DEG#4DG/GD`3SL-K"3TG%M7%J823AY8F<&XESPHOG M:*ADDDA1$0SW5_\`M!'(_P#DK5[]S^D,"`.CM@2\+M'D7U.D>6=2L#."C^-&EFR)/R7[LX[V2#>/M;M M:XX<5/Y3&ZX0AXUBAKO5MCE7EQC0J*VVW)IJ$VDW>%?\OK=/I(*TVR;(K\5K&3%C/0R[RI0KV[2R",9&2<>T;FK,:YM" MC5$QCG=HOV[Q(W[3Z)S!?3@,!@,!@,#5N\?\2VWOWK]@?N2F,"N/P<=/YM71 M7;T[?FFTNG3ITZ?C1MWT=/A@6W8&G(J)W/\`CDN;^PS^MW.B7%7JZ>OJ_%5V MPM]HQEV25_&KE=>=KP M6\N)G(6@Z7O,%J:3U:YBKWJUE=V%E8RER86U<%["]-+*5MH5:.1__9HEPJ=1 M(.\QBB`)A"'BAQ4\G>DNO&%4B$9I[!U:<:ULK* MM2%6KEG@K`_LCIJJ^6B6Y6\AZ7JNU3'#H(6*\K*)RH?7K3.V.*331TO;=?PV MU*C8H+>E,G+H\C'/*`4IB+G33%-?J`&$/JAJOWGE[ M63$J]<\=@`I"F=J)'EN1"I1DS=2FKY_ZW[3@8OTNNGH_'IVX$-^6_'#RILK+LVOVZF&K3-ZDQDFMUL;$)2#:R+0I62KJND&9 M216*B0/0,L8H6/<--1[[UY^/VX\C5-6$V%NG<3:^F8:@D;5)U-A#PNL]?ZVC M"E<7)DTF@?OD*/[E8JAU^AEOBIU$2E";&`P(S<=;?R;MR<>^03=,G^\.+[%ZV5`12!OJ=N! M;*3]B'Z?ZXX'ZP--ZN=;[<6';)-R16K8ZK-KTZ1TBOKV0LKV;D];@D(LWFR4 MIY)-FQN!EN@*)1PF:`7Z!ZX&Y,#5SAUN0-RQS-K%:]-H(VNWSB5FEI*>+M)+ M:@6!$D='L8DC4U:4HYJQZAUESK`]!Z)2E+Z8"(AM'`K:\N$NRBN`NZ2/#*%& M5EM/PK/L3%0#/Y#=6O0;%/T']K2$4Q[C#\`P+)[`URM1)A7;#+9)-D7="":T-S35M2IJP0ZZ?22\X282OCE!2$/8RV]H MW*+$ATY`C06AA`R!C]#@&QL!@:[UE2)J@P,C#SVR+GM%X^M-HL:5@O7V>^;1 MS*Q3#F5:55B%:@X!@2O5A)Q[2/*=$[@C5,A5%5!#NP-B8&M=GT:Q7V,K,?6] MFVW5RT)?:?;I61I[>"7>VJ!K4LG)2M`E3SL9)E:UVWH)@V>JM01>`C\$U2@) MRF#96`P(?\N*I9#Z>Y/W(=@S8T\_#_T2JFP33`QPV@ M\V>+,6-!K[L(\&Y1/Z(K#W@'7HY1^0#3=_XJ>/O8K^HT:5;R,PJ?:FL8:&I4 M>,==].VC4H/%3`DY?[!K5+,TCIT\4C'RD2XEQ.S([.9F*R(A,22\O/$O+@7AG*9GZ2"+@KLR@"H`;#Y]\:^9]YX_P"MIQOL756\ M+%IF/L,ELK5_%]NZ3L<\UC4+6XUS%W.;:N3ZHHZRKJ/C#M9=PH\27<- M`]Z9JF4*^M`>'VX[WUEJ39J7(31#RE2EGJLW,UZN:4N,LU)'ZIMLW$/*S"VK M84Y"W`WKGC%8B1;O(M@DJF44U4U0;IBJ'8LB.*/%R`E(^;@N-F@869B'K62B M9>(TYKN-E(R08KINF3^/D&==1=,WK-RD51)5,Y3IJ%`Q1`0`<#?V!KN(JMT8 M[-N=ODMDOIFBS]4LED:69J`3DVO1+>KMU$FDB5D[`S5X9B MN8JH)*@*:@E[3?`1P,7UK7;54:!4*Q>+X^VA<(.`CHVR[#DH2(K3VY339`I' M]@<5^`33AH8TBX`3@V;@*:)1`H";IW"&;X%1WEA9R3I/@BI'HD<)LN?&BW;?'BS\G]!2^K: M3:J_2K>%NU[=:U8[1!.+%",)F@7.&MS$SV-:NFCDY%%8H"@8AA'X]!#H81`( MHZ2XG\^=.;K!";OVC';$WE5W&F+\D4_LF5>KC@NN'B^T7QH1\XJ M,$""7N`.@BN)!.5=)-)-,(V:N7*Z_P!8"Y,_+W+519#BQ"M>\#`Y1;ODJYH_ MJBZ(BJ0P'1,H45$^XI^@_\*4Q"[!9J[/V#8EA>6!JSV`XMQ!Y M(1#41'G.W=$N\UMO29+@E3[UNNU[WE)&I[7MD=;;A%,8J4A8">1W2I%T MI(C)T^._85X$#^FZ75,NL*QA,!0`I0">/%GQV;8U!R)WGL/<6QJEM[7&RX38 M52DE:4ZU#.I:#:-T9)2/2%8J[%H+)5L5)3U@V] MXY.%5CX64[8=3L3752Z]NLK*P$L]!>[#DK'83)I/4SA>'=[=N&QG<>FJF1$8 MI%BR64,LX%JBJL?J%D6`P&`P&`P-6;S*!M*;?*8`$IM7;!*8!^@0&HS`"`_H M"&!6]X.FR1O'?K"P*>HM-W&W;/L-GDUUUUW,Q-)7>6KJ;]R*JAR)J$A(!FW` MJ92)]CO3XX'G`8#`8'@0`?IP/(!T^`8#`8#`K@\J?\` MFE+_`+_?%;_K&ZRP,!YVRK"J=:-VA)>0:U>JVOYQ!`@[='8U1P3@9L9)LL*7_=>7U^O;YP:^6GQ^R6B.J% MM;Z89UUY[5LNX2C+8_:JE3DBOI9]'=[4Z28^WP(T\H>),?PGM$_8>5NP-D\@ M;'<>/]ZKW&"]1%.KT77C;=F'TKKN8US8*;*FN+B8?L8&]-[1$.3.8TG"NR6K^UCH]H05'#E+N3`X2` MX0ZWO>IN,NOZ3LR#1K-X;2NR[!.UU&8CK`$(>\[6O%Y81:LS#JKQ4B[91=D0 M374;G.B*Q3`0Q@`!$)7X#`\=0^^'ZH8#J'WP_5#`=0^^'ZH8#J'WP_5#`=0^ M^'ZH8%6'D\_9<,OY86LOUG6!:A@,!@>!^@?P#^M@=?/C6R7=>?#FL]8,B"RC M-),/FR[E1NLN@N]A=!(H*LA%)!5))VJF)3$(!S`4OUC"'3H'8-P&!0ERO_IS MO'O^\M;?[$WI@7VX#`8#`8#`8#`U#R"(^5T-NQ*+<-VDFIJ/9)(YT[0,Z:-G MQZ9-E:.'34BB)W+=%P)3'3*<@G*`@!@Z]<"#GAV9M$N!NL9.`8(P]"LMBV/8 M]:P!BK'EX"E2%XFB-XRQ/59.4)(S'SQN^6]5,Y"$:K(I"43I'4.%H.`P&`P& M`P&`P&`P&!7!Y4_\TI?]_OBM_P!8W66![>3C1J_Y[^-%N^;(/&Z#[EU)HMW: M*;A!*2CM-0BL=(IHK%.F1^P4.8R"P`"B(F$2"'4<"Q@G[$/T_P!<<#]8'@?H M'\`X$7.,["6:S/*%]*-=>MB37**ZOXG\7DC$/TW,2SHVM8!!U=$XJ3DU8W8B MCB%5"6;O/;O"J%(&TU#/BG,QE]U<9(IZ5)04E3 M,Y'D'K=FZ*FJ`"*:AD%S`4P?$H_'`LNP&`P&`P*F(SQ3(U:5MC[77.+FYK*- MM]FDK.]KM'V96(6%;N7RH@V:MVZ-*[C-8B/(DS;=XF.1J@F03#V]<#F_YM:^ M_G)_(=_#)7_\"\!_-K7W\Y/Y#OX9*_\`X%X#^;6OOYR?R'?PR5__``+P'\VM M??SD_D._ADK_`/@7@/'94,9OK`4`2$XE]`M@UM M*%:B/>/<*0$$_P`.[KT+T#[F?`+:;!'V[?R0\ZC)^HLKU>6W5$FMWKJG64#W M4GJEXZ],#G'L)W]B1>A"`4@%*`?5^0=MK\X_S@_N]IG^)_`?D';:_./\X/[O M:9_B?P'Y!VVOSC_.#^[VF?XG\#XW_C_VA)M_://([SF.A[AD[`&]JU,P5!Q' M/6\@S.#J.U0T=`5-VU(8Q`/Z:I0%-0ITS&(8/L_(.VU^0#G=8FKZ'<5Y_&FV=4HB%D(1V5RF M\C)&!K]%B861:O4GBI%P7;J&63/V'$Q``H!QVT/%9==HL:K&37D0YDNHVIRK M&9C6$K,T)PS0DH=Y&2,$_;-Z]4JFE\PA)")17:K.@=F;KIE42!,P&$P<9N/Q M[[?6U1M(;IY$.4^P*LSI=UES4ZT1.G7\1(HQ4"[DH=C+"XH*YW0M';,#*+I` MW7.;H9(S=0H*`'7`TKNS7L51]---@J,]5MTK5+UV M-I=)K+ZFV>.M$A#U&.9SBAE)5@T=-WH-&YDUTA`0L%N_&SG]<>/W&7>$-,7= M_*:[U;\H9;.@=D;$D[C;]2[SN;O:$E<+S`04S![@*?6%5&,;/6#)S*N9(S^:%;"FD)O0.%Q[3Q`6,DH[6?^1[GJ[A5/7]G& M-MM.&3]L!U""W!Q+F]XD[]%(#%/T:)>H(@8.WIT$/!?$CLM$J[EOY..="4PZ M>"HY?FV`=9LM'D.T=-F8QQWG85PD_9D5,L"@%4*`$%,`[A,$A2\.^7!2E*'D MZWV(%`"@)M-\?R/.7'YSG?7\#7'+^+[`?D>< MN/SG.^OX&N.7\7V`_(\Y!?;@,"A+ ME?\`TYWCW_>6MO\`8F],"^W`8#`8#`8#`8&F>1LJA`\>][3KI-99M"Z:VA+. M$6X$%PJA'4>==JI(`H8B8K*)HB!>XP!W#\1#`@[X9IR&DO'?H^!AI)":#7[B M_P!$DIEBB]2AI:3B=@61\K(0*DDU8/W<.Y;2J0I*+-VZO7N*=,ABB&!:1@,! M@1%V;R[@M8\F]/<9'NJMQ668W'%%E8_8M3J:4MK.I$,ZL#3V]SG_`'R*T0L0 MU>.<_1%0")+I&$?K#T"76`P(][DY#1.F;]QYH$CK[9UQ=,*E-6TUCV9)>[;?9JKK(PIFQ'($6$7"@!V]H&$`D)@,#\G[NP_9^S M[3=OPZ_6Z#V_#J7K\?T0P(Y\?N1$?OY]N1K':^VI12:=VO8=2.WVRJ8YI["] M/JSZ17-PUU[IRY5GZ*_45$C60*/IN1((D^K\<",'E?DF3#B>V0=KE16E>1'% M>-CB"50PN7P<@-?2'H%$A#%(;V<>L?J<2EZ$$.O40`0]7(NS12_DG\1M>Y:6ER!HJ23B_E$OJI"'9"A.':EAG4A[V&7]5HDN=T@GV**ID352,<+ M,"?L0_3_`%QP/U@:BU5O/6>ZU=@M]=33^86U=?)S6=W3?5FT5WY3LH5,H&,(%*`!P?XRZ3^,S\3OSK_`/$? M["?C+^SORV6_\R?M!]EOG7S?V'R+_P"O?VCVWNO=_P!7Z7I_7P,ZP*X/*G_F ME+_O]\5O^L;K+`L?P&`P&`P&`P&`P&`P&`P&`P&`P(Y\L]RV+0&@KMM2HP,+ M9K/!O:/#P,+8W[Z,@74G>-A52A-%9=]&-7L@@P8JV<'"GHI'4,5+M`.H]<#4 MWO\`R5_\E.#7\(._/XL\#B!G?)^!7HAK?@X(MW*Z3,OXU=Y!\Q;IL3.$'8#^ M*WHS!R\`&WIG[C$Z^H(B4.F!KK?%F\BT)H[,&CN2%D17T"JKH)&5*4#G(4W<`=6*O\`B9YAWC0NMMVT M?7E=6I5PU:OL!Q(S&UZA'.$H0S@741+2,?--J\SJS:1J+I!^5(S^1(5!%99= MPV4,5H0+W>>6E9*^<)^(6@;=<;=K+8\&XT53:#6Z?3G-VFMD[:::(F(EYK!K M(1]MJE8BD_51UU;EGQ_@IN+DV):YRETU% M3`>@Y&);S9]GQ[%$0>`F5FO\U^S3P6:H#VO$6:BB0F(F80#^C!@,!@,!@,!@ M,!@,!@>!^@?P#^M@4)\4/Z<[R$?O+5+^Q-%X%]N`P*$N5_\`3G>/?]Y:V_V) MO3`OMP&`P&`P&!'39_+?C7IJY537.R=RTBM["NUHK5.K=#&5+*W-[/7!RW9U MM%Q5X0DE-Q;&5<.TBD>NT$&8>J03*E`P"(2+`>O_`&?>P(^\M0$>*O)D`#J( M\?=S``??$=<60`#`BKX@FYXOQY\?ZR]*DUL--0V%4[?#^LW4?5ZUPVTKJC,0 M,PDW45!I+QZIR@LD8>X.X!^(&`1"RS`8#`8#`8#`8#`\"'4!#[X"'TB'^Z'Q M#`\%`0'XB(_#[H_1\>O3H``'P#[OTX%7GEHAW=AX]:I@F)D2O9CF+Q-C6IG) MS)MRN'>W81%(5E"$4,1(#F#N$"F$`^Y@9GR1^'/SQK!U^`CS''__``O!]/U. MN!8@3]B'Z?ZXX'ZP&`P&`P*V_*NH8G$P2E155!7D!Q63.=,"=K0@D*IQ4N M);),MJY7@O\`QZ/.V!ZNV:LH.(3Y&:G4D99XZ>G39MFD>T(=5114Q4R$()C" M``(X'[G?(?PQ@K,YIY=\5NT3[*,C9AZUUK#V_;+5E'S$@,5&JO)?6%=MT.T6 M=2/:B5%1P58#G(`D#U"=P8F;R@\'B"8I]QRA3$,8IP-I[>8"4Q1$#%-UUI\! M*(#UP-7\A.??%K8.@-X42F76Y3]MO&F=C5FIPK31F^R.)N;MM-G(.M,FJKG6 M*#4OSJ6=IH(*'4(BH^*F'E)C=#TAFE9BU=*.B0DGZS([>0_K=%H+@+,^:_DBD-L M[*X\%XU<>[_LEQIWVH)!5A,JI[ZJ]7BMN:CN\O`4BN0LA=:_3JW9S'3) M(O$DU''9W&:IEZ=X?=S,Y^:0V%/:]HK2EWNMJQO-?BG:HO9IM5R$=0;9KW7[ MJI6B=?EL>O%,'HL/QF/_6! M,BHJAK7:XL.U0%A`OS0*-\L]4/0'N3];O+U)W`'>3N#Z_P`NCBQ_SHC_`/!^@?P#^M@4)\4/Z<[R$?O+5'^ MQ-%X%]N`P*$N5_\`3G>/?]Y:V_V)O3`OMP&`P&`P*"?),T\@TOM]ZW6)MV,\ M>3&-:*7)UP^<51SOYY$)P+7YZ]F6$TJC;7I_M5)^G[*,`[0\0S44.7O`YS!J M7P_M/'ZWV=R&.J%*M5G-<:1+>[IMI,D\A:%Y) MLX,Q3*^<+-.XP"D1`V!V4`_0P(^\M1$.*O)D0'H($-<600'`BCX? M@]YX]-"6AT!5K%?"[#N]SF#$(5]9;=.[/N1IBQ2JB92%<22#P@^1SQL1WS%, M5`A.8[_Y/[0WK`3\4U?;?-/?]W;Z0&-Z/H].O4>_K\,"R5IB_F>/NKJW'R!HXUHY@<2X!PJ(JBW40>;FKBA4WJ20@==J1VW25$ MG_=IE'Z0#`LWP&`P&`P&`P&`P&`P&`P&`P&`P/D?,F4BT692#1J_9KE`J[1Z MW2=-5BE,50I56ZY%$E`*<@&`#`/00`<#K<<\-5ZRL_/;9_XWI&ATO158XKZ) MEKHYBZ&$[N2=2D]K[#CHC4VAD&YC*1^RMRRY%XE:08(C)ECA*BU*503.$P^! MYQUKJ-Z+W'0W)_:=9<)ZDXN2E%K+O2G#31+>4BY)_N?F=(P4P![!L:6@ MD2F;*J*=3R!U(R+*JD+M4`P]UJOC:@TK$E'T][?N/U>O!("KS5-HB!M]^0[E M,TEW%F=:^TXW9M!"C\0Z8[9^@)HMNR@#-2+()N31Z2CE8.?4XP4D;+:=;GJ/ M&&G[\E8EILOE#LB$I]-D>._C@T=&NG[N'HU"C)%LSKDMR!M;4RJ2DO(`F]R8WCR MAM4LFYG*?Q_KSKW,ZDT=-P(F1P60=IK/%V#8P:QLO&;CM:XW95"M7XJ6]2U# M;E;CS2YFP\5(5VKZEO9VT>Z)Q5X545-RY]M.1[2-9LC.4@DEV9':HG27FY!- M$@;6/KJH+[`JCJ/XUZ_9;9V;69F*XB\,YVN'22U]K(`A6\CRIYW65C(O)I#T MV#0RK:)=J+*LSKECFQG$RY=.&@:]/JSCXM16J;Q6'E.-NK;V".Z.34%27;;; MW,KD>O;7LD?C3PXA8UTJHPU:XLJ00ACQ!A(=JC\JCUQ13?210W3X@4YA'F5Y M)$I[6[+3LFG)Z9]35$?)(2[37;55&\+QM4+(M.K%PZCHU9+W0M^K8KLRH)"* M8%$0[">`P&`P&`P&`P/`_0/X!_6P.N[P0!0_FT\D*@B8Q25*33$QC=1+W6K5 M7I$`#&[NWM2'IT^``'3X?#`[$>`P*$N5_P#3G>/?]Y:V_P!B;TP+[R,D[;L&#-$O0#+.GCI1)NW2*(AU,6E49%P#@6KJU6:=GWC!CVD3!O%LW3\Y&Z7Q$B8!U$1 MZB(61X#`8&@IKD_H^OG>0&H]^)WY74MQ87%/5VQ;-J6^GCT'R)*[L2G* MH(V6L.3/6K7UGD4HY(!SI=Z(]WU3C\>@1%\FOPU1H,?_`/N'AY_EF@,#A]QS MT,Y\JG"^K)/$U)^&XV\I;#(1WI*^JSB+&_UU&0K_`-8R0-Q*_=UB03*!#BH7 MT#=X%*8HF"S4G[$/T_UQP/U@:7TMR&TUR(CK?*Z9O#*\Q]"NLMKNW.64;.1I M8:YP2;966@UB3D7%JN%F:;Q,141*H@;N^J<>@]`W1@:Z;;9UZ\VK*:2:V5NO MM*$H\9LB6J2;22%TPI,U-/J]%3KA^+((@J3Z8C5T4T?<"Y'TC&]/L#NP-BX% M<'DT_P`5&@_Y)FU;`Q M7?D0HO(J-*90HB.?L;-7=#0[N'(U0;%;L6#J)*#1!1"&]P[7#;)%[Q#7$Z$C M):\J?*2)U(@QVC=X9&05X]>)[BJ\J22[>L45G)2:4`]W=:HZ'2]$2*(*2CEJ M#E=)*"CT$'0:O]C6UZ1KII7]2NK9K:VW%Y.\7N(DKWM]P^0?8#;VAY3EUS5D M+2P^<-M5P4\=2R`66;'0]$6[Q^(@>-8@'(2#*&D7'(:RR&VZ^1@T;HP/-'R$ M0$9(>\!!Q-,6A>"/"*&00?;S*;?1D+ MQ(XGLH1TUF5=5M)PJD``PP),S1B1H]@J!`D9`P9#&O+^7854BXW7VM(;D_K& MD,EM<:OWPY)P#_EEY(+!1KC9MH4-W/Z;0A]JVQT]?SNP'*[.[OGEIDWTDW9.W2]C M=*+/4C`BFW%LJGZ``AZ08'84P&`P&`P&`P&!X'Z!_`/ZV!0'P"01-Y@/*.Y, MBD9PBE6T$7!DR"NDBYE8U1RBDJ(>HFDX.T2,H4!`#BD01ZB4O0+_`'`8%"7* M_P#ISO'O^\M;O[$WI@7VX#`8#`8%;WE+UGLC:7&1A%Z_I4WM:*K&Y-57S;6E MJX[<(36ZM-U6=,^NVLV#)`AB3BTUW-E_9*"4J@-1,3O5(FF<*E*)QAY$6[9N MC]J+<<;36>2&Y^:(\F+QN5:3BF[3C)QOUZ=I`1O&FR7"%-[Z-G)J@+>S-7O; M,A,0I&BZ(]JA&P=HLOT?IC^N.!H#EEVAQ7Y+B?KV!Q_W+W]`ZCV_BZL?=T#J M'4>F!'3Q5@Y/P-T,\`B36O2L=;9G7\.FX7>*UO64O?+/(:[J[UXY23<.W]=J M3AHT6.`P&!C9J;4#VQ.^GJM;/>4H,*PE=#0<8:V)5H'B M\B%>3L8M1F"082#E1?V@+`W]90Q^SN,(B&28&-6BF4^[LF<;=*I6[?'1\M'S MS!A:(.,L#)C.Q*@K14TS:2S5VW:RT:J83-W)"E61,/4A@'`R7`8#`\"`"`@( M`("'00'X@(#]("'W0'`XF)KT!``]""@X>%"3?+RT_0+#`WAI4/@&W]7? MP@5/^^V`_'AI7_G?U=_"!4_[[8'RM=Q:(8E5*QVGJ1F594RZQ6MXISLJ",H0%%3]`ZF'J(],#ZOQX:5_YW]7?P@5/^^V!UR_*$RH]VW/S$V_!6V<= MS.H^!^A9O7EFU=LV6@&[.Q67D/;JJX7DW=.EDFEA9(-791,R>"JEVB8Q"D5% M-4@=FFL&,>M5XYS&.<\'$F.HB/Q$<"OSR:?XJ-! M_P`N'AY_EF@,"Q_`8#`8#`8#`8#`8#`8#`8#`8#`\#]`_@'];`ZZG*F2J:// M;E17]D66Q2NO[;J7BC%J<:->,'2^S>7VP&;?;4K0=)1T@Q3<.H[7,H=F^&U% M[$FSEJ=NFZ)GBJTJ%=:/ MD]>:K:218V!G]Q6"-=M3N2&=**/7#187RK6):I-3AKY.#AC16KJE&ZCFM@ZG M?V^6G^,?%>R*/$-U\\MFH+-E9;F%S+D[&Q%M"Z*B9)V]G&?SQJ1%<56CEPD3 MI'QY@XFLW*WV>K[:N]QO$/J6WPI&Q.=W-1K96UL3U)'+V51!IP6X+NX!*1C& M3XL(V8H+GB7ZYXZ0E$Q6-(S*R!40V<1L\3L>O*=5]-T1'93F"-<.#7!Z1@VC M/7W$JH&[7;OE]S'=L@>)-=D/G*WNV[=?W#YB\6-',3KRCE\]2#0,P>( MW?91D!9TJP;VF::V4`P-%#.W)"%;)&;1+9=1V'#OT==/=>$@X.M6:R\5KM=7 MDYK[72#]\ZY+^73D,L1*5=W6[N'!F\JSXW_.&@O';MV"#&0C&H.'!6\*DV;. M`WGXG4+(IRF\HKZ^0]+A;XEN+4T7/Q5`>GE*E7#M:YE58^)6>Q];32 M39G,9JW$7#=3]K+]&!>9@,!@,!@,!@,#P/T#^`?UL"@C@!_2]>4S_P#I3_A- MK@7\8#`Z]?()K)RWG^XB-VQ%'24/HIQ*'2[TRE9L$J]OTSYP7U#$ZE!10@F` M.IA$?@&!V%,!@,!@,"M3RJW&T4SC+#N8Z[7366N9_=NIJCR(V9KU!P-NH/'R MQS*['8%BBI!DDN_A.BHLFJSM!-50B#DY.PY3B40H\XS;6JT1;>*U%XK[HMU@ MV[#<_-Y0$/K^!M-GN,+?^'M^ORCRX;!W3(=0#KQ]W,'4?H#KKBR?$?I^`8$9_$E,D MF?'9Q>]-C(L@AJ*YK)C2#4[4DD>MV.:AS3<2*@%.\K\U[3W+%P)2>NU4(?M* M(]`"QK`8#`8#`8#`8#`8#`TUNKCUI3D97F53WEK2J;/KD;(!+1T3;(X)!M'R M8(F;^_9?MB:C5T9LH9(3D,4QDCF(/4IC`(:"A?&CP!K[5=E&\0=!>W<+@Y5+ M(Z[@YHYE0(5,HE6FD)!=-,I2_`A3`0!$1Z=1$1#A'GBP\=S]45G'#_2('$5C M?UM4TV2?5=RN[4_:63ANET]9P;M#MZ$)VD+T(4I0#Y/YJ/QS_P#1`TS_`/=] MQ_;^!`OGSP-X!:+K_&2U1_'K3^O:W+\R=)5+9LW\K,QCG6L)=O;7-MB9UPL[ M.0L&[0CDS.`^'P3#XX&.ZJA?![>()62V/QST5QOFE50E(&J;Y:,Z)+7'7DTH MX=4#:5.5DY9NRL-+OL"F1VV5;G.JT4$[=R1-4GU@Q'F/&\<*RKDY$2")2%,H8.T@B` M7!4KG7PL?L("!9\L./+B42AF2)VX;H',3`N.P&`P&`P&`P&`P&`P&`P&`P&`P/`_0/X!_6P*" MMQ/;Y'>1[EZ^UK'Z^I%@;<8-&GL7++9R#(:WQ9UF$9LD]VL<6JL)';R[VLR; M((M@"K9BL,8JN]5]%KZ2H8C[6J%KNM:JGJV7F].DN4RIQIX9S]@>I;MYY[67 MN4#95-55_P#9[@/PK.L5TO\`,HR&]-BY715%XR?OCKJ-U9A^ MD@V#U19["V?Z3KE5U#2ZA;FU,7SG[6 M11'O]9LW(NSM)-R*#8R\NX4SD(S:1,=$\=]%QD5'!)M]#,)07==3;0Z[=HLDV4CVADV19!^J&:3:NRF. MP(Q1PUU!$-W,PHXQ/+ M;F9!.X?\2_!33<8_]VXXE\9!71>0KG:R;5-8\@^4[5FCD22C[O4/'QQ`^/P= M%I2>T/(XEK9A98S7J6Y=>HT=E6-8 MK;/0LXJA!2+-C'1!DS)OCE;=JPB<0Z!@5'\>N1-X8\@*3R$U1-Z"H.@M]\T& MW$BA\=JWI?6%/LU^U.S,M!R6]6%GK+:*V`8T79&JSDR2X+LT7#CTE!!(Q"B' M9W+\`Z?HC^N.!'SEL(!Q3Y-"(@`?D^;G^(_#_P#MQ9,"!?C"Y1\:Z]P&XO5N MR<@-,UFQU[6K."G*]:-F4ZMST3+14C(MGK%_#SLQ'R3=1%1/ZHF2`BB8E.F) MDS%,(3T_*XXI#]')SCV/TA_CHUO]SX#_`/Q)]P<#'(+G%PYLCNQLHGD_HM1> MJ3:E>F1>;,JD2W)*I,VCY1.->2\FQ:3S0B#Y,!=,#N6H*]Z7J>JFH0H>MISG MX9OK3+4QMRDT.:PP;%I)2+939]1;LTV;XJ1FZC>:<2B4(_4,"Y>Y-NY543Z] M#E*(#T#[5>;'#U&P-*NIRAT&$T]BG/(J3>LH='JY)^VO%&Z(]1^M]4W0/HLG.'AO4FT>[G>4>A6R$G+L()F=KM. MG2QCR4F&E6# M@O>@]C9./6<,GS1A;%)U*4FJ ME*MIF,9V2&(U4E(=1XU,=`7C)-ZD8X%$0Z*%$!'K@;*P,$C-H:YFK]9M5Q%Y MJTELJF1<5-VRALIN/<6RN0\XFFM#2H8&= MX#`J'\BVWH&?U)Q5W1IZR4?;D%1^;.KK5%56J61.2L6Y+'0U[I##K#4CN';3 M,=+W]S8B*MQ;K>FW3]NMZJR()F,`6JHQ<1.L(I_)5EFDNK'LS@PF(V/7>Q2: MR)%C1BOU7*2*C,YQ(C+IL8Y]Q22T7K9.V>.U?@..&P]-T?>E2MU`O=:J;YR$LPH9X69:5>4<&G7,!<(52;2< M-91PFD#>0_;?;&*V,ET#1FJ+=HN5J_B@I]*)42[TJ7+.9=;I")JWRRU%AK!O M.G.]=!9K/\G:%L;7Y40_LDP>._9I_4$J7['`[W6`P&`P&`P&`P&`P&`P&`P& M`P&!X'Z!_`/ZV!UYN0X4]WY(>0T39H2P;@L#S6W$9[J7BG!NU&,1O?;4,ZV2 M^J4[LUT@T=`AJ;3:W=+2Z\ATA&0N$G+I)TNDR;G#BGE@G4B;S5EM\QT7:H1A M$Q/D5\BK9&6:L-?0C*85,PXA\.$PJP1RLU'%?@R75CD4A8O'0.UV[B;=)I(A M]<6[L\3+:3KFO-1U>N6="I.GO`7A1:)B1B('CYKIC\T:V/G=RW452IZS%LS;R-><<:/$)QKEX^*.WGW3Z0A8^L6K>]R@X[W)2D#U7 MKE'T@%K!-#B[##BQ6O"4T&36)NM^XR7JVL)G6VG59*+D.1GECY)*S!)M7=FQ MI=9-&98<>57T>FY4]_Z$0ZBX\K]PBVBT6S%V&8N!V6QO^T7LA?:8TY&Q5&*V MY7\MF+I!#4WCKX\*O49]AQJX\LS0B\=8]P'K)G2_K@S:.5'7HR,EU$S-M@<5 M",H8(WC_``M?T=,+T)!XE.S[3&.GS][SDYE2[N.5D*I78\90D MH@A**/%&RRX.%$7$NX1;-PSCPX!<2\@O*,&Q)JN6._!R&JGVUG*>@LUJ4E:! M7V@,VM66[@QW*4"F_$Z;4%1]842%%3ZXF#`OIP&`P&`P&`P&`P.N[XS53K>5 M_P`J9U!`3!:I5(!*1-,.QOM.?;I!VIE(41*DD4!-T[C"'<81,(B(7#;;Y9ZB MT9M_5>H]J3!*.?;E;OUBKNP+3)UNM:V9*Z]&OFDJ]+V6?FXWV]ADT)\BC-`B M2@*$2/U,4>@"&[*1L.@;,AU+#KB\4_8$`B_7BUIRD6:%M<.E)M4FZ[F.4DX% MZ_9)OVZ+I(YT1."A"J$$0`#!U"D+:'^T$<2$!'U>RP%T3 MBE(@"+H`"1SE3%=P5,PA!3CM?MKK\@^+9)K0GB:C8JFR*VM*S*Z:WQ4'VQ=6 MTFRKHEETM:01;_(@]GYUU(*F008L7CQZJ50;O6J7$CCJ"$BFW2>$-J*DG%9-HL5PW+WJ1!E$_36(`_5$HCTZ# MU#X8'H6\>_!AP<%%N(G'0YRI((@/XHJ47HDV13;HEZ%B2A]1%(H=?I'IU'J/ MQP/P/CRX*FZ=W$/CJ;M`"EZZEIH]I0^@`ZQ?P`,`/CSX+"4"#Q$X["0!Z@0= M34[M`1^D0+\KZ`(]<#Q_-Y<%>T2_DA\=>T1`PE_%+3>T1`!`!$/E?3J`#@>2 M^//@L4#`7B)QV*!PZ&`NIJ<`&#[Q@"+Z"'X<`7QY<%2"(DXB<=BB("41+J:G M%$0'Z0'I%AU`<#\_S>'!/_HA<=/X)*;_`'JP/U_-Y\%A$HCQ$X[")``"#^*: MG=2@'Q`"_P#T7]4`'Z.F!\2D6+9 M5FJ*37=<@[1"8I52E$I>U,H$`G4_>'F(\%_#:)LB=J- M:>0^;)())."LJ2BL^1C3I>JW!P=4?4,/JB MJ3Z@!Q;/P?\`%)BQC(Y#9')(S2*?IR;8'5[HSYRN[1>`^)\RD'NL'$C+M/6# MH+9TJLV,E^U&3%+ZF!Y:^#WB2S\A6[]CHEK-QL8_3>*$7(U=(&.40^L`D()0WNR\=O!2/9MF+;B M1Q_!NS02;(`OK&L.UO21(!">JZ=L5W3E3M#XG4.8'`KAC4... M\]@5/C-J"L72I:VF['6;'6J@Q@)."G:TP?2$)+Q:L0#,&;Z/>+"J!R`'J&(3 MU.\$R`4+8@'J'7`\X#`8#`8#`8#`8#`8#`8#`8#`#\0$/OX'77W=,WH.=7DB M;);&K.D=.M=1<48[?7(&5>N?MSK33BE1EW,M2M-P\='N7SJ_[3D)MRS9O/4_ M^C7`E400=/3LTBAD9'-A;SFDHBJ:::-+>SK!G7CTX#.!D8&M:GI[5)>$>\R-7\3"\1^)D:6-=R,/I>J65$8M)",[63T&XL$/51&3?F# MG];06TZHK0:&K:HRP\N==:X&%I;2YC3U-0^*WCO*0K=5QL'<_P!D8>N:RLW) M2%'VN]7NI!DZY` M>6?D66=82Z^Z-GR+I@288<=VTFP*]44>&1BG,4F5Z[21BF[%BY#BK=6-FO-M M*75AR0:T/?>G*V_+SBW_`%5I6VG&_B;QYF8=VHTXMZC2DX"3:IB;XED\?7#"T+RP6[>=\:/3ISW M.3F>\=PZDC#UB*)*%L38)X_NB>Y56]:;CGT3NEY,[G=-Z,=^\B M_(#Y"8LT=%RFP+1$"C'!PEX=ME$UYF/K<8XD0AT%XI)<69E%$FIG,X\7<)AD M7A3;P[3.8NGS2/E(=EV) MN4"+K>BL!B&.8P&$0O\`L!@,!@,!@,!@,#KV>,5@[.NKDC19J8@NE7+HK$3IJ%,"9"(G`P"8Q!`,B\Y+N\,J9K&2;5.0 M4UO#1MGEY"^5[5U;V3)QM]:6_69X*JVR4FZQ,O\`6FNY>IIS3IP^9N$2RS]H MV8.2^D;ZP2^\4[:PL^.=I;'JQJOJPN\-KN=!!,4)GK._3VHY&QJR,-8]B4R- MA:]'1<_*2;MV+8R;)N9:**U.8@=0$0@]M:T-T/\`6,.,M7%HN9P[XEV-V5X" MB0($*6M[W4[#)C^VB80;B'4/A\<#L*8#`8#`8%2OF1;0;GC;J8LU29#:YRNKY*+\(=_T?,(W"/I<:9+16LIA1 MT1NN46\IR!W@54GR8M>T.TE47;%1S M+78ML6>;TC+VN+K_`"UYI5R-D2[IYZ;=).2LYFNS!9DQ7*4DA(G#,&+'8\G>ZS%Q%/U[K[D74J M+VFXI54>*K/^17E^Y&O$SSJ-WV#/$(VD(CCRQDV/O"JODT(U[$M!=N"I0R#9 MJL&Q':MNA[7L^PO]CTNM;QB*$$'S,Y50B2?XJO'AI=K`DGX?CCQBBY%(6,GL M9\V,D*ZJ1G+HCPJ,G)-CG/&1Y0PY@I&C#Z"BX+4TY)5Z2DWT]P:MD=IO';.,CRN59TK2:1-[=T0KE_O M9\>L!.#&^0;G\P:2D;.2T[&S\8BPX0\/(QA)+R<4Q;INQA%/E:L@2*(]`@"\ MF7ICH!R9X^P*[#UQ58[2]$:;9@JNVF.*W"1U\D2U#P;U0G-(')S%Y1JMA.T7 MVX=X_)C,%OZ>W&DCR$K"A=N-8V/C M8W9$B`[%4E+3'(1!1B6K6456(X2:ME%$&J"R8$$2F`YPOTP&`P&`P&`P&!X' MKT'I]/0>GX?N8%+7`F+@B^0?R33M,D*^E#R%L@F]TK3>)=(V.*OR%DM"3AR_ MG59R0:RK.2<-Y)V!$6S<&ZCOTS?L2E*&%>0S5UF3Y*T"2U9L7R`W+;6R:A<) M**TUQYVE2:;3*/2H/[#5VX6-A8-D1AH>M14[)J18/8M!1T+IV/KG!L3IZH3S M\?.M)[6>CI)G;M:;9US=;-L.TVVX.=Y[/J&VMK;!GI0&"3B^VZTT<0KZ:TBD MT(T:M$R$.@R9)=P")NXP50[?_P!ICXL?R/;-^Y;D!@=D;`8#`8#`KX\F&NZ5 M>>-[:>OO(9;BW"Z MK5FAV\S/-FSJ'!M-Q+P`;H&*_P#;LS*MDA;IF,4+^\!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@08\EO^8OR._P#0AK^Z>OX$Y2?L0_3_`%QP/U@,!@,!@,!@ M,!@,!@,!@,!@,!@=;K?"K-#GOY$E-@;*+KKCRM1^)$9O&)K$8\DMT;P92NO) M-K4..^H#,EF[UE(;7E?79R7LC#*.FI"MFXH%57=-PS$K+:4MM6DM(>DT.*Y2 M0\`=WH+1)X:/?<WWCB7-WAW8R&E!UG*;@?:)CY7?O,JF>V/H/Q M^\;9>-<6*NZIXT,5(U,\MM.T5A0SHXG42<>X(E*ODRH!'Q9PY&-9L$F>C8>% MU'-R%?\`?2\IP9X46->4CYW>4Y&K19)?F_SH(S[ M'7"F6K$(GKKA#2W\TQ5>6,E"@NHGL>8>LROFD6*CMZ@^54CHY55TM(OVX M:MD5Z"%#E06M-G?\;+C>5(OD+OJ`C'#?D1Y6.1KY5XK^)?0S&(2-.):65GVZ ML9ZL<[:LC1K=6+8F3C474@H&_?#"SN8W4,P/*!HQ?:NAWK%_%ZX M38UUR=K0V3J(1:0CA&JE=G:^HT131,8H@7J0"=`O3P&`P&`P&`P&`P*#_%\4 M!\B7EU^@!'=$9\>G_P#/6UQP.1\QDK0UK+HFMRFHG.P+[&Q<[;X&T6C<.R=2 MZZI]7=W_`%M0YX8S\7MJKC^T[#=3MLB5P11'UF48V4A0F)XP9*I_D_ M6ZF5JFLZ;(ZMWMMK7-Y)#WNX[.K5FN\%.)*RUPK-ZO,C,3TW#3[5ZW4(55VN M9L8IDC"`E$,"ONZ)LG_^LI:A%9MZJT+P,G%VJKEHJ4&SY62OC?W3!99,I%#C M'2JJ)E41,``JHF(@/<4`[#^`P&`P&!75Y)V-@4UGHN?IK"@6J^TCE3J.XT+5 MFQ9Q&MQ6Y[7&,;>U9:QA9EZF>+97&4;2"[Z),\[6_O8X@"(F["B%;W&3C)RV MV#8N*^O-L<7F.B*3Q;Y+;(Y/6';-NM=0L=JL+VZW6XW^O:JU@WJCF07;P?NK M2T2G7"JB;=U[`G0$SI`D<.QM@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"#?D MH]'\ASD3[@52M_L8R]T#&`HFZ=1`/C@3B+] M'3[WZOTC](8'ZP&`P&`P&`P&`P&`P&`P&`P&`P.N'LF)MDCY5>93K5&MH.Q[ MOBZ-QL7H&Y-B(M'&H.+$*XUDHUO^]+#A%$DX%@0IGCM0SGM41; M$=F,'S,(G72VKA:^PO=VXEWB]M7<:@FRD3\H_+KR5,;/CT@R:5DH!&`W3*3.['+BK)SZ]5YW<[VL?*HW*_V$\DS31X6<*XN(.\ MEXZ#9.G9(8WRDSE.*%84VP/9MPZ<-0^9*I2P7:D52M:;H++<=?@6D_PEXA/T M4E]><&=8O7[=V^Y<\JVX.`:);@>S+P%@8E6>2!7B1F4>NY75?/40QI=WKQ:E M6A56R3L[QPO%GAZ_R&Y,LHA^IR+\H^]B2]@01X_]V&PO"HZK+Z?\@SZEW.?V/47G*0CN MM;#M3Y_)V6]PSBMBLRN$Y(RC5C(/9*R)']VHJJBD)Q5Z@4"]`P+U\!@,!@,! M@,!@,"A#Q?=?YQ+RZ=/I_'1&?NZVO@;Q_%_!>3*>YCTO?$#JQ:D:$VQ;M`:' MB/D*LUL_5UXKT"FG/;MDY_YG#.P;7=S*,%F,.F1!JHUBA(JNN!C'`-X>,FS, M)'CA)T!C`:XB!T'N#:.AG=,&Q04='%-)RTDI8Y3E<"*"0B MO(&-T0Z)B`]3?M@GP.Q[@,!@,!@4&>6KEMQPE).N\79S<^Y=0;)U1M'6&XI_ M9VJ=-FV0RU<[CF2TE7'4S)JV.L/H5X2/L1)(CF+,\5*1N=!1-3U#H&"4O'OB M+R@K]TUGMZ7\GFWMY:T[65I5HTQK*FQUP' M-[O,BC>M=P7)=K2W%3Y`\FS2Z:O&?Q=ZK=L8PJ6D-,#,"P@;#N67!%,'7:LT M>*R(INY'VS(&;,0X*O0L&PKFGXJO::E);7+^RR:G$'B59'4N2_ZN^1_DWY(& M:+D9Z(T&FP(Q9-4CAXHF).K2#9 M&,[#%YX*+*:V@U(&BW6=XMJ;/<.-':<).3SO>WE=Y&'5;G6V7M*1F47DV''I MM)MUI195\51C(1J19%T5O%MV#)4)#>(4;<;9?DK-?XVNPUW-S`D#6N&J+IT^ MJL-.&AE3/H>O/GS5B[?1$4H/MT5E$$3+%3[_`$R`8"@%VF`P&`P&`P&`P&!0 MCXO?Z1/RZ?OT1G[N=KX$SN67#_Q^7:\,-LAZ M$LUXIT[6@TRG2X)O)V05629Z^A+/E@2*W]PDFW.<2].O;@;Z\9/+M"M:7XR< M0[5QXY>PVQZA5XG6MHMT]HBQL=8URG7Z,"K;4O.7F1N_6M,VWK3QW MFL%#OT(A8:O+N.6FJ8=P\C'*BR:1W$9+5AC(,E@.B8#$43*(8&Q/RD?(#^;6 M)_IC:8_O'@/RD?(#^;6)_IC:8_O'@/RD?(#^;6)_IC:8_O'@/RD?(#^;6)_I MC:8_O'@?"RY0>0!Z9Z4/&4^:>R>*LA,_Y>:6;$=BD4AO=,#!$J^Y8J=_0B@@ M7N$!^`=,#](\GO(`N[>M`\9CM(67MNKI?E]I=-D[]RD*H>P7"(,+GT.G:KU* M7L./3X_3@?6;DEY`2E$W\VJ4W:`CT+S%TP)AZ!UZ%#Y('41^Y@<,/*SG^`0X M_P`V!-C\Y`1*`#&P=67S?S#3NM838$9?-"[$NG'[7%U'Q]0OVG)8>4>SWYW[Y;<7,#84KM=K-/)@)XZ,B6+`LPV._4.Z='>" MD@W*$>MU;JY-5*C;8?Q?'OE(^Y+7>-F@Y:[[M>F[;`5>@:=8.4Y9+2?'.VU. MWVF.H.KHJ`7DA"R,'#ER"C0\HH19^[259!]]!W5KN0U3H>P'<S>,9(_9,;*;[AIG0C.:+8N8>V66Q"HP4"/3?R*@9=6-@2UIV+JM"BS''4.0AM66US7&E7VG%V' MC5XM>+\8TBJH6U1D5'JN*;=]^RD:[7(]>`Y0#WA$V1P2A"@LJ'N2?:V+K1DQ M:15YM?&N>V<*VN*:M:XMQR0\P?(5>4+'/[CL)62:M':^@/G3<'BBC@48^4C4 M4W3@C>(;-FCD-GK+WPEZV7(35WAJON./I!#\N^7+"08#J#Q]Z:(R"5_)7A>=4=OW%FE$7?KNS+.5W)ES',KV]Q>X+V,!@,!@,!@ M,!@,"A'Q>_TB?ET_?HC/W<[7P,3\I$_HW8O(C6\4QWEQ7<;%UE4INOV_5O)O M8BU9UY5TR[$U9L4LLPDF49/-JOLR<;58D,]9N46SJ7K,JH=!42-%"B$^?%JC M7%.-]GG*Y,4Z6+;.0.]+1,HZM9O6^E8*?E+P[^8U[1[QXV:DGM61H()^PD4" M@@\7.N.02-Z:13"H?M'M`>@X&G:-S3XC; M.ML['JTS.R[ALS*HL62JQBD*803 M3,;Z`'`DW@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"$/D8(>PE$BHF,I M;]$M#`N@BX("3[D#JUDN8I%B'(1A;#LZPQV MLY56Y,J)K^$A_LPU:(7J(08Q#9)=LB#5ZD99(G0Q`#[KM>([FY8N,,?1]?); MAG>.FL(ZR\N-:P[C7]$3WQ.6YKH"1N^F(VKC=J9,2Z-8ERJSL@5Y'?8\TA$( MQBJBAEA*F'ZT_MFV;?6W-LF7=6O2^VH-MLRMJNUBL&0AFT8W82L/H1JTT=9!HSQV M,YP.X,3+TL=9MK6Z),K-S/,_FV_Z/3QE;82,BTE`"24>J,UGP.72#J6>(-T0 MDSXDTKD@'/5#8LS7;%?T>=6STKM.5%DXC:I)VM.JT@D\YK<>[7=.V<($B50C M9-90ZP)$#O'OZ@`6^X#`8#`8#`8#`8%"/B]_I$_+I^_1&?NYVO@/*C;[U1.0 M.O'U`J-%KCT_'V^W%QLQ;CUKW>6P;ZVIE_HPWO7L<%LA99:N1.MM8/']K475 M%%N[,4K<%>X>W`GIXU]AS^S>,3.P3EZ1V@W9[,VS7*ILJ,H$+K&K7NCUZ]2\ M;4+)2:5`QD4SA:H\A$4BH)F3.J"J:H&4/T`V!5>@R>.?]9P>N&[5==O'<*$W M,@LDF8Z;)LM"H,4EW)R@((I*/'2213#T`5%"E^D0P.R5@,!@,!@54>62C7>T M:RX^6BG:'=\EF>K.3%/O=WTW[6->0EJI:51O,#*EL:$FOZ";!LM-(F2<&;.T M&KD4U5TP0(H.!HOB%OB$VOO6B?9_Q$PNFVS1S+-3\@*FKHV78ZS5=P[U91P\ ME*O5X)=J:228"U.5L\%\`+E*5$Y5>A@O+P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&!!KR0`(\0;\``(B-YX^``!\1$1Y&:F```/NB(X$XBA\3?A_[>!^\!@, M#5N\OCI/<(`'7KJS8/P^GK_]DI?X=!Z`/7`BGXKBMB>.WB$1F?U4"Z8K8`H" MAU2G4[G7KG*=1HQ4`AG'<)2BF`D#H7J?IWF"?V`Z_<^[@,!@,!@,!@,!U#[^ M`P&`P&`P.OIY#N.,9R-\A57:V7<:ND:/JK@U+;1O=L:)0I'[JNQFV;1$&B6D MU8^^#K157LLDHN]1&PN('X[J]R.K$A&[#T,PVU M`ZI6TE7GUML$A)T`EG=4-.VF,23AG#IZ0K%DY8_%3O*H9-,PF`0WSXS]7<>D MN8G&67XS;#E+0;7G#"T/>22T57W+I!?9VQI&&L+:M7W8D=&M:I-&CUKBLS91 MZ:R[Z./44D%5%!34$@;>FDYU?9%E976'2WLNOROY22/#7A54'@,(K9>QH';] MT=W3??*B1E$F\&&NM53RSV/981W$E<<'N%2S!R-OB(%*?<$A$THOH>/(D9NU]W+.@6 M`)*>'9G`QT+S@CZM29K6M:8\V]CM(#7MD:@QL5+B$*G2$V%=GF82,O[:7CT" M@5P473DP*]WIA"Y+`8#`8#`8#`8#`H1\7O\`2)^73]^B,_=SM?`W'SZ; MM4>46E)+32W)>:Y;*Z;OL,TJ'&EUI:+=)Z*3=AV7-[QK\[48ROFM[1% MM$E,":CE^"H$-ZA"`(3&X+7B-O&A6QFESW+O<40`.Q#@,!@,!@5*>7MR MP)I_2;/9B.P_R5W_`"`JQ.5SS61GYYQ#6+:#L+N'0L#6,:+O%-?.KRC'#,J) MG352233!#JY.@)0@CHY'A&YYS<62^)MU(I^W>7AWRT3HKW:+?6XZ11KZI(\E MV0V,F=FZFG%U59%C2MNJOJE`1[>A3E#LLX#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`@KY)X-M9^'&R:R\5209V.V:)@'BR\BI#HI,YCD#JV/=G/+HJ(KQ0%; M.#?URF\B$&0OF\F+1+E;R-(W^8 MLRF(T?>D&R^SW38AA`A^G<4!^&!0UR&8W'7'D(W]J")VERK;Z&TCI9]LV0KD M3RIVZO-+JN=2P#JIOEYM]9Y>TH03K:UD8DD1;E>KM6CD3>D"1.@A4NMR6Y03 M5B90](Y,\F;`>7,0&K".VCMZ7?-G*BBYG#!@@PE3S%G;1S1(%@=HL&ZSE+J; MVJ9BB3`["^Z>+$JGPMKMRU;>NN4L6)Y1[(>:^K\>4L*]V'(66$ MVW8]:2RL)(5P)=%DR-"G>BL0"KLT@#J(6]>.IHR9<%>**,8V:-8P^CZ([C46 M:1D"?+W\.B^8K.$S`7I(N6K@BCL0#L,Z.H)?JB&!,_`UKLS63#:#&K,7]IOM M3"IWZH[":.]?6V0J#Z4?4^0^8-Z[8G$?U^>4N(CT'M,4IRALK M`#\0$/OX&L:[J]E6]F[&V@C;]A2CW9,?3(YY4)RV.Y/7E4)2F+]@V=4.I*IE M:5=[/%?F5E5$CG%\NF0YNT2_$-G8'IN@JCZ[93TG"/JIF)ZK M=7H;TUT^[J0W0>A@`<#7^HM=_BEUG2];?;&Z[!^QL&VA?MKL69^T-XL?MS'- M\RLLWZ#;YC)J]_0RGIEZ@`!T^&!L;`US=:`]N$]KR;:["OU+1H=J-97T'3I. M,80NP6QHIY'!5[XW?P\FXDJX5=R1R"395HKZZ11]3I\,#8V`'X@(??P-=5F@ M.Z[?MEWE:^7FPMMB'IXLZ1/2Z+NDZ\)4X-2&6)0(@C1%6&^U:ZHO943JK"Y= M@4P=@%Z8&Q<#'+A`+6NI6BKMIZ;JKBQUV;@4+1671&-DK:TQ&NH]*>KSU5)= M-G.0YW`.&BIB'*FNF0PE$`Z8%/7.CQQV#8.OE=GUWDGNE&V:-XNLZLBD$9%6 MN^;CL&D9.6VS2)>UVPA&DPYG)F[-DEW2+)L7W3])LN4`40(00^[BTPY)\@]6 MUE>K^0V]P]OJ5(H*.RZ3:.(>OH^3HMLM%#BYUA!.#[!J%>GYILT3<]1>G4># M)-R@H#@#*>H(;IX[>/>P:&Y#J;W/OMK.M'M:GX6>H-.T9KW2L-<)&=0ATTYV MYDUDZB:]87<*M%"JS%2(*ND=8PBL8PG,<(^0GB>WE4D-R-ZAY`;=#NMYK6). M]W-SH:GRFV7D+9)B1G'D`QVJK=$+=!1HR4JY9.M;URE>Z:W-:-LGAM_L++MYE4I&^:DVEL"7V M9K2A;$G;A5JS3-[:RTY(R\*6SD:)1B_RL[EJS^H[`_I(@&;Z"XV[8W<>;>TG MR[/YRP/73:M5YK#KMT32,BN5NB%VGC)Y(2^\^,VM(79*DZ MWWC3M;4&0O"%LD"24[<:O;8E1_KO<#61-(/W_TB?ET_?HC/W<[7P-K^0N`L6S>1NJ-9\=Z?LI#E7' MZ;M5U<;4UYOJ.XX#%:/6N\)#O*7,6QW3+PXOB$O;6XN$HI%F4\6HF#OU"E7. M!@E;XY7]0><7X-I5J%;]<2%?ONUZML6M[`MZFQ+R;:];V)8HG8DS;-C'9L"W MV;GK$U5=JR2:1$3^J"292D2*0H58:K524_UE[DL5(C0AT.%U:1<&;(+HJJK# M#Z/<`I('6,8CIZ#==,H*)`5,&Y4D^G>0XB'8YP&`P&`P*BN7EBY=:4H5TG)G MFQIO5:&R>4]9JVB7=FT8C;&K'75ZB).%@M+3L:QK\NYDY]2TN4G:\V9!UZ<< MP5.H8`.9+`B?PXW;MZ,YU#QGG.<7'NW/:E,6MCM?5E+XFQ^GUKY.5BORB$C7 M:CL".JS"-FIFH6!0%G0`X14.BR6!$%R>KV!V)H-%%MTY? M9F'S:-BHJ-9(G\ZOE=+U=I?JPYEZ.,A$6.$=3[/VTBB*QA M*=(J9P+T^(;3U_JWPR;'Y`3%AU3OI)YR%W/:%5ZD^H^V;=$6NMVYX^).K.]4 M"P:LT:E,*MHY1OZR7<=FV*B:E$;%#W/8M)H4/L6M&MBHOJY&RB48E,HK2$4GW';++D*R.%Q' M"B,K,-Q#XTQ-+MHWVHQVD]=,ZU=A@7M6&UPB%8CDXV?&MR2BS^"&4:E*M[18 MYE$._L,(B&!)_`8#`8#`8#`8#`8#`8#`8#`T5RBG)FL<9^1-DKLH^A+!7M%; MP.-?.DC'^6-Y%LVEED?<-VPK-_>&0(I MVJ+IM5!%0Z(=H@)@*)0'[N!]_0?2Z"/<;LZ"/P^L8"]!'X?#J(X$'*ML[7^F M[]SXV7M&VPM'HE1VEK"2L5FGW96D=&M?R:M*()=X]#K.';QTJ1!LW1(HX7>A7>_M>[) MA]<5ZY/]`[VTUKU+6%CK\Q(42X4.+HVVN/\`8:G7:V]K]RKMT?0;R7I*BZ2" MJY'RT?&=A5R!RU^+%'<,1IN^16R9FW(&7/'NQNM;L-RK*%? M;H@Z9%1]BR5PS"RK=".GXM6R)N89915$I'@=`.4YB#@0,XGT86V;7V]R+V\QOD=9:G7H`)D[\E$K-8L`.2OA`R[@K`AC-T^IO M1#L'X#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`A]SD7@X;0$G9YE:*BFL-L_C M<[E+#)G:,D(J$8\E-3/7[E_+.A3(QBV:!#K+'44*DF0IC&$`ZC@9P/+WB>`B M`\G>/GP^'^.;70_[H6/I@8;L3D!PFVI0;IK2[\B^/4O3[_5YVGV>,'=.OD1? M05BC7,5)MR+I6,%FZJC1T?L4(('3/T,40$`P.L9S]Y%U!WKC='%EWR:A=UJZ MUVQJ][IZ?:5R#CQO.K'6HD@EV<[=M*UPM&NTO3+_`#"2RX2IVQGQF)E>PC@A M"&"LSB7/46LL05$KFP*I-6:T$G;'0(2%CHR/]TM)#/QL5\_CI:) M=)%/WIH"1[()^F*GH+F6P)M[0W]IJZ[0Y02SS1\HH+=L':_P#'D!PX*<1` M4`I5`X\:H`Y2?L"G^QT5W`7_`+T!^C]#`F/@8#?]I:\U6UK;W8MOA*+B MV>X7O7\!:(F5NNL3UHE_K+1P"DM4S7*(-/5;YPVZ`+I M1``S;`^*2DF$/'OI:5>-X^,C&;J1D9!XL1NT8L&2"CIX\=+JF*F@V:MTC'.< MP@!2E$1^&!CU"OM,VE3*UL37=EB+E1KC$-)ZK6F`=IOX:=AWQ/4:2$>[2$2+ MMUB?0(?=^`]!#`R[`PJP;'H-3L])I5GN-;@+=LIW,L-?5J7EV+":NKVO1H3$ M\TK$F!))),ACJJ&`I0$1#J%)G.FA1]]T]X^AHC?8LGM)'A) M0%9>1T]#2VQM@U*G026FE("9J5+KTFTDH=\O.V5\@_?HKQAGT8HHB=RH5`J9 M`@M8*GR%AMHZ:2KEOYPTRZQZ%EKE%@GT?N:T)5.ITK7L8[C7U,V"M`5*P3]> MF+[:Y9M+$0@4'%1AWY3B#LXB=P&[.`E_UEHWR:1DWMK:DO3T8#7VY:M:WN]; MW+/65/DW4BT^QU;8WW8S"HS\J><@3)OUB/XF%61?N%D2M"E(4Z@=@7C=Y'M= MWB-BZ_R.DM<\>-E2FO=?;5K2=AV!%1='V?KG9$0YDX2YT"7M*L.K_6KQ@Z9R M44J=PO&.$BAZ[A-0BHA0;Y!>7EXJ/._;=QT1,Z[VW2(*0U7`B('Z:V MK7U@$?B(&^GXX$B,!@,!@,!@4(>'($S\C_*V[.DC[C\J7T?6*BBFH"/VRW0; MT2BF0G:EWAW=H="]W4>G41'`W#RPG7T;R$O'*;CA<^/&S+QQJT#)ZEY#:NVJ MA>IQCKFI34^YV7$W",?ZQ@[;*M;@V=Q"B4A#E9'7I6[[65LVJTE6VJOF>S;E-W"6A-9,7)$W\=2*Y(RBC%D@Z* M5TF5`06(FIW)$"IC4/\`M,G*C^1[5_W*M*F<()U6961=-6ZR(MY(PJ M-#KM@5]00P7BD[X%II:@\:?(31.T'9;,%;V?=^*TK0*W4D0@9):;>2%K MD)QXUA"/&*QV":Q4C',H\30*(%5P+N,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@11YJ)IK:$<(K)IK(J[@XR)*HK)D51524Y,:B(HDJDH!DU4U""(&*8!`P# MT$.F!(K[&U#_`)*UO^X<9_:N`^QM0_Y*UO\`N'%_VK@>PM2JI``I:S7BE#Z` M+"QH`'X`!L`8'G[*5;_DW`?W'CO[6P-1[_@*A':'W7(.*U">@PU'LAXMZ,`R M=+>BVILTLKZ+9%HHLX5%,@]I"%,8X_``$1Z8&KO'5U_(-X?=P]1#CIJ4!'KU MZB%-B0^G[N!,S`^1VP8ORI%?,VKTB#E!X@1VW2Q;2$I[7YF_0:H)/9'V*1D&7OW2:95WG MLT#"1+U#&],@B!>@8'W8'K52273.BLF15)4ADU4E"E.FHFP[ETW,S=.(ITNDHO M'KN6AQ24.B8ACIB)1$0'I@!^@?P#@1-G^6O'#7]]FJA+.+I'7]^\DDY- MI$\>]Y2\>9^B# M`(>IN,.H"'QXQD;?4'VPN1-FF=NU/6+[4%;EH>M1K.I5M1:7EG+9VJZ!5J=0Y50MIOW% MGQ@1VL;+,M=-<-9":BM7OI-(S*1HR+IS8:S6I"0B$6JD---G*AW4C\%%D#@L MY`2]YS]I!*'7@YM46I4?C#P8NU/V^ILW9VR];U=K:K'&J0,1/5*E5K5-"9:Z MT^@UJ!6TA'0=*=24DGZ5B@* M:1W$V@:Y5AK4;S!Y2P]709)H3D6O\`/#>U>A7LB>5;&C8--Y&2*44T;Q-OR3M0G3?JMUG*BT$LNZ,HV4543,D] M6>*/&W>=8PJ>DH0%OAZG=T#H'%.?%+XZW29TU>)>JB@H9(QSMV4LS7-Z*I%2 M%%PTED''IF,F`')W=JA!$AP,0QBB$\*_`0M4@(2K5N-:0M=K41&P$##L$@08 MQ,+#LD8Z+C62)?@BT8L6R:290^!2$`,#E\!@,!@,!@4(^&__`#A_*W]W_P!J MK_URW3@;GJ#GF%PQE=RZMU_PJ#DU2;KN+:>[:AM6A[-UUK0)(-PV:2M2]9V- M7KBL$JO::D_=FCE'Z1ET'$2@T$G02BD0)J\(]-7/0_'.I4/8J548WMQ8-C7F MU0=#564HM7EME[%M-_5J=-*NT9*(URLI6,C)NGZ?84$1`AC$[3"%->H?]IDY M4?R/:O\`N4X^X'9&P&`P&`P*FO*I85TV7$[7%HV?L_2^B]Q\AD-?[JV/JB4? M5JQ1[23IEB3H$`]MC1-9&$K]EO:K1)[ZY#IG03$X@/I#@5%<`H^MT[EIPSCW M6X-Q[/W\7C^+?)-^V326QAI@+!%M>/VJD64T5@[BRR2 M)*=$@#HL>_\`Z\:E.;KT*I]?H'4?IP);8#`8#`8#`8#`8#`8#`A-?%I)3R"< M;VA%'9XIMQCY0/5VY!4,R0=K7WC@U2=*D#JDFNJ0!3*8>@F`.@8$V<#$+QK^ MC;,KDG4-AU&N7>K3+15A*U^T0[&;B7[-<4S+-G3*0070515,D43%$.@B4/O! M@1B_FZN!@#U#A[QR`0'J`AJ2E@("`]0$.D1\!ZX'M+X\N"A#G.3B)QX(=0>J MARZIIY3G'KUZG,$4`F'J/7XX'!/_`!I<"9&PPME<\4M,E>0+*88M8]M3XYE7 M'B2*%9ID&PKT&B_D5"JOWB49&(-VA'#Q0H&4.!0$XAU'`V!@4S^'&59S ML1SRFH\RAV$KS\WA(,S+)BBJ9LZ2KZR(J)&$13.)#!U*/T#@7,8#`8#`8#`8 M#`8%"7AM_P`XCRM?RJ1_=CNG`EWRLY;;GUGR"@M%ZSF.*&M6CS3Y-KN-A\MK MO9*E7+(J>XOJDYI]'3K3MF+N8A2H(/'IG*Q3%2=I]B9BB)RA,;CQ;[A?-2UF MTWRT:5N5IDCS!9*Q<>9N4L6I7P,YN09M"UF7F73R1=*-6:":3WU%!['I%2AT M*`!@42ZA_P!IDY4?R/:O^Y3C[@=D;`8#`8#`KP\@.W=DU-EH/2>G6>J4MF\D M]N$IE3*/&C=4CR[AMCQ47O#4NH(+5NX(&!]S?E=YE7+20=AXVM9(!'D0.9LZWM7$7KWUU!3`D:@%F. M#M1'IW*!W$[2_'X_1@?#^5YYE/S9U"_AMK?^%>`_*\\RGYLZA?PVUO\`PKP' MY7GF4_-G4+^&VM_X5X#\KSS*?FSJ%_#;6_\`"O`?E>>93\V=0OX;:W_A7@>5 M.7OF2$1]+QFT0H=I>@*;OK1Q[P(4#B(EM*?4HJ=1`.G4"B`=1$.HADL?S%\L M)#NQE?%O%.4S*I"P+'\CJ*R.@B")`6(\.Y5?E=*G<`8Q3$!$"D$"B4PAW"') M?ED>4K\U83_2>UW_`&E@/RR/*5^:L)_I/:[_`+2P'Y9/E*_-6$_2Y.Z[_M(< M#W<1ML[UY4\P[9?=TPW0Q1``N`+UZ!U^G`QRY/[)%5&TRE.@$+7;HVN3;^K M59U*H03:RV-G&.G$'7W,XZ35;0J$S)II-SNU"&3;%4%0P"!1#`]U6=6!_6*Z M^ML0R@+4\@HAU9H&-DQFXZ$L#A@W6F8AA,BT8#+LHV1.HBDZ%!'W"9`4],G= MV@'/8&$2,Q=T-@5B#CZ>T?:^D:W:I"SWH]B:MGM=LL:]K*-5KK>JG;"\EV]F M92$FLJ]36*FR-'D(<@BX*)0S?`8%('@\_P`7/,O^6_MW^P*W@7?X#`8#`8#` M8#`8%"GAA%-_NCRBV!JD[,PEN6#Q-H_52,W;.0;V3:;P4$VRZ2+U!XW2E$SK M%5*7H1=(`*`@;`XSRETC3FS>2M*JW+2?N.I./S+1!7%,VKKS34=>YNQ[9F[Y M*Q3_`%W,WT=7;`G*N`0!&RT3%-Q0!\\I8>UTR/ MHKR*);(^*B6-*BM;.).IM;G8$Z;;9_7T,BV94RV72K@TE)6/%--9N_=J@J0B MHG*`5-:A_P!IDY4?R/:O^Y3C[@=D;`8#`8#`J"\O])UU:=8::FMUZUWI>-)4 MG::D[LBRZ#M,=#6?5#)2O/&<5L&9@7\)+C9*W'OE13<&249*1W>"Y5N[M3.% M7>M.&O%'E7OVM0O$^ZK$:R;1$J!6+5P#DX+@IU`.T5K6AQ6K=?4O6\$_GI6&HU9AJK%R5HEG$ M]8W[&$8HL&SNH6 MR[-O4+:+NC]WU/B[PNWI;=>\B];5%LPB'G(FU M0'V4BH"":/8ZQHRRU1AKE-)G22,JT4D#E$3$1$J*Z8?E]K'4/$GR%<0XKC-.5_E:SV*MLO55/.S5T==VM(UN\?5EX_I4A(MPIEGCUU`7(_C$E0.)3$,D0 M5E53!=S@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"*G-#_$0I^_'QB_ZS6H<" M5>`P&`P&`P&`P&`P&`P&`P&`P&`P*T^!S/U=[>2ZQ.'3UU(R',KY$J9ROZJ2 M495],ZQ2AV[<@D[TBMT)(Z?3N$OID(``';\0LLP&`P&`ZA]_`8#`I1\(D:LV MU/RWDSK-3HRO.#=@(HI+=[I#Y>C6VJONT>T/0]4_UD_B/>3X_#`NNP&`P&`P M&`P&`P*!_!2/3\OWK_TM)_\`XXP-D\]:Z\VQROJVN]7T6:A=OU702=VMN[$> M4UAXQL9+2\G?)6&/IT'->K5V/;(^PS"$BH]6,Q:N(HI^Y!VB=4IA"9G##C3K M74=>2V+!:VI="O\`:J;7Z'+-M?;>N6Z*3'4JB/Y9.J0]4M=M8PHF3?`\/)2Q MT8]NH]F72Z[A1PL(K&"IS4/^TR$.PME<(]O\>*3QTB]NH3MDLMGI4_$.EK+ MK=:#A'2SML6+?HI*2B0(G:D174'U2&3$`!40"^S`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8$(N?[MTTT=40:N%FX.^3O$%DZ!%0Q`<,W')O58+M5NT0]1!;M M#N*/P'I@3=P&`P&`P&`P&`P&`P&`P&`P&`P&!6_P,_QL^1_^7%8/\CFH<"R# M`PW8E3=WNB7"EL+=9Z"]M5-X^X5-:68KLD[!6'[MJ];,9V*,MZS M54Z*A4UB%-VCTP.8K40O7Z[`0+J:EK(YA(6+B7%BGE&JT[/KQS%!FM-32K)J MQ9JRTJHB*[DR***1EE#"4A"]"@'-8&`/*5*.MFP>P27^XM(>'IT[5E]9-EHD MM#FG\U*PTDC<9=N>+/-K6>$1B#-&9R/"-DV[MQ;G-P&FXV8=4&6>L+W!Q$@1FPCF[5JQ79I(KN%`<+G4.%PW`N`=5 MCB;IZ&$<7X\;=]#*E:DE M!YK\AADR,3*'8DD17J@OB,CK?MQV9'7>"0G^L).G7X]<"Y'`8#`8#`8#`8#` MH'\%/_\`O[_*TG_^-\#Y/))=*-&P;WCGH?;]DD-:ZSH<_8^2NQ;0QK,3 M4=Y;.MM!C&VO-SL]?^SSRX638$:WEJY<;!"6!W3[K;9"4G++K^4GF+ES`NE5C%/% M*H`3Z@%P*M-*"R#_`%E#F&#APT2>&X=T3Y>@M'JNG3D0KV@A=^R?D4*E%B@C MT,J)RG],A8*%C&ZCN1E961=J)-6,>R;)&45 M54,4A"%$1$`#`Y5@^92C%G)QKML_CI%JW?,'S-9-RT>LG:1%VKMHX1,=%PV< MH*%.FO00ZX%R6`P&`P&`P&`P&!0 M-X*AZ?E^?H\M9\/^&/OX&X>07)_Q>\AW3.+Y!:DONSGM+?R#&*>6+B-R)=R$ M0HB]!.0:1DXSULVD2Q+UTR*95`B_M70%`3D,`X$HO&59+?:.$VF92\QLO#3: M1+K$MX>7I[6A+1-9A=@6F*I48RJK.%KS>*AX^G,V*3,I6B0&;D(;H/7J(5D< M6I5"R?ZQ7Y#G:\N0*UPCHAY7X^UJQ$>I9&,#(.FSZ0A&>JJ@-B$!PL?O\`K*J=53]/K"/0,#L= MX#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'K4226`I5DDU2D435 M*50A3@55$Y5$E2@8!`%$E"@8I@^)3``A\<#V8#`8#`8#`8#`8#`8#`8#`8#` M8#`K5\?[QN_VEY(7#91-5(O.RX,S'3/WE!Q&:KU7&/$Q-VEZ*(O&:A#A_4G* M(=1Z=<"RK`8#`8`?A\<#P!@-]'7X8'G`I+\"W^9]LW^5=N7_`(.I&!=I@,!@ M,!@,!@,!@=>W_5]F\JOKGE]8I#UUTYOD@N7YDX6*JJ_E&L`D[ECJB)S+F7`T MJD<-?]HB\F'[P=-_L'CM@=D;`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`\#\`$0^GH/T8%1VM-6@&4,0O?V@)@VC^.CR=?]![0G^EX?^)[ M`U7NSF=Y`>/FL+1M_9'"/3:-,J!(@TN>"Y5*2\L)IR>BZW&I,HT-2MO=*KRT MP@00]0@%*83"/0,#45+\H?+79FQHK5NM^'6K[G:):-M;@J[+D)98B`AK'26R M;NSZTMT!`,"!&L=]^6K=^QX.@:FN>[JO8;`;8&R;&SW`PI-,J3VOPULA63GJ'7@ M]H3I]W_VO#A_N_B>'`XOQ2<8=O\`$[CA:]>;MCJ[%7*P[OV!L1)C6+`2S1S> M%L[&LH,4U)--FR(9T"\2MW$`@]"=@B/4PE`+-,!@,!@,!@,!@,"A+_5^_P#- MZY'_`,JFX_N/I6!?;@?@X=0^'W_^W@=;WAJ`_P#O$7DQ'H/0-!TSK^AU8\=N MG7\.!V1J#34-JUS9G M.P[_`"<<61VW9T@O?3.") MCMVZ788X&4[0^/A;Y#T>='.FMPT14D8*KZDU-R,6K\Z[DW"EALT7:+KIEK#N MY>$<))?*%!BX0JIP3,JD517T@/W$,`!?A@,!@,!@,!@,!@,!@,"A+_5^_P#- MZY'_`,JFX_N/I6!?;@,#K?<-/]H?\FG[P5(_L'CM@=D'`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8%: MOF"_HWN4'_HW3`^(]`^.T:,'Q$?@&!T^N-^C-LU#E1I8]DISZ#/KOD7JA"YH M/GD8C(5US$;JUQ5'R,A%@^-)I"2>ML9YG]-5_=^ M_P#6FI:A:+VEO5QI4EAUY0YN]ZQHF@YA!_MJ0CY-]/6/9-SAI-WL64(SCD?C]S^=$8[4U5MJJVS0>Y1JUBUM>*O9G9HNO M;'UK'M'=J@8*:EWU2?3K)5)ZBW<"(%25]/U!63633#M98#`8#`8#`8#`8#`8 M#`H2_P!7[_S>N1_\JFX_N/I6!?;@,"AOB%`1:'F\\EE@1@T32;C5NIF;FQ"Y M-[AJDM":S,$45F=0042F/EY%#J$*`)BP*!OBH&!?)@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"//*? MC92>6^DK7HC84K9H6JVY:"QLM#/E-OQ+:RKB8CXEFL^H+@R;)D]?KEBJ34*X+Z5]6&01(NNLG;=0JB2J9S$4(8!*(@/7`Y'`H/X&.E'?E^\HZBI4 M2F3;TEJ4$$$FY!3:.HQLD8Y$BE*=^'H3*VFEDX!^M4[M8&# MQ2#;MW?7$GD'>HS6NH-NM M[?=IJM/KC$084[84$>4JL*'%*C6.?L6E(KRR,M(;'L\TZE&_'/BIL6VR&NZX MX5D"19:E!W.X6A!C=YR-!P+)%JR<.G1BE*H"KQ,OJ&"TWEXQBXK;'&;1%@WS MSUBY9.O:OBZG-:?8Q"U$?WMA(^_V6X;!,5/72NMY[[16BNQ*\_/U\H(E^72L+!-TU5)N2 M:RHH"DS$/3=B/HJ?M9SX%9'![=T5R'Y>4M_>]S6_95UU-IG:U9UK$N.(J7%^ MM1PM+)2:[M21GW=@NECG+)?DUB1[16)B46\;#]KD3(-Q4[5`ACX_J;L+8?BF M\D-'U1%S4YL.T[9V;#5:%KSH&)=-[([GW,?$ MV>T*/D&)RK)O)!7L74(L8071()0LXY37DQ;KQ,I^VN57)#CSL?96OJ*UONL= M5WC1L13F[R*?MW]IG-@/[G8ZK8J^C(2/N&R\HR*X2=MVOM6Q3JF]NN&#\`_Z M7GRE?#_DK_PHQ_7P+^`-UZ_3\/OX'G`8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`BMS@G-C7O4T!M#>NJ]UT"3 M6F)O5C;?ME5-1JE`2U=VO9I=K7Y*6%RLN1VN\-<:9JVE]*TS7 M-5VK"V>'AKC-Q32T[K7[?811NC%TBT.NV?-W9V,6LN"ZBQTQ*%;L'=KQK MKF+YPKGK5\:.O<+1H$U7>)+F:N4I1]8(6,2*Q1X[K/L^Z<2]96O;-N&Z62=)./6,D\AYV'LL;6PG'[>%JUU"QSUDE MY.XU-)`\>]>KNUEW(MRF747<>JX5";F`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&!7MS\W`Z@JU7N.T+QK6Y2S?(NJ[81DM;N[O%:VKQ]?:_K+*0N3YY<9AN MX22F4UY^/*Q:M@*\.M8!>'>$DYQ9-1R]>-4VY7)BI'*8(O^*& MW:BH7CRYVW'?=;"X:;KV]-BR.Q:N,"A9_GE:2IU'*\C_`)"Z50;20KF.4`(H MHFF`_6,)0N-Y+;3GJGR(X><9*=R$UA3 MKXLG1[/==-KU,NME-BU2I2AA?-*OMYFQGVVNVL\FR>FC:XTC^^8&(58@_9D6 M,5P%=M#=04;SM\PLW;-E5_5%0K;S5UCM-JM595N=3=047<8<9*GWBJ,5F\K8 M-?7UHN>&FVR"A#*,'QP`Q3]ABA?!P;AZ9`<2M$1.N[W&[,H[.C-2UB\0T'-5 MJ%G8E5^_<-E(2OV-Y(3D-"L@6%LS;.EU5DFR!"F.;IUP)78#`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8$*^4_$RU\@[IJ'8%&Y$WK0%IU.QV)#-G]0JU*M:< MU";,CH6/L+19I<(YZW:.SI0#<"K"5#KYK5*R<*E2Z4B]8M*Z7X2YG M*2PE,B;HF8@CWB!0$0""%SG..G,VZS5VX&^/#DC1]I5=>.L26V-#;(I.JI.M M6AJY5(B_6UVW">II0:2*Q?57CG4>]]0"")/V2*=,HG7L4H^BT59%X2'L-I^:3*)B-V3E9)A[..%F=0Y M?:,XU10[@013.H4+^_'0]@Y'@WQ??5N,6AH1WJ6N+L(QP:,,LS(H18RJ:@P[ M&-BP$SCO-T003(4!Z``].HA-+`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`A M7Y%O6#A)R-40N9:$9#7SIRK85EIAHR,U0D8]5Y7Y9_7DEI^+A+>U*>)>O&0` MY9M7JBZ8@9/`@+XY>+N^]7;:)M396B:5QHH%'UKO"G-H.L7]G;W]_;;1WDIN MJGM!BJH9:`:TC3,#)/(N'7<'5D5CNW`^F0A^TH1[\.$SN)EP0YBSG&^`J=OW M'^4-;'NM(*\OUXBJRTJZJFOS)!+.RN(]1$A(M959),ZS8BJY")**HE,90H08 MG>+'*ZM;+?\`)GF+PMY(7.R-;'&RDA*<1=A:>UFR19HIH>P33J^F:S)WDAXU M9%`YY!K)-EU%4_V]P00%80O?VG"1=RH'+B=G-K06J:!'RL?MV[5O3 M^OFM'8W2ZMU-WJT:9FYB^7AV9P+5X-D:O8=\"P%]\43N04"G,KMFC;_/(B[E M*U'/I';E`85L+D_I[&O2UH1W1>Y2$@)12_K(51PPE/E)TUV[HY05:`H5,2G` MH@%__C@/84.'NG(.Q0#.'4KE;1B8F0AK!K>T5FT0)5EW,38JY,ZJ<*T]9@\; M..PY$4T#IKIG`Z93#TP)SX#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8$$>?= M?VG9]&[*@X2KZQOVHI/5UG0O]'L\'N^9O,W-(2<$\K[:KL](/26:8B'3-%VF M\:MDT7A%@15*JH@"Z(A4=XU86BTODQLNHL:73:;>6W'6\R2[%E$JBW`$S)E*J4P:IX%P.T9'PC+.#TUP^2-Z0`J"!CB4>[XX$/%J?S M$2BW.H_Q0^5)#@TNHPFY75BL&,ELV1D6S'YY-L$K.I6&<5"UM]8T3R)&Q&KA M+X=5$#NC@H4+\-NM35+D/H2[T[3'/:W]3J%8U+2I2>TO.C.7VH:]O,+3-Q M46[LJ[M-_8HNBN;'6]Q[`=5]6J^*^ MV[PK,;5@0C8ZNQQ)71X5D=M-E[/[8OU4KZDP9G MJ*1:O4F+F_KP[*3<^B\4B%E4B.DD05(8`CIPHV/>=0>"WE?>]=6=Q2KI#;AM M<=%6MF4#/(`ME?:6JDM(LU0275:NV\/-./2<(E]RV4Z*H"54A#`'&=^3-FJDC"Q,[M&%V%'\@6$O--R6MJ:N0I64M8X4KXYG,@# MT7R`^D+=;L=*)*%"VSD15.+4O9M+;PY0;ZV3I"^7"/T060T!6-TKQE=N]C:6 MF+E*?!6/6,$P?S5R90-^FQ;K2#8B2*9.XRRJ:)1,4*;/>+([/\T\6M7K/8:M M:.3&I:QL+[%PD%9[=#TB4W)LL74K5ZM8IB'C+58E;"WC6#.+,+@7ZKWT00.) M^I0['W`NN2U0X8<7ZS/0SZO34)I'7K"4@Y6*DH.6BWR4`T]PSEXB77<24=+H MJ"(.DEC=Y7'?\"AT*`2VP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(@\]5Z MBCQ,VVC=]=R^V(&50IU=)0*_;RZ_G;!8;/L*IUVFA#W@RB1*G)Q=QE&#U!^8 M>UJHV`X@(!T$*5.)M3J&ZMU2=?WUK#D)(W0]$VI;ZGL;?W+.2W#9'#/C?N./ MJ\EJN$9Z[A*C5BTBK[,13>2J$F*Q)MRSCG/8X*3JF')^*=.[O?$7O]IK_3M< MY!V^5W)L:+9:;MTBSB:[L%I,1.KHZ?AI60?KM&C=$*^[=KE[E"=RB)2E$#"& M!`6C$EM,\I*-K6D^)W3[ODW&.%;?3*$IR@O>U34MS%+_`#89V3B#7VUU.EN( M91$CPAI7T'"($27(03BBI4V]^;I MIDU>;>Q\V2R,GLC!P;2.IW=<"16`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!6CY(J5 MS-V!KE>H<V'D+R#<++Z%@]VL]0V9I>=>0NG-U4#;=;7 M8&JT9*G82M]VUL:C%KRCINA\]3C.CZ2E3).G!S"4YA#T^)"@;2VGXF-ZZZTM M?VNK=F7+<>R8&M7UVVK1[58WG'+N4VC8OV$'ZRCI=TZCE6[=%(PF$ M.H8'8.X2#M!7C)J9[MM[`.;1*5"!E&S6OZQ)IY&#@WT-'KQM?D=?H/GS"#F( M@3*).`:@V:G$`%)LV+T1($KF[[56J)%)-B?UET5`[R&(50)6QN M[.2TQ-1D-$^1'QERCN7M?[MG:5MCD%O7;E8UG$QNO8QUKF--$6JW$B M%=@+52;LE[EH^NU%@_;(.!]\J+^0,4B7IE.?T0HPBHRRW? MJ][3F<+=937[Y[:#;ZN<9%1_VFA['4I!)M)FDSMEFJ<@V.^26%!,Y53IF*'8 MYX3LKQ'<2>.L?LILX:7UCJ*E-+2W>3ZMH?$EF\0@DN:1GUEG2DE)J@0#N3BN MYZ+F.4%W`!ZQPE#@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@56>0^J;:L=S MU`JYH'(7/A22"B#")< M)N"S*21G`."*(ID"/O'"H;5K[_D?.4C77+G2W$ASQ8NR#37/+.\FG)QOO$?? MKC/:[@[!9;S?X6!/56R_OS.Y%LDJ^<%,FDDEU7M\ MXHN;TR`*ZA=S:Z2!18>G550J2)"@8W40*0H?0```?5XD^'NK-%:Y<^2_EX\A MJ73:RT7D-*H6ENX00C&:P/89?93N*59'5FI.QF=E;U5!L1PJH!A=H%.HLU%, M*XY7E';^8ODOTWO"V$,Q1F>1VDH:E5DKI=TTI]"A=EP"%:@&GK&[07%N957;0[O;6LF4L^0742-%1SOD#:T780AT3"X-&IB162],&R9R**%,`=D;Q\',/"3BZW-&O8OY9I6BPJ:#YLR: M&=(0D,A$MYAFE'2$HS-$SR#,KUDH1!2+)*N]B12142QK=TL,0NGWD61*8?4$/MJG$:]4*"VRL[Y3\D- M]2MVU#9=?0=6W3;*Z!O-MHZLTBME;SB[PQ41>'.UUOL"`N$;'C/PQY%B1M8` MKI4714C^X(U7.`&25$#$"RS8^C]7;/J\+KZ]:BUQ?->U]Q#J0U/M42R=UF'" M+:.&3-2-K*L*[AD3PK0$DF1`*0J9#F`HI`0.\-/U;@]Q8K]4ZLW29!`0[$FAX=E7]+:J@XVO6:HQ\10*K',:O=&%;BK;7FC. M':(-H6RQE.;M*G'S<:D0$G*,:DFR35*8J(`0"X&V,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! 9@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#__V3\_ ` end GRAPHIC 17 g899224ex10_7pg010.jpg GRAPHIC begin 644 g899224ex10_7pg010.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X0/2:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C4M8S`R,2`W.2XQ-30Y,3$L(#(P,3,O,3`O,CDM M,3$Z-#7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN"UD M969A=6QT(CY+34)47T,T-30M,C`Q-3`Q,38Q-#4W,34\+W)D9CIL:3X@/"]R M9&8Z06QT/B`\+V1C.G1I=&QE/B`\+W)D9CI$97-C&UP;65T83X@/#]X<&%C:V5T(&5N9#TB"\T8C0'6'?K_^X`#D%D;V)E`&3``````?_;`(0``0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@(" M`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@";0(J M`P$1``(1`0,1`?_$`*P``0`!!`,!`0$````````````)!@<("@($!0,!"P$! M`````````````````````!````8"`0,"`00'#@X-"@0'`0(#!`4&``<($1() M$Q0A,2(5%D%1D2.V%QB!L3)"7MUAYH<&T MU,66QE?72)BH2?#14D,T)34F)[CA\5,Z=496ABB(&A$!```````````````` M`````/_:``P#`0`"$0,1`#\`W^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,#\$>GQ'``/4.N!^X#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`_!`!^7\S^G@8=<=G%E9;/W%6IJ_7^S,&BSJPQM:OE3=1#FI_6+:.U50!E M8/I:792T2^C&S0D8W.K[M&);-ES)-D'*"!0S&P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&!Q,/3H(_;_`-H<#&/1=4>U>W;D)F8VTVMSE M"1AH/8CN,HDFW4BG*;JM!$QCDZ1GT-'QK15>.E%UVZJ)RJ.6BR9T555#$`V! M>[`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'X8>@?`!$1^``'V_S MOA@8O<=INQOW>T(^4U#,ZOC8.[SBDY1=N<2BE` MED(=TU81$?%3SPSM5HK'HD24;Q MNTI=-T2T(>Q,*<-;(M$%G86KIN3V6VP-1;JN['8W#6!@X]DYGB+N73M5-!!N MD0]*L49XSN74Y7MC%8*4>>KOU1L4386TLFW6BGZ+V$7? MI1L9)-W2:J#I][5`Z1N_O[0,(!4#_P`E?(>,G(6MO?%IS'),6(KT\0D@-(?, M7`1R7KO/=3D>^=0$09%+YP%>NFYE.H`0#"(!@?&,\HVUA]HYLGC1YLP47(6K MZAL'*%>+:-*X1:F6C:!KRS."KN._T0-'578\W*`D82"`J^CZ11Z`8P"8.H?- M3R0WM%Y),%O'+SX(ZB($+,_*;6U%]$D,)3'!=L[_`!A@SDGP`0P"P:J+2`'* M)10[@$,#M,O(IL228(2C+QQ<]56+J%1L#=4^OM>-5%8MPF95$Q6;O9*+TLB= M,O7V!DPD`ZAU0`3%ZA;Y+RU*K1$5/I>/[G^>&G)XM7B7_P")B+*F^L2C]6+3 MATT3VLKI-XI(H'1#U$R$%0HAW?#`]]CY0+1)KR+9AXY/(8Y7B'?L)),FE8E_"47O^39\A_^1JO_`+-]P[,JWBVW1&XF`H2#Y+T?4ZB5'KWJ="_'` MY*^2ZV)>T0'QS>0\TB[!TH5C^)"'#M;M/0!5?W87(6P]IW)`[1$IA[O@`]!Z M!4$#Y(%9F'92BG!+R),SO$CJ"U+QO(Z!,`54(4`<%N")5.\I`-^A#IUZ?8P/ M42\ARIR`97@QY$T5!Z]4_P`FI-3IT$>GSR73M'J'QP/)#R6116@/%N$_D222 M]@ZDE!_)?=J`FS8*$1>K?,M8G.#=50"]H%[S]>I2B'QP.N3RI\,/( MD9J_3?JLUOR69(`73BRB:0,"9K,"R?MBE']&4HGZ?,[L#X.?*'56@ORN>&OD M12&+=IL9`/R5I8_MG:PK@FB(I6-0%A.+93YR?>0.WXC\0ZAY_P#"KT3_`$/O M(A_V4)_^[N!T7'EUTC#R]3B;GH7F%K4;M-DKU:D=HZ48:\B966%S&MUV4>]M M5UBPDWS0DLBJ9JT*X>*)"8445!*)<"5K`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8&$NEN>6G=ZE6=@D'D@(O9)(0!5JAT)U[^PP=@AD#NO;T'HZB+["LS&0> MP#";KD5*J1QV1%(MK8)IE"C,N?>N&Y#L(Q1Z558J8G6$@#V%,/PP/MIO;U4W ME16NPJ49V>O/I>Q13-1\1%)PO]7YQ_"F>>BBLOZ*$@#('")3B54$52=Y2FZ@ M`67DN:NHHKF#7^$CR-OJ>X+-2EK[$R7U;;A0EX1")G)E0@6)26(\.\*TKSDH M@FS.B"Q03%0#]0`*GTKR_P".7(B8E8'3FRV=RE8=-TNZ;$@+;!$<-V)V9'SJ M'=6:`A6=A:,/I)H9=5@HY31(\;'.)2N$!4#)3`8#`8#`8#`C+\R'\6CRL_P1 MJG^7?E4=-56OM8DZATG!!.+H* M:@%[#!,9@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,#6Z\8KI"0\N?E9=(Q[2.+],2[4&[0G1(#M-G/&+ET`B4#`M*.&@NE^GP,NH M8?C\,":OEW,RE:TA-6>**BJI6+%2+$^;/8Y!_$O8:&M\,_FH^=45:2"L5!2$ M8BJB[>(MUE6Z)S#V&+W8'F1 M3/4\FT6HNQ-!&UU-GE.FNJ9!$]4J)5%B(BX.D0VSJ24RA4"G M3,L8H?$"`8HF^3J&!G%I1-5'36I$5TE$5DM94)-9%4ADU4E256**HDHF<"G( MHF@$MMA3('41Z$-N"P=P?$1Z]>P/N8$P'.69@F6CGD3 M*3E8BI"8L=4<132?FZM!24JA`6>&EYU*G/+F/U;"V-85!51K[L#(`8/G@8OS M1"L^)5GG+;I&NR=BN4)=Y(CZ<:$E(B9KD\\9Q:,JY&#A;5*5+LKCJX1<.=!. M0,S(FB*P=2@(#WF"&JSF`G\XIU\80,(%X_.C"!2B.$7S*,>]#-R++.2)!L7X#`8#`8#`8$7OF6=KI^.7D-%,V:KY_:$ M-=U:.2270;]K^8VC34FJIU7)TDBID4)\>I@^7Y0P,]-)K*.-,ZD7554656UC M0EE%ECG45544JL4N-@.I1G$Q"<-)7VI-FLHXAS%65BE M'`MU%3J$-T"[>`P&!;*WV+9L5>]6PM0US'VNB620M"&T[LZN;&`>:TCXZ`.] MJ[^.K+E@Y=W4]DGP!DHDW50,R)]^.)B_``N;@,!@6_?6:Z-MFUVI-==N7]`E M:?9)N8VD2R1*+6N6B(E(%I"TQQ4U2?3;]6RQTF[=IODC>V;A'F34#N4)@7`P M&`P'VOZ/_P">!$#&>8/7#2I:WM^P.-W)BIQ.W$9@==2M=IT1LVOW!U6IFP5R MS,X:0I\VXE4G45-P9"%;OX]@^8@9%<<.:5GW[R!VWHN9XYW73 M2FHM?:YN\Y*7VXTY[8TWFT&#>7J]:DZ=5'$VWB7R\05VNJF!#!YKV#XZ9.XX!,!5K55[O`Q]IIED@;=698BRL58ZQ,1T_`R:2#E9 MHNI'2\4Y=Q[U-%VW42.*:A@*HF8H]#%$`#W\!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@<3?I?U08&N5XPV1D/++Y77`J%,#BWSP@4` M$!+UV[83_$1^`_HL"8;FUMU+0_':W[8"EU_8$A5Y&I(P]6L[!NYAY.3L=KAJ MP@W=R+URRC:TDH68,`RCM9)DQZ^HN;T@,`A6/&JT-[OK-K;S4/6^N9R:D70V M>L:QO-3V1"L9MBDV8*(R-PI<;&P11,!*O3`O'XQ]5;$B]=3U6O>YFFS(79MFNA4TTR_`I$R1K8I"%#X_-*4``,"HPB\]3]<3D"M(-&LB@=0B3E02%5+UZ=<"Z&I=TZWWC"3=@UG/.YR.K5ID:3 M82R59M50E82UQ+.,D9&#E("Y0E?G6+UJQF6JA@4;%*)5B]!'X]`UC.77E,Y? M:CY/!6&(CK-/QM8U7>8YWUVIQ#6$>;AF%=YPKOWB$UL`(UL2F-&UG]>`D#UB58,A:OQ<*I295 M7*OI->I2!?/2^NE^8%$X[!OG;')ZX'VG-\C:@WU[NO=:-K8L+UIS7UCGX7E! MK*K14C&.7%)6K.!''*A;#Y(: M0I5TK]8L*<_5Y[8=-3F((`\)[F:^:@V%O"+8VVBO6%%UQ/6 M"MRIYDLV1LTG9:6KD5//$*[`(N57+@JC%T@=0B93%((E63"O?&&G5D^$>DPI M5:FJ=6#14L:(JUCEGT[8(-L$[(D!C-2\A1-=*/I4!()US)1QFI53F*WD\.4G')R911H'WMN0^K;FW]=^(IJ`5F)EP3*(]O]D'2^ M/Z4P7TXP3=:K>NN5[?36P.0(W<>Q=SZ%N4]M*^2MZM['8(M'2\ MY(DD)!DR5K,$LP5:&1O=V:D@99'^R&ID2QR1U17$$3CW+*!*U@,!@,!@,")S MS;`L?QR[J303,JHK-ZG("9$`74,7\:E2.?TR=BAP,4A1'N*`&*`"/4/C@2AU M,Y%*K65$SD43/7X8Y%"&*->OVJKZ\M#2U0@TIR,&/D M(F7J\AJAZ^3(ZE"KIB^3=A]Y`2'.`A,KX2+#+W7AM/;"LSM"4N&Q.1>]+K9LZ(R$L5NDFB@W27(@F5)-----)!,A"D*!0#`UHN?PV`W._FVWA MPKA$W&TGZR+NS.6K=%C*P]*3FUE8=61E&40TFG%282J95'2#L%D1.T0(#MR@ M!@W=>.TA)2V@]+RDS<:_L*7D=6T-[)WFIMD6E8MK]S6(Q9W/U]LW*FBA#R2Q MQ4;E*1,`2,'S"?H0#'U[_&4U/]XUL'_/[K/`NKREXOTSEMK4-57ZX;1J%84F M6TO(GU7HJ=`QSG$`^41$1 MP*P\:8`'!CC>````%%<```````%EG0```/@``&!G/@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<3?I?U08&NSXR_XUORI_X73O\`G:G\ M"0#RC;4H]-XZN]<6:Y\@Z//[F4DZ_4IOC37E;!L)F->C_IVP.G;;Z6KS92HE MC"@A*(?2#5PY:N3%1,7H=5(,<..'-W2/#7QL\==B[>C[8QA%[59--N&E7I\@ M%M&]UV>OB,V]NUUZ9O_`,W- M`W#0U'[FC[0X.Q]I@0EV)HZ2",E(`2G92C$5%2MW[-XZCV5!3]KMTR6@%W5A7AZC-+.V M;^+8(QJ#E9JJFX7>),BMQ4%,QBF"T'AEM>O[AH7:/A@=,"N5/:LVZWMFA$D$02($P6`P&`P&`P(J MO-'+O8'Q[;>F(XR9'S&P:J,W,LF"R8"XV96&:OG*_ MF-S,VE4*(=[KFN<>7(5TW#!>&1.+UFFS555)W"4"_,`,YO&=;->:D\?G#. MOW?:VN8N0N]+54J7TI9Z"(+5M$UM=J^1< MW!U*T;`O&MI2MQT^X@G2[4UKB:--SEK;M&"9OW`X^/ MCDC:-5\(>,=+=<3>7EV/%:Q9$)9:;0J#*UZ52/*2BA'$:I)[.@IIO'B!_P"Q MB/6+5P9L!#B02F*)-W9/4(14X$,(AUZ@.!E_@,!@?G4/MA]T,!U#[8?=#`=0^V'W0 MP'4/MA]T,!U#[8?=#`=0^V'W0P'4/MA]T,!U#[8?=#`=0^V'W0P'4/MA]T,! MU#[8?=#`=0^V'W0P'4/MA]T,!U#[8?=#`=0^V'W0P."BJ2*:BJJJ:221#J*J MJ'*1---,HF.HHV<72WWO8=+J<+(3/0_T>P]XH^=@B<03*7TQ4"X^MN:W%S9]& MK-^B-U4&`C+4X>1S&)OMG@J):FL[&2+B'E:[(UNRR+"2;S4;+-%&YTRE4(H8 MG>B=1(Q#F"YI-^Z)4E6\$GNK4JDV[1!PUAB;'IQI5RW,X*T*NWCRS(NUD3.C M@D!BD$HJ"!>O7X8%V>H?;#[H8#J'VP^Z&`ZA]L/NA@.H?;#[H8#J'VP^Z&`Z MA]L/NA@.H?;#[H8#J`_((8'[@,!@<3?I?U08&O;XQXY-3R@^5^6%R(#??C6XYW+C$MJ7A)7)7?K(Z=>V_'Q%;&-/5EJ=GKVWL M323J_P`.X=E>*,8_WB:"AUS)BH9`X6EXL+1`>9/4,1#2[6>;UC@-2:^XFF#M MI)1LJ\2UQ7Y0\C&RK"O5%A+LGR$LFJ5TC%1J:QCF$&Z7Z'`GPY;34M7>,'(* M=@I^T5::B-.[`D(:R4R.=2ME@I9K6I%6/E8QFRB)UZMAU$>D!#AU$>HCTCFWQ$?LB M.![^`P&!9?0FAJ'QOU\.M-<'M"MW>M,6].S5K7MCUNR@6]B=(T5U#V>>@;`\E9.JE+[-]9F;JOII-7IC`= M!LLLF`"!^I0NE@8W63A]Q[TETE$5.TQB&]- M5,R9^TY1`Q#=IAZ"'Q`<",*K>('AG#5^&K%NAMD;@AZF1^C0V>V-DSU@;:Z: MRCBR/I)K0F,1]7HZL(R$I9E'RPMT0.J_:-'1S&7;)J`%_.//"?7O''9VS=N5 MS8^]K]<-L0U<@;4YV]LQS?D31M1%5.M%;G=QC21<.H5@J+-NX>N'CA-H'I@? MH8PF#,?`B#\LM35<.>!VQ&MAFHYS5.<6EZ>9_2*LLV,'WQ] M%C4D@:*A\4TW+@GR*B(!+V'^V/YXX'[@,!@,#4*U9:O)%O:D4J>U]SCV6XVW MM>[7Z/UOH:,;0<@\=:WU]L0]+N6Z-A71X>,CM9Z]KKY11HF'M'SF07;$19I+ MN%%2(!5V MK(!(HJ1AY6-719J2'S&X.`(JLD':>U3R9.IBJ:Y9\YM@P.^K!#L=@[)U8LZK MTC6N*NG@=N"J7K?VUUGPPZU:7"+U;HZSM:$@>U0E6X(ZD>>0>U([:@ZS^,7DL@DZ;.-8\*-?GAU)D3;#VL M4R$#>KI[,2&9P[=NFHY!-==9=NP2!VH'5;N><*<)6-CQW/\`W3--=SSZE>X@ MZ;'7BQ=F\C%(Z/246O[R!=2(KZNU0M(%,Z&7G%3M48(Z;YT1`'+5JL%6-6O. M:IVV<@)7R0RR(Z=@W-DY7;7DHAO,Z1XU.'44WD8_5P3<\V0CMP[+?N'R3)"/ M9LFKQLB<'3CV[LS9FN'DMIKR)#'49Q&\LMP!LS;,K*,..G'.?H;5ILJXT5M8 MX_\`^OF[DW:#Q316N4G2A@6+.$D3MX\4D"E4=.18$"H%]BYE;R8(): M>TJDUK&V>2"NJ:D-$LFWVK]TD?0NE:7[4R^T;VJNH9)X^A^PJ*Y4V2?KN@,B MD'E5N0\EJRFN(=OR]NS3>F\E$7=-X\3-3K4Y8=,Z@D9!Y*+;OY#S)6LG$ZV: MC"IG>MXMXBY>*+@G"LU%%BN"-@[SC;7,T("[;*)Y$I8W'G7,NWHC#=B.B:TM M+\E-QE4<-'6J^.VKFK%>7NB3EXB+9*=:.T&R[\BA&1%VB#AXD'JQKGR<)V"G M:D3YG.6FW):NM;UM>JRU0H\A`\/=/BT=.&EQWCM5>)=Q,K?9F-32)`FE*4YV'S0V(H>58C&: M=UF)23$%4/?18*-)V1=-&SENJ+I9-M'IBZ,%7]OD="V-*"Z\B,2QL\34E;YR M0F2ZWUD[U;PQA(R%2F96!OFSA;H05UO:[EXBT:1!B,G1F`*2R_MF12**A;&4 MV-Y%Y"K_`%UK7/"P-S;+L*U1XA:F/HNACN#E$[CE5(]_>FE/G8YF]U7JQ>0( M+D)N9640;0B?T@Y3;E6:HN`\3;5A\C,;";QJ3?R`,MFL='Z:L-MY4V2/U-1H MG6FKYQW>HN=5[HJ\[7G+TT0 MZ?$?2T-+H'%N\%/JR"FN5^I>)VE975D=I3C_`!VVM::OGMPTR^[5:*A,VCDC MMRBZWFYJT,Y6`A)V-]SH+2VPI&#+8A020C#"1>.;*`FQ,#@,4]94S6/-7D!I MW1VG*C3='3M^>?1#^\M]/UF/BHH]9A+9>WKMG6J_9GD>O(2;JM,!9N2F9R3= M,JS91VLU,8IPV6Y[A]Y6#`=>L^4&+$ZCPHECY;CO2FS9JP-WBH"<@@G)NG3A M'YH%`Z10.`CU,7H'4.HSX=>64[J3+(^4>';L4S](99EQSI#MV[3[E/G2;9=% MFC'J=H$'HDJY#J)@Z_`!$/6+PU\H_:7O\J@`?M#N`OOB@;I\X"F&0*(E` M?D'H&!XKWAWY:R1C=2.\HL&XF3&1]VT?<=Z4TBTBB0XKBVD&[5Z[7,10"@0# M-DP,41$1*(=!#S6_$;S"$2F.%3MUB-%4M/UEJ1LY,*'H.%D34IT+M) M$I%`,D!TA4[R_/+V#WAU/R0?,C_*9T7_`"(UO]B^!VG/$7S"J)LRM/)13&JJ M38$WRBVGJR\(\=@H<3.FZ1:6T%@@*0E*"(F7$!*)O4'KT`+1[1C_`"8\:=I\ M=W-]YOMM@TZ_[:J\/8:;&:WHK85*LQM5"C9UNYL"]/B'2OU@"RJ-^ULW15:D M,4Q%#CW&(&PA_P#C_L?#`8#`XF_2_J@P(`?&Q+,8#GQYBYR46%O&0NUT9>17 M`HG]%C&V_;SQVMV%^<<4FZ)AZ!\1Z8%^?(#R:HVU^!#W9NE=ZQ]/U]9MJ:[I MD_;IIKL[7B5JK;VPL?K31F\['4*2O]1+.1BQ3'F(^/[B-$U?15-W=APQ`NJM M^NGBIXY5]^QI/,#:MDWD^::QA+A&.KO$[-CF5AV4YB_8$VX_TG=+6C`TG0TU9(JMBE)JJF.T0D7Z:2AC`#A7]&(;#_)Z<@J[QSWE+69.(6@4M M57IK)(V%E:G];70DZ[(194+,C2&;^V)UE95X4LBNP2%PV9"JL42=@G*$9?@K M>PDQQ'L\[!U_6U70E-NV/W<'KZ=M\TM'/FD/`-UD;.2ZV6U2\>^7*!7+(@NA M!6,<-U3%*8X@`348#`8#`8#`B.\W*[AIP&NKXS,\E!,M@:L6M<85=!$'\&I; M6K1%%0%A+ZQ$;"Y8+=A/G=4@'Y`'`E1J8"%6K0&'N,%?A@,;[8A'-NH_FC@5 M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@19^5G^\+A]_K#N*/X03^!*6'R?FC^>. M!^X#`8'4D'0LF#UX5,JQFC1RZ*D==-L144$3J@F=RL((MRG$G03G^:0!ZC\` MP-3KABC7$.(?=;:E:-,:3L&R+.UY+;!BV#S\=7,"YSU^L2>K.'6A/HUV-B=P M$DU79I3;R,5:MG)E7#1N*/K2KY(,R'K:^)6FJ1;/7>L(/DW3ZI]-:,THY<1J MG&#Q0:,-7WB"&V=TN8=-*LS&ZIF'!PY2`Z9A=KH`VCC-HYLL[QQO'EJ_`[8OM?08NX\A!* M*$4D)50JY)WL*7VML.1=62A:YY'U[4"+#:-XC9!N_P!">)7B@A&M%#ZWHTB@ M@SB+!R@LT"DY6.N@#'>PWL;Q8XI M25AO4G/4'39K+*R8M5@;F*FXF5VB+(/);R]80:[GD'^Z98*<^;5 M>&YS^1)LC((W/>%F77?5N%XK\(AKT8LT;P43-,E8596!2_ MDSWD2,*TA>.G&UO$D:)FUZVE4#1/;Z%9.(J6D6Z$+'5Z=Y!RE)]-`H`Y$\BN"@@ M=I7$>BX6Y;OZ4[UC!QS-/9=UXFV38,JE7*B[3CGW(;R[P)RCNU2;A5)% MW'<:VS]B5VX7.5@P>PZ0@L1*#;-V[@+@)SM\AMCV51YLK7?Y54'6I-]O#-]28` M^:1_%GB:A*PTK'L;V$D[*0P()K.F+HPOGY%YQTT;-PQCY,K4.+XVU*H2]%F* ME5;?7I.'X'<'78M6]^NTPK!RY[QN#:_(K?UD4A*U:=?:%U^KO*VOCR$4T. MSL<0SN.VHUT_KU.!`_K(LSO'WK`5KU5"C.3?#&`N6U./V@N85SOFUYVHOZIK;9<=$QJU)UCL&!,S=M8]W]'?1EX353`BC62* MNW6"*#Q]TJK:R\N&L]80"EE=*ZYWIOZC!)SCN+43DXJHUO;D!%NSLV,8Q5;R MJL>R:BY'O%(5_5$A"%,0A`WAPZ=/A\F!^X#`8#`8#`B@\EIGA;OPV!J4ADS[ MD9D?B=,#B1C]?-1&$Z8BZ;>DI[PJ(=P%7'M$0]/X]Z82O!\GYH_GC@?N!3]I MMM5HT$_M%ULU?I]9BR)'D[%:9F.K\%'$763;(G?R\LY:1[0BSA4J9144*!CF M`H?$0#`\(FT=:+LJ5)H;"I"\;L:7)!:_D6]IA%X^\31F,E)$B:D]1?';6&1. MPAW2P(M#*G%-NH(!T(/0-?KAF^0B^47G9DW7O_:QTI;WSGZ+B6<_)^@T=[P< M+?1T%(G)'S3_`--,?1:+F!%RIT3.(%,.!2.IG;7:7A=(T@(W2%XCB;;EH&L5 MSEE;5-;:\K/LYHZ$5%T:SRNP)"0-86$2E[`BD5R[7;`9./1;M\#L-OAE.Z_XVQN]3Z\VA,62V:RAJ&P842,4;PU^:2S\\-I*SVIH.N6+YRH5 MH];SOK/4A:NW2X+F43P/!XS,S. M4P=5A6P)LL!@,!@,!@0^>=.4+'>.[8[853)#-7K4L44H-`<@N8+Y%2GHF5%R MA[$O;&";U@*M\2@GV?/[R!++5?[V*Y__``&'_6]O@>]@,!@,!@,!@,!@,!@8 MW\A^7?'/B@VJ;SD'LZ-ULVO#B8:5560A[/+A+N(!*/7ETT@K<'-&;BR2E6XB M*P)@;U`[1,(#T#&+^&&\;?\`I15K_B;M']@V`_AAO&W_`*45:_XF[1_8-@/X M8;QM_P"E%6O^)NT?V#8#^&&\;?\`I15K_B;M']@V`_AAO&W_`*45:_XF[1_8 M-@/X8;QM_P"E%6O^)NT?V#8#^&&\;?\`I15K_B;M']@V!@%Y!_(_PGW74^-, M5J_?$+;7]'YH<>=H6ILTK%]9GB*'3)F7G=^5#6NGP^/U-VC]GY/_Y& MP`^8/QNEZ=>4%;#NZ]HC3-I=#=!Z#T'ZC=!Z"'3^G@>3/^8'QTC"3*%VUR- MA&.QI[7%COJC%MHS@3J._7B8Z1?3!>5'F*Y,/B)K1IY!X";"PMN/Q M)!$2B4[=)@]CD2J@1O%-R$,'N3,/NRV[?FG,7MBHT;D_`5Y-?D_O*'/!RW'/ MQH\%+NFS1HINI:5CW#-ZFLS%=4S=@8"G#SFB-3;4C3D?4 M=:62R::L&RU4>+G&.9DWK79GD8VP"\7*+\Q>5EBD8-2P1&G($[%:<*G+,E6K MA%)!T]Z-5(]C@5812XA9=RS-CVM$*;>J,:^8?[:7>#4>'M/F9`UBD.'_# M&OSL2LFYN98@&K`'D>!W3=^_*Y>I*RBC1BF'@U2-D(M;6]0D]'R5CGIZ36NO M`SQROC0R=6U/'0:4=ZW+;FC9V;9M)N):=LKAW/)*V/WS]L\>K-T"+2RBAV0> M\21K1:[NRP6G=UFL%:7<,JGSGYP5^2FX>Y;>V##S#\(7A1P>@FP$/$5-I.RJ ML6HK!AZ0H.?:HJ.I)=R[9!S:_7)CL;3U1CZ!#1/)JO0)"<6N';.34E^._COT MU]&O(5IR!Y,OJ\=Y$6G;*E>46?-Q<+>Y5=*ILV'IG%1Z8*$0DZ.II*;<3.T- ME63CK/7]NUV9N6H2,DCR'\L')51L2`?ZFU?%=%+%#\=VKM(\80&3@[-U'I&; M-%&T:V=O%@NPX2V&XV^V:G-6*GR[9Z<'V59:S;::XJ^)3CPZ@RH#<))-<(R` MG=^SM9;&(F05DYA46+N'`Z[Y!O'%C&I@N46;O4- M9=@NY_8%+AM_TRGD#D[O]G#Q)-.>,OCG*0"U@8\=^.S8ATH^>W#(,D$&X.$2 MNG#AP5%[))F00CF1PHM9K7T:OJ.IP>L[F^U9;;(\L7"CAS(O7K3:/,+:D.D> MVR7+GG%.3#EG,--4A8E&D@NSG.Y4I1;OI%$51:QZ0?%*4V9%;:Y=V>QD+$@BT30(*U8=#Z[I*0 ML3A),H>PN55BIQZKL1HR16GT&TXXX&>/29*WLASL:T:JV>6:WIS\G9!. MKV?;FV?=%IJW$;A0Z92B[YE4H2O6^7B2,VH+Q"C]$L>0KE9XY=-@O3XV^`&P MK=Q;I6Z]7P+Y\S<1\+#D*=G M[A1NVN-,L[$T;8*U/5/4KR*E61E$U M@1;B9F-D]=[=LMY>+1S-!C+N+%.UN)7CDGIWJOM7+XSPQ5#`4A0V M(0#H'3_R^7`_<"WK.%V*EM&=L#R[Q+O53VE5^*@==DJJ3>:A;NQF)QU/VU:Z M%D3+R4?.PSUDU+'':E(U.R]4B@BJ6:PD@C$S3F,?H1$HY9 MA(MXV46:JIL)!>/,J@5\BS=F(H9$3D!4I1+W!UZX%+ZQB;_!:_J.=RY,Z7@:A1/J%*3U/VSKK:7U$VLC)+:KVHQI$FXOBUB8(\!P82MG0`Z:(]4^@]Y`Q-EO&M:J)R-X[V[CW9JW4N,]1W8 MUWKL?0$L]F`@J'L5A6;O".[#H1LFR>,X.&N*5T.E(P8E9-$UFJ+E(X`(HD#$ MCABX=L^4GG7=QX1`OVLK;G#(+![;Z`%V@[W@JV";]XX:,_H@5BE]SZJJ2?H] MW<H@'1@J#JZ@^''7=,N$3L2*TUL;:]/0W7>*ZI0Y23U?6[_/H%OFU6S-G M7-NQS>BQDT;VK)HP(65;LWK<"ND3%.'#K2REJ,9L>P5*KT6.@;]9MGQUM1MZE>.W8,9,4'!S+&Z$<` M%5\'HZ&BO,38(RE6NAW.HQG!F@,XVVZ]K#"K4:U0K:G:609RU%K<%(.H:MP[ MQR4BB2"2KI`J0'*4PB8#@''1JN[CEKK6K7!5R2N M-YVDW&/GY>+`]JC7CR7615<-5W*XLI=6)$BUBD8]U",5GY&\DY.I'R#E\W*BV,11 M(`F@P&`P&`P&!#UYR&]==<$Y="UR4E$0!]HZ[,[D(AB22D$72*TNO"I(LE#$ M(JD]GDVK= M_@6;T>AOYO47Z7(Y_J>2O06::&+=:;8VR/JPTT3-PKQ9!"XN',F%F`H+"\%( MWM0ZD!/KT,8P7DP+?1!]ICLBYISR5"+J0L#43Z]7B5)\=A*68YYP+TE<$79? MJ\2%1(2.&+,S$5C>HN"_Z$F!<'`8#`L'R?L'(:K:)O\`/<4J'2]G<@8]K"FU MU1MB30UVF3SQQ9H5I-ISLT$O!&8-V-77?.B&*Z3,99`A0!01!,X7T:"Z,T:F M?$02>F;HB\3;'.JW3="F47!&ZBA$U%$"*]0(8Q2B)>@B`#@<7QG9&;HS`B2C MXK9<6::XB5!1T")Q;$7,7YQ43K`4#"'Q`HC@6)XPV?D#<-,5FPM&KQ`]XY%]R+MNDX2-V\=[:H'5-8ARCT.0IOD^4H#]@,#'[;VR>= M2/+"ZZ!T'J'A+,5J+UI6-N5>8VB?8T9/+T^=EGE07;3IJX@JP+/(7&!D`*D@ M@"'L/0.*@JF.0`Y^W\N7_,EXTO[>;J_N1@/;^7+_`)DO&E_;S=7]R,![?RY? M\R7C2_MYNK^Y&`]OYW\N7_,EXTO[>;J_N1@!@ M%32/C4.3X]Q23^Z4S#\!Z=#C"*@7H;H/Z$>H?#^C@1D^6*/YYO>+]=CN0NON M(%%KC[>-"1KMKT/:-B-[0PMAH*YEBD9!.T0B+5&%4(*JJKM)VFLV413[4U.X M3$"(3G8\JM_Y"PLEJ,;58XW956U8PCIYU86<]5]FW=E4ZU3Y%769THV+,6'@ M[@9W7U$EUY`$99HZ31L%\#DSQ1TYKB+Y:UW8.S-3T>3V#M%I M"UAO;W_%.O[>;/25S=C&!;O6TK879&=3D7RK;TR.'J*KM$+Y M0CN;*N1)YW.42JA9OC+`UV%XJU2NW/6KE/1,M?["O6M(4:;]SMWR4/(1D?$VK=5EBBB1T?U6;_WZ!'KL46I M4FZH4JP=U9I3M*0R&F+T71;J].8_B!P0"?D&FV.9]^;W0U@DN57+I:QP?O8K M6R9(T+%[6>1=-"&/[V0%0#LFF!Z;AY/1MHVW=+OMIG&7R(9_0_-KF;5IE:6K M&A=;/9=[9(G@%PMC?8JN'NQ5D7#%D\?QS0TBQ>N#.%"'EEV;1`/95A'T2II: M`;Z;]HJA)P4GX[/'>ZEEX0T:K7RG7>\Q>;[R/,_?%=P;QV:660D%GIHYP3T0 M%U.NUCH!2_N*L:`W+/+;@L0:KO$ZC#(O"*O)H.7 M<9KN)E'IXA)>'(/ID(>/8JJJ@]D"A4;=I:XJR:1=1K,@;BEQ66L M1%M,>/7C^YKR\`KR=Y2J,&KZOS.W4XX7#H"/'"RSAXN5C'CZI7[W`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`V+L!@,!@,!@1$>45 MC6WEWX/*V-LW<*1G(6OR57.N#@3,[@6^:J813MJ*`AVN@92#M(!4ZI=BIN[[ M&!+L'R?FC^>.!^X%.V^+:3E3M$*_D%XEC,5V;BWLJU?+Q;F,:2$:Y:.9!M)- M5VKF.79(K&4(NFHF=$Q0.4Q1`!`-?G@!O[;L?LG1>@ORO+%;M'Q23NH:QF=E M\*I77].Y!UNJ5]TC&5S5>^WNP73F;ED8.'4E(QR[:`Y?-6BOJ^N82IX%`\89 M*PPN_?/C,U1W&L+!#N+C*QSR61?KL&YXY[NUXNHHG&'(^!4&J*GHG3`XIK=A MA(H`"F8+-UZ;VO$>.W0NKH_0T'O>E;"VGNFZ[7C=0V*_?4M5I1)ZK2,%6:=: MN)"GL:W,6Y:5=*(L)1H[C1DV:BKLWN41(8,L=T;IY.<=^!G'^-TIJ-IM6UVU M[L9O,6)W0>0VT6^C_H^7]S7)!JPWM7K'?)>+KT-(.8Y5[.H-&[EJW,NP2*W$ MB.!9W@7.[$M?E\>VMY&P)W"NQ\*\9VUW1M'G4/,U6M-ZZPC6 M8.Q*I4S9 M[NZ16P]OWYQ!,K&-GN]@FJ2\5;-_:%LB)21ZDB\B3>X!NJK@9E>%/7T)'Z>V MYNHMEB)F[;PV!%.[A`P+$D2PI#*G0!&=/KLE$)TFA(M+<>%G!=RJJ+$&KQ=P M"Z)A(H&!-+@,!@,!@,"&KSMD45X%OTD6J3Y97=.F$T6*W4$7RJEJ$B3)80.F M((NSF!,WSB_-,/Q#Y<"82'342B8M)9JDQ62CF2:K)$>J+-0C9(IVJ0]ZG5)N M8!(7YQO@'RC\N!Z.`P-6:];PXQQ7,'F]7>8W*OEQK)W`;Y8-M35O4>T]YQ5; M;T8U)KCM^S+%4!*6AH]-2:64^]]K=8"GZD`O438$@/ANNS2^U7EQ+5[:VU]L M:ZCN4=A@=2S&V;;;+9,M=9,JI6G=7`BUS'Z:8NGB$B<[I-0J1S'*4QTRG[A, M&(O-VV2$'S-Y&3MK1YL6_0]'A=&FV9;=";IV#INI<8FLW6ZQ'RDNSAX:4FX/ M;CJ6C9UM-G8-&#"1;+)+@HDX0/[@H9G6OQ[Z,U]K6V(W*Y]0!(HF80[,".K7NKZ7R3V\ MS4XML5OHV.F13Y6:>.$/,2*D/$2I@B[SVQLM+HO8 MU6)C'QNB3AT5RW%ND8RGJI]O>`1UZ?\`*;Q8U?J'5NN^4/#]M:]PZKBGJ/'R;UM*/G35%NW>RJRCM,1!8JA@D/I>Q> M."O$*.YG[RXQZ\VC8[](4=RY9,>*6N:1:++/[8V,:EUF20?7.1E8.:XCDHE;PH3J MD>@DS12;C0.#_P`Q*/.BHS("H;;!<01.W((=3?'I\>O4<"C-ZT]+:NA-A:4K MOC*V]I>#MB]>MD@_JT7Q!@ZR\G=<2;>VUL][KL#O"(;W*M@]B00=L%S=R[58 MZ:9TCF*H4,$.,UA6L](^D:%+ZZU!>H_6KACO+D57XWZH:,\?O&M.0]C(T+CY M%2*TBSA^2>]%$5K'(***J+D=NBNG1S%39$$+T(3<(A5-+1[;C_.(Z?G+PP9< M,.!,E8%6FS^4-Y<6QW./^8/,!2:BG\U&4B(:0WUB13F??)>Y[WDH=915D5,/ M68,I9O([KMTGNM.O;9AGT/">0?R$LI!6/@==UV/6<6A/B/P?:OVCTZDY'+^R MA'1F;0JS)RH"JOO)UP@U0#Z(QSJOM=.Q=*T8X;3;152:\>G!FTNSF+457#>4 M=3//+FP*P/)F'EF\Q-N'!"2KA=>)=K@@B96;=KKM`Z3PM53@-MS,IMNX6+5$ MS(LX_FUSEB_7:[*Y8W]F^!C7>''#=G`K>K'Z\2E'2L*N%;`&J*1U8]FN9VH^ M>D#U!C=@1MTUK',=KZ+T2_DXE;C/XK>-JJ1H=IN#9RK,`B)_<+ MV`:IBJN+\YL1$^VMCM8]8V_/+ M7R8DY5S$-M?Z\+'N(]=SQ[@BQZJ;LD4+"*+QX MDO\`B(T8%ER"K,(Y;I'MFCJ)QW!$F?I3@=P!(""AW4Z\,9,.H9M8D+%HIE!:FB(W9K&/D'GCY\>\A" M.&-1XYU].312<\O.9ZD18')F5H:1KU9^F18?<1[U^9FS!U-+.7*(4R9]KMOK MS9*?CJXCTV[ MC9V[C13A:#E=Z66I@*38%"#[I=$6[($XY%RHX#R(R2TVKK(683%VG>'.U+0[ M<7>^.RVR3Y:>5?D.=LX92%+I<"4C"Q_B77&-!)95K[)D^:M2M&9VD(5RZ-;NRN5FHE;`D`!"_>8K=;32RM*EH34HQ5.KE\;OW1%2MHA&$JTS M2VS^>U(O-"STI-W.P/:8B+N9UFL_L5C;+NQF#*F[CIA-QRV>^0WBCPKM572L MJ[S1B5;X_N'F_G&];'+1V`>219G=2*)V\0^. MDF8B*:1"A$=ISFKR&VEL'A_QOGKLT#15-W_H-&NT**IM5K+1,T3L^GR#!Q). MH=F:4E';&4;F536<.UECF54.H8QU3C@;[.`P&`P&`P(9/*Z^$FS>`$;UZ%=< MBJ^_[?:K&`31VT]%MBC[\%0;-Q`LJ/WDQ#*+AU.0Q2HJ`8)F@^3\T?SQP/W` MI#832J/Z#>&%\,@2CO:A96ES.Z4.DV+5',*]1L1G"J7WQ)`L0=83F+\XI>HA M\<#7?XJ2%JD=M<166]+!RV7XDQ=[CD?'F.S:%I^J0MEL#?6-M+0U=O2-,F3[ M`='B:,V=A4E'\>U2>)F(H<1`Y@,#@K-R+'DKYR+#!ST@UEX^7N,G$61A4PFY M1C)QTOO55A)L*4Y!$L\^C7C<@HQYP*#\Z12#\%>N!FCX[N35G:ZF%URXY*ZA MD9N^O;?;=-5Y2>H:-GB]94"OLI2^+S]AJD)2:Y9UX-RLNY>&0BT3QI4ETE55 M3)*`@&;Z?-;B(K&0LR7DGI8(RQU:=N]?=*;"K:19NIUA[*1M@GHE-5^1:081 M,A"/$%C)%,)5FRA.G<40P(=M,[-HEB\X7(C;=9LT7:-/\`7"12!-FH!02[C&.02@'=\,#I/BNC/*#R"KDOI^_E MV=7ML6RS^I8[/#W"1KUN1VG9ZK3]C5-[&U<=8(2:,ZG%`$$].65D4%U4U".$ M4SG#.+P]Q]!3XBL[)2FE69R.P+[$:G;6UH8ELEBD"K,R*H-['9S5A1&L MI,2ECE5RKI)@!U4RJG/@2IX#`8#`8#`B`\W;=5YPJ1:(%.=P;=NJ)))(B2ZH MK)5A]*V^01***2I2.%HJOKE;@H)"+.132`P'4+U"79DZ(^9M'R1%4TWC5!TF MFN3TETR.$B+$(LGU'TU2E/T,7J/0?A@=G`8&C%S>U=R@V!S:Y=*Z3INU[73T MN5U9CE@H#>4>QC3;QJG#JTEPX0C%0.PL31B[4,WD3E329IJ=3KI]2X$VW@$8 MV2,T%R3C;HC)-[M&\I[7&W)&;4,M/(6AA2J0WGFTVNJHLNM*H2Q5@7,DMX+1MP- M")#$*3CIHNWE(9F)G[)\S:]OIHJ$,FF$7^Z](WMI M#EXCH"_.F=7H],U[([8U6WD?:*[4K2L]9I./CV3QV*<6Q)4#14A**)*.6P.` M,42B)C=@@(``]0RRP&`P&`P&!"KYW:\]M_$;5U3C8)[:9&TO1[Q8!19OIM5R#9%8X"5)14#"`@`X$!.WO&?Y"-M;'M ME_@^*6SH>!L!N]&,:`8G;W> MH8!6.$I=W=\STN#6G.'#SQ_\CI>R:Z)H%T[OI;?INQP,@AI[8U3N4C&MDJU8 M14:-';"LJ1\8BX(#A!N*!G)U1*HJH&8E0YI/)]=S68M>.@6B#Q14BON$G*KAPN9052%Z@80M)M?F/Y.;'?:W, MZBX3ZEU^/NB6]DH:>Q59^_7G\G;AQ`+LREWKM^/LS M9R^Y*N]/&-4`O0Z-)0Q]RW.9VY64NI4XK@/P\A4P;RL)IV,L!Y").M&&3`HJ*LV[DP$DGY0K[V&T8Z^:T M;.Z95X_D@QJJC7C[QRB&T1+<;_%GI9VQDX\N]-V2<69.OV+:_P!6&"J3198S M4)!RDO&Q8$:ER:R[OE'YB.0BC%2<>. MI%R@S2ED>,ZB+=1!NFBDDQ<1#(50.VC&J22@7,1BMB?C`L;%>R05)Y`0&G(Y M*S[)B*7$.>._B,XZ+522F9#5](?JPHHG>E316<-4T7:I&\.W1; MN`H0J^L@HFH8!CK;9+_C#=IET/'KB0$8_3WQY(]S(QB$U-;ZY0+3H#(QFEFD MBR;2:JL\H*+HI"2,FD#0D?'*!<1S,6&)LFW9IQM^O5_;-68N8#FOSG*Q73U7 MP]UF5*(EF/$3B+'S97<<]N[8TBW2,L@@HJTD!&0DTEI-=E'(A2J$.J#+3]+K MNFY="(:2TS9.$O".R$F6,]NBRQ26/J+M2U;(GD+2>OM.*'"R'C7 MSJ0;M*R^5"NM5X\7K**7,*;9)_,.'#A$/*8LY]>T\=ZBPUE`16T#UENZX<<% M+)5GBU#X@:X8SZB;;FKRR<(RCHD]LV):0@.&Z)U&$@G(R!X]L9626>/$PIQ- MYJUE0=NV8FSKF\T-8;OD8VM(3;V()QJXPC%RJ+<%/_2&S2J;,K[_D[Y/N1*@LVQ#VUY]-)RU/T$-K2)'F,Z]G&OD6XIB= MM7DC"X#Q]S\DC5N>KFQ8WDSIAGRLC6;/9.[UN)A_=,GBR;DYP]$%4U00 M.&/WD`\7VLN.'":U[UK6TMEV69@F^MBLZS9:[IU"NHIW"U5^#>@F-:UG`S4: M9BVGUSH&;.T3$5'XB8#'`P2%>6B!F77`V:J[W9[QTOLB[<>JQ5ZB[AJJ@U9N M[!LFFM8]H#UC%MYL8ID#=545W"XG,HF)3*]!`@!`K3.">U=$;>XO[-MZDD`Q MW(?0,9?XR3U]/T9K4+7)[HHJ'N4 M#JAO/8#`8#`8#`A/\L46BI)&82^]&HO6C0418F6C]R<:5V3^4(LX M1$$67J*II'3*JJ55P!0+V'4.4)KP^3\T?SQP/W`Q5Y<;5LNM:'686GZ]HVT[ M1N.\,M.P=$V%>W>O:[9'-GK]DDGT4K.MJ;<[5=Y4'05MK,+-T1=E3J8GIVMN M[=*4]ZFO`,ROI=1&$176%+N53$Y@Q\X/2LM,[6\[DNJ5.0FG".T%DB&:QYDW M+QG+RWV09-[+%JC2+,>I#5M>:^56;&;.XAXNV1DFD3Z"B2XN" M!@8E\;.7VQ-CWN"J=ND^*>O*S4=-;KBJU=9[BUJM>MZYAW5&N4N^C_1JE$=V M`E4D9F7='>L&B*Y'`NUBF05!4Z9PDK\7DBA+>3WZ0:R])L#5;@=4TVL]K:ID MHFOYELS;:H8MY.F4Y.'KP5VNO46Q5&S<6#,_8;N.D0YC!@9;Z]W_`#FXZ!Y2 M*3N-H]>PM"J.RF<,T`-6DWCV+LBRLX MBQ(1^B1,JGK'#(3PT4K9-8XB_6/;!4U;AM#85GOYY-2'EHF1G(1TC&0EL?4DIV_U;6D'=N:,Y$+*H05?>%3+[8.A!3Z=3%* M$<>R]`>3JC;#VTYXQ;(XLR^G=N;%NUZ>T?9T!>(&T1'UOB8N/?-7ERJICRK] M5=5NH=)9FLQ69@FF!#F_2ATO$7I[E_Q\A-SZ@Y%:EHFMM>P-@93&JY&H!5GC MJTR,_*69S:E7UEAY^7LUO81C).-28OK"49@&O8BLX6%/HF%^[A6N>&O=X[RL M_'_7_&:YZ[VQ9*5;FKW:>S]B5.UL)2"U51]>R;!2)K-`L$6#+UZAZJ*@.3*' M*K\X`Z``!3<^MY-;6U*QM/&K@!961%FSDC.P;D^+_`)#5^1FJ^1-=TEPFU^[U75+764J!KS41D7JCA9=3J5,H2S<8->674W' M?2FM;F$26VT?6M3K5E3@G2SZ%2FXR);-Y-**>N&K)=U'I.RG*BH=%(QR``B4 M.O3`OO@>-8WDM'5Z>D(&+"$(B* MAOFD[^X?@&!9SC)>=U;'TO5+=R%U(VT?MN04FT;1K=G86EH:0HQ\Y(1\:Y;3 M#)5P@NC,1;9%V4H*'%,%NT3#TZX%J]V.(]7F+P@B7+0R[TC3DY9HUR8I119* M1&NJU7W)P-W@-,.K=6%KONU[(34VQ,Q9#6Y)G:7#UB5F`N"G;MDW`*CZPIIAF]@,"W M.J)G9T_2(Z4W!2*]KN]KO)DDC4ZO<%+W$,&+>8?-H-PG95(*N>[\VCL"NV#7D5"ZMA86FO->;':W)K*R=WF)5& M4&Y1$I3"QS5[5/JHX:MBHK'70Q#$.F4+FX$<'D>CF4NQX1QLB@5TR M=>1'C$#A`QE"%4!%>X.4NIDCD4#L70*;X"'R?:P)'@^3\T?SQP/W`8#`IB[* MD1IEN6442232K$^JHJLM1N46^>>Y$Z[ETX:R*GM8\SB>6>O40H)VT@WM:V!-!M6XK:5M5F08 M\J.9,06(6W1Y%-GIE+6$^)/%.$@E&%@B=5)JG=PS!>!5203%/VL:=1,DC('" MKD6^PX:^ZS:M:)5-?N>,+=HW*^%$[>/;.HMNX(`(QB!Q4D;5!'C?XW]%,:LU6G^-G&E5_/NJ]*;Q;M$DUY!\1N@":`^YDB M"+=!H(>5`KZM+K_4$-7]=723X[7>;10XX\=;'`R`;V\BN[FD>+UUR-Y.RBPI M349I*M22;:65=3C=5LY;$2E'R16Q(J+5#UE!?5JJX:MA;LE!48N"BYDB+2RK)@@%+4.NV.& MI^CZ&MK`FPK-`UY&3JRIF@=Z5DH):(WM(&W!3=F=MPIR6@]IK;TXUQ%2/7:?M2M0S,]! M1KIF,8H$4[*S.S(I&,E"(EDY`X7#4)LYWL*!9KP>KXGE14:L>4UWKXC.&=<6 M/$MQV?(K*K7Z_G:`A4YWD1,59@86Q5`0.X.7TV_MH1LLLZ#%'=)C4/CMOV_U M_>4C$<<)NQ5^[Z6^NS-*.W9S^Y":^0A'=VOMQGQ0=6N_<;K!*-SO$TU/0;*M MTVY6HQ\0W;`Z"K^:O-SBU-[I\=V]W4!5IW4KE..W&8Z.NJ^-LCTX*V2L!8RS M;J-*IL%@:&L!]+`T5^DG2+A%R^01.HF@D0,!-.>(3: M&]:[J?;\1L_BHIJ^Z_4&RRC6NU_=5\,[JU5EGYA9UB2AYF/?)R; M&4C7B<>59F_:R*15R*IB4X+%`_7N^.!E;@6^B*_?F>R+I8Y;824QKJ9@:BQI MVN`J<7'KTN>BCSGUMG%+@W<'E;&E;$W;'L:N$R$8"S-Z8F]4>@7!P/&L;*8D MJ]/1U>FPK4^_AI1E!V,T:VF0K\PZ8KH1DV,.\.DTE@BGJA%_;*F*FOZ?880* M81P/%US$W.!H5.A=C6UK?K[%5N'C[C=F,`UJK.V61JR11E[`UK3%9PS@4)5Z M0ZQ6B1SIH`?L*(@&!6>!#%Y3(Y>3W?P`;M%43/0VXF=I&>S]U(2Y_P`?7$\% M6T48$SJ-G+5L)W2IBB43-D%"B(@80$)G`^3\T?SQP/W`Q!YC:3V]N>JZG6T; M;:#4-C:DWC4-OPKS9L-.3E/?!`0-NKSIA(,:XZ92RBGM[699($U4RG.B!#'( M!N\H6#XJ:*\@&E+F2$V+M'BS9='2^P-E[%MS:ITG9;'9#R9V1+6&WOF-;/*S M9JS7XMO0/`ODS6F6L4X?G%(MW-9U3QD'B2GM4#"0$T0*`B/QP,L-`^-[D#4^/7 M,'3^]MD4O8%NY&TM*#BMEQ6R=YR5G=2[%A/I087B4MAU?;5^$?2"`^E'ME7+ MYL=RW>*+HF33(&=?`WCA-\4^-]4TQ86M2:2M?E;,]<$H]EN=JKBI9J86D$5V M4C?6;*Q-Q.DH'>U.4Z#8P=B)A3`H`&9.`P&`P&`P(4//,H)>'%"1[$%$I'DQ MK*%=$7;-G13,)VM;"AI$$BNDEBMW0L'ZGHN$P*NU6[5D3IJD(

G,3N'L,HVJWU^MV;9/%[5#+7T+.22$8]NK^M[7W MBXGHVL@\,DE,2L6WFVBBK1$QG/IKE.5,2`8Q0S>P&`P*;J=JB;I"DGX/Z1^C ME)&>BR?2L1)P;P75.!^X#`8%I=^?#16Z1#Y0U+L;\#IG`U MZM),K?&TO6S>K1T1N#:4/>=F2'$3CRBW:1NHM"M8V[%C[=S.Y(OCNDE3*4>8 M>/F%=.L7T44RIM8U)1\Y47=?B+4>J+17=``1H5D11A'KE0^DY0P5K'--GH7S7[5. MB4MCRY945LXT_I=:.CIGBQXI=!JMRQ)KC>W<,ZBXM[MVQU&/7]NL7M=RCI`T MODWY1 M)Q/9IMFSH#'3:0KN/34]421K4I'05Y,,;R.R[\T=7RN,.5=3UO&O]^I&-(.U&S5%)D/5VL8B%9M_K-&RNY7,WO*+;;9:UV:B.9'.",;M75!X90`1P/8GB M!P[B)10KHER2?R"/>5%)P[146(^?$7EUH^/0"G4&HND]'P-B2;UM#\-.';6(=J*1U)@VQW$$(P M1G:K<7?LF)U7JLE(X'?73M<'?-05^NT"J5O>;>IS+_AWPQ59,F&E>!&IR&61 M?; MKK/UTA`2BZ6.H1(S:#:F,Z"FG+G3[364,DJQO5KXH76XOG-&IOTC(R_)CS!\ MAED6Q7]OOY'#-&64T.E)D*OW/#H,Y!J@DYS:24V>>SVZDTDT1L2VJW?Z&DZ71:=]) MQ$J8U,K4[!;J+/U62I4N^=S+AS0W!&$BHX:N&QT$G9#??5_0;*!-7" M\>.0.C9;2DK!Z_MW(:*X^;8T8!S0=?H-#V?;JI6N%%UUE)3ZTO<)2H15N815 MQO+9FB1Q,O73#T72/<`D^(927WR(S.II&@1^SN&7)2GNMFW6(U_1V*LYQUF9 MRSV:87323805>@MX2$Q)>S14]9TJ5(K9H@'J+JI$^=@7\X+:\NFJ>)>C-?;$ M@EJS=*U31:6&`<.XY^XB7SF8DY$&3AW$O)",6<(MWA/4]!=5,#]0`P].N!EG M@,#CW%#Y3%^Z&`[BC\AB_=#`_>H?;#[H8#J'VP^Z&`ZA]L/NA@14\_I%FPY& M\!2NP4*#S:`().O0$[1F=+?_`!*=F5?.QZ)1Z*J;]IQZM$U`[%/T!@F&COI#Z/8?2WL_I7V37Z3^CP6! MA](>@3WOL0<&,X!G[GN]+O$3]G3N'KUP.Y@,!@,!@,!@,!@,!@8-[K_=T<&/ M\!^7_P"#FG\#JQ],@+%Y%;]:K*R@K'+:^XK:<'7!G9??OM?+W/9F[6]T?Q[1 M<3M8B8M:-7CDQ>ID!V=FT]$%`2,<\B&AA0Q>X`Z@(?#`B%JOAMK52KNR:Q%

4#.+V^@2.V66.-J!@\ MNL0U>G=1L=8)7\6+B8=)-4U#I*%3<(H+IN'"8I%1<+)'"M83Q=6"&D=76,G- MOD$I:=)Q$I6M2.R4SC\2L:XKDR=-G(L*717&J7M=@9`]93"*1?I$]VV9?>4C M$;=6XA1_\$7*J:QO6KG?-O?+V"V1?PV/>2.J7I9P6_6,9IG/*N=ENW-&7L^P MTUGS(A3-I&44CA;$3;BU%LF"(A[*WB_VRM=UMCCY`]W(W8^M`T\QG6>J]&QZ MU"EXE[PC0XC6)>=FXC MT&)M2%X5K"^J=(.F%HMR!S+#8-C&ME0B59MMV+K#1XVY>LMVPMVE;@K(:HFEZ;7V1S& MBZ\6VUGGXXE''D(WT M:0W^V(PV].DUUII"SW&)0AS5]G`J6E"L)V&$KL;"J*-FD?&N6;)JFLKZ29#* MJ"8/LV\7>T&4KJ279\]=N-7&AH20KVFV;?3''U&"UU&RD6S@WIJW6TZ06`;R MAX5B1H1\HV4>HMQ.1-4@*J]X4\MXDKPO![5KRG/3=PQ^\K.-OW`X+K?3B4[L M68%RU<`C:+0E6B65_72D9D;EA_=EB"L>]H5L#911(X5!,^+S;=AV'KC:+@4DTR]X`D MGVA3:GB,N+BBV?6CSG9N>0I-ZNX[&V'#2>L-+2:FRKD:5;S2DOLJ7?U=Q.;` M36D&3<5&DLY=LCI-T411%%(B8!7!?&IN@NRTMQ#Y"=U'V4TI@:[B+4KJ+0:S MFM4HS@7;BOU!@K2SP]0:/W(%.Z/&-VJSKTTP5.<$R`4+,+>%277K<53#\]N1 M_P!2X:TQE[9TXD/2DJJK>8F6"?;725@4FQ(R>M:\\'OG4@^3 MN!=B]>-'D!LJZT&Y73R2;WF7.LI)*R4HGXKM01ZL%;VPN4VMB;IQ,1'UYRN@ MQ>K(`#F,<*B18Y?6!,PIB%'\F^$G(MUQPWC);7Y\7O;T/6]7;&M2E5L7'OCV MUAY).LUJ5L,6T!S]4W\[#23=U&I'3D6#QLY02AYQ_K2*DKX\:;!V$5"CW5\M+,6]20@AD"*6:.K0)1JTH\3?LSF8KKJ, MTG*S?T%`RJVG3/(TMKKB3R';M+/*/*1HX:U-[SCM@[+L03-3W9)+[4>[*LS; M65I6W;!0]&JL9$,9M51LX(=P90$FZK-NBI@6ANV].5=DD=$5"M\NXB(1V%MW M1M&GKMQ[Y+2IETC-/+'S31:@9'UTG4H@Z<'*5?JY!%RC/,DD3*MOFIB9)0$U/GF! M0/F8'"0\8/)T2HF@_+-S+9.$U2J'/,O$IML<"&(8I`:M;)!?+VCW`@ MEZ=0$,AC<;.>_8@4GDG5[R)=JYUN'NDU?55!0_11(I99(42>B)0$IA4$3@8W M<`&`A0X?DV\_`^3R4A_V.-+?W=P/W\F[G[_*5?\`GQKU MO26T\S8V^DW5[!/96O6$7#=&1F]>Q2@+^DL=`6WS`Z'.4P2D!\/NC_LCUP&` MP.)OTOZH,#78\.7[M/RI_MRC_G9W?@;%.`P("]3.4G7\X'Y+"CZG1OQ>@VBG MJH+H??D8#1OJ>F"Z:8K)?/#M4)W)F_2F'H.!/I@,!@,!@,!@,"%WSJ(QZO$G M62LP[(PA&'*;4LO/.Q=LFBR$!"PE]EIQ1@>052;.)8(EFM[-OU$[IUZ:*93G M.4HA,VUH1`"*"/0X!@ M7TP&!3=SMD+0J?:[U95UFM=I=:G;9/N6[99XNWA:Y%NIB5719MB*.'2R+%FH M8J:93'.(`4H"(A@6RXX\AM;.I'4P\H=O/,IQ"\_"O*_*BI`S4A`2) M',6^*"R/IR,8J!3`)B*$`#%$0'`L9NO]W1P8_P`!^7_X.:?P*5T]>JA=O(GR M[;5.=BYQ>BZ$XU46X%CCK'6@KA'77D!*OJ]*^H!2$D64;--%A*F`E!-R3J(B M(@`2'8#`H76^RZ%N"FQ.PM9VB+NE*G%)).'LD*JHM&R"D-*OH.3*V5432,?V M4O&KMS_#H"B1@^Q@>A2J/4=QT_3*S`7*[6C8>M-94RM6BU+4N"DK)LJZPU0 M8C)6!I!69\S:1Y90[I3T&#I4R:!NA.G40"SZ%^\A'WWW7&KC$/WM0$?;,H+@W,$B+GE->_1, M[]=42BQ]+C9W^V]MV=?4Z']3N_2],"S7(F]>/T565M#;@1FY M6LLZ_@*!5K;;MA[5NS73,W M&.M4,F\!:Z@S%TCZ#AXX@?T:`^3\T?SQP/ MW`8#`8#`8#`8#`8'$WZ7]4&!KV^'&(=#RW\JM@`R/L2[]&$$O>;W'O/QE[LD M.[T^SL]#T#@'=W=>[X=/LX&PI@,"!/5W_P"X(Y(?O5:[^L&C\">S`8#`8#`^ M*JZ3=%1PN!4[G3[[# MDL-&M=:ND`HZ=LB3E3G8NQ0YWK!]0"%$`[Q-U-VE$1[2]Q@*`_#` M[.`P.H+!G[LTB#1L$B9N1H9^""7O#-$U#K)M3.0*"YFQ%E#'!/N[0,81`.H] M<#MX#`XF*4Y3$.4IR'*)3D,`&*8I@Z&*8H]0,4P#T$!^7`^39JV9()M6;=!H MV1`2I-VR*:""0"83"":*12)D`3&$?@`?$<#"+=?[NC@Q_@/R_P#P$3*X=),@B4YC`GZ MANWIW#U#O8$;7/R)93>T?'$R?E?F02YTU"63^CE$4ERO:]JO:MAC3*F7;N2" MP"0BTO=%`H'.W[RD.0XE.4)(R_$.O]/\\<#E@,!@,!@,!@,!@,!@,!@,!@,# M!GGI88.L4KC_`"MB&%:Q:7,[BK[BU0(N)UW#UVN1,A`^)C&``^7`UL].6,?/[/L,(RXU=&S4-ON&D7N+^O;JKT'6FF6?O&\ M(N6!9ELT4W,=54"("5<)(.?GDNUG)W'CQ:-94BS;`CN/W).(VM6I)%_%M(/? M-5BJSNC6=KF=5NX8UGEW-5K5S:GC59=RP3:J.S)^F4Z*A%A"A.=O,CBYL?8O M&2B:[+#5Z4UKSHX^6ZS6R,K,?%T>?O"--#Q^G9RSX_G[NO;V;2J)NX``!$0[90>H``@(_:`<"]FL]X: M:W.V=N]2;4U]LI&/1:N9#ZDVZ#LBLT&/JLQ.0GM8\X*?>D`[BIB!N@CU^`;!^`P&`P&!IB2]>U/M?1$1R,VQ MR/DDN1>^.;Y]<[J91W((8)VSXQVC:3_75BAY76Q98J$)3XZJ19%4CJMA;M&* MA%15%N!4BA*OQ%J7'WC]Y+Y;4/#"YUUWQ_V?Q%<;&N].I>P4-EU*/VC2MDMZ MU%OFLL>;L;F'E#5R7$R[?W)3*%6*8Q1)Z8%">3`A[\U9UC\:M-1)'+ILSM?+ M;3M$G@9KG:N'M4OT1>Z9;X@KI(07;)S=8G7;-0Z8E4*FN;M,4W00"7QFU08M M&K%J3TVS-N@U;IB8Q^Q!ND5%(G<<3'-VID`.HB(C]G`[&`P&`P&`P&`P&`P& M!B)LZ)92',WB:_+/^P\RU>Q[H6[E(BA.],W8-FNUE$P4+Z,BVE)=BJ19(Z"J;F-E9-['.TCI*"`E52.7[/3J`#@?1#QT< M'VSB--.M&HQ*3-!BV:QKQM&II,?\`VLBH*W_K.[`]NS M<"^'5P84>,L/'O7KYEK6K#2**DG'.8\]:J(R"\J->CUXUXS>/Q9TH^4XJ:K.\67.Y4=C'2'N3N%#"8 MZPK?27J>H8QA^/7K@=QEXS>!T;Z7T=QEUW'^@"X(>P3FF?H`Y220 MD5R@B0B@%Z``J=+V+I77]6K38KA9M! MUZ-K%J?1\='NGCMRY0C&)5S)HM?BFB7X$[2@!0"S>T/)?,22I5Y"4Y%1;]ZL5--$JKIU9=QJKJ%22*5),#J&$>TH``? M8P-AC`8&O!QM;*J^?OF4X)Z7I--,]5^Y=!-3^R*_Q]33])%10BSD>X@]WIE/ MV!\3=`$!P-A_`8#`8#`P`?\`BR\>TBK+N'?%#5:CF<.^/(ND6$JT>&/)&%1X MHT=M)5%Q&&.#3?"[BOQ[MLE>])Z*U_K.WR\(:N2$[5H@ M63Q6"45CEUHQ(!750:-7+B);J*@B0@JJI]YQ,83"(9/X$-?F]9*R7&?1D:A( MOH=>1YH3&V]75_8%6U3.[!IT-LR\,'\I3J#)V&+96ZT1T6FY5D'T% M`KN224FU9I,EC'.DF8H`B?\`]`W0+AX#`8'1DY..A8Y_,3#]E%1$4R=24K*R M3I!C'1D75+=5+Y7XZV4>S M0%QJTN5P>)LM6F(^?@)1-J[78.5(Z8BG#N/?)H/6JJ1C)*&*"B9B]>H#@8\; M!_=@\9?VGN4WZ\\<<"T^H9>)LWD(Y=2MPH!(#@<%%$T4U%EE")))$,HJJ MH8I$TTR%$QU%#F$"D(0H"(B(@``&!X=7M=6O$#'6JE66`M]8ETU58FQU>8CK M!`RB3=RLS74CIB)AF[E21ATYAJD95J9PFF#A,HF3[@`1P*@ MP(XN>/\`C8\W%&00D.7/DH%!@BP!CN31D:L")N[WKAKQQH1E9%7YB?:NZ]8`,'QZ=@?$ M<"0G`8#`8#`8#`AY\>G[M[RY_M_:B_`BR8$PV`P&`P&`P&`P.)OTOZH,#79\ M$/\`?[Y'_P!OZ$_"'<.!L48#`@)XK+H)^=;GZBH4XKN=+UGVQBMUE2E%%AHD MZW>X(D=)KU(8.GJ&)Z@_`O40Z8$^V`P&`P&!!%Y2+UMK7'(?3]S&L[]M.KX[ M1.TXK1\=HYK(/6B_-*TG=P5/2V0PKSUI(R5:+5%TSHHR`*M"K%,HU3,L5?H% M,>,G6-LTGRHG-5T1AM4M'I?%C7T5S%E;T_L4G4I'FDZ7BI\QZ1(VB6D4G[QI M6YI\U?*P@FCQ]$O<)B^@JH&P)@0Z^;05B<8=1+,"IJS[7ECIY[4&;@1(QE+P MSBKRYI,/*+!VBVB)>TI-&SM7N3])LJ<_>3IW@$P+,SHS-H9\1))Z9L@9XD@8 M3H)NA2*+@B)C")C)$6Z@41^(A@=G`8#`M=0-*:GU98-CVO7E"KM1LNWK,-RV M;.0[($)*ZV<1=&"8GG1C'5=N2&?+B0.H$(*QQ*4!.;J%T<"T4_H335JVS3-Z MV+7-8F-OZ[B7L%2-@OF(+6.M1$B233>,(QX)P!)!4DT[#XE,)?LV.(CW$5+QJYD%$5RHOH]TH MD<2'*<"F'H(#\<"FM4ZIUYH_7E6U1JBK,*5KRE1YHNKUB,.[5913)1TX?+)I MK/W+Q\X5O\`BC=IN6@XXL!C@90P2%X'!1--9-1%9,BJ2I#)JI*%*=- M1,Y1*=-0A@$IR'*(@("`@(#@4O2*+2]9U6'HVO*I7J/3*\@LV@JK58EC!5^' M;N'2[Y=&-B8U%NR9IK/72JIP(0H&44,8?B81P*KP-='>M8N$7SWY8[NI&X]I M:VD:-O;QA4>:J-&G4X6I;0K.T9&HU68B]A-TFWTC+M8Z-?.`:)E<$1+[A4JA M#@H/0-BPHB/7K_Z1@#^D`_#`C+Y\RIT-[^,N&!`AB27,]-^=P*AP41-$:>V0 MD1(B0)&(H5?Z5$3&$Y1+Z8=`-U'H$FA/T(?F_GC@F1_[M^N__-@2.X%-7.P/*I4;-9X^L3]U?5^"E9EG M4*HG'*V:SN8YDL[1@8!*7D(F+4EY51($6Y7#I!(53AW'*'4<#XT6R/;C3*M: MY*J6*B2%C@8N9>TNW)1Z-IJSF1:).EH&PI13^4C$YB+44%%P5!RND"A1[3F# MH(A5>!;:[7V9J5DUM`1FM+S>&E^LKN`F+)54H$\%K1BUB74H%GO2LQ-Q3Q&" MN3.52%]+M$3`%R<#B81``Z?+UP(=/'6Y;N^;/EU6:KI.4B\A=7 M-A41.50@.&%3M;!X@)B]0!5H\;*)*%^4JA#%'X@.!,;@,!@,!@,!@,#B;]+^ MJ#`UV?!#_?[Y'_V_H3\(=PX&Q1@,"!+BA_'G>0C]I:H_[DT7@3VX#`8#`8&O MEYA[DLYV=3M5;5VK>M-<>U^,.\]BU&4JOJ=0#[>-/:CZQX\7.S.&Q/5-E`5;.D$G+=4`,4%$%TRJI*`!P*8`.F8!Z"`#\<#[X#`8 M#`8#`8#`8#`8&*?(SAKIGE),4B,S/-LWB5 M,GH@^29D54(B1R18B)53^F!1,(X'CJ^'_BXHDU3+>N5R!FZ M2B:BR7*?;_JO#'746*LZ]6P*I>JD10$B^D5,OID+U`3=3"'S'P]\7A(4GXP. M68"4QS"H'*?;?><#@0`*;K."3M3[![>@`/SAZ]?AT#!SE7PRX[\>^0?!FF'O M^\H+5.R9KD(ONV9M/)S<13R=;UIJOZ[1*SR<=79LG!)QT@!A,9C[0[@G1(PF M$0P+RZ(X?^-GDK05-EZKW9R$>0EB+VGAI3EMMZ!M6O7Q'BHJ1$O592ZA-5N6 M`K/T$?T$ MW&&^S_0=?8ZX$7W/&8@I/E'XLRM9)I(^ERPLIC$BY!BX524-J.TE;*+%(9QT M;>X[>_X`(EZ@`@80'`EB)^A#\W\\<#E@,!@,!@,!@,!@,!@,!@,!@,!@8(\3 MG*`[]\ASIJJP^W6(04G'&318(`5T9,J"Y@,@IW$(X M,[L!@,!@,!@<3?I?U08$*'C`]'\L/R]^@"H)_E4PG4%C$,?UO=[-!R("F4A? M2,Y[Q3#IW`GV@81,`B(38X#`8#`8#`8#`XF_2_J@P->3P2,S$MOD6D?7:F(Y MY&,V!6Q%@,^2.PF=G.3N'#;IW),W)9,I$5.O111)4OP[!ZAL.X#`@2XH?QYW MD(_:6J7^Y-%X$]N`P&`P&!$AS^Y"QD5M*"X^6?3>G]J:IJ7'[9G,7?1=QPJU ME01U_K$7T#7&.N84"&8C>U;BHF8Z[D!*1D8Y2?$YNH49XSMM[187!MHC8?'G MCCHR'V=QTKG,G7S'CM`2],;1M>N-CCZDK5MAUJ72,=W;<_>+KF><3IV:4(WAT)BQ*R*\PK("#!* M+1:%.9N!*X0Q#$(9,2F3,4IDS$$!(8@@`E$@E^:)1+\G3X=, M#@NN@U06^:+%`Z+IF]:J*MG3=4@]2G(8Q3!\0'`Z4# M9JY:F:LC5[!"62/0=K,%GT#*L)AFB^;`07#)5U'KN$$W;<%"]Z8F`Y.X.H!U M#`[[>0CW;E\S:OF;EY%JHH2;1NY165C7$S%MV;N2B$7S563CFLCZ_T>Y?,"*F=-&[[VRGH MG4(4JOIF[1'M'H'Q6L,`VFF5;<3D.A8I%HXD(^`6DV24T_8-![73UE%'7*^= M-&Q@Z**$3,0@_*(8'JJ*)HIJ*JJ$222(91550Q2)IID*)CJ*',(%(0A0$1$1 MZ`&!3SFY4]G7V]L>6NMM:L\(T4:65S.Q:%?=)OSD38*-YE5T6.7(]44*5$2J M""AC`!>HB&!4@"`@`@/4!^("'Q`0'Y!`<#K.WC2/:NGS]TV9,6+==V]>.UTF MS5FT;)F6N8V.U]( MN%7EW!S:$`65!DU>>P2:F2U]T7LNQ\ M8?$/#@:T%C6<1#;T?QMX;P36S/(Z>63T]#T^,JEZGPCV+EW%M99%P4P&3$3( ME,;M"/[G3ROX][2M,CQXJO"SC]KJWZXY,HQCO:E`DZTSI][HE)LUHA$:P]EJ M;1Z[/H0=G9RJ*DBZ;.C%(=(XIIB)4Q(%R.+=`T)#\\/$FCJAG35G-M+)5NV$[)?T3((D3(*0)@!<#<<)^A#\W\ M\<#E@,!@,!@,!@,!@,!@,!@,!@,!@8-<40Z[R\@X#\GY4E6$/M=?R8=!=?\` M8Z8&2FFD=QW#0\E@]/M8&MKSNB-Y[RAM&7WD#XVZ0_L<9"V:/L4 MD^Y=U?4B<.N;9\FP@-73D\%@A4+_`$NW5J+9RRDXI1`,0OX&_@-[1)H76EZ)Z2 MZJP.2;TW85T8JB2*16QU0OO06B/H]Q"=`[3',/V<#X*>&C@(JCZ"FN+\=,05 M*H!][;K/ZQ%2E*9)8#WPQ54@`H@!1#I\X?MX'P;>%_Q_,D$FK+6E[9-4"`F@ MU9[RW.T:H)E_0IH-F]Y3113+]@I2@`8'S9>%CQ[QJ1D(S5MTC$#JG6.A&[LW M&P0.NH!047.BTNZ*1EE`*'<<0[C=`ZC\,#ZD\,/`!)5==+6M\27=&(9TNEO/ M=":SHR294DC.527DJC@R210(43B82D``#H`=,#B3PO>/U-PL\3UE>DWCDB2; MEXGO'`7730[S=A3F$"=P]`#J.!P/X6?'PH\1D5-77521; MI'0;R*F[=QGD&Z"G=ZB#=\>[B[014[A[B%.!3=1ZA\1P.R?PSJQ3BU=2VU6+1],$8 MM7PP.O";*U7='[) M-*M[`:[4VC<%*M((N6ZZ;X*O8KR:%F$CIHF1.BMV?>U!$ATU`(K\]7E:\]A'A"*P[]E(QRT;.,)N/>6YZG+04HW7,F+3N1,"! MC)G65Z]V!Z>J/$_MK4-.@:-5?(SR9C*O5XQQ#U^K0)WE9I\+'G?*O&B,57XB M[)F8`S*J*8$3<@@)1,()E$0$H?!YXP>7;DR!T/+?RH8F(U11<)H1\L=!9='N M)[I,CC:BRR)UT@**A14.45>XQ>PABID"C];^'G=FJ)Z_VBF>1K<$=8MIS"%A MV%-(TV>BY.W6!N=^H637$RSHRQOOANWM[C=0KAGXR.7#5\ MU>*>6'DT_2;DZ*QKYA9_8/E!,H/J.A9;F9/R?-4`H%172+\P!Z=>[N#FS\9/ M+)"-DXU]Y5>1T[])H$;&=S$9;3.&2/W\'!62,;NV-CS"\26`BGN$'!>TA>T" MCW"8**6\-UZ1EM:OZYS7NE/B],0LQ$Z?J\!3;X:$U6XG62\=*3VOU9KD++SM M9F'3%4B1P0>@R.FD4IVY@$_<%[HGQ[31-W(.Y1 M9/UBN91\6`Y30C('K])4I52((HM0`@"FB01-W!8=QX0JC-5^"I-GV/JMU3(M M[!^[+7.-8UR]JQ$=*LGTNUA+^ZW38'E=G+*R;*M74J5JNY$KE4XE,G3M#;6U.WI]KI];_DZ8%M]G>,+A_P`6HBI[YT/2[=K[:5$W M+H0U>LT;M#8;Q1)O;=V4"BV:/=LY6Q/F+V/G*I:'S)RD=,0417,41Z"/4)K` M#I_L_GX'[@,!@,!@,!@,!@,!@,!@,!@,!@8.<4/\>/D&_?2UC_[8=`8&<>!2 M&P(NXS=&MT/KVTLJ1>I.NR["H7&1@4;0QJ]B=,5D8B>=UQRY9MYU"*>G(L9J MHJF1<"=AA`!'`X:\B;E!42GPNP[8UOE[BJY$,+A=64"UJS.U6-JR11EY]M6V M*SAG!(2CTIUBM4CG30`_841`,"LL"W%Q@=D2MMUA)4Z_1U4J->L,P_VA67=3 M:3SS8M?)1C=7U""8[R+<7UV]2%(!]0A4F\RW$#"`% M-WB`"(E-T":G`8#`8#`8#`8'X(?)_0'K\G7Y,#7]\#[DCYMSTG M*)4!A]:,(S85MU--7:SW"FWA784)L">>6+W3B,1A]`RD/'/D(ALW1,QY*2'"#0S^5UW4]7'>5Z37CZK2*Z]J=<4A!L4N6#M#&MR#M\Y MACWB*(E,JHBH(%4?F$`*`]H!'/PQD'DGYPO(HX>$9`=OK-E&D&/7!RW!K&O] M-,&/KJE46*E(':-2BND(@*:P'+VE[1*`;!&`P&`P&!`1Y+X75U@YT\;XG9VD MMD7!FJIQ3%0GS#]O4/ M@(8'5WW%[CH7++:-8JO*SG'NBT)ZSIMP4HNF>-7'S:@ZKI;JQW=U6H&S3=]/ M#5%&4=.3.5H]1G$M9F0;$#W"SP4$?3"6OA#3?J%Q:U!7%(;;M?>H5L7LK#[W M=Q;S:K*8E7SJ2E4[6I"N'46@L9\Z.9NV0/Z;1H*2`%("?IE"++@#_&]^4K^E M5_US8X$_.`P&`P&!#%Y)*ZTU1N[4/,-/G#0^&$Y"Z\L>D6#NRZD>[7D[^QEY MA2U24<:OH3JA9>$ANB3CL+$*`P==JZKCJHB4@7DX'WS=5XV%N9I?NJ]PN` M]5%OR;U&)T2^W70`3*=WP!3U$O\`TB&P,N@!GA@>7-S<+6H>3L-CEXN`@(5BYDYF6C7B15V< MA&23%5=D_8NT#@=-5(YTU""`E$0'`]3`I^4ME5@Y>NU^;LU?AYZWN7S.I0DI M,QT?+VAY%LC24FTKL:[C&Z\5Y;(;)DX[2>FMLVS27)"$T34H!]L-CL*P:.H!(A]2I]];9ZP MO(YVZ,[64+'1Z;PX&7(H84RA*_P2OT1M#B;IF]0LML^9:SM>>@Z=;CLJ=SV, MWG(J>EH2RQ5BMR+",1LRD+8HUTT1?$1(1RW1(,Y%3-^X*[:X[-];5>R0Z^X]3O+S9W? MM]\P^MWQ7,O8Z?VR)H=T[C&XND5!,D*J0*!WA>3@#KC<]OY%VWE5L;CO(\:* MTGQHUSQNK]?N!F;+9^U9:F3+9]*[+O5?9B*L1[)I#-X^.!V!'`LS`4HK)$*I M@3(X#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`PVYROAC]24-Q[%.3(/*#B0@K M'JL`DDW*;CDCK-`>K(54?6.W,<%2CWE[#I@;X@42B&9.`P&`P&`P&`P&`P&` MP&`P&`P&`P(XN!W^-GR/_OX9W_,MIS`D=P/!M%7K=WKDY3[A!15GJMGBGT'8 MJ[.,6\G#3<-)-SM)"+E(]VFJV>L7K94R:J2A3$.0P@("`X"KU>MTBN0=/I\% M%5BJUB*8P==KL&Q;QD-"0T:W(TCXN+CVB:39DQ9-DBII))E*0A"@```!@>]@ M49/ZZH5KLU*NEEIU;GK=K=U,OM?V66AV+^;ICRQ1P1$\ZK,DX14=0R\Q%E!N MY,@8@K(AV&ZA\,"L\!@0]^,3]T#Y6/W\EG_6Y;`F$P&`P&`P&`P&!P4_K:GZ M@W]2.!KK?S>3^\+F!^WM$?@\ZP+GV+C2;RDH&O*7N25EK$CQU&)O. MT:XA*ZGH]PE8^L5+D')TVP,`DK#)/V0[&3]LT/)MD9"`6,5R_*3_2K'ZYL<"?G`8#`8#`@#Y,VG5'('GU2'G&#R5T70 M?):K:_DN.3JI1NM76Q5K*X=VMY;7D"G8)-VVH+]2I)F`D5E7R#Q MF<$3-5$1+W`"@'*)1*<,U\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@81\_3I M$TK1SK"Y!(O*;A[WBT4(DY#KR;U:!?244*TZL4:A0D96Z54H.-@*K`PR148N)@HQJFUC63$A3'ZH(M4R@! MA,8Q_P!$81,(B(07\`?XWORD_P!*L?KFQP)^[IV2LRDA<6=>C?2C_J+()N"(`[>'%%LF MV]/U"D!,-J#C9SEXOD],YB*%+]];%Z]2C\WK_3P M,OKM<;`V9-MGKV%UU2;7>I=G&E0-(NXNHP3^P/VS`KI=LU, M]7:1YRI`HHFF)Q#N,4.H@&!$'Y!=DV.(BYZ&\=?-Q[$344TFXM\$%IE%)[&/ MF:<@S!\4^? M&U55'"1/&_SG`[90B:OJ5C4"*8F.BFN46ZZ^W4T'B?IJAU.B90A3]2&$#E,4 M`[!.=^US'(!_'%SA3()R@=3Z`TN?L((@!C]A=Q]Q^TOQZ!\1P/@XY[;6;(+N M%/&_SF,DW256."%:T\Z7,FD0QS`BT:[>7=N%1*7YJ:9#J''X%*(B`8';6\@% MD:H)K.N`O/\`)W+-DU$VNF*I)J))K0R,FNL"<;L=TJH#9VL#40`OSE`-T$#$ M.0H>L;GC,)-FKYQP8Y])LWI&`-C(Z4J3U[[EZ*W5!Y$--G+2T8FV(F05%G** M*28GZ'$@@.!]&G/&0?';D;\(.?A3.A>`C[S15:C"`+$R9%_<*R>RV:3(#&4# MT17%,'(=11]0"F$`ZR'/IZLV3>)G M-J&;;RY,2^UJ6Q1XU7*8?$J+G7FOZJU4FAAS/F4?**R-89W3>OZE9Y.I:#Y17&Y5I;TUZC9M)[#UA M%ID8R";>QKS%TG*M*14$E`1Z;APH95$Y3BAZ?4O=WE"170N_JKO#2NJMPE5A MZJ&SJ#5[P%9=6>+DW4!]98=K+##N)!,K$CQ>/!UZ9U`12[C%Z]A?D`+LA;:J M("(6:OB`"("(3,=T`0^4!_LGX"&!1$YMV'B;SKFBQML3M.W.YGRR"&U^A4'+E%,[I*/*L`=IPP(U_'@JY6\N7E- M4>"V%8'T8D46I'*:7M4+1[=B!BNRD6%R5BDD"Y@#TC+`P9>&8M)*P1^M[-6IQ['QSAPJU9/)1O! M.%E4&JKD#D3.H`%$_4`^/7`O_@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#%_ ME>P"3IFL61XMM,)J\E^,RBS)VJLBD5%KNNF/%I`JC=ZP5!S#IMQ>(AZ@@99` MH&35*(I'#*#`8#`8&./,7]R+RG_>X[P_S96?`KC1'^(_37[5.N_P0A\"ZV`P M&`P&`P&`P&`P&`P&`P.H_8,)5@]BY1DTDHR2:.6$C'/VR+Q@_8/$3MW;)ZT< M$4;NFCINH9-1-0IB'(82F`0$0P-)=4M6@=0ZR&?D9ZK:ZB'6SK,GJZ8FKG&:\I]C]K89PE5LT M$,*MVZJ4F=[)M*XJY<@@@DLU.8'BA"8$O'#7?UEY*: M0;[4MU70ITL[V'MRK)UU&/G(IRPB*)LVTTZ!&7B[("_&)^Z!\K'[^2S_K(92V@B7K8/(G2$K=G M,B^WPC>5#;W`(^68U^LZNK=W8-(";?),3BM./.]THJ;L3`)R.!5_F-I<.>/5 M^GXF#@Y>QZZC'+R-J]22HU72%LX=QZ+BKU=NLLUC:T_;M".(\R(D0\<^5KRJ/%AX)2 ML!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@8AA+*$<=5L M3O3C2EW;4I('[T>TW8U!2/!'K\/OJQ/C\>@AE[@,!@,#''F+^Y%Y3_O<=X?Y MLK/@5QHC_$?IK]JG7?X(0^!=;`8#`8#`8#`8#`8#`8#`8#`UZ.8O'.?Y!^3N MT+Q]SIFO:OJSA55KK>+C8Z_&6&;1R52),^WBXTKU\W$DNX7=M4RQ M@'*)C"(``1L*^,KE3>>/T5O>@5SA1;-?771\7M*&3BM2IU_93I&=H*=J?5FJ MP32C2CA:WL7"JK*-.W=@=XY334("0G`I0RQ\>FH]10',+AN3C[O6'G[[7N*N MP[]RY!B5_,VRW2]X6ILQ%Z^OCU(!JZ!JBZO#-J@J@Y7D&YZT1N\037Z'`)W> M(Y1"F;:$3G/W\K.5Y@`_9T3`-]WH@$3[2%'L^;U^<)AZB/QZ=``,L,")'QF1 M_H[E\HLJ*#D@/^>M_9`Z.J@+-<8V(C511;HE(#A-=O\`2/54QS"4X*$[0`2F MZA+;U#[8?=#`=0^V'W0P/W`8#`8#`8'!3^MJ?J#?U(X$!W\WX_<]\COWT5G_ M``0IV!XW..2?5WECO-OHF][DE+Y=]+:F-R#UMKSA73^7%"B8:MJV;ZF.]B+W MBYQB%;=S<$Y.LG&M&A4ET&Z+A3O./=@3'<5K+'W'CIIVTQ6S6>Y(R=H\3),- ME,*=$Z\:6AJX(E]1:W$MGJ#)RLDKZRY3(#]^.!PJOQMS%:J/)'E5QXT%NVS;_`.*VNJUK M.RUNPVBU.]@EUIM&PN[+$6?5]5ORSI1O/U@L+7FK\I42J)(K',`*&4%518)G ML!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@8`^1.(<6;6>CJ>E8[55&]RYA\8* MU(SE*G'-;M#%B_V7'J&<0DZSZN8N2;.&Z:R"Y`$Z*R93EZ&*`@'M?D*0/^D_ MSD_[5NR?]]8#\A2!_P!)_G)_VK=D_P"^L#78M]QY*1&_N9-?;\P>61-.\=D[ MC'0*B'**O4]^&PC[9D*9KO7LM=-G.U8D7TK3(:2ERHK)`Z?!&J%(JF)RX$<* M//'FLA-1\,/-'?4Y#R3RN*O7L5MB>A%03>`W,XCT9^ZMXY*O/(XT@HU=.%RE MBBN4_5.==LFFJ(3=\[]"<@M+\+MS7%4T;*T] M\]VC*3MDJE&/7V:D>P72(@X]V47;(SA5`ITBG,4-AO1G^)+3OP*'_P!+-??` MG02A_P#*41\"].H=H?8_H8%T\"U=NUW/V796IKY&[.N53AM;C>/K!KV$5:!4 MMI$MT*RB8Y*[(.4E552TYRU,]CC(]BB;E0P]W:)BF"ZF`P+=ZVI4]1HNPL+# ML6U;+=35YN5M92ML2AT7=?AK-..92(HT6G"L(YM]7::P6(Q8BH0S@Z*0&5.< MXB.!<3`HO8U8F+K0;C4*]K M)Q"R@+(E73.D)R!W`(8%6-$5&S1JW5<*.U4&Z**CM8"@LY423*0[A4"`!`46 M,43&Z``=1^&!V,"U,IKZT/\`<=3V6UVM<(JH5ZEV.KRNG&;:$/2;;,3H!OD$+K8#`M=K:A6BD2&RW=CVG;-E-;O ML27NE9C[0S@VR.M*_),8QJVUW6589@R5=UF(78J+-SO!5=]S@X'4-\HA='`M M_M6H6*_:ZM],J6P[!J>R6.&7C(C8U490\C8ZBZ7,3I+0[.?9OXA9XFF4Q2^L MD8"]XF+VG`I@"&OG)P!W-+0-NWG"-2MTV M>T+?'$;8J]"J1=XGGI5)&,)'F9KK)$]0BJ8>D(=OB?9>7O)+5U7?ZQDV^H5K=6"RL'3'B+':L8UCE8IJ@NU3(FU;=/:G`$TP#M`+ M@\8/&WNGCIR,:;LC>0&K("J30N4]K:FTOH!;5-0V8V)"R+.%!_%FV1:8*%?P M\R[3?E=,62"ZB@*E,8074$0KZI<5_('KE*SQ-$YM:B;5Z?V'L;8"2%EXKDGI MI%[L:ZSEUDD7LLWVK$H/3-WLV=,ABMD2@0@`!0````JW\2_DV^SSAT)_V/U/ ME_-W0.!$`YT_Y--,;,Y=Q_'O>S^YNHG?=5V#R`<:PUO3TK;+RFXM=UBZ2=MU MUJ*Z+2T5.K13-V5JI%HSS-TL1H04N\QA`@92Z,U]SMY'U]S;=0>8>$M4'''1 MC)]BEQHH3.YTVT@9<7]4OE.?.&\M4)N/(F4#-WA4UC'`_0G84ISAC1N/;?/W M5,5LJ"I?./8W)"_TI4:Y(V/6^F=6U;4M+VE%$<24OI]22DJ+;I?<&SWL&V7< MJ1<&:-2J[%BZ?S+E))(R)0F/\<'*O\I_C=0GUPDW8[QJM.IZ.W(:=3C6-@>. MYV`9S-8V.E&QK6/9FJFTZZZ0F(QRV;D:]JZC^73441<._4 M53.=,Y3"$7OB]_C$?+K^W3%_ASMG`GMP&`P&!XEF:3;^N6!A6I9*!L;V$E6E M?G5V24DA"S;E@NC%2RTE]?WO8MIJNS^&%;V8G87%'4N]EF]G4N)"%D&%<90>O69F'M5SLCN?H MQ=1-1PJH9,H7Q\05QC[#`;<@JER6TMN77]3>5U*N4/4G&$O&0]'&=7L$PK9I MB`<0->>33>[$4`S=9)-RT*HV6`BYC"8H!,[@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,"*3EO:;,ZWO2*A+'LKJD07(SQWS]<(]81R-/9V6R[;VE'3K>%E&42 MTGG=B$E?C7#Y!R^=-$41;&(DCZJWJA*W@?%PX;M$5'+I=%LW1*)UEW"I$44B M!\IU%5#%(0H?;$0#`UN=,:;XO7K:_D"G-L\M:_JH=E*2Y=,]@PLC:VL;)3DH];N7$%VCWUGM/% MKF$]O>Z8F'E;?7F%>O/'?8UJ=Q5=J=O93=2:5E*@6]-[7+,G8DC/`/%/3(O& M3%PD7U4"`8+"^1GCKL':6B]'\C[/OCD+%0=\UXC`['FKS%.:EKW0-*G*=+6N M(4VSK'16FX"SRL.U"OYI*;L^P^0%1H&[=MWFT.FK MRP6R]W#7M5.Z4,+%E'1T37H1BW191,6R;H,8UDB5-),!%0QPS*P//D5%B-SF M;F5!;U&Z1>Q!1<`,NL1$!$I$CB"9?4ZJ'_0ID`3&$"@(X'H8&!FF)*+JG)GR M,W&T24;7JK$6O1$E+6*9D6<;$14=`\::8_F)&3?.ETD8YA&,E05676$B1$^H M]W0IN@87[#VYIS<.TV._&YM.\:=&6"G;9T\PY9;BDVU6LG*5.P5!_%,8?6=' MG^0?&*3K5\T^ZL#G5]^UXXK&]=`?6ESLRH2=]@+3),?I&-/.L_IAZA("Z; M"51J`27^*W1;NH\?]5[VL]L6LEPVMQKX[TZ,BVD4UA:]1M6:VJ3M6BU-JBF= MT_G+"FZM@2U<*..6E=&:R93NF]>[* MU:RV5!UR7DJ'LR_VRXRU429-WAX^!)'35SN-X#3;;4(&F;'=7B4L6HCJ*MVEG?3$%9'+&1CU'#/JF).JQ>\ITPO5 MP:UM'*1FZ(G8_'^8JC/7NJ..VI=>Z+OD)?G$3IG4QIA&DW;8;V*>NE(BP M6=-11)NR4,X%N@V,GZYP3``"6+`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&` MO.T:Q6(SCY=I-K`,#GYB\465AL,J+5@D6%B-@22D8M+2RQD`(SK+B?=NVPK* M`D@LJ1JW&[DAIJYZ;L^\]7QL9;$ M8I1.02NU!ETF4M7YR-LT"YD8&6DUH>S0J(L'RS=84"E7[\#R?%'9*%3N?\`1IRV7&$UO7(Z(N9U[)7MEUBG M52,$D>R,FVD['=)U-A9*@^$HH.HT5W;EV=0IDTSBCU(%:V?D=L:_<;;VTN'* MW:3RNS57VE%62Q26_+*\]Y:%(O8(U;CXAHAQ=?\`Y@IEI081#5>XI1QX9HC( M"Q.F=P/N$PW3=(?XEM0?8_\`I?0/A_\`VG$X%T,"G']PJ458X"GR=IKD=;;4 MA*NJO5G\W&,['9&T$@FYFW$!".'2.<.4FLQ#ODS(NFR@ ME6;JE$BA2F`0P/>P/%L=EKM/@Y.SVV?A:M6H5L9[,6&QRK&$@XEF02E.[DY: M37:LAC``J*J$(`B'QP/7343633524(JDJ0JB2J9BG343.4#$43.41* M%;/UR(*.BI"@18Y2"8#"`8%08#`I^"ME5M*DXE6;+7[&K69QY6+(E!3,=+J5 MZR1Q4CR%>G"1[EP:)G&)%TQ6:.`3<)`'Y%:)EI>6T'N&,BHJ,VYK]_(R4B_UY8FK&/CV+6P*N7CUXY5 M*FDDF4RBBA@*4!$0#`AOYYPDK$<>?&UL&O;%ONO[*GQ1JT1#V>!=7"08ZRDX M"%T)*,+]`5JFJ-I-K:IA:=/`O9#N.F6.>E!0@%2`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`JF+)"LHD^2 M[6HH=R:JO0,N?';)<:7:5JRAG!E133(@`.@/U$Q^F!*)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,#`?R"P,-::1QUK=CA8RQU^X!#K@7J_(ZXB_Z+'''_`"'ZR_8Q@/R.N(O^BQQQ_P`A^LOV M,8%1PW&OCI72+)5_0.E()-QZ7N$X;5=%C"+^@!BH^L1E!(%5]$IS`7NZ]H"/ M3Y<#IN.+/&-VDH@[XYZ(=(+`R!9%QJ'7RZ2H1J:B,<"B:E>,0X,$5CD0Z@/I M%,(%Z`(X&'//GC%QKK/"7EC9*YQYT;`6*%X^;7D8:>A=2T&*F8F19TR669OX MR48P"#Y@]:+$`Z2J1R'(8`$H@(8&=FC_`/$KJ#]J[7_X)Q.!='`I:2H]-F;3 M6;Q+U2NR=RI;:=9T^U2$/'N[#5VMG0:M;&WK\NN@H_B$IUJR22=@@HF#A-," MGZE#I@53@,"FZO3JG263Z-IU:@JM'R<[.VB18U^*91#5]8[1*.9NQSKM!BB@ MDXEIV7>*N7;@X"JNNH8YQ$1ZX%28%-W"FU/857G*3>ZW!W"GV:/7B;%6+)&, MYF"FXQR``NPE(M^DNS>M50`.I%"&+U`!^4,#WT$46R*+=NF1%!NDFB@BD4") MI(I$`B::9"@!2D3(4```^``&!]<"DEZ%275WC]EN*G7E]A1-;D*=&796)9'M M#"J2T@SEI.N-)LR(R"$*_DXY!PJV*H"1UDBG$O<`#@5;@,".F!YP^/\`UA9; MW7JO-J4ZVV2U3-ZV)$U[CONZ/G+#;'[L(>9NEC;1FJ2NYAY(O(GVYY-4%"KF M0[2JF[>@!6(^1[B%_P#U_>`__P!?>1?_`$3X&M-O?BOK>#H&R[I"4I^@_P"5 M"EW<\2HWD',ZMJNS043V%'7+:VX)JDY%Y/`$\]<`D MF9TZ3*$U5\\4'CQA-1VN/JKMXRE$4"W=9L MN@631`Q5`3.W,<`#X@/00@0Y5TS9W'3BQP3W+5N0EJF+QL+4D%5X2XZ^=R6M M%:+ILM(A+K6-9(J5VR*2UA5<6:S2;N4E'*B1GZS5!($DTFJ)"!B=K/<6\MM[ MFK;U[M/D!/24`I/JZ_=);#O5UME/FIV`>1[",K2+4'4PNO>IE!G#.$XU)HHN MD[`I^I"X&VWXZ]=5"P5/EG&7BK1]S7AN;FWJX578R2NP9Q%A4:Y0(B!BG\]> M%;!/R):VR$S5K[IRLHW2ZD*8`^&!(W,:JU?80C0G];T*<"&CT8B'"8I]>DPB MHIL(BWC(T'L\0OCO MLCYS*2W'AFYE7\F,O)RIMA[8/)2KU1^_6.(KB/1L!BL=2VR.3,B*!TXWGSAP)(]=4"J:IH5.UG18P8:F4&M0U1JT29V\?FCH&`8(1L8T,^D7#I^\.@T M;E**JRAU#B'4QA$>N!66`P&`P&!P4_K:GZ@W]2.!`'X"&QWG&SDVS3<*-%'? M):XM4W:/7UFIW%)J*)7"7:8@^H@8_<7H(#U#Y0P*FU@YY*<>M#..$*OC6E=O M2#*'F:`?:->L>IXG0&[222LFP:[2V,[EWB<]#NK%'`W>S:+]F]DO+6AM*7"392]IUIK2M56??1CEV\BSRL_QB/EU_;IB_PYVS@3VX#`8#`8&O+Y2-J<@_QZ M;3UUKKDY?M%-]6<.6?(/56OZ"\2JTINN\QEUMC?8<>,^U0)8+"VJ^NZ^J[4C MFJQ_1$I70I@1%WQC66Q&WOR"I3SE-LCEQ3BZDT#M6A7ZW[.00FMP&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&!B!R^F"02'&A\HNX;IK7Y2]>XW'3;8%[1`INX:7+ M@7M,("!3=?D$?D'`R1UF@Z:ZWU\V?`Z!ZWI%40>`] MGQZ=?Q^;-Z#TZ_*`?GX&LDE0$ABF`Z91Z]0#`Q.;>,#@0T*0J7&:AG,1L9D5=TXLS MUV+(R@J^R.]>S[AVJR`X_!(QQ3*'0`````P/D?Q<>/HY2D/Q2U4G3J.!X:_B=\?:EA@+(UXW5&(Q+63G)?W=BF4F:$G*N'UBE)>25<.D8Y`@@*PD*5(H%``P M+R8$/?B+_P#$%_UAF^_^`,"83`8#`8#`8#`8'!3^MJ?J#?U(X$!W\WX_<]\C MOWT5G_!"G8%_.1/-_D75N1FS]*Z?<<(Z)#:GC=>.)&8Y:[DL.O)Z[KWVL_68 M'U)B8LC-LM7H<.YBLY%5)*%$I>G00D]U?8)FV:YI%EL3FE.Y^=J\-*3;C M7$\M::"K+.V**T@-/L;ANT7G*Z5V8X-71TDS+H@!A*41Z8$)OB]_C$?+K^W3 M%_ASMG`GMP&`P&`P(?.6!]N;VYQT/CKJ"9T/IRTZJT:\W-'[OVAJBL;?V'(% MV'*V37TMK[6%=M2C1LTAW4+#.%Y]PV4,KZ()$.()G$B@=KQP1#K1NY>47$&Q MT#03&XZK:ZQO[G;F@M;--8,MFP.RV4ZZC&]^J<65W%UZXUQ=@J!6J3HJ!F;D MBC=`$^Y0P2\X#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`Q"Y>?1_H\:/I,4P; M?E>Z-],5C)$3^D`?38Q`=5A*3U#2X(`F`?.,KV@7J80#`R]P&`P&!C/S.HEI MVAQ*Y(ZYH\.I8+C>-+;$JU8@TG#)HK+SDW6)%A&QR;J2(_=`RI MF`G5,EMZI'C??F1$$^SI61=E:`Y#YQ3@"P)_8ZX'UA?(+SX6:-23/B0W+])J MJK)*FCMR4Q"-`2CWI&`TI7$5T2"B8H"=3H05`$"B/3`J64YW\ZXEJS=N/$QN M)PF]Z>DG%;\U=,.DNJ0+![QG&1#IRQZ%'H/K%)T/\W]%\,#P_P"$.YO_`,D9 MO_\`RMTC]C6!]5O(3SA1.!#>([?1A%)%4!1W!1%R`5=$BQ"B=*N'*54A5``Y M!'N3.`E,`&`0`/E_"'8&V2*MZH5YN5ZV`T?-(N-BW<03Q<[554A"D4.D)B@`"`8%3X%G[=L>W5[;VH-1&@Z3N'+3W`8#`8#`U]O)]0>+I>66L]@\T]1[8@])SVM(^@U[E7K MC9=H8Q%1O,?*7.<4H=SI%79NY&*:R<:]`[211'UG:BBA/25206.W"VO!_P`= MW&3D?-V/<\7H+D-J71+&8ILWHN]7O?UQ2OV[5X>0DWSZV2],043"'H#IB2," M.]=5==R'K"FN*8]I`V4\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@8F\KFYW( M\:DR$(H).66GG!BJ'1(`$:DLK@YP%8Q"F.F5+N*`=3B8`[0$W0,#++`8#`8# M`8#`8#`8#`8#`8#`8#`8$=OCR_Z\G^L2Y,?\BL"1+`8#`8#`8#`A[\1?_B"_ MZPS??_`&!,)@,!@,!@,!@,#IR!7)V+PC-5)%V9JY*U663%5%)R9!0$%54@$! M4235$!,4/E`.F!`C_-\"KEXY35@*Z61(*2*SHM+I8.544A$132 M46`QBE'XE*(!@6"W9JG9M'Y#GJ37Z?]:Z2 M_GF-835NZ)I*SOH&AD32:IQS=)VVCC)-Q35[DU%`E;\:7(?46W-'0VLM3T;9 M.O([1E#U(Q;06S)"`L,M)4J_4T+'K^W-+=6)23B+(A98QJX.JIT:N4G"1RK- MD![2`&%WB]_C$?+K^W3%_ASMG`GMP&`P&!X-JLD93:O9+?-F6)#56!F+)+'; M(F<."1D''N)-^9!N00,NL5JU.)"!\3&Z!]G`B%N,3PJY7;4X?\L]T3M_NE0Y M#5V#H7%_C_>H:3>Z_)=E&]ZL%ALURHT<:<@#2[^&7:IF5>F]DV4C4CF45[DO M2"\'#37&FM!@=?EP/W`8#`8#`8#`8#`8#`8#`8#`8#`CM\>7_`%Y/]8ER8_Y% M8$B6`P&`P&`P&!#WXB__`!!?]89OO_@#`F$P&`P&`P&`P&!XEE<`TKL\Z%%% MQ[:%E7'H.`$R"_HL'"GHK%*)3&24`O0P`(")1'`@3_F[RWN>,.]'/I)(>YY% M23CT$`$J"'KT&BJ^BB41$2HI=_:0!$1`H!@=SE;"V'='+K?5'U!IAQ_\EUK7 MD#R2>*3=;K=7G2MC2Y#,'*P$]F=<44P2$ M)4N*/'JAZ.ICV7K>MX#6MPV8A69?84)6+_8]F5N/=UN!0KM>K51M-F:QKD:/ M5X9N",6T;LF+1LFJ?TT"BJ-B1$3%H)KJKR4G)5"89,&"*34IW*JKQTL1,I4P$YA-T*` MCTP-7:C[SVK4M<^-'7D]PAYDMY?@_?E)S9CQKHRP/DIYDTK-FJ_M:2Y'VZZ[ ME1:72661=I-4A](0*L;L**@2N\#+M8=TDG\XAG(I"R^F["ZCF*#-Q.3'T:T81WTI+*HBX<>@@BCZRANQ,A>A0#V\"V=AHEBFMG:Z MOC'9UPKM1;F=3<4Q1FJLQ*SE:/\'9S M]:W>!`?_`#=Y)1;B=O-%%<[59;?4@DDZ3*0ZC9536]$(FX(14IDSG1.(&`#` M)1$.@_#`M9S9U3QYK&W+;7.1^V=ELMGV76E!95RV3G"OCQL6P\G+1#U1I`R* M6E[XA2I>72OTQ)LTFKV,?#$MV+IPD5F8K04SD">SBU75:CQTTO65Z9)Z\<0F MO*W'.:7-QM0AYJON6[!,KEG,1%`21I,7*&7[E'#>*+[%%8YB)")0`1"(WQ>_ MQB/EU_;IB_PYVS@3VX#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8 M&$',\42V#A**Z:JA1YOZU`@)*E1,58VL=S`@H8QT5P,DFL)3'(``)R@)0,41 M[@#-_`8#`8#`8#`8#`8#`8#`8#`8#`8$=OCR_P"O)_K$N3'_`"*P)$L!@,!@ M,!@,"'OQ%_\`B"_ZPS??_`&!,)@,!@,!@,!@,"F[C_>E:/\`!V<_6MW@0+?S M=7]RONO]\"Z_S=T+`MOSBO.O7W,#=M)A^+G'3:TQ:8)/7&T[IR&V;)!:F\S4 M>.\UNFN.]:U]%^Z7TW1X:HQ8MU)^/;(+2=@6(7U$U6PJB$W_``TLD'<>)W'. MU5F)M4#7;#IO7\O"0MWL;RWVJ*BWU<8+LF$S:Y$YY"R.&J!RD*^7[5W20%44 M*0QA*`14>+W^,1\NO[=,7^'.V<">W`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`P;YJ_P#Q[A%^_DU?_FVW'@9R8#`8#`8#`8#`8#`8#`8#`8#` M8#`CM\>7_7D_UB7)C_D5@2)8%/6NW52B5^2MMXL]>IM5ADDEYBS6N:C:[7XE M%9PBT16DIF7LG*#QD\01=-'; M59-PU=-7"95F[ELX1,=)=!=(X&(07>X/3L"+)LC.NRO^L9HFY.HX(W$_7L`YC&`/E$1P M)CY:I1)IE`R=LX ML;N3NR2K>)D7%4414%D4"*B'1,#C@2><*'MRDN(/&:0V M&212O+S1^M7-K1EHE"`D4)U6J1AY!!W!M6$6VB%$%Q$GMDVR!$0`"%(4``," M+'Q>_P`8CY=?VZ8O\.=LX$]N`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&!@YS35!*?X1"/I]3\X]8I`"I2'`14UGN4OS`4`0]0`ZB40^<40ZA\0 MP,X\!@,!@,!@,!@,!@,!@,!@,!@,!@8#\!F96T=R]<%9@V&2Y\JH@`9\8'A6:KUFZ0;^L7&NP5LK4J1 M).4KUFB(^>@Y)-!PB[03?Q,HW=,'A$73=-4@*)F`JA"F#X@`@'KMFS=FW0:- M$$6K1JBDV:M6R1$&[9N@0J2*""*12IHHHIE`I2E`"E*```=,#[8%(RE`H\W; MJK?YBH5N4O%&:SS*F6]_#,'=DJK.TMVS.R-:_,KH'?Q*$ZU9I)NRH*$!=-," MGZ@'3`J[`8$,'AFFBV.N\Z;`5N9F6:Y[[NDRM3*@L9L#U"NK@@98I$P5%/OZ M=P%+UZ?(&!,_@,!@,!@,!@,"F[C_`'I6C_!V<_6MW@00?S=H&`<3=OB@LY._ M-R"E/I%%5)(K5``H%"!E[14IS*JBJA\5.\I>TWP#J'QP-@+I_3^Z/_D.!^X$ M"7B]_C$?+K^W3%_ASMG`GMP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P/,DH6&F#QBDO$QDJI"R:,U#GDF#5\>)F6R#EJWEHPSI)4S"30;/%DR+ MI=BI2*G*!@`Q@$/3P&`P&`P&`P&`P&`P&`P&`P&`P&!@WP4_^`\GOW\G*W_. M2[P,Y,!@,!@<.\/Z/^Q_Y\#D`]0ZX'[@0A>#W_%SS+_?P[?_`-P5K`F]P&`P M&`P&`P&!3=Q_O2M'^#LY^M;O`A!_F]*C8W"J\I)I]KE+D+U42]0%*AK M\S?^RC)$3=]B?P^:<_I_H1[1^&!/%@,"`7Q5NQ?^0/RVO!]IU7W0P$?8O22+ M3[WL#;R/WEZ1)$JX?>_G="AVGZE^4O40GZP&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!$]KN6YO\>;#OJK MU3A$CMVIW+DGNS:]5O2')C55%"4KVQ;A0$0"U--\KN]MB;#BM4T;@ M4\LM^F*M.VI*":-/HPM8.@2PU6ROI.G,6=7V-!B[1,\K;\Z$TT27256; M$24(<0I:\^;1&"V!0*%2.,$EL%?9-AJFNZ\]#6'<&X&&J='KV:O[`M,_N&<2HF MP-@W%S&2]-JEWO.N:NWM4UKD%TXN0?%?22#AVB)@$HF`HAFK49/ MS915GUM8+=0K';8Z`D)-?9M13V=PSA:_L&+3F4'M>AX-2.HS:]0CJ+9MJ< MDKUM:(K;"U0=P,RKUFBJZ#8KN6KJ[F,,LF];+I``'!0P)=YB$`Q0P)4,!@,! M@,!@,!@45LEXM'ZZOK]LBDX#%E4[1`5>0]Z$W3J8O3ZIZ[$P%$0#J4HC\O0/S," M=G`8&O?XGT+T[OC@;"&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P(XO+>)P\>7(L4W1&!P8:Y$C]0"F3CSAM_7 MW:_4*?HF9-D;[Z8#?-$"?'X8$8_"]3CCHCDG6MM6[R/:,WN[N*]ZUFG7HB(0 MI\D]V[>7,>:P;MM+B:V!8W@-H1S.)M4RRY7,>1)0&I4^X+X^0[=T9Q MYY::0Y'2NMG5FJ6I>/?)E>-;3L8E%TRDPGX'SIQ^4_(&_G'Y?E-4]=&'Y>H_*.!.G@,"!+PV?NA?*Q^^I'\,- MT8$]N`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P(Q?,C)LHWQPIS="E^R.!I=:QUA?ZKO6F-)FK^U?ZZVGK9_/^);;W[5^P/P2F,"'S^;S M_N#)O]O^^_@CKG`G5P&!`EX;/W0OE8_?4C^&&Z,">W`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&./+ M#C34^7>C+;H2\3UDK59N#FNN9&6J9XI.<1^K=BC+(V2:GF8V68%3&2I3"#YM+LLL22N=$?\`TO/5)W'/ZO*2 MZCJ@**RCBOOH=JLT!P91-%5N0Q2]2]\K=DV"G(';56 M8LLKJM1[`(J/D9(Y(U1CK)B5$1?MTU@,("8IR`("'3`NYQ%\5FG^'&X5-QZ] MV)L>:E5ZG9:@O7;"E3$ZX=C:'M+37:S M6W7(*THK3$O*MF+"+=S@:ZI4,QF'3HR3>-=2<\H@1(%#`44W2)Q,`'^`3VE, M4Y2G(8IR'*!B'*(&*8I@ZE,4P=0,4P#U`0^7`Y8$"7AL_="^5C]]2/X8;HP) M[0%:D5G,@A!M*ZZ8.9,R2S9`!;(.Y%!,P@(B`JE^'Q MP(:N`55L]]\(&SZE':.I&\7$AL^YM82B7RUMZ/5)6&^GJ4\EKK8+8M8*V>"+ M0G*C]\5RG(1ZZ18LAB*%$`,8/SA%Q0W/84J5KZD>8J";GK#U.Q6SCWQ_V,;9 MR%U=.21AV3<5S%*#A,>Y4)#;]MD[_`,E%3T,T MY3&W]T-Y6?WU)OPPW1@3VX#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`PJ\A%>H\WQ.VBYOVQ6>H8:`)4+$GLIYKPFU6U-&WJ-R0VYN3:LON2M[*VS7^"6U:=!P M&G>/FRM0:P@*`G+-/IBR6>R;&]F\M5IM-E;D]FBT9(,6)TGZ!3#Z:08&-O&> ME7>Z>`^YU77%7V)>9^V[X00E:?K\J.)&Y=*[,JR378$5KBS,XZPU,5 MV4)/Q&Q7L'5F$O973A%FCZT@[>!WH*/@74.1P8P!-QN26MC#R!Z`HCWFKL:D M1^Q'$/L>,XQ5>KZI;5N71H%?<1]ECK/=Y*XQ>P4:M;GK0G2-&-?B_=N%/9@H M+595@&)?@Q5?K[0\EBTHNHYDU>1$6H_<+.".EEW9[)N,5U57)%%2.%#J=1$X M&,!A^/4<#88P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!AAS__`!FD-N,^*'(>S:ET5L]AH\:NWU;MFWJ77:E MBK%NTND8MA>);7.`J1Q/VB+`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`[%14,JQ^@JF3N4;D(!1P-CR\6GC'&\QZO#6[AIL> M?Y#2DWKIK!\C8KCH26IRK][`^LTEV^[P5*FSC*#&19D)`SA5-5L"'HHIKB7M MP->.B/08>/+RS.5#HJ-T^8]44?1KJ,?23.P1R&R8YS(U]T+)B\&.),,4%$B. ME%&9$5A((.45!(;`VY>/ZL0OHC2RU>KZ]4KRNJ->GK]8=.G3UU7H(U3B1AH5 MT[?%(]<.8R-])%0RP>J)R#W]3=1P+NX#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8&"GD@F).+XH7%K#RS%M(6.TZTJY*LK;I&@3>UFLUL&NH2FG:==XJ7B7] M6MNS8DJ\4V=$!QT375(9,I3BNB$.W"_BUR%TIH/FE<=CZALG'VBO>'&]J:-( ML=Z)9%[]:EI?9MQJ=K1K;:8F$JLAK77,FE6B'6,5>1`1LS>$`Z9G"GJ.C+'.8-@B?4A*!Y$J1#?6GD>:;WI6 MYFXIL)G8[^L<6VQ->T2,IKRJU>I##O(S8>U9%LS;RSI@)T%F;=KPECHU#F]"NZ+5G,]8YG86T*O:F^P2;= MI1(*'91FJM<7:TM(DC(`>$E&1C."/4R)'231$ZX!%?P_MD!(:UY]UJ)L!9=\ MTX;[-E9-B7D7RQVR>,14K<^WC%G50Y!:OI$##C*I'440D6CDSU1`@$*B9%10 MY`\GC5^,RI^!LJFJ7VT/K7L#:DHT5/I:M3%@V7'4^9W>S@+^C66D,)G82'U* MAY%0'(JLTB%5[#+)=>\0Q4U[LCFY:[IJCC[N-[Y#%>+5?VW27D""^A)U':U[ M@W=S@E*]6MIS[Z4*D2J1C>)7.BF9_,-D13Z^W6*FF5`)]I&B-@WF@(3.O:9I+Z7XS4TKG3,968:!WKFJR;)&.=G2+) MHE3(Y74#7ZU/,ZFJ/%[F_?MM:N+MQG2/(0O)52KCL]35`DLS^K;$C0E!GT8V M75ETXN,57Z40(?L4!$4S!MV\?G$2[T-I1U`5XE1@7&I==*P=53E#3 MB5;ASU"'-%P24T=;R\;+4)C'6W6^MZUMVYLWL] M?JW!M(^%UW;):%A[.K/N9`L>=`5_7!-T8R)3JE(40@M5Y$0$!;N4<]R2N/+" M>[=X>U?CO3ZM$W"*O-FI;:R_46TV4SI[>K,P49Q4B^030340 M5;"L`F`I`[NB-J7K5'@OT\OKO83C4MFV!N]KJ4NT&BS9LZH$1L/D9+P5AM"# MITLU*S4C(,[@WKD7;JH`(J$62,4#E#WMVZ^W?XJKEQ9O^NN:.Y-^$VUN.LZR MV?I;:]@;3[*_Q\\L11]8:9!RDO(&KPIMRD9I+@===J\>-1]V*:AT%0E2VGH^ MEMN6VM]Y7;EWMZFJ6"[:^@J#QW96F+C==6.]0U2N2;&!?1*,6YEI!M88D9!] M[119!/W2;@_J*`=--(-9JJ/HM]PPYY0,NVD7U&OW/-Y$S\Y5XEU;IR(!M3-C M6VC2->K,;<::>T_3%W@XUHLF5RZ*1BY57*UW^#;:QD-9K6AZQ@3VJ-LBB:Y".1.F+=-7J00#X!!AK?V'+FB\FK+ MM:Y%7:O9)5469%"]AP7,CT">V MZI5]'R#ZZGWM^XE)1+*EN*M+49^VUVARG)L^=CEG%`DQEI2%F;J^KRU>%VE' ML&+J&72(X66,J[;J"WP-8K1"Q%^"7(?7*+^T0MNWGSOHM(U%)TR#KD[8#;-K M,(2RP,14?")GIW\9!,&3P[LPNY`3.C.$#"H(KK]3]?OA_P!$(5M@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@1#^4U;F++5R)HNF>,-)Y$Z)L,?"2=Y5+/7J M-VI3[[5;8%F@IFNM*#<:K9P8Q18=D\:N(HCM^#U$Z?9U.B10,".(\"W?Z_\` M(YL&09Z%A[6[XQ[GC9VC4G8'(1ULW5DQ8X*PW2T5E_IO?#&(=:NJ4_,O2OG7 ML6YF[J52*0BG1$Q0"[_`JL0GX:5MKQTV?NC1;0G8""JA2'0:D$Q MBA(I.:3WI*<[8+;XZNXF.=&Q<0S9K;#>5`CCE*=XSI\@V8II6M]!/D&D1%6B M14!`C9PW<@S'M]0"&.F8-<[BH_UU3^`&^KO=:_JNX6=/G?\`1^J(;=T7$2E" MC+FTU\VDY)^B>6EJNUC)![4$'_<=67C4G"S5L@"Y5#IE.&VSH%].2FD]62MB M<4MU)2E'KTF5774/+P-)"+D8]%Y`(UR(GIRR2S)@V@5VR?19ZN)CD,8!*4P$ M*%W^4",@)MR-UE7CB03.ZDI6L6>HS3N%D8.0%DY8F?(I%!(JI.J@]2A8 MFD<,K]Q-XO\`,I.T630$Y$SW&?;$ M03=D1AXC;>XIMXN[*`.42LXZ.AE'3DK)D@L98A#'%4/G@9(J9BG"_-JY9PFF M+5QATCNQ:MO>1?(B>2K1:AJQZZD8"%.A&2[^7N@FLXQ<^A0FKN,*R07<(%=. MG:O:FD8$EQ2#6FXR2NV(3Q@:;> MSF5I1*#8IR"LNT]=S[644=E.+A/U%.Q43%[C=.HA6N`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&!$=SWL&V&&^M4P\]8>8U)XKO=:6)P^LO"FLOYN\/-WIV` MAFD7L25K438[=`TUI3&X'8%;L3(/7[A0JA^B0B0+'ZUG-G2.L/(`PC)_F)<> M,S#B5Q M83!&K;B(G_FZFL07(D=(-Z)F,"Q2F3`"[SN0]Q@.`E#M^W]C`R,\47#S6?#W M2$]Y(N6C!M3Y5K6)29UDQL$>F@^H]`>-!:IV9M#.VR+U386S"*"VAT4A%?K2.8V1-G$O6 M<8^6I<,HDI*D>-G4\BU432.1%2"].7*^,WZ*$:"Z,`;A''ZS)7/1FG[2BRGH MTDYK:F/_`&-GB%X&P-CJ0#`%4I:'<"*C!X"I1[B=3%^R4QBB!A"[^`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&!A!RLUSS"N5UTXZXU[WGN[W6)KW,U!RK-)F[CA5['#%R)T"D6(;8M#\D&FD M^3M;N/(ZP\D'^P-%WRGZZI\EK#5FME(NSR=+L<:D(3-091!)5W8'SU!`ONC- MVK8`ZFZB(G*&)'$;Q^SEL\;FB>+W**NR%$E:5N$NS;=25E:_8`F6-:W'.79A M59A>*DY**4A;?$+D2I?'!PST;L MJF[/U9QOKM0NM;1E7L?;FMSO4D\K4F\C1B3H,HV:L4BQD22$;*O$3K"F'IE# M]`/?U(&OXXXB\C=4\'GNG]S\8]IRT#L'R`)['NWXMV<1L2ZTO5L93(-JSOD3 M7ZDWO"M!:J@V.L)/;J'2(Y`^!MR5XJ9("#(BDX11)#QI4D7C46+M) M(K)$$TW3(?BS GRAPHIC 18 g899224ex10_7pg014.jpg GRAPHIC begin 644 g899224ex10_7pg014.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X0/2:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C4M8S`R,2`W.2XQ-30Y,3$L(#(P,3,O,3`O,CDM M,3$Z-#7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN"UD M969A=6QT(CY+34)47T,T-30M,C`Q-3`Q,38Q-#4W,34\+W)D9CIL:3X@/"]R M9&8Z06QT/B`\+V1C.G1I=&QE/B`\+W)D9CI$97-C&UP;65T83X@/#]X<&%C:V5T(&5N9#TB"\T8C0'6'?K_^X`#D%D;V)E`&3``````?_;`(0``0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@(" M`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@"'IRA(.8*BPD3$U(7E9VB8"A$!```````````` M`````````/_:``P#`0`"$0,1`#\`_?Q@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"A2 M,NLQ?PS$D<\>!*N7J*KQLW<*LHM-FQ5>`K(N4T3HM0<&("28J&3`ZA@*7D?3 M`KG/IS^YS_J8'.`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P,';6@ M8J3F]33YHYTYL-9OBCJLK%D)AHC'JR\)(PT\Z=LV#M"-D"#6W3GVTWQ%4DU? M$Z906*0<#-7W/L_2<^?CX>0_['Q^WRX\?#[WV_ZOI@=^`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P+?EI-A%&8FD5$P3?21&:!5"$$!'GQSSQX\\8';@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"RK%'SCF;J3V,1JRS)@\?#+J M3I7B4RU0?ZW/C_`&,#ZP&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!AR_R\NTV#J>&:.6B41.N+ M?^,MU21IW;T\7#MG44FV,\?MGJ2:3E0YSF:HN#B8"$.4I#"<`S!R'M\_D\?] M;C[,#[P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!8-HK1)FRTJ=2 M;`J]J;F:=H.0D'#4449>*4B7+1`!XY`!'`^L!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#1/Y!.U MUKZ@:;@=CTZM5ZT2TS?8RHG9V?\`%2Q35F\AIZ7W&,;3U:Z)UE&(66?M?"P6MQ!R2KB. MDQ8N5"1]CL5;E&S;EHN1,YVADW`'372.9(`!4*ZKV3^58RP&0Z*4))MPKY(J M[(B7"XB9`"H"5T2\MB%!)SRT/N)CX`)!#W!"W67;KY0Y5Y.5EAT3K*=GK MB<<24D9"Q/6-;,X?MTW2:L4XD+-'Q4\BH@(^1&,LY%L/T M"9R+#&J_WHL(`N"9^$C!WV/M5\JE-K[^Z6+I5KQ6MQ:R0/(J`FY&QVT4%WK5 MFE])#UF[V&7?\&=E\U$&"O@0IU3$*0AN`]A>R'RX*`FHGTGU>5(Y2'\%;,V( MJ(&^]P(*;81.B82B`>)B>11^T/R8'>7L?\M8$7`_2+61E#(^+8Y;DP(1%Q[P M&]Y=,=I',Z1^FY)[93(CYCY^?`>V(<#V.^6L2*`'2/60*"5($3C<6(D2,!S" MN95(-I%%QQD2G-/%'Q;& MC6A9"U14$&EU6O+:FOGSI=7A-J@_5<$,(IF()DSG`+Z+OCY=E3)^'3K2:(*G MC4OT]V;?HS2"`JBJJ8NU0\$&9B"#@>!%`Q@+]_\`A8%>_:]\NG@H'^:=UX]P M2H@D;]I;?P(8H_WP90G[1^5"JA_``#%]O\HGP.K]KGR]?\E+KI_QB(_^<_`L MRJ]F/E@N+^VQT3U%TZU7I=A<5B86L,I/UAB[DVI`.JK6G\]?6#2UP_B8/%_' MG<-#B/!5!'`O/]KGR\_\E+KI_P`8B/\`YS\#RCNOY=/K$XTO4/0X+@BJ[5D1 MV`V&(.D)TTT6J:P;/*HF^(8#F,4?(#D,`AX^(^0>K]KGR\_\E+KI_P`8B/\` MYS\#&>X^X?R5=?==R>TMM]=NNM?J49(QL,J9I<9>7DS2$ZJ+**6190]VDP69 ME?'*"H>9%/'G@`+R,&CI0A.?`IW#=-8Y2>0B;P*8_` M1E(")L3,&$TZ]ER@HPEC?1"H1XP)(=82DE.:XH4W,*BXEIFEU67E'`@!/?DI.!CWL@J5,IC)I$4=K MG$"D$2EYX#T#`U'@]N=@)#?MDHX(UUSJMMN]K7(^[JJUI$[*(8T9W.SVL_H$ M'_XL\L:KDB#ANM],=PFD"PJF*EX>(9"[R[1NVE^J>W]G:YE482Z52*@74%*. M(YA+(M%WUPKL2Y,>.DT'+!T!V$@J0`43,!1-Y!Z@`@&B6JNY'9VQ]=.K5I:6 M/KW*;#W-9MP0MAG=TRZ=$8.#T^RGCZM%5:$JTA`#)S;MJ;V#I)(G)[@)"JHE M[@J"$KFIK3+7?65"N,ZE!-YFT5."G91"KS#6PUQ%])QS=TY3@IQB\D&V:ZZ3*N=FFHZ M74@+3'HMD%7CEH5+[[_W53E,/MH)'.8HD*82A)MJ8J)=6:U*W5*NW+0*:5!< MB7L$61+7(T$E2H>:OLE4(`"!/(WB`\];D'WA.!^`LB1Q^F\"'`7'W/[H2A[?EZ\\`(26 MU[_`$'_0\9_,D,"L8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8$$?_`/T2)HJ_&U<2.">93;,UR0G(B7A49UT"/W@^SDX`&!,EIHYE M-1:L$X`50=;T4RA"CR"9S5>*,)0'[1`!'T'`C@HC"HK_`",;*6?GAUW"#U!_ M#M+I8E*]*L[2->*P?2=!K48#V.MR_P!.BFW*J_49.4FBZATTU>!'`SQ\G'^@ MKV"_H*K?Y0:C@11ZLIUS;/IFN&1R]H(8&NQ:?&6*M7E.W7R(;N*> M[)9'\5`-&KPD?[GU8O$7@D3$6Q#\*BF'Z"-1-*8PU=K]GKIB:+H3>H0"=/CC MQTK$'8UO\-;FB&QHJ<(G,1HI,A('L.2@JD`>)O4,#(N`P&`P&`P(COF2A33W M6.JI?2`^;--NQ"S@IK!#5DJ1W-.ND?&+C*3H'8^T28?MO-,"B98@BF!DQ-[A M`DMU$W79:KUJQ=&\G;&@4MFZ-[A5>7*%8BB+#[I/T:O)PY\B_=-]H8&1,!@, M!@,!@,!@,!@,!@,!@<>0>H?F_<'`M-I?J*_+-'8W2J/"5M@UE;$HUL,0X3@8 MM\R6DF4C,J).SDC&+R-;*.$E5Q(FH@0RA1$@".!6XF9B)Z,CYN#E(^:AI9HA M(1-'*1@,FHFE-M*15), M%[OKA`Y54P.99,]D3,9)`1`?;6'P\O(.!\2F#\N!)57/\7X+^AHO^9(8%9P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(2/G(`KSKS MK*!>M_KH26VJ"LG'.F2+R'>J1L!).(\)$JZ"J)EF[A4RK, M5-UK:.N[EL*0FD8NZ.W*;>HQ-,@+%+$1B1<&-(+)^PI["A!+R0JO`?H@TO9Y M"Z:EUS;)9Y79"5L--KTK)OJB9\:JNI%W&-E'J]<_%&C"2"$4?2"[EYIS5+UXBBTV454R*"!.3%((^(!E+`8'0Z!R+5R#(R!7@H M+`T,Y*<[8KD4S>P9P5(Q5#(`KQY@40,)>>!YP+0UVTV$QJ$0UVG.56QWI,BX MSDO2H"3K%:9GI1:PY8N*D,(7\0/9ADVZS2>1L8.1. M5O\`AXG;&9"CX\C[OF(_=`+O$>`_K@'[X@'^O@0Z5?Y'^S.TW]T5TKT9FMA5 MFF6R6ILA--]G,6@I3<**8/F+A)Q6DB`Z*54BA2IF/RDH01X$1*`:==K^XW:; M9UCCJW/=?F-'UG2;747UQUPKL&K3=GDK-&W-*)C$).WP3]F]K2-%K] M&J7S$%#"`";P#YT+K?N!4V'XI:>D[7>K>:@MF'<2NB=*44`'!#%45;"0YC'*&Y&I]:?(%ICK%45X[8E!J!*;'%,I MI-UI-M=K+6H$UO6"4([M<-L1(MI<14`Z5E%@9-S/':9#(H$49V0VAS,X.;\X8)V8A"M%7#@A@2$./$?O%$)-M);3HVWM? M0]IU],J3<(V$]==KKQ,U!NF4[`I(LYF*>Q<_'1E31.5MXE$I2'6$P@/CR$S%9_Q M>@_Z'BO^US7`BSTOL9W,_(EORFD>;20?QSU4S=D=N^C];RE.@8EHVF'L\M9& MT@O*2S"Q3+9"%")%J@9N!A\BHI&!8,Z_)L/ET6[!C]G^\-5_RA5+`BIJ$1`N M?CQZONHW>=FUCMQ!QOLNNT*@G&-']DAY*\&3VG5_QRRKP,37Y%A5DB`W>&G( M9,ZB_LD47%7V#!.W/[CU+J`^KZ9:;(6#?[#6:UW7L:E#2LLK-NT#PL;[9CU6 M)D8R.*5W-M"*KK&;LP4O'^Q'D/WA'TP`_9_7+_9#`@(^-C?9M5T_><$GI7?>U/QSL;=91"?T] MK]M<*NU%1I",",I*87M+9&,?"+<%_!590A6RR:@K&*(FP,H=9NFM4WO#2>\+ M+<=GU]I9.R>R[S+:BD*WKIA$.UJ-O:U/H6NWU!Y4I.TR1FKMD(/6B\JLDBX, MHFEXE(4<#0:Z;,[3U_:_9#6>E.R$CK6@:"M]TK>N]8+22[5-"DTC\0=(P= MRDTY,[DW"TE.S#_P<85UXZ!H*8JQCKWP*H10Y#%P/T,_&*OI)TQ[)26H+"VET)C?=K M48I#:+#,22NM(]94FMY=W$6A096-^O:OG?\`?"A3+ON"J.%#*AXD"4_`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`A"^<1TY3TGIAF M4Q_I'.V'ZRR8-Q,F+EK3Y@&JIW8?[B8B+A8I4Q]%0.)OM3#`FAK/^+T'_0\5 M_P!KFN!&=KS=%H#OM?=/N]U3VRZ\J]MT_%ZKK%&=H_LP]II3V+@^R+E:WD4M M'5J!.D8\6A"IN6D@I*&.<51%-,@98^30>>BO8,0^S\"JP?\`V@U'^W@0V0=H MCJ?TTZ,.G4!:8AT-8U)=[+)ISD'8O;VX MBLC'AKE@UASF2(=F[,@199=4$BF:IDH#Z@(?EP&`P&`P&!$M\Q, M7)3O6FIPD16Y"RO7NVHQY]-%MDUWC*.K=-NMKGI%)1=%1!#Z:NP3P5#',0`0 M]P1\@`2&"2;4;M-_JK6C](KDB3W7]+=I$>E:D>E3`P&`P&`P&`P&`P&`P.!^S^N7^R&!^=+J!VC9=0.I.\-M M+4@U\8RW$J%KC8B$+5JRL\V%:6B!&+=*(%-60!D( ME<.BE2]]0YQ\"@/&!%K==3:[@;OW5J]PW_=81WJ^U6&/IK&9=/9^?V[.Q\\9 M%1[=FC0J#:7.\=((ME7BBC<0=OD7'`D052,'Z4OCQ!P'2KKB+MN=LNIKQJL= M-3W!.H5>1DEDWAS*II',9^D<%Q-P(&]SD#&`0,(;HX%HWB@TG9===U'852KM MVK#Y1NL[@+3$,9R(<+-%2KM5E&,@BNW%9NL4#$/QY%'U`<#6;:&E.LFE-4W? M8;#K!IF<)KNHV&S-*\AK^C1ZTL=DV5?GBDI1_`O$FAY%=,"`JJ50J0FYXX], M"$_H)>+Q*=X$GRQV6HJK-[&V=$S.JJ56JX6-3L%A@I^TLZ&Z1Z39`I2N"^(?IWP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P(2OG!*@;16H/)%X9R3;BZJ+A,JHL$D?U/G47"+HY1]HK MM2==1&@9:H0IG# MFO3FZT.O2A%+ZM]-)#8XZ9VDZEXQ.-I#$L#&*1D@U1=KR3Y;P62,F7S3#6CN MUV"NUVTMO;5\Y.:O4&-UM:GUSKE-ESRLI'2$!N+49J$LFF*[T&:?ZLVL22RO MU"B;A\5$42IICP8-N_BC%5;H[J(7'D<4)78Q6HJ%*(I(EV!:$T_9$2\E+[9S M``AZ\&$.>!P/'VIWI+T'M3UKU=`UW2KL-BR59_6VZQ4QY"S4O"2* MNWV;,CB)=JLQ69R&O=@QDLV=*(B50Z#J*?K(G)Y`51-4Y#`)3"&!)SIDH$U# MJPA4A0*77%&*")@`#(@6JQ(`D8"K.2@9,`X'A10/3^$;[1#)6`P&`P&`P&!\ M&43(*93G(0RIQ32*8Q2BJH!#JB1,!$!.<$TS&X#D?$HC]@#@?>`P&!Y3OF9' M1&)G2`/3H&=%:>Z07(MB&]L[GV`$5?IB*<%%3CP`P@`CR(!@>CGD`$/4!$HA MQ^4!$!Y_>P/S(]7FG4B[:)W#IKLONRN:]B8KN)-;,2AB6)K6I&V0T!!$K[1) MG]65U((5^4<+K@)FIA=$!'Q!0HCYB&O^O;I4Z-9[#3]0]IMC4Z7H^T+!/ZLA M)?9"=6Z\S%8K^S)`B=<>S,HA(UE_8;;3&*]W%QL3>/?=M+[:MK\TMLR2J%LHIZ^]OLFB+RPN*XP+1?K4J\+PRA6I_:* MF5("EY`>"X$QVJ[WU]Z[=3:3)5?93R\Z@HE6CF5>M22A;/9[%'OIT(F*(SBX M5BU=R+MU,21&C=!NT(!0\2@4"EY`,6.>Y\]N2UZ:I?5"5U4$]L:L[)N,_&[W MC[Q'ST%`4.S,:FB9*M51P@Z;.I631E#(_4K@1=./-P*?VB&6A:]_A3'B;Z>E M5%R*8!^K&Z1(5G[_`(`Z\QMP"+H&WZ3V/'P]S]'[O'Z3`T[[=;K[5:NK2M#W M!$=2[G4]EZ]W1(.F3:&VVR:R<'K*E,K),0LA]9<4/HI*T#(`R8@DHJ4CCVQ$ MPF4`A0Y^+_II5M:PSPU4K.R#-BR=+H*4F(11V\>W81R9Y M&:;ID$SU5$%3(D#V`2264!0)AL!@,`(\>HX'SY!_TW\4P_V`P'D'YC?Q#_R< M!Y!^8W\0_P#)P'D'YC?Q#_R.'^U@/(/W?WA_M8#D/W?WA_M8#D/W?WA_M8#D/ MW?WA_M8#D.>/RX'.`P&!!O\`.0NH73^CFP.UDTEMIS*QV)0-].Z.WI\B1-RJ M8#@0%697!BD`2B(@L;@0]>0FLK0\5V$$?L"&BA'^M'-L",JM;O[$/^\=PTS) M;5U^K5*[?HJ4B=9QYJ`I,R6GYRHV9>15EG`-#7%C8Z3-L85P5(BA5G!9@04` MR!/-(-#.QLEK]CKKM76M;Z,W90#.Z#;W5^NNT$;FA7W;B+[$U:4K4!2@EG:D M$XBYMW<9"<2,"9546[Q)),1_2C@2;_%@N1?HWI8$W*+D$!O;@B/Y`#5SOC+KM?D$Z/$D9P-CG M6,Q,6"[R\1-(M3,D7<9$S#6/9LB-W"20/4UW2*PJ)D;D43":XA0*0I0YX*4I M0Y,)AX```.3&$QC#Q^41$1P/K`8#`8#`AS^;%2!3ZJUH987`R`[:@PKR2+@& MZ*C_`/`;']=]8/L+"=$(+ZL"``DX6,0W(^/B8)3-3@4-7ZY`@%`@4.G`0"J> MZ4"A6XOQ`JHE(*I0#[#LY="'5%4$FH2+20635,!/(Y%!*(\<I5YQ:6MT6BF)[0Q@G=:9S8MDOQ-O"/WS63>QI'@`"_T;A\P05%/GQ`Z?/Y M1P+B\0`H%]>```#UY'@/L]1Y$1],"E'K\$J(5=I,H+IUZ,PO%(V M8,@9,0!9%^Q3*11(_)#&*0_\),H@$JE<_P`7X+^AHO\`F2&!6#K&JZ]`3"223DIVB*:J7M$.F&S%:4F;(WA%547A6)XMC]:X2.<4$54P5#Q2.FZ1&+Q]I8[ MD[ER%.O[J+H_6RM(W;\-V9V%V0[?BTR+99=^FJ+Q M$XI)BB(94G>I:-4D86JQG<+;J[_6(.)OM;ME3;[V)UEI^%;(>V[JL*R;A)R[ MO9$O&JJM&<>L]'@2JJG(H*:C8@8RD>N(I(,FD1M/M0]V+O!TU0ZG:,>[+4CM MAR%9(U<'?[8WJ_4C5(FD4DJ($DOHTTDGK5D`(J*'55]Q(*P;K54H5M/3MH[* M]E@UKHUFLP[#[BC;A(-ZC8=EJL&Z$?J?KW!O`<3-IG#6&3;I+2*ZSF/233$@ M_P#7**Q`H%;ZNVB0UR_7RAJQU6976,OC M=[8.Q&S7CJ/CQB]%UHZC4YX"*D':K<'#@S]1\X4%-'Q!HY.8.$^F\@R:FK5F M[$;YK6RBL#;`O!Y'8JQZ#ULU.JOS$CNF;8NW99K:5C8-U%&$(P7C?>.H8/+V MFY57@4FO]?J#:".MD1N[NW,AI63G?U+Z_P!?0O*CO='8[9#5X5H^LU$ACQC- ME5-MWU$8N+,QJ=?K90TY.% MG(G;W;608;&WG"BI2_KY:7"L6K`ZIT]YBJ=JO*('6^@*= M\84Q(=D`4LO4>K.K&VBVW8W;+.*T>S:O>S_820N;PFI*FW34=MU==:>4.U;V M2P71:0*+1F4BJR/F*@B@B?6+5E@M/9VD[`U[;9ZK21=)[#IBNVI M=R]V4G!6=*]2<+8I6=A$:_(4ZU6!)D1=ZP0.#M("%*NX7*8`*&Q';K2O7GK9 MT6['U6D13'4U7N<%,STH+.ATQCKS8-0E*`Y7V'19N61KZESJMM;231J MU!M&M&":C7Z,GTB3E4@K%*=,50VPU?\`%!UHO.OZA,675,=`OD;A(Q?7`O\`#X?.N`%,W_:5V2_#S>*@ MQP;39@V^J`?5T)`JOB944P*7U#T\0P.M+X=>LI6Z22M][$*KD$PJNPV.TF1?(AOX1#<5,/(AN/4!]!P/G_F=> ML?\`W^]B_P#C08__`"2P'_,Z]8_^_P![%_\`&@P_^26!X[5\375F$KUDF$9[ M?)5(^'DI1L4FUWZ@('CHMXZ!),JL6KYIJG;>1O=]P?+T`0+]W`K_`,3\%78' M2.P2UBQS]DB)7;LO(L%[*5;\88LRUROQC>/?N%C))NWQ?PLZROL((H$%4"E% M3Q%00E,P&`P(.OG&4`-/:21^E%3SV?,+?5^R@(-?9JKI+V_J#&!RF9U]3Z)D M`4U`()CB`IDY"1.Q=A*W2MJZ,Z_R(S$39=Q4M>8J5B*Q3>P"KJK),%9&NJ@" M3@Z,L^CP.8JBI"MR)?\`5"JBF!@T+H<3;'WR0W&.5T[>*WKZ,V;8M@H7M[*[ ME1H%CMX4!"MA.Q\2$0XH"D]),I,Z!%%W1&1TVZWMF(H*"0AI%L*"IUHUCWIW MZVGMDR5MV#"2B!8VRZ3?URKLX>.W-08)R\;[2:H+U!]:)->!35?L8U5LDLIR M4J2@-?(H2Z_%>`AT;TN(E5*!C7L2`J50OW?V@6@!,D*A2^:)C@(E$O)>!X`1 MXY$,0]TI16,[H=,GK[33F^0\9:&:2EN1KMFD65;4MDN$`R=K/(9`C5Y/UIZW M.^8MW"YV[3W1OY<#ZP&`P&`P(EOF`N M#&B:`HEC6AX^?D2[)G(*-B9=-,\8H6WZ:VI47\@L(IJJD>0;6<^M:"0O_73= M/R$`]0"2741/:U5K1/S*I[>OZ63S*;R*?PK,47S*;T\BFXY`?RX&1,!@,!@, M!@,!@,!@,!@,!@,!@,!@,"*?YD3&+TRDO$[8H&V;KLJA5TR**+$%](<$9B<. M4G)#\*"8OWO:(2Z*7=(\C,5KK_K1[V)V.VW-V>CUVZ5RD*^]MC9I$Z*U3)HQCZ0+).':SJ14 M-YI>!':1DS$Y5,(;#PD?).RX%HNK;$W2O698;?;$^IZEB09; M[WU'PX0>W>^>[W#PSQ*;7:?7Z73>Q*FKOJZ75%4VQM-?'-H%9NFO-6&[+JD3B3;JE(4JHO'R M[8@E,D1LBF+11/W`ME6&U_"0[1^];3"T?I9.Q(IQ3:W2B1SM3.$?%9RY9K/'!.2C[`46TVIA64- MZH]2IV.G'5HO=T1538M^U';"9>.CRCZ0("2LJ5C(G/^'C M[3MVN1X8'*(51#\!IKG=-JN%[=I3#)%>-[B=Y0=L&K\)@5FQ#=8^KT<8':\, MH/LDBG`,TR+1B:11#^^E&"Z06ZT86>YV;7"S[74.G8DV,:ZZ:],Y25=*T;2] M&:,5A)V3[&,XQ%!('S(A!=I'>.3N@FFI]_M4G:7#_1T MY:7#;=^]I9B:/VWWJV+"QRRC;3^H(YFE]6QU4J\8)0[9FQ(W8.&YQ:M%#$5? MD4"O!)VQ6RQ4K8(&I4OH4P%#]H-NC(]!")EMU6(#F M"%C3I'S9&:+YPQ?F?.R339O)N&S5@50QUCA)$*X2#,_1"R0] M4W'VY"^=AH?9]H4-I\]^NDQ+1L/`EV,V9;!/>:W3PDSL3$IU/?*`W8D;@9DF MW,'@;UX`-HS[:ZA=O(T(5IM6HW.!U];R/[!`/'?X(PE'RM=L,$$1,,K6PCS3 M<"JTG%5%`;`=$ZB1"'.)?(A@CS[9T_2M6VKL;:>O(&FO6'7/I<>8J^OJFVJZ MVOF]NV)NU907DI'P4*Y<0SJ,!_*Q M<6+$LG),(XTF^2BXTK]XW:#(2:Z2ZZ,H!Y`!#\OK^;_4'UP+7NC=1S4[,BF*7FM7II$GO*JH)D.M% M/40.HL@W=K)IA[O)A*BJ8I0$2D,;@HA'/\4B]L)#V*JS4G7;!&N*Y>5%(V:AG:K"38*K-ZNLU44:.T#D,9,YR"(N! M%U\N.Z];[SZ]=?KKJ:V(W"FR.V+BV1EVD=,1[5P]A*N9LZ*"4S&QSH!;'?@! M3"0"J%/Y$$Q0$0#,79JP,X_Y!>D45=(51>L2](9,(U:NSEA/+3157A7T;'3L M$W8M6C=K&[`C&#P1;.C@NU0Y=F*B0R)PR)KQ:N,_D_OKIC>=H35E7I$S7IFI M72UZJF*M%-9:1&88HT-%ELXUR8PT=^KJBR<4:$"[S)P?8"\;MG(2F2JUMC"556"UO0G5@W!JR/8,7KM=9DDO>7D97VK5,K1D M9`S6,6.*GWB%(&_W3+?<#UQ^.KKY;[9'SMG1L]\L5&@8R&>5F+42DK#>KV\9 MIO):Y6*M5V*B6+2&<'4<.7B1`'Q*`?>]`Y[W/I=7L)TIV)`T:V[6&OSJ,T[U M;6Y_QF*N+ZP5]6!NRA8>4=U-N6<437C2NI!RG$O3("D+D/:$Z03"-S&.W0.= M-1$YT4C'16$@JI&,0HF35%,QTQ4((\&$IA+R'H(A@=V`P&`P&!#Q\U3UHWZO MTQO(1GXBP>;CC`6]B01CI%NX1HM\/'G9K+L9`ID!?F3%T0$P,HW*8A3IF,"A M`E2UN!"Z^HQ4VR;),M.JP$9HF4.BT($#'@5LD=5194R:!?NE$QS&$`]1$?7` MO7`8#`8#`8#`8#`8#`8#`8#`8#`8#`BK^8I)=UT^.Q;_`$P*2&V-;LP,Z=HL MB$]QW*'*8BSA=N@`^9``_D)BE1\SB``43%"[X?Y4NBC*/A8U;=[G/@8!_+@?0?+)T5,`BGN!XKPF502HZ^V"H8/)-13V MQ`M;'A4!3\1#_9F`/RX'R?Y9.C1#"7]JTL?CC[Q-;[$,0>0`?0WZMASQS^_@ M?'_.S=&3"!1VK,`/)3#_`.#;8?(!Y!ZB'ZMB/'(8$7?6>;97:5V])ZR:([-L MNIK(QA>PG8N!8)AN'O-N5L53V]+://"?5OW-/2ED MFL2P:1I0;H,&:J+=9=!,X8%3O49?W$U4*#782+JN]RTM%A6*I#2;\FN?CJE:(,[FQ;',;V MCJHJO7S1PNZ$J7FHF&))UI`U-GKN2@*/.6=I)N8!QTPZHFLUH>3V];26;"R& M[C]AV49(-E'"JDB]5D#(R/LF(B4A%UD3)F$`S#'1"5/DMV6ZY M_<=^S:5]PP%HW;HJ]:^JCHB2B[::!RW)$.3,Q$T05%$B`_BHH$*%@)(72SSN MI7DYKAK&6>3;RDITPZ4)Q"K&A:N+59Y;0:TP0O8_L@1)%?:O<:W1:\(TA=`Z3BFYU[ M6AJI>:E4XLJ+1(C!9DN=%LZ*15THJ%\QDCLB4OT)(VQC48KL-"4Q&4IE'58Q MZVC_`([]%22KU-[<[@F@JC7Y/="E?;"U:(+*`HX,T3(D5)BF[*4,(-RUC9.M MK%&M6=_=]/CVI.'9MX,BS'>7R-=@91RX%.1D+7(BVL*M48OF`/EE"D30;(-O M$IE$F)01#*,6UVK(VYCJ:GR5:6[21U.+$;$V@R4=VO7'0+2#&$11CM6T*5<' M42?;,G6J'M/GXN%)==SRJJ*C9LS51#R-XPK2OTBH(:EL;F@MKRX9]?>NDFYD MQV!VNVA!OXY:R=A.RKK M/26V4UGE3A[(AVR[C5>>?M-?ZSK5D0CT"]7^OC%.4&(EWT5'M#-DP.B^=-I. M0,X,@5XX46(%Q25MB*M7--U>JZ4;&>$4CWG33I$^/8ADDG`S"[-+L1V6*S:' M.Y?E=*C+$CY)8648C_?*KDL@'U`!540CJ2MN.=MNQ7"*3R70A>XW<1T#N,F[ MS+(NGB[CJGU5C&JI'S=NV?IC#K+1H$79-RG]OVW:318H8"Z[ZU+=NR-NJ['I M_H^'KETL&N++8:=MS7]HO\YIC7-MKMTLT5)*N',XU;5BQVN*A$BOHM0C9HF_ M=ME$TP3`Y!":5/HGT\+)O)8_7+4CE9ZT9,P:O*7"NHMBW8FQKRJJ3-&UY-0M5G4'"SN1.YD;"R=QS-%J0BABG4;D.$N?7V!@JSHS M3U>K%H-=JY!ZTI<7`V\Q#)A9XAE7V"$?.II'#S20DVI"K)E'GQ3.`;$U72-J)4Y"[Q2LLE0[]6]FU@J4C(QWT%RJ1G1X*3.:.=-3NTVAGJG*"H MG05\N#D,`8&0@#C^N/.`$!$!`!\1_/P`\?UA],"U6%/C(ZTSMO1,0]A-.$BG*QV4(#KT.X^F(0%U?OG`3"(B%UX&-MQRLM!:CVG M-0*2"\[#:WO$M"HN2"HV6EH^L2CJ.2<)E41,H@H\2(!P`Y!$HB'(?;@1Z?$C MLQ'8_7RQECJE"4J$IUY8U.+B(0B8`[,QUS1AE9Z650;,6SN8GYT![OZW4Z/O5C2E8'\5>KU+\15 MJQ+&P92C9S7(Y1]+,CHO5F9$WCE4?-R)@.4Q@B]^;.#A:SJ;KM"5V)BJ_$(7 MZY&;Q$*Q3B(Y'FMM3',A&QS=O%$^^H(B8P%5`3?<`2F5$`VAV0R7=_(1T]?" MJJ$96.O-TFI9%NP:/#^#]TA7&"SH7SIHJFR"1E4P]R/(]=)'$`51(BH"Z847 M6LU,$[HW6@1BVG74@QW1<;Y/7%77MQ-M9IKJ2KZB#74Y7#S4D1`QC$MLE#R* M)A,8OB<>.! M$>/SX'MP&`P&`P(9OFW1:J=9M?F=-SJE)N5D5-9%XF@X;K*T.])H^#=8ID7: M*JXE*MY"42)8^@#P`9`,;T'CRY_VIOS_GXP,< MU,VV!NNQ0N1*2&NP>P?[*SP9IC]<#LQB4QL?ZYE=@$242S'(,OI?O"CS[GKX MX&23*7P'RY*&5V!GQF+(TFFU2DC-&QI!)DJJLR3?"B07:;19=-%95 MJ1?R!,QR$,8@`(@`^F!]N_JOI7/T/T_UOTZWT?U?N?2_5>V;Z?ZGV?TWT_O< M>?A][QYX]<"A5#];OU?8_KT,"-G$7`R'ZM%>EA@`7*PM2M?Q`QG8B5IX`<3? M:?G@..,"Y<#'<"RV&E?KNYGY""7UZLRJ@:_8,6SI.>82)&\S^O2D^X45%!PW MD'ZC$[`I>?93(H4>.0P,B8'`_9Z<_D^S[?MP+.I@79-E-!?%815^:X6X\`,% M[_L$I!Y]\-*2D`712,$XE7/IRO?'S(+D#B4P@('F7\_\`J#_:P,:^6UQV MT?UI!-(DH)?`0&8-L5;9AYXWD''W()"HH5L@?[-R=T?^Y*7U#)7F7\_^H/\` M:P(HOF667)TW5*@9F":VU=?I.@E=I)&$QC)![`*% M`PB($.$A4!JO6"D)$.%-;T$R[B(8F75-3J[[BIEV27OBH;\.Y.*OF/ES]O(\ MX%><:RUN[`P.]?4AR!W*KPX.*G`K`=XN5,B[HP*,#>3E8B1`.^D541;'ONUG(R"4+([DFZXFJ[<*KF<&:JIE2:E40!)1P%L&94 M"!U96GUMD[79>OTO>VMA>_1HIM]S?)7V#F9;\.(I'LG,DVD`TFTDW#=)!)\' MBX14(/NBB*#PP73+,]HR=WGY,EOID=OIG&*#MO=(G76TQ\>.B8B)3>O-/4%R MB:%B7.TC(//8>K-EB.U02,9;V`$RV![[-/05)@]>1J50LEJK4M-"OU:ZH+%` M=@]GM@22Q93\-F:S,[=M M5PW`U8SR,LBEW-[:0#AXT_9\U46240ZD=7VHL'S]Q8FZ4='L'RS,WNQQ3)A[ M?UPB@8,W7=H@P+J:JTNB5.?L;..B[CU.ZV)0<@G%ZCD'4":OK[DW8_QW8RIUH2 M;'[L;%;./HF&B]/-T3R+]2A+)2`QAGT:N)5B*@V:G.V5572"NQ9-D26QZY)R M<)2(WL%!ZV*KK.A/2-'6H?CMTG)BLL\V!LITJUC8R6VW(0C<&J+Q9X/9,`N5G$7"+ZBN-DNGR;(C9](;K^2+?DBJO(-R@G+O%7;O7 MJS^*)(`D(>N4DQI4%I6O5#2!8BXD=N'O2_IS,'=DD(TJ:C9@ MY[/=CD4C%5&T&=N7*[9*75(C&)F\S*$D`=^(8YKCK9@W:\4+42<7O/:%ILC2 M&[5]G&&VJ?3+7(4J$!7(MNXCG*\>BNLV8`99!-FNDD( M!E]G0^W8V@+V/2-JK$:U1D*YU8TTZVCJF(U7ILCQRS9-KK/4UA-*.[5=#HG< M+.9(KQ+VTU5$T`(4P'3#.G3RF]JZ5NKL9+[0UA,M(Z[46G3Z-TOEVJ]JL]RV M3"#)H,XIJ^J,FE58:L.22<@8L4R;I-X)$C9$JGBO';`5UX_9SHT^Y8O3EDXN#=,I\6KZ0KD9XO'QCE;E(W.4_!0.!0"X MMZ]O-D[W^,.=V%,QVK8:Q[4N#_6\M78J:<-'84MG-+QTHZK$7-SCF3E+49\B MR*+1('!RLW)U@3X\3D"]]5[5^4FB:5UO&0W6K1BU:KVMX5O7TK3:WE>N[R%K MM=;?2MY6K/KS#O&5E/'MR@JS%!$4E@$AP3P)*NI>S-E;ET#K_:FU8*KUNSWV M-4LS6'J"CU6';UB2<*+55<%)"3EG7UDC!"@Y7(94!246%,2%,00P-C\!@,!@ M,#'>V(EE8-:;&K\HY>,HN0"`\8$;GQ`4YA3.OEV:LII.<+);>G'PKH,'S%%JFE6ZZP:M2K2`(.9 M)4K-JF90XMVY`,IP`&XYP)9\!@0E?(UKB5W-V3UM0=8?@-,V[&Z:>V9]LRW[ MAG]<5MWKUW;9F&1I815>*C)2DTUM($?H*(K@`D.XDK$/>EG7 M"+CHR0CWE;WGNBM6-P_V.ZVTUD[75VK6(L$G7+XO[X2UU+3*5X.O\`)O'Z,+58[94\ M97W2UR*AV5Z7JQJL+5Q/2K2#;-7+$[QLT;"951,53?I%0C6[%]3NTVM:!VOW M;O?9D1?:](ZND:O7DT+G99Y[%L[%O2C3M?AFT3,04>@V90S5JL)UA6$W]\D3 M*3[AC"%D7>-IC/XI>J%QL#)O(V:#VS--*[%2*LT(3<+-7B\!9(M-A!SU>66: M"#)LL1T(J'152(B4Y"NCB8-LML5WK*]FNA5(V!6-O3$RXCM,O:(]F->,I$)" M&BW1(0*AM!TO-H,F1IE)NW&:2.5X9FDU35(8Y>2F"L%#262;G>+;IB2LE5!5!9'BEW877L M`10J(@HAZ'\RFX+]G`^N!+)K1M]'KNB-.$@^EIE5;<(F*9$/8@(Y+A(Q/N&2 M#Q^Z(>@A]F!>^`P/SH].'W7_`'CJ62*AHQM'.FCP`,/@*1T13+]A"B&W_Q/-7KNO\`9B>G+)=K'-Q_ M8"R:X;J6ZX6>RECZI1VS4:Y'-4)Z6D$47#7\9<`JX*0BZY1(50QP3)P$M^`P M&`P&`P&`P&`P&!'?V.W%VY;]B8/1O5V&TP_5_8N&U["XVL6P(G*D>ZR5.%./ M>0\D@E[:*P-3^T9$3B(F'SX]`"RFDM\NJTFC1XHDX*HW7D[Z=R@HD1 M3VE%/I'J[`PNCD#P*14P`)P\Q*`"(!Y_K_E\]N.#\$Z:>;M`^X).0Y#1CY&#]^C=<15[)I]=6^O!OU+,FGJY2V_K6C8 MRHRJD9XFEO=8&C^5%2N!\P.!DBBF/`CY!+5:.\O6?4$X]UWL[8:U2L=0K]&< M3BSZK6^2B$E+;!_BD0U_&(.$E6A7J[!(%1(J9,3@H`$$YBJ@F&7M)]C]*=BV M,_(Z8OK"],ZL\9,)]9C'3L;^&NY%!5RR153G8N+54%P@@D75NGXR.*.XODL["H29G3VK5E!`[^TIZ-A)=F5,[GS026,0I`5]A(KEP' M<;]I#S9%RD0N&NO\X)O#_A^RK[**)N-(?&_I>+8,W!*)2Y!48Z)6VRH5PEPY MC11*1VU5371;K?4_0T%&56=R$2C*($2!N4CQPDFFD9FB%RL:E9*K.;0N%FV9$Q^W%(! MU)=P.Z)N3P&@H%/73KAR@*);NS;((MQ6;*",:Y$@F(=P*<>0*(Y@)6^6 M77$A^SB+^E;5>*F>D73VT6*4:G8-8>1*V>]GNR[9J\"-CF$69TI*.$W"RTA( M@)&A5'#LJB1@]LLC&Q='%S@7ENBZ55MU150<26C])K M.XESI;H7IX6A'PL55'47L?9<,]>CUU^.[KZU9(_75"@O%D4 M8M_M>0K\8'O&32;NU'"2J@BP1()U0MEI6JO!UZK-:/4'+K2SF781G7?2\JZ7 M-L7O+N\DN,DIN3;S26!*<;Z9JTRB654+)IH)(`T.]`R"*K8CD*#UNU/V\[5T M3=FYB=C8:G[4F;=8]$2[=[KN*C*+6X[M57C4[5[E65I-1==",^/3L#$CM5ZV[IN#V7OXIN9B^%\H]0D?TQ$R MJ@*Y@W32T3W#:LF[)#O(W12:H-VR2@=8M<*+@D@4B1/(RUD53.8Q"`!A$OKR M/'`X%BZ]W7V:4T?MF1CF=*WCM/3/838&IY9Z[82%$3GJE4)B-;+6+]7*HQGC M&GF,7*@],Q8E4.NT1]M$%W1BD4#1GJ+T:V9LWK37;76.U=GUC#;'LMHN_P"K M,)0&,NYJ$TA8[#5I0M=L;VS1CZ-"=:1Q`D!3;-UU@(5(X@4IRG#6B?Z*-:KT MIVON!#:+"1'5MJW?%_@3K45=M[%3UBL[:6_\5?V&(VZKJGVUJ@F=99U5K`W213#E5556'D$TDD2CZ'54,IP`8&A?Q MGU:3I>G+379LS%.69[)EC/6+9\@Z>,%UJU6')F4HU(8CJ(D$6SE$YVSA,BQ2 MJD-QXG*.!)'@,"![Y2JA3]P]@M7ZGN-^T_HMA'ZD=W]';E]AI!:P3[C]:)VO MAK9G+-';9(89!!162%L82_I1.?DPB4@AHMVWGF2/)6U2K:IV)[#FL:L!--+1^KRPLYN-.P3GE*TW361ZQ;,@66R!VX@5X\EDG+>+-K.'>R<#[+M:&;A*? MKZ=@=L@9R9@*"Y#^K@"B80U"[@]Q[EN;J1::W(=:;_0XC:&ER7]2X24_$R,+ M6%:QN*%@G$(]`6,6H_%<6K54%4A*N`2*'][&)YJ%#S:#:4VP='NDM3CV;*(11EU518.3"RDRLSD6$A"`3IQ$KP&VR+-5JS-,5*S,?A=)8,;/8G-<2D+A!D3LD?(Q\4NHX07 M0*RB7R"B@F^M51%$B03#!]@?U,#G`8#`8#`A[^9=@A/Z!UK75[#$5I&1VTY> MFD)PZX,3JP>L-B2[*-]MFQ?OU'TX^:IL&8$*5,SUTD50P$$3`%ZT'Y0.NB#J M$U$%5WZGL*"8Q56&F$T_*/+,[E(>"0%^U;5^">2#]-=DDU4,JD=%(Q"IF,!? M;`#8&:C22JR+'2G;=PJW1576('6C9B7MHH\^Z<3+QB1#>''V%$3#^0!P M.6W>:C.GH1Z&E>VAW8D.K[)^MFR&Y0222%=10[AS')-4R$1*)A$QP]`_/@0C M="^L^Q]J=EF79VJE8)4#779:T(6V.FWX1%KC45X^>FW+E>-='6.)F2DRT;K- M3*'<>3C^$;VUC%"1CXD99)2![60J<9-)%0[/WZ93EE8Y8:\Y0D/HV1(YC/>) M&CZ98FBS'=-R`!T$5T%#>BQ<"7S`8&--R;%#4FK;ULPT$]LY:37GM@/7XUYSIWV>V=!76*ND- MLZ6A]L-J7,7HB_8C0S=I9GM#90[.G>01O6WZV-6CV3)'VOIS)IJ$;?ISG,(" M<._3/3?M'UU1LC/2]?VE2FMJ=1[F?(S[&Z$E$Y1>'3=MXUP(6'K7)G;"BB]5 M`/;!,3`8/,!$I>`SFI1/D,(FD"CXJ"IU1(F8>1$/ MN"8/3^I@6!L=[WMU74W=UMDUO`L$QDJY%.3Q.ZNL$B\3=6JQQ54B3`T_S76Y MU$!F)IN54Q1$R:8F/XB!1P,9V39G<#4=QL=/WWL3M!"SLVT?3>C7NKFW7N\4 MR3@TB$82+;8]EEM95.(92-;FE&1G2WBS`6\DF":)!#W%0UUZH2I7&CMO!O&= M5_`[OV7G6UNJNN52J[D[0;4:P4;)I::@G$$#!6+J#>=.:4>.&JQFSDCX2"JQ M0(O]6&P#@-BSMZBYLSNETWL!!PCZ7=R7]YR6D_C@ZXQS"0BVL(:$01[9=64O7^M4&M;M5PI$[.'M6B-!':+/MR=XM MHNO%1GOO?3\55)-.@/;,JX<,(YPF9&0;$(N?WVXECD`K!V\U"2NS[K=-JIPN MWT('WNUW:QHHM^JW6J(<_3J-.KG66/N[`G:[LM'(#$3G9.X0#5X`=4.L3? MS3*C48&/3.P33BG)U`(J=(@K*>;L`OZ>8S\_LFC3EBI%!@MKU&ILY32>G[`[ M!QJ'HWIY-,BLCO+=[AHYAJE+;%:H(MS,8E`[4Q5/!`JIDT"2"`8=`:_3X MD+A(=2)B\-C66R-$&,=O_P"1WL$\E0;)Q=72.G$/RZ_4FQ4#VT5D$$8ILF5$ M4$P6.B&05G,VCLZPQ$3*Q\3N&$IYHZ]6EDL8^@?C5T.R@F[YQ6ZRY3"+A)K< MKVOD,B@^2*U7!KPX]B-G#$+28E-)+Q0QE2&-6DC%(F0T@JR\#+B M!2@*HFX`/LP)9../LP/%(.TF#%Z_5(H=)BU<.U2H$`ZQTVJ1UU"I$$2@=4Q" M"!0$0`1].<"+%S\MFEC0;:T0>DNS]BJKA2:3+:H[6#3]63_@A_!VHWG36,T< MX21$!]X0.'TW'Z3Q'D`#EA\L>KIL4_P'KQVSG47Z1%(!>+U0@\1GQ7^G,P!B MHVL"R1DWQ5#"FH!C$$"AZCY!@6-\;^W]P;5WKVJ21C8^IZ,BMF7:X/*5;J^K M#[=A]@[1L8RT8TF/9,L@F2+C(1\B]06/[B"HI$)YE#D@8HZD?&KH3>.AZ#MN MY6C=#6P6]]#CS$YC&*8HB' M`=5C>P^O_C5W=UPBJSMEQ<65Q;>NG2!3E=)"D51%=NN0BR*I#!P8I@`P#]H8&S&!P`@/V8`1``$1^P`$1_J M!ZC@?`*IBH``X$OV!\F`1#@/MY#\O'IR M'/J'`_9@0NW6J*=DG]/B]H;[EGC':78;<=!U92+?UQTW?(VM/]-RMKCYE&.G M%H\KN#;R,-2%SINU%`%P10B3E)8XG$X8`^6^E3VNNNO6BGV.ZIWF3C-B6\II MIO2ZQ06:K4E8*1@T85BHMFT/%L8AF8C=(H>XH@9B[G563DN[?QZS MKNM3TG4FC*&9+RK&!&4BFT\A/-Y5@T>/%46S%BND=!%T)E'1U4D$CK)(^1.% M0TE[0]:-NW+5G7IA3M(S%84AG&\)!S426Q&W),XR>O4:[AW,$J\G)BPD:R#! M,[YRU6(B1LH=0Z9"D-X%"I;)TE:*1TTKT[9M1-V+RN=8WE-E-HH;17)(LGKK M?Y['&U)MKJ-M2$3)5XJ$@;\05<1[AR1^HB(ID*@*I`O2PWBIU?XP>FL+,3U< MB)M_N-U/M(2WU5I?T):"K]AV+%6IV2DJ,G;6R1S,+&W`J:B8`0[A+DX'+[H! MM?VEG:LZ[7_'[6*??K'0)>#L\#'2^K:\B]62AZO-N:PYKRDE'PLHVCF,5/H@ MI&G?$.Y9B1,2*`<[<4RA--@,!@,!@,"'[Y+-:?A$SK?==4?VESL5=]=H!!@[ MOLK$5%E`TO4=SVY''9Q"3208MU8.ZZRC9TJ)40)*/6@(.C"DJ`I!@G6/QZ=L MXC=]7[BPFQM!R>P9Q_(;#>UNT);%+`)/[K6G+)=)=_&,U)*2,+::45/XBW!- M8``#*$^T)'T1^1<7*'U(]*$V8JH`Z%`=Z+.BH>1`"Z$(.2N-75A M;2W:J,W3)WYBY8*K)+H@14`$+0UKU3^0/46B)K05&V9U8CH*5&3/'VMK"WV# MMM7+.N".Y=I$+PD`U8OA%0RR:#QXDJ\105*1,R9442IAG;H'H7>_7A+=%1W& MUH#]I8[C!W:"NNORM&$;:91_58N"L(J0+=M$*Q:[0U?;J.558]NH]?.7"XG5 M\_+`D1P&!JMOZ(V7L?7_`&!UH77"DC5I76CEA296$N\1!VBW6!^Q$[V-BB/4 M'K>OOHY4P`TK+%6)J2UN M-?<VV/%J`:1LS2@MT"(6%)1;VW)WX?6*GY$2D#[@!)1@=#E15-!H`P,F3&36%3WFT-42AR*?*Z MA$S>8E#[P<>@^F!7<#$M.F=NO]H[CBKE5*]#:J@EJ"EIFRQ[TR]AN)9"KB_V M$O8F?XD[38HP=F439LOT#0ZI"J&$J@`50P9:P.!'@.?^C[<".N@O+X]^0615 MV-$PD//I=3KJSCV]>NNHUVJZFR.VY%(R4;+)>PT>!#C[?7^I^;TP(FOF>4`G3I(@J(D%;;M`3*17W_<6$ MK:QK"FU]DID_?*5(3F]X2I^T0_`^YX`(2G5S_%Z"_H:+_F*&!6L+_& M!,5"Y1OX7,L!.*9C$!P@[:.D%``03=Q[]LDX1$P&("J1?(IB\E$/SL=>VDPV MV)V&AZ06G)[7K.X[Y6[#NRZU:LUO576K3E558P26Q82HQ$/&4^%VCL9W%*1[ M,L>1-9R6*$%O%,@K8&>):3U?3=35-Q&4R:OFJ;A9BO=%:DL(+J[@[U;UDYMB M\5WKLX[9@G*KZY(5P<[=@L@#=['F\U4A068LT@\T[`"JKMUULB^,2[9EXJ.B MNW79L)%"&U_UPJSB,0E&/6SK,49]LDOLX[!(C7W&RR@-A<>\_P#>.L5L0*+4 MFL%9V/7E4U(F9Z*:IR"O2SJU.J(GE-Q31#&=27;?M>]A(U5K&0$E/`$N*IDE M$#>R9\DXXQ-F2B>RACZ`JL,5W8[K&;249(;/FH234"5ZZ]85FC MA(*O#,50<0XKM!`A?>("(K.P]]8/0:&=36Q=-V!UKJ$JFR:547T[I'K6*4`S MTIU`U),KNQ1WYV,3>.&2#N],V91D@9,EH]8TBV1;"JFL*"Y@HDS)4G9T#88A M2UV-#JC);%0C[C3$>9@V".72(@P(FD M(,&AR'*%4D)2=0VO-U1A(P,%O:`HLVXG)ID^&0T9\;77]G",!EVE-3;I,XR; MW&YKR+1!9^B@V2.Z5$2E!!-X@J%.J=#UZQIE;JL0%JV3JFS["?6K2VN'LI#Q MVQN]NREDW%J-9+^^5;I.X#KE3)--Z_*64%4R[?S7>&$2$8.@N(J4X2U[E9AM M>)-M-K37#?MWV]`CYO1.LU$<@F5CHS0=;34"$6O)(V,^G(JFD+H%%`MU[5-*J5%.P]59V15"U6NYJ2*TF\[?=M'/Z91=*$9-"R M<9&/RND6J:/LF(Y7`@,@V0^'Y)\CUJV`C*NT'\JAV1VJC*/VAO)H^DTV553D M'K4W!?)J[>%.HF/`H5-G,PU+(%+4_6-) MG[@MFTB=)JH`"@"8>6!MI\?%.H4]);[[LHVJ7BGNT-G[A;V%@UN/O:B&IQ5H M)*QU@,G+5JMO5EH9%)QM8B:)3HNE2I)JH1M:A6%8ET)DM@1DH)HP00BWB,V19RG*(KLTR&*L M0YB'*("7[O&!>(!Q^<>1Y]<#&&QM1U/:4CK>2M"DX575M]9[&KB4/,NHA!S8 M&$/,0S1.;!F)%9**22FCJBV\R%.LFGYB8@&(<,G@''[_`#@#!Y%$OYPXY_-^ M8?ZPX%MIU=BE:'-K(LY*]=Q"$0NUX;?1G*@Y.X(\`PMA>E=`4XI\`M[/AZ^W MY?>P+EP,8;HC&<[J/:T`_>.8UE-:RO46^DVC8'CB.9R-9E6:[QNT%5`'3ENB MJ=1-,3D!0Q/'R#GG`C@^'&!85[K-8TH^R+V)O)[9LD@3RBGL.VCO"%@(PC=! MM*%0?'6>)1OU"QA2*7S4X+Y`7R$);L!@1&V_XP[[-WE_;*MW2VI1HMML>];* MH59BZTFNAKB:V#(3;Z?-67Z=QCS-G+TEA=HKKI(H&<)K&\R\C@:;?*OK6S:A MZU]::-;]HW?=L^QV9?WK[9-Z%L:9>"^@_JDXLXE;IEU]T]TQOMDI=-.C/:JUFA2* M5+RDF\EGT=!6;<%:L+SZA9VH87\HT M!276F/P>[5ZQ4J?0CA3$RGN.H.RN$/8.!4'":ITE#$(/(A)!KY--*C4YND?Z ME!O4ZRD@]%($/K4B0;$I'(-PY!O[A0Y\.1\?LP+QX#\P?O!@.`_,'[P8#@/S M!^\&!SQQ]F`P&!QP'Y@_>#`>(?F#]X,#G`YP./$O(&\0\ M@YX'@.0Y^W@?M#G`YP&`P&!I`/\`^4A'_P!"`?\`+Q@;OX%@[3F)*NZTV-/P MSCZ.8@J%;IF)=BW0=@UDXN`D7K!R+1R11LZ!!T@4WMJ%,0_'!@$!'`T5^,B^ MGV#J&[R1-NW3Y-;1<7$1#59_)R[YVI-%0CF,/;<%B ME1Z-2AVPO!(=57L?J!)P6/X2X7`_,_KA['5:(W]7K"U5VA"/>\FR(O5_7*$2< M.+?OS;<6[9K1J&TGY6X?B6I*&V%I*+-2B9LJY,H=Z7P(V\0V73A;7`RE_O%_ MV%!(;X90RK?L_P!C6GNN)51BI$Z`Z^M7;=6(+LZ3BUTP`R3J3U"LEUYKN,0=HI,]>` M_)]*$=#)I,")%(!"I>ZG[09W?C>%K[&QX52OUO=57IRH*V9T^AVNC/CHT7,Q M3A))&MF734B;!NM_7H0X.)0B`MSNE2)B*4:BHUP++A7%*1UC7J?7J):);K]9 MYYZWU[JB>2CG^Z?D"W&K.1$L38]VF/H7:]9T_'2;,7CI^HNFB\CD?<<"5@0& M1P?B%QL=VVVO$6R(B-DU_P`8CM)VT"+6C*+U=UU&MU/>T9U<1D'#U0+-&M6I MV*SE)FJXD'"_U2QSB#/`[TY6&I<;K./AM02YBRE@^MZ8]0W#]-M,[&EH^+:. M%>T':19F$E)+N6Q4S23)*0,4[4B/WTE723=RU"GU4L?54]MW:PW^8M4Y-)DB M^U/;NKQ[B7))R*KQ2';=4^H*+1LQ!*PS,JJ0DE(,"*)17F83G^I,V<,PV1^( M$L>GULV&6(8OXR'+V2VL6(C)(JXR<;%%9U4L='R8+JN7'XBQ9@1)?W%%#^\0 MWD8P\B(2K^0?F-_$/_)P+`VP)!U9LL#@IX#K^Y>7@40/X_JY)>7AYAX^?'V< M^G.!^873G4[3\CU-T1O&[P%HE:Y<[%M\-QWAK-QT&AJ^'A:Y9:G1I!JY=NXE M#\#CK?'M)%=,Y)-PZ<@=))!Y]K:9C[7^O>U( M6JGJ$O=PKKRK+MF5LH`,:H1A(M8I94CIZ54#E-'@H9(IE?;\0S+TGK]8C/C8 M[.RE;AY^":S;'LZB,?9Y-Q(S+5C"5R>C(EK-II-XN*+-L&!`;NUFK!D9]2%L18-[%&7]9.VU*3BEXEZO`3'X0S.5I*_5+-G")RAX$$$RA,UTC,8>G M_6$Q@-R;1FM#C]P0`?.J1I@'@`XX,`\A^3C`VD\@_,;^(?\`DX#R#\QOXA_Y M.`\@_,;^(?\`DX#R#\QOXA_Y.`\@_,;^(?\`DX#R#\QOXA_Y.!CW:SQA&:VV M)+2:CEO&1U!MSZ4=-&BKYVW8,*_*+KJM&*?WW;E)`RARI%^\H8`*'J(8$>_Q M+.8IWUUGU(28-.1[7:-BC%'ZS1LQ7;N6#%WLN8CW1M?N$V\\YDG.JMA!3FR@KD405C"7=.- M4%@((!)+K%5=QKFA.79O-XYI536=J>X97W'*E>CCK']PQ2B?R M4,/KP'/V\>:GV@)XET2X4^YND&Z.O:0Q>L74A2[!8 MXUL@RDVBR3--19-<[,B2IDB>YP`9U[UV&%JE=ZZ6&R3T96X"([?:%D)F5F%$ M&T,I>.%Z@BZ*V?,UDG;"19*B!A27072(H0Y!^TH#Z\!@J+!=)BQ33DU5/!E?1R]NV5LPG"- MV<@FRDGBIQ\0X.5(03\C%*&!:CWXB0D:RVI;_N'V`>5!G-O;,WK+@T0I"ELD MD]6DG]A48"K[#F;=R+A1<[I4#KBL,_2N1)3N3V6D#["!(EZ4<34?V`2<',D*(`3 MP`A2@`>1I\21&:-510[C=D6X45LLVHY6U1S-A8I"8,X-*O)]) M5B]:S!I0SU<70.$3_4&6,901$1Y"M-_BIK;>696$G;#MJG8XZ%4KC&?;[&C6 M\NRKJK@CH\`QD4X`7S.$.ND0XM"*`W%0H&\.<"BK_$I6@BE*]'=K>S[&MFD$ MYXE?-;HE:)"T$FF\[^L:K!&)9LEY()%L1P144P73=D*N"GD4`P/6G\3E93N* MEY#M;VI"S'B"0@64EYC"7`(Y-1-1..-:_P`&-)GB2"3D&H<)@;@?R>H<,_B2 MH4?&0<*P[-=IF,-6)12G5F8./1K1&<3+*'DG!ARM_%%4J:U>,:AVI[9U1C(2+B7?LZWL:,@FCZ6>`0'DH\;1=>:H MN9)V"1?=7.4RJGB'D8>`P+B_YM$/^6CW5_XX0_X'P/&[^,&/?@8K[N)W+>D. MU>,3D=[92<)J,I`A$W[-1-:%.11J\32*55,0$J@``&`0P+`<_#3IUW6F%-<[ MZ[%.*C$O5Y.(JCFRU9Q6(N4<@K[TDPKZE3&*:/5A6/YJI)$4-YFY-]X>0C%U MUH_N/3'%RJ>P6/R!5^*IA6L7KIAI0+/)P,L:#E3-'43^)$FS0$1"/ZZS(C'/ MF!'3=LJH17V5D4Q1.&`KL\BJY(6'4E'V1VUAMCV3=]DI5ZI%A>'=LI"D34HY MCFR]MU5 M%A2)C:&K9C6FX+#**(JZX@8ZFV%RW((N"+U"2.+)P$H#9D=3Z8"LD4U""N*P M:DTNNUF9%&DQW=.ZL;=/5QS6OPJ(@;:?6CF/KM5*#H5#"S3`_!@ETZ_?&=6=E:$TE=I?L-VDJCNT:OI]B/58:_HQL%75)^ M';32\7!Q;B%44C(I%=Z;V4>1`I1`>1YP,N?\TC1O^5'VT_XRV7_`6!V)?$O2 MT%`51[4=MTE"@2?M-9DY]!X^\6!Y#@<#[+\2E``Z0G[.]M#D*!053_:@U+[HASY"!P@O) M/R_,'V8'J/\`$SK86HI$[)=M2.A5$P//VLI'`J0E3`$OIC0/M#P8IA\OM^]Q M^0,#RH?$I02+HG7[/=M'")%4SK(!M!JB*R13@*B0+)P/FD*A`$/(OJ7GD,`A M\0^H$13(._>TIFK@SK\>:DVTS!9A^YF7D='1CEP4Z+1@S:)*MXM(121 M13)Y!Q]NZWQ+W`]CVR^]7HD_@?R'ZGW#^SR7 MP_1\%-Y_>\,"@%#D1X$?3^H`".! M1&UEA'DM+0;9\"LI!I-5I5L5NZ`&A'I1.V\G!D`;*G4('/B0YC%#[0#G`KN` MP*>A*L'+][%HKB=]')M%'B(HKD!(CXBBC406.D5!7W2)&'@AC"7CUXP*A@,# MCD`'C\HX'4BX1<%$R)_,"F$HCP8O!BB("'!@`?M#`[L"P*YM&BVV\;'UO7Y] M%_==2K51#8$$5N\1<5\UX@0LU6.JJX;I-G:,O#B95,Z!U2`8AR&$IR&*`7_@ M,"/2FWBK;#^0AU8*=+)S40TZA6JJ.'B2#ML5*P4OLO(5:S1PIO4&RPGBYV+7 M0,<"BF<4_(AC$$#"$A>!BG<3^%/KK94#(NEB*O\`6%X66:,V24A(*1@UZ40= MJL63OVV#YR4OD":"IRD5/P4W!1$<#0/XFZ9=:3I/84=?D9%O/N]IG?(H3PL# M61*NHT6H0M73G0CG\DW:NT8.)03!H"ZGT12>QSP3`I?S-(I.>H<>W.JU277W M-KU!G]6``4[E=K9DA*1P/W&GMMCJ***F^Z"!#A^7`E2@T3-X6';F,D@AZX%4P&`P&`P&`P&`P&`P&`P&`P&!8VS M;*]I>N=@7&-39K2-2H]KLS!&2^H&.6>P,$_E&J4@5H8KH62B[4H*@D(*>V(^ M(\\8&I.OK-WOV'KBE;"CY'J0Q)>*77+E'Q+RK[C$S1.RP;.;9Q[Q^CCB)BE]0#@`$?3D/MP( M.M7]4]D[N[=[PVLZME$C+=I3N#4'EQ@F[9Y%P%P5+?PF[>_ILC/2KA]%IP+6 M/,N5JL+E5=$Q2>7N"0#A^A#>DC#J:8VZX?"+^I(ZMV8>U'AEV:K\TK?A#PSCR3:M_!$H@<@'(<1#]HG59W&/NLO7EW$J) MJQZ^D]8&:J)%4*0Q0I<,502@J4IP#W2F^T,#/F`P&`P&`P&`P&`P&!!+\YZ1 MAUIH!Q[RA2I[!MS<6X`3VE17JZ*I5CB(>?N(?2B4O`@'"AN0$>.`G`KG^+\' M_0\7_,&^!6L#0WY.!XZ+=@Q_-`54?_M"J6!V?&@R78=(-!-W"PKF&$LSA(WL MBB0&SJ\VARV!(#I(J'1%%4!*3@//(@(#@;W8#`8#`8#`8$+7S<%<+]?\` M5;5J@Y=+'W`+DK9JR.[4$K*C6Q99?R13472(W;"H8WB'`D\C&]"<@$O], MU&L/"?P7==@G)?NG)]U>)9JA]Q0`4)Z'^PP>0?E]<"YL!@<"`"'`AR'YL#I* M@0IC&_A&.("H9P+_``"F,4I1$B?Y`'G`[\!@=94RE.)P`H&-P`B!"@8? M'D"`8P``B!"F$`Y^SG`[,!@?(E`?4><`4A2<@4H%Y'D>`XY'\XX'U@4AG7X& M.E9F>CX2(83EC_#OUAF6<:R:RL]^$-C,XG\9D4$2/)3\+9G,DW]\Y_83$2D\ M2CQ@5?`X$.0XP-%V;"/C?D85:Q[%JP1/TJ)35E M9MO94(F!7UW2YFMLHNP-W2QY5N\A)1!ZJHLDV<@NY.5=(JP*8#Y?T)%UU.CV ML0V>O)%QN?5Z;-G'1;J9?NW)7"9BF*L8`2`/(Y1`,T M:0[PUO<$_K&MEU+N2G-MIA>HNGVV[0=3B(B5L6KVCUS=(AU%1]ND;%"N6*<: ML`?4,4TS+%%(H\E,(!O/@,!@,!@,!@,!@,!@,!@,!@,#%.]&RSW2NX6;9F,B MX=:JV$V0C@(*@OUEZE,)),@3!-85!='.!/'P/SSQXC]F!H72/D.ZFZ+T7UWJ M]SV@SD)_]@^MU'<;2F#R[KQ3F,J,%&.HR=/7"OD8.9*]35)]*[,DL443^0%X M#D*^;Y;NCI?/_P`)=A$"-OJ`,&MKZ`'/]_EJ7R@B\.0\?R\)^H??^W@*/_SP M/240`?UNO/Y!X#6UGY_/QS]/Q@0^52V?'GL[>?:38_9:>O!HVW[DD[5J%Q6F MM\CCOZK).Y:3>J2+2`9"Z:+OEC-TP(Z*DJGZ\"3D38%^T[N#J/3T)VSTEHUP MYL?6.UZVOTM4V=@(WK=VA[]?8N-HHM:Z>U3)IVXPB0O$577OF4D#)%]]!L5) M)-)%%A&<3"1U0UA92SUB0<'DW M;R`0.J\(T=BD0ZBI!1#]%[0;7=??E,ZDZYT5HZ@6ZU6M.U5/6-(J=D3C:1:9 M6.C9>OUN,C'I1E%DSB\;_4(&`JB1E@^Z/\$.,#,*?S`=)C@836Z\)^*A4P!3 M6]GY.47!4!5+[;V4AA5'G@WME'@!-P40N:G?*KT[O-QJ=&@;=;#SESGH> MMPWUE"L;-B$M.N$F4:B]>*MA(U35?KIH&.("!%%`YX+R8`D;`>>?3C@>,#G` M8#`8#`8#`8$$OSGG4#6F@4P!+V3;"MRAS"=0%P53JR142II@F*1D3$54$YA. M4Q3`0"E,`F$H3@5S_%^#_H>+_F#?`K6!H;\G'IT6[!C_`.T-5_RA5+`[OC12 M,AT=Z^)&]GR)7K)R+)C*?A]<@60**%%-54K6(9HE562$I#( MJJ`3D2"4!#\P8%U8#`8#`8#`8#`8#`8#`8#`8&FB2#`WR"RCE10`E$>FL&@R M1][Q%1@ZW;83RJH(?]5!%PT9@)_^I^X`?W>!N7@46R1ZTM79^+;M(5\XDX64 MCT&5D:'?UYXJ\8KMTVL\Q3$%'L*X.H!'2)1`54!,4/4<#`_6K5>P-55ZUQNP M'6JSNIJV#,P\=J"HRE.JL-%!`P\9]'^'S4K-22KI5ZP55Y,Y.D@BH1!$J:*1 M"%#3+YD'[Z,ZEQ#^+D9>+DVNZ=>KQ[N&7<-'*;Q!G:%FYC/&CEJY:`BH3W4E M$Q,V=A[%B<, MFLG37[1)S,-'*B3E04Q55`_)C"8`'`R!NWKWNJAZQVCLZM=U>RCZS4>C6F\0 M\3,NM6(U9[)56#=S39C*1T5K1ES%.CQX$621%/S(8PK[9%_J&Z[=VX4$J;E-N<0DW+6J\L@=)S`02P'*=-8AHA@9)0B@"!DQ(9N(& M3$AO$0$/4/MP.\M;KI2@4L!"E*4`*4I8IB!2E`.```!#@``,#G]7*]_V"AO_ M`'+8_P#L&!I#\BE6KB?37>@-8:,C%Y=E38]Y(1K"&8/_``D[_3819Q]8[%@T M]Y./7$@&<.$$O;#Q.LDGRXH-80/7M=,;13J M]4(*#AVM=NI=>R%AK+F<77;J/TET9&0,LQ>('47%0QB$#?4:_7>/2#AN?Z+9 M?^P8`M?KW'WH.&YY_P"Q;+_60P(T?D>B8=FMTN6:QL>Q4'NIJ!(7+..:)N`2 M-^*G,D!TR(G%-0Z91,7R`!$H"/(E#`E(+_=?[8<#ZP&`P&`P&`P&!!/\YZR1 M=9:!;"?A=78EL<)I^)OO(MZJ1)93R`O@'MJ.DPX$0,/EZ`(`/`3?5S_%^#_H M>+_F#?`K6!H;\G'^@MV#_H&J_P"4*I8'=\:)$R='>OI$C)G3"OV7Q.E_!-S> M[4)A,'F?Q5\A'S#GT/R'`?8`;V8#`8#`8#`8$-7S/V-[7-*:E<-B++H.-J23 M=TU([?1R*AU:!:D(]TJ_BW3.125B)%=)X@F0X)JKMR`H`E#Q$)<:>B=O5:V@ MHX6=G0@(1$SEP/DX<'2BVA#N'!Q$QE%US`)C"(B(B.!PS#&1DXF" M7?M4IB4CH=1DE+R$?&G5*\>LHI63;%1[MJ^9K@8 M47;-PDZ;+`4QB&%)=`YTE`*2KYYUC^)PQ)=HF!\@P-W,"AGLL`G8$ZH::BBV=:*5G4:^9^V+,K0R#E)DXE48TR@.U8] MN[73345*42$.H4#"`F#D*Y@1(_,^D1?J77D5`'Q5W?1"B<#`'M$_`KL*RG@( M"*Q@0`X%(`@8QA``Y'@HA*U"$(G"Q":9A,FG%QY$S&(8AC$*T2*4QB&`#$$2 MAZ@(S$_,Z=V!'Q$5&)*+R,B_<5N1(@R8MTN5G+M MR?[B:1`$ZAA`I0$1`!"ZM%[2JVWM:P%MJ03*#),'-=DHNR0K^MV2`L-:5-#S ML#8("322?1,O&/VIB*HJ!R'H("("&!E_`8#`8#`8#`8#`8#`8#`8#`B)[3G! M+Y%>FA2D"Y!RFH14A1()0"N[CWI\INB[=IZG7&U=;9"9WQ< M%*)1D*]6Y)^U:S9G,.V^HF%7+2,6:1[8\VC^D(#D?'R$Q!$`Y#/`UOYD14*< M-A=3`*0JA#(A%R_M*&,9,2JGYJQE@42`@@7Q.4O!S>11'Q$H:P=C8_O4QN?4 M4>V,]I6;H9NV&J$X0FJT'K6<3MOXBY%HM(C(13,AHPL8=R`E3'U.4@&`!$#8 M'Z"R_P!U_MAP/K`8#`8#`8#`8$$7SH"K^SCK\`)J"W&_W'W%0<`5$BX5EM[" M1VGVKJJIBH)%?^I%(8O_`%3`G#KG^+\'_0\7_,&^!6L#0WY./]!?L%_0-5_R MA5+`Y^,HQC=&.O8F'D0@+00/0`X*G?K80@>@!]A"@'YQP-\Y2*AE&[4Q3%<6>P-64>DH/ MHB+@RION)G`0EPK`B-<@A$.!&&B1$/MX$8YKR'/[@X%=P&`P/*FR9)*+K)-& MJ2KHQ3.54VZ1%')B?P#+G*0#+&+^03"/&!ZL"UI"EU>3MM>O;Z!CW5PJD/8X M"N6)5$!DX>&MR\$YLL:R7\@$C697K$>=8H@/D9JF(<<#R%TX#`8'6LBBX15; MN$DUT%TSHKH+$*JBLBJ42*)*IG`Q%$U"&$#%$!`0'@<#Q1,/%0,>WBH2.91, M8U`X-F$>W2:-$`44.LI[2")2)D\U5#&'@/4PB.!4<"TX:BU*OV>XW.&@VC"T M;!5@5KE-(BL+N?4J\4$)`"\]Q4Z10BXH/93!,I`\1$1`3"(B%V8#`T-NNG-X MZ_WPKLOK-2-(*5N;U4-0G(:\6.RT]-O:7FT;;L>>GFS6JU:<^M6GGMG4574. M=,YW*AS&_P"F"K.+!\AR0(BAK/J2Z$[=154/VJ[60]AAO;8W7[JAX,'%*H]GME3V!=Y'8I*=:[Y7Z^,7# MNI/7T>59NWDILCD&RKE-`3D$P@(^@A)Y@1,_,F@1QU8J**B0.$U=_:V24:>8 M)G>)K1MO0.T2,8Q"@HN502\B8H%#D1$..<"5UDDF@S:()("U21;())M3&*<6 MR::1"$0$Y3JE.*)0\>0,8!X^T?MP,"]K[!-53K/OVS5R3>PL_`ZAOLK"S$:Y M>LY&*E&5 M]IP,U9YN[W2PW:8D'K*%09-.']A?O56R**)C?HTO`@F,)A#D<#->`P&`P&`P M&`P&`P&`P&`P&!#YV73/*_)7U-9*:ZMLJ6%A(F40OD.=TA`0R[Z8MIW3:75/ M$NVRK1NG%I&]L'350RSD`/Y`8H"$OJ''MAP?W!]/(_AX"8PE*(")?3@?$0P. MT>1#T_<_LX&']7;#N]XG-I1MJU'8=;1%'O3^JTVPSDLR?([1A&!UDAN4-'HM MFK^(BG"B0>T5`$QR@4#%$?(`P+KN=[.:'TM5ZO"](*\];: M^J+)1Y&U3?=1-8;%-,8HAI^5;1+77Y&\A:K'(>^X7\7)U73E8_Z10Q^3!C3; M>K^U':?9G3K8TSHV"TW7=-;2C]@6)K);AC[!:@@Y1S4))TD>*94^.3CY6,1A M#IJMO>7.94QD_N\>0A+4!0]>0#U,(_8&!$G\E[B\%V+T;:I1<,?5X]I==.9: M5!\)+(%[+-H(P,8BR,04R09X`\@LJL4%#"X(F0W@'`G"6PO]U_MAP/K`8#`8 M#`8#`8$#_P`Z)"CKSKXH*?)RWNZD*KYF#P(>ML#'2]L$Q(;W3)E-Y"+_F#?`K6!H;\G'^@MV#_H&J_P"4*I8'=\:)TU.CO7PZ M15B@->L@'!PK[ZOO%O5J*N/N"4IA3%8#"0!^\4G`"(B'.!O9@,!@,!@,!@0G M?-X1=;1FH$&Z+U;6/8"KC#[@MCZE+QT3K*,W%J.63:6&POI6OV M"R2-6=/SI2CIM'/4XT[UHFK].@=$"A,#_G)]=O\`Z?-*?\:E&_XWRK7=VOY1:,K%[@)Z00CFC"T$>2*K&OR+R3^A:@X*"BB8 M$%/S`0-Y>(&"4?4;MUWAT MUWR35R9``,H8IE0((B/WL#3G8B7R';;U5<:-^SKJU76^QZ3.5E6>C]M;&7?Q M4=:X16/.\9M5M`F!'@`]1 MX`.<"3@O]U_MAP/K`8#`8#`8#`8$$GSG_4_LUZ_@4$_HOV@V_P!\1-^F!W^J MZ'T8)E\1Y2%`5_,>0X-X^@\^@3@US_%^#_H>+_F#?`K6!H;\G'^@MV#_`*!J MO^4*I8''QDD2+T;T"=(!_30]L654,0I%5ECW^V`=5;Q,?S5-X\"83"(@`?U, M#?/`8#`8#`8#`AI^:=)LGU_UW*!*R<-+QFRUBP[B/%9-*0-)U:9C)2#=NFSI M!PU)(P[E5E(,9)LD]CGC:09+@84'C%9-VU6`AS)G%%PW,HBJ!5""4?$P M\&`0^T,#U>0?F-_$/_)P'D'[OIQR`%,(AS]G(</U>1D;U76R%/:(T:.E7C2 MP/YD99U5RRB*`2C!>9>B"R+99X*@E;+B$>VRML=`=;;FM6ND^CFO[C4JO=T( M1/8-6WC>Y2/E:U]0Q.YG6#(@K,9!RV8.%!%!-T=!1=(4P5$OWL#/W<'7?QQ4 M/3&O]H=>JKJ"ZRJVU-!+Q@=PCQZC@`'G`8'`B`#Q^7^H(X'.`P(P_DK_\`P7_^ MFQI[_P!]\"3HO]U_MAP/K`8#`8#`8#`8$$?SG^7[-NOX`(^/Z_W`3%]U4I1$ M*RV`IA;@D**HE\A`%#'*=/GQ*4P',)0F(MEW2UII:R;$68!*IT/64G<5(L7R M49^)$K=65F!CPD5TET6)GOT?M`J8AP()N?$W'`A@_2O>OK)O):AP=3VK5S;" MOD4W>--G1 M;L'^7_>"J^GY_P#PA5+`[_C30%OTAT"B!1]LD#8C(J"BH>W5.GORPSNJ3<=]8V?7)%:'<*(RBC8HIB`J>VH<2A^4H1Y)=+N]38T>H M9WVU7032(D=DR[D:T9*M6:"I$?P\%#E%LU%1NW(*8HE73(02\AY`)`#WK=-. M\KMTNHP?]NH1H"1CH-I3NKKR47%1%`#"D1['QZ`'5>*@()>2*1""(`?.!67O3CO&JBFK'K=P62A5?:6:NN[.M)%PJ7Z9`?J2"1C'M44/J"* M>@JG4_2%+X\$%0X>UR,C('`DJY)W&US[RCG'MVSHZ,J3O;K]I'R:R!0!,( M^-_5![(%%WI[0A*S9>T$S*L8Y:)96MKW.UQ&/ M81K(E:2$G%#*GJ\[84VCM5L@"[9%L"1UDR'Y.0"G`,M=3>F]NW]I2+V-<>V_ M;JK69U9]D5J1A8/<#EU&1[BEWR?J38I'#E!V=VJ1"%_3G*I[:RPF,F!">)<# M98/C/5\TA'NKW2%,J)RK$#;G!E5Q%+P53/\`A@@DF4"GY(('$?(/O!XCY!J! MW7Z;S'670ELWA4>V?:&9M<'8*8F#>V[2?J,)(DM/-:P43&ATXN3^OCXR8.*2 MA%3B"9#AX"!O0+6T_P!(.S.[3O-B5SLQOBB:X5M9HY&M[@D=N5R]6R)BFL=] M=,`U( M2B.7$!*;"D8&RUQ:#IS\7T"*MSB'SN0CI:[)QQFWG[:"S-8HJ',!4RA4.N72 M/M_V%U-4]O5KN'>*C7K`K,)UR*L5@VPC+EA(2?DHB-DB`WM'TJ3:8;,0=MP2 M%5,B:Y0`Y^/(0V!F_BN[5.YV2DX3NO;HUI(IL6BA9BV[.GYI5B5HW0D"/YAK M-5Y%\'NE/["7TJ1?:\2&-R`F$.[_`)J[M0]BY."E^\MP#>)FXC@9_C_B#W MOXME9?NS:%E#"DO(,4&6P%6IW)0,8P(NU-GMUS@DL<1(H*1##^4H, M<;!E'LX-68_4?B$^[:'(W#W$#K"=4P3N4CX7.OMDI=1L3G9^Y&SB?K$!-N&[ M5Y1R-4%Y6*:/UD6Q%*:HH5!-1P($`QC"!0#D1'UP,OR/P_Z+>U\:VCL_<;"/ M>M*LC.@VD*<89I[2R/VM;E%"+5!1)BY81K\S<2-RIHJ<>X)/=.(`<_(P/(>9N1X_)S@29:WI2>N:'4J(E8+%:DZG!,(,ECM MCXLG9)@K%$J(/IA^1%N1R]6`/O&`A0XX#CTP+VP&`P&`P&`P&`P&`P&`P&`P M(1NU4-8)'Y8NG)X^'D562%7BI5R_3.LJV<,H.;NPRRQF_DLW2;0"]?6>J4V^26L;3,,T$H2^1+%.4?5QZW?-7I':4I+D;F M152%9+S25,`&`>!P*]2H66KE/JM>GK$[M\Y!UV&B)>UOT$VSZR2<='MVCV=> M-TCJ)HNI5RB9<#G`8#`8#`8#`8$$7SHE+^SGKX;Z@2G M"^7(`:<#PL4U9:"=R)O(``6IBE)QP//O?:''J$OU^;SZ^B+BE4F+64M1M3SG MZLQ;]I%R#"3L!*DY-#1K]C-D-#O&3^1*FBLFZX0.F<0.(!R(!^<+H(U/%]Y( M^!JYKZZ7;[`=.+%$6W6$/`+1M7+K6XK628MT>,-[VN+/#WDS"/8HL5D4U$'" MZ?DHD<3*!-5\G'^@MV#_`"_[P57T_/\`^$*I8%2^-\R1NDG7H44G"1`J1SA9L<0.4BZ2B1A#@Q1#TP(?](Z1[ MZV:Z[GAKSVUVIK][KNY(05:FY"C5RXU#8E9FXX9=O8(*/DE8N/05;D%(ASHB M8$#G,D*+=0IB`$D6D-=;2UW$S3/:>\Y?>4E(/&JT9*2=+KM*)!,FR!TCL&K* M`5MRS6VM?['D';*B7&KTF2AJQ7_U>@)MZE,666AOI MI`ZES;@U4;+`NDKP8O`@`@&BJ%*VJF]BI)YU3[\RCZ`3!&"=O>[5:*XAVYA: M`X;L58[:3%0K=XDS*FJ0XG*)!'@"F`IBAYB5S85-=VNYM>IO>VO1S]9_<[NQ M8]T(`D;89!C")-9":F4T-H+3DE)JP\2@D(D7\U"-DDRAP`%P/;\:%$VK8&-* MW;5[@$#UME)C?Z\;JU]>-BS%D5-8-@2H5H+!"R#Q[KI5Y7U6ZYS/6"3-PX.N M*BPKJG,8H318$:ORW`R_S'-DB[^G!4MBUL,?[YB%/];^OD"']Z@<0$SCZ,5O M0O)O;\A^P!P)$*X/-?@Q'U$8>+$1'\O]X-\"B;`UW3-HTBS:YO<`RL%-N$M79P5.H"KR?"69>J7%#[RA!1*DW/X@!S%,4/UBZC*!-4:Q*7T*77M+*4.1'@`K<:` M>HB(CZ!@9"P&`P&`P&`P&`P&`P&`P&`P&`P&`P(FNS[Z29?(+T_91RC=DG,H M*%FEU$&1UI)BRL,HNFQ!T=HK()E*#D`(0%TDS>YX@!O4,"5Y`0$H\`8`\@X` M_(F`!(0>!$>?7U]?W<#OP&`P&`P&!&7\DQ?-3I67VSJ\]V-._HTQ\3FX+-#] MT?!3CCCD?NCZ!@2:8#`8#`8#`8#`8$$WSH@M^S7K\8"C].%_MQ5#?4F*4%S5 M=`4"BS!,2+F,F5005$P"CP)0`P*B)0D=[3TROV[JS>5K/9=F5N%K6I;+8'ZN MK[2_KLS(LF5+>'?1CMJW,,;8V+UH4Z9F,@DLS4\Q\P#^$4(^>L52WQ9]UZ.N MUQT-N-MK&-=N+%6;]L'M>RV>SATG6O;##PDXXK2#\B,P_>QTF9F1-)N'TH.3 M<`4J9N`W/^3G_06[!_;_`(`JOV?;_P",*I?9^[@57XXA<#TFZ]G=-V[596IR M:P)M3J'0.@K:K`HU=$%59?=3K M?USL4=4-J;#;PMGDF;63_!641/S[J,B';LK)&6GAK\5*)P3!541]LSH4S+>( M^V4V!E74^[-8[OB)::UG:$;"U@9I[7IUJHQE(6:@YA@LJBHRFJ]/,HR=AU5R MI>ZB#ELD*R!BJ$Y*(#@95P&`P&`P&!J9NK7.\'^Y]6[:TLWU4]=5#7^SZ1-L M]H3=NB&HI7>9UW+,G$86J0$TLX62-3E"G%04RE`_V"(@(!073WY"_I#G;UKI MR9R*9O!LI;=SF`BI4RB03+!4TBJ$.JF/H'CP"A0Y^X(G"V;"P^0VRTNS5F0@ M>GJ2UD@)&(4=1MHW$B=DC,M5XYVBDV>5EVBN\:M%S&(N98J0GX$4Q`!*8/-\ M9%3E:#U%J-#G`;?C5)O>Y*A,"R7%RS_%*UMBX0T@+1P*:)G#47;,_MG$A!,3 M@1*'/`!(!@1!?+W3K`ZTF.P'UR?GUA76*E?G=6M9AY7BR]TLDFR1H=Y079JB MTM#FJV%-N*\3()';C'"X70,1R0OD$L=<`0K\'S_V'B_YBW#^S@5GD>?X/IS] MO(?OX$>VJMT4[3O4';F[XN"MLU6Z9L_LA:7U=E%8-E97+PN\[K^+1Z*K596+ M;I%D7*GTPJF`_P!.!!4X.(A@9`Z>=QZ[W`AM@RT!2IBEFU[9F=8D&DO-P,Y^ M(.'<>+\'K!Y`.'+-1D7@2%4`YB*B')#"7UP-C=I22L/K+8LLE8#T]6+HEOD4 M[:E''FE*NHQK\@Y)8DX=(IE98\(9('(-B@)EQ2\``1-@0K]19-PY[>:/C2]R M)SMTQ5U3LRZ-WLVR=B6CJ3M;H[&1BT[!+2[]VK-.GZ'+B$!-%Q&MR(K.DB*J MFX">7`M>[O:O&TNW25X*R-2H^L3SZX%DF9I&.-5FD6Z7L!7\>1!R=^R&)36] MU$$U!53Y*!3<\"$2/8^T=9[C\6W8V,8X`!`"81)+VO<^^8_N*F5^]Q]WR`H M"4./RDF4/$,$E%DVZ:C MV2D%F[-JFHNL0A14.4!.8`#U$`P*@U=-GS9N]9.$'C-V@DZ:.VJR;ALZ;+IE M50<-UTC'26062.!B'*(E,40$!XP._`C'^2%0II7I`TX[G:M53J#DBYVMGCX^I.'3V">%;&*M]')MDC(K"7GA,YAX$ M`X$/SQ=!82'I_P?Y?]X*MZ?\`U@U/`KWQVH*H M=+.O(+*%547I:[X52JJK`J61GIE\FH)U3J'*H';26D)*#.X:FJRD M)(1-7,=15\]:N`%10$&ZYDR^8;V?&B4MVJVY.QKZQT63M/8'8C>9LE6HI7'L MZX/5(P\2PIME7=-8QP^MK5)V=5XY4:E4<>Z13WW)3%5$)-L!@,!@,!@,!@,# M\D-PJ#59*\CJZB;-G-A2FR-PN+R^M&O;[:8*`DX7>5C0@8"FWB!;`E4[X:ND M:G>*%9/8QTHX4*NY;+)E(`?K90%8R29G!")KF33%9-,XJ)D5$A?<(FH8B9CD M*?D`$2E$0]>`P(U_EP\?\Q[8HB=X0?UFUOX@U;@NFS96-JH*(-A03/\`<35%/S3$,)474]KH#3S_6 MIO*M4Y"I16^M.KBB1P#61DZXQV+4U6Y3*D2439O7L6C*\B4#E34.3CD`'G`C M)WMU3C.GOQ8=EM61MTD[[]36 MJ5/K-9E;K,*V"XR<%"1T7(VJ<64754EK"]9MT7,Q("HZ4$%7!E#E]PW`AY#R M%W8%OVFJ5B\UZ5J5SKT+:ZO.-OHYFO6*,9S,+*-?<(L"#^-D$7#1TF19(IR@ M<@^)R%,'!@`0#WQ$1%5^*C8*"C6,/"PS!I%Q$3&-46,=&1K!!-JQ8,&;8B;= MHS9MDBIIID*4A"%````#`J.!%_\`)&[EFUCZ+?2(+'C#=R=;"_7;G03<)//% MTA'HI'52<'+]0W<._+Q(8/$@\\#XB`2@8#`8#`8#`8#`8$#7SJ'NR95T M"M37*^*+-3*J`Z51L=-3\R")&3)NNN0J[E M8B)?O*@<@8=7Z]U[K7W3U9LO7S+5#.$[#6-37J+I&,Y3X$4G`G((F$OD( M;I8#`8#`B&WS#[2ZV=P+[VAUO4-7[K-M/6=0KKS7=AV;6]:[$IZ]<3+#EG:X M6RG.VFX&50B/9.9'Q=*.G(HD()2'$X9IZ`Z_>P2&]MH3!]6PDYN[92%P>:RU M+8*[:Z]K)BUBSM8J'?V*N'^DDI^317.Y=B5-%$J@_HB^IAP)$,!@,!@,!@,! M@,#1WX\3K*];4E5U%E5#[C[%'%18YU#J";>VPO(QCJ")CB*G(B(B/)N?RX&\ M6!&-\O2RB72*[E)(&8E7N.MT540;>^$HG^M\,_F*`?ZV!5_$.>?7GU_P!7`AIHJ%3E^^/R0PVRF$2^H\K0 M=-Q,E"2)THMG8575;B4XN**JS.E+.96;9CP>/USQ[M-/V7(***"!O+T"72B739-C^)+L3-;#?;7>7)-&735F-M)*M M&KQA)2=8D(M]K=95HWD5:X,+*HG074\A/,>\9(X)>'B%I?'5KRE;AZI;@7C( M"(KG85D6[ZAIFUI6=LQ7TJ_N-;6G(%1)Q*.G$`WGV(RAVGA'H*.P9,D3JE'D M.0W`ZL[:M,G\79)5I'7&>NM-HE_U#'L=8097MUCY2O2,O1JLYB(XLC&D?2D` MP48N55D%R'/[)E"@*GW1"(^K7WM7_P`W9MO5A=(V*W:BFK4YC)K;4_8EB6.L MROZQ4ALSK4939%4\_)()3;%JWX32$H.'JA0$3$-P'Z3.L&VJ!M?5$`-$FUI9 M2AQL!0;BU=PD_`/Z]<(6L0BLI`2#"Q1<4\(]9)O$A/XD,0/,``PCS@;$8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8$0>[Y2AL_E)TE&VIG)*623UM1%-?+,(6*EDU M)QI8]KDD$9&0>&/)5J,;QS@'!U612G7%$2*\D]0"7HIO(3!XF#Q-QR(<`;T` M>2_G#UXP/K`8#`8#`8$7?R1S*;2U=$H=9$XH2?<37SU1TDX0060&,(LU32+] M4@NV,1P>9^^)N!`I!`O!C`8H2B8#`8#`8#`8#`8$#GSID6&A]=U2MDC-BW2] M)JO!(`KHKJ5Z).W:IJ>0&*B[315.0\0`0EGVIH[6F_]0LZ)M*+^ MK@SQD)),I9JZ"*G:O+1R+1VQL%U--.[`V22>UQKJ5TQ;JTTE+!7:BC1&PJ;'J$NW0421AI>SH-'AF#I:9LFRX5SKDFPH)E$6-XFUJ+,MH0( MZ2,YDYF$A[&X6;,EGCERJ")?$3@?W"@$L&`P&`P&`P&`P&!^4D^DMG;,H[J; MTC0>U:]Y0W=M!&>LD!8G2>C+1')[R(@05TO:54?OFK1%K)+5]TZM0'?1:;Y,Y"* M`(\\>O`^@!>C'Y:-"2R`N8K4?:F3;`H9(7,9I91^@54@%,=(5VEC62!4I3@( MEYY`!#D/7`@L[+6>=W=VLV/L:NZ_[!1>M-C3=8L;V$;4>>K]W?Q5"J4.RRE]@]_U*ER]9E:O;&-$ MT[;+)*7*LV(A8FQU,X'DJD6",]@7;DS64!1PJP>%2531\RE.4+Y[*4_4%JO% MXD4D45-D@4@& M\%4Q$PB&9MC7/3Z^E'5*U51NQ<3N4*?8:G845M)[&-KFZ4RU2+46A'5*N.U[ MZ:D33(:\@9I+M`422=).CI-A.*(-@U/UU38]O3UHFZ:X['U.[Q=L<6B#N]&H MELE&TC#_`(/'M4:D[A7!H;\"G6TLS.YCYUN9068N%/?0=%*DD4-XNL/:&_:, MZ7;=TI8.NVVK7)SLK9(RAK(ZQNR-6]N_1R25C1NMA32;."K1YEUW+1!JB"S@ M@>V95(#%4*'56.V1$?CFMN@KG&SD9M%:2<--:L4JA>6;668U;86M9J-C7\W] M$"RLU)OW,DF10LBH[$6)TQ,W-],0P;2=0^[]%Z]:K"B7#6?82PO#S#B::_J5 MU;EZPUB49-JU5=PTD_D;S/2UP>,)/WRI2;M8%CM`12\0*D7`V:??+3H")307 MF=4]GX-JY>-(]%[.Z@3A&!GKY8K=HV^NE+.T:%675-P4HG`1`!'[`'@)12") MBE,)#)B8H")#B43$$0`1(82&.03%'T'@1#G[!'`^L!@,!@1HR/RE:+(YLJ=9 MUEV3V`PJ]A>U)[8J+J-Q-UA:R,0'W8E*5"90,W=B;_J;A)%7Q$#>'B("('GR M9U1NZ.S0ZK]T'+C\3;1J")M&.FJSA1:--)K<(K3?FFX;MR^0(C^D43_2%^[@ M?#SY,8&.8&?R/4ONDP125$K@[G2"Z2""1A;)MUCN330)?WPX6%,"\\@)0_V0 M8'*?R3MC+%(ITV[LI(B7DR_[%%3B0W(_=]HLSYF]/7D/3`Y/\D[4I4!3Z;]V M5#'`GU!?V)JD^G\@`5``QIGA?VQ$0^[_``N/3`Z''R;UU&13B"]3>YZDFNA] M6W8&THHB\79E4!-=TFV/-^Z**)O+D>/42\?EP.Y?Y)VQ/'V.FW=EQR)O(!TH MHAX`''B/Z29^]Y['_$W_`/UG`X1^3%BYX,VZ==U% MTR.%FSA1+3)C@W6;F*DY3'QFA\U6[@%$S%#U`R?[H8#_`)RL?,X?YEO=42`) M?;,&G3^9BBBB8XJ$-*E*F)5S'(``8_($\N0\@``[3?)2F!$Q)TQ[L'.8#>Z3 M]C!B^T(&X('F,SXJ>9?7T^S[,"G)?)A(&;"=7I#W/3=^Z)0;DU2=5$4?>`H* M?4B\2,!Q0^_X^UQY?=\O[K`Y2^2]^=98BW2/N:B@7ZOV%PU2LJ94$VX'9>ZB M1R!D1=N>4S\"H"(<'Y/Z@`1Z[$WE:-O?(/UEWK+Z`[":PJE%C"Q[Z+LVLK?* MV1\QKKFU/YJ6AH*LPTE(2+!O^MC)%P5!-44CJ@*GB4Q1$)E_\]/4G_>KV%__ M`-8=_P#_`)N\#Y-W4U*!3"6I]ASF`!$I"]8M^@8X\>A2BIKTB8"8?3DQBE#\ MH@'K@5GK!V?A^S$1?5VU$N>M[+K*ZO:'=*C=6S9.2B)UHF#@&PNF2BK-=<&I MBF63*/D@8P%-SR`B&T&!9M]MYJ12K)<6U=L-R4KTTY1$1%)8ABC]F!7\"*OY*46KJ]]!FBJ#M5PMVXIZB!F M:*BRY2-OIUE2`1,5.2G5*D8X^R?A,AC>28`(B$JF`P&`P&`P&`P&!`[\Z3@I M:)UZ:'.J'O6Z]N4DR&$$CN&L+`)`=8G\`WMMGBH%'^$!C>@\"8!"2'M;?=5T MOJQ<([;=Z?:\KU]UG-4=I8(J,=2DO^*3E/=MVS.#:I`FULZBO<$A&)TR7; MPZVL:3(H2+B0D`5]\QY-%LFFD9$Q3)!,=\FX#_F*]@^>>?P&K?EY_P#G!J7] M7`K?QSE*7I1UY\7+1V!Z<\6%=EY^P)UK).JJ)&\SJ"#IL0.(L7"JRA^3E1$ADP3%$+U^/ON-J>.?;)T];>Q:]IBUMUG@N MNSC:$L_>7JQURR)MC-(P\O(%.YDFP3CH$&BKH&HG5,`P&`P&` MP&!P(\!SQS^Y@6\6W50[07X6:O"Q!$S@7A9N-,T!N0@J&7%R#GV01*0!$3<^ M(`'/.!`/U-^1QGJZ0E1;OFJZI@('D82II* MF.(%*'(^GH&!!C\P"K**FZ?9E8Z_O$6=`FHE],-W%V)K>JSIWDC(:\>-RU&Y MU5JELMW:/$I%7R;M%HR!)<4E/$J2@3*:84I2NI-:'UPI'+4$:-5PIZL1Y!&* M5XD,S)&&9`/(H&_.'/.!DS`8#`8'SXE`PG`I0.8I2F-P'D8I!,) M2B;[1*43B(!^3D?SX'U@,#77M7"V*?TG-1]4@W-CG"W+3\FVAVK1X_4* MN51[=;754243\2HJ+MX`ZARJ>7"IG(_?-P`<#Z>N!*W@,!@,!@,!@,!@,!@, M#5W8R#E7M;UA40<^RBVH?9%5XB*XI"\0.CJ%!-`$P24!S[;I5-7Q$Q/'V_+D M?'Q$-HL!@1@]T^M/6ZN467V8XU[6H";NN^=(/=BW4KU]&/'+"T[EID;=GSN3 M4E6R$0WEX-VX3?*I&;D%%10QQ_+@:1ZLH/4_0^]Y'K-OZFU/8D[/258G:AN* M0NUE/`.Z;98#8-J_')B,FYL(&H1<`E76,>H1BNL@NL_34,H8A1\`R'OACT1E MM.;G3ZNU^B.MQ:TM&I0CY&N,+4[CV\U:-AUM2/DF$V@#R)EZI(-`"BY^G:QRB"1G)/;-[I%`]2^/D`2FX#`8#`8#`8#`8$#7SJ M-_*B]=G?Z;]#1?;X,$M&YVT MT[ZS[(0K3!E*V-73=A)`1ZK[]H^93"3Y[X)"W62.DIY M\&#Q$<"&'0]TVJV[H:*A)S9_8NQ1MM/7KG5Z?;=>PU$AY'6M@U%>4K/*W&)K M2K6'@7U&NQ6;)-H4ID5&ZA3F*"P("J$E'R<_Z"W8/^@*K_E"J6!5_CDD%I/I M/UZVX$Q?,P;N=#]E7[88]@-?[H;TJR;"T#NN5U\^V! M6*G%5II;BH-RKMI`\0Q8M6[-Y'F:BD0Y"D,9N"/F'N%,FAZU825K5DL6Q&@I8L`939E_(F6:%@N$4)SNK$NU(0K M[VQ$5$SI@'J8HAR&!&7ICH[W`UC9M,7QETZI;"SZVME/MDM98C?Y(RUVYO!+ MD6F(25CY;84]38PEE1\DW`-HXA$S<"0H$\DS!EGMWIZ_,X7<'?#:6DX[76WJ MIMWKM,:XK+_8C?84>:JU(:C7I=E+)T]9K"2"$W.H%,8%D4W*;?S*0Y>"F,$P M/39TH^ZH]=WRH$*J^T_1'JI4B^*157=?9.%"I%$3"1(IU!`H\Y#VS^2)_<]L`Y)^ ME4(/D/'B8)6/!N`4\N`XY`-JL!@1=?*[KW;NR]$U"L:WF8J/KTKM&DP&P(R4<*-DIQ.V66 M$J]&3451B)-8D?%WB59NW1RF2%)%+W/TGC[9@AOF/C`WO(;:L.FZ=<*+<+/1 M*[K61M;IZ_GH!E#1FPHFXN6BJ2L@A+J.ZY"NJ6HT,9$`747D$O!J5+W11#&! M>K/[HJD^F*8X39?(%/[KT)I#K[V1A+G7&VXM*M4:-;$G\"%D@K5* M;6K];@[>^9*.W$-F:;TQW:;9-=^2I)$KK MI,_]I,'K7NGJ1!L[$A1701>?B?U2*1S`(E3R0;Z0K\(,LY47\53*1X)^VHFN!TPWN^3CUZ+=@P_]H*K_E"J M6!Z?C45]_H_U^5]PJWE7[&'F1'ZF*K*BXDG4 M0>4<&;GW'9.S;0"7ZT7^V MR'W7$S,&3.MX@DB`)HIBHJ*9`]3G,)C"&Q^`P&`P&`P&`P&`P&!'%\JZ9#=/ MK$JZ90SV);;"U,O.EG7<#,51/L4\C>`O:%.1BD[:L37)JLK,*OW%'_"8HZ"]Q+*%*@C9QFSO2'(SY M;?3$1$!\Q-@4VZJ;=+9->)Z[;Z\/4E)UP.U7-R7L19YM64TD!;$H;:%(#%>< M<+"J!COU`02`I/NG\C"4,DX#`QM`?M@'8=T&T_LV+J@&L2&NRP'ZT'V&9][" M7XZ>Z'D?"MD:_5>8-",2F/[?B*AN>0$,DX#`LJB#L88M[^TU.DIS?XP^_#@H MBLZK%_@`^T,:#T;`BB[_`!@G)RKB0/9-P4Q`+R)0"]<")WYDO7JK5")J*)/5 M-^:V3C%$_;$22!F-J]HXI*E\%_;3\S%()DP$X`(FX`0$-I8K178YIXJN^ZNP MWAW"C=9XBOJ#1)2$*G[!5&[`@4YR5A[B!#@81.X#W3>?J`>(A<(Z5W8;W$3] MO=I`U5^K`WM:ZT(F_3!?V/I_8??LP,1(S42J^OLCY@\:]U,Z+$2;R]C6%W;QG!4J*]YE$QCQHNZ4,!3+ MC[@E,0/ND#3.`^3OL32K[L.+V1MVX;!@6$-8JU75:[1M?41Z6VMG;5LUF5XZ M4KKT\2DS%NY`OO?5^)Q*91NL4W@0-D:QL3OI<>NMJ[-N>[4=3JC4H1^I)05C MTA`PTJL[AV3/Z-I'*_@*[)XXG9!=!H5Z7]"9TL<3%*4,#9/X69F0G>O.UY*4 MDW$A(2.^[-,2":R0))MY*:J]0D9%9+V_%N)Y)TL9PH"2:9"G/X@'I@3%8%IW ME.\JU293UJZJC*\&02"ONKNQEI*K(N?JD/?-+L8)_&2SA'Z'W0("*Z8@J)!$ M1*`@(72F"@)I@L)#*@0H*F3*8B9E/$/,4R&.H8A!-SP`F,(!^4<#[P+)>(;% M_7V(HST0\AIDUX&S`X,>-?P\\A-%@RPIVQP(X;+QYE@.3S(MP M;Q*%[8#`MFKH6]NC-!<9&!DG"MFGUX`T!&/8Q)E4%7ZAJS'2@/7[\SZ>9QOB M5XY3]E%9;D4TB%X#`N;`LZ_-+X^JK3]R1TR(HD4R;Q,4CG!3Q.!?`P7,P(]38LDY)9NYD2-&Y'[AH@=JU< M/2HD!TLV;*+.%&[=5<#&(0RAS$*(`)C"'(AZ\#7/=&J=CW&ZZSV%JVZ4>GVC M7D7L"&(I>Z')WN/@VR(N4(DJJONYV0\>M+0B)7*8%`RK<3D`Q!-Y`&AW6R?[!TF^=DM`:UV MMUQ;[0UG<8R&9NML0-R=7?L%/2,1)V%TJTD9?<+^5C64"0%BIM&35TR;&7,I M[2'NJF,&5MQ_'WV#[4-J[!0(S>BT]U0P>Z!O'`Q1"S/>;1\WI[JC M!V_5KM^TU3K9Y&+UC2M@LR$'%%G5:)/1[R>L&SJY%RD;1XV(-+/7I@;R#XB@ M`W9>(&`@=_;70W:O8TQUCH=^[*41,\YNDQ*I8J)IA]5)JLW.NZUV-;HVVK+N M-BSGUAD4(4[8J"`LRD4537`?)/@P5I/H7WE2`P$^2S9'WTCH#[E8F%Q]LYDS MF$HKWQ02*^20<*%X4*'(`8`,8!#[3Z%=W@]SW_DKV<(>T<$O:KDP407'Q!,5 M!->SB*/V^0%X,/IP(8&'>N79U;KAW'MW6C=G::[;YAYAI%51&\W0I6-7I.T6 MHJN_P(#OIF;?MTWS)PFQW1$0LFWEI*LH4MZM.,HM=5PT31D7$814J!Q53`JHE'R#[<" M%+K'2^S%3[.=>97L,3?RVEI>T6MEUXBKWLRIV)G6)E?75H?TH;4Q:3\Z^=/4 M-9EEV:A"(ME$W)DN%C%`Z0A)+\FX\]%>PGY!"!JP?;__`'!J7Y<#V_&P"8=( M]`>VBJW(-?L'"*Q`3,02W2S$.)4P]")JG*)R_;R!N?RX&\^`P&!8>T-AU_4N MN[ILRUJN$:Y1J[)V28.T:N'CGZ*,;G<*$0;-4U%E55/$"AP'`"/(B``(@$3% M8TQWN[:5VN]CD^X;K0L=L*/;6RDZFU\TF):LUVIR":3ZLLI>0;3D`WF)=5F8 MGUYG#)805$Y1$P?<*&W_`$?WIM3:L#M.A;P:PI]LZ"V$MK&Y6*N$%"!MKUHQ M(NE/1S;Z-@5('92&,H8B*"1SF$2(I$`"X&\F`P&`P&`P&`P&`P&!'M\G=T"OKPS:2V#M72U(0<3;I1JU;KV/9==8,ER"B51=8R,DH@94B::IP:@J< MI!$N!G;IPU.PZI]>6"IB'58:BHS!4Z?E[9U64"S:J'3\@*;VSG2$2\@`\#ZA M@;)X#`8#`8#`8#`8&A?R5Q:4IT^VT9=LBX)$,JU8?<.*0.(U.$O%7>2,PP,< MP.$'<;#%N&;ER=)V!D3>151!01`1'\^!?F!#7V[U%NG;?R%:7<:-N%:J%OU-H) MKLPCBX/[$S@W\>GM:4@Y6`4"M,GTB9O9D'A&CXI/9]YCYD%3GQ#`UCK?PJ;+ M"[$G+QLG6T83',4P9,^'5&3;Z*KKIJKD24($PP#S_T<8#`X]!_=_K?V\#17N;+V M>#NG3&0I]=4M4Y_G0,8\L.BL*"@1,SJS9O%;KCYW)"7[#@T$H^@X M&\A?%L@)EE^2(I^2BZYB$`I$R!YJ*'^Z4I0`HF,(^@8&("=C.O:RQ&J.]]-* MNE%RMDVR>T*0==1R*OM`W(D6<%0RYE?N`0`\O+TXYP/SU[JT':;A8?59N@@57Q_6^_@)@,((`(P,$(%4+Y``JF\1\!\1X`#>H<\"$N M>W8.PV;K;L:N5*)0GK1/:9LT-785U]&+>5FI.FNV<8P6"16;QYDW3Q8A!!V.IY:ML9&&B7SIY88R MNU/:$K=/JGAF/TYT48U0Z`KF.8Y2@<^!*5\C<+&5KX^]U5V&;`SAX"F42%BF M@'44!I&15WIK%BV!14QU5`0:H$+Y&,)AXY$1'`J_QEE.7HSU\*H!@.6!M("4 M_/D4`O\`;?$.!]0`"<5=C[2VW=WFP]F6XK(8N-?S[I`K1%&*C3*K'20;M2?I5U#>ZZ7.= M4Q4P$J9`V[P&`P&`P&`P&`P&`P(^?E`EH.(Z>WE:PUE>VL'%EUXU3AV=A6K4 M@I('NL*M'+1[UHBM(.'*3Q`GZ!L`+&3$Q@'@A@$,W=,O;_S3.N'M%7*G^QC7 MO@5R)3."E_5J/X*N8I"%,J']T(%#D?R8&S&!\B;C\G/IS_T>F!]8#`8#`^3" M(`(AX@/I_"^S[?7GC]S`Y`Q3<^)@-P/`\"`\#]O`\?8/&!S@1X?*->FM+Z@W M:-78/7CO9DS6=7Q"[)R+,(N5L,C^(MY-^Y*!E"1B)(,Y52`!@6$Y4S%$IA#` MS#TTU'L?26EVM$VB>IN;.A:;E-*2-6E9:=/)H62RRX'H+9IZD)ZZO#JA/I^WH M[1EVMH7VSD>ND&16C6-GSOX=H]J:QVJP-5&I#-B`03$,L90XE#=@-P=:-=HVH*U0K)0-H;XD(H:\VDI9U9(&%J-3IDBWD7'T+F&=5HFV'#Q M`Z:HC]:V2$Z(\%.0,5_$)$NX'3F]X.1?2TE*PO:#9,1)R$HU%K^(/HN-K#%S M)%(8RB@.Y%=`RSHACG%-8XEY'[<"6?`8#`8'6*A04*GYI@8P"($$P`H;@!$? M$O/(@`?;@=F`P.`$!YX$!X$0'@0'@0^T!X^P0P.&3.Z3C9`[$HF?$9.C,R@4IA M,[*@H++L+I%_MB8[/6&B[3BI;8U-;ZO6U- MJ1I6T+/4W+R.C6%R;O:JK/PSMQ(E(5T!P(L@F('*F(>(F#3+7^P9:BM>_P!K M>\;[!IV/VELC1<&:QPT8[UM;)::[$;5ZMU@UQL M-A:K;,7SKQINW2^T4YF.E_&X7R>;T=E%W`91TQ.V=/Y(AG*CP[M18_WP]@?` MYP"XN\MOOK*P=4'.CVVN[3L9KO.==U^.NMJ1C*THX3TQLQNY)+J,72#XC4T2 M[='(J10@$6$'^UO2W5][7KDC,Q@IUR7M-TBG!4T MFB+AA/E3M*962;U!Z)4TU4SINB@H7^X$!"(75,2;>FT-IVJRT.7>QEC@9YS- M1VFZ#0'(5N.866"D.S-WQS+#]6 M3AN]?"@#3VSW>Z@H8Q^'_`"6O1ADR()_W M3(P@(KF_N5"HA_=8$H/8*\ZWI77.>;;/V#'ZR@[[2%]:1]J?M9&1,TG[S6'< M)%BRBHA-24DG3<[@S@4T?$031,8CXA_"*7@#`!@$,#>K`8#`PYV&JDG>=$;AIT)'IRTS9-;7*'B(Q85`3? MRKV!?)1S0?:6;GY7>&(4``Y>1$.1XP((JEW"I32'^/MB;5._GCOJJA(H[).S MU4[=>^9+3)F5]X&@`W`3C]X`((37=;^T%,[/PUEGJ54 M-GU6/K$FRBG!MEU`*BM).7K,[X#PJ/XE('?MFR(%!53[A2F.4`\O7@-DL!@, M!@,!@,!@,!@,"-KY87L1']-+6]E!=%6:WO5CF'4CGBL;+I2C>]0S@RD-*IMW M814J6*2=>RY,F\3#P40V(Z6`4.H_6\2`;@^F=?JB)Q\E#&6KK%4YU3\ M![BJASB8YN`\C"(_EP-G<"D2D.C*G8'5JVU9-RH4WBJFBE]T!*(B%\8'R8H&#@0Y#D!X]/7@>>!Y]!`<"D0D*W@ MVR[=NL[7!R[7>J'=N%')P47$!$A#*F,)$4RE`"E#T``],"LX$47S&ID5ZHUY M)14[`&4`#BD41/X'\?$0V.8=0'[=N MR!'MQW$,DB@?P\MM5N0*<7"211/]4\UXLLZ3*0OZ/W!,!>?(@%'UP!NFRXF$ M2]M.YY`$1$"%W3'"4H?D*`J4HZ@@'[IA'\XX&&;]\7&J-H6>)M=^WAVAMLO$ MQ*D*D_GMG1$A)#'@\,_9M$)%6H`LR8M'BJJGL)`5)1103G`3XE5:,.0RICN4'R=53=.!$RO)$EA.W3'G[@^0X'N2^ M'+JTFY0ZIR;Q+SQ@2X8%B;-UY!;8HECUY9EY5O`VAHBQDU8-^,7*@W2>-GOBT?E35. MU,H=J!3&*7R\!$`$!$!`+[P&!25(=HK+-9DY5?K&C95JCPNJ"($6Y\SF0\@2 M.IXB)0,("(`.!5L!@6+0]>5_736S-:\,DP7676F98&H MG*0K2.176!-N@0`*DB0H?>-Y&$+ZP*;*1;29:G82*"3EDJ*9U$%"^0&414*L MB;U].4U2%,'[H!@>QLW1:-T&C=,J3=JBDW02+Z%311(5-),H?D*0A0`/ZF!W M8%BS>NJW8+Y1-C2)'PV773"XQM;40?*H,2-;TVAFL^5^Q)^B?&.E`M_9$_\` MN1BB(>HX%]8%(GYV&J\+*6*Q2C&%@H1BXDY>7DW2+*/CH]FF*[IX\=N#IH-F MZ"1!,8YS`4H!R(A@1<=9>O=,VTX["[>CK]O^@2-Z[-[D-)LZ-LBXZR;O6\+9 MW#*%5F*JB1FJTF&C%3VE!63*MZ<#Z`&!@TW3[KN;L]W`'9CS:M,RK.MWI9&9?)HT=B=JDJ54$3-"E2*7GC`QQU]U5\2' M9#91*'3F&W9Z]3<;.V$@["L6Q84;&X*[0D))890LJT(\L!"N3JE()BF52]TX M@KU[4S>?@KU6M[C:X^[2,C>(Q^YJ-?ISN`EG\;9GS MR/069+RBY"';H`;W7)?N\`!B!E7475?K5+]@.V]=E-#:F?P55LFFV=:B7=$K MJ["!:2FH("7DF\2V48"DP2?RCE1PL"0%]U50QCMEW_8KP(&/D7,LUC&:MXL4\:/:IR+Q57Q0]L!.<1'GG`SU@,! M@,!@,""7YT4B#K;K\N+=,QT[_;D2O!,`+(D7JZ"AVI">(F,D[,W*3.?V5 M+'5GKQ)^SY34.FJG[J9%#)>RJ%BP5YVMVD[%:`G9#J'LC2D'HRQV2\2.S-NH M-X>0=1E@UY8*B_H]<8EBA=KN)*?FV3E0"N?841C04.!3@0@!EGY-N?\`,5[! M\_;^`U7[1Y_^<&I?;^Y@>_XVD3(](^OQ#`N`FKD^M_?)TE%Q!Q=+,N43F1,< M@`8JG)0$?(I1`#`!@$`#>7`8#`QMN+8;?4NJ=B[/=QZLJWH--L-M5C454VYW MI8.-<2'TPKJCXHIJB@`'.`&,4G(E*^NNSY+64CL9NU;107UL51\]BI8\(T9M48]5O#@W24/R M<[A8#F-R(>XH&^6`P&`P&`P&`P&`P&!H9\D"%/=]:OHMA/ACZ$]W!HEG=ES^ M^DU_5%QMFJ)V3ZZ1:(JO(=FE"BNJ9TB9)4ADP*4_)@*8,N=-#(FZI]?OIBH% M9DU94D8_Z9T9ZB:-0C$48U0K@R:1SF58)IF,`AY$,(E$3"'D(;+X#`8#`8#` M8#`8$47S'(.%NJ-<%GY@^1WMK51@I]WV$7QV]E;-5G@&16`S4BS@.0]/O>/J M(?=,$JC,KHK-H5Z#E`W(`?96\WG6S54&,[/;@L!V;Z0DVT8A95QB#&7+'Q=C-&%!RP16!NHB()J M>X!""4,Q:1Z_UO1GZZN8JW;)OL]L&:CIRTVS:=L-<+._6AH9K`0[/\2%C'%* MPBXMH5)$HIB<"^ACF`"@4-,/DL?>W-=&XQ1HY,T>]R]8.UY%+D4F9X\[A-!L MH'LJ%]U\+\1)R(#XHFX`?M`)1L!@,!@,!@,!@,""7YT3F#6W7Y/WFX$-?[!`P2_WN_!JO1MIV8:&=V$M` MUE)W$T$Q.*3N7+7*TK+#'H+%0="@=T#7P]SVU`3`?(2B`<8&IO6_?78S;2NM M+7<+ATT;Z^O[5Q(-X.BV"^R&QY!(&CPY(ROEEY1*$>OF#A`1=*$(N4I$52^V M4P#[85OY./\`06[!_P!`U7[?_*%4L#U_&N;SZ1=?C>TX0_[G)XHI.E#K+@`CS@?GHU+L38[&]6OKOTQ[]Z] MB]4:]6LKVM1V\J6R?/(*J09E74TTIMZD:_*1=XJ];8-'+ILJ@LV138(BJ<"$ M$5!#?_XV5-,!6MSM-7WN>W#;&VR55]R;OFH96(1VC?)8LA+*2D,=61D?Q*'C MV[SVV[@HIE42.4WB(B*APDOP&`P&`P&`P&`P&`P(X?E:*4_3*Z)E=Q4>[<6[ M6[)A(S#Y..:L%Y&YQ,IV-=ZWD]ISSRLU91N@FLS&69LRO/:D5!<)KMDW(*$22.1-0HK'*4WCY` M(AD[`8&.V>V->/\`:DYI)I9VB^TZW1X#9,W3RMY`'T?2+1-3=>@9]1V=H6+4 M;R,S7'J!4R+F7*9`1.0I3$,8,B8#`Q%IO==-WK`SEFHR.7!F)#.RD*=8B)S&`?N<<"(9=P(E_F$%XL9%N3=U M`,L*11,Y,C^&6LK@&?Z0B8.B-C'.43@8OW!#@!X,4)5H?V!B(H6IECMOPUC] M.=QX^^=#Z5+V3+^/W?>,GP)N/3RYP*E@,!@<#_KA_9#`_.=TS[P:MZDM^PM& MVA3MP/9JQ=C]D6Q@I4*)^,,"1:Z[.(3(YH@` M;L-_F#ZU.UTFS77?9)TY74*D@V;:H;+N%U3B!2)(()6HZJRIS#P!2@(B/V!@ M?!_F'ZS)B!5-?]CDS"'(`?5C,@B'(ASP:U@/'(#Z_N8%1<_+?U]9*E0>ZH[1 MLUSHE<$0=Z:%LL=N8QB%7(DO92*&0,/-J/M.$ M@[0%RT8#I?M#`ZT/E?T:Z!46VFNV#D$5U6RPM](.%P1^P>,"DO?EFURBJ)6/6GMN_1Y,`+#J=%F(@'CXC[2\_P"8>7(^GY./W<"I MP/RQ:/=7BL4:[:PWYJAW:V82$8^OVO5&Q5F"J*AF;YK"0C^;M4JS?N6ZJ"2K M-@NF)TS"(@4!$`V1#O1UE'U"YVP0'U`0TQN_U_\`LYP'^?/UF_[\[9_Q,;O_ M`/-S@8-[*=S-#VS1&W*14GFP[;:+QK>\5.NPT1I3=7F\G)VMR,;$MG#I?7[= MLR2W]"?O7K M@5DT6SB)_1,6XN"J)()JN@E53IE.;R4.@`%`0\@$)2L!@,!@,!@,!@,""#YT MBI*L+(FPIKMPI"2,:DHBH^CI,B8HN$BG*)T3 MF#G`AHZL*4>L=C>OTS#WKH[M&2VC,6B,3J&D]25J`N.G!4IELLWXO7K;%LHZ MRJ1\BO8/CU#\`JW^4&I8%5^.%PY<]) MNOIW:ZKA9.KS#0JJQ`3-].RMUB:,TB$`3<-V[1$B:7J(BF4HCZX&[^`P&!AS ML0WD7>AMR-8ANX>2;K6=T;LFC4IS+.EUZ^_2(V*";AJ?Q7\O`_"J8@01^\'V MX'YJK9O#IULO2G0#5-FE%JU'ZH?E)OXL)5K&BYCX/]6A2L#5&9C8J?ZKS4U#3%%#/7@/W"BAXE`RBQG(++\IK'$3ID\N4DS%((%$O MB`;48'2HW16,F=5)-0Z)O-$QTR',D<0$HG2,8HBF<2B(1'[1'`[<")GYF%!;]2H%Z4J"JD?O'7CU)! M=-10KE1%A:?%`"IB!>%/+[X&Y`R?D4/O"40"5:)7,ZBXUT=(B)W,>S7,BD42 M)I&6;IJ&23(/J4B8FX`!]0`,"H8#`8#`8#`8#`8#`8#`8#`8#`8$07:9T[8_ M(UT\33?@@U?L6HNT!CHIP"[E&Q3$:W5^H>,W+Q%8K9RLFF9-0ADP74$H\F'D M)>$0$">/D)P*/!3&'R,8.`'DQORB(C@=N`P&`P&`P(Q_DF0=N'?2=-!9$J`] MTM2^ZW4(4IUE2$EE4#D='73(C[2:2H>`D,*ICE`!`0X,$G&`P&`P&`P&`P&! M`C\ZQ$!J76]0RZQ71;/L@B38J)A;*MSPM7,Y<*N/+Q27;JIHE33$HBH54X@( M>`@(28]J&NPR]7+E8-;;2FM5S52U=.V-Q)PD#'3;J49Q527>GCBK+MU)B"5$ M6_)'T:H1VVY$Y`.8I0`('M.[KDM-[(TSMRQZ6VO6FC*4?.[+,1/7.DZFCK?7 M7M!F'EF:MY&BT,;%=&42V(O*D:K._:>C%I.UDVI?-1J$QGR'62$N7QY;HM=: MD&\K`6.G4F8AY%LOZI3G.4]?L9BB[`8#`8#`8#`8#`8#`T#^2ZVO*#U8D[PSC64R:G[/TI:5HB135, MRE$Z]M.JS*<*JGD0YC$%8"$`"B4P',`\\`("$I]>$1@( M,1$1$8>-$1$1$1$62/(B(^HB.!6,!@,!@,!@,!@,!@,!@,!@,!@,"*/L_6I& M9^03IQ(M&Q':4/'2TH[1;F6<.TX^+L9B/I%\S;,7";:-8*3;3Q7=+-TS*K%* MEYJ_X#_`/-*4H@']0Q1P.W`8#`8#`8$9?R2G]I7I4I]_P"[ MW8T[_`$I3^I9HOH)R*%#[?RE'T_?P)-,!@,!@,!@,!@,""'YTGJ1->]?(TPF M]YU>+H^2*"1_#PCZY'-UCF<`;VRF+^*%`$Q+Y'\A,!@!,P&"6K;SZLQG6K94 MA=&CV0J#/2EL7M$?&R2<-)2$`G27PRT?'2JJJ"<>_?,?-)%43`!%3E']S`@W MT5UV[I;-"LMNV_6)IQKIG;*)/PT!9WL.QL\T:QO#UJ M>(?F``#\F!O5@,!@,!@,!@,!@,!@,!@,!@,!@1W?*@FFMTNV`W7:_ M6-W%JU4@Y;C*-(0%$%=F54AR#+ODU6<853D""X5**:`&]PX>)1P-)NJN^?D% MJG7?4E!0$`Y` M.!#`SLKV6^5,Q7`(]$J*F8ZJ)FIE=DQ"Y4$2^S]0FX*2Z-Q=JK>*G@T*%P8M M`3`IQ%8%"J;1>"L*A/0H@)/`?4?/[,#/5&[+]R4ZLQ#9?1&[.[L"LC^)'H6P MM3,ZH9'ZU`@4`L"V]F/D<-87IJ%T,9$ MJ8M$BQJ=RV=3OUD3?BV2!=9^I`W%6*49D>`?P32`#G2$O)RF`>0O"A=E>\+: M`3)M?H?8)"TF##Z M8$=/RF;9V_>^LK2&OW5R]:CAD-F5&40N,[L#6EBC$I%NSG&J$6M&5&@E'T]#\E$/(H^X`_;ZX'?@8JUD MZV\Y>;%+M6-JL>R;;"L#?62E95756D=;$7\JV_L0+.W0)6!5N?Q<%*")0.0> M"`'J8,JX&.]LEV@;7=I_8LK44=H%8I*5$U[0D'-3,^3>M5'"$NC%.&KX2.8X MJR:1B*$`BYR&,/@!@P*U11N8TNICL4($+\-=AQN858'A:V6T"P0&<+!!(**O MOPDLC[@(>Z85!3XY]<"ZL",?Y*__`,%O_IL:;_\`?G`DXP&`P&`P&`P&`P(& M?G4;I&H_75T+LI%T;A?FZK&JDT]N\VM%:SV=V%N%JU;`L MZA9HIPEM2L7AFRB*FK'SSD(\B4JFV=*.'"?BFJ5-,X!*7\G'^@MV#^W_``!5 M?L^W_P`852^S]W`^_C-_T&^OO^X_X"M/_6_^X_X_VW^!_K_N\X&]^`P&`P&` MP&`P&`P&`P&`P&`P&!H-\F%4D[YU+L]&A#M$YFZ7_3%3B%)!4[=@24L6VJ=$ M,#OETD7"J#,KIX053E3.8I.1`HCZ8%[?'^U.RZ:=>V*W@99C0F[%82#Y$%9G M)2+944S"!1,F*B0^(B`"(?D#`W"X#\P?O!@.`_,'[P8#@/S!^\&`X#\P?O!@ M.`_,'[P8'/''V8''`?F#][`.<"!CIE=-1L>T.L8MKUPV%IFS5*?LM'D[\GM-C8[-=[7=:A-V M2`CM[1#R$C7,ZZE:W7I-TF#`040E$TT2D-Y'(`2I?)Q_H+=@_P"@:K_E"J6! MW_&B8I^CG7HQ4D4`&MV'E-`BR:?D%XM('4\7!C'!18P"5@.EVP)R#?.XN8AK5JJ5BY9@Y,S M?Q$C';,JKUA)LG)!!5%VR>($.F<@@8AP`P#Z8&3?C[%P;I=US4=>\+A?7,<#<7`8#`8#`8#`8#`B7^9\.>G;7 M[RY0#<%$$?:(8R1O[QLW!78E3.!$!-QXB(D#WO`.1$0*8)4*]_@"#_H>,_F2 M&!6,!@,!@,!@,!@,!@,!@,!@,!@,");M#"3[GY#.FDLTA)!W!LVKPSV<39K. M6,0 M"`B42B)_00^T./RX'IP&`P/DQBD*8YS%(0H"8QC"!2E*'J(F,/```!@<)J)J MID52.15)0A5$U$S%.FH0X`8AR'*(E.0Q1Y`0'@0P/O`C,^24WMJ=*U.#\$[L M:19LH<&.10@<\_E*/^O@29X#`8#`8#`8#`8$$WSHE5_9MU^,!1]@ M+_;BJ'^I,4`6-5T!0*+/VQ(L)DR*""HG`4O$2@!@5$2A+S<9W5$;K9C";BLE M(@:A7(>/.!$Q2>N M/4;2?:[K[<]"[98;(G+QMJO36BPXZGV1*GDX=O!.RS"Z@/(]"/0 M6EE7Q&[=R*9/THIJ%#=3Y.?]!7L'^7_>"K>G_P!8-3P._P"--RJZZ1Z&46S`8#`8#`8#`8# M`8#`8#`8#`8#`CS^49^$3T\N$PJ9W]'#WC44I()QQF*2"&2?C^<&==,NO#DQUE!<:_:+>;@Y5%Q!1_(' M#WCD(FF94`'@PE*4O/V%*'``&X>!C*^Z^E[I.:_EXW9U^H3:DV,)V4@JPAXLEF:O"I^3C]T2ADW`8&H?;*P7;3&J=X]@Z M9>9E*:K&I4&E?ILRA&2FOH>8BYY5Z>W)PH-&DB[G7[:3!LX]UZ9$Z#=(I")F M\C&"-7:?:GN12M2#LZG=C='W*:B9*697C4=EU75];[6I+>"_$DY=R_J3_:,\ M]D5V:T?Y?3M@,=5HJ1PB*J8X%$T1W>[5[2UY-WN_=A=!ZF:@]CJWKR&7UE#7 M"];5G):?=0Y"UNEM-JP>1$+JP+&V7KRO; M8H=GUS:SS!*[;8T\5+&@)J1KTN#4ZJ2P_13$2NV?LSB=$`-X'X4()B'`Q#&* M(>ZB4R$US2:E0*T5V2NTFMPM5@B/WBT@])$0,>WC(XCI\X$5G2Y&C8@&4-ZF M$.<"Z\"+#Y+89N,]TIL8O9DKI+M_J.#!@6=>FGNE`%KU='/L>T4 M3J"UK3%(%@7]XIDRH`\$HD!,P'%0!$Q/``.$O=LTUJG<]-J,-MC7U3V%%P[: M,E(IE:X9I+HQTB,:FW,[9@Z3.+=91`XD.)1#S(/B;D/3`M2D]0>K^M[7%WFA M:)UK4K?"*OEXBPP5:8L)*-5DF[AH].S71('L"LT=J)?=`/%,XE+P`\8&&_DX M_P!!;L'_`$#5?\H52P.SXST3(=&^O:9CHJ#^KUD4`Z"Q%TQ*M>[6L0/<3$Q0 M.4AP`Y1X,F?2.0CB%KS[;-0;3TNU`Z#HIW$9#*.%R@**P![8B)#``A@ M9!Z&)'0Z=]?$!.NJDCKV/19+N2"15Q%I.GA(ESP)$^4W,85%0A@*!3$,`AZ" M&!MQ@,!@,#33Y"$3..F>^D"),5U%:HP(DA(D,=DNJ:S00)(+@40,4JRG!0,' M(D,(&X'CC`B*^66J:A;VA.TVJH;L@-AG8QD!4Y*&I6NH?1]HE4X-!=T[1O", MPM4E8]>/L)"RWUS1PFNS3CS&(D90"8$PGP]E2-USV M:Y357,+GLCM`YDEG9G((D!C5?:\2`5)!-10@\J&(FF"I_O>(<\`$L&!$S\SQ M4S=.FXG!7R)MZAF1%-(ZB95!9V,@BX.4!*@D*1S`!S<`*@D+]I@#`E.KW^`( M/^AXS^9(8%8P&`P&`P&`P&`P&`P&`P&`P&`P(ANVR":GR*]'E`#],0'QU>/[ M@I)8QD^!_+YF#CU_)@2Z)#R!O]M_^H0?]?`[34$/L].?3UP)--<= M?4/J42^=]N"WT8I\N5_9K#4GU:2ON!X(-/J/!0O@/D9<@^1?'@P3AU[_``!! M_P!#QG\R0P*Q@:&?)Q_H+=@_Z`JOV?\`E"J6!W_&D=(_1_0`(KMURIP-E2$[ M5($4BG)>;2!TA3#[%41^Z+&FAVQ3B[2"$AFYZ0JZ MK%;L2:?"#46*CMB*A3K>Z4>2A M?/Q21M]@*Y9S0EZUW6Z_O!28$T"))^\&6=T7#MO\B548M>M-)F]7=<#V)B MJCL*UW$^M[IL@[)=CYR\:Q8IOI$:1"JF="1)$_MR+I),_OC[)D`#7#Y#NB-4 MZW=?`V)&[FW]L5ZI>ZO74(38=R;3]::!*I2JJLLNR2B&YB.D$6)DD5/<(!3K M<>OEP(?HZKW^+\'_`$/&?S)#`K&`P&`P&`P&`P&`P&`P&`P&`P&!"WW;V3JK M6?>;KG=-G;/C:#%T*LL99=A(5>Q2KN3:RUIA!`$![&5KGR'G_N;O_KQZ%^VI_;X@'/[N!]_\Z1T'_Y1 MM:_^#=__`/DE@%/E'Z&)F2`W82#\%@.(+_JKL'V"^(%$`45&H@4IE0-]S_9< M#^;`["?)]T=7;/G+3=R#\D:0%WQ&-&V2Z5:,/KFL>>5<$2IX^S%(KO$_-4W!/<^\7\GB;\V!UD^6/H281#]N M29?NG,`FH^PP`1(43>!1_54>3FXX`/RB(8&G?:7NMUP[/V;J!4](W]S;;3!= MN]56B1A4ZA;V,BV@(Y23;OI,C:4@V@.D6YG)!.5,3G*F(J"7P*80"=W`8#`8 M#`8#`8#`@H^=!=$-9:`;"J0'"NP[6NFB)OTAT&U5*DX5*7[1314=)%,/Y!4+ M^?`F_KH\U^#X_P"P\9_,D!P*Q@:&_)Q_H+]@OZ!JO^4*I8''QD#ST7Z]_E_W MBM7^4&W8&^>`P&`P&`P&`P&`P&`P&`P&`P&!'3\JK]S$]+-@2K5*+<'B[5JR M1,VF8YO+1KD&6R:PX3;O(QX51@_:*N$R`L@X(H@LAYD.40-@9LZ-MD&O3_K@ M1LV%FFMJ2GOC(<\E!>2C$I!TJB4!$J3=PY='423+P5-,Q2%`"@``&U6!UJ(H MJF3,JDDH9$_NHF43*C*FV;IFQN6#,3(PM;B&L=&5!W M(':-P\$4RIIF!),`YX*7D`NBCS2NZ-9PR-(^*W6UGU#%62R.J@TDMI:;B8'\ M5,\%E-ST##2E533*G*.&W!G2`&3<&3Y`Y_$!P+9LU4[;S,Q0*;2/CVHVO=!P M$HUN=CU5&[,',"BHDQ7;N6+XAO)ZDO[3?V M@D&ZZ]C[!MFV[-U=?](6316P]3DK#I_69:L<*U8QS]H MNYA':(E03413!$`]T5/<22##/RI:^C[UTWOLB_EWD.;64K7=FQZC1D+\CU]" M/%(<(Y\W)PN#-PTL"HBJ0Q/94(10YO;*U!--,@>@%(0 MD.!2E`/L``XP,2[OAM+:7UO-['4ZT0FPFU>!-T^K]"UC0I&=38(B=5Y,'1DT M8QLE&Q""(KN5?<$R9"\E*/Y`A:Z>UZ3NFY=\[@U=HGK]L9QLBW7N9I-2V_LI ME69FI:_C[41K(!&T6#JEVKBS!O*+-$CODC>RD(@B@IXBH&!M2T^/>J:YZA]I M;%M*L4^(VU>-;7:S2[;5:LI'52HLZ8U>W:L5:LGDW3Y=PP-.PK=S(*G(D#L0 M!("$33)@8T8:X^.QEUEU=2]B6=K+KZYI\X#FS2Z,\V_#-C[JH<;M>B9*>UGK^0DW6J*,9Q(/J9 M6G+V2!.":HMI)XX5C#++.Y!FFFLH)Q$WFH//KS@;"%TYJ(OB!=5ZX*!#^X3Q MH]8#P4^Z'N%XB_NG^X'J'KZ!^;`][#66MXJ1;S,5K^D1(J>X`E;LA<@FJ7P-Y'<)CY%\ M>#!.)7/\7X/^AXO^8-\"M8&AOR)1Y10,=+Z:,37!LCQQ^A2+R4H\E`-IL!@,!@,"++YB43J=*K`9,I>$-AZW6 M4$3ID$I/QT4O(H',45#>:I0X+R;@>>.`$0"3.N$(6OP8%(0H?A$<;@I2E#DS M1$QAX*`!R8PB(_NC@5G@/S!^\&!%WWPE-K=>;E2>SVC",9&Q7!BWZ]WBK2K: MVV!G+EEG3R=UM:F=4@7S9M(R-%>EFB@!Q()BR@@(*!_`#GMO>'UZ^,+9EF5L M\9+V1YK^%C;1+QSIDT8N;1"W."B[]#LU$4V;-<[:1CG[(4$2_IC)F2*!C#P( M;LZ(TW2M,4T(BCA921]A4E%V1I)RH*JY$3 M)IJ*B)Q+YB81#->`P&`P&`P&`P&`P&`P&`P&`P&`P&!X)*-CY9@ZBY5@RDXU M^D9J^CI!J@\8O6JX@19L[:.2*-W""Q1$#$.42F#[0P/R>QWZQZ\[E[;M-4MZ MM)UQ$=KU]ZHS,8!3!/S M*'Z(%]LU?>FN]\&U][,_#T);9>M)M&7-'+U.Y33"EM9$PMI%*3,QDJ@[3F4V MZJAUVZ9B&5`3$*'F(?GP#65EVE7MB4O:.MG1V:UCI$82L4,/U%K<3'U^-+*0 MD;#350D+(G-U2"@4FBC-^,HJ^40.HDZ$B0)\A^DSK;].30.C2,@(1B&IZ,#, MB*QET0:!6(KZ4$US`47"8(^/BH(`)P^]P'.!G3`8#`8#`8#`8#`8#`@5^=1N M8U*ZYO`:F,1"W[":F>^X4"('=P4"L1H*0G`QS/"LC'`P%$"@W$!$/(`,$Z%< M_P`7X/\`H>+_`)@WP*U@:&_)Q_H+=@_Z!JO^4*I8'U\99!)T9Z^$$Q3"$%:O M4@^11YV!;1]!X#G[<#?#`8#`8#`8#`8#`8#`8#`8#`8#`CW^4)ND]Z?7&/<1 MJDLUD+OJ)D[8$FV-:^I:N-H50JS<]CDTUHZOD=%_0_7+D,BT%0%5`$A#!@9> MZ.(L6_4'KHE'%;$:%U35#$(T$3HD548%4,X#\X_1(9RA^?'<55ONE>IS#2^U8W=6L+Q`W.DN'E6L>WF4] MIV_5"TV'8$G(NJG18%W(PK%U77L(S6?D.#A9)1P5P) M!1_#V7LB3U(*7TR?MB0020#P\../N$]/[D/LP*A@,!@,!@,!@,!@,!@,!@,! M@,!@,!@?!^>`X_V9.?W`\@$1_P!3`A2@^N7?#6FR>T[_`%[2NL5EHF_-R/;S M])N.5E9Q1S$I/7;J'4-#1S,694DDW!`,BZ\SI+I^9/0"F$/-5-'_`"6T^N[; MI]?K74"(KFZ;1=;/:8]&8MH-(M2[UAA5WL76VC9DW0C8J/9QJ9VZ8E5-[HF\ MQ,4?'`P(RZ4_+5#U1A5H7?E91AXB*7B(V/9[`]M5M'"P:1)8TDB:C)NO95CF M:9/O*"(%*(";[PX$[&C:?-:]T_J.A6+Z8\[2]:T^K32K!=1TQ/+0%?C8I\9L MY43247047:&,0YB%$X>H@'/&!ES`8#`8#`8#`8#`8#`@1^=0P_JCUQ+R0"C: M-D&]3![HG+$5+_F#?`K6! MH;\G'^@MV#_H&J_Y0JE@5#XW4%&_2/KT55-=,ZU4EGH`Y]CW3I2%ML3Y!<`; M&,D1%PBX*HF7D3E3,4#_`'_+`WBP&`P&`P&`P&`P&`P&`P&`P&`P-`/DWBK# M/=0;M7ZD@LZM-CMFKJQ7FK99!NY=RMHV-6JZW8MW#E1%NW5D/Q04`4.("`?IG!$^3``.1Y'C\H_9R/YQX#`YP&`P&`P&`P&`P'V8%L*7:F(JJ(+6ZL) M+HJ'1514GXHBJ2J9A*HDHF9V!R*)F*(&*(`("'K@0=_.,+&3UMUUFV)VD@W" M[7EJUE6C\JZ/LO:]'+*(()H>XV=IN5(P#&6\^4C(`0`'W#"4/?\`()<=I:^W MQH"?ZZ6O8ZN]I;4E7@4=952G/YRN66G)75P^1?V.4:R;8"-36A1!NLU]@R2I M03*Y5305$#AMYU8VC\AEQV2C#=F=%4G7VMTJG,N5;/"OF*)OX/D<-A/C4*)>C_7T.!X M&OV0R8BF=$#)'O5I.DH?HOJ MW*1/R_>.7`DOKW^`(/\`H>,_F2&!6,!@11?,6F)^K-1$J22QT^P&L3$16`/! M8YF]F1*D*@@<$"JBKXF/X'^X(AXCS@2L(@8$4@,D1$P))@9%(WFFD8"!RDF? MP3\B)CZ`/B7D`^P/LP.W`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`"'/_1^;`@5[A]2=;:MW\GM6-ZVN]XTW:5;LRT[6(_L"]UW8X7;< MC8WLG*7D#6&7`ZL"O"R:;=!!JH+1FY)R9$@>WYAIUW:U],ZSZ4=0JM*MVLE@-!1=S3V*RKS6P2GXK$P$C=6"Y(F8G*ZQD@9.5$43IG>ATUXI!6PE;R)?,;(JH^6]OVW[D`4(5+Q,4X5OL?23Z^Z?\`=J'K^EM& M:GJTLXK\]/DUCMF9O=J6NSO8%+7,C<8"0I$"UKQW$8Z*Y2;HN4TFY%N4T!!8 M3X&Z_P`9A52]&>O0*E4*;]7K*8H*@8#>T:^6LR!@`_`^V9`2B0?L$@@(>G&! MOA@,!@,!@,!@,!@,!@,!@,!@,!@:/_(+`-+5H.(K+N:?P(6'>G7F#0?QJS$K MU-:6W'3H\RC9I)MWD;)N&3=RHZ2;N$%D#*H%.HFRS5068U%LC&Z\CZG'OGPUQ1LL#96R+HMV!2&5*HU(45/=*44S% M$P;;Z\VMOKJ5VS3U7V-[*2N[-7SM#K$D^EY6OPL5+0=HN4W8X:I&C*W]>XMC MZ%26K;DDDXC"/02.Y:BLDFF`J`$JVR=>72YV?5,[5=N6;7,90K@,]<:Q"1L3 M(16TX`[W(DL[I5-P8RB!%TS%$HG. M7Q\0TA^8-VJVZ46I))TJV!_>];M%DT@Y*]2"R)/!:K?7D;9.6%O9[9'1,6^C(N M5,V%E5F;2&33:!%0H(&]DPAYC[IN?3@`#+V!%1\P@_\`W7J<')PY[!ZK`/%, M%"C]VQ#PJ<5">P3TY`P`?DW!>`\O(H2KX#`8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8$!_RP5NG*;JHEAM=CTR5TYU&Q85>N[)F'Y'C M:;J6QWEP\WD+'Q;E=*J;$9@I`J/P>1Z2*H&%=8$4SEM/OHRP),K%2M0DHNPK\Y? M"T<-"5]P$BLX0ICZ05!PL[4(=)P=I[228^BB87UW`J$'2/CW[(0$&BU:M8^, MJ[)NR3L0VITP;--A5-J5LXG7*SF4>F,J@R`E(F1,@:[Z*[0[6T M9U]^-&@:TK%3NC?=+O8TF*2:/O?8W5J-^:2,D4EIK<=6;M3;E#3S,49!!.#8`I' MF(Z<.R>(HKD%,Q1^]@1_0C^:VI0M)M[!\WT-G-U@ M9%R`R\*_BFD6B1"9X]Q$!74=*M3%`IU4?`V!3>IU5N.V>Q;#?^@.L%ACZAK] M]"4*=;[KW0A=8N*F(J8P;%K%JNS:X1S22C%&!(I-M^%J-7`'.879DP M#]*P!Q^?[>?7`YP&`P(N?F$*!ND]I$4C*>-\UL8#%<`@"`_K*D7W3$%5/ZDO MWO#V^#^I@-X_=Y`)+J]_@"#_`*'C/YDA@5C`8$4?S$"8.L-'X.!0'L1JT#E$ MWB*I?IK0($*']V('`#\?F+S^3`E2%GK,R@X;R;7[J9O:2!(%A`P"&@7=U* M,2Z.=.GK"0D98UMV'N"\NI3]2RZVK\A)6I5Q/3;NNTE-K$I,:LXE)8QH)8&: M0*Q?"GBE[PD,$H7>_KEUZVK&:FV#V)[&3NFZU5H*)K\1!*2D&-8D95\W>NPE M&<)+1TBHG97*2@HJO$TE`%FU*F8H!R8`PCT!V-2IGL[9JGJWU5BZ+9& M#F:VM.,5M95YNPL4(S@%&40W%T+X[YNBL:/D_=8'*@8R8,C@<3)!?79F9D[) MT,[NSLEJ;9^H_J+_`.RQB-JRRTG,6%DA>]?@E::^T5,HA6JI)"82MHYHHNR2 M434.DJI[AAP,5]19JUJ5SH_$GTT-CAJS%,DZ7NF;H%DG(B`0NMGV*IM*.1MC M:3;1->L;DT)`HP3L&:OLI*N2.3BFJ)L">@G'WA``#DW/H``(^@!R;\XX'W@, M!@,!@,!@,!@,!@,!@,!@,#\TGR6T>;:[ZW#:9;0]O7K5ADJ(DRWXC685S62( M2&FHV@0U+P'A%W3DBJ+A`Y?T*B:Y2'*&SL1\A>]G6N86IZ5^ M/_Q7JK*,UY:()L[FJRW@FS` M4"B_'MV,UOU?J>P=/=FU+AH'83^V.=LO%-XN2187%2\&?-7#^K1P1#)\S;MD M:RD+OZ@5Q4?D,Z3@(@/9+6G("(#Q*.1#D!X'@09B`A^Z'H.!Q_SAO2;_`)26M?\` MW3=?_P`%@1\?)SV\ZQ;@ZISU*UKM6F;"N#NXTE]'1$))F._CT8^6%:1F4V[B M.,#E-"/%5`Y2G1.4KCS`_P!P2'";NO?XOP?]#QG\R0P+8USM+7VW(5]8M;6J M,M\'&SLE6GLG$F6.U0G(CV/Q&/$ZR*(G5;`Y3$3%`2&*GYR_O`8!'_4P/SG;?Z^]N[#;Z MI!*=,838U$U)V%WGLN,=RMWJ:#/:4#LS8TG:VK"::I6Q@X;QR;19+Q37(IY@ M4"*I^`J)&"D?*S.[6L77?JK)[AU]$ZDN2]NV5]=KF!G&TW%0C)E&0S&!*+N/ M4<1R[PT7^E`B9P^E(L9+CD#X&^_=_IEJO?D/0]PVK;,9I^VZRH+1BTG[0A$3 M%)?Q2"Q)6):VJ$G'"33\';3SX_U2A2G]]!84U`,0`+@8#^.%Y9=8=A]GZ;1V M-H+:]%N=;GMK#:],6J)+%Q@]`NR52ZRIS!JKH=T\U M+2<;)ECVDQ'QEB>(QB[AHR0=I."J%>&!,HD.8AP_0:3[!_JC_K8'W@,!@,!@ M,!@,!@,!@,!@,!@,"-CY9'8QW3*VR1$H9PM&WG5S]NUG6C*18NEVMXAU"-CQ M<@15K*$6`!!9N/@ MF0OW4TR<\%*'H4```],"];_UUT/M6<3LNR]/ZZOEA1CT(E*:M=3AIR33BVJ[ MERVCR/)!HNN5F@X>*G(F`^)3*&$`Y$<"R/\`,KZB_P#)KTI_Q=5C_@[`?YE? M47_DUZ4_XNJQ_P`'8#_,KZB_\FO2G_%U6/\`@[`?YE?47_DUZ4_XNJQ_P=@> MZ,Z>]5862CYB)Z[:`````!P`>@`'H``'V``8%G4?7E#UG$N8'7E.K5(A'DJ_G743589A M!1SB9E#$/(RBS2.0;H*/WIDB^XJ)1.8"E`1X`.`O'`BM^8!)13JW5E")(*%; M;^U4LL=91,BB":BLXU*JU(<0,NX,LY(F)23M-N#2>_=05 M&J[%J>M=M+)HSZRIE?IW!)+P*0GHFH4X!ZOBR>W1SLR55GJ[T^C&A* MB\29O*&VUBPW/*0158\KY6*+J=W*-W%:C7A&?XJ$N1%51==N*:AA*?`ROVP@ M-C,NG/<>9V16.ORQK-L:1-+SB[D5&H M@*KARLM]=0;W8:+PLP>G5F!J!7%BE$)EVI97 M*L2NLE8&\@BJ5BZ/RX$&'=K9-Q5WY6]B: M:GZH=F&L9W64U";,T+M[9T.2:IFU+BRFW;2/@=;V:&BY-M+1RC-%P=1-=T@8 M3)@=NHFH8-4_D1L=MNG3_J39+Q,UJR6).^[+B5Y:IT&WZK@V31*.13CX&/HM MTA(*80)',6":"C@6S='W&H@D0Q3B<`D![K]JY_3EKU[0:QI73FQ'K;33':TW M9-LS50!C7H]L;6>W^ MU;F_Z`ZZZUU#K9YK6[(VZ>5D:>RVU.W-Y-U:4D?:J$78)688U-)V()I>VS09 M+@L8YUBG210,&4^XT/%UWHKVM9.H/7=-V+8_PF_;#J5#MCBU&_%;-M6OI,K- M+NY)".EU5YQA%D`%#M&Z!3HJ)(@)$^1#6#K%K:&_`OCHME_[.6*A.)&'=M]7 MZ`3J;^;BKR]:W>WNY]RWGF'U;L,+8F*;A1RB"A6113]TB8""(?H.+SP(C M^4>?W\#ZP&`P&`P&`P&`P&`P&`P&`P&!'=\IK0DETVNL,<'W^_ESU/$`I'M4 M'2Z(O-EU@HJ@5Z]BXU,2D*($,Z=M&XJB0AUDP-Y`&=NEQ?#J5UQ3\3%]K3=! M2#S%(3F*E7F*9#F]A5=$!4*4#<%.<`YXY'`V;P,1;$VVCKZW:HIWZB;!N#W: M]G=UQM)4V"1E82F-X]HD]?V.]2"SYH$'`-T5@_3`543F`Q2@)_`IPR[@,"UT M+$]6N4G5352Q-XZ/KL3.)75('IR M&2,"*CYA%"DZO4XIE3IBMV#U6F0A0Y*N8I;$L*2H_P!R0I$A4`?]F0H?EP)5 M\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<"'(<8$7? M=MSI(^VJC"WO6N][O,80,=:'#=F1Y'I;+I#&7E6LE(N5 MQ5405423]LI3*`82I!#1VM;.$NCW4QLYF6\M(1&T=['FF3[8$;L2X5T+5(DL M-:C+5+1#E9HC+JU]1)9VBHFW52452`4B&,4T\T^1_$I^&A96-;3*<5)M':Q@5415]MP(("NJ)4< M#R]##ZHU9V2F]+W_`*OP'7GM$UHK@(JTU6R6N9J>Q:FLZ2=S"\4TLUDE20Z< MBK&MEF;K)I\F\22;'5*S7?"L)A(=42HD$P:D:/@7]FA?BT;P< MA6Y.`U&ZMFR=G1LE.P#5:F,+?9IICKZTO8QW8%)E-*8>P;Y*.(BFJW(L4YA* MC]T`#]#R8F$!\@`.#"!>!^TH#P41_,(A@?>`P&`P&`P&`P&`P&`P&`P&`P(Y M/E8AINP],KI!5Z/D):5F;IJN*9Q48*!W4FZD=A5]DQCR-54557YWDBNBFFBB M)%3+&((&\0,4P;`]+DSH]2>MR*I#I*I:7UZDJDH42*)*)UJ/(HFH0P`8ATSE M$!`0`0$.!P-FL!@,!@,!@..?0?4,#@``.>``.1Y'@..1_./YQ],#G`BJ^8(J MINKE2%,RP$)V!U49P"2)E4S)":>(4KI0H\-4`<'(('-Z"J!"?:<,"57`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8`1X]1P(4OD&6U-2 M^T-$V?MJEZ0W!%AH1U4H75NS=FQ5'E&)EY^NPQ4_`2T/,01&+Q9JD*AR MJD=`/ M:1>O]I2%.!S"1XD4R0"D("08J\+-6KQ%%DDFH@X M01>NDQ.Z*)C$#H[37`FS>OWR&W%LQVY7&]:C-2:G=U3:4NQ1!I,5:\Q$P_E* M[248I9>OQ<@6Q$.1^28>M9<#"H1)(4QY"C]9W]L'5/QL'@H6@S-.L4O;:YN! M.9B(1W-1A&%FL*E`5;/'KL9I19\],X4;MO:3$P^0FX]1# MQ#\H!X@(E,/V")3<^H?DP.S`8#`8#`8#`8#`8#`8#`8#`8&@'R:VZ9H'4VP7 MB`:LW4O3]BZ8M,>$A]]@D^KNU:G-1ZCYJ55!9\S/(,4DU44U$SF(H(@8``1P M,Q]+?O\`4SKPX$5!4?ZFILJO[BRRX@ZEHA"3=%3.X455*W*Y=G!(GD())@4A M?NE#`V?MJ-"A85DBNO' M[HH!(I(&+Y>GNE)^7C`E6P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&!\F]0X_J?V0P/SM]O-OZ;[#]@I-77=UOK38FK*T:E/:[']=+C M?YN+MNG=F2EPC)V,DH1P_2;UAQ<0;,I<5(YR4S`/,GFH9,F!@'O*HFWZ8=2@ M18(1#.X;+WEL!E#L*-9->PL06>E?Q=.+K58L_E+QU59)V54K`R_MB\;`FN0A M2F\`#=GY1-_:PU/%:TJSG0VNMD;DM6LR.*[L'9%.@;/&42LIN@9@2/;2;=PK M,27XD=PNDU5\6:"GB=0BY53D*'F^+FX]027Z0INEJY?;%N:6J4]9[UM/8%4@ M:T5&';2D.F:NU1A7I*3CH"%,73.-+.A)N6U@0;.45G9VR0-P*1 M(IRG.<,/=/:%%U.C]4>Q2EFV9*6A?5,U2W&N:%&PU@83U=B[]:'P*EKTXDX> M'F5Y!?ET\;.O?02!0C0D-P!B"/]P8`$P`8OV#ZC MZ_EP.W`8#`8#`8#`8#`8#`8#`8#`8$=GRG.19=.[:]&1BHY)G>M2NG!IN&0L M,2Y00V16U3(2,$NBY"88I&*"Z[4J2PN4$3I"0Q3F#`SWTR,!^IG7(X"F8#Z; MH!P,BE[")@/76)@,BW\2>PB(#]TG`>!>`X#CC`V8P*!,LYIVZA1BI(D:U:R1 M'4ORF591^R2(GV?;Q_7P.<#$=5K MVW&.U]GV"UWR(G-53;&H(:NH[.#;L96F.H]D[)<'$O,IM4UIO\=D%$E4/-53 MV"%$@``?:&7,#X4#DA@X$W(?87GD?W`X,0>?ZX8%OUIC86#>1+8YI":<.)=\ MY8*-V)6)&44J8A3G%91N0H^1Q'D1']S`N/`B?\`F-6%'J[23\CX!V%U MD90"E\S'(DQMB_B4H!Y&'R2`0`/41#C`E;04]Y!%82"054DU!(;^$3W"`;P- M]GJ7G@<#MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.# M!R'']3^S@?F^[H[1VOO79-@I<;THL5-BZW*J5(F^$]/WJU;80:P%L>!+R^O; M%789M%%BIE(RB\<4_F!A4]\5TU#$\`Q%WKDYR4Z7]0E;@\W#*7!M?]O,I61W MQ#R$3LM;97F5>UM8K^H^C&Y@C7:#8M=BY9=N\37:"8Y%")I@GXF$_Y@L*K_ M`")]89*TM:I"5S<$9.218KDBF@=@Q0(M)2:0A&CZ4-^KZ:S"'2>.#&4>+D(T M3(DIRIY%\1#S_)C8*N;IQV2J+27AAM;.F4RQR5>;NFGXTVAY39M=9,YEY'IF M^J292#Y@LFFL`$?7\^!]8#`8#`8#`8#`8#`8#`8#`8#`T(^2:IFO_`%C7U\27809[_MK1 MM*+)/6HO3M36;:]4B0?,H97Z5)J-^IO7YF MJ#SRCM8UJ+`S]`C9PJG%-`CD7'LID(4B#E%J51'[1%$Q1$QA$3"&T&`P&`P& M`P&`P&!%7\P/^BY4OT2AQ#L!JH0.0#"5`?.>#W5A`A@*F8!\`$1*'F-'VRML3L5<'\Q1)=]7I]>2A:G7; M"T@TG,G&G7:)NE453,5T%#!P<1`(J?DSW4[W_P!9.K6Q)JO1]4LP[%V_5['! M1,[#6^):3]129UVPFAK5"2+UD]AG$G&^ZU\15]]NV/VW[B62"F:IZLW*W.\7\ M8B&D]MU0\15:XQ%;VU(B`:L2E`3$.9,A!/Y`=4XG#<75S)LO#_#H@[AX:39. M[-N5^^CI%O%R22ROZUC*M9IH+W[Z3^,MYS M"0G8+2!SASR0NUZ&8P<#P/)0GA$.!P/H>RO7(O/._P#28>)?(W.U:*'B7GCR M'F>]"\A]N!R;LKUS*`F-O[2A2E#D3&VI10``#[1$1GN``,#SL^S_`%K?MD7C M/L'I)PV<$*HBJ3:E'\3D,'(#P,X!@]!^P0`0P/4'9'KL8Q2%WWI``1`+?;=S>I;QPV:->R.E M5G#M=%LV2)L:KB99=P"E#D?0`^S`[GV^G]G`AINE:ZS;.W MSNFM*="=K7?:=6G6C[8YZWL:E54DF-C:`ZA;B2!:[]JZ*K2VQ9$W8N2LB*F. ML'U8$O27:"7J-. MU+V\<>5ESB`" MIQ@:AP/65;274_NI/R6T]![-?RVN*#&-R:AV6QOS^`;EVG6%#FD6K6,:GC49 M0P\>\*G!_:!,"#]\P!LKJ#55=[&:[^-ZJNIR)L0:W;7>UWG6DU!DE%YZG6&W M*MEYGW))S&(J5ABA!K(++I*+E3<&333Y=>VBH'Z$44B()$13(5-)(I4TDR@` M%33(4"$(4`]`*0H``!^8,#MP&`P&`P&`P&`P&`P&`P&`P&!BS87,UHA"F5E72WN& M2``33'GQ#@1P+SF?B7T#9(./K5BV5O\`F8&-%J9M%.KE4"LTE&#<[5B=%-#7 MZ1D?I4%#%(`&X\1X'G`HC#X<.K$6+`8ZV;T9C%R9IF.]F[5D`92QT4$#R"`& MHI@*X,BU3*(CR'!`]/3`[*[\._6&H34?8JI<=Y0,Y'*.1;RC.XU8[M-!Y'/8 MUVV3^IHBSNP?#_`-7+:^4E[59MWV&:5!HD>9DK MS"&?"T9@?+`R.A\<.JF$HA,PNVN MQ=>D$V#V.<.(#8L-%J2*$G)FF)07ZC>F@JJ>1DO%5;Q,0IA3(```$*`!2(SX MN^O4-5V-.B[5NJ/@(N>3M<>T9WQ@U,UM:$HE--;("[>LIJKR;.4:MUD@6%1N M0[=,03Y\A,%"AOB3ZJQ*C8SAYM:P)1[J8?Q+.PW*/?1L3(6%(J`R!%?'%HN'KM$%68"(**&/Y'.D3%0> MW*'`WR+A)AK/1+6;05,+"3:*D5(J@X:K-G(-W`I%*X;B<6[M,H$6(H3[N!E` M6KF.*7<$FR%HK:%?C8Z+G4V3A%VS"20C&[ M/ZDS1T@11,PCY$,4!*(8%E1W5+KW#V:AW&&UC"PUFUC'-8:B2\.\FHEQ7(5F MO).TH5H2.E&R"\,J\EW*RS1 GRAPHIC 19 g899224ex10_7pg015.jpg GRAPHIC begin 644 g899224ex10_7pg015.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X0/2:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C4M8S`R,2`W.2XQ-30Y,3$L(#(P,3,O,3`O,CDM M,3$Z-#7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN"UD M969A=6QT(CY+34)47T,T-30M,C`Q-3`Q,38Q-#4W,34\+W)D9CIL:3X@/"]R M9&8Z06QT/B`\+V1C.G1I=&QE/B`\+W)D9CI$97-C&UP;65T83X@/#]X<&%C:V5T(&5N9#TB"\T8C0'6'?K_^X`#D%D;V)E`&3``````?_;`(0``0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@(" M`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@";`(S M`P$1``(1`0,1`?_$`*P``0`"`@(#`0`````````````("08'!0H!`@0#`0$` M````````````````````$```!@(!`P("`PD("`\+"`L!`@,$!08`!P@1$@D3 M%"$5,2(607&Q,B,7=Q@X46&1M;=X&0J!H6)R)+98.L'10C/3)97%-I8GURA( M6?#4U296QM:(F#E*X5*R-'979VA#-45FIN8WAYY(3NZ(]/1($YL!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,#T4`!(IU#J`D,`@'QZAT'X=/[.!H7C]J>PZEK< MA#6"THVHSQTR7CW'M5D7C)DU8)M4F3YR*Q&3XR`$[4CH,V12HE*4Y5#@*A@W M[@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>A_@'?\`<(`F'[P! MU'^T&!'GCE".X2L6AXO8%)B'MM\GK73&2I)!K]FJA+D:C"ULD5(")H,8XC50 MJC)("HH*]W:'Q$`"1.`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M!ZG#J0X?3U*8/X0$,"/W'%Q9I&CNI2T6:*MBCR>?(1$BPC7+)XUC85)O!J,) MQ=]`5A\^FDIAB[45458HB'J]`$Y.T<"0>`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&!Z'#X=1^@H"(_<^Y^_P##[F!JG4=TE[Q#2,M(*0KUB$FL MA"3,/'3\#\Z8H&,@J_5KUC%P]CFIW:1P9K%=.$WS4"."^F50"`&V,XXAT45SBX7:QJZ@!V].U(PB( M=,"-KOR8\#H]G'2,AR;UU'QTP1=2'D'ZLRR82Z;4R9'*D4]@>)*+1ZR8>E&N/1]O(J]8O\FP<> MY3]-8>B1_4)T,/<7J'AQY-^"#=LD[#D?3GB+A!-RT")C+=-+/D%C+E14CVL1 M7'SF0!8&JQB`@103$;K'#J5%02APB?E8\?ZR3%9'D7"K$DTEE8XJ-+V,61^P/J(R"X( M'[$3@"ANPW0H]H]`_+^EG\>ONF3']8^'!Y)%8'CVHT;:@+O22B";J-.U2&B@ M=EY*01FAY,L,1R%)VEZ!I8Z8*DC0 M4^PW:+TR8@8$^O<(?

@__NMLK_T*P/)?,3XU MC#T+RHJ9AZ"/0M4V68W0H"81``I(B/0`ZX%AE/MM?OM3K5XJ;\96KW"!B;/7 M)06CYA\R@IUBA)Q,@5E)MF4@V(]8.4U2D6234`I@[B@/PP,CP&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!!#@OSOJ?.B&VO-U/7] MHH3?55[)1GB5GD89^M,KJLCODY%F$.LLFV0],O04U#"8##](A\<#=?(G>*NA MJ[6+,%-F+LUFK6E7'L=!(NUI)JDXB):13>-B-6CPJJHKQI4@34`A3^IU[R]O MQ#/=17AULG65&OC^)^1/;;7(Z;=0P'Y1;1WU/S$;?^,%QT/#&IT9?*5/V&Y0=G"R MP$M8IN!9MIJ+CXV+=TZSJIPXNAC%1=.6Z0F*Z]N<$07":>`P&`P&`P&!3WYL M96.A^*U`./@C6HPD1&<4M*JLTW#QR4TU3(ZS/_4?.U'JY32UD++2IT"KJ=$D MC+"D@F4B:12)D(4HAS?[5_6,`&'XC\? MC@/U`.$'Q_Z)G'[XE`@_\E=0^)`Z="#_`+5?$@=H=`^CX8'G]0+A%T`/U3]` M="@`%#\UM1Z%`.[H`!\KZ``=P_PC@>/U`>$/0H?JG M)G'T!+^*(:KIX"7XB/U1"*ZE^(_

*FU'13BN_8*JKM'!BGA#$ M`R*JQA[0`"CU^("&!^K'A3P]C2)$9<6>/B)$':SU(OYGZ"H!72[06"JGY6!4 M[N]H/9VCU+]WIU^.!R+3A_Q,8H)MFO&'CXD@D4Y2$_,UKL_:510RIR]RE=.< M2B7U31)(\9`0^P'3.(A( M\SV!6%G$133\DV;)]J*"?U2%*7X8$R_U2N*@`(!QEX^=!'N$/S,:XZ";J`]1 M_P#%OXCU#`_=/BEQ<216;I<;=!IMW/I>X03T[KPB*_H'%5#UDBUT"*^BH(F) MW`/:8>H?'`^T.,O&TJC%8O'S2`+19FYHQ4-3T,%(XS-,J30S$X0'H])GFBMBGF5JSJRN0L"YE5C&7D'4;%.T)5 MVS;.G:AU`(JY<*=3")E#&$1$.=_,CIC_`.Z+6'_$&J?^"<"O#ROZ=U\R\?/) M!:FZKIK6TG@:O?<"B0B(]ZGJ=H`/7I M@3=XFATXK\:`'X"''[30"`_<_P"3FN8$@'^KW_\``#E]^GYG_B^K@6CT[ M5MEHTM*QMH1V_!1\>WCF"\XE)I2\!98MZU>5=H[9/+4*35V95!@F?\LX(3KT MZ=0#?>AX4E=T]K>$2?STH2-JD8W]_9X5]79Y M4M=12/7*[.UO8[J<4.E;V;(J\2>2`'2BRCQR8Y@OYP&`P&`P&`P*3_/.?TN& M]"<#T-[+DUJZ1]+N[5'/RROW^1]BU#H/JR$A[7T&R?P]5PH0G4.[J`7.0DG\ M[A8B9]A(Q7S>+CY/Y7,-O92\;[]HDZ]A*,^]3VDBS]7TUTNXWIJE,7J/3K@< MI@,!@,!@,!@,!@,!@,!@0=X,#_M%R<#_`//#RK_E'=#_`*.!.+`8#`8#`KM\ ML-BF*AX^^1%LKSP8Z>K$;0+!"OP217%E+0VV*%(Q[OT'*:K=;V[MN0_8H4Q# M=.A@$.H8$DN)IA/Q8XT''Z3M3HJF2BJU31!R=RF M&G:$)T"-QZ@N=8G4H$_U0CT^[@9MXA-KZ(NV\>5<5I/0GYI89Y'T6QQ:C&X. MKM$U^'9"[B).C)N)1-F_K:SRW.WLPHS2;E;C(+OD?45(R0.8+\L!@,!@,!@, M"DWSTG,CPVH+H$'3@D?R;U;*N$F3=5VZ]E$U^_R;]5)L@4RJHMV+1100`/@4 M@C]`=<"YZ#F&=AA8>?COSDVB+UK[EFZ(DY:./07+WI* M%*=,W4I@`0$,#E,!@,#6&H-OTG>=(;;"U\YEW5;=3-G@"'G:[.5643E*A8I. MK3K=S"6-A&2[7VTS$+D*91$H*D*!R]2F`1#9^`P&!HS=/(2C:'DM+Q=UC;Y( M.-[;DK&C*8I2:)9+JUCKE;6$S(Q;^ZNZ^Q>(4RG)(P:P.9=^*3)L8Q/4.`&$ M0#>>`P&!JVY;'3*[7`4D^I@Z8&TL"#?!C_P#4G)S^?%RL_E&2SLQD+=6DBO?;*/$0*0K MM)1/IT`#&#:6!I2V;OC*CN[4>C5]?[:FY/<$'L.>C]@UFB/9G4E'1URPBW[Q MAL^]HN",Z7*V@LJ5*#162/\`,G"2B93%,4.H;KP*N_,L\,U\=^]$6\99).3D M5]=QT(%::2+Q1E-+[(JJD>]E4X]0G2(*LCZ9A6*JB*ZB11(8QB8$PN)0]>*O M&<>O7_H_::^(#U^(:YK@#\?W>N!(+`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8'7?_J^'_`+E]^GYE_B\XP+:N7^Y['H^G4"S5JP MT^NN)C:5XAW["9=/6\S,/!]W%H]6!#"LT`[DA`.)2&^C`WMJ M^T$NVN*;;B.ZX_\`M)7XZ:4?5!5=Q5W;B01*X/^MYS34'2=(0)M'RUWE%K#4K`Q:;%:O")( MKF:.3-E%`0G00ZAR&`P&`P&`P*5O.XX<->(FM%FJZS9;] M:C42(*MU3HJ^FYB+TU<)`=,Q3]CANL=,Y>O0Y#B4>H"(8%U.`P&`P&`P&`P& M`P&`P&`P*YN&^RM1*W7V*Z%!8S*1D&S MDJ2Q0ZD,)0`P?$.H8$^:Y;:K<&B[^IV6OVABV<"S-FWZM6;3"D^A$#$6J>K8))RZL=$G>@N6%!81%NEVBIV]![>X0D MW@,#5FZM0U+?&M+'JJ\*3:-9LZD$J]<5N77@9UJYKMCB+3$.XR7;%.LR<\]*K2M?<16J.6UAK\-#LYR?G+#$MTXI*, M(O(.)X07/6Y!C"-BQJHD(JL\;R`G#M*G@798#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`Z[_`/5\/^`7+[]/S+_%YQ@22\W5=TE#21G;=)2&:G.D'S>5FY$K0JPF]N M"KI80;]@`(!T``IQCD@7_K"6U$1.*8+<=#I"H#@K02`IIFAD[P='27(V$O7K MZ@D.!/I$H].F!M3@-9*':](\CMK\E);=\DJZ=PMVJ_V MT@:G9:U`5RF/Y.49-O7%@\7CSF4:I'19D(0APVWX392$='-!0.FBJF^Y,ZPBE@62(KV(2]=V!%N%V_>`^@_;(/#*-E MR_7;."D5)T.0H@%SL1&-X2)BX9HH[5:1$;*C![_`-@V>QVC:=+A;M:RPZBM4J"+*'BY:VUDKYDK8"_-DVL>F=^8\LZ6 M6%1!`QD@OF\%4Y6+1I;DG9*;5("CUJP M6M>-9@[14.5,\D\'ZXCW@`@0H4:\QI#;C#G7S^0UI&GFX]2\MUK=&ISK!JV6 M82,3$UHB*M?/E3&*F81(4) M[X#`\#]']D/PA@4P>*&OIUG1;M0FU&CMC M+=B8/;<8SE5.7*!2@DR3C.@`!@P+H,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@==_\`J^'_``"Y??I^9?XO.,#97FRV[475'UYQ M1=,MIK7':STETCI'7&QZ9KIE&M(223K,2VN1[J]:Q=HKDQ8)TGJ,CG;)H&:E M=&*?NH";3;A M)1*C_2^O#O(65(U6=,S/(]4YD%_2551,.%2VM(:]MZ!4G-G+$FVFY+/,W6QVUQ$U>O1D4]C;386<3+R M-=K,"W;0[-,S-%%JFS],BB_0R@A:E@,!@,!@,"DGSVI.E^&E`18K>V>J\H-3 MILW7H`Y!HZ-#7L&[LS8?JKD:*]%#$'ZIBE$!^'7`NDAFTBSAXIG,219J7:1K M%M*S!6:,<66D4&J23Z2+'MS'08%?.2F5!$@B1+O[0$0`,#DL!@,!@,!@,!@, M!@,!@,#J=S_C-J_-_EGS>O*VY)/3H0'([;-::QGYK%IV',_J=2UW/REHG;$O M/P<;!QTG*7)57TU1(O((E,X;G$OJF3"R+PMZ^JVJ-?\`++6M(O*&S:C2>5DY M7X#8;1NV:L;DS9:RUL56T31G<8W0Y$8N10Z@DH;U3-:566O&PK3!4JG0" M;9:;L]FDFL/!Q23M\VCFIW\B]42:MBN'[Q)$@F,'T+CQ=3"[:ARAY-Q,-Y5:O,%Y1JRFV$.\>QB"CIL MDJB03`$M^H__`#1_M?Z>!Y_L=/\`N_>P&`P&`P&`P&`P&`P&`P.N_P#U?#_@ M%R^_3\R_Q><8$UO*G==-V2T#?-;\+Y?9 M0IR43JJ\DDZ7KLTA6H*N+1-*)9D*7)L:]"Q:_K-&S%\$:A),I+J!Q.@4,#66 M@Y5S.^=8\X\5*6;DCCS\B) M8^%%R93M*Z7,1%`P@-JEM*`VM* MPZC&K0K$T18I:NSUD9PQ&WH=S-B9VJ<@'54Z]BA``+LOW7Z MFVOO8JI(OAY0ZE(S67*H9NF[/#WHC<[DB)B*J-@5,'JE*(&.GU`!^.!=+%%E M"Q<:6;48K316#,LNK%I+H1JLH#=,'ZD<@Z571HTK=@L%L.#S7;&:CJV:KJ6654I*0M)]=S($FV]1,R M3DA[S(G?E6,C^2$F!L;`8#`U7LUCNEZ^UD;4%BUQ`1S+94(]V^CL"L6&QO)_ M4B3&5+8H'7Z\#9*^C7+X[D5&1VD@_)(,44DU0.V4$Q>@;4P&`P,!L+:^/+32 M5JO98.&K$7,R:FPH:6K#F9DK3"N:^\2AV-=F&\O&)U5XPG_20%#JG)JSVBS[2H-=C]+/*Y).+?6&%+FV3 M-U9=43EA9,7%6C$&8=CT%03(!N_U1%00WAQ-XJPW%"HV>JQ6S-G;54M-AC9Q MW8]KRL3,6%HW@Z?6Z-!0#)U$0\*B2"A*]5FJ#5(R9A1(7M`W8!2@&WJ'#[6C M+%L]SL*YUBTUF7N"3_4\5!51:O2=-I7R.,17@+1)*2T@E:);[0)NUB/$TFH> MW4(02=0'H&S<#4EEKVY'VWM8V*K;)J\#IB#A;TVVKK21U^:;M-_G)5I&)T"3 MKFP`LL<6CMJB]0=*O$!C9$)0BY4^Y`2=^!MO`K:\N$[;:GP%W9<;2",!M*F/T8_T'2Z3=L8TDDW6%8Q5B]J(D$@@<1*&YN"&K=VC7XQO'J66X3FO*RI+V6<61*"TI-R)DR^JY6,=4X M%*`FZ`&!+_`8#`8%-W)'F?S6A.:L_P`9N+^M=&66IT74->VAL6];E5M%9K=" MC)WYHJXF;?:WDV!MG6MUR)N0SSJOPS31$0UG%Y^WI6R4;*(Q2JS=BW=HMU70' M*T(9P`9FKR5\OZ&TG6H'"G!!&VUO6ZVT]IO#(;-/4-(U@K9%TP;[8N:4H>NU M^P3:)EE63%!=XLJS:K/!`K(I7!PU6?GEY7OS8QVV&D7P\E:W=K[^;S1D;%5[ M9;NW&+A+THQ25>?+$`=J),$Q= M+"DW,FH<,*9Y89_9_'\P@./<0VD M-Q[.?-=MM=5TN7=II.4J,M;U7($F+^A'K%<.HM@@Y59`HDBX%-RX004#@G'* M[S(+%T;'!`<2XK86])%1_1]-*UN^-]JK4V/,Z"6N]ZKTG.':437L7'>B^>O' M;QL]0]9!J"?OE!9X&`O>7_EC+7][74FW^':>M^.TX:LWG9K"D7-]2Y^].7@, ME]8ZU??9]R_V%<*Y*J-HQ9"/:BF,B_1;>X66$W8&31V]/-G(V[5>M@M/&-EM M7:56+?5-6O:/*%NFKM?]JR:EUW(W;1CJ(H<*64(G')D4>+O',FL#=N@J=)QZ M(8$GS(\M#G7EQVXPW'Q&D]85ZU--?T^Y1]%M;AKO+8SM!4"4'1,,%7+9MAV, M)E!2++Z;)!HM(HK$1742;N%D@V"EO#S7J;`B-7FO7$9"Z$HGYR-GQJL2V]IQ M\JBT8,E%.]Y329%(>J/)\$EDF#5FO)+N/:K.`*#-,SG`P)KR\\P#_7\'L>.V M'QOE:8SNZR.N=/%=+6?'>'9GV_O<=QMJ16NZFSB=>P$>M&)*JR,DZ<.T5E_E:""D@82)!G(\&^+(1`S M+RS69SHOCC,HL>1_*AM9=CJ/MV;K;3[:">\2$0-DU7QMD=P;#DX3@GI-ZJJR- MN[?-UB9])_\`/&7JD73BUU'*"LN5.&:'62*ZD$@C9QFB^7W&6C[^OW&7E_J9 M;5@[@KFG(&QK4Z3&SHROGDZ[`Z.I#VFVNQK2;IM9_1!),$F3DPJ.4W* M[!#WF!.M>^^8Q.Y0&M2WB6B9WIDVRSGI[$@.C!A`<@?+2IKMGLUKRMUD^@;U=(_7_'>'0X^ M5IO=N4%A?MS&2DM15&4JD<_0H*KD!41G9TT4@>(34DU4D&X(@N&QW>Q?*G&W MR)5PV5!O%,DB M+^R04>+"BF*!%PQ!/>?E77U=3]EMN7=#.^W1:GE8XOZM=<8ZI%;4Y%)-V+=^ MVM5?J\G&M?L13GC,5WYG\TJBDS@T2/W/I>Y;MU`RTVP_*XG>=@5=;G9QV)5- M%TMY9^2FW"Z5K1M;Z2GFL6E,_FY7ECT])6[W4L4H+ITW8E1^7-BE]UZ3A5%L MH&)M]T^6U[6M:R#/E/13WK?5B>,^/6G77&ZG,-D[*H;4K=V.X;'%+Q0I:DUT ME!J'DW*\V8'#1F5(ATQ>N$F>!GB.S_(^I9-J)*^1/23+5G'ED_;<@=\2'&VG M,=;4R_,GS+OU735%VP2NR[HSA'0KORLTD4&3X48[N5>."I%#).`G(SG38^=\ MCIGE'L]Y9*C-<<)S6R'AXM^W))/"-Q247*S`@'`Y025"+ MG.5AN';/`+Q_4ZI1\!R'WO?XR$?1\W-1NN)=>VMHG6(R-@F(VN;=@X^5DI.1 MCSH*J.6A6CTH)G!T54C@P8'`\=X-*L>0C)V:3DT'K!`CQ'J"`(>X. MD0#IE*<0NYP&`P&`P&!21Y[U5T.&=`7;-C/7*'*#4J[9D10B)WKE&'O2C=F1 M93JFB=VL4J8'-]4HFZC\`P+HH)Z_DH2'D96)4@91_%1[V2@UG2#Y6&?NFB*[ MR)5>M@!L\4CG"AD3*I_44$G<7X"&!RN`P&`P&`P&`P&`P&`P&`P&`P&`P&!7 M'Y;Y1_!^.[DI-1:Y6TG$0E'DX]P9!LZ*@^8;4HKIHL9L\1<-'!4ETBF%-5,Z M9P#H8HE$0$)-\3!$W%;C.(_2/'[30CT``^(ZYK8C\`Z`&!('`8#`8'7MY0-* M27GCR?E-J7FTCIMKK3A^E>>/FOZD,]L+E3;'#O;:FM='P8I223Z1K4I+,3N9 MR,21]O+,_P`B]6;,DG"I@R>59[<>;3?I221I)NBXFKD]'T;&]T&249MQ>/'"2:4M%)I.UU$XA!)%< M-LQ)]@H[8M1E[%0D^8BVK54]W;H:3C.1XT>+K0"JS9)+66M&,B=C"/\`:KJ% M8&MAD7YDH"7^V$B)F1(QBL&8!*VYI:MP/)3 M;E9AMS1,4$%SVYW1)6D/K'B1K%N@A(QO%7BTA-HKLU]BE1%DW<.4VQG39^8D ME(D6E%6#-`/V@HU*(@M)PS'1AFD0VF91[X^>$L\JW3L^R+1'LP>2'-+F8J[. MH,8G"NWOSWJY*#R$4D#*+%=3KIHD@&(SD>B$+R5L,KNZ9+%1[B8C^<_D(5IQ M/FEE2:.DX.1X1<+X-P\686:>F=95 M:$TU3X#92S0L[X^N$4Q4G[/77&'7K5\R*?F#RU9P)S1:%X:/&JJS*/<'6=1[ MUP5FR!>4=/5VX?@]7U^TUYM,Z]XGY/14K-"3EGR^:%<1.Z.?.\59!5)IQ?XS M)LU22B&NC2B1X(P0YQ9)-`-$1(]OS.2`,RBU-FR&SJ4U+2Z+$R;*MX1LLY=!K_`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`=)ZG&71&`F-NN(9D!E!<,R#*"F$O*@DT;M6JX87 M&K4I.IZS>!K.??\`&.Q2Q'G#[B))),AW1SXY#*./M4/)#D2X>`Z[]=&<-TIT MB\\JDU12].6EVY?3C8\P?<:>FHRS[DGK%N"!)M^`@2U[G7S891[V)UOPNUW' M&!Q%\:N+46\8+M7&QEF3X6[Q^T(HLU=*$EY+U'AF4>F'`.&U3D(+0T9&ZIF4 M]9/CS#S@IX\7,OP#5)@W:\*N)H.%7SN`=,8V M3126?0PKJQCLGJ='4XZ3;(!QK=R0B^E8QQQ\:)+MGT5,>.CQU$TJ*;67W=>$^ M',ZVVYLMN4$JC+;3:[,@D+-`:W:H%".CZ!14B-X1DU;&6]JJQ63#\&!YP.*EYV$K[=!W/3$5"-7+UK&MG,O(,XU!Q(OE/29,$%GJR":K MUXK]5)(HB=0WP*`C@8G4MMZJO\M,P%$V9K^ZSM;,8EBA:E%JW,MX*)K\ULV)KLI49ZXNZK`;!V'78=BB#=I)E;$?L4W": MC!0`]L(8KR\6M$GP'\9.T]=\57'("+UU4DY.=@K/3IBPP-<8AJIG7E#VZIT: M3*X-%6&01,^1>%5%BB>/3.HJ7U2` M"AI3(WC#;V\=M&"O.Q)78TE/;(JQ8!:N7+7HZ9 MR)D4V)C++-FQC@W.!0N[P&`P&`P&!25Y[796'#.A/3(*.BM.3NJ7)FZ"`N7* MQ4(6]JF39H`8HK/3@3HB4!ZBJ)0P+H(*53GH2'G$FUZ&Q9E=/WBB31D@9PN4 M#JJF*FF41,80`!'`DSQ-(9/BQQH(Y(BX27DWY+N-6UND0^U8?C]H.4A>3.T(^*DJ'Q0HP1>TVFR=E>TE'2` M/KM)PC@C2';`!&BX)N1?+H,TU?4#7\@VU2;6JL4C&76Q<.YZY!-U>!0D9>0Y M5>6SD8U>HNGDC*G<$;6";T,WDT$%5G9BIMI)BV(X4,A"-TP6#84>:[NMK6%< M++2WO,=?6$E';VW379YE*<;_`!::!9OO1?Z^UDB[:#!AN`*VT=*BW<'11+<9Y]=DPY M,\D+5;HR.G1U`V;P"4V]>2C,T0Z5(D_>"+)..CCAOOYS:V$]MI\_VQ'+[\B: M\X2YP\SV:<>.K^"^IVL8M,/N+_&$5B(H!LUH5-%-$$FCER#M8)65]1X+-FF& M`V**EVE,U,RUYJ6*<1CR\M%.`/!B_M)UN]W6^;2<>G=^:'-!(2(S,B5NT?NK M*Q)/&8I13A5LY>JJRKI!%(,O,T9E8DJC/R/US6WE>@]/P;:>.T4YD-B9&O*-BR30K@YEXY5T=BW!6;> M+J(!Q[U6O(,MKJ*;+&>T-8I&/994![YCN7F/NX@/V[+BEQ.2@G2P*T,AT M4X(S"NF[&:3M:-C5OF*+-D+>,1>.5@U^Z1UPYU(Q9>[V1 M:^'4_L=:'D'46B^EN4WELY'S*D<1"104<-H!Z&FVUC1=*"O[HC"5811"D%&" M1+Z@9[%CR!;;?VJUM;C4T1R4B6!(TVSZI.1\UI+QG<*9"+:R;5DDTFX2N137 M=MOC8>6]F@W;K&DB,VKN262B&K=`X87&*:D9Z;I#IC1-L6+C"ZV:TF^,VB7, MBSDM]^3?D0O+*VDV]=N.W[0TVXU(=PS;2*/S(K1NJT;_`#.4238(1K`P?CM" M9V^PB^1\[1MQ4=#E/6*0"7)OE=:5EX;0G"ZE,VK>29.UBQLJZ\>OCXE(1RP5DYIB1*- ML/-7EJZ>"J[9*%19HFO#3]OO#681A(WB/Q.?$07CJ^UBG)%(]PT@$W?R@KL$D.MAY8;.9PCEK7EMKS$^D MNY=!(G!XBV,:$C>Z37D9$0R:6BJ0^UC=(Q;9UUL'&`U@80G*3DO%#(.-^>1O M?#B5?5YMH/1SN/>J3B&O6%K42@R#$.@9>@*D'&*IL6\A(&#RZBMO&OE,9(5/ M7L+RUC*>WI*U]FJBFU!!8-MRCG8S#:%R1^U%9CN5PZQ*KO?> M*4]6G.@/%/QT=.D)AEK36,:_B&D5*;'FZ4T5[E#D2=23YJE).A2BR)(@'$2S MZHR6H:C\NIMD8:0MTFVD>&G&NW,F\YNCGSR7=-%;$TY%\E4UI9I)3FJW$V[0 ME7K20;MPE)8Z9/E\*GO",UTUC>>G,V.3;--8\) M]=1,8F^_5MXG,_EIHF/VA-.'YSK'-[V0:+$)(2!%GQX]F4.":)Q98+1"[35, MFXUVFM8#^/C@&^.92VV:NM25Q+0L0#IF^-*>-;QWJHO(AU6 MV3=ZN>0Y>\MP6=RJ<7\J6.K*-DI4ZIH@RBB)`7FW*BR`?6M"L&K'D"YEMPOD M:(06SKR,^0A`\BUL.PK-!.QC)?AUQZ%6L-*UC'6RK1M,;7F+3`Z=6NDS M&M/F+R)%9TNQ*[33^<:996"UU=]? MZ[L=]B=IT39CZS-F3JG;*A(F#<7JD)PI',>.S]?$C55X4[M(I2.'7>59(Q`' M`PKCWP'4T+R:I%NID+KBF:/T5H62TYKJ1KPR)]T[D<79>K3EGE=\O$8^*K+[ M[-6:`>.V*C=,ZSQS)F6/Z/I^F(59>)!ZC&\)_*/(N(UE--X]QLU\O#29GA8V M71::@LSA6+D31[IC(%82!$Q26%!=%;TSCV*$-T,`;;M$'Q?/XN>)%&W7&3^J M],S^Q%#7JU4"KHNE-5[18L]@V623/7K]4=A3#"O3UN;/(DYVY!=I>Y2("ZB* MBI50USY!-BT^_<=/'?JA1[.Z6U[:ZI1]A25ZMLI"P]CUW`.6\!18-"<,^F(F.8M&B,>S.LD@D@0!P,QTRVDF?GKD&DQ*P\[*M>+=:;R$U7 MH8]<@9=TCI#6Y#R4-7U'LB>#C7H%!1%H+A;T"&`@'$`#`^?2MOD:E??*\TG^ M154KNHG%V!1JO%21HT_KFK M5RIR%)EPK+IP1#JXDD))1V9Z>@V(HL9)A&LE5U!`![$TS&'H`".!<["S$=88: M)GXA?W43.1C"8BW0I+("YCI-JD]9+B@X32<(^LV7*;L4(4Y>O0P`/4,#D\#X MF,BRDB+*,7";E-!RNS6.F(B";IJH9)PB;J`#WI*%$!_?P/MP,::7"LOK5+TE MI,-%[7`Q<9-3$(F*@O(^+FE7:,6\<=4P2!-ZHQ5`@`83?4ZB``(=0R7`8#`X MZ7E6,'%R$S)K"WCHIFX?OUP267%!FU3,LY6!%NFJNL*2)!-V$*8YNG0H"(@& M!Z0LS'6&*CIN(<"ZC)9BUDF#@4ED!79/4@6;+"@Y31<(^HF8![5"%.'T"`#@ M[05>>2#F3UY84ZM;$'M>L<*DRFE8QE,IH,'LY$QS&P-3QTBBH#J.4=M.INS MU>\IB@&:8&$RVPZG"7BHZYDGSY&W7F/L4I66",!87K%XQJB+->=5>6!C%.:[ M"G;)2"0IIOG;95T)A!`J@E,`!FV!6AY@+`%=\>6_G*2[MM)/2:YCH)9DD=5T M2<7VK25HTZ()@8R9TUFW>!^@]HE`<#JWWWEGN_76@.-"6L^1G+RN6JP:^<.[ M(M,;W50HA4*Y:;!1V<'JZCQC-.60KD`C5C-G"KER@9DX*1$I'"9R+8$G_&AL M[D'RTW2YUCNOFCRCKT+/0U*UUZRMU(U-0 MS@CAY&JM@1[D@<"8Q"!+/D1H'G%3.4VD]`T7F!RTI%0WJS=P]4VU<-V2.Q*U M]OH",MM[M<($9#N:G92)1-'BVK-`7:#3YB_26=I^B@;VZ(:WN,-N>J2.ZYUS MSWY([BU7JS>%5T&UU]7>2S>H*#9[<32DE!Q]I)-;#K]TM:Q$*^#) M=)S']R*CQJLU,X4#\=<:\CK+,Z^V/N#G9R;TSIR[;BFM/R6MK3RWL,1M#1C: M!U=L2=KS'?=FL;6!:5#9EPM]1;%1B?EQ6;9@8Q"NGIU2K)ASUCU5JK3',/?N MK;1MW=7(;5LSJ3C9";.VOS1V*\D;H]UCJUY:EXTCF8U3`.BK2[XW>*K0D@2/.C M3Z-%OUFL(ZV-+PZ)@0*==%S-/V0OGPHPR:22@8/&OM=#K#5YQUYL1]Q?F;TZ MCN-G&EI()O-Z>2[=)YJ6>O-]R+'GCJV$&36&;)A(R0C*.&J10_,L7.+'Y(2=CY+1L!(I M(2/Z^OD/B:PXCX^BQS!_%14%PWXCJJRSTM<=UV-$Q)EXT]^HSD5TC"BXEW:: M+0.0$]EFAU=`5G457CWQ8YL\\<7!JR1+EFQIL1'2*#1_S;YC-([UDF(10I#+ M1B3HRKEFZ?BW(1:>=JJI!\,A*U!Q`[;9J;0=N=32\@A7>1<+0Y-QQ[XY+2D5;DU.RS:#&MT=P@]C)&5T MJ]E?O-4@I?'OI0D>O)R'%_C` M];3#&#UTNG59->5=^/3A+, MP5D:3FUK[&*-PFN:/-5=9D=ZWC(M^^2L2:DP!',>U*`K-K)I)!]T@V+'' MWE'6+=1X[N9IH^1/GU`F5C)I6WD.V0KO"?B;ZK!\2,6ADI)&..SCR*NXU!\D M4I%+#("*(?-'Q5["RZ.18Z5J=:VDYA@)PAX$/D5V5`XHZS1F):.G^7_*N+9) MN4%+\RAU4DVWP46:RCKY>R%637>ND`XE!]1T:=;4W>Q['.:!5O/LN9/+!K'N MOSK>0??BKYQ%M>+_`!QB85([]WK`9X1A5B0:A68,4#0C$WI!)OQ#]=@7Z,$Z=Q-TG-V6M-=%>.S0\O'MHT;Y;8-1[#U:>WBO#I.4B"U M]RM*O`3C(P"12+@RH:)F=S<,(ZN;3US)[=)8-!4&^JS>VF8;!CI7D?Y..2Q7 MT0HLVMC`S0T[$:(C;.W4;+G*HA$2*8D]`S:*9*"L&JM@>4#5U6FY:944FFO+ MY87>HY?;U6@ZM<]1\4M/(W22D'\/Q;KSZ72CK;,FIC]"&/+BVB$)QW'-7KG\ MBF#=0-GZBY'<8-T,EZC1F6Q['Q_UC:*`PUIQEFR1CK>7D$Y974)BW!<=^VU29QP!*-X[M*%EVK:9C=5:KNUVM>2@>S2##VB* M?L-$E:ZFFD]<(34ZCP)X(2)G!;GR5N;%D@Z1YCJM/*%G&JB MD<*Z<@Z,O(J-D#!][Y!RD7<;J;WK%(,V$L>.\BOD/(S&NQ\%',#PS`G#/B8@ MT5?OX((M@[2C7CJ.[SP[EP*P@XFWID6X?*_`(]WJBNM-$0C&0,Z\5(EM#R3F&@8-5PTC3_9Y4RT:F ML:/;%5FW`*)!RD>UMTW/:T;.=0-HW8L;5FLEX\N!"[QR.O=!5&O,FT'^MCRN M5^7,VS6P1[^3,[CV\J921:"7V+!-2<<.EFP:^X9A6`\PUX)"[;G]\6='B)+, M]N;:E'W)S1FR:9(V.H40+5O'1S*/%6-8%9F;(*J^D8<5=[R57VLVTA8XK7W)0ZE'/Z88)!R+EVW775%11`J:8$(JH(57>-)6[H M<`_*4M0'%6:S:4U=CNU;>E+*185T-8SWVE]L>&=-7C>:"$]86*H^JD1T!!42 M4+U*(87L'?4QH_Q_<*]96IK(N:W;S;DVO8W>C]NRFNSOU&5VD8.I:UHU^U0U MM>O%!A/MG\QG8=X1=-I'Q_8447H(^H$WN9W-;?O#'B-Q-CJ3K>K6FW[!U>>1 ML>Q[BUVQM>+I2T2W@95HN22V7&1]@D7DFVE53@%@=$=-@#I[?L3*80TAQ+MG%?3D`?-8UJ\6*/M3. M2.@0Z%.9-7N`H;EXN:H9;9GO([H?;%8I]^J$JA=5=F5_6>R6YI5?81-JV^X0 MS/6K;[=W6?@(FYJHA++^_,P"(F2I1BZ3LS=4Y0D]X:]=5UII&W;E&2O_S,!4Z#ZKZG5!PO/TRB-&+N%2MK@RH,F:R!P5)_A`B44$`N.P M&`P&`P&!2AYY%`2X>ZX4,H"1"\I]0"JH8X)D*B,5>`7]4XB4I411$P'[A[>S MKU^'7`NI;K(.$$'#55%=JNBFLV7;G(J@L@J0IT54%$Q,FHBHF8!*8HB42B`A M\,#]L#\02*GW&`3?6-W=#")BE$1^(E*/P#Z<"L6\^25C1-E;BU]/:VJ=69Z? MV(QUN[N.SN16JM7P=KF9>GL=@11JPG91]TZ%2GRC=TY3.!1:'5!(XB<,"1?$ MKE4RY40FT9)O1I*AO]3;8G-1SK)U8Z[;XJ6EH.'@YA6:K-FK"RT5,P#Q"=3] M!3D!0AB")@`P"`B4QB&Z#^X8H@8H_>P/!"%)U M[0Z`(B(@'T=1,8PCT^CJ8QA$1^[@>^!^(H)&.!S%$3`?U`^N?M[^SLZB0#`0 M?J_#X@.!^H`!0``^@```^\'P#`\X#`8#`8%>WE4F5ZYP*WO8FLB_AW->'5\\ MWEXE%LYEHE>&W-KN22E(IJ].FR=2<<=L"S=)Y$M@4=.W;RX^P^TZC0H.5LLC'-W[".D;7`TA]M.8NDK- M3L0Q.5))PNT`P>X;J'4";.D>"FH+#&A!<4>4O)35&K-?/4Z3*2W'KD/K*5K. MUI!N@6U_G#M+NJ0TN*EW=-K(6$IM8UKU2,BFDH<.#LOBUXB1FWGZ]L MYK212@`-S'` MXAT$,#'T^+/C`+897E!K+G',Z@K\%]EM:*6+2_(36=)I%1L2]*@:^PC(N295 MIPE`V:YU6F(+O4DEBN)$R2JQNI.I2AR.JN,7CNV5R8H>PF?/VU\F]M5UNZ19X<[5NHF(2@3DJ,_U5K@C+7>R9WB];-@MVVB>.T_*,S<@O*! MO5U,.WLKNG>\A8$#R*FDV(-FUB%635]!XS:IR$D1*/2CV!PR5@2W-]A[46<; M?IY>4$146CGFYRP^91S_`%#P&TN^)-.VO'KC&T?F9HP.S'L7'(D$ZZ1B@LT- M*R7J.!;M`#B4G5&1J_'^6+KZ;?Z6+:XYOX_>#_O8U*_0>- M132A-`5Y%LU<)\,^(R!G;J1K4G",E^YV[3%5U&+.O=.D'$X[:MVP8X:'*M*: MQ85O3S)5M*MEI_Q[^/N5ASQ43%ND5V:LGSCYHJQ1'2;$B4R[/)-T94'+IFH] M*F059IPJ=H'VUQQ7&D-O(DAMA[:]>M#>S\C//9JM:VEYVAL!&:<1,?Q$XLLV M#1XY9P$0_=I0"B4,=8D>PD",6768 M&S:?5;:DX'Z.+!N6TGR1WC%0L4I'V#:R)5DFJ:"J;8AW#DD7%J$<@^=X&-.S M4&(UE>RQ+EQ6'8,_&\@=JIN#*;^\IG)V55"&:::U66&1;JK:>D[*NM%N5 M(E9LQ=-V:\8Q*E%H2#]4,H:!LN-V>T04+06O,YM1GBU0J:[^+=\=?$]Q*7CF MD>A/RS82(5J5VU(U)`$A.F"1IM4GH`9M`LU%'(:P[M/*ZKB))M%WBS<07VUU MY/3.J3NDY[?_`)8>4`2SE=Y>MC+2<>:8=Z?"RL4SI(N$F[1ZV:`]>)(1;:/: M*AG,K);`=W;;:[O:56@^0L/27RG*3DTV=JR&F/&EHYPB@_3X_P#'AL=DA%S> MZ96!2.#IVC[=XJ[;A(/P#M9M,#A$75>&)U(M%ZHGI?2CJ0??J'<,9>*D$-D\ MP-UPS<9*0Y>IE>^T:&#-5I-4C3?!I[:[. M(N_RU6+\CG/QNWD86#TDP@QCTG7$7B@#R,%U\^CVJQ&:0LR+?+3O@E%_>3[Q MLV2#AJ\SMA9#0J%0TW3H*W/V3LW!SA#-1ST5-Q6*6TJ2U-6'./F;&1S_P#. MUS;VN]=/(U'BAQ<-`"5ZA2VD@=*",6!5,V:,%@C(U03_`#)\(9=%$O<1LO6J M:&L*J7E8G27+CC)QD5N>Y[!M"PR$QR M/G4MBRD%JFUT>]*Q,K78=M8G\7772!"F8>JU9L_6#AN(]%Y.5G<6Q+UQ8UVA MK%&$T+*V)?9VR:[KU:$>U^DJ(-[CLVAO[D$]`L4K_(Q[@T6%8D%H9M(G;@=\ M:';+]0P^[\W9G6VW*G)M="L5J-16-=VMK'6?(JM0LM;K+<=@49#YWM?=]SK! MH6S[6EKRI99.R1[F2=K-T5WZ(I-$TBHBB%KU1A]D5#EESF)&I:2TFK]@=$3. M[>7-/J1*#4>.6F);3S^:GFVI:K,SEB=I[=OCTZ"A'2SA5DDK&J/7":B@-&HA MLML6N,X/1"C#5,](TEJZ5'@3P-E7A4KQOF\F,[=?KBJL9%5HHL\B'*C=94'4V];I,PX0`7(WTQ\IT)'M5#R:3GQR M>.MTLO`,H=%F\<.)3F-R\*DBL\CSL6SH9=-&6!Z>$7.!2&7GGRBJ`(V/B48? MD6D[W#/$K:`&1\A?D96?N&4Y>K/!KG2DN)'$V..DZ6BXB'2<#!]\*(_)@6(S M:)NIIRN6NXOERL/'<8.)3)B+MNTJ17Q@BO;UU95NU25&&C@,X7=O6 M&'6M.KX71R&D76J=;0E_A*Q0:C:'P',T5N2-?A$W$DDV`&[1 M=Q[<#*F2.LH'8@#Z`^\'X,#S@1;YL0&HK-Q1WI$;WLJM,U4>BOG]IMC8$#R% M;-"N6DU`S4.U[I7=]3TI=#Z`K>RN*#3B[7IS75FD*:VV/<(U5E:+F>\3Q%FL5ZS95RQ3CT MW@J(MS`H;T`AWXIW,?7N&WE1?)MJ];XNO3^S'R+>S-9$M5LS&&UG9'"`3L>S M$)0T%+H-@%PV(8JIT%#)]Q1$3`%E/CNV2A2>."%;Y&U/0G&AG7&\U>M:T[-&$OL:FD)*TD$'[H;.U1`E0U78#^1_>=,>ZRMDYMM;9XJ.:=L).R%L MOT!6%4AY0JR9FJ)II!(XF`LFY^($"W/`8# M`8#`8%(_GQ9MY'AE08YV056FKE,#D$#D%1!4P=P"` MAUZA\<"Z&OP<96(&$K4*@+6'KT1&P<2V,JJN9M&1+-%@P0%=]_5WE"J\5MS*$."A3D5X@LJ115%8.H7I^"KDIJJE:;WK$[3V!KC7;RP[RD;JC+ M779^OZNG++S%0K#9ZT8PMDMC>X./9+1_>=ZHV.T6]<"$<*+)+E($P-UR_"_D M/RCM3NT=6(T+<%$W3JR'L]:FW]VY#0UUKU?LTNYG(9PVGZA9"- MIJ+507379ND#J)E.5LJ0."TC;^![#QQ5JAR5RXEC-NN/S:1L5:EIW3B4Y,[. MA=?.8UG/V&"<.$W;[8"#Y`I2NED1?D7^!#`/0,#4FB]9>/W;?#3A*$WR&T]Q MZVQKNF:SO,Y=-7;)TKK;3>$1*W7(ZDS+HIF07"0J)=CNME7)25W13T>6-?I#1ARGY M,M#P8Z&\=FD9:3BKWD>5GLBLP3IUS1Y[(E;*T[BY17$H M28?\+>)9'H.AKEH]H].=5TBHY?QAP(Y>IK3#IHS;!COIE<,=<1,#H]FI6'JB M,CX]O'S,,TV+Z[2\6FX,ZYM\RU5@<2T7`LUY560]"95'T.J1E@7GW"`I!]3D M"0?Y]_M#N1)C7$(UFAY%_(;%I.VMLN]O:O6RT;Q!XF_*%EDH!*K0L@:$<#&( M.%H@CU-))'YXW$I".D^&/!Y>4F6.O.*.H6Q9.. M'EMRD=1K284E+XG&N&Z"1'"""Z;MQ[..`95:1=)!@4B[JD$-Y^1O<<=$N8F,XS<=D(84W;?625FE'L"=*$7,T(U9#&Q7Y( M'[W`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`@F5NX2;A*WAY/2-EM&T9ODR MC;>0^^;-9M(26D>,"%GC9^L@JB&0-(R)CX[ M?)`W5/Q\*C-1K[R&^1I&:6B9JVV"#=MCH<3^*"\:X>&AVG-WG37# M?+-B\K]E`U7CJYQ/X?!$^\;FA47!%H15I7#B6+3.,6Q[Y%T\?IA^RR]AB+EJ M")KNMV\5R.8T\"<-^'CUUZNG.!6DC0RT`WY+\H&K%0\8&SF\']C#8&][FL\ALNNM;C9*. MX6*2-_-[&.4$XF,1BP&*:%CCMVRBY$O75#LFA]`?>#\&!YP(!<^Y:1LFO`X\ MEXX7?D)![WKMJC)-IK[:.J]>6NLK55:!EHZ<@VNQ+-!/9:4A))9"2;KLD7C= MFNR3]V3L4*10(U<1:'R)FN4L3M/DOJGE*O)5'6-MH.L+YN.[<9GM-H=>EG=< M=R+%6K:843F);8EQ&(33=SYR=%T&Q4U2%ZE$H0>\3[.0B^*GE2B_8Q;F4B+5 MM2))&?+$IZ%1L@="F5ZJU*RPM1<4*8*Q"23>I*" MY623+V3(/8C7:"(E0<%,TD$E3*F`Z"AUSF$-_>-6686?RHT"4:Q^K&,?)\ M3E^R)TVV=H:N:-PI4`W%C6F,FD20;H$(3M=HN@,X*]]8%A,IW#@67<MX2+JS+:;BM5>FZEJ6NJOL#2M,L&PZDM,5Z\P1U9S91(9\W282 MCQ2/!.#EE0*FJHNL=)(.?\'T3?&G%VX2]^U.75KV>V:*L/ZD.[K#VV5V,H]/ MBX.;P&`P&`P&!23Y[FYG?#* MBMRJN&P'Y,:O,J\:")7+!LE7K^L[DD5`*;T31C5,[CU!`2I@GWC\"C@3FBN< MW".JQ$+6WG,C2$NXA82&8&F)_<=(D9V8(A%M"HRTT_;R**#R6DT>U=RH4B8' M64,/87\4`^_^D%X-?Y6_'K__`"M3O_"N!ZCY!N#(E'IRXX]#\>GPVO3A^(#\ M0^$J/Q#`KHUUR:\>4?MKG+MW:.PN-EL>_GA).Z[EIEU0[/9[-2D..VDF\LQU M^I($=OYEG)6>K+,R(LQ.FI(-CI@'?W=0VOXHN0>K]].>55JHS>D4M_=-MU#8 MP:BJ\\TDGM*K\AH_5=7*+QFC7:CV]MBK;UL[5;L18A)HN$DG+D"^LH%P>`P, M/6V#16][9:N7M]<2V1(UAW=6%%4F&);8[J#"21AWEG0@16^9*03:6<$;'=`G MZ(+F`G=W?#`S#`8'Y+B<$C"D)2J=2@7N+W`(BH`/00ZAUZ#]( M?O#^_@><#`JSLJDVVQW>HUZS1\O9-N!GN!C+BSPK.PP]9>2[1O.SJ/<`]RG[@=,#)L"#_`)&$(N0XEW>#ED8EXVLUVT76RQDZ196) MF%IC?&M6I8A^B@`JKM9`AC)J$#\<@B&!K?@_QEXX6/AWQCG[)Q[TG.S\SH_6 M\E,3,[J:AR4S*R#RKQR[I_)R#Z`6>/7SM4XG455.8YS&$1$1'`E&;B/Q1./4 M_&/CT<0^`";2^MS#T_*!A$QN,/'DPB/41'2VMA M$1_=$1K741P*=]H4EWI7GWR&C=(DU!QJH3OBUI"W[$WE$U>IUT_'K4T;;]F( M;#E*/4D(H(>?V;LAQ$HQS%R9DY]J)DU5`5,@@@H'',8.BQ-`TPX5UY8'NA$K MQ%.N#/#UR5DGN7F]M\S!Y9$N2')UY8A4>&J))]\O:DS/`;MHQF8).60!;V4< M`9.LK9@F=RS+CD!"M]L,X9B?G5SM:LXL:3Q(ID.R1E4>)?%$%45F_P!L2)S# MQ)9RD+E_'KNRR$@FM*N63!N&&1;VQR=3TH>6T-!LU'\9&2/`OQN>Y3F1E[LP M9G6'F'RLLSEK$2GV:B55UI`#3C=,8[O*JKZL\N3TPYEN[6;.=SQSS:3!^T^4 MRK?R6^1%)M,Q,@VD64BS31X@\2^XX*QCEC&/?DS4(A-RG&%=)JI)JV%8J90_ M-TO:&,GHI6E<=F3G=4'"&2X.\!9B9.UK'&J@,)(_S#F+RH<%?)I1NQ))A(H% M20?J$=L7#H6;59U*KOW:(?A"KT2-IFT91_LJV36EI"V(UKFAS'6DY-UM#G7M M*(;.8R,XS<4(R$DGTHEKM":D5X%3Y&+-/&Y27BT-!^-WCF>N)5]+=/(%E7SNX:4VNK6C&,@F98?=.'98 MU@*#1!P\`-.3%CE0AXXKU)*K26^;+!0OI"9$"*R3M(5C&;0[,AW@8LU0H] MDI%`?DJ5S?\`$^5D/=\9.*TR+221;$8LE@_2H6G?LG=^3C[:<]J#5V[(0\A`\F^7U/N#^WT'B-Q@ M8UUM(U/3>D6K]&*:5_<6=R/"#@58E3#<-T6URDBJ7FYS:0DO2+E`["O$9$ND^:?,"8D[I6(/;EP96X5XO@1Q$LL8\& M3@V2'S%Y`G+!AZT810A4TSR[TRJ`:;MU!NENWK%Z@#C#,5MU6>..IK?Q0XZ5 M7:VXZ-KKC##.[KLTDEMWD';Z/.PCBO;$9U@7+B143`7[F2?(QI%W#CW#DX1U MT!IW1]MUGL'D;M+:ESC="T)U5F&X;:AMG:B15NV1 M:MQZL\?5(L;>O1],LSJUV.:GHR5W>RIJ3I9>,*9@V,9^LW*FA$D4<'"9$>KK M^1HC61DR7>Q<1'MN2;0M5?)0LCR*\N/)%>30C#7:9*H]:/K1I99\DW=-&P&: ML91DV!TY*A7VB;6E)_84BPBSII-QE&II!TU6DWXH1[1NV4"-&F^+ZVO*Q<+[7 M>0O*N(<\H]HOHWB!IC4UI@ZUNSDK7XA_9AA-X[E0M\"=I`5=VQD%9-Q,.FC1 M&-B#*/%#&4?MVPA)376I'NL4]NMT^2A<7VRK!'&08O3^HX"#00:&,D$H=FQ1#:0I,)#\T#*+X]MV,8V=% MD?'GP'6C7T<#)RC(,SDYN3?*=NS14(ALYC$ M/G(%]54R@"]"(CRF2.!B*+ZA%UQ96_P">6]2O'%ULETERHY2MR));K\D^ M^737Y,QXX<>XN#14>R^IG)S*0:A8M0K8S5$T7&F*@G(R9@Y7B@ML-QY=C+;% MHE(U(X/P*:_8S2U+*U!;36LTKO6T*)KJ[*,4TV"M\B8=(%I`&H>R0]R1!M^0 M1)U#L-A]`?>#\&!YP*TN<]=WRRV_Q9W-I#1=BWV?5T;R,@;+5JW>J?07+8-J MTBL5N"=OY&WND$7D4FX8KK'2034."[=$P]O0O<'R^/JX\J8&D:KX][PXA6S4 M<#JO3<'7%-S3>W*!<6=JL%19P4$BR+5JZN]G&"]@1.X=E55<+$0*W$ASF,8H MX%>OA_J*<]J'R6Z^CJFUMK"?WS=*+]CGUH>U)I,04S#SE;>Q"]M08S4E"D-# M.E"^[(@NX((=2@)^@X$C-5^.W?\`3:FQC8Z4X^TIQ&\>-^Z:KK*S5E[OR0K+ MW9FZW%SJ2+^QW*!B/MG3VNO5"LI=LZ;HE>2!"G,@JE\`#EX3QJ[*J"QSTY7A ME!$LW%RP:DV29IQC:LQM>W;"T;)N[X#5G))1J--]S'M!^1@B1@=-`P';&,J! MD0KRXD:IN6DO,D;4.4IVW,>:W3KA#3&U]UUQ9G3=J2\5QYL1G#V= M+8$WRU-*C):_'VK%FDM*5]N:IU!6$;RCX%E`8G0U09,636"C$&S1HU2*BW;-T4VI4TD$$2` M4I2@`%*``&!]?V5K'_DY`_[CQ_\`WO@?$QH='BTUT8RF52.2@]?@/QP..BHEA#I+HQ["/CDW3E9\Y2C&:#%NXD':AUGKY1!!,A M3NWBINY50PF.H;XF'K@O7[P?>P/;`^!%@@@Y7=(MVJ"SI4JKM1%$J:SHZ:0HIG/WHIL8E9H9PJBZ%-%%4.8?ED$K!OUY*;R@FNR8F)%KS8YTQ,; M&M*'Q(UZPCEGD'Q.XE1TLK(JH7)9O)'2=J%.\>QZ[T7CXJ\JYCF+<,/F#1#2 M'U!6([1K12HN&[65\=?CM^6/$)Z^V:-:Z`V#DY05X>1WX^G]NPE>,^@Y!MY#_(6P2E$"P,FT\2#,3KRJ='B)1RX@#(09@4:M MD@C8X_KJ/'V!L>)1OX7;6K9SKZL5_?\`68917BUQKG M)@\1+M8^3VY/U-5P9LBJX775<)@QC#HD3DGA0U7).-8JZ[OK4UHV<7B38=F` MOM7>35_&RO(?RN<@'[^/KRNG]3QK0&#EYIB8=HN(D1C118.FB16<>+:,3=/, M#8HO]MR&X)]!N]ID1RG_`#>Q1VX]*A)<:/$CQO<&:LY9(S]ZY/"2G(>PUN'( MHLW11:HOE$$Q[6\&U,=R&`**Z\5H=2>OX:]3?%>UVU=_I_3DHJ*O(KRS\GY4 MS20=;-W"T+VKN-0-I^-;2*)WI6[!RV*B\>IH1B+%DJ&U3+W`E]W7*RVV:G`\ MF$M?1,7RXY:,&B:6C^`.H212DI&Z#T"%@>E0E-HOQ6%RLIZG?[H_S62(D<(^ M..&+21HU"OZ/BT-.STM3)"9D_P!1_@I,D>_;'D!9".&"\ES(YGOY$[YTTK\* MO('L(EET3+QRKDK]Z*TJNBV;!^ARC'GVK9[%NYO[Z)DI.'\@_D"9KRL8$1&M MY8D@XX,<+N\CNB=9BZ=*,6AG$TZ M=N&P5-+'J3D-=+$:MZQ33WKR@EU+(5OL79%LEKY5'M8T]7:@0\ M]1]C^ MS<\P5@ZUK.TTIC<&-@ESRKJ(;-9%"$?G;&2*0R[APT=)-/O MW/4>K+Q>=TW+1&\-,/&J?:LU-U>2S?CL')7$->3(X:J M6]JY7,@J9HH[&.E%COY`BTPY9,D0Q(C.-/6M'5>`X^OT*XPF'DKX^.",PRM3 M&`_!R32>QL-IF*K2;5L7E[S,.T3IT74-YNWVUK8?4BIBPO.;GJBD9IL[D MSL6/!W6V?%[B"G&`KE8#B>)B@]? MUY14,*=2>O6E(V&\#;^P'_&^=V+)1O(CD]%-:[)[[\EV[9`C"N->.G'M"LI% M?I:I9`V6KP_)P10,FV/'1RB34C^3,&S'*.W&=QIC-&I4**Y0)4Q5QH'42L=7 MY#C[XN.-W^`1SO9&US-7T;%S.V9"NM3M45F_IFD%F9H^/!&-;/7"X:3X.N]= MOO+E:'FLK!;+]!/N'XKJG(%FMZ6M_?:LXLFW6JK]84W%6LS\WI0YF*# M.("-:)$CD?8E;JJAV30^@/O!^#`\X#`8%`'@>5>+Q_.A:10]M(+@++`'3H!S_C"%_P#@>I_Q1_L?A#`Z\%:_SB78 M?Z`F_P#)#K_`[$`?0'W@_!@>KB% M5C0$7[5).O;`7=2#40*;TU8UHD=P!^@@F"7*B#2$C+&BXU MC'&E)AP#R6DA8M4FPR$H[`B0.I%X*7J+J=I>]4QC=`Z],#DL!@,!@,!@,!@, M!@,!@,!@,!@,!@,"L;S(1;*3\;G)+A*9+L>\IS"U?L=DTX4'J8%$. MBC8IS"`CU`/I'Z,"6_$O]E7C-_-]TS_)S6\"06`P&`P.NSS_`&_*S6W,S:5S MXYZ#Y`W>+W;Q_P!,Z_MNU=.0+UQ8:F M0.>F(-!_I?C>6NS)JW^>Z-7NHN^`/*Y?=V_1 M&*Y+0K4U"O?'SRU6V#MVU-77,S>3!PX1VMN> MJI)NBI:AU5:8VI*H:AU,BN?V#=").\^70G>5%8KQRJ^.&5Q=EYM0MG0LE>\7 MVVD_S'1:56X8:NE;+#AHKC>S-76D8>ZOJDBR92&W=KO0<.5EIQS)@#<5O1;^ MV5]=0X:_.3G3.4.9UN/CTY.R=:V'M1;8G*.Q6;9L>SV9RBEXX(ALQI]SLZ]% MBT8#4GRV-!@K$0C,S)>,[&K9RFF#@SD-DR&S/)RO;+GL6/\`'??6=X2J;BA\ M;6J[^I.-9\1JPX1;1[IWJK7*,2UCY6[2T:Q;>\EWJZ8F4:)(HHI1X'9'#%2+ M<[#5VLZQ?^,?:DSI8TRG?]XTZ9V!$/[ERMV\F[0>GO'('99X(KVTPK]ZS;NG MD$FP2;.UVJ"*BHQZ16.!RP7[RM.%]H7I/@;>6N^+O65Z#6-JHR\*SC-`Z?#U M&R-(X\Z]76.PI\Z8%T'+J4.\>K2;YJDNNW,FW122#[88G-DPZHJR/BGN1]!: M7*$C$:+F=N0I8C8>YK!(F5'=6[)R8C#/=L3D8Z(9ZD#ML5!E*+J2+E510&WH M!S3!EY1G#78UI4X(69/>FY+2_C]M;Y+O.A,+J73JDR?WNCM(-Y>1?'TM3TH5 MHV:1TBQ7?KIKD/)_EGBB*R`?'&EYV.;11$X;Q3/8;4/'EJFYT-Q_<;7A8_5] M:VY(2CYR?=5\+*+)O]TVJ.F7(N&*RJS0D6"B[L53.W`O2AC[N@^5%W3+I6#\ M(I\]@W1`*@6/B!5 M:I'[W+APH'JE0/*$QW7/[OAO'/KN'FV>D(31>CJ\UM^N#UKCK"0,;.L65@HD M>:WE;2TZ"ME>G`[Q(!32<';IG*@=0IPU_KS0/E#UUKYGIMEPF>S>GWMN9VG9 M=3F]O:T&R[I915>KD-"4#9NR8^996J8UE$/8$ZQ(8@D24CW(1*AS1R)43!'F M,LW+;@3R:EI>$XI4726U.1>N[35M]R5KV%JZ,L;R M_P!TY&V"K1A]D7>_[C1=J$MVV9IM!(OK&RB'+9!A9[`@DD!W)&Q&*0?B3FKR MZO-_VJ\U'HQ#4)W2)W$RFZ==[]LD1N&<4R]<_-HVJOZTH'CMUPRI'$)[`3\?Q;EG\K6:9 M5;K?BK6^E;$VC!W'84',;,NB;%LL^BEWAQ29OEEGRR1GBA#)AG[JM>99W&[D M<#Q#C&>S=]R#=/8V](S8T+'[9&B,IOYC':HI$VAN+V.N:'%PXFBVZ,.W;*D2 M44=F.:04,ZP,C"-\LOSW6:Q_'/IPVN]*PT4UU'HPMB@4]/TJVP[M5Q'[1^S1 M=S"O8MD1J*GHL9"076!@4ZRR)"NEU7`AC)JIYBUZSM2)>\.HIQ<-]3+)YO+< M#;94/%;4O]88J*IM]:1UDC=PH%USKMM#J#&M6$`DR]DQ.MZ!R.'"K@0YF.K/ MER0V+KBXL.`FI(Z*TK0U:+Q\UDI9*VCJ71[UXQ/'R.PZ]7`W$)IG8+YAVM@D M915T9NV[R(E(9=90X<%$ZG\QH:_GM4I<5JH1;<=P4M_(;:,OLBJI;'WPV>H- M'$I2=@WUOLY)]5:3(0R"4*#&!38>SC$C,6QTDSK&5#@>8XFTF6U7G#GC% M*/J36`JVA*:^N](+KKC>@O'(,)B9U15&.PF2#>SSPLT!<2+U1R[3;IBT;G1: M'.D8,'-H'R[+Z_=:U?\`$C0LA7[M?T]F3]H!R5^Z;[BL"&S4W MJM3D7R"`+0T5\O8!'MR1J9$XX3MCA+WAKH3G8[Y[2W*#E/IG6FH*FWXU'TE5 M*]K*V5>2K%?9Q$[57=>@(.!B;!/RK5H9)H^7,90Q6Z/4J2?:0$R`%Y0?0'W@ MP/.`P&!U]?`>Y*\@.;3PCE1X1WR8<.B/%7`NU797$;(+%=*NS-&!G2C@#]YE M!00%03=WIDZ]H!V"L#U/^*/]C\(8'7@K7^<2[#_0$W_DAU_@=B`/H#[P?@P/ M.`P&`P&`P&!2=YZ)<\!PWH4T5TX9DC>3&L7+IPT$X."QY:YL$LHF0$Q`Z@.( MTZJ9B!_KA#B7[N!@AU#`Y?`8#`8#`8#`8#`8#`8#`8#`8#`8#`KD\M$>,CP`W MTF5DTE%6Y=;ND8:3EU(.#G%4MM40I(2QR)).%*A793U/1>B=VV3!`YA,JF`= MX!)OB;^ROQH^`%_Z/^FO@`]0#_DYKGP`>H]0#`D!@,!@,!@,!@,!@,!@,!@, M!@,!@1LOW,;BIJJX2VO]FU MD2^NN7J+56IC(R*0KLU&\TN[*J0'KF.`# M>T9K>BJH\:*$(0_:<_;U*`@("(=;GS@G<`E,!1P(O>-"^U:-YW<;+5,.+( MW4JWYP):X3=BM))]FJVC-1[#=.EXB-)!,7D*Q+\?1;F[X!GGD=N M/)[7G)K<$V^ITCI>A7?;6U2Z[OM4UK&:G=[GIBZWLEEYFY0$7%/ML,CP,N@M M[B2.].BLY*Y(8BYO4P+G?!'L6Q;A@.6&S;BX6?V64V#JJJ%?.W;R2?(U*A:P M:P%*@7$I(++OI0T!"%!(SIP8SETL=1=8QE%##@7\8#`8#`8#`8#`8#`8#`Z] MO@#(FG5>:":*2:**?(X4T44A.9)%(D0]*DDF91R\4,FF0`*43++&$`^)SC]8 M0["6!ZG_`!1_L?A#`Z\%:_SB78?Z`F_\D.O\#L0!]`?>#\&!YP&`P&`P&`P* M3//4F*W#:@HE64;JK\G-5H-7*::*PM7RT#?DX]T=!P4Z+E!L^,FHJD8/RJ13 M$`0$0$`N?@VC^/A8=A*R!)>491<>TDI5)BA&)R;]LT11>2"<:V,9M'D>N"&4 M!!,1(D!NTH]`#`Y3`8#`Q=NE8OM*Y>JRR"M:5CT&;:!"'%)PSE47#A1U)FG/ M6%9TDX;>F0J!FR29!`1!4PCT$,HP&!P"K*PFLS202GF:562B'+9W6Q@_4D'< MTHZ24;2Q;$,F7VS1LT*=,6@,S"H_)&L$+:/<+&49Q M@MVBRI'(QZ(@GZY@(=7IU,'7J.!DIA,`=2@!C=0^`CT`0ZAU^/Q^/3`QL[.P MDM`2`3P'K)X<[,:Y\I:=Z4O[H%B3/SKUBNP3]M^1%OZ9R"(]_4!P,E#KT#J` M`/0.H`/4`'[H`/0.H`/[P8'G`T7JS4MUH%XV_:[1O;8NU8C8UF:2]/I-O:UA MK7]10C9NJ!JS5#04/'/'R"SUTH)G#HYE#-DVZ9P.LFJY7#>F!A,M7[8]O%1L M,;?GT-482/L3:S:^1KU>>L;J^E$6:<%)/+$^9JV*#/5U4%3II,5DDG8KB"X& M`A0P,VP*N?,[&2$EXW^1)F$PZBBQK.BR<@BV314).1J&QZDBZ@G@*IG,5H]] MP4XBF)3@=(OQ$O<4P2^XA.6[OB?QC<-%T73=3C[IOTUVZI%D3]NNZZ0W8JF8 MQ#=IRB`]!^`@(8$B,!@,!@,!@,!@,!@,!@,!@,!@>##T`1#_`+OC@1&TW#0\ MGOGF@I(Q,9(*I[=UBFFJ]8-'2I$_U:-+F],JBZ)S@F!C"(%Z]`$1'[HX$G/L MK5__`";@?]QX_P#[WP/H"`@BD32+"Q()(B044PCF8$2%-8[A,4R`CVD$BZIC MATZ=#F$0^(B.!1KY&-F;9TYS@TWL_4U7U59UZ;Q'VY)[`5W`1VK5*CJ\=L:Y M;6F\IMHV3BI=_(5I95HH+5B=9^Z:&72;H.%C$2,&[O'AR=N?*)SOR0W=KW2- M%_-W`:EF:I;-7Q\E!H3NM]GURUW&*M$I*S\S(RD0T>P3-!ZBW44:KQZ3E4KE M--85"$"#.D]-\2>8-FY]PFR=@PKV0J7.#8>R(M]7[36%7U@UQ/51YKG5ZY[% M/I241(T1M>[<\?PJ+=<$%I]LB(@<#@FJ$Y?'9I&E\<.2_//2VNTY5*I5!MQ" M.W&:?&?RLC-2VF9AY9+%++_!%2G/XNNV!=?@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M"L+S*_-?Z-SDH:,4CDTB0]*-,!().3F4A@V13P=DCCMUDBH20*"F9,ZH*)=I M3%,7X@8H2YXDE*3BIQE*0I2%#C[IGH4I0*4.NN:X(]````.HC@2$P&`P&`P& M`P&`P&`P&`P&`P&!X,'4!#`JBYE:TW]IYGO_`)':CY;S&I:]?9;5*\GKV/TS MKRV*I6]V?6ND&DJWN]I)*2;9L\C6S4XHE:)I(+!WB?L[^X-=:@J4_0H*@D0B*I!,7M%,P@( M9A)\*.?DLL19QY&[0W,F"P`6+I)HA$07@[`,Q-TZ<83FSI6":Q=I8NGC!*IKN<+4]M5QJ^B*G*$3!!9HFQ7,"9?K M%Z!T#)M.>*S>6A9;9N"-5WSEP]]-82J*G`I>@;T_4YYF_Y:\K_!M7_G3P-'\CM&LV MQG7-ZV-D8>2I48*L`C?EIH#VZ^5FG)$BB3]YL<(#Y56?*5,SIBZ0(80,<@@` M]`LVXC6"Q6KC!H2Q6Z>DK3:)C5=->S]EF02"6GY96&;>]EY,J"2"!7\@N`JK M`0A"@H80``#X8$B15ZK$-VE[BG`>@?1@=@S`]3_BC_8_"&!UX*U_G$NP_P!` M3?\`DAU_@=B`/H#[P?@P/.`P&`P&`P&!2AYYNT_#:B-3IHJ)R/);640J*J*: MID$9BN;!BUG;,5"F!M)LDG8K-%P#O;.2)JE^L0,"YN#B48&%AX)LX?.V\+%Q M\2W=RCM1_).D8YHBS2<2+Y;JL]?+$1`RRQ_K**")A^(X'*8#`8#`8#`8#`8# M`8'@1``$1$```ZB(_```/I$1^X`8#N#KTZAU$.O3J'7I^[T_

762?1OC]WK[!-%)1Z?7+):0.]KT0HW*+E%!F^65*<"@W4*)@`)3<3/CQ7XT"(@ M/7C]IKX@'0!_Y.:Y\0````#^Q@2!P&`P&`P&`P&`P&`P&`P&`P&`P(:^0!P] M:\3=F*1[9H\<*2FK69D'RI4&XLW^X*`QD5!5.8H`LA'N%5$@`#F,J4H%(H80 M(8,JX4%$O$CCJ04TT1)J2F$%%'XHHB6(;E])$>Q+JBET[2_5+]4`^`?0`2@P M&`P&`P&!#'R"-0><3MBHBX,U].P:>>^H1JJ\$XQV[=B98 M?J-RJ"J<0(01P,RX7?LG<>OT4U#^*T<"3F`P&`P&`P&`P&!0!X'G:I_Q1 M_L?A#`Z\%:_SB78?Z`F_\D.O\#L0!]`?>#\&!YP&`P&`P&`P*8_.>ZCF?$.C M*R46$N"G(BCM(MJ=TX:(M[,^I&S651EG2C59%=1C!6EPS>N$0$0<(-SI"4P' M$HA<5"A,!#Q(6$T<:?",8!.&AP]PWA>%)]SK$_'4U$IP:[;Q3:QDVRCL<)*>"]C;'+EP>L+50 MT6$<,<#5,KGU3*@I\"@)@W#@:OV&CN56;U8.JWNN&==1V`DMN@E[9V-W,/M7 MA6[$1=EK<8)=!FTNY[8I%'*M)=S(K%-R`E,H*88&T,!@,!@:CTBAO!O1C)UYJMG/,*DK21NDZ.M?\$LBSF31L(4#Y<$L'J'0^9^OZ(BEV8& MVC@)B]`Z?$2]>H]`[>X.[[@]?J]?A]WZ,#63>"V8CL]S*'M-6'3YJ2R9M*6E M6WJ=Q0V($X[<2=D4M_S&!A#B(N`6^OOHV;A&M) M;,["6R03B(TPC!LD^C^U])1Y13(8Q MQ#M$Q>@"8#%#>?#!.72XA\7B3J[=S*EX_P"HOQ;F!1;TBG](@@8W0/C@"M?YQ+L/]`3?^2'7^!V(`^@/O!^#`\X# M`8#`8#`8%*?GB(!^'5"/ZR*2C;DMK-\U37!STD'T?6MA/H^%2.U;.C(NYU\W M39(*J%!!)9NFJ2[J+ M7=-#':.5H]=Y8Z_ICF>CJPWFW[":DTEIZ61>N(^-3:0$9+2!UG"$-;D7;./-UCMB5EG:-?4"R6\L-+,*_K^5#8%!FW4U M;8VU0#:1?P,(V*_&@1$!$>/^FA$0```1 M'7-<^(`````/W@P)`8#`8#`8#`8#`8#`8#`8#`8#`8$-?(&TC)+B'N"(FFK= M]#S[:FUN58.UTVS=_'V38M/@GC%5115#N!XWD#)`F0P++"<")]5#%#`R;A&U M;L>(?&]@T2*@T8:>H[%H@43"5!HSA&K9LB43"8XE102*4!$1'H'Q$1P)28&` MV75FO+C["M%0A9R[:G@ MB9,.@=,#/L!@8)2=8:]UNYNCRATZ!J;K8USE=AWMQ",$F2UKO$VDU0EK1-J) MAW/IA^BR1*HJ<1$2IE#[F!G>!$'GHP8RO$W;T5)M&\A&2K"K1DG'O$B+LW\= M(7RJLW[%V@H`IKM7C18Z:A#`)3D,(#\!P.=X3H(M>(_'-JV23;MFNHJ4U;-T M2@1%NV;P[=%N@BF7H5-)%$A2E*'P*4``,"4.`P&`P&`P&`P&!0;X,?QN?7\[ M2P?@F<"_+`]3_BC_`&/PA@=>"M?YQ+L/]`3?^2'7^!V(`^@/O!^#`\X#`8#` M8#`8%,GG/KMCM'$*D1U49(/YQIR&H]B;MG3A-LU]M4Z1LRT2;ATJ=1(?;,XR M(664*015.1,2I@902E$+B889<8>*&P%CBSXQK$9LL.+DT267%JE\R+%F>='8 MQP/>_P!`5?RGI=O=];K@\MMZ*UGJ M*1TRHNC:-BKD5M.JC.N4)\@+K)M3-W30BAA)W8$A>,`[=V#PXVO5?SI:ZD]!V79O%B'W9 MJEK1NR\28W_:$5IJ/@$;Y$3+%6JR496=31$DHH+5=T^0?^J=0JZAEE`[9/#5 M4BW$?C"HG+)SB8Z`U$!)1,C8A'124*!('0K0`;AZ/;Z8]OTB3X_'K@23P&`P M&`P&`P&`P&`P&`P&`P&`P(D\Z$TU.+6SBJ)D4*!J,J!5"%.4%4=DTY9%4"G` M0!1%8A3D-])3%`0Z"`#@L2S5Q2PN:BE/PJML91#6?>5=*58'L32!?.W+!E-N80K@9)"(>/F2R*3DR0( MJ*I'(4PF*8`#FC?BC_8_"&!UX*U_G$NP_P!`3?\`DAU_@=B`/H#[P?@P/.`P M&`P&`P&!4EYD6LD_XY:LC89HZD)F4Y$5N*AXYG$S,VXD)63U9N!C'LB1M>C) MJ<53<.UR%54:M'"K=(3*^F8"#@8Y8_*ILJL$CR*^/SD];7;E,_NAU]7K3-L& M2J";<53G=36NZTK[5PLL8K<13!4X)F$Z:?U>X,">>8',; MIXWN3*UA7)DL\98YVJR7L?:DY,`X]+S!;K&= MDIQ"$25J)/253?*K&4`P&3`H@(![/O,#N@LG#!&>,3F$K"&.^^T:LA4YYM,- MTP;`,6,`T;4UXPD%%'G4'`.7#0$TNAB"=[XRY1K` M9T"I$?LH`J>J9IPZ8"J8QD%'0MCBF`@83D$H@=8WBVY.HF(L1( M&ZH7GW"A3(KK"X3!/1RK?T"&1!,>Y0I_44)T*)>XY0_*F^6/E,//9I MC_:27:P[BNP^^H]$E=:HF4C'S]J_X]SCIRK(G3$A%$_1-W*$]1NB`',`D"I^\ MA`X!KY;>5I[RO&._&-O5K5%XQJC%**--G!)*S@O'(*/EI5'2[MN:"DF0HE:H M_+DG)%>XRQRE$"E#/E/*!RU%!BY9>)SDY*MW[-%XFLPDK$0J(+!U!NY)):=C MEB.DP_&`I3D_<..!R)?)[R43;H&D/&1R+CY!9U%M%8DR>R7CMDM+K%2:INW+ M#0+F+]4"=RAP2<+%*0O3N[A`N!Q43Y).:C:1M`V'QE[KEHE2R-$Z6G7(G:<2 M_959:,8>Y5LKB9U(]0EI%G+>Y$RK9%AW(]A"-3B7UE0R9AY*.43HG<[\7W)" M+-Z+53TW1=@.#>JNEZB[;K':*>D]1BI^3.;KZ9S?%,QR_6P-!K[@L%7E'5>KUOKWR27:Q^I*5^9TQN/4U=XKH58-S2&R;I+7*IT7/X:JJ6JV%;&N@.$C@COB)QQ=ID633 M=Z@I#HB3E(S=RD1S"MER)N6Y_KMW"95`!1,WUB'`0'XA@2CP-6W'8%CK.P-3 MTV*U=<;C"[$?VQI9;]!'B"5G5+>N5\9F-D+F#]\V?G;VI]T8,@:)K']QU[P` M.G4-I8#`UEKF]V6ZO=CM;#K"VZW1I.PYFF5Y]:',&X;[(K\8SC7+/8E7+#2+ M]9O6IE9\HD@F\*@Z`[<_>F'T`&S<"('/5V:/XE[?D",GLD=A'U=\2-C$DUY. M2.SO=5<%CXU!95NDO(OC)^D@0ZB93JG*`F*`B(!SW"945^(W')PK#QLV10-;0\10=G M[EL53U=]J'5AA)F:LMDD=AOGJ3./[FC,C8!6.X2`IA$+#?'_`'B-OO&*IR;" MV;JN#^*L5^J5K=\A96*F]O1-SJ5RF8*SUJVR,*W:QJZD%*,CHMA2(`"T!,1` M!'M`*M:XY*/]8FV`U,N03$T&D=-N*I>\HJ:@UYZAB)=W=U.5(.H@'Q`H?N8' M8A#Z`^\&!YP&`P&!4WLWRC.*/LG92-1XK;JW%QQTC8I&B[CY%ZX282474KQ7 M4FJUSCHNHN"(/[-%4$:P=+4B&;&,BXU%BX7D960?29BO$W"K(\=Z78UJ7HV3_U*8=`P.5_4HXD_P"3MJ7_`(FQ/^P8#]2CB3_D[:E_XFQ/^P8# M]2CB3_D[:E_XFQ/^P8#]2CB3_D[:E_XFQ/\`L&`_4HXD_P"3MJ7_`(FQ/^P8 M#]2CB3_D[:E_XFQ/^P8&G.$M1JM"V9SOIU)@8JKU:"Y05]**KT(U38Q<85WQ MJT,_B3?W+MRHL<``.XYQ'[N!8'@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@1,YR?LN;/^]2OY1:A@1G%FI0L#5:XS4TYLA3G75>.=IV(QJ M&Q'TNRG#2BTU',UXQ@X6;N6T,XCS3$$\650G?=JB8>[H M`4YUX`__`.FV[CT#K^KPE\?_`.R5)P.S3@,!@,!@0IT7Q7M>A=];WM58V>1] MQRW:_EMC_F)D:VS,XI>[[7*,'-XM,':RF%RM5[0W:K**1BA`32:$9R!UCL5:+T5%5?:"-=X\NV+M>+UY<-JNH%U;%]>/"OP80U5 MGW\2+YPT%OWI.`*FF)DNWT@M0P&`P&`P&`P&`P./9Q,5'N91ZPC(]B\G'B4A M-.V;)LV(QD>@V*JJ)SE0033`>PA0`.0P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(FI?\HM0P.7X7?L MG<>OT4U#^*T<"3F`P&`P&`P(FI?\HM0P.7X7?LG<>OT4U#^*T<" M3F`P&`P&`P&`P&!03X*_^OS_`#KIO_?G`V)SOEE-<\UM0W:F[?T-7-G[)U#" MZ3B]>;>T1?\`=3PK&4V18'["YMG=-DXMM1824E'IHQ5=RNF+]5N"*:;@Y0(F M%BG#J[.]C\<]9WAU;]87Q.Q1\H^C[1IRF6/7NOGT4$[*-X]&(I5M<.;%6W<< MW1!L^:NS`J1\DKU(3\0H4HMF39I_68'ZR!!(I)\5@D'HB.]M?RW'736@+72=9VWD7;M@5Y MWMN^5XUCBZ'&:_H+V^N!B6*[HD.M9I]*..U9I/4'**@>H)0*<^RRI^(NY202S%O.GBJX2#<2B*SB+;S1[Q5 MRQ*\FW;'3W'E\U3(46V5"%UW$REG4 MW%7)ZMO96PV^(=U]1O4V].G&TDU;UIY#V02N71ED'!73?\F'8(=3!M#`8&K] M;1.VHIWL*NG%/W MS$ITS/6;*0,FJJB!BBJF42=0Z]<#(>$A7).(G'!-XLFY>)Z?I!'KE%+VZ+EX M2%;%=.$6_Q]]<9=R;&@;!Q0FJE2]H,X71QMG5Z^V3C[>)+<$%':J M93DA5/M=>-87UPLG(M6+U5D^,<&IRG,!`6"P3Q_0E`A^)FJW>MMANMLUZWDM M>PWFQWL`:I/;9;-@W2PW"[2+NH&79=\=#IBY23<>NNF;J!N@AI_1N@*1P)\AU/U1KNCZXE= M>OT4U#^*T<"3F`P&`P&`P&`P&!01X+?HY M\_=_Z5\U^&9P)#TC4'D/XKM+EJSC["<6]LZDFMF[)ONO[+M"W7^D7FDMMGVF MPW9_#7"*@:S,1EN3@K!*J"FY;.$5W"3@J8E*4@G($W.(VC9GCMH:I:SM-@A[ M7=$I*YW"^6.NPX5VNR]YV-=)^_6MQ7X$@^E$0:4U8U46B"9$B%03*())=>PH M4J&,!OZRT0H$(42<1Q`3%[NY01IIC=RG<8Q>X`-VAV@4.@!\.O41#L?X#`8# M`8%7?D^LFOI2I:5X_6SC7)@:^A]@$U=)1$EJ^MN[E,W1G=RJ-W M<*M"175(3)*H@9-T3&CU=?\,X+2-(Y3:HV=9ZEM>_; MHM6Y[_.Q^L55B&JM`DIU])(U)\Q=NG(SL6=-HX>->UR(]C[]XW\&`[O[DW\&`[O M[DW\&`[O[DW\&`[O[DW\&`[O[DW\&`[O[DW\&`[O[DW\&`[O[DW\&`[O[DW\ M&`[O[DW\&!$[G$!C\7=G@4IA'I2^@`41$?\`E$J(_``ZB/P#`Y?A>'3B=Q[` M?@(:IJ("`_<_VK1P).8#`8#`8#`B9SD_9.^]M3:^I6S]?: M,UW.,M9S4I;[I1$[DZNJ-HVT-"V,DQ>R3M"%AHC4-4WK`"96I M_;:*BR/#QQ_]84,82`5(Y"%"HO\`^)<_]4G_`,RL#LA8#`8#`8%8_DQ=Z9J= M;T#M:^6S;]3VQK;=40_X^#H:MIW;9UIMLBW$ELHT=2G(%CK)`6FE,72,DD[5 M1;$2*0QA5'M;+A`+QUU/1#/EO!1SVVC\6-5[`8P^C[ MZC5F@4KH'4<#S_1[?\`YX/(=_[2W_\` M)6!X-X]"G*8AN<'D.$IBB4P?K+B'4I@Z"'4*6`AU`?N8&(N/%Q3G94".>8OD M,5*U(JFW`>5$T3TR+N%72I0]*NIB;O<+'-];J(=>@=````/E_HJZ)_E?^0O_ M`-JRP?\`@'`?T5=$_P`K_P`A?_M66#_P#@@WU7+9,J!62BSSM'U`7162+W#Z9$_AT#RAXN-1V?R]?+*.'3LZKKE7MM90SIZ*4DV592-TY3R#)?L!9F_Y-;1?-%O34*JGZK5U++-U? M353*TY0$/B`#@62ZSUY6M2:\I.KZ:D]0JFOZO"U&O)23]S*R)8B!8(1 MS'W\F\.HZ?O#(-P%5901.H<1,/Q'`SC`U/>-,4S8-_U!LN?/8D[/I":M$[2? ME-EEXF(.[M]:<52:3L<&SH;0P(<>0&'8V+B!NJNRA5C1EAA8"!DRMEU&CDT=-76L1CXK9VD( M+-7!FKHX$5(('3-T,'Q`,#(N$31!AQ!XW1[4IBM8_3M&8-2G4.J1H.G9+6;RM:YBMM;4FZWK&K)6O8RJ#*.K,QL M)FHSB886"WI/'*:AGY?JI8%MOCH=TMWQ0HP46+VO#QK&T;7B9ICO"5CI?:Q; MM$[2N$=>W5V<1"AHIK-2%N;O'"C1N5)%F*OHE(`$^(50_P#Q+G_JD_\`F5@= MD+`8#`8#`J1Y^2;F_P"V]%1/&W<''R"Y<\69JU;X?5_<5B>-(&NZ=F*3(46\ MO+:I$Q4BE%-GHV>+.9!T[CG`-3%=IF[2%.`5T4;;?//FUR$INU]+;R\>-SV) MQEB;F551-4 MP=EJBIW1*E5)/8[FNO-@$KD,6[.JBU?L:LXM01[<)Y6NM)1T]DF\*>3]46Q5 MU3J@CV]P]>N!E>`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!^:R@(HJK&*H<$DS MJ"1%,ZRI@3*)A*DBF!E%5#`'0I2@)C#\`^.!ISCKLR3W-HC4>V)F-9P\ML2@ M5JW2,6P*[(R8/)N,0>KM6R;\ZCU))%140`BQC*D_%,(B`X&Y\!@,!@5RT_\` M]ZSO#^9#HW^6';6!8U@,!@,!@,!@,!@,!@,!@,!@,!@,!@,")7.<3%XL[2,4 M@J&*2FB5,HD*90P;#J(@0IE#$(4QQ^`"80`/NB`8',\+?V3>/7PZ?\E-0^`_ M<_VK1^'PZA@278/&*H7VPW."N\9O%C[8KJ-':)B"=%51,PEZE,(=!P-]?TP/C@_P`J M*M_\2]H?^@V!Y#R_^.$>O3E%6_A\1_\`$O:'P_\`X&P/(>7_`,<)OQ>45;'I M^Y3-G_0/7H/_``'^@>F!ZCY@?&^!A(/*.M=Y0`3%^QNS^XH&`1*(E^P_4`,` M?#]W`U5Q8Y#:;Y,^23>^Q=&7AEL"F->'VFJPXG6,;.12*<]&[6V4^>QXMK!% MQ#X5$&DJW.)P2%,05``,(@8`"X'`8&H=)[YU+R+ISB_Z7N+6\T]K8IJJ+3;. M-FXM`M@KJR;::CBH3T9%/%#,%U`(90J9DC&Z@4P]!Z!M[`UUMG;.O=&:\LNU MMK65O4-?U!NS=6.QNF3D4$@!)!0P"H`B```B M`9^V<(NVZ#IN?U&[E%)P@IVF)WHK$*HD?M.4IR]Q#`/00`0^Z&!^V!K&P;BU M[5MHZZTS-S:S38FUHFZ3E%@R0\T[2EXW7S:+>6M=:79QZ\-$_+VTP@8H/'"` MKB;M2[S_`%<#9V`P-0ZQWGKC<$WM.NT24DY"6TS?7^M+^A(5NQ02,;;8U$B[ MIG'/)N,8,[`S*FH'1VP4T+6/D!;++3*&K"5F3FH9O,56E3=^E#6N89)G9U>/-`0#CT%W0E36 M<`5(OUC!@;CP&!J_6^VJWM%_LJ.KT9;X]75FPY;65@6M-2FJNTDK!"L8Q^]> MU1Q,-FQ+/6C)2J949)IWM%SE.!#F[>N!M#`A?Y#II*M<,M\69<3E;UFL1=C< MG(U4?&3:P%LKLNY4!DDNU4=^F@R,;TBJI"H`=.\G7N`(4<:/(YK>C\9M)09- M!\SKL\AM<5*/.ZHG%Z_S,)*]D:B!I.`L+A-E`2\,H`]Z+A%T8JR0@8G=UP-K MNO*]KQDVG52F;#NNEF]:UO(O;W(LXZNOBW-]; M0B%HAR+TJXKH'6`6Q3*%`X!@6P`("`"`@("'4!#X@(#]`@/W0'`\X#`8#`8# M`H#\%3EN9SS^9E72,[0Y32;M9L!P%=)J[5LB+5PHGU[BHN5F"Y2&'X&,D<`_ M%'`V9Y&*?%-N1.MME<@]2V[?7%XVL%*-6ZK7]ZU;4$?0=V/;/)R4E8'\-9=H MZJ;VYU;JD1HV3<>_-\O1CU1$@E-UP)G^.Z@[,UKQ5H%:V=)B^=*/[58J/'+V MMI?I6IZKM=@?V/75,GK\P%2.NLY6ZW)I-W$BV5<-%1`"H*J(D3,(5./4UV_] M9:BE".621'O%`PG3<%4%5=`E%DB"U9CZJ!2OO7:E5Z]%B^@10.WK]8@=D,/H M#K]/3`\X#`8#`CUOSEAQSXNQ4=+[\VW4];-Y=PDVBFDNX=/9R3,J*Q?<,*U" M-92Q.X](Z!BJNB-3-D3=`4.43%`0YC1F_M#\B:TXN^AMC4W8D$LNF:5>U=VD M,@S=J>LW0+8XA=)I.PSY8K$X)D?MT53D2ZE`2AUP-VX#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`X*P6FLU-LR>VFQ05:9R4O%U^.=V"7CX9L_GIQV1A"PC)> M1<-DG4O,/E2HM6R8F6<*F`B93&$`P(N\):[`..(O')9S`PRSA345+.LJM%,3 MK**##M^\ZISH"J[?`:P*.A47()[1A]DM?ES@J+=RY(,F;TVY$43G]00D!XB;;KN^\UN55PUM MLNBU02;I>HH83*']-$I"=YS#U$>G41^G M`^G`_%PV;NT3MW2"+ENIV^H@X2(LB?L,4Y>])0IB&[3E`0ZA\!`!P/VP&!Z" MDF90BPID%5,BB::HD**A"*BF94A#B'<4B@I%$P`/01*'7Z`P/?`8#`8#`8#` M8#`8#`8'YK(HN$E$'"2:Z"Q#)K(K$*JDJF<;J-5JZP<4QRX2&5,+@2E"9V`P&`P&`P.OWX*##\S\@1?>-S@')Y MV8(XJ20.VPF=6\!?++`H*YVK\"@FD0Q`(0[502F$3'`H>/(>M'G\A>N64SJ# MC-N]C^I^Z=,JERMV=%:UH<4[#;5B2=3M4=V5C,5V2MXE%NDNB+-1W\N!04U$ MB@<1"4GBO@.2%!U@?7^PZEI@NC6JEOLVJ;SJ7?"FW8E)S8+[+/SZVK#$DTJ/=F91_9)NE&YF1DS]QE!]((/30A$?UE:JJNV#XI;+Q16;QKA869FZRJ M5(GS'>M`.=%9-HF6$7;GZ>HL*X&Z%],1$H=D$!Z@`_N@`_PX'G`8#`8%)O$[ M7W&[;'+'R`V;D)7*Q?N1E2Y%S=1CH_=L5%S`U;CXV8PZFH3:_KMO;JLF=J+/?(&L(IUR$G7%K?&1:`OZ:BQ?34]+N4(JH%T(?0'7Z>F!YP&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P(^O0!AVX].OPZ],"4V!29SYKFQ-14K M1>&";Q[7G;]LT7A]S5.0B"'8BL_7=0,HWUO[-=BMZ)ETET!`BW4#E$>H"(;T MA_*108B'I^]+?IJ^W&H\EQJ\+J34]-JNLI:;UY>ZI#G7V?&NIJ41H\S/LI]] M:8,[.0>&4(\9>V2'L;VNRD99^@4$4^[N,FH%P<4=RK&L%'G_`-<49-#NOR)V_1R=LD9< M/;J=%&_Y41^H;XD^@?HP/OP&`P&`P&!UX?!$FH%X\BJHHB")M_Q*9'/IF`%5 M4YS;!E4/6_%.+&N] M>2FE:=MM[;7<;:W[(^IJ4-^*TKD6C7&(K33\`=E=J'>MBIIF`Q@,$X?&K=6M M[XE4B4C*7K^GP,59=C52MO-45'[!:UV'`56]3T'&;9IE,,4JU+3YDU;.B*C\A8(TC8JRJ4>(JB0 M%5Y.NF6$0`"]'2@=HF^M@=D`GXA?[TOX`P/;`8#`8'7)Y5/>,G)/7G/KD)R2 MXPPUHL_"3>+[1E:F-;;`L6O+_=Z;&RM4A8M>RV-NDZ8F>MWMK673*X9O4")I ME22*3M$Y@N'XI<0N-_%2JO4M`:R8T7[<(Q3E[)99DQ6H*L&DG9+"]D M95=C&%='!%N11-LF8QSE3`YS"(2OP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P*M^(7(38%?XUZ%KS3B+R.M$1%ZCK3="XUY;19H.;79LTF[1:':S6ZH6>-& M2S4@.$5G+1L1=$H&R=,[;O'YT./3E78M)V8YH!EE:LZ=F/'UB9KD3K]E&,)J4; M3;QDT`%4P%R@BH4)3^,JD[/7S-=\BT9K/`2%RX3%=-:HSY_5.BT-W+)(D(8 MX@*G:4-QX&O]IV&^U6@6.?UAKQ/:]\CF[4]=U\K;HJAI6-RO(LVKA%6VS;9Y M&0R;)@NJZ,=5(_J`AZ90[SEP,[0,J=!$ZZ0(+G23,L@50%BHJF(`J)`J!2`J M"9Q$.[H'=TZ]`P/UP-:6&P[,8;,UU7J]KJ/GM9ST?F]G-MG:S@M?P M,#=WT1JR4B;TWM[[8%&;B@!R.!H+?DKR8BXBO&XT4O3ERFUY-R2TH[BN]LI<:PA MR,Q,S6A5*G4K2XD7Z[\0*H5;VY$TPZ@)Q'H4(";=Y><[N,R>N;3OO1O$LM!O M>U*KJ8[RH\@;Q$.HJ:NB$L,5,3,]=M:,*Y7ZO%'BSKR+U<511;$-VIF,("`= M>'DWOFLWG$F%XPXE$2MG"J9PTS65W]R>\BX.!EI>TSTL:>?/'$9HFJ422? M1>M=7V1ZA(C:(S;U*?ZR(WAH"5=2E>8+R367&/!PX:RJG1L0.UYXZ>)NTM`( MVJ\[)V/JF_-]C4VDIU4^J*0YH\.A%IR%FM!G:T6FLG`H(.$[0BFV3CFC5#TT MA.8OVMR0U?1M4W0*>_FH*MN7(LFDW.B=!C"QKQX4Q3M63 MJ4>(E64+]8B0F$.H@`8%750YF^4;9-*@[]3^%=43A;/44K#6A2^061I-/)!L M1U$E/)2'([7SZ)A'!3=#N#QJ[DH"!_;?ZC`^)OR/\Y;ALQ<_J(<=D/?&5("# MB_-DW+,4G*+432"7YZC>V34%;U"#U-W(D,;H'3H(:9W13O+SS+'1^O-S\=*/ MI/7$=NS6VQ['<]-[:SKM@YTT#EJSY`6W4DXRKN_-K:WTS M5)/3E"M;KC(KJZ>M%+962?97QG)(VNP6R.*UE5"R"2:0-%`!%0I5OR024X"; M$33?]9*U$5TT?,B53B;(O(]PFB=="7%6K;#1.LJ8 MR"96C!$U@51%0IE`]P@4O<`G$I0[&9?@4H?W(?@P/;`8#`8'5\YV:VU;Q_D^ M5FJ[WY#T*%!*UQI9[5O8C9)R.D6AGDK&6A.Q1;)JZKR16IR+1W MNB(E$$CBH8IPG;XZ]@V/>5F86VN^3&6Y(T^@0KIA:=#3O'R@ZIM[(DVR=M8% MY=E6YOM2R>0LLBH=%1J!VZJ:":1U!ZF[@N6P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P(K<'R@/$#C=U#X_F?I/[H?_`+';X$I^PO[G]L?]/`=A?W/[8_Z> M`["_N?VQ_P!/`=A?W/[8_P"G@5ST[_WK.\/YD.C?Y8=LX%C6`P&`P&`P&`P& M`P&`P&`P&`P*WO)QK';FS-2:36TSK!WM^T:RY6:6W!)41G-5NOJS%9U\K89. M5;C)VIXTB$".U5$6PB8%C!Z_=Z2A2F#`ZV._/&KY`=W[KVUMJ"X@S.OXO85X M>6YE3#[*U4\0A$Y@Y"+M/>DN2)9%VF[.9918$TRB"BA@*4!`@!GF@>$_DCTQ M6=D523XIW>R0%]2FI4\6QONE6:RMT=ZEVIJ:"G)>=E;=)R`QD)';:D'2K-NF M4[Y8B8&6(`#W!W"Z/#*UVEU"OK&,9:"J]?AE3'2:(',K&1+1DH8Z#!-%BB83 MH#U(B0B11^!``O0,"*?D3^7?J7[Z^<>Z^4?9B+^;>Q[/??*_M=7/F/LO5_)^ M\]GW^EW?5[^G7X8&8\)RICQ&XY^F!O3_`#14OT^[\;T_D[<2=W3X=W;]/[^! M*'L+^Y_;'_3P/(%`/B`?AP/.`P&`P&`P&!UYO!(1O]K_`")'!(X.C,%2^.]J\I8;4 M%+N=[9KIRLA9MJ2VK!OX,$4DU)"2@H>Z5=K;))@W3],[LS==?M/VJ'-U*`!- M;1*VCC:NK#3CF[U\ZU#$(N8NJ):O?0[ZF1Z:+M95['QIH)9>/;JHOG"@K)`( M'(J`&$<"D*WOED/ZQ_JQ%5NB1-SPUEF#951ZF@99(8^[R!ED45TDQ=+E7 M:G3]!$RA_3*97J!2'*`=AHG42$$?I$I>OW^@8'M@,!@,"ECBC<^/^LN9/.^% MY"3%)IG*.;Y`3=IJ,_M>9@&T[/<<)2"J;K5+6A6:<$B*5.G M"F[-F&B#>FJFFR9I-FI7!3`D*HJ]Y#")!*(&"P_`8#`8#`\=?WA_M?Z(X`!Z M_<$/OX#K^\/W_P#N'K@!'I]P1^]@>.[^Y-_!@.[^Y-_!_P#+@.[^Y-_!@.[^ MY-_!@>V`P&`P&`P&!![R2_L.\B__`+$-_P#&2!P,]X1_LA\IL]I&YZ(NN^92.I<=?E99EL-E'5)@52G,5)Z44CSNP>`9ZH!4C(B5(%"A9 MOP0V!'[,XS4BT1S73D807MAAW,%HRKVRD4BMOH.;=1CNMK4V\QL3:JS:8-5O M[>4:.T`$KM,QB&.F8AA"HK9B;I[_`%DO08+%;M$8OB[)KM#NE$FQI)N:E;;3 M4!AU<+&>NB.WQP[`(B8$T5#=HE()S!V/B?B%_O2_@#`]L!@,!@=:CG#LB=W] M8^26WYSBEQ>VUQ?X3;09Z7V2MLR-N3+DI/C7Y"O*7][KFZ4N4CRP4`R<6SU& M*2[H$023.NX2'O42P)7^/"'V]8KK';%T;QUUAPMX#/$)-Y$4)Y4FP;ZY%>Z@ MGK*I;`M,N(/'<'"1[Q5%]'^HMZB[58Y"JNT3E7$+J,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@5BLJ]K*PLM<0O MN36",K5ALE@CEWDHVM=;=>B5>R'#VYR*D*=/O*8.X2@&B_Z+[F!_VN_*O_,'E@5N\*Z\MO+A9XD M:,DI6Q3ZZ)@?%%4QBK%*,;DH+Q(Z/E>YI$CP*3UVRLF@L_4 M.'K>H9%^2=0;(D-U2[2F:J"7L/U$W>7TPP@_ASV`ILI';BGD?Y;'V&W@Q@$+ MN9VP&Y)1I@43-'$GOF70L.+98Y?;>A^.83=_W,#(;;XFMKWVO2-2NWDSYFVJ ML2Y6Q92`FYF,>Q;\K-XWD&@.FQW`%4]L_:)+$_\`FJ)E$/B&!D(>,CD`4``/ M*GSC`"@``'VE8#T``Z`'Q<"(_`/NX'`U[Q/;:JGS@*WY->:$$2Q6*2ME@)%3 MD8T^3KGPW;*@W M]@BXV+$NU&ADQ1%P+I=.*9^^!8Q#B0"E0]/N#J)^T>X(L ME@6R\&$!:\-^,;05W#KV>D]>LP!KFX4%]:[9K*SMM@7FJ-==6"8G7]6K$FU8UO8RP;RXN;*+N4LA)Q MNOVJ\+#0X4RB((M&IHFH(*Q)GA&QS+'!V[7/W]#``!LC`A)Y(%")\&^2I5$$ MG`.=;/8\OJBH`M59*2C(]&2;&3.0Q)")5<0`.IQ$<"5>`P&`P&`P M&`P&!UW/!&0X7OR,*=/JFWW"IE-\!ZG)/[=,<.GQ-]4JI?N=/C]_`S7E;L_: M+OFS]I]2ZOY[:DOFOM/KZTDMF:VXZ4_>=%V/4S7YY.*Q:%*FY,E;E(<5G:#^ M,L",V1XT7.HU-L>C):SV?J^6L6P]HW*78;JG&8*HMKGV`P&`P*%]I>/GGE.L^;&J]<;'XL,-%:#C%F*$$@ET,D]*8X'4`0`X$*$W^,^O?(G2;#3X3?FTN*]@T]5HIU%N(S M5^O+M"7R6;M(5_&5IFB]D9!M5H2/B'162IP19G4702%/\F/4QPL)P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(3^1MF[ M?<(N1C=DV6=+A0C.!103,HH#=E-P[QXL)2@(^DU:('5./T%(01'X!@9IPC_9 M#XW_`*'Z1_$K;`E)@,!@,!@,"&_D&;Q+GA;R-2FUUFS$-;2BQ56X'%09!LY8 MN8=$?31<&])Q+I()J?5Z=AAZF*'4P!DG"+]D+C?U^G\S](_B5M@2DP&`P&`P M&`P&`P.N]X)?3_.'Y'/2[_3_`#]0G9ZG;ZG9]H=P]O?V?5[NGT]/A@2#\@NH M+=8N3.N-DV73.^]XZ&:Z-G:9]E^/FZG&K+#&[?);G4Y$R=GCF^Q=?KS,$\@% MO:I.$U3$9'4546[@*FF8.+\9_'_D;IS:EH?W>`V35=3RFIGYWS*\;]1W1'3> MR+%M9]9*,UCD$[#.$C;1JS4"B5;L+U!)BS?R2(JH@X*<%"A'7;@"/]9&XT]` M$>G%Z8$?W@^QV[?B/[V!V.B?B%_O2_@#`]L!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"'?D#CFTGPLY*HO' MJD)].J2-<31L!P4ZB``W5+&=BH_2"9C"'QP.;X-KHNN'?&ATW4 M*LW=:7H+INL0>I%F[F`9KH+$'H'4BJ2@&#]X<"5.!KVV[6U_1;7K:D6RR-H: MU;>G9BM:XB%FLBNM:)R`KLC;)>/:KLV;AHT495Z*<.3&(GUX-P=^R:(NUDXB M=:+>HV,L@)5@`#]P&*`;!P(>^0&/9R/"SDLF_F!R_!EPB\X<\9GC05`I54=]PJ M:@$436*!R6'<(&`JJ)U$E``0_&*82C]P1P.#\AVR]"SG*JB;5L*O$/D#K>.T MG=M0!K7>V]G6NT*QLZG;IE$+C98Z,;T^W)A+P[B&-#+*J(HJ&[52`;L('>%J MWCWG:A9.,U;EZ%K[1&M*@XL-G+"USCK=5;]KPQ$I/LD)`\^O4*6L:QKRP."/ M4S-E_K)%.#A0IP`H53[9[T_ZR/QN$JJW1?B[+E.05![.P*;NG\D4H=.B0G3` MXE'J'?\`'`['9/Q"_P!Z7\`8'M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@1+YX,S/^'')%J5XY8]VI;8J= M9IZ/JJ(MF7N5V1P7262,UD443-URB7J9!4X`("("`?=P@*4O$#C80A2D(33E M&(0A"@0A"%@VI2$(0H`4A"%````^``&!*;`^1PP8NUF3ETR:.7$:N=S'.'#= M%99@Y5;K-%'#)50ACM5U&CA1(QR"4PIG,41Z&$!#Z\!@?BBV;MS+G0;H(GQ51<>T? M';J*+(&=(6C1D8>H-=966$L<[8MX3#],5$I4&J:",<04S>N!E" M%"6_CNK+ZJ<3==1\M6+E6)QT[L\Q/%N^R:WMB1L/;I%7.H.5:RZJU MM44][&-V2+-!FS5(D5`O;WG"JC;G^'7(\D@A]W"+]D+C?^AZC_`,2ML"4N`P&`P&`P(LW"']D'C=^AZC_Q*VP)2X#`8#`8#`8#`]>H]X!]SM$?[/4/N_>P*!O"R MT*PWAY061&*$85IR6;MRQS5P=VV9%1MFYB`U0=*)HJ.$D0+VE.8I1,`=>@8& MYO(_PRW5O?;^L]NZZUIKC>T+4:[1:V;6U^O;RD.JU(5_=T!L>T6.N*O63ZK. MT=ATZ.-7)A14$W[>+[_;E<"IZ.!)?QO5II4>-/R)M;:38UVVWMUKRT!K)W*O M]9:EG'VRIY]+Z6UZ]F(Z)V`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!%'G0HJCPYY,K((&=+HZ5OZJ#4 MIRIF=+I0+I1%J50_U$S.%"@0#&^!1-U'X8'MP8456X<<95ET!:KK:5U^JNU, MH?#`E9@:ZN%JNT%:]90U:UL\N='1U=$,JU*2\78GL-(%%_:&TS-LD8P$&0@J@HZ*L?JF4V!L7`8& MNJ+:KM8I?8["W:V>4*.J=V4K])F'-EAY]'9=4+!0LFC>636+*5Q6VRLG(N6` ML'G5R11B901[%"8&Q<"*?.H5'W*Y()T=%OZQP$ MB/KJ`!.\WP+UZC\`P//!DZJG#GC,HNC[9=32]!47;>H5;VRYX!F=9OZQ``BW MH*").\OP-TZA\!P)5X#`8#`8#`8#`]#?27[_`/HA@4->'/\`:'\JG\Z0?\#L70#2\XO0F\]K[<\I:208O%#5N-M)FEG81I)$L>) M"/'34ZI/6*)TT!*8"%#;'"[1&P^/NFI"J[7LE1M.Q;9M/:FV;A(4-E+,*@A. M;2NTE<'T;7T9P?FIHY@O)"1,RY2'Z?`0^'<(4_[<_P`Y&XT_S7I?_$W=N!V. MR?B%_O2_@#`]L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,"+'-_]D+DA^AZ\?Q,O@>W"']D'C=^AZC_Q*VP) M2X#`8#`8#`BQS?\`V0N2'Z'KQ_$R^![<(?V0>-WZ'J/_`!*VP)2X#`8#`8#` M8#`]#?27[_\`HA@4->'/]H?RJ?SI!_QRW3@7T8'HI^*/WR__`$@P.N+MW_.1 MN-'\UZ8_Q.W;@=CLGXA?[TOX`P/;`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`BQS?\`V0N2'Z'KQ_$R^!YX M0F#]4+C<'Q__`*/4C^U"MO\`2P)38#`\"/3[@C]X.N!YP&`P(LW"']D'C=^AZC_Q*VP)2X#`8#`8#`8#`]#?27[_^B&!0UX<_VA_* MI_.D'_'+=.!?1@>I_P`4?[']L0#`ZXNW?\Y&XT?O<79C_$[=PX'8Z)^(7^]+ M^`,#VP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P-1;^UD[W/I+:NIX^=2J\AL2AV6H,;&O'#,(03RJ!>WN#KUP*FXCQO\`/VKUFL5&E^3JQ4V!JD0WA8Z. MA-5NE&@,&:*2#)`C:5V#(H,4&:27:FFV!%,I1Z=.@%``Y#^C\\DGMO1_I8+O MZ_N/6]]^:=OZ_H^EZ?L_1^V?L_1]3\IW>GZO=\.[M^K@0SY6U[GKQDMFNZ5/ M<_[1<&MBUEM79,T^2;6&B2$[':M=46-?5**,QM4L[5N]Q^W`!!I1BD:9>512 M:]Q"./43#`=!4#F1S.O>Y*U3>;&Q:;^::/IFTJ&UE;IN1Q9(Q>^K7N$C*9=X MUSM-X\UGL",CZFJVG(Q^K830BDH7M95NN]-OV:./;VSV!=5W23O:,3NS5%.49LJG*C*'F5VYGJ;#M5=)@A='B@P[7VW#M_2$/RIQ]'U?5^A3L^I@?A,^*SE3.5ZQUV<\IF_KE%V*&=P[N M#NU5M)M=4FO5`]D6CDHA6>4@XU!BK+*12#EXA''?J(BJ*!%5"I=W:!A`.N!M3` M8#`8#`8#`8'@0`>G7[GT8%#/AS#_`*0_E6_>Y3F`/O?;'=`X%\^!X$`$.@_1 M_I#UP.M9?':[_P#K+VF6CHP*(1'&B028$`I2"D135FV)`P&,0"F5$73HYNIA M'X#T^@`#`[*@!T``#Z`^`?V,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#KU^938FJ]4&%^V_KA MUM.LUVD5:2C8Y60OW*/9%XVOK,+@X MCF5@B;WQ/HM`3JFP:.>-^=C7:Q;Y#YJP,Y,H@^=QXH*IH*)`<0G+X*]P6K>6 MV>4]YNJONK&UU'Q/H;Z34A/3[>JX?2/7X#@=D3`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`ZU?G>UNMMW=?"O7C:W4JBN;!6^0IVUGV).MZQ3F3B&C:3/H,Y:>=B5I& MJSBL6#!H=8Q$A>N42G,4HB8`B%XR]11/%#FAK^^;=V]IN!KLIK[8U2DB3.T= M3(/82U/J\QD74;))5[8]RC48=`6P-4'SITS,_='%-)M]0PX&N.0E'XI<@N7' M*6=G=PQT+-1FY;]<8UO1FMXV).;_`**RUO65JU4]6.*S"2.M(N9/:T5&S$"FZ]U]OCF=4-86VP7>JPU*XU)'L5IH]AUM..;,K" M75>Y(.Z3:B$GX!)M:%'0((N.\2MQ3Z'4+T4,'8ZP&`P&`P&`P&`P&`P&!0SX M<_VA_*O_`#J#?XX;HP+YL!@=>&S?YQ+KW]`+G^238&!V'L!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,"*_(OACQ]Y4RU$GMSU26G9O6I9U.F2D-"JX6"N;.24=NT'[D6V^-QM"+/FIE#M'AD6ES00 M!PT.J<43@4!2$YNSIU'J&217C=XX0)6Q(&2Y!0)&:(-V18/E-R'AP9MR@!2H M-`CMC-@:H%*4``A.TH``?#`W1I#B;H[CQ9]@W76%;FV%OVJ2MEV#9[+?+W?I MZT'JC1TTAW,G*WJQV%ZH[3*]6,HJ!P.J=0>X1`"@4)(8#`8#`8#`8#`8#`8# M`ZY/C@LU]I=F\TMNU94$M@;(K.[K3.4:D+&<%3M5HC)G>3R&@A!F)':PR+Y( MB8))&(HJ)@(4Q#&`P!8SIORI\-]FUYRO;]I16A;W`.2P]UUAOL[?5MUK-@1! M1)\P5C;`\*W>D0=-U"]6[A8Z0`4%RI',4HA*6P7IDM3XIIKR(B(X)`LW9E+5-1)_ES\"J))';E6Z+D*F;HHJ@10 M-6ZIYTV*];;U)J387%7=.@I'+#39S:,GKY.+DV]%C$)21C&;.OV:9FSS MQVCM)4S)RV:+)-S^MT,0HC@5@^/)*=7E/-F2M;"0U+/!N&XJQFT7+4SUOKQR MA)[U7"Z+,R`)W2=;(F+L4P^)P2Z?#K@10TWLOQI:QK#B[;EXG\LN2U=V+;4E M++S4W_JMO8J[;7CB8(@_L\*=>>6"+KYG\0LZ]!)1]/KD!9!R==0!1P+B^7%, MA+51.)33C6MP7K>OV;"T2U7D]X0%/>(Q&F'-,BCVAYQ[@9EK\D1%O0'+E[*& M!--))LW;@X,FW,N.!!Z);QK/SVZ+9PSZ)E(=IQ7AFT5)0#&.C(*1C4-&71-B M^A8V'(E$1T2[:E*HV0:%*V21,4J0`0"A@=DK`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8#`C7S(GH*K\4N0]CL^N6^W*]!ZAO4I,:V>-U7+"W,&<"\77BY M$KLW! M-\[GY!RVO*LVH5/VK6XK6J-F)$P4+J&V4V;*XC;4Y2EC23=FLS,NBL3XA]?" MZ,@YNN^=^&L]PB=?5V6V!LB,G+S.QS^8AZC$OE=]M7]ADHJ+51DI%I$ME3+' M10,"R@$[2=3"`"$6D-Y/S:&7XS*^7_C6.FBZO1U2A3R\3M@K&+4T(TT.@Q-- M'U^E.-GJL5/ M:U@@60T^BU@8F/>&@'+!M% M?U@O4T6SCVL2TCN-R$>UBF+=%FRC&[/2]Z;H1[-HW56;M6K))($TTTSG(0A0 M*4P@`#@=B=E(L)$BJL>\:ODD';Q@LJSM+?8HNCR:J2<78E8R&=.565ZVZ-+75G:;5IG0U&UE=N.NO=95>#-26 M#>;HR\C-1M/EC*,:\2+L*+)0AVZ::0)F*8A@QWQNV"L52S>:.SW6FR&Q*A7] MW6B9LU$B:XVM\G<(*.F=Y.I.N,:L\_P2P.I=FD=$C17\FN)^TWP'`KZI=EX] M;KW%(;"Y(<+=Z4C3%(DEB:CXO\9^)Z\;75V#IXT,A8=P[)BOLE9[7+.G;PJ* M\>B"3-942=!(W'VR@7!\X)"+M&D^*%WU=P5W1LV#(QNPUW7D6PVMI-SH.'DJ MQ',$#[!UWJJ1K,[')-GC=`2M?7*D#-DZ2;=3.DUR!&J?DVL9Y[-;3-E!M%,X M_BNI)3X/%OE[2-;-M%WYS)@Z<3+LGL6[0A#@<[IA];:^/:212%7L:[:$=(V-T[*FJJ M=1-9(4B`F;HF]'#2NMEV82K^']U%1K`R14C>DH;T0`2N`T'XU;3;J+;?-!N[;*D=3^S'>V+PR))5Y" M%C3HE7**[%)P@[24%L#<%A.%PG*^K:=JG'_AQH)V;?FV=2REDKOM=S:PL3JY M*D9UZ+2<1VQ-BMXBEWZJ;C9W*;FT!7C)%E\LD@>KN>O8B8`"&>U]?52[^=*# MU9/L'+NCVOB1.469BX956#=.ZO+:'V+#/HZ-6AS1RL4HXC%3))^V%`4N[H3M M``Z!9OXPK5J6[:@V78]3O]YV=(VZ9V%N.Q.0SF!<["OUF@*C3(]E(C]GUQ:- MX&$IY8N+9)G;ME/19]Y@5$XK*!95@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,",G)WC-QBY$5>/>\GZ%6KA5M8H6"T,I6R2\S`-JBS4CTEK+*'EX28A5VD M>,=%$.Z%544>QN!C!]4!`((<(X'Q&&VM6[CPWA:[&;5E66R8.IR2'YZ&3R7B MJJC!)7U*,2OKGY*\03CY]@X`#$]95JN5=$!*4YBA&/QEV"Y5.\>9FT:[J'YP M+[7MZV::IE&]\2-^UUGC)K>3R$KOOU/JM?F\BBFAW?3]?X?'I@1:VGS7Y&0FC>=?44KL%2#C[&;B.WD+NJP MD44*TQFQT#>G-E492R@N4$H-L^]84W!A4(5`H''N#Z0F#X+)X)GA;,M`:`S2 MK^^-DQ#(/>OWQWD8+*LR3"4%5\L=/TWQ)`PE,U3;LU.T3I)$[C!@7-X#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`BWS=B*Q.\0.2D;2*BD0^D7C%@@X9&:`N/K',D8B1BF36*(I'"GWQPUG3UXWS4+ M;*<\M"W=EZ?U/KJF1M!M1+EN*K5S\Z]ZL5>D7!9R/7A8QB+)G'L4! M8M&O>IWIF,9ND'Z>,**O4[?O,?"ZPLL;3=BRV_)Z.H]MF(T9F+K5I>3^[T(2 M03HESK.HZU(LH.'V);..E;1M$-6[8QK4B**CMLUGT"@U*F47 M"QS`8P1`V188C7WG>K5LN<@V5@:1Q,G+%:Y5O'&19J1%:T)L>2G9!"(9B_.D MV.S9JJ%;)>L)2"!"]_PZA-3P\,+"TU3N-TZVM'[3K4QN"2FHYPZ@K['6ZORL MI"1#L\2YE[<$9#V*E*U52(=PKV(BV31T#E=;X@H4A`N#P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&!'3DC6+))TYQ;(*Z;NB&]$K=^DI&@:*CZ/)6O9RDK M4GT/&1K9GHPMHGK+"(3"+I)HW7]9%$O58O MMDQ#`C[P(I-QV4'G$UYKV00BKS>-IWRJ5*1*1DBL@^ M5!0IC*X$)7R[97SH:H<2,!`,V2G$%)9_5J^9"VU5JU/Q^OBCJOPAFK9@VLU? M02$S=L*:*";UN!>TA`.!0"PGQ!;4MFX>-=VM5R5IJLBQWS>:LP+1M;U;5D.V M@8*OTPD.R6J]3C&#$K]BV<^D9111ZL"1$TA<*%2+T"UC`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8$K32HK@5J\224627$HIE,?M`0HHI]QO7$C:>IMK[;X:\NKU96&L MMH6VF6#;_.JJ;XDJ5K:$A*VZW'::]3"1,;$M+96Z$[;D6:E%JY>LS'3*917N M.0,5X6S5]8?TZA=9N+1'[$+(WRV4EK$MB,Y=K-+N]\.X&1C9!%8K]M9"`HF* M"*9Q`#`4Q!$XAU",[W6_B87\[(L\U.5-Q)M:^_C*(X8SAK3::W"M1E2RJK2)-,I`HJ*`@EVA M!6[+2Y?,+J4=+PB.L9F8X(JM-"0UJB&L<$#..^..RBZ[@YI@[^9LG:\!)HI, M7"(F=ID]H=$14!,0$+)O$!7J]!:4VZM2JM%TFBSV\I2;JU;:;(8[1DTTW%$H MZ$Y-R\^WCX629)V*QMW;EA'R@4?5]J4_I@*G:`AUIN)>K*1<.6E0TILNRUG:U-V M1';`HJ]3J%NVU9W<=IR.U_KKD'J.5HLM<[1-6BH\7[.RFV\859JY9JRR[$L? M(FOS81]>>7EC?9@U!A;*X=Q]1I:S'S:L:` MNV4&H_3117.@`*)M^O:(=`Z!'?9LGNG7_+2K,$^!7CJV[S'ORX6.1I^I4-N7 MZ6ICD)A%V-ZV+'.IR.UA2WY9=(KE:67$L@B0?76.1)0#G"TGG+L"PUOBEJ.# MY8[XD]`[;M$B%@LA^.5-V98M:7:1IXM9F8U98'-;>-]DH5Z4B79&ICQ]@@'# MU[U626(@F9,@0GW!LZ,C/+5HK?<)%.S-@\<]IW&SC9V.D&LBN1EIC=MEC6DO M"GE'KZ/?`R:I(KM2.S*D.!B^J93JH(3U\.%7US&<?AV[=(5@H!S%F(SB6$C+5VS(0DFVDDB]HG;D0737."JA`(7J%5W`#;VXY[F+`4 M/>FY=>&VQ'42UM+%K*C\;-!2Y7]1@23L7!Q/ZS>A+!8DZNQK[N*0?EB99"&] M?H1NDB83E[@Q#QFU:9N_)?S%TZH7&7UA/V>^S,%7[W`M@>S5(EI/8>\FC*S1 M;244(5T^B'BH.4TU3E*G<4!`0#L3E<[/V3+5.15E]UOD46Q6ZDR2I7*HNX6/$_NB*M".7"2J3DH]0 M7;HK`%7?)5TC2?.+Q->/$YJ<:U3C:HX>(,R2%BL4VU@J)R&5<-VZ3E=U*6"9 MDR-!`A%555W:YP`QC',(B%A_C('=;W7FQ)?;D[NQ5)Q?WJ-;JVYZLSKJ\&Q< M1L9,HIU+WS3[<#$0[.42A7(2;^11=OXM9\U43*Z.G@6<8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`AUS0X@M.9FOH37$MN3;&I("/GTIB<1UA,,XU*ZLD MQ0$(.UM7K1TE)1[91$'#4!Z%0>%(J)5.SL$-;\7/'S&\4+!$O:+R)W9+4N-3 MD@=ZKE&&GH:BSSA^V=)(/IU*DZOJTZ_>Q;MV9R@MF(#M1!0O8J1(2 MB(`/4`^-ISGBVB#9*0\Y5*4!%JFW77;<%(IP!WK8?361.#/HB-1U95],(34M/0SQ_5JT MBWJZ;]TO\^;]9"1>/!`6;%F?TD04`2JA6E=[,CNKS#>/FWVR"B?1V[P^IECL ME7.0)*#,E?=4[UE)J`%-^F(R$5Z&>JR%7TAN4KMC M1(]A([[G%:XCKNTU6QP*E8CZA4H>`<*H5Q09.(E3Q3!(KH)])M8GBQ#.GZ*: MRPE`+AL!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@5S>1S4FW]LTG4C2@5B M[;.UY7MH$E-[:5UML\-/WC:5#>UN:A&+&)NIY2"0,RKMADF\B]C%'S0DB@B) M/4*8I3E")O$SCE=J;R;UA;N/O'KD-Q,X_P`=5[A);J_/YN(]T4W`K,QR3"GT MN.U.XV9L-2JR];FP^:?.5O:.B)%5;B0H*]%`B5I%FH_V=_6%&B1ERG6AMF=! M;)ME5P[$=[J#V$>+(-C?5(/7N.'PZ].H]`P(P>&O@?%;+FC2`&`TC6BZ)U5%%/JK2[<"B($:+%4")WE8YT1 MO-3?KF0I$@L["'V#N(=RQDU.2<1*MG1KY7V4;*5Y!PE M;K5;CNJW.51T`+3WM9-['.&;Q9%(SGTRA=)@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,"%?.GC%L#E#J)O6-4;NO6BMDUJ<;V&JV2IVVR5:%EEA)[&1@;P M%550EY&">1BZHI>D;O:O"I+`4X%,0P?AI7@KKS2>R(S:L/M3DQ;;+&PKZ#+% M[,Y`[`V)4U6LHV41>%<5^ROEV3P4U5`6;G4(!T%B@ M46;V+)U>JU#FH[LL1KN9KUSD/#6-FL]H:2K>K6-2?KWK:3*B1:IX\ORIW!RU-_ M-=L`MA-8FH"^=NU/R;APNL"Q>\>Y0-2?F+EB!W$\9W!WN+\2=+_4B_6+\2]# M!Q.$2]!#Z?N8&G]G\8.2_P"OI'\KM;U&IQ$%3N"%JU]6V#"R1#UDTW:5C<`J MU$8U]VPA%IJ":2LPS,DY52BF!VR(B XML 20 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock Award Plans and Stock Based Compensation - Schedule of Stock-Based Compensation Expense (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 701us-gaap_ShareBasedCompensation $ 298us-gaap_ShareBasedCompensation
Cost of Maintenance and Professional Services [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 60us-gaap_ShareBasedCompensation
/ us-gaap_IncomeStatementLocationAxis
= impr_CostOfMaintenanceMember
23us-gaap_ShareBasedCompensation
/ us-gaap_IncomeStatementLocationAxis
= impr_CostOfMaintenanceMember
Research and Development [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 223us-gaap_ShareBasedCompensation
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_ResearchAndDevelopmentExpenseMember
92us-gaap_ShareBasedCompensation
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_ResearchAndDevelopmentExpenseMember
Sales and Marketing [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 216us-gaap_ShareBasedCompensation
/ us-gaap_IncomeStatementLocationAxis
= impr_SalesAndMarketingMember
89us-gaap_ShareBasedCompensation
/ us-gaap_IncomeStatementLocationAxis
= impr_SalesAndMarketingMember
General and Administrative [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 202us-gaap_ShareBasedCompensation
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_GeneralAndAdministrativeExpenseMember
$ 94us-gaap_ShareBasedCompensation
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_GeneralAndAdministrativeExpenseMember

EXCEL 21 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"$YM"'"`(``((;```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F=%NVC`8A>\G[1TBWT[$ MV,[:;B+THNTNMTIK'\!+?DA$8ENVV\';SPDMJBH&0D/:N2$BL?_S8:3O(F=V MO>Z[[)E\:*TIF:S6UKHIRYF=^MT>TOBJ0LLN]DN'+)*IIWKVDK'1,J?3?TN9?*2D*>=XYK0 MM"Y\2AB,[TT8GOP]X&7?CW0TOJTIN]<^?M=]PN#KCO^V?O7+VE5^>,@>2KM8 MM!75MGKJTPGDP7G2=6B(8M_EXS7O=6M>N0_DCXL#'R_BS"##[QL'G\@A03@4 M"$8HH"@&%6@*%6@.%6@2%6@6%6@:%6@>%6@ MB%6@F%6BF%6BF%6BF%6BF%6BF%6BF%6BF%6BF%6BF%6BF%6AF%6AF%6AF%6A MF%6AF%6AF%6AF%6AF%6AF%6AF+5`,6N!8M8"Q:S%_S)K3`T#\?'SW_^4<P"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I5!\<8B]. MP[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4 M_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&74"T\U<%J"`=[!ZH^^CSY MLK$SO+=N5#9@NIS]NHFD++28,5\YS3$$X4UD^&'!Q0]47P`` M`/__`P!02P,$%``&``@````A``IZ.`0S`@``J1H``!H`"`%X;"]?$TCZG$#PG,#2D<`X$Z1U;:"N MC70O86`OP=*)R3`Q[:*)F?*K`7^QG-.E/OUBB"6=M_C&PO=V]R:V)O;VLN>&ULE)?1;]HZ%,;?)^U_ MB/)^!R2!M57I5-I.J[2MU>AM'RTW,6`UL9'M#+A__?V2K.$$#P1/X`0^OO.= MGX_#Y9=UD0>_A;%2JW$X^-0/`Z%2G4DU'X?_/GW]YRP,K.,JX[E68AQNA`V_ M7'W\<+G2YNU5Z[<``LJ.PX5SRXM>SZ8+47#[22^%PIV9-@5W6)IYSRZ-X)E= M".&*O!?U^Z->P:4*&X4+5,YN*Y MJ2C@R^5/7L#W.@^#G%MWETDGLG$XQ%*O1.>"*9>34N:X>Q[WX[!WU1;Y:(), MS'B9NR>4]ZZ.O*(DBD;5)ZLHGJ58V>V7JF6P?I$JTZOJHXAVTZYB&%C5MUYD MYA:XW^_WVVO?A)POW/M%R/>(?IT@?J=^#51=WGLB#)UB=\I)MV'WJDE?:K2P M2OT>E0W"P%Q(O#'WV:`R3E5NM,J$LB)C>&=U+C..L-B$YURE@J@D"9&)3I.! M@]9-3&3JP(]P,W4P573<$)7D2#-_5*@9I-]&,SQ-)B(U)52G9N/XHI!'F\UG M8N?SKIT',^=*_E=S7_=\4EJIA+5$(!D1A;-=A6E9%-QLF)ZQJ9PKB7W%E6/7 M::I+Y:@,-7*^*_.52\.>>5X*]D-P6QJT1KF.#4R0-M=!?U<`/VA*0':WQL2P MPM;5/+B%,.RF--3'.=7QV'WAQJ"`#7MXS>6\&0CDVT/LOJT+#]E;\4IK'G:V MR5_(+`KIZD)KN]@M#@,3@U-B/&Y;.`07VQ_UT$3I95%B>*'\/Q7K`D-R@2#D M;ZH#+K8Z'IM3I],W=KWB)F./V*I-ALW5":G"_KKE,>!!R1"3(&.:95^2?O6T#";3:@. M!7+@$;EW:[!'3#2J0\'$=-X9AGO(1CRO>3YB?CA#%MSEVZ6C=W_CK+*.-'U&@ M(P_H?8V_ME9T)MN(`AUY0._5@1M'_40=@#R@]^G\$BFV#`$ZIOQ@<230S?BG M.A2A^$2@04U[A(WH3HV/`[H]EXA.3`G"8J>P:GBSJL?5#.(Y>?!1[%90'0I0 M["$-$O>/=49U*$!XDMOQM"($DHU%B<)T8@2J+:G,1:>T*%S MK#//:-9)C76OS@\/]RG/4_SKJ%[JQ_9D.&J.EM[['Z^K_P$``/__`P!02P,$ M%``&``@````A`#NG`VHW!0``210``!@```!X;"]W;W)KNFSANXZH"[DOZ^/6_>?O MA[O8==HNK_?Y6=9BZ[Z+UOVR^_67S:MLGMJ3$)T#$>IVZYZZ[K+VO+8XB2IO M%_(B:N@YR*;*._C9'+WVTHA\WP^JSA[W_="K\K)V,<*ZN26&/!S*0MS+XKD2 M=8=!&G'..^#?GLI+>XU6%;>$J_+FZ?ER5\CJ`B$>RW/9O?=!7:>@6$,Y#HM,U)U[B0:3=9E_""I3L3B,.6_.DCW"E:D%K;>O]^+M@!%(1=L]E"JDZQ3/;2>K_Q#$="@,PG60 M`-CK?GYK$`\)]>N[S[M\MVGDJP-%`U.VEUR5(%M#X.O"D,:PU(]6"DM40;ZJ M*'TL6$0+Z7G9A:N-]P**%AJ2(B1QG0'"*"*[(E0B@-U`$=9M4PP@@S_6_LI( M#;(8A72^=`KA%)%-$6$T0`A'D,[D^#DW!=ZZD/A!BC`>PO:"I@@)^_PKA3.C M@4R\G#.Q`F]=^!PG3JR)$<+\/HF,)RR@@(P`$AXMAW[""U9WNR`*3'E%_A`6 M!4%(K&E%W*9%^GT6CLDFM,(YM!38HF75;(H0I,5783!.V]/.S'Z6+)?CL@BM M:`XM!:;E$UF%FR+$*!^C@4RL#BAC^W]>MPI,]0CM\D$(ZA$L)UDRNSD+/U`# M3.)V4@I,24UJ!R%(:@DE2TLK(]TL&2N+*`5;8@:K'FW1&@-C26L,\HJ#U:@& MU@[I#X/5.)X2LRS\\QPR=%G3`XPMK(DA!HFQB,=V5>L@&A#X\2@II699]T^H MH=W"3A[L*9J<(H@Q*IL9+73R69[,T&")+M:R4XW!98>QO>LRVK\RS(`24Q9Z M\Z9C:+B$V"BW3AAB=#ZXSZSC)--!-,!?LG'?4FK*1F^GAJ9+J%DSI^HI"?8G MSKQL=@8,<@7$\7@L46JS[)VA.T-"AOUG!-:J(<;3JF?>&!THUBCIZ/#HRJM-' MWKJ:(+/\(Z/=?*Q(HAN?Y><]VJ)EE4NJ,==R"2?"44`$_C`FA>%4-XJ(`W^L!TK2LOL;A4-+ATE&`[-2EW+$F,(9+93$+&/G4V-/K,,N MU1AX?.H5@LN"V"=_EJ%DU@"^^-`T+*=7@H4_?TF>.GXR;GV=5V2&-SIXXU&)YB@R<3ZW3B&?U6V- MRL/0BC=)*=PD]=^AN' M1]G!%4[_]017=@)>W_T%@`]2=M&UL ME)9=;YLP%(;O)^T_(-^7KQ#RH9"JH>I6:9.F:1_7#IA@%3"RG:;]]SNV26J3 MKFUN0L#O>?.Z0I6TFZ7H=^_[J[FR!,2=R5N M6$LV+>DD\:$DP9+X!6VQO-]UC.-M`WT_10DNCM[ZY,R^I05G@E72 M![O`@)[WO`@6`3BM5R6%#E3L'B=5AFZB91Z%*%BO=$!_*#D(Z[LG:G;XPFGY MC78$TH9]4CNP9>Q!2>]+=0F*@[/J.[T#/[A7D@KO&_F3';X2NJLE;/<4.E*- M+BU5HP&)X"=]/-!2UAF:I/YT%DXBD'M;(N0= M59;(*_9"LO:O$46#E3&)!Q,X#B;1U$_BZ6Q^B MY8RJ*$,)\JPDDY._1M@83:I'2L6?6Q<<`K"YG$`590B&V2*8C@B,QB*P+C@$ M8&,3O#U%2NSV'EO[;WHW&GA"J"&[BL+0)!M+`&8VU7=8%AT"]Y:R;_^U? M5F(WEOFH[XV1#*E,1G.0 M"J(+_1E,%#?O/7,B6:\?BELFX7VEO];P_X3`@R7T05PQ)H\GZLUZ^L>S_@<` M`/__`P!02P,$%``&``@````A`*ESHVT2`P``2`D``!D```!X;"]W;W)K&ULG%9=;YLP%'V?M/^`_%X^0TBBD*I)U6W2)DW3/IX= M,,$J8&0[3?OO=R\&!&1-T^6!#_OXW'//O=A9WSZ7A?7$I.*BBHEGN\1B52)2 M7AUB\NOGP\V"6$K3*J6%J%A,7I@BMYN/']8G(1]5SIBV@*%2,.HY*< ME539HF85S&1"EE3#JSPXJI:,ILVBLG!\UYT[)>45,0PK>0V'R#*>L'N1'$M6 M:4,B64$UZ%<'U2T-*K#)9?3E40M)]`7D_ M>S.:=-S-RQE]R1,IE,BT#72.$7J>\])9.L"T6:<<,D#;+S M;@SZS=E)#9XME8O3)\G3K[QBX#;4"2NP%^(1H5]2'(+%SMGJAZ8"WZ65LHP> M"_U#G#XS?L@UE#N$C#"Q5?IRSU0"C@*-[8?(E(@"!,#5*CFV!CA"GYO[B:`O);*D/@M"=Q;$B^T9WX8+=[#$K0L M<.]8/'L1AK/Y(GI3BV/R:FRZIYINUE*<+.@]4*YJBIWLK8"Y\\=DTSOVFF'@ M%)+<(4M,EL0"+Q14^6D#Z:V=)ZA,TF*V!@/7'A-$[ABSZS!84A#8JP3GABK_ M7;U.#()1#%83U6W-P##RS)]/(E_&C,2`3=>+07!,H#Y]UC,_&L?>&LR\%[P; M#(PBS]X3&<$Q@>L@\F(2V6#@`\2214L7?V/(SD`:<2,MD-+0!6R<`#[/RZ7! M15--RW'`K<%TFH+P7-(EQ$CC?*SQLC8$3[0%$S.V!A.U'>[ZD_F=F3\W*WJ/ M$`1/A7@3DPQFT#*#@9$%>)`-ON_+%B#XK68UF$'DP<`H,NP&P\C7-0@NFN;N M3W(WF$53!-\[;X_7YT?ZH,/^0V"SZBV%+5A[DWH_V!^F=CSN(TT_`.5;3`_M&Y8%7RBI8!DM=&P\+:4Y"\Z)% MW9P#>Z'A!&L><_C'PF#K=&T`9T+H[@4#]/^!-G\!``#__P,`4$L#!!0`!@`( M````(0`S*M5>Q@,``,\,```9````>&PO=V]R:W-H965TL#JRR<*U+5IG+"_J%-2].\&U25CN>Z*Z=*B]I&AVT[QX.=3D5&$Y9=*UH+-&EIF0K@ MYY>BX8-;E^6_S";G^T1?ZUJ"ED&]9)KL"1L6@N"+T)G'L3#QZW#DBP^H#+LG>! M<^]"@H7O!>'Z(RQ^[P+GP<6;S>)@=KID)ZE(][N6W2RH8)@_;U+Y/I`M.,LL M+V&M,"=CWG^5=LBW-'F4+I&]L2T8SJ%67O8^6>Z<%UC?K-<<4`/'44-T13Q5 M+$-7UR2#1I8.3&&"Y*Z,.8KQ_1TV4@$8&,YY/)L4FV(O>KT(YR$0.#634P%%)^%K7Q(-FJ.9$"6B4X?^AE(-,RHU.<$#-L.3$ M,ZHSQOM*'I6`1BA_O)5N]'[^I-@@\XQV<4#-0#8M1KROD"D!C0QZVWPR*3;) MC&9W0`UQNV(TL&.\J6#]0JTA@M<'&#NU"7EO5]@7>]$=))Y$$C6B\\A>/7LU M"79V>,.44C<*Z="+5!X<=H\DJD;GD?UY/@]V\_=['4'1_>EQ'QDJSM\82YNH M0W0\V:$5O'E-A&!?US`]HX\=>I&*B= M+#"*5%*,0)7);04)?HZJ#$-4W%?B5J>B[9G&M"RYE;&KW#,2,!NCXW[VT9._ MG\YX`[:337JFW]+V7-3<*ND)AKJ+$&JTQ0TI7@C6=!NI(Q.PD>R^7N"/`X6= MA;L`\8DQ,5S(!XQ_1?8_````__\#`%!+`P04``8`"````"$`T@BE7<,"``#: M!P``&0```'AL+W=OWQ\?,ZUL[I[ MJROT2H5DO$EPZ`48T2;C.6MV"?[U\_'F%B.I2).3BC]4XKOUYT^K`QMT"Q9153 M[X84HSI;/NT:+LBV@GV_A5.2]=QF<$)?LTQPR0OE`9UOA9[N>>$O?&!:KW(& M.]"V(T&+!-^'R_06^^N5\>P8;TOM:YN\/5&9@*-!XT4PS9;P" M`?"+:J8[`PPA;^9Y8+DJ$SR)O=D\F(0`1ULJU2/3E!AE>ZEX_<>"PH[*DD0= M"3P[DC#VIM%L?GL-RZ1C@6?/$ETJQ;?;,BX]$$76*\$/"#H/A,N6Z#X.ET"L M[9G^UQ[P1<^YUY/,5$!+B/1U/0VCE?\*.60=9G,&$\1C3-IC=("@9Q`%/KFB M)I#\^LW*&@R1'J_LQK"QF#`P22XF8UWIJ#H-ANI($VSMZX;%Q$:2XU3:U]RVB:\1H<&.B(G;+Q9C1=S,G&K:5UT9\VMD:+`K MPTE@8S&=C/G8J+0ONBKT]^OH8'_$;RB%R``:N`D>TT[;_?M9U"2*NU>>'#]_C<<\\UE]7U4]N@ M1R85%UV&ROUYT^K@Y`/JF9, M(V#H5(9KK?O4\U1>LY:JF>A9!Y%2R)9J>)65IWK):&$WM8T7^'[LM91WV#&D M\B,*'6^X?K:D M&+5Y>E]U0M)=`W4_D3G-7[CMRROZEN=2*%'J&=!Y3NCKFI?>T@.F]:K@4(&Q M'4E69OB&I-L%]M8KZ\\?S@[JY!FI6AR^2%Y\XQT#LZ%-I@$[(1X,]+XP2[#9 M>[7[SC;@AT0%*^F^T3_%X2OC5:VAVQ$49.I*B^=;IG(P%&AF06282W M[0%?S)X;L\EN!;2"ECZNY\1?>8_0A_R(V3C,$J,!$TP1VS<0(\0#?8-(\.U< M9/BN2+-I*C(@4P4;!UG:7IG"MB<+$P'@S*F`_[MCP!F&TS%63A9GF1TF'C.? M+$PRSR_);,`9ANN8.3COB\,0W[8M2))PJFP[B2^2<#G$)[J@O(\[8L!377-R MW@N'B:VLI1\/6>V)V[IH8J.$S.=#>"(JOD24`4]%!<%X_FS:C<.XM$$R/_?J M-$RB9-P]4;6X1)4!3U4MQPXX40YR[&`]W@<1UFJ[*7HS!YQ[./1>NYW=[6:,MUT:H)L-)%&/$&Z9RT909_O5S M=7.+D;&TR6FM&I[A`S?X;O'YTWRG](NI.+<(&!J3X&F;Z&0Q6%8/Q1L8WDC0TDFM?4@GY3 MB=::%QF^3V;+$2:+N??GM^`[TWM'IE*[ M+UKDWT3#P6PHDRO`6JD7!WW*W1($DXOHE2_`=XUR7M!-;7^HW50 MD,MKEA\>N6%@*-!$J9?!5`T"X(FD<"<##*%[/^Y$;JL,#\;1:!(/$H"C-3=V M)1PE1FQCK))_`BAQHCJ2]$@"XY$D&47#=#2Y_1^6P9$%QA/+^&H6$O+R-CU2 M2Q=SK78(CAXH-RUU!SF9`;/S9PB9A6PZQ_YE&"3I2.X=2X:G&$&X@2)O%\/X M=DZV4!EVQ#P$##P[3'*.6%XBAO&XPQ!0W,D&*_NRWR_G29T#.W6N)D[N0UCH M2TF[;3QB^0[B%7*F!$R[7HD#@\$]#P;3R?G6#P$S[M0N>PMG.P--?V=7N@%< MD(^]<$$9A@IW51C&TS<*`J:GH+=PI@!H^@H^WMF!SW-/DU=/0V&.F*D_0G&4 MO/$&.H7G>.=[T!7Z0#C@DNN2+WE=&\34QMWQ!&B[U:[]W*>^@W0?X/JWM.3/ M5)>B,:CF!83&T03VUJ&!A(E5K;\^:V7AXOO7"OH\AP,61P`NE+*GB6M1W9]C M\1<``/__`P!02P,$%``&``@````A`+W-BG`_`P``GPD``!D```!X;"]W;W)K M&ULE%;+;MLP$+P7Z#\(O$=/6W[`KVZ>ZSA84=",I"P[ MU*21AH23"DO0+TK:BHZMSMY#5V/^<&AO,E:W0+&C%97/FA0Y=;;\MF\8Q[L* M\GX*)CCKN/7#!7U-,\X$*Z0+=)X1>IGSPEMXP+1>Y10R4+8[G!0)N@N6Z0)Y MZY7VYR\E1S'X[8B2';]PFG^G#0&SH4RJ`#O&'A3T6ZZ68+-WL?M>%^`G=W)2 MX$,E?['C5T+WI81J3R$AE=H,,`0_Z>\C MS669H"AVIS,_"@#N[(B0]U11(B<[",GJ?P84G*@,27@BB4#]*1Y^F&1R(H'O MCB1V)^%T-G^'%,^DI5U*L<3K%6='!SH/A(L6JSX.EL#N)/5]XC%"8[838<!.CPELQ+9#J"HHVO0EVKC?Y$$*?1Y@ M\3B/")KEY3)WLM4F6W8XTK1Y`=(+T"*WEXAX9D/22T@8]A`K#>B0CZ>A-B4( MVK%W=N*/)&P,)M9MJ;S=CA?2P8(E";IB+"F^ZJS:E"#X["6%%Y(,)O!UO]R, MG=_:XD^J M3=>*:3`#2>.%=+!@29K9DMYV1X%M=T+_?/QT]V\,)M8UC*-S5YNS8:)S'0U\ M?]XWO3G?KX8MS6H2CZZHZPVH-HVUCRMK,$;[1?MUP?XRZA;4[783SI7S7S>!$NXF-6([0,P'UN\)S\PW]-&.!4I8*OOSN`<<#-A MS8-DK;Y==TS"9-0_2W@1(G#]^"Z`"\9D]Z#^H'^U6O\'``#__P,`4$L#!!0` M!@`(````(0"/5[!5G0(``#@'```9````>&PO=V]R:W-H965T8^?:1'&J-E5V*VVEU6HOSP3C&-48"\CM[_<` M26L[;=/F(39XSGC.#.#9S5Z6:,NU$:I*<1+%&/&*J4Q4ZQ3_^;V\NL;(6%IE MM%053_&!&WPS__IEME/ZR12<6P0,E4EQ86T])<2P@DMJ(E7S"I[D2DMJ8:C7 MQ-2:T\P7R9+TXGA$)!45#@Q3_1$.E>>"\7O%-I)7-I!H7E(+^DTA:G-BD^PC M=)+JITU]Q92L@6(E2F$/GA0CR:8/ZTIINBJA[WTRH.S$[0=G]%(PK8S*;01T M)`@][WE")@28YK-,0`?.=J1YGN+;9+H88S*?>7_^"KXSC7MD"K7[ID7V0U0< MS(:87``KI9X<]"%S4U!,SJJ7/H"?&F4\IYO2_E*[[URL"PMI#Z$AU]D<2N!Y)DMZG2?I'$KB^D/2NA\EP=%D*"6UYE^ZII?.95CL$ M*P^$FYJZ=9Q,@=G9TP>37[<'?'$UMZ[(EP+:0*3;>7\RF9$MY,".F+MS3*^- M6+R">($0T/=1^LUN\EU-Q19=2"9B&@L9$2\&XK>#] MWAVXV_N@TWO`'-.87,?NUX;`:>EHO+B@)1Q^85O7=,T?J5Z+RJ"2Y^!('(W! M/QV.OC"PJO;;=Z4L'%G^MH`O%(<=$$<`SI6RIX$[7)^_>?/_````__\#`%!+ M`P04``8`"````"$`1DM-X9H#``!\"P``&````'AL+W=O.U`R:Q%C"UG,P06GVK(WG/Q[YO/,>/#VYKDLO"T1B]4(EN=N_?;2]A,$,CW1DDB?U[2"D9R+ MDBAX%<=`UH*2K)E4%D$4AHN@)*Q"QL)&C+'!\YRE](ZGYY)6RA@1M"`*^.6) MU;*S5J9CS)5$/)[K266Z>3A67)!#`>M^QC.2=K:;EROS M)4L%ESQ7/I@+#.CUFM?!.@!+NVW&8`4Z[)Z@>8QN\2;!,Q3LMDV`?C)ZD;UG M3Y[XY8-@V2=648@VY$F1PS=:T%31##*'/)V1`^>/>NH#?`K!B6P$VHG\W;FY MC;27P+KI/W1G-R+M17?OE(V?&DP-,[JA,(0W@RX_F MVFK*"S`!5Z]DNIX@C.39T+%,G6(T7?CS93C%(/<.5*I[IDTB+SU+Q%",H![OJJ;5N^(QB88&3WH>!_]G0_^M^M3A&<+5^9XY?HUCT%'_7W9`E MG<+-!ZRF'XC70;1X"+)P0(S"@!S^53I)IW!!8,YX$"T>@BP=$*-8MG40KIV( M)6:\R=0@,)&)PF;AMC?Q&XU[%N-J18\C5;7!6,E5S1O:JS8M,D!C;N56XVFR7>3 M"8XF4TAFKG\'$^Q46&+%5UQ.IWV]P6#3+P=<[LYN-8.D.=LNL9HK'-T'>TD; MU_CAM'-5V$X$]JVFU_O;+RNS^6?A*EK/_R[&=!USMC&_ZI**(TUH44@OY6=] M5L$PU7ZUAZ_V5&0'X!A3DR/]3,215=(K:`Y30W\)G5:8@Y!Y4;QN#@('KN`` MTSR>X)1+X<<:^B#..5?=BXZ;/3?O_@```/__`P!02P,$%``&``@````A`#@- M\=,M!0``?A0``!D```!X;"]W;W)K&ULG%C;;J-( M$'U?:?\!\3[FCB^R/0J&WAUI5EJM]O),<-M&,;0%Y/;W6TV#J:[.),Z\)/'A M5.6N)-6XIZ8WLSU[9X78A]61\W]C]_LR\+VVJ[O-[G9U'S MC?W*6_OK]M=?UL^B>6A/G'<69*C;C7WJNLO*<=KBQ*N\G8D+K^')0315WL'' MYNBTEX;G^SZH.CN^Z\9.E9>UK3*LFEMRB,.A+'@JBL>*UYU*TO!SWH'^]E1> MVC%;5=R2KLJ;A\?+ET)4%TAQ7Y[+[K5/:EM5L?IVK$63WY_!]XL7YL68N_]@ MI*_*HA&M.'0S2.[[@OT;\F? M6_2WU9[$\V]-N?]>UARJ#>LD5^!>B`=)_;:7$`0[1C3K5^#/QMKS0_YX[OX2 MS[_S\GCJ8+DC<"2-K?:O*6\+J"BDF?F1S%2(,PB`GU95RM:`BN0O_>_G"C++*@>P M5JHFU[K_J.Q0;YGD3F;9V$O;@O`6>N5I&P;QVGF"]2T&3J(X\!-QYCIG9W(\ MG9&:C-`E_RDS.<'NKY+%C>C"1D"-$OR9>B-T_W]99%!U!(Y M8A/%0984X+F])R_V0\.4SE@`@=C.:%*&`,T6#)K/VY)!U-9T!*KC6G&0+0JD M%,@HP!"@B8;:&*H_/EC[J(].UH&$=!M(:B"9@3",Z-KEN$2-]'X#>6JXPEDW M38.0#*1D(&'-*DQM"R\,8S':'ZD[ M3R&JB6(?OH`9/41CLB%FJ@##B.Y%CC[DY0,/:E!B#S&1DWAHF`X6*)(:G&Q` ME,UH,5^2M`R'Z`[DE+O=@9J)V$$8D?>#Q$.#<[!`D=3@9`,"YZ?\`N=YLYB\ MC#$_X^=Q:A7B45SRR(Z_H]?KISN\OD*X/X/;GDA_Y'WES M+.O6.O,#A+JS.1R>C;H_4A\Z<>GO/>Y%!_<^_9\GN.?C\'W=G0'Y($0W?H!O M0L[UYG#[/P```/__`P!02P,$%``&``@````A`/NBLQ"!`P``/0L``!D```!X M;"]W;W)K&ULE%9=;YLP%'V?M/^`>"\?"9`F"JF: MM-TF;=(T[>/9`2>Q"AC93M/^^]V+@8!)DS0/`>SCP[GGVI<[OWO-,^N%"LEX M$=N^X]D6+1*>LF(;VW]^/]W+SY_F!RZ>Y8Y290%# M(6-[IU0Y6@I*T6I1G[LCS(CQ?>_/5O[8=A?SRJ"_C!YDY]Z2.W[X(ECZG144W(8\80;6G#\C]%N*0[#8 M':Q^JC+P4U@IW9!]IG[QPU?*MCL%Z0XA(@QLEKX]4)F`HT#CC$)D2G@&`N#? MRAEN#7"$O%;7`TO5+K;'D1-.O+$/<&M-I7IB2&E;R5XJGO_3(+^FTB2CF@2N M-8D_=OS`BS[`,:XYX-IP!%=RN#JFRJ('HLAB+OC!@GT'JF5)L]L\`E)+E'EMB>VA8LEY#AET40AG/W!;*2U)CE$./W$:L&@:U& M\*RK\73>&BD(1BF81]2VU`/`W6H;&>\=(J))"^DI`8>Z2M"MX-V=U"C"1;$- ML%9`,)ZV_%JDQD2MZE5GH*<@Z"LX[P6"06'WS6%DO+G&3*NL^]^=W%_2T0LA=M\YK1;"I]9@%[9+&1+UX;OOQK$YACF[W]`'1]?H0;.B+ MO/Z[ES5&>VE,KMZ9["F:?$01@DU%QI%:UIA:D1,8CJZ,^3!H(^KIPD^A427& M4(?/9Q07&?I"4Y_&=/9]9Z"G`&J+J>#RR<-%ETZ>QG04=`9Z"GP(N"OA?/`5 MVHS>/'L-2*-9&Y;:%=J?9V M^ZT.V/?E"\K!J`-5?0ME2W.VA3*7PU M/0?`&\Y5\X`O:!O?Q7\```#__P,`4$L#!!0`!@`(````(0`Q=;:\H`,``"0, M```9````>&PO=V]R:W-H965T&]4B$9K^9^-`A]CU89SUFUG?M_?C_?W?N>5*3*2<$K.O??J?0?%I\_S0Y< MO,@=I>[4M:*201M"`*],L=J^61K-G7=QDO:Z!8 MLX*I=T/J>V4V_;:MN"#K`N)^BQ*2';G-PQE]R3+!)=^H`=`%*/0\YDDP"8!I M,F4CTS3>E[V5XJ7OY# M4-10(4GQ.B)T)D!>JQ$"[VH< M0@HOFW^4I`^YDN+.?;;.PLA8].0KO.S#<#/5O MWZS[37\V]*&^;"#&4F`M.`K@A78D7`_>H-WHS_/1@#`AL64Z5JRS/8E;ZUQ9 MG4[<(PM[I5W`29JVS-@Z(@19GM@K[NT7>FQ_7B+LCU!Y;1LY;V`-R%:!Q\R* MJZ+317L\P$YH>W`A-<=VJ3]*<=2Q:!79V_>GWNO*TJWNYG*)L#':LA+KJ]&D M!D&V*=:*>[MN;-;MMY6,GDYZ:Z8!V2H^ZJ(P73DJ>E*#K=#VX$)J$`3587(3 MG@JC*1MG?W+Z`*`].*SA,%-2L:4K6A32R_A>#V(1D+:K."0N]9!HQKQV`V:T MFFSI#R*VK))>03=P-!R,P06!4QX^*%Z;66+-%4QGYM\=3.,49I]P`.`-Y^KX MH*>7=KY?_`<``/__`P!02P,$%``&``@````A`,*#"!7-!0``*Q@``!@```!X M;"]W;W)K(8\8_'^TX]FYWV7 M75^W^Z7/9J'OR7W5KNK]9NG_\_>7N[GO]4.Y7Y6[=B^7_D_9^Y\>?OWE_K7M MGONME(,'&?;]TM\.PV$1!'VUE4W9S]J#W$-DW79-.<#7;A/TATZ6JW%0LPMX M&"9!4]9['S,LNFMRM.MU7US0%2/-6[>O@Y)O6]IEI\W>S;KGS:P;I_L*BLWG*/7R;IF[KJVKY=#S-( M%R#1Z9JS(`L@T\/]JH85*-F]3JZ7_F>V*$3D!P_WHT#_UO*UM_[W^FW[^EM7 MK_ZH]Q+4ACJI"CRU[;."?EVI1S`XF(S^,E;@S\Y;R77YLAO^:E]_E_5F.T"Y M8UB16MAB]?-1]A4H"FEF/%:9JG8'!."OU]1J:X`BY8_Q\[5>#=NE+Y)9G(:" M`=Q[DOWPI58I?:]ZZ8>V^0]!3*?")%PG@4^=A/&;DPB=!#Y-$CZ/69QT$6-^:P&C4,!W4--OS_P M\#[X#F6H-"1'2.9[!N(BBG<0_`@)@-Z1(\AV.T(=6XM*Z M;C>K081>0N@A!.E%24;9V6$1,S/:(9>ZY,[O(@4FI$BM1,0Y'+'".ZTDI,"&5$5(( MT1LL3LRL2.IDV"$%!^<&5B/:I27(O+G&:%Y12&I\RX]+5<819EQI^PD"Z" MS5EZ2K*;3)U-75V0\Y9KC&7K]A.W7LIGKSYS#%W948:L.]<85(9GW*Q:ZX(Y M=#RR*NH2(\9^G8.J'U3D`%H.K4MG6WB2"%+:0N=X*VV(R)[/-493#$/B M.@6))4@:@2(8@1^<;PA\VA`B4QRM(6*PM%%&VFNA4V`X869CN/1(*[A2 M/VP)MBO3GV`Y1XPVM41,]'/BL66:+D%EWE:[N)(@6KY#D!#(.6*T?HQX3N&& MYT9>EQYI&A?*.FT6D3%375:[6<0A9V9CC8!"O?%"QT%A8Y&%IAF[U#[4+?BT M6T3D<.8:`\CCZU8TD0_SG,"X1$G?N*`A]@(0P4QNS$%K^-8OU*4&OMY:3]S) M25=0^RNY>`O`I]TA,B=,DT#,"04TK;,8E^@[/2*[3'3:(V*SE351IT>08U+P M$U&'G+HWL4_I^1*.:+=#Q&27YQJC[2,524R)$02\.I\X".)#/6(<14A2"]88 MM)`[1L]R0>*A4=Y5C_2("^I->T-L5HXE%8A!]>X8BSBM>D$@81I;-7#ID1YQ M@=ZT-]#2Y<+V_CCC<\*_<`!)Q%-C02ZU#W4'N'2EO]EC:L,:`R^AZHZ/O?>^ M12#OO7#AW2S>.C:RV\A"[G:]5[4OZMZ50^[C4[P3SMD"[N;`MLCS`NZ*Q^?! M,0!7M8=R([^5W:;>]]Y.KB%E.$O!&3N\[,4O0WL8+P.?V@$N:<=_MW`I+^'6 M+YP!>-VVP]L7=9U\O.9_^!\``/__`P!02P,$%``&``@````A`"*)L3W2`@`` MU0@``!@```!X;"]W;W)KO!`A12-70=:O42=.TCVL'3+`*&-E.T_[['=MI$Y,T*[D(&+_GY?$Y_F!Q M_=PVSA/A@K(N0X'K(X=T!2MIM\G0[U]W5S/D"(F[$C>L(QEZ(0)=+S]_6NP8 M?Q0U(=(!ATYDJ):RGWN>*&K28N&RGG304S'>8@E-OO%$SPDN=5#;>*'OQUZ+ M:8>,PYQ_Q(-5%2W(+2NV+>FD,>&DP1+X14U[\>K6%A^Q:S%_W/97!6M[L%C3 MALH7;8JNO&B7U+"\X$JZ0+=IX!/1USZJ4>."T7 M)841J+0[G%09N@GF>8J\Y4+GYP\E.W%T[XB:[;YR6C[0CD"RH4RJ`&O&'I7T MOE2/(-@[B;[3!?C!G9)4>-O(GVSWC=!-+:':$0Q(C6M>OMP244!"P<8-(^54 ML`8`X-]IJ9H9D!#\K*\[6LHZ0Y/8C1)_$H#<61,A[ZBR1$ZQ%9*U?XTHV%L9 MDW!O`M>]21".-IGL3>!Z,`EG41#%_T?QS+!TEFZQQ,L%9SL'9AZ`BQZK>1S, MP5FE9P))/I\>R(N*N5%!.A34`DKZM(SBA?<$92CVDM6I)+05^1G%0>(!WALC MI&T\HPK*$-3HP)C8!"LCB76IU+CRHP<6`"1F/(`*RM#T&&`V`#"2(-`I#+Y< M3>S^_/U^"P_>,1Y/!0WP4OOU*R.9:3K8M?3/EN07)18D5.(8\O($4V(;+O;M M-Z^,)-9P@[[\?)^%$X_!4>(!3C#`,9+W2_E^OX65C,%2X@'6807IE;HRDGT) MH_,UO*RQ\-2A>+1;7"ZB$@_P!A-\921[O$F:I$DR6".Y+4FFX30^K&,++AT# MI\0#N.F@I$9R$&UL[)WK;EQ) M_+[#O<-#08"F`9)/4K>7IT8*BJ%[9K98L4C,8#/SAL.J0K.EB54U=I.9@ M/\Q#[!<#NX">18\R3[*_?T1FGCQYJDBJI^VQL6O81HN5E\C(N$=DG&__^T]7 MX^I#,U^,II/??+6_N_=5U4P&T^%HJZ M67SUWY_]U__R[6*QK)@[6?SFJ\OEC&;-_5P<=DTRZOQUP=[>X^_OJI'DZ^JP70U6;+OPZ=/OJI6D]&?5LV1 M_^GAT[VOGGV[&#W[=OGLQ72PNFHFRPHXJN/)CV=+"\7#!TVP_+7U_5\MWJPOUT=[.T_*G],.QVNW:GZP^'98CFO!\M_ MV3CS]'K6E#_N[^W\<_FW0TXTM%.]'-<7Y:\)D+?-?#35J8?5BWK96SF->SE: M#.IQ]?NFGE#!K&,&+(POQ7N6M8Z6AZ=36= M5"?+Z>#'[>KDLIXWB^K-:FE<`\K*:4=3CC%9L"K_M9B.1T/;XGD]KB>#A@5@ MDD6U]?[D177O?CGYU:0ZO9RN%C#"8AN&&3>+135=7C;SCZ-%4RUFS6!T/NH3 M_8MFD(C^8;EH1%^]6+#U/_1^KA>7QGD#_4?SIQ7W-0;=/0H['!@[+ZIY,V@8 M=#9NMJM)LZRFYU4]'D\_ZH"]66_GS:P>#:OF)^3&`MR)R>U(U2#6N2R"8;L/? M79=RO&8P]/""^!PMQ95.78.X]P#D5UL_3)=-]:0G!S]_^ORI7,DD\.5T/,2: M^6_&[,OKGC![C_!=C"XF)G.Q2@)M+5QZW]O;W=O;KV;H4&3<"O%UL+>]MV?_ M5RUKY>5T/OIS,_QU-<$FJD:+A;BO7E:8%H/+9%O812)XFZLS1$.P./K" MU]7'9@`>W0#!73?]=77P8/OIDZ?;3YY\8V#QSR';*J^[ M;K`-=TKY+$C1JZ'K+C/OJ-??8A]@G#;+$>;: M_4UZ_F0)"LPX1!R_'$W0G".P]W:Z,$3>8(?>3.")LLMSWSRMI?DOF^=$5AVVM=9;N`VOKO'J#31$4XIWLM.:G03-;5EC< M;A]6F'SUEYAON<_2DR#OUNM%3)_A:M!CA=?X7GO?Y-2`8?R/:-.4]O6L6>#I(6YUA"`;& M4S/MRG$GF*JN6*[J^8]P7=\@_ZZ9<)UC6ZD>7HTFYJ](DI6+^;ED47+[-P#W MO4YV/I]>56$LIE.YEJOI$;[V55-MA6/V]-S+Z;Q!6P4K=W`-/C!G,&W62L)7 MW"QRV$T(%Y_E!J:W2U@,WK,&AQIMYA`MZY_Z-(&+)FC7_O8#=OX&Z3P'[6Y8 M8L8UQ`AD2Z/G"3LLS:XN]'`)7EP:9;2P,ZNHYW$.CF[)LP+P$T M25'^$:A3I*#ZPVNS"WMQI,Q6>AMLI>@Z;)R2&4V.^BY^PGUMZ;KO;]XX6P4G M1V;4QK'/">I,)A*!9R%L@?5[8XRA-R.%2FZ;>?Q3,Q\HN`$=0E+"H#$\LM5\ MTA++MXV/&Y?SC!AVSO`5A\:;6)Q.AT$VE^./KV;CZ75#T$54E#F:Q'&^9&R` MIYP2B,47OU#\K*="U@S9=+AU'!DD_9;8IZ=X")\5UYO;((]*:+O#(Q3!>TB1 MI]ZT.W'ID<).+PD?;8R*V8AS&Y%K7*G0),:LI1C::*8EC M_JK_MK!7E-JM\K]AZ1<-@@^#W<48!DI]I>#*GV^DITWT5Z+:A#9,,!PM9M,% M=@M\<3[Z2;K'XG?E^".W%]`XYM(Z&]WJWZ]?92'%E:'`-C2]F'GX/2F?XE=M M7+!6DDFY&F"0+4\DW7.[;$%$R3P#S%:5=QA?+ M?7K`K=NHG%0"=^Y>X,U$G?`X/2>R(0Z6%=Z3'.\(N5Y[S`6C+SKC_7C?VMC4 M5*'.$EJ\C4'3#(/9VWR!;"QF9M+>9=\&,9]PRA5\&)'GJ@F/8#,AOH:)DUMUUHMWONAVV MJ[.D7N%MZ(L$4`G[#;,;H-XX[V0UFXTMLH#D0(0,D/XK92R8031KQ\#/R).U MUJ&RQ^.RGLP!2XIP07J"4%R7N'J4R.VO8:!L$;34>*7K!;=U3#"$0+B[;$7T MN\04TJ=U0&[Q--[,+^I)E-.ZF^>KQ6A"CF7-HDI3BL'>DL*Q6.5F>WA_M^JM M?+9AY:WZ/I;48C`?F7FC>]DT-.7.MI4\VZVV8,SJKW_YW[+^ZLGU7__R?^X3 MG*QJ\;5I\\`JG1(%('PM\Y>$%$Z)0OW+2RRS,*-2](6P M%3$KTVE7]00GQU,IY[4<3I)E.#!HS!DC&,EU(5E(`+/6MMV3;>&.$8E>7X@9 MS>!R,AU/+Q3M9;J.D($VF@SQ`>;7NZ2]&G-#[&#_BIPA:;JX',T$HN(<5<)& M]6;2G.`T;]OA)T!"DL_S>`#6S,D$P*KB+-Q6[UG%#`!#]8%*@;V/;=B.FDF^B@,5U&BW$N^WI! ME'&Q;5@/5(/P&8^(IP0"&!&6;VEB@7M;#=@4BL=1,^R1;QPHN[L<*30PK1<=PH^,[07(:`GFLAG/-F+`3/3Q=?5QM+QD,;*- M!$=LG4C)\^9"@631\F[)OADQ51]K636#Z9S$C<6=$32B0G.`Q2DOFG']47S" M#Z_KZ\^?J%_8[RWY9E+]XVK2?/[T8,]*"QYVL3J`)\>-(@3"*`A<*IX[6W&# M`S8)RGH+[GWU]HUQK@X#]XZ)1C$+?`JH'YJ/U>^A14\W5\H%3`P2*&NA?5I_@0C"-8[,=* M]#)LR&B3ZQ_@NTZJ'YMK3C-$``Q7]1BF$Y*(C)E`-;>%W;`^E\27(GNX+!C7 M\PLI4D,JP37E/#U31'D06 MJBMN)S>(6J:%K1V(RNA#>QTY!1N^!/='PD30UO3C!%+218V&HWINE]$JGA.7 M/5)E1T&>P"*V1CO(@K3D'_FE'KOF]FO9O`W53JE,YOT_5=^/R)@VP]WJ<#R& MI,!GX+<8C7&RL5B:"]2(X8J\DNY2,N/D^$C2PF]-]PO>)3J-?U&%2'9(19B5[(8I M3&QINPPQ;>7/6E$8X$MD:(0IH.2O::ESK_>Z5KV7I`SE82'5C`KRZK:'4`BR M""*0^66H_;.@KS55D"9U`9#)[(?QY)6E`'I;]G8^XY> M_`N@FG#PQ:*>7[?(J[(A>A!;#ALMX'QY M.2?>Y](G()VHV.`R8?R1R7WA-\(T@A(D]67OHMS"M<:%S<:^JJ\1K9;I&HAK MXF[Q:@5)[VX?;=LXK.%0*Q5/Y^YB!<1:I_W]?+7$SZNT:(_-Q<*M(-`]AZBN M56Q*"/?V?VB"WW0UE\#1@%L)KYS*UQ(VB]FI28%B%9+,@2(AL0TTF7NH:ZG0 M579'_GR)U%E03#?FO*AM?"1N2GCXXVIB9FC+MQWDK#\6K.G,`@;P-Y6;15A9;`RW_]R[\N5'OZL#J<3+`$*H(Q1`=E(KR4-T&MZ#_!3F,F)KF!Q-'O M@=CV0_'JVGO\>=(WB@.[ONAE!V)-,H@C;M91?U=5B"A&13>2)_@M'Z?5&0%S MDL,8ULIM_QMHRBC:SD=SK),_K>IY,&MTLYM,?V$W!%PD"81,U'D'UB0SURT, MTV>$9$N)O%B&*!1D1^9AN"C6^[8HCMX:WA>==;+*Y9A3Z9`MP"*W M(FHJ22L$WXWU4I[J6H=ZQ+$LI`824$2\E MOQ@:+RZ2AQM-.L;R]1M)82R:+Q&=PNP?FR`T&NZ&8<. M*,D6*;/5D/)L$9UT5-Q8R"V1&F%.6UYTE[L5C9E+"^0MS?8$]E9SOSK!F<"^ MDITHPNL5[+R95(?XN>,462BD0#V9X`XKB.1WBZD6BL38^W^<4K&?!7G<,Y1/ MU0L(SNKQU-6X1[S6=OHT11C2.+/F$)0$!J< MDR&^V#35P8BZ>P/$)@LDW-ZR'QN8=4Y\X#:X4DB1`!?1;G3KHO6?3/NVQ;$? MP)4$!AHC"+,UF,D":3>$2N$Q3P+`JTI(=&-'A3 M+,3X^Z(^;Y;$/=]CV[O%#X:ODN#*6+"K%*R6'N=H/OW)_#7LSWO[3W?WJRMJ MVW56+MB==)QU&(1;VA;[?+P+U5LB'8ZI0`_'>%EC()SJ%6J.!H^I_WWHF MP.[M[SY-V&`[K#K1/TD29Y"40I/!(;LZ)+_B=K,Q!UKY4H]V]])224TAL(BT M&LP!?Z1SI0X5[X%H(8=P\Q^G.^8-!./^'(4W_:B)PE!&"ET-BTN:;&;='I-@ M7:?SHBZ>GXUO@Y./,2\/*B6,;9OT"D+4&D2!D31LGWX+&>%!(,]RP\TI9AQ@.E^<-X6J[F"$J9Q[L M(OS39&4BXF3Y,V'R+*27RLE"8"1`F.)U7-=$L8Y-L+:\7E+UD&`EQ$Y/@ M@"SY>LO.PO/0,E)G)@BJ'U23?Z`#:_;=8QHR@G0IT;%EM35^96[>:/U?QE6J M3O#<`^`!$[D6$$E%2242%&":\XYT,8;HY8DC!TJKDF@^T6U9J2 MUU>6\[!+<#WSTA/KF/79VL36P]K/IVQA4;*7AR?/+1T17A8,QZ6PGZE-4Y(BR,"3)?L$JU=4H0:5`]WGM,S;R6"JL0 ML\_^I:<+:!L.5L<$'X;OK*U"O)H.F[%%1D"@U05)TLN3@2@R?(I40W$SYB%& M`FQLMJ.\^@Q&4ET.HQDKF!N`2XTK24`5/[O1NTPK$_'&+#-&&%H[ MQ&SG3GC'-ZCB**)2R0P,WG^X#K!;M=4H`M< M!*D0YP>5D20`7+_@2:4"A/I>I&&YA.:%C#P M0)"KO)7!%(1>^E#<>;O'DN]`/"']%5$B5=`NJ7-@"2N>0NJH.,Z6RQ1',>D_52 MILQO]9RK>DTNB2BH53Z5HC(;]B*KB]E0-99WB^']NPI)[2,M@)G#DXUR(!L_-EMLF#)GT,341#BSHH6>H_ MD5VS):D"B=80C##"T=,")J'JX0<2%C@BO"G&?-`+"=M)<*6MVG4E)`GC8WV) M[3/#$SY9?E3B-JPQ(QY&1G"FLE5%+K5>AB`WQMW9KO%^Q@.1CR556#`>ZN:GPD7O(9>%("(BN\\;F]709K%.B[ M3Z)7(>7(U:0_]B-5,N&@8JP6&N>@J(.535/Q!O%UJ:IV6)4.W8UFC97A-8L+ M=W"F?(]>,4\M.ZV\`FX$?X)Z(&\RIUZ\*Z2',W`X4Q`!)]F.Z,\L>4/89#G' M0I\LS:>2N\#[^%@1E41D;I-G($/;[MP80VI[W!2.2KPA@0]*G<09G!N>(F4F M9*C([L^QE_W6HHEEX"/WB,JGTW,UC_C>]@X-#?B+_O:KER]Y\$]W`V'^FOYS7.]+7_^4!_L-87 MC?\!4IG.]<>O;9OEL\^?S.;FIB6BW4%BK\A5RA:+N=T!!P?$QA21^M/*M+IQ ML%GO2N5RU+:LU8P.W$E->C5>*T>QF_7K/$+7>C1>)5 MFKD+ZZU2&<4'RO`(V`()'HB$%QR9RUL%-^4[=\&X_VL7[!A_.XAHTQO2.N;G M&@TYD>5\%X5<%VML3%&7@F)Q'>C0=0>$+TL8Z:/T+]+F+-1-G1%.R1`?-`&Z MOKZ9#A_\IZ/#=9(_R*^$;K0`[\1)34POT#72Z2+,'/-A1B;FHLF<";I@1-^5 MO9?/5,EU&*(P1?`E[(3A@9)O]:1L)PPKF73264CP4:_>]10."M&&H!@6G58@ M,C2X<$E%F7'4/>@L1..I+0J$H)!A'KS!/<)'PH^PP&,6L42TM<`EF%/4K,^L M`3F8(XH*]9C3E8<<-XXG/C((H6L/_T0YC+?4!2^#8DCH#\]&1EM(\W#@Z5DL M;_H87_\I72TSFG$68[624?=>=`-9W,\";VK7 M(MV!LRP1EU]0P$D9?PO(AA(38F\G!I5]N`:_Q0#H586_Y"(_?S+#EZJMS$!& M)RX_?WJ=BB$Z6.8F^[/]F?6:^T+L/?@[1IQU.>.K^& M,@*QUC_3+)>Z5?U!VS;,K6`1P3PB^E\.^ M;SO%E#\=;:#QD[].38Q:8L9T[F">T]WOXG) M`H(\EIHR;R_-B_+":UZUJTLE;1O#Z!*$2W(OR!,%1109@KZN>VC0F6(<>=[L M!'IPSS2[D*"'UI^>^*$B$)WLL8>:$L@&&MZ[Y*]3'BLBNAKDI`X0CJ1]O?*S M=X,6`P+_]IPMA;,S$*5?6RD[A+B#AB52@H-L[I$K!X\269;?+H#]&6I1"5(N ME*.:.$U%VJU4-MH"5(OIF#VO<_6B**+*[&Q=*;]>M&UD9(RL,'F>LO\WEU9;'OM717ZK.PIEQBQ9[T'#,\HKR) M_#9H,D=/;G"M,=N\'$&7R*U&2SG$P@P&2S29&DILX@80.CKU;L.9]VXM)H^R MP!0"2D=1%:%H0OLX_/R;_?[39R. M?=4-\%L0>"/5"+A;[ENA?CNOQK87'N^FU9])MO?N1L%!V7C5.RZ]/-&O^B=2 MC8<_7U4&$II&&K=AEK66=C1)4E`V,'8+.LS1DE]'[GI@P#/\V/_V'YFA4FVU M)B"<#TL+(:W8!!/![H@AML5]F,2C;68?I\Y^,[W1R!KWX?V!59Q"A(W$/,R/ M?9I-#J_VG.=8LFA:)Q'C-0L9:U2M',=FL?2_]YZC%GVE)!S5?>4E'(:ECR/A MR@KV*S@*L-U@1+WU)GMP+K-L*5YKW-!PZ2$1M-Y9F-I%1J0GX"W!/844;Z1I MO`_>4IAL$=EVS/POVKE'RQ%P;F9.34$0[6,(NWAP:F&C.#KK_[(F>/2-8E\> M3@/:*WK&[NLOOTPD;6L_N`%LG&):RV=^N76!C!+1'?AS/]4FZI85^I'B)GUN MN##AYOUNB!:E5D(*%1L2MH,MP^,_N,C^9`0KZ1Z6^2-4NJ#^V[PZ6_3<:E/U M!M$F],CW=S@DQ,VOJS=MX\7R*-^M:HUID,J;$Q2/=JNT5E:94ZXE^HL6H+KR MJL1/U-_V[#2\\`3.P]KL(G5B@:'Z*MWW/K2;F04+0&E=`L M'D"@C!`'*G7,37*YM6\VZU9TGEP8,J(E4"_6]$+5WZHVF7@#J^+3WY M,3Z4XVVL&L2NS89%]E4AD`S.#]/Q!QEGX8U=G.K.J9XKL2R.XF(%X>O*ZNK[ MJ1@>](0W4-?5X06/7>QJY!@-JW^LR:[/>?[J#USWGJ;WYEB58;\CV)^L(TQN MH/J;RE<\;&C.YIIL51O=>L64R!:S]""O$Q`F,"YYHX$Y:F^1D+%OD"7JK8G; M_\"`YX%@@_!QO@P6`D^>@%^GS*%`-A9PE66U'%TK28[TP$H(%;G;GL;K:ZDU1ADEF+VFYMT_7 MTQAP$)[N[??+%3,+$3I99PZ*>/`4>2\0G\P&_S-++PZHZL,&-I2J0E"0"*Y( MOVP>-1``D7)=77GDT03RF/;P/+M45>P;$K.J.=("Z5#0OED`,#+A6N4=\8FU M_.]4,'JRA)Z7U3].5W-K1*JGU^1?W?@-=>96LKFW^^31KU2:=Z8MPFL^K1"\ M!+=KX[\BZ!9]0/5]U_4'H9&L?FK,7#7\>Q:1E%\C/4(C^&K MMV<.#[1IB48JU&P??3;8]V=7]=K9,8:1U6ZH, MX`WZ%"4J0B5JK(1>TOTEA&]X>!]%T_YC;^O?9:^PHI)A?+Z62;2"//#`>\6T!M6?0GK-9Z+I@:!_OJ&"SRP"JT6B^, MC(56E&*G9_E%XQD)`\L$;.11EUM+ZVO>G>%HX'=D=6>WIP]L-S%?1_@I7P'M M=V-I4-4!O4A.(9<,-G/6@I,O#NYN<._);EL%K6U$;'IH1+Y\:(\`#9D&FJ[5 M&C2R?@?*>T\>/#(XEQAV*D$TQ*GS7JQ[%Q[ZGIR26=^#0V\_7MZ\SA'9#[@G M5,#.7#]S#345,FK,)(Q1.*[6ZKX*!T`LH*52?.M*O1N]%$E1+%`G'YW2&!7S MQ<HRGR/DKE(JJW<,CBAZ_'5H7R%!$Y]S] M(O:?H`U%A[#-6,ZR!J*Y5ZF312R9>GY=?5_3.PWO6D4B?GQ=8D)=`(D$&`?$ M+DX]$?'H[0'='"]^B-(UT]W==R&7A@O\8*2G\"\LNP!+1@1(ORC;;4&XBKL6 MLT6E8&]=$.OT`N`-DR(&%(,[<)<0#Z%.LD[27"P9!.\<1)@;I;8O%F=G=BH/ MLQV"P`]'$6B$C](@CJ(CBS/!.02E_IO364Y3 M@=6`Z!:(N&]8-Y63*-^J%@M]9H*T0&0;6C2[Q*YO@^I)%"*S2]PE(4'/`VX* M'0=3)5[QAU9<%Q?$;V`+',$[$=SX9"@3XTXXJ+6T2,"@7:P"C)";EK''M!8` MSQ1@YV;;%\0"D%EY$#"L^B6@"2>Z"8*>5GBA=R+\*_2A,O$A$FCCMX%`NWI* MHG327*"WU.,V'3<"(D$U5YL=.QK&2J@'ZWL6A"W2&[\0Q>K4-'_/*[=2-!YC M*2'\-L<&OK&H55HW!*LZZ^I2RW5/=6Z8.[P^L2QTD+F>=R`."@[Y71:QCX>*F MG-)ZNSWT'%I`HQE^_J0J],^?"'Y<\?\GGS]!,.4Z25,@,2P#VO3>_F$8V+M- M2>_@>):K/&\;L+9FD'<@*H=N[3_LI=B=H-B%#6YJLK^UO[=7KG<82H91#&,L M(Z]'MBKYVZ[>S_4/U1$TMN+ZD4LB`X7=_'EQN96!*4P*'Y\_;>R7;5T!/>JS M(UG%EY/N2MH9(OORL(1G:[\7R_B;L5'N<6?D;#UX6,[=ZM]T=KY"!Y233ZRA M[:$LM>HMIAXF(7:?__6YO;&66HS]<&W)=#SH"R9&D9VLV05@$X4TK[S`:W/#(?2/LJV'&_YPDX&?NC#QZ&6$1++CX*AS`0%L:$-B#Y MFU)AP<)8T(B*%YRJ!,#+:GZRYMQF!ZB72Q;](0YI?A6X MA>I"TUQ4/*:RU?WE\4?!$5OOJI9Z2,^F"!\V9.B9YB?O(?/%*L61;F_0TW&@ M?$&(?G_[X"OL=F*=O\!#U:`,C#0[^T_ MV'WTJ`(4T,9^$G_W MMI,#??=&Y9;ENU'VK1-2>G0$#B5%^@)*80!)+]UP`L3)_VW$KSC;!.;QR=O0 MA^]8#F5D/.PCW"^$I[GTX5D)OH4ORARCS'1="__F`O(R?C-&KFA,<1+3Q0U3 MB:4(3.^1P*N"KU(?NNJD/V+E^*L(?3 M0Z\"#KN,0(=*850M/H2!`]?'S:.T,+(FR`OQ(BKKL1C@FT>_BL/-UY$?2@0U ME6]I`TG:Q!MA4V]=T]W5B_#O"DXH1R)&0'2.:!&O2/AHYZ'%8"GELOLT*2*`-D<4T34#_/$%;E:9(7"6^9'WVP_>9ID M-`MWV,!Y*4HW9RK&W-O?WWW\L">B;]$(CP%D[T':ZT[Z0'*TMX^BC\?V7#J*8QN^C*.9/D!/:05VQ`79HT_)##6 MF1L>,9-Y@7S%<,NU,*P=X47'H'R).Y&D#C'TN*?F4L"A*%WH:VBEM:V%(LT< MW^)*5+0F8(X!HGDAZ0GL"A(C,RGWTN$# MN&;OK[&.M*>&M4^FW;R*9H4_J[.7"!8(E71VA6-I!([E)JG%F*3B")3VZ*!/ M;W9-?9\76PTMH.^`LDV(W^M"'^YMDT?(SM^BQ!S':$*UF##3)D-%:P_ZC8)V M\$YX/A[4N.4QWRB$[24>=T`A\H3'2%QY+;-).^22VJWT;K#W);!\7C3;<.H13?8:W@]I'(+% MZ+'5_G.24W4>Y<&,&3>?/S4J3'ZAT>#BH$CTLI[U!EXJE\KGT& M<6PA;1U(5@IA2S8HDB*%Z MK)=[]V#$)1O4 M_(QEU2;MK`=(]O8YJ\WTY9,!J!"8;!*WYW$F-7SOV'(,LN2*$N2/$T7MP.D?(PHKO]`6]1D4+)^J@RW$V0VJXW7E7L M'#94"D<+Q"U<;:;6S(XZ0SV6=CLH[,<&D%QCU^`QJEO1VRJ'OR=J(Q[@,ED^ M0J0ZRHOU@](Q*9<469?0A;U8XJQ,O<8Z]`8FCL]\8'0V@<)!90T#&3R-M`2>&#INN&#(+R2"`.K1=E%\6=!-JM<_M MH=HNKO]C`AG=^5RG\0;?VKJVG?TV6,DF^BDR<`9H3;)3T!,)$SP&60J!*>B\ MH\PR;I,76BF.[^)?ER'GQYYTQ94]*B8=%HSTD.^PQA=)2XFY`4.4U7G%&@;# M&RK6P6!-ZXM4K+0,;66W&>*BY4E.LJU%-C$Q)_<[?=5+Z0`7-^'E'%P40!)7 MCDWQ!8,D@"3*[&CFJ+:BU1]^3N'1F4+,TK8;[;GE,V4EI[%4Q2CVMU7/J>TKKU?B>]J_I(6?>) M154TT7]LHC-GGK>MIUD6";-W;!B$L&0^4[^[!OVH`"^?X!JT0>1=!9'TZ5>< M%?O"-2DFZT+B!J3,%U69@4=Q>??[&@4PH7&X'M,!!"2A6@<=0U@/R:8,=OOR M1#L*\>!O=C%\^&:8/AW$CW+P>;W@A2=*[TZ(6(?R)%_6'[@@':VU6OL&T'*) M=NGPE!)GFDFKKL96-+#L05M'Z,:=)V0RQ1T>>B!$9<">TPI0[J,FI_!3('4V M:%.V&F#WZ4^5`VJ5D>5S8^!&ORU4]8SL9&AD6)C"DH+H>6+S:K[A[&*265I! M!14MQE1A(^)F7+HZ[T2&^CK<9P;:%7G3H8/H`S3\;+:@_5\ MX4/+L:R++(DV@HBS8-BZ:\A8/S^#F3U%>>G!D]U'L8*]JS807E`S1J-]NL,Z MCV;$(<)H*P@9V*-9L@Y2Y!@')'.[2C96JNMWJF-^E;TG;6D)#$*0JV!VI8>= MG1Q*/.@:8I-4ER/7/93%GV3)CR;^RCV"`B0;J=H5KYH;MK2,4XZ#CH#@5JE@ M-=/'OQ."6=+XDT.)OQ'5:>[(BX6]V=ARPW47Z4UCYEM(`.Y5@2'0Q,1SK.JT M[-QJDE@K>T9INJV=83RF9M6BWAYHHC6^&Q_SWBH3^EYW_Q;"/I%Z+C57$G)I MQ`V5*03VC9JS':+8443;PV3E#KF6CQ82NA[?LONI^23!;"EDI.7;!+-*0LP4 ME]TIRDV;^I=R$(31VE(H-&3]G<@A2E[WV(U#2$2YEF;XSK`F7>"Y?F4'+1R] MP61(MF_NR-0DB?:CY(H!2K2\0RGND`[68`#`,?2L#XQY.&(WV&$O'M M4?;HVR('-%XL=0?HF>5O%@T-$5#9#:KGS/*6F9+)`K52%_EY.E."X\M7>&(Z M]V?A"!R`'UXVV\F\4ZA?$+LEBM4M&H9BSC-VA]3SE)V$J_!4.E*!-,9I(6?O MACBSE+IY[2QF!,RQ@V4;/@VI=K$8MQ9;,OH'?DQFQ)M.^"(`[69$XI#<49"A M!F;2]ZI,ORL3GQZ"F/=A;`!VK!]]D-]'[FV97LEPL8[_A&0:]2A6@L$2![<\ M>YO)6(1ECV\+RW8:&O%)`!J@T["U10#:O.Y%17^@$QP&P'3>JVG=>KS]^.G3 M\F!;)`P?]QY-;NUO'SSXIC?VF^T'>[VBT!?-9,KSJ[5[]N+;D2UT%5T!$'U` M)V4)J2\0;B6D/P0[KL46Q%7*RG+2UM[N0?_,![L'/:2)43O"CW?">]AZ%P/P7)C/ZE&N6[P.F) MT;V#;X\(589+P#9 M2#^5&[U,3WJR;AW()'*T25^TTM6D4=YU/S^F21<4L-[&&A2H7.N1UQKN(&)S MSPYI(C2X'*6\!4='O+O;BA5'$'_=RT4/Q-"U3(OUNH(@.G5*?7S4_5R,C+9U MWQ4V(6Z,=?#S34W>FN6O9N=#VE/HB55XGFE;^#?$@_4]TU<[R*CRB%%)0_X5 MFGCDNV1H9A.5A>HCT^L.'M\U"Y==FQS$RBCVFJO0["8$4!S_?"6$M)M50P&* M(07C%U\&OA-F%,>D@P#ZEG]$LYJ?XLMZ[Q&13)4(B7N8/;/S!Q@\+8^:BJNS MH%]G,-'V\1[X^0J731BB;*S!LO>]D`)0G5)YH;2)W!O3UIG9G@MFD]`JG!1Y M2=4_$Z(UU*?4_3H@UMGZ-X(DT8LHFJFRHQL=U5_ZS&HRR+\^[G$9="^XT?JNBAMO>)]^>Q[FXK?@&DI]M/;OGXTW/+:4`2 M,Y$.K3E,:HHV$1WJQVII\\_?X?"P1`MK]-[ZZ@'8!:*LK'+GG M_IV";"DJ=23#*+4&Y=$0CA\$6?L'ZYV$FF;=_GK=A?>=MVJ-[R M83IO,C;6[5\`KD_#0OR85'M2\1W//*U4:E9BG`BH]>K`#8PF+ M?J474](D$&0Y5V.RR),I94 MJ,KO[SASHHX[L8`"_!>*_'#RVT'8K&]WLH^\D4DA?$*)BVYOZX6U4N,30N]/ M7E3W>@+O%;7B_ID\`N`KK_&WRL&/:M(\>H.K<`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`T49BM:BL=6`YZ#@VI>RWBIT#2Y"_1^6P>-;4Y"::S2#(N^KU%B5(8.WST!5M':>R M_&O[XO6F"Z;VJ:*W#15:RH'=?H6;M'>OUZ+U?,/;I5%(:EQ(EJQ<_4Z1'21G M%MKX6^)"F1C+=SYM&S5!`'\DVV*F13SL)HGT!4M\Z;GE>B,5MA2$N7^CB/O" MT-;/IO#]&ZT&WCSO5O&YE2CGVX7J7]S@\%UQ;.'PN5^OJENX' MY4:&D>`N0Q`MYM8_E[WS]$6G\+FM5RH7L*8@CAF/49K,A#@5EZ!&Q[IN1#8I M)[?AEX77=82G3^6X&#]-A6&DI?I?(9?@QD8:U0=^LI*;-$(SVO5 M0H,3J4.EY\OMTBWYN;H=1#:=I;M[6Q*^#M)B@X"X32L[%$Z^%"QUJ^<)GI$4 MCX^@K;U-^56%Y3-?X<[![:XT_?N'L9-,+B_J'9GY->]/RV&*:-MWB/+'I^6@ MQ\ZQU1,LO^M>7"G^RH>_UOV<=ABJB1"IZ1AG6?OQ#)T9>.5;IDQ%M. M>[PA>ODW7:M-OB'^GY"^*8H='S*\IAJ$**35N2@M\39_R'`2'C(DV[T\VSOX M4M_G,['Q0N7`TUE'M9833M+W,3P0)JQMXISO&IK'(@,$UN%0K;[Y[K"[<)NF M!+5J.:*?;^S=4)=?GD?>KSO*J?J#L.X88Y_G+]9I(I3`]]VVH_;]@2I#.B7F MG2<1Y9X/UFNG%[$J5U7.")I&#K!B(B5\Z$W)=S)9Y/K"*W6Y`XZ-[(YF+$\@BN[>SQ2-*L07DZ_C:Q9F<0;F3\ M`,"[U/=MHR`(`8XV7EX"A9.7JM/?INKTV^#YLAK#V\5)#RK\#!6-E7\G1.*5 M6YM1E8,F-7GCC;=VV-]41P8[U_WZP1)X?"(O,22(&;[RM>;>OEXLEL_^KP`` M``#__P,`4$L#!!0`!@`(````(0#D-4M%(PL``&M@```-````>&POVB1VN;#\*W9G^ZF[U;V]__:N;;?+JNY^? M7#?10$2XG>E/2;*Y[O6VSI,;V-O+:..&\,DZB@,[@;?Q8V^[B5U[M<5&@=\S M^OVK7F![H.C)#`CI]WFPLG"C9VXBT]WTM>F2Q="YSK#X]A%-M+'Z"^ M#$S;R62S-P?B`\^)HVVT3BY!7"]:KSW'/40Y[4U[(.GV)MP%5I!L-2?:AR]00FNG\/HQ]#"SR`8 MP#S\VNW-]B?MB^W#E0'"\O8PZ^M[<#S7_EE M`R^PP$B_%WA`$U[L<0WGU;-$-)E-$X0AV#3$*]2F`$RR\6*]3?8/)38)ND;- MNH[QGZ"+65%O5V>Z#N/BP(?'Z,JY(GKBQ^5,MRS((8-^']U*"3N1LNFB#_K. MINQJ=#;+AM;0&G=JF1"+A[RAPJ'5I2L;%%KOQW=GA!UZWIWV,+?\X1)V<>T$[#&)/*DWZ>(+MF3`C%%X5N-8 MC71BZTH\>`MUIN?[^31C:&(A#E=N M;V#&D[AQ:,$;+7W]\+J!,CR$R1GVCA[_7L.W'V/[=6"P8E2NP3;RO16B>%RP MXC]U\^+JWEK<,[T$F2R*"J&6M1B?0.C]?+KH'NEB.NU:J&'!3\="WX_PIV.A M%OQ9=.;3M".978',Y6F)AY/U_N5X.IU.!E>3R61J#@>FR9R\3"/:"U?NBXOS M]\[<=(A@!`BFP\GTR@`@?7/"5)T5P1``C$>CR6@P-4SXR_+QZ1%T[=.1KII5 M@D`1JP2!(E;9?+'70>9/>PHLG2GNJP2!(E8)`D6LCCO.P+"VJ)A5@D`1JP2! M(E99C=QA7X4E:<6L$@2*6"4(%+':6?&99N"I+6':TZ<%?>+CBT+M==&BO@1CG#B0_#7$D:#L42:`]9 M2.F3;,&H9DQ+-H"8R$)"LD47-A;;`;(VDA9R-I(&DC:2%K(V0K"7=:[,DZMH M!UO3^P1;UJ3?9S.QUO%2+I``+XF8QC:'_FQL4N+1QC:R/LV8VBB=6@X1VPU5FPYZ;#FWH0DD;2S)@C6WJ2$S':QC^'=?W/^.` M_/=U7@/`4M?MSOBW9P5*L7[][[W&`8N6ZS3N9COXBAQG82=36*;,55X MAA5X!JD@&3S'Z#GW*#>3?`N!7K@9WM0`.$IE58I5E6(([=#3 M"A?`FQH76##J=C/D#:IROC*'D*0+&`J/0!JH\TAW44ER+N@L`-1[9-YA'4*" M`E.1:@@`1PD$0L1`T?@[H!@4C<`T&A0-P12",`:?L4]0)H014A$&P*.D5Q1U MPD`8,<[H!@)!588DT6"H2I$4@ZH<65!AJ$J1!(*J#$F94)4B*095.9)0H2I% M$@C@$249DC*A*D52#*IR9$'%4%6*)!!494C"Q/#$*;)'ETWY(BI9/QWUW[1^ MJKVL&Q=2!U63)N`]:\YG3WSF"%RPN1292N-]>G:V=JH]1;'W$TPR\7X]!Q93 MW5C'^SL3SZ%7?HSMS8/[`E-1ON_TLJY>ZVT/<7_AF$U5T^5F>6GBFFUFN#(W M`"'9,L]^GQ2)JJ2FH`'V&'3MM!PTA,D16(YW1*/E-&"DU97'2R4;C2!PC:MQ MCV2ODW:-`8UOW7'.VT4P@:EV$]0*RC%0JJ!ND,L5DE0UQBI5CLY(U_WALE#' MB8GJ!,IQ1J=,N;3NRIQP1%:$H_3_RY:7E0VMHNX<=4PG@'!=MJX?S-/EX*S@ MJ`R68UU&PG6X/_W>`\B6R!L!'1&]G6-II*I\=&UP1/GP:LFYA_+%COZT*\': MNVB_#$8);4=*J>A[@S659?@OIGM4(@0W[G4/<&HZD:DZ'T+(@Y<2"RP.2VL@H><8.`2$1)8) M2MK**G@$%J@L"+>VLG(>32".R!I)^OZJE$2VN`H>02KQEPD?M)55\"CF"5,R3U`;"QY%WX\D?;^?4<6(-R0CGDLI MN(-7Q$=8NG=NK+.N*`8/CC`P,>&2PL_/A43B1-)'DN+^$$6YCT0)6'3)`/HC/#8; MGLBM@5^XA\08QDJ\C9B\+XCNP2/3;<1`:XY&C#\\W-I&#+3F8L2DBO63C)@/ MX6:7,R3F4ARZ941\],)G=R5&CNAA`T#*2/KD[I+8SN-/[%*&I&,^X6V3N0PQ M1?!'4F;W>*;UYR>X2S)S(AZ=('T':V@9X'_>)<2-V(H(P;U-&2$/7@)WMV>= M6!"!L*1$1'!R*1>QEU$D9?S-CD/L+4+7W8O1"HN*BEMHF=\3?+`\ MN[DVGP^`HU;NVM[YR4/^X4PO7O^)/3<"@BG]UG?>ERAA(F9Z\?HC/I`#>C%, MN2'=?-S"0Q[@M[:+O9G^\_U\/+V[MXR+27\^N3"'[NAB.IK?78S,Q?SNSIKV MC?[B/^`R?`K_-3S&_8BGW+.G\<-)L(%YO?7A6?AQ:FP*_G-Q;::3-QP^NPL? M8,/*169$;YO_+P&W_P4``/__`P!02P,$%``&``@````A`/MBI6V4!@``IQL` M`!,```!X;"]T:&5M92]T:&5M93$N>&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6* MV+&;K4T;Q&Z''FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5 M_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU M>[66\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0 MVJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG M9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW]N\*1R5D1SBB!4- M?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC M>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG M%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>] M;=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM M&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P M68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/ MC^WPNA[.CALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9 MF]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP M$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/9 M9/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2C MLTFQO@'!\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1! MGS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I M!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QIT]9)6RW; MK"^XT\WYGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,< M8[Z4%3]F\=%]LNH0X9\_'N\6 M&$E%JI04O*(1?J,2WV\^?EB?N'B6.:4*`4,E(YPK5:]<5R8Y+8ET>$TKF,FX M*(F"H3BXLA:4I,VBLG`#SPO=DK`*&X:5&,/!LXPE-.;)L:25,B2"%D2!?IFS M6K9L93*&KB3B^5C?);RL@6+/"J;>&E*,RF3U=*BX(/L"_'[UIR1IN9O!%7W) M$L$ESY0#=*X1>NWSTEVZP+19IPP\T&%'@F81?O!7\1*[FW43GU^,GJ3UC63. M3Y\$2[^PBD*P(4TZ`7O.GS7T*=4F6.Q>K7YL$O!-H)1FY%BH[_STF;)#KB#; M,W!(^[5*WV(J$P@HT#C!3#,EO``!\$0ETY4!`2&OS?O$4I5'>!(ZL[DW\0&. M]E2J1Z8I,4J.4O'RMP'Y9RI#$IQ))J#^/!_\-\GT3`+OEB1TIL%LOA@AQ35N M-5&*B2*;M>`G!)4'PF5-=!W[*V!NPV.(<-Z'Q->0X,+2$PMU,%ZL!O?$&H,M=KJ8];7L1F#B MVYB>8*B,\8(U.,+PO&1M<E+@U(V7HL$1AJEN@!@\%+OLBM@9CQ6QHB"U#3XINJ]9]&UL MG%;;;N(P$'U?:?\ARGL)X19`0%6HNEMI5UJM]O)L$@-6DSBR36G_?L>>)-BF M;;I]`6*?.3DS8Q]F'@M:*B01-"<*],L#JV3# M5J3OH2N(>#A65RDO*J#8LIRI9T,:!D4ZO]^77)!M#GD_Q2.2-MSFX8*^8*G@ MDN]4#^@B%'J9\RR:1<"T6F0,,M!E#P3=+<.;>+Z))V&T6I@"_6'T)*W?@3SP MTQ?!LF^LI%!MZ)/NP);S!PV]S_02!$<7T7>F`S]$D-$=.>;J)S]]I6Q_4-#N M,62D$YMGS[=4IE!1H.D-QIHIY3D(@,^@8/IH0$7(D_D^L4P=EN%PTALG_6$, M\&!+I;ICFC(,TJ-4O/B+H+BF0I)!33($]?7^X+TD$0HR^=T2158+P4\!'!IX MI:R(/H+Q'(B;Q%!&F^IKF4**FN1&LQ@N2$)">QY7HR191(]0TK3&K!$S"X,6 M$[N(38/0G0!YK49(W-MON./,C2+U!W$W60)V_:;_E-/=:(L0ID+3@*)I<*NEND@[I: MA!A+@;7@*$@^HD`'>35(_!8AIFG1V#OH&WM[..F/VPHZZO2?E6<%W1W209ZZ MJ??Z-6*L^E@+C@(P!U]!=X=T4%>'$&,IL!8%2YZ5(,FYAX- MSSW`6^WLCE\QF=ASZ[<=T*`]5=-!VWN\/37(*HV]XM;F!1_N;D^,'@J7TK(8 MW^1JD*T"P\R*J^)#3ANC:[YM=#7(5M&8K?Y+BP=GZW$E:0NT;DY'6]`P'2G3 MLVG6;4&0+<5:<=^N_(,T(V&[` M_%:1/?U.Q)Z5,LCI#D+[O00J('`"Q`?%*S-G;+F"R-XL`T#``"I"```&0`` M`'AL+W=OWFXX?UD8LG65*J$#`T M,L&E4NW*=65:TII(A[>T@2)ZSE-[S]%#31AD202NB0+\L62M[MCJ]AJXFXNG0WJ2\;H%BSRJF7CM2C.IT M]5@T7)!]!7&_^#.2]MS=X(R^9JG@DN?*`3K7"#V/>>DN76#:K#,&$6C;D:!Y M@N_\U6Z)WRY,=/@F5?6$/!;$B33L">\R<-?_S8@_T1E2((320CJ3\^# M:TE<(ZB+[YXHLED+?D10,["E;(FN0'\%Q'U@1L80ZGN10HB:Y$ZS=%P0A(3L M/&]FBVCM/H.EZ0FS-9@E1@/&MQ&['J$S`?(&C1#X5&,(*7S;_%Z27F1+BJ:* MSB'!1-$Y(EH,$$LC>#?6>%F;!B<8,C]8$0;AP-M9NC68J*L`[?%N-&'M//N? MG34XP7`==HZGKAB([W5IO(FBY=)6MK,!"^\]2R"^ZRW18%N8/YO9&V\-9F2) MF8B-4C\(XV&!Y5!D"]$U_N_ZT8ML0?%?>I,B`[G@E`V(0V_^ML"%+?!R\6CP MM'BFR@QFY-1HPK)&]Z?)ZS\#5R\KT(ML:\)@4B1;@S&I@<1$$X6[\?,P"MYY MJ^"T&,N[+$N#)[)";S#,#9Q2G\=&T#'.D MUE04=$>K2J*4'W0[T/L,LZ93;:%3=>>Z.SR`3M&2@GXEHF"-1!7-8:GG+"`1 MPO0:,U"\[4ZT/5?0([K;$CX)*)P.G@/@G'/5#_09.GQD;/X```#__P,`4$L# M!!0`!@`(````(0!M[!5%``,``+@(```9````>&PO=V]R:W-H965TGATPP2I@9#M- M^_<[@P,%TE1I\\#%/G-\YLQ@9WG]7.3DB2LM9!E1W_$HX64L$U'N(OKG]]W5 MC!)M6)FP7)8\HB]3][(]9W'#7+R?T MA8B5U#(U#M"Y5NAISG-W[@+3:ID(R`!M)XJG$;WQ%YLY=5?+VI^_@A]TYYGH M3!Z^*9'\$"4'LZ%,6("ME(\(O4]P"(+=D^B[N@`_%4EXRO:Y^24/W[G890:J M/8&$,*]%\G++=0R&`HT33)`IECD(@"LI!'8&&,*>Z_M!)":+Z"AT)E-OY`.< M;+DV=P(I*8GWVLCBGP7Y1RI+$AQ)X'XD\2?..)A,9Q]A&1U9X-ZPA!>SN#:O MVJ9;9MAJJ>2!0.N!:"CRTVH< MSI;N$U0F/F+6%@/7%N/W$9M3Q-@+6XP+BEO98&57]MOE;-0A&-5A>5'NV@YT MI03M,C5B\P;B%=)3`J9=K@3!$87.:3T8^0,7UA83MFHWG8'>RN./K(S@B,*U M77DOW)C9VL9?540#+=_+&!1O"9OE\1#!JHF0X67%M,QP<[ M,*O5!=.)A[]69$]3^!E-"-*R-Q70T-0,=6Z=G&F7Z&5$8-!0U:I.VW6PQ M'5''H'GMU&L*/8OP?.M\]^^7"\%#%>.!"HOIJ&@&<#"AB,E` MA,6`SD]86>X+8K;'@:L4>3P/?;%R*K>>+?2P)%1/V;P#X'#UN0Y`$ZE-,T++M#^ MYUC]!P``__\#`%!+`P04``8`"````"$`CEE8E)P#``!3#```&0```'AL+W=O M59L)1%J6X:D-.W?CY+L6%**SET>FE@^/#JD2(I=W3Y79?!$N*"L7H,5EO#(#[%H.,&%-JK*>)0DL[C"M`X-PY(/X6#[ M/&DQ!+TBR-M1,=6Y4/H*LP?3\U-SJH&*':TI/)%DX9!E2^_ M'&K&\:X$OY_1!.<=MWZXHJ]HSIE@>QD!76R$7ON\B!CA*..XI>*0<6Q8O]T3D$%&@B493Q92S$@3`WZ"B M*C4@(OA9?Y]I(8_K<#R+IO-DC``>[(B0#U11AD%^$I)5?PP(M52&9-22C$%] M^WX:34;3>3J`)3:*M(/W6.+-BK-S`%D#>XH&JQQ$2V!6GHTA/J][!BXIFSME MI$T!+>`XGC;C6;J*GR"$>8O97F.0B\BN$>-YXT9N8C,(!9AT/LX[S&..HC;<'4*K-2I+%'!W'8+]D9^J`QFH9/4CLO$ MW7G8Z2FC=0B)9WDV=KW?&HPN*:TRLQ8,0KLB_$KRF!<,5Y>9QW& M%Z-N(JO,WRX@!?;$I'UAFJPUF)DN_KXL3*YT[WP14$RVB&'9JHQ\,5YY;`W& MRE9KP4D0!*WM_1*TU;\JI@59(NP55X77=-\^#63ZI%,UJ1?R;0NR=V_;*])' MA!812NQ/'T)7VKLZ+3)-TI7FMY(69$LS9G[RN$*\ICHL69!IE*X@O\.T(%N0 M,3."4-07E2L):/\C>925G\!>0]LB`[(EF17((76]]GA7D==]!P;IE3:<^IU/ MC3<@VU;4K5C=.^V;H2M,-46KWPP49EHI>-[?#ZG?!6'.\X5U*[:9+\S,=F;T MJ0@_D(R4I0AR=E)SFRJ2RZJ9*;/1,AOK"_?R`D:Z!A_(-\P/M!9!2?9@FD1S M"`PW0Z%YD*S1\\>.21CF],\C#.\$;OLD`O">,=D]J!YY^7=@\Q<``/__`P!0 M2P,$%``&``@````A`"PAQC&5!```_1$``!D```!X;"]W;W)K&ULE%C;CN(X$'U?:?\ARON0.&EH@H#1!*MW1]J15JN]/(?$0-1) MC.+0=/_]5MDA[0M#X*5IRL>5XSJNXYCEU_>Z\MY8*TK>K'PR"7V/-3DORF:_ M\O_Y^^7+W/=$ES5%5O&&K?P/)OROZU]_69YY^RH.C'4>9&C$RC]TW7$1!"(_ ML#H3$WYD#8SL>%MG'7QM]X$XMBPKY*2Z"J(PG`5U5C:^RK!H[\G!=[LR9Y3G MIYHUG4K2LBKK@+\XE$=QR5;G]Z2KL_;U=/R2\_H(*;9E578?,JGOU?GB^[[A M;;:M8-WOY"G++[GE%R=]7>8M%WS732!=H(BZ:TZ")(!,ZV51P@JP[%[+=BO_ M&UG0*/:#]5(6Z-^2G87VOR<._/Q;6Q9_E`V#:H-.J,"6\U>$?B\P!),#9_:+ M5.#/UBO8+CM5W5_\_#LK]X<.Y)["BG!AB^*#,I%#12'-))IBIIQ70`#^>G6) M6P,JDKW+SW-9=(>5'\\FT^_Z=`I$^EDD1]$OCL MDY#HX21QG^1)3Q+-IV0Z&Z<2J&7)*M&LR];+EI\]V'I`7!PSW,AD`9FQ/$\_ M+0_4!>=\PTER*J`%:/JVCN?),G@#'?(>DRI,XGL#)C(1FRL("T)=2)R$0YH` MUC`L!&IK+R2&W7)=Y\M"<)*YD(@,Z>5:4P5)I)ZX^(T=H%K`8`2"/DY1[C38>3[.I8:J4*,U?> M$I+YLZ6F,1Z3N;4OJ1IWY00_L@F/VQU.L@E;#TP51JNA':!:P*@A[%B#TVT] M)7I,T!ZDL7$B5(^8?-!T'Q:5**N&;A_<(DYL57O03,J:V)K>'*7#*)[VNO$3 M]%^+[VS4^>4L6U3;4GJ07D=E]I\1JF-,7FC"&J\1795E@PT-]2-.HQ+-U^7I MM'$B5(^8?-")-3YH9>/-2I1_C^BJ0#]OUSY+#[C2KSU`UM5DC<9LL;Y#767G M)NN9Z2$IO@9"7W]JN7$B5(^8O-"=-5XCZBHO'U%7,_Q>73M"B18Q^:!%:WSN M5%<9NUDGIVLO[H\O>F[7WAJEY#+J="TZM,9WI'[*STV>EG^D1#/]OGYVA.H8 MLWYHS_?S469NZ.F\&Q'-\7L^=H3J&(-/]-"I(-&FF[DO2#U(N:_[@F0..R]( M_;!J81*&\Z&;3-Y73H_Q$S:Z=GI\/D%6+^U!6K\Z$:I'3%[6*7%[OT7*YF_K MVX-T/L[IH&-,/@^=#G!#ME]!KNBK0'"P8Z->$=@<=Q56XYH'JUNUNB_6K-VS M#:LJX>7\A#?F&)XS1-5M/B4+N#!!KUOQ#5G`O-\"JV@T>%DV?0HE77=_6EXT=Y<]OR#J[=\M\#_,S"X(H63@"\X[R[?,$' M##_&PO M=V]R:W-H965T']J?^OW^,O#_W>Z;P^O*YWY:%XZO]1G/J_ M/?_U+X\_R^.WTT=1G'ODX7!ZZG^18[-9G M&O_I8_MY,M[VFUO<[=?';]\_OVS*_2>Y^+K=;<]_5$[[O?UFD;T?RN/ZZX[B M_N6-UQOCN_H#W.^WFV-Y*M_.`W(W5`/%F.?#^9`\/3^^;BD"3GOO6+P]]5^\ M13Z>](?/CU6"_KTM?IZL?_=.'^7/Y+A]_=OV4%"V:9YX!KZ6Y3,A MM(ZK&?C'L?=:O*V_[\[_+'^FQ?;]XTS3/:&(.+#%ZQ]A<=I01LG-P*^&L2EW M-`#Z?V^_Y=*@C*Q_/?4#ZGC[>OZ@?TT'D]DH\,B\][4XG>,MN^SW-M]/YW+_ M'V7D\:!J)V/MA#Z-DX'_,/$F4W;2T9"N5KW3IV[XT'3>T6ZJV]&G;C<9>./1 MM>YFNAE]FG%V#H\6234\^C3VM\4UUPWI\ZZX/)K_JD?^QPV1#=5L5L41KL_K MY\=C^;-'*X[FZ_2YYO7K+=B7*0N5T[I0VNJ$YI:]O+";ISY%025PHN+^\1Q, MO< M&Q/5TH`F6;Y,U5MTX3.UK2B M[-B#J3/)2V44T-;4)&@^D0E:U49U*0")@,1`$B`ID`Q(;A.1#HKLCG2P=94. M$\12$7O>@81`(B`QD`1("B0#DMM$!$JS(P)5^^-@1@VZ2X`;RI@5"9J-8`4D M!!(!B8$D0%(@&9#<)B)F.O5$S-V!LK4,5)%ILZ9=$+H@Z`SC9UXK$3&;8B5M@&-.M[/)/+.U0F+'ZL M/6`JC:+:R"R?&$@")`62`(78B,Z2(E2$#FN@A0\ID/*M$ MA3_RG`TRJJ_7R3%.#4A%9?-RYRRX5(%$LFD:D+-4.S:XJF M,I_UIX.1(VAB=MOJ,*D[-0Y3()DF31?.RLS;NI!99!5W1Q:5Z!-9 M5,@IT+FLD)6GK;H+M#8R<4>Z'15HDRX_&$GOL?%.[>ND7JA2<)^:ADWA9C?U MF)N&;3W*)+,VM)/,RBB@%7UE-U"24B1;(;MD@Y&3C96GC+I+UM@TF59$UY-; MXS$[[4?,2JV2/Y/ZI:=0\%"C%:(0480H1I0@2A%EB'*! M9,RL2.^(60E8$;-"UJ2N/$`AH@A1C"A!E"+*$.4"R9A98]HQ\S[A3P94G?<^ M8U)J5:1#(7$/'8S@L5)M96HG]`!%B&)$":(4488H%TAFB,6EG:$KJU]I49$& MA415``H]0!&B&%&"*$64(:Q5(TI(A]5D4;V68`H1!0ABA$EB%)$&:)<(#F7KBJZ_2Q`@41Q M\PR+LP!0B%81HAA1@BA%E"'*!9+ALQ1Q2_GZ\V5?*1BQ9A4:^]4-^A=7!ND6 M8[*J"S&P;N+EJ%@LN*/RN<:[U8FO1(88ED)F6,Y&O=(MG&$U3V/$L/@&$X;E MC:X.JVHG3U"-S+":#JOGNRMS66:KN;^3PW+/):F`S;":#O6P M]&4YK&:SD<-RSW`UK#^AO>GQI-XXK=J9.CE;:BM'CKM/GQJK6HXCBA#%B!)$ M*:(,42Z03!H?R7;E=Q=\H$YPN^`UHB5O`EPA"A%%B&)$":(4488H%TC&S(>V M'?/-6W"@CGL1OD+V%JRM+!0BBA#%B!)$*:(,42Z0#)\6J@C_RI2SN;.9*-0( MA%7@DA!(!"0&D@!)@61`H&KI,5HTSV109,ZX]>01!MU]90VCEJ^-&L,C-^\]DM$)I:5BKW? M7%EP;.XL.(5H&S>]K>A!(%M9WY&%B")$,:($48HH0Y0+)&.^I*A895R)'045 M;:,KMBYO6J[NX-1(% M[GZ+NS)&7045-D8FQ$@C7R\P=GS>:F M14O?,LV7Q+TWN?-G+'2?`=E72%2TJ^%UL^Z*5GX:11#I5J:BK7O/*JLQ7^^H M:..OW2:MQ]5D7+72?74,@^KL8U:H\G-$9!?9%U;Z]DK_4V)RK.X7[%L(C<0&``\?C9'U M\+%!3=1P?D3:2N\`,_?[HMAXH0GJJ$8U:GI^;DHM->WL30%ZSV3OOON0.#=> M6GJ7$\`W&5T3\'OY285X36/P;WG=@E5(%&R-VM,2:E=TKV72$B&*#;(+]@;O MJ6G7>,\0\6L4'(X:N\J7>BU"_?)]7QS?BU6QVYUZF_([O_)`*NSYL<;Z?8S` M7[R0)PK#N4*/.1;\_.#2E8"N5*L)VHSI2C5L]\ID0;\^O>!KNJ!?:%[@'C50 M:\7UY%$3^O+Y4IL97:EN`:#-`UVIOD%WKH3!;!&1@$=O="NPR"Y>(0F^8#6- M;4A04_R7KM![+R\7&=7[I;9_/]7OQ]_7Q?7LX]7;%&RV-4:4G MCNI](?7'6>\I7\LSO>=3;2\?]%Y702]LT-=5_=Y;69[-']3UL'Y3[/F_```` M__\#`%!+`P04``8`"````"$`)<)FA\0)``"C+0``&0```'AL+W=OK_+.K^GX^___;P49V_U6]% M<>F!PK%>]=\NE]-R.*RW;\5A4P^J4W&$;UZJ\V%S@3_/K\/Z="XVNZ;183_T M1Z/I\+`ICWVIL#S?HU&]O)3;(JRV[X?B>)$BYV*_N<#XZ[?R5*/:87N/W&%S M_O9^^F-;'4X@\5SNR\O/1K3?.VR7V>NQ.F^>]^#W#V^\V:)V\P>3/Y3;J(7SJAO/)9#R=SZ#W*PWAVV;8\*D:>M.K#>#;I@%\J@:3@3<>3867 M5_J9J6;PJ0=XEV)-;8_4@>9H^Q7_N<'(H M4Z')K'!SV3P^G*N/'DQ7>-CU:2,FO[<46IA3,DXZR[J2#+)+J'P1,JL^^`'Y M4\/,^/X83,#/7P2=IX\]T4-:,A(Q$C,2,)(RDC&2,Y#9Q7(?5ZA.N"VN8 M28[OTPGQ71H%L#J9`/DCUVBMC70*,!(Q$C.2,)(RDC&2V\0)!WCVB7`(ZR8< MZ,23)/9S9R1D)&(D9B1A)&4D8R2WB>,H/!W'4;DN#L16=3W[14/79TD"LP"L M&0D9B1B)&4D821G)&,EMXO@,&Y_C\W5'A;7KJ"13,ZD&;(3(=C`_WZ$A(@;(4E@=[&M('< MU#8L:-)D/&OJ"W_DD84UTM_K>*$H@@1!=R^I5A%5#/1"RIA,?X^B.8H"<*(I MZBDGG"V)!2F`F=68NX%3R`@590QV@K%CQCA....(HY2@SJ5D^- M$:IG'.4.!L30WW88BRU'X8-V:%K&*=J$L4^'JB MK#V-S`AH$$(TLD.LVAD4HY513PSJ5D_1R$AE'.6(&G4W+J(^M>,BDC08?7(G M]X0*66\ELK-H/G>G[5HU,_M]R$BDR*WUP>ZG97V0@S$=I:RCK+6C*4NZKH[< MJ(IBV([JC6R3M;.3;1(YV:91=SZ$H"&>A+P[4Q.:H1BM[&R[0SW%=G:V,?4< MK5JR313,GXB+,"=I)9&S]@4^2RQE)>_;Y/T'0Y&X^P)Y6"%QY8DY2CA*.==7;BQ%`6X',C*3(>(H1F1/M3O44VQGU#..M MKD$X>2KB=?5Y?*U.L-3=NA-I9-PE42$[?PTRX:%S-$2CL5X_(HYB1%;^&M2M MGJ*14<\XRA'Q_!5U*XN7/QG`=O/)"_5&J0F9&6XP)8O-D[)R[Q(#>CXT5KCF MAAQ%',4<)1RE'&4.:XOACX_6RAD7RMR%'(4<11SE'"4Y@USW16EKNW_#9UD) M.SY+9.J!M2BVH3`R)&0D8B1F)&$D921C)+>)ZZHH-6U7?VE+$S>%I*A4R/B[ MUL0L&7S]E$+"5.]!@4]VJD@IP0>N&#%'"4+V[P=+ELA. MNJBJV?+:F]/+!U\:P;\Z-#Q^TJ;[$E*)@($)'>HB2>[H*35"'1>1Q@!UI#$A&1FC@5VV M4.$$C:[UGAHC[#U#)'L/IB-Z=X8&';V[H1:%LIW#-T(MZVHG626"]4SG81"0 M(:U]:70]6=$&/8U4*UBMFM_HB6@LOM9]\O"B7+=-JH>%769NEQ-2PN1=7;HQ M%37Q)V(J2V@GIJJJ=M.77)2L?5U[=[L8HI$YY$0*W;A^-`V[U1,TNI[#>IPF MS!+!$40\68_^H)RC[CTI'-PJ^^_ZI:Q1<:M^A=S,)AFQ5D;7,CM"(=L;?M\K MK+K3^8Y^4FVCXXP]RTL&+UC,R%*5=_7J9+0X*GXBHQMS$DNA`)=FYHRS5E:` MNMT.TF&`WL[&2K*1J9OE*.,D2R+V\VFY#378X6'9VY M60=&5Z-[WWD>+FII-:H0#`8CMS;(1)Q&(40C<^*..(H1&?7$H&[U%(V,>L:1 M>&?3S"09+_D.IGQ3[E"<7XMUL=_7O6WU+MZOA`NLQP>-U@W[Z'2(8V7 M\%Y0BQ.3);Q&T\*G2WC5A/-POH0W$EKX8@F_X'.>+I;PFSOGH3]9BL-%VS?3 M902E,/\&BFIH(\\=VCUX1?:T>2W^N3F_EL>ZMR]>X!'+'Y/.\B5;]C`<``"PA```9````>&PO=V]R:W-H965TU9D.19B6X:D-.VW M[U$D)1Y/5NUB+U7]X_'(.Q[)(YG'S]^.A\G7O*J+\K0RK.G,F.2GK-P6I]>5 M\<^7X-.#,:F;]+1-#^4I7QG?\]KX_/3[;X\?9?56[_.\F8"&4[TR]DUS=DVS MSO;Y,:VGY3D_0J.:?7V?OZ4E<RBI].8#=WZQYFDG=[0^B_EAD55F7NV8*ZDS>46KSTER:H.GI<5N` M!O^P:&>P$6,CV#;[E6'/IO?6;.G<@Y:7O&Z"@JDT)ME[ MW93'_[B0)51Q);90`E^AQ+F;+NYGC@5MCE5T1$7XBHK6;/JP6,SO'ECS(TW. M14WXRII6W^^1BJ"V-1B^HJ)M7U7Q3E2\[RI>VU>8:VV3\+VMKTM1$;ZRK]9U M[K$@D/BXLH@28V:/C8G)`Z.-,R]MTJ?'JOR8P.2%H:_/*5L*+)>IE1'&?=S% MW*60@UAC6IZ9FI4!ED`TU3!/OC[9]OS1_`JQG0F9-96QL,1&2K!`9FH]'?@Z M"'00ZB#20:R#1`$FN*7S#03\_^$;IH;Y1EJUED!QEN8(*2&K>#KP=1#H(-1! MI(-8!XD"D"-@`B-'#"\_,A:8],J`&:C$P@(;N.8R]GWGE`TA'B$^(0$A(2$1 M(3$AB4J0Z;`"W6`ZDX:9A&W7YP$783XA`2$A(1$A,2$)"I!?H']$?EE?"E@ MTMAV3M0`(,0CQ"\K8FM%LCI=_H-11Y%/D4!12%%$44Q10E"V'R6^5P?Y!9/ ME&![D^&Z%NBN(QM"/$)\0@)"0D(B0F)"$I5@4UENHYKZJXDNSY&0#SBR89LX,@BTX*>0F:49XUN=@#0FD$CU'M$<2:E.LS8N<2\@-2<2#;B)Y5BJ MFP;<`=E&YP^>DB%_B"S-5B8?1W-^@.='*()\BZ"`HI"BB**8H@0A'!HLW;K! M9IZ=(9LYLF'=5B:(GCQ##;8EV1!DG90>^MZ0D+6T\0[M"RG':L-I/L/%@50" MT7*QI5`*C74G&A(BW8EQ=Y8.[DXBE5SH#AX,EN/=,!@\)8069'"O+8X@FCK; M;7N)N[010NKBJ`^%+Q6IW;8=XNLQ'>$5[42=C#0A%L2>M\.K+14)*^U,4WJ- M_1A**@=LCEB)`:BR+/$D+MG62[(/H"S=$P4>=V%0J/;2PN="$\A-^%(F0.]3M(#868NUACRYKCZ10 MKSVF*)&HU8[BC^U`R"^_%'^M%GR*$`CO<):V%FZDE++1]Z@WFVP@OI"ZM)]) M)6K0ZB,32J&^\:A'(XW'XXTG4LF%QK'_82T9]?^7\GPIRU32*I8B:(=7@=1X M[5%OG>X53PK-NPW2IRB02(G7'EW6'DFA7GM,42+10+SJYY_Q>6S38XY`ZJF> M(H\BGZ*`HI"BB**8H@0A'",02"A&?F(S$]#-M9T&'^GKFV M9BZ[+P`[]!+;AJ?.-JY(B2,?0?62N0LWR0.Z%BYX(2\Q.ROAK?J&_`A)`$-5TUX;_NI--I[^Z9$I*@ MAA`!W>Y^^QUC#-A#V*:ZE]+\/)[QC,?V&!Z_?,_/RK>TK++BLE')3%>5])(4 M^^QRW*C_?/4>5JI2U?%E'Y^+2[I1?Z25^N7I]]\>WXORM3JE::V`ADNU44]U M?;4UK4I.:1Y7L^*:7J#E4)1Y7,//\JA5US*-]TVG_*P9NFYI>9Q=5*;!+C^B MHS@G[%IQ;7GR$75Y7+Z^71^2(K^"BI?LG-4_ M&J6JDB=V>+P49?QR!K^_$S-.N.[F!U*?9TE95,6AGH$ZC0T4^[S6UAIH>GK< M9^`!#;M2IH>-^DSLR""J]O38!.C?+'VO!O\KU:EX]\ML_T=V22':,$]T!EZ* MXI6*AGN*H+.&>GO-#/Q5*OOT$+^=Z[^+]R#-CJ<:IGL!'E''[/T/)ZT2B"BH MF1D+JBDISC``^*OD&4T-B$C\O7F^9_OZM%'GUFRQU.<$Q)67M*J]C*I4E>2M MJHO\/R;4>-0I,5HE\&R5&-:,F+I%=4STF[?]X/EYXV:K!)[<^,PT%LM5X\&$ M=1A;XSH\VX[6;+58F-9J.3ULJ^VX[#J2CW6$1==8A"?W=S(^ZU8>GJT\@029 M<(DVL^FDB=1.U>38-)8/37HY<1T_/9;%NP)K%F:\NL9T!R`V5#&(]:M\@I9-69HMEB"BQXQ(T?ZE:1P:N##P9 M^#((9!#*(!H`#<+2Q0;R_/^(#55#8\.]VG(P")84""[!NS@R<&7@R<"702"# M4`;1``B!@(4K!&)\U^&Y0*4W*JRM02XL10>W3,98=D'9(>(@XB+B(>(C$B`2 M(A(-B>`Z;#=WN$ZE826)OLOK@`G-1:&5&*!=)]2E`"(N(AXB/B(!(B$BT9`( MX8!!WQ$.*MV$@SNQ960X[X@XB+B(>(CXB`2(A(A$0R(X"IO_'8Y2:=%11N;P M&*R"M33)G1"/CX.(BXB'B(](@$B(2#0D@N]PX-WA.Y46?6=D.,F(.(BXB'B( M^(@$B(2(1$,B.$JK8WSXS6A=,+W%T8ZBSXS,^UU^AXB#B(N(AXB/2(!(B$@T M)(+/<$8+/D\[2J5%1QFQ^HU;!HX,7!EX,O!E$,@@E$$T`()_M(@1'/QL14/U MB*XWJC>J`0NG6]1D94J+FDM!UG52IG3^.5P(IJD3,G1)E=M+\0W"XZ@_.?T> M];ID@P$7$@TNQ+&'O10W&''4&!0C3>NF&\NG/F7)Z[8`WT!H),7F4".VE2.K MON#,Y":WA"&(,T<[CGJW'8X6K-S4B>2,VPMP-1Y'O1H?HX"C3K,T+V$OP#5' M'(V$B595PS"-A`,N4%T\6!$FQ(.AN3&(!T,FNZ"Q6ADAER#D8>1C%&`48A0) M2$P-6D_=X3,KOP2?VXH,5F&_0`Q=S-<=::4@83HI.?6=,2&R-D15+I("]P8D#@AM**[8T)8`2A, M"$/PM_/>,-`%C@D--T@\'5R&KQV7,&*83>C7NE0P>[2],RKK\]O>4S:#3H;; M#%MBZHU-0DQIC4>WC(IAI?7C,*SLL&DJB#NV0%:%"M%N"U,Q_:6D89 M4]GF]$+<>9>>05FC>["N_7XGJK]AD>]JQ,%^++D)". M';H=#X>T0OW$N!AY'`W3\0/:`]ZOUQYB%'$TDHZT7!_&ZQ?+E%7W0EP8&MXJ M"4(.1BY&'D8^1@%&(4:1@(0<,<9O(A^X7C8]Q5VJ1<,+)D8.1BY&'D8^1@%& M(4:1@$3WX5P0IISN0!;$9'KJZ6$F[=`M,MF!\2`7'7USOSP,HS_2V*C8IQ7V M[CM/RV.Z2\_G2DF*-_K9Q*`7D@ZS;SI;0X>/.LUW&;G%M.$5&6R),E_8\$9I MA%LVO&T9X4L;7DZ,\)4-%_@13M8V33C<`O<[F][>QEH(M#3W!&FT<+4#;6,M M.V+8]*:`M<%E`?J,M<`7L.F7$ M77;00F^.N`7NWS:]78^U$&@9ZP-7;PC*6`O&ULK-U;<]LXEL#Q]ZW:[^#R^\26?)-52:9B M\7XG:W;WV>THB:MC.V6[.S/??@Y(@B#P)Q6S=U[:Z1\.#T6`(`F0$M___9\/ MWX_^W#^_W#\]?CA>O3L]/MH_WCU]OG_\^N'X?_X1_&US?/3R>OOX^?;[T^/^ MP_&_]B_'?__XW__U_N?3\^\OW_;[UR/)\/CRX?C;Z^N/[3]>GIY]H^O79+G_??;5_G\+]_N?[SH;`]W;TGWZ=SM_R#]P_W=\]/+TY?7 M=Y+NI/N@W.;KD^L3R?3Q_>=[V0)5[4?/^R\?CC^MMLWF\OCDX_NV@O[W?O_S M9?3OHY=O3S_#Y_O/V?WC7FI;VDFUP&]/3[^KT/BS(EGX!$L';0M4ST>?]U]N M__C^VCS]C/;W7[^]2G-?R!:I#=M^_I>W?[F3&I4T[]87*M/=TW?Y`/+?HX=[ MM6M(C=S^L_W[\_[SZ[G[U;GIY<2??3;_N4UN%<9CX_N_GAY?7KXORYF MU6?JK9:D.2L3R)_^R2KU;OUYF)UT7Z4`ZL_[Y>4OWK) M];OS]<75IEW_@25E$]N-E[\3'_S`@I?]@O)7KW)CMOC`@E?]@O)7+_C&K90. MVWY6^:N7?.-67O=+RE^]E>=OJY^5[([=WJ'VR[[IW[:AJV''DG_H1=^XJ2N] M0ZE_Z(\\VJ,.U.]*[T;J'_VBZ_-WFXN+\\O-E;3SH67UCJ3ZS]*/K/>(U6B7 M>&/[K/1.H?ZQ<'/U7K$:[1:':_FD.P"TQQ/O]O7VX_OGIY]'/)%V-#<>6N4.+'%-4ED\JS8=CV=?DL/$BQ\,_/ZZN5N]/_I1CV%T? M"[T+@0NA"Y$+L0N)"ZD+F0NY" MX4+I0N5"[4(S`JM!Y"AC-SOAH:9P?Q(#XD M@(20"!)#$D@*R2`YI("4D`I20YJQ6$TA1^\%3:&BY4AGMX5[G.J"SNR@,Z=G M#$%#UX#XD``20B)(#$D@*22#Y)`"4D(J2`UIQF(UCU3B@N91T6WSZ$J]Z63< M+R`>Q(<$D!`206)(`DDA&22'%)`24D%J2#,6J^+E@F1!Q:MHN^([.9,_HZ/6 MN=,)AB#=7A[$AP20$!)!8D@"22$9)(<4D!)206I(,Q:K+>0";T%;J&B[+3H9 M=P*(!_$A`22$1)`8DD!22`;)(06DA%20&M*,Q:IXN9Y=4/$JVJ[X3IPSP873 M"8:@H1-`?$@`"2$1)(8DD!2207)(`2DA%:2&-&.QVD+&!@O:0D7;;=')N!-` M/(@/"2`A)(+$D`220C)(#BD@):2"U)!F+%;%J^&\5?-JB+>^>">GCJ6#/)7) M;I4VN

R;%O=)ZX=+J(B1KZ",DG!:20%)%B4D)*21DI)Q6DDE21:E)CD=UR M:D`X'IP?'F>HR1>W>3H:]YH^:D0>R2<%I)`4D6)20DI)&2DG%:225)%J4F.1 MW19J++B@+;JAHXPT]!Y_HZ:UI'G.Y&PUZBI7;E<9HO2"GEE0DT\*2"$I(L6D MA)22,E).*D@EJ2+5I,8BNWG4`'%!\W3C2:MYQD/,=O9IIV83I<6LK@+R&160 M0E)$BDD)*25EI)Q4D$I21:I)C45V6ZC1X+@M_OH)IQM76LW4#S7M7K1Q>]$0 MI;N,MP+YI(`4DB)23$I(*2DCY:2"5)(J4DUJ++);3@TGQRWWBQ-.-_JTFF<\ M(.U[$%&F$N:(MN M0&JU14>C4\E.W?=QSRX@GU$!*21%I)B4D%)21LI)!:DD5:2:U%ADMX4:82YH MBVY`:K5%/T:5RAY=B%V[IY`A2G-B[?'.9U1`"DD1*28EI)24 MD7)202I)%:DF-1;9S:.&W6\_JZR[4?KXK-*3U54PEO<8Y9,"4DB*2#$I(:6D MC)23"E))JD@UJ;'(;@LUD%[0%MVXVVJ+?BAN31IOG$:!Z/SG7JBTQFKD'Q20`I) M$2DF):24E)%R4D$J216I)C46V6WACN&[I^O>J4<2?W$MQN'\NA_.FP>X=B2/ MY),"4DB*2#$I(:6DC)23"E))JD@UJ;'(;A8US%[01;I1N=5%.C*G[)V<6%0/ M,>)!?$@`"2$1)(8DD!2207)(`2DA%:2&-&.QJUX-H<=5/^H1K]_N[WZ_>9(Q MN5SI3G2/,WFNM+T^^K3N!N)6BW1DZG_7!XU/,N?.W1:OCU$]V$P%;)QGO7P3 MI<]$`2DD1:28E)!24D;*206I)%6DFM3TU%:IW8AJ[,U&7'P_>=V-X:UF[(?U MXU9;;=SGCOH%U5XV-!O;MD\E?X:@U<9Y>L/7JCIK/T*1KO#A89,+G>% MD4EE@E8;YUYX;*+TSI28[)I20R:7N\+,I#)!JXVSC^N>A)3@+Z4^PTF8=L M/4UFUMPG!9K,@B$ITF1RQ:1$D\F5DC)-)E=.*C297"6ITF0?XYP[9K6)TO75 M:&K3VZVV;.;BC#,7/:G)D5'G=':EG8Z2Y86)(`DD'F<^<#3$ZMKIVI`%^G6K?? M+#H[Q4DNT!&2;MC3W*8.==!X96Y09()TY<:DA)0:FO\(F0G2V7-202H-S6>O MIH)0F[6.FJW-1D?,U*:].ZDYF?'%X,25NUQ?ZTOWLVX*9WS-UY-]D'"NP7=] MT.)=[?)!P)1CRZ/H/!YFOV&B(T4O%O<@\C/JRV[5ST96HXMD=,1W2S<=D M0XQ>90XI(.4@\YFK(49GKGN9V9A&%4]MC+T?J"FB!?N!"GUH(#)!.GM,2DBIH?GLF0G2V7-202H-S6>O M3)#.7I,:B^QFEAZXI)E5N-/,'8WWJ=6U,RS;J=LH[73*_*9X0XS>$A\20,)! MYC-'0XS.'$,22#K(?.9LB-&9\U[ZOG=YX1SX"E4^U?G:7;$<\LW'5$.,7F?] MBW4V<^NT]P0UX[6@PW<39-:!OR,9QNM/ME-/QZK>;<@C^:2`%)(B4DQ*2"DI M(^6D@E22*E)-:BRRV^+`M-HOSL><2I,'QE0;G)DID1W)(_FD@!22(E),2D@I M*2/EI()4DBI236HLLIM%34$MZ"+=C)7513HRES0[:9;NR*C[C`?Q(0$DA$20 M&))`4D@&R2$%I(14D!K2C,6J^O/_R,12F\4^??4T:I%!YH_!7A]C3S1?.W.# MOHG2C1N00E)$BDD)*25EI)Q4D$I21:I)34]ME=J-*!=Y5O_I[A8LGF@^5WF< M9NQ(W20:SJZ<:.X7/#S1K(.D8XY2.54&C*YW!5F)I4)PA@\-U$Z>V&R:RH-F5SN"BN3R@1AHMD$ MZ>2-)DY9GKMS67_IQE.;Q=F1NIFI\41S'S6^B-%D)G1]4J#)7/V$I$B3R163 M$DTF5TK*-)E<.:G09'*5I$J3#-"&?7>U<2>:391IM;X*)UI-30^]_01ZWLTF MC4^@/=F#RHT[T:RCI$,.']W=*3T3I#^Y3PI(H:'Y[)$)TMEC4D)*#8S5T.,SESW,K,QC2J>VAA[/U@V[W3. M>:>>[&N":W>B64<=ZL2>"=+;Z),"4FAH]Z(GF,^@J%RK<:9Z.QEVECQJ11_))`2DD1:28 ME)!24D;*206I)%6DFM189+>%.^/TBZ[238*,#UL7'5EWXU;7SH3*SD29KC(L MJ,EG5$`*21$I)B6DE)21K+-* M%S4BCU$^*2"%I(@4DQ)22LI(.:D@E:2*5),:B^RV6#:#<,$9A)ZT,U&Z M7W@DGQ200E)$BDD)*25EI)Q4D$I21:I)C45V\RP;UE]R6-_3N*N0/))/"D@A M*2+%I(24DC)23BI():DBU:3&(KLME@WK+SFL[TD>&]2=8$?R2#XI((6DB!23 M$E)*RD@YJ2"5I(I4DQJ+[+98-H:_Y!B^)ZM?=%$C\ACEDP)22(I(,2DAI:2, ME),*4DFJ2#6IL`0).9;@P-F5SN"B,= M9*_0>60@-E%ZA8DF/L%ZZ8YR1WW][3]PT69Q!ES]#>SQSM:3V6RO7[#]`NZ? M']>G*V=C?!.@-R;09-*$I$B3^FIOF]EIE]@$Z,R))E;3U;(!:!MNUT=/UD,] MZU/G&Q8['24CI&&78I`9Y'+R=E5A3KHT.>) MIH+P>6(=U3UMMSH]=6X4)CI@Y@-9!X@K=\2I=MO+TX6_R])F<9JI&YO*U=]0 M*>M3Y]O3NWXY.=D-06RD+I'9_?U^J?X!E[4S31>HXMETX1M6&0TQ>H>.S2I- MZC4K?KSF]:FY*V57^;*!Y14'ECW)+S_H#[@S9#X@J[)+)=_ZU\OY>CE#@2:3 M/30TGSW202953$HTM=GM>E'CL9FKI;Y)8!YFU1X8.K#UVUNX>G1*=96;M=@NX M0SOW'/:/IQ_2RR=_M&WTTP]7'/+U9.VQ793Z^9+9WNKIYVR_G*%`1XWW MV#=DC_1R)E5,2C1-[+'+QEKJUR"=>W0]C<=:)(_DDP)22(I(,2DAI:2,E),* M4DFJ2#6IL=]VQUN$!UA4'6#W9TQ(KY^RR,U'Z&.J1?%)`"DD1*28EI)24 MD7)202I)%:DF-1;9S;-LS'7%,5=/5E?IHD;D,P;A!H7>AT9"Z5=U>N>!`?$D!"2`2)(:QQQT]C8X).T,'KC1TD#TEX(QU?1.EC_Z!IM$HFA1ILM,[@_381.GTB28. MI3=J8/3_OEYNLSA5J!);O\VRZZ-&M>II&N8%G(WQ38#>F$#3N*ZPLDA'#9F= M5HA-@,Z<:)JHIF7#K0V'6STYXP?WEK>.DNV9OYXU0?J3^SWUPX>5,T0.]!+C MZ_?URKE9$NJHT?"!%!]>5:*7F%N5W84ERMK[#A^M-BK]U\^'-]L+K) MSW8IZY'G+J9*9#URRW^J1-8C-Z"G2J0.Y![H1,F5+",3*1,E%[*,//,\52+U M)D_@3I5(O64:^ MGC55(G4MWPR:*I&ZEN^I3)5(71=WU,ELHR\>7JJ1.I: MWFP\52)UW5W4N+6SDKJ6M[Y.+2-U+>\@G2A1W6?*U0%DRJ6:)VM9*GFRCE=2 MQZO).EY)')86G&Q`U;^F5B";<#.Y"3*TWZJQ*3?.DQ(U6I\J64G) MU#(RE-^J(2J7":4DG"R17R*3C9FLELO-]D9NA#/;3DIVDR6>E*CG'+B,W."7 MDJEL\A#$5MW*YS+R+,16W=%GB3P`L56/-TR57$O)U#+R[,-6W=CG,O)SV2-^=*I$?LI1Z MFRQ9;V0]4_O.C62[F/[XO3[GF)Y_NO:AZS?WBBOU7ZV]/KZ].#7,(>'WW;WW[>/ZL` M&>%]>7IZU?^C5O#SZ?GW]AKXX[\%````__\#`%!+`P04``8`"````"$`?J_@ MLN@"``!+"```&````'AL+W=O[UX:0-*RE+XB8XW/N M.3>^9G7S5%?DD2LM9)/08.)3PIM49J(I$OK[U_W5-27:L"9CE6QX0I^YIC?K MCQ]6>ZD>=,FY(<#0Z(26QK2QY^FTY#73$]GR!G[)I:J9@4=5>+I5G&5V4UUY MH>]'7LU$0QU#K"[AD'DN4GXGTUW-&^-(%*^8@?IU*5I]9*O32^AJIAYV[54J MZQ8HMJ(2YMF24E*G\=>BD8IM*_#]%,Q8>N2V#R/Z6J1*:IF;"=!YKM"QYZ6W M](!IO)Y0C=!?!N$U%NO;$!_!-_KWG>B2[G_K$3V330V M4CX@]&N&2[#9&^V^MQWXH4C&<[:KS$^Y_\)%41IH]QP[[C.H5$@682 MSI$IE144`)^D%OAJ0"+L*:$A"(O,E`F=1I/YPI\&`"=;KLV]0$I*TITVLO[K M0($MRG'9TNZ88>N5DGL"_0:T;AF^/4$,Q,>:'$-7Y?^*A.J09(,L"5U2`OH: MDGU(X1@Z,5`:13E`0163^5$IW(&:0+3 MY6DBV*IW<;J5L:EH2.O>F^ED`?C7&X8;AQ*'%8BOYV;1A3MPLQC*OBZ%X*&4 M6QF[P1';.P6OTR)X2'M8&?;C^KP#."272R%X*.56Q@X"&$=]7FQ(&.$@>:,? M=N-0X[@$C>EU9'G>3X#G^N+L+/J%FAL,9RSA4>XQHZ7IPI^\;>DP`]P0M5,! MYKI-\;KJ_`>M_````__\#`%!+`P04``8`"````"$`$4'$9I,$``#!$P``&``` M`'AL+W=O8=+K_?JIL0K`Q";SD4BF?X^-R'1ROOWV4A?5. M:YZS:F,3Q[,M6J4LRZO]QO[WGY>O#[;%FZ3*DH)5=&-_4FY_V_[V97UF]1L_ M4-I8@%#QC7UHFN/*=7EZH&7"'7:D%?RR8W69-/"UWKO\6-,D$X/*PO4]+W;+ M)*]LB;"JIV"PW2Y/Z3-+3R6M&@E2TR)I8/[\D!_Y!:U,I\"52?UV.GY-67D$ MB->\R)M/`6I;9;KZL:]8G;P6H/N#A$EZP19?!O!EGM:,LUWC`)PK)SK4O'27 M+B!MUUD."G#9K9KN-O8C63V%GNUNUV*!_LOIF?<^6_S`SG_4>?8SKRBL-M0) M*_#*V!NF_L@P!(/=P>@748&_:BNCN^14-'^S\W>:[P\-E#L"12ALE7T^4Y[" MB@*,XT>(E+(")@"O5IGCUH`523[$^SG/FL/&]A?.0Q2%\<,"8%XI;UYRQ+2M M],0;5OXOLTB+)5'\%@7>6Y0@=J*%%Q`@O0/BRAD)@<])DVS7-3M;L&N`DA\3 MW(-D!6,O;0OFRJ$,[UL21FOW'98N;7.>9`Z\7G.Z#!=(.V9@ MF\Z,R9*!/HUOI@GFT&#RQH;5O$X^C#M1@W]W>[#A0I6@CL`%Z]5B:U4"3]&EO4V&R2B4C0S4$ MO*N/*^3$Z#IWU(B!*L@GW=6\?;@D2VQB:-P2`)6[F'C)(B,J%` MI/4`Z;C"%2XA51(9D82=W".^(PFS-4DR9)"D><'T*G6^T'4F,;E`-&)V:"@S M),FNAT%7-ADR2-*<`"61*)A2IJ$MD#:DEBD8*=,L8R!#9VA#!DT&;YBV\X;> M0$SF$(4CDF:Y`QG:0QL:2O(-_D!(Y-SU!S%0W=Z7D%JEZT-*>?[XL_Q!9&ML M8_[@:_YPNTU%MH;<^@2\77T[NC[651W8TY--P9<.T.^@-F0HCKF*DQF(TA)'3@C_+$$2VQC9V8`@T0[A=&Y&M(E]"2O?$(Z>$ M8)8+B&R-;K M1WF!XW:_P`7*,=G3/Y-ZGU?<*N@.,#UQX*SE%8S\TK`CS!TN0%@#-R?BXP&N MRBC<$GAH#SO&FLL78':[R[?M+P```/__`P!02P,$%``&``@````A`*^;\>&J M!0``9A<``!@```!X;"]W;W)KOM%=:K?;CF1(G00TA`OKU[W?L<<`>DI3V)6WP\7!\ M9GS&\>VWMW+OO_)0UZMB\-VY?_S]\-DX7M-FQW6V;XZR)7_ M+AO_V]VOO]R^5O53LY.R]2#"H5GYN[8]W@1!D^]DF373ZB@/,+*IZC)KX6N] M#9IC+;.UGE3N`SZ;Q4&9%0CY.\JH\0HC'8E^T[SJH[Y7YS8_MH:JSQSVL^XV%67Z*K;\, MPI=%7E=-M6FG$"Y`HL,U+X-E`)'N;M<%K$#)[M5RL_*_LYM4A'YP=ZL%^K>0 MKXWUO]?LJM??ZF+]1W&0H#;D267@L:J>%/3'6CV"R<%@]H/.P)^UMY:;['G? M_E6]_BZ+[:Z%=$>P(K6PF_7[O6QR4!3"3'FD(N75'@C`IU<6JC1`D>Q-_WTM MUNUNY8MX&LUG@@'<>Y1-^U"HD+Z7/S=M5?Z'(&9"81!N@@A@;\;YV"`!$M+K MN\_:[.ZVKEX]*!IX97/,5`FR&PA\6AC2Z)9Z::6P1!7DNXJB8\$B&DC/RQUC M\6WP`I+F!I,@9NE[/<9%I">$R@30ZSC"PBE'`2D\+_Z)DIKD4N+,?5]R!N(B MTB$BGG<0AR-H9W.\SDV!5SYDOI>"]7&UI`EB8ET!2N/4>N"\.?S,FQ5XY<-G M]^8%S1-"V$RG<1+'RV6W8LTL=0'SV25)8'VV)*JT/DZ;FD2E6;@$$L18TE@/ M'&GBKS!0DUR)&",2)(B)M43SQ"%_L$&^0$W/(O7-1;=VY&9`5H';3QQ]&/'OZRG3 M:*H,24MB0`M=W#&/B7(I'>_GN\R^Y-H,'=%Z#>* M2_!3ELW0?FUBT+MIXDX>K3K@1)#AU,0PQ$-VB9@RV-';D*$=V\1$GQ)34(C! M%X=LD%$G7-[4N2)`1G%1!02ZTU=`)PU>^HNMT^9 M/D/3AI1V!PC&^VYBRNWD[.H@K,\N9IIV-/?MQ.`_R-]F=GN/1'S@3#. M>!Q=T(43?[_.3*.)LUK&@[H8D-G_0V;N^&5FG_)\CJ=J)V.":)(8D-5Q["=. MQCCQ]0]T&?HY$\1_$AURY=MOQVDG1V)1[V@N&>+AX\X'_(R7B][S3+(<+V># M0YX)8I+)K>.8RU!YJV7F(QFB(\-GO\T&KLX1A`SB12\1[KEN>/!SZDLVKGZH M$AMG`Q\W(*1D=UY#"6/@,%_VC%W)B(>/E.R,EPMZ=."V72^HHJD9/I7=S$JZ MRY#X^4B&9WQ=4%_G"#)E%1-S2YUA*^4N/6+I(^FA:[LU1ZV=(^C4=EA(^*:0"":)1P!"''^2+B?9V9,K0!8$>7=%2_5C^_=_4LT@K" M_JB'[F)`AF,DYE1'!Q`MK1[KR"A(+Q@GHYY%?H70`T1B0)8KVT]<%J0GC&1Q MIC>$M#<(!-DL3D_4(3N:]<*YE,YTAA#LYWJ[$F!Y:RWLI4 M[O>-EU?/ZBJ3P;3N*5ZS)G#-JN\D@VX`;CF/V5;^S.IM<6B\O=S`U-ET#E+7 M>$^*7]KJJ&_C'JL6[C?UOSNXSY9PLS6;`GA35>WIBVI8W0WYW?\```#__P,` M4$L#!!0`!@`(````(0!-T@-CO00``"81```8````>&PO=V]R:W-H965T&ULE%C;CJ-&$'V/E']`O-O0V("Q;*^66[+21HJB;/+,X+:-!F@+ MF/',WZ>:!MQ=/>LP+X,Y=;JH4U5]F]V7MZHT7FG3%JS>FV1IFP:M M_/%WNMB81MME]3$K64WWYCMMS2^'7W_9W5CSW%XH[0SP4+=[\])UUZUEM?F% M5EF[9%=:@^7$FBKKX+4Y6^VUH=FQ'U25EF/;GE5E16T*#]MFC@]V.A4YC5G^ M4M&Z$TX:6F8=Q-]>BFL[>JOR.>ZJK'E^N2YR5EW!Q5-1%MU[[]0TJGS[[5RS M)GLJ0?<;66?YZ+M_T=Q71=ZPEIVZ);BS1*"ZYL`*+/!TV!T+4,#3;C3TM#>_ MDFU*7-,Z[/H$_5/06RO]-MH+N_W6%,?O14TAVU`G7H$GQIXY]=N10S#8TD:G M?07^;(PC/64O9?<7N_U.B_.E@W*[H(@+VQ[?8]KFD%%PLW3Z,')60@#PUZ@* MWAJ0D>RM?]Z*8W?9FRMOZ?KVB@#=>*)MEQ; M@Q-HKYEC5\-8>`YCG?62K&WO$]]?#S[@.8J`GS,#`)E]!N`Y#OY\!KS!"3Q' M%<'_16")4O25C;,N.^P:=C-@ND"RVVO&)Q_9@L.QI*(`4Y%_5F.H"W?RE7OI M?4'Y6FC,UT/@[ZQ7Z*5\H(2"`H'>*8%*B70*L6V5$W_$(2HG^8CCJ)ST(\YJ MXEB0G2E%T&ERBC[N]C$3G(PRL9G<]LD*!27HNYIG+\)`C($$`ZD$*+%"9\^/ ME9/W)G3O5!)BKU&P@D/LOJC>VO$]E1`I!`<-CQ4K\4E@WY/<9R-1&`NMX"FV M^ZY[K[>B'83(VGDKKV"->UPO/@CGP%4EAH+CW0LF@$V?$V?EKV$?PGV*QR08 M2"5`D0%K@RSC"S6*,GHW6DIQ*@ MR(#%1)8QKQI\$):#`@X%1ZJ&`$0UB+_1:X%')!A()4`1X:LB'M>"DW'P>.X+ MCJB%;]\;N4]]-%K'Y,8CP&NAT9/1.M)3"5!D\`.8M,@_EL')6`9:J4/!$3*\ M#9KTD6Q%$F/9YFWP8C!:)T42H"B"?62^(DY&B@B:KZ'@2%TE`-%5;J`W%1Z0 M8""5`"5V6$P_$7S/QM&CK(8#211D@:S10VL\6<>D)QJ2RHBJA>^CLUN+B%T7 M5K[[CD/0SAP.)*D4`S+,<+T4VHA$0U(9417PK72^`K'QR@HV>+TE@B/"77A> M@&9/-!#N"F,-230D?>!6%<1WS/F"Q/XJ"R($3>R@6$.2 M">%+V0*[2"9,(UJ6K9&S%WY5=*$($RJNL2'9 MPAD9&@'A$=G"45G'8[*%$[..)V0+!V<=3^&:W./6]`&XI5ZS,_TC:\Y%W1HE M/4%H]M(',8VXYXJ7CEW[P_T3Z^!^VO^\P/\C*)R;["603XQUXPM\V)K^PW'X M#P``__\#`%!+`P04``8`"````"$`576D+LD"``!P!P``&````'AL+W=O5MF^-?/VXM+C)0F;4YJT;(,/S.%K]:?/ZT.0CZHBC&-@*%5&:ZT[I:^KVC% M&J(\T;$63@HA&Z)A*4M?=9*1W`8UM1\%0>PWA+?8,2SE1SA$47#*;@3=-ZS5 MCD2RFFC0KRK>J1-;0S]"UQ#YL.\NJ&@ZH-CQFNMG2XI10Y=W92LDV=60]U,X M)_3$;1=G]`VG4BA1:`_H?"?T/.?43WU@6J]R#AD8VY%D18:OP^4VP?YZ9?WY MS=E!#=Z1JL3AB^3Y-]XR,!O*9`JP$^+!0.]RLP7!_EGTK2W`=XER5I!]K7^( MPU?&RTI#M1>0D,EKF3_?,$7!4*#QHH5AHJ(&`?!$#3>=`8:0)_M[X+FN,CR+ MO442S$*`HQU3^I8;2HSH7FG1_'&@\$CE2*(CR0S4'\^CCY+X3I#-[X9HLEY) M<4#0,W"EZHCIP'`)Q*?$G(P^U;04R472.B),>,M(( MUOV_1A.486B`WI)TUM-;8S<.$ML^,$YO!QLC`?.Q@/?-,>`,P[._^#*>7.P@ M86"+>1'':3H&;,>`)'C+&4AOZ,S[P@QXXLA\?._&00:.##9&CL3CBTUG_[MM M3-#8F70Q$>`@L3-F/CG=#D_#^8OXD;1D+.U]3PQX(FE:+`?IBY4,[K5M!*/1 M.)[\_@('7D9+= M$UGR5J&:%1`:>`D42+J1Z19:=/:?N1,:1IU]K>#+QJ"]`P_`A1#ZM#"SH/]6 MKO\"``#__P,`4$L#!!0`!@`(````(0"$!U?X.@,``)D*```9````>&PO=V]R M:W-H965T7;`!*N`D>TT[=_OC)U0""1-7J(P')\S9\9CO+A[+7+OA2LM9!D1.@B( MQ\M8)J+<1.3/[\>;6^)IP\J$Y;+D$7GCFMPM/W]:[*1ZUAGGQ@.&4D MWA)_N;`%^BOX3C?^>SJ3NZ]*)-]%R:':T"?LP%K*9X0^)1B"Q7YG]:/MP$_E M)3QEV]S\DKMO7&PR`^T>@R,T-D_>'KB.H:)`,PC'R!3+'!*`7Z\0N#6@(NPU M(B$(B\1D$1E.!N-I,*0`]]9!E,2+M]K(XI\#49N4X[*I/3##E@LE=Q[T M&]"Z8KA[Z!R(^W.!)!"[0G!$9L0#&0T%?%F&HW#AOX#I>(^Y=QCXK3&T1O@@ M6BN#VN7*"$9EK`JF\(2CF]#^`-+;MAA3NM)H2[48^FJ`X#6)\`[ M<^^\ST[XN&K@\:`YKMJID:=',V\G9@8U_J!4W>FW3-"K5F/&P0E#5\T_[1X` M^U!/8_J.@!'LS`\,=0\`N"78,K8-'7_GW$7`?6T+KC;\"\]S[<5RBQ_Y$+Z? M=;2^@*Q"W&''\=%\Y2XF?OT&+@85V_`?3&U$J;V&UL ME%7;CILP$'VOU'^P_+X8R&V#0E;9KK:MU$I5U`H;$IK9QK$\9L5@G%;:!;T<"70AO%';R:DMG6 M")YWBU3-XC"<,\5E0SU#8B[AT$4A,_&@LYT2C?,D1M3<0?ZVDJT]L*GL$CK% MS=.NORB:VTOO/1N;?9".@ MVM`G[,!6ZR>$?LTQ!(O9R>K'K@,_#,E%P7>U^ZGW7X0L*P?MGH$C-);DKP_" M9E!1H`GB&3)ENH8$X$J4Q*T!%>$OW7TOE-)X&TWBVN(T`3[;"ND>)G)1D M.^NT^NM14<_E6>*>!>X]RV0>S!;AY`(2YC/J##YPQ]B@#&J7*R,8 ME;&VF,J]#QS+Q.=E)M?((#BET)(A^7BR&'B]LL?,NPUS[&=ZC1""H>1CI;>E M[$%@]2B=VR&=436!Z?)J(KA3'\KI(Z>FYM?0(GA,VT?&#I;G'2RND4+P6,I' M3AW@##[:X'ATXR54]OV=CJO&_'T$NO^_&=/PO!4X(<>:[TLA>"SE(Z=68,2- M>-'+!,#O\W>KQ@*'T-C,VW/JQZ&?%DJ84GP2=6U)IGH^MU=U&G"+6\HH6*(K3]EFQE5B(;1F2[3?;M_M!=3T<7*W?'K=/F[=O]X-__R8_+`97 M^\/J[6GULGU;WP_^7.\'?_OTU[]\_+G=?=\_K]>'*VKA;7\_>#XTMSK:O?]Q_N'Q^WK M.S7Q9?.R.?S9-#JX>GV\,]_>MKO5EQ?R^X]JLGJ,;3?_@.9?-X^[[7[[]7!- MS=WX@:+/MS>W-]32IX]/&_+`A?UJM_YZ/_AH\@W4ELT,_'-W];3^NOKQ;[X]'VBZI^21<^SNZ<]ZO7^DB%(SUZ.I:^EQ^T(#H/^_>MVXU*"(K/ZX M'XRIX\W3X9G^:W8]G0_'%9E??5GO#W+CFAQK285M.9:^1$12IM>J>_H>*HNJXFPW/U9J$>_0WUJM'U9#2=+YIAG^AQ M'FK2WU!S?KV83B>SQ?ST4&G!-$.EO_U\O`T5Z6\O'RO*A:9']Q^7>7GC)[?) ME7IU6'WZN-O^O*(%2-.W?U^YY5S=N>9BEOA`M7ES+&TH7UPKGUTS]P-RA#)B M3[G^^Z?1?/[QYG?*S\=@\X`V%;=81@N7C*[9N@2B!+($J@2Z!*8$-@,W%)8V M-J/_3VQ<,RXVT:N'"+)@%8&(%K%*70)1`ED"50)=`E,"FP$6"-H"($DFM"BZ MMY*8$Z[6_8#,LIQ8<$_CNK+GOGN23#*0&(H!((`J(!F*`V)PP1YWD+2^"8Q(JE!4] MKX.N)1X$3\84Y+0-+LH+7VO4)@`0`40"44`T$`/$YH3%A:[G+"ZG-SUGS7WW M)$\`(#40`40"44`T$`/$YH0YZI0/\]3)H-'TNG\"-"WQ*`14I,"HV`.259L# MB`0BB4@ATH@,(LL0CY`32?D:.9T+E==4=`6,WCP$E&<#HAJ10"01*40:D4%D M&>(^.SW4PVZN&SET_47IS!A\JC0O1-RZEOK6+%.E6,2""2B!0BC<@@L@SQ,#BUU",, M7ERQ,.1Z*ZQZ0'4%2""2B!0BC<@@L@QQGYT2RGUV,F!*E[*>*K#RBHH%HQ59 MN0ZHN%(9=@(2<` MU14@@4@B4H@T(H/(,L1\'I72\+3/C3G7?P$5(J`X#5@FJSC/-2*!2")2B#0B M@\@RQ,/03_^-4/\%E.WQ2T0U(H%((E*(-"*#R#+$?78B[/)T'WG-EJ=[0,74 M%X=@RV25IA[U'UI)1`J11F00689X&/KIOQ'JOX#8U*/^0RN!2")2B#0B@\@R MQ'UVBJO'U'N!QJ8^:#92-MF-?WF\-VJMTM0#$F@E$2E$&I%!9!GB87"ZK$<8 MO(QC80!EMW3'*ESLU8@$(HE((=*(#"++$/>YU'].!/S::=`(M6%`?$>X+0\$ MDU5*BR`7,QV`5A*10J01&426(1XBI]EZI(67>"PM0/4M:7>`M``DT$HB4H@T M(H/(,L1][M*&OW1$-$)U&%"1%>4I8;)*60&"4:"51*00:40&D66(1\BIMAY9 MX44>RPK0?353OUB`0B MB4@ATH@,(LL0#T,_=3A&=1@0K;_HX!)1C4@@DH@4(HW((+(,<9_[J<,QJL.` M^#G!;7DZF*QB9&I$`I%$I!!I1`:198B'H9\Z'*,Z#(A-/:I#M!*()"*%2",R MB"Q#W&_ MG_(;H_(+**7T$D@-1`"10!00#<0`L3EAKDY*P>>V_C#3A^?-X_>'K0.=TSZF M%^.:,\_/32M&=;!Q=[/IE.&V.%86R2IN#Q*10J01&40V MH&;H/%BE+/RU8*%:G'B4!RN2%`<,EK>9S/T+BL.JV%E%:)8,4IQBNY$HZ%NG M:LV+C\.JN%B;9!!;L7DK/&;]9.4$965`)-EB;\N`J-.(:D0"D42D$&E$!I%E MB/O<3T-.4$,&Y,ZOLW50K)9EM*(Y;:TP2X+V3+$2H1[="[@)KJ[+5UME;)BJ MM@V/JD+)JVB56M:(3-G9HO#"QCK'.N.A+:7JZZP+'D6G/"_7 M-.[=V$+:!50D:'D<'*U.)ZAOG9Y;1+]%J.=N5MMPC<;%J:*,K1]+G.;:I*)5 M:EXC,A?U:&/%8SWR(#L1FP>Y.7BE%7TF9;WVS07DQ*,\><;#(AK+8'0Z97U# M>IA"OA[K@<>RGPBG*QXD+"CN9;#* M;LEJ1`*11*00:40&D66(^UR*\#-Y@\I[$I3WHEU92T0U(H%((E*(-"*#R#+$ M?>ZGO">HO`/*)G6)J$8D$$E$"I%&9!!9AIC/TU*"GY[GQIQK[8#Y5/O7G8AJPS5B`0B MB4@ATH@,(LL0][D4Q]D-Q1GW42=//:);O3B_2T0U(H%((E*(-"*#R#+$W:?K M:)\I=^;%E'N4+FC+:4EJ(`*(S`D?HA-Y/;+2:\+\XCWUJ%!*A0A>1JND4FI$ M(J`@W.?70_Z_N?A0*L[8"$6EW1IR)<^=[2<+IR@+`\J5R@C$=3!*DU8#$8$$ MU3"\+FYMI2MO'D^?5#)L\CXK)*V7N-%CEDP=(!*LSHC:V==F$ ME;+H,HDY17D44#YQ*#+YQOJ5$1+")<@_FC2JT\W8\$?M)GRE*GX"RC7^) MJ$8D$$E$"I%&9!!9AGBREM+G\FL!JJ"I1^Q:`*A&*X%((E*(-"*#R#+$W)^5 M*LBY?_Z\N:G&KPD!T?&,NPO_4,J@6$PYTR;B.+M3YZ,J18D;U<@=3YZ^/,]0 MG004AU5LU,M8S(>5CESXL#IUP_#\L%`US#R*PTH=^K=98S$?5KJ)X\-RU]Y\ MOVVBY;;J,]'RU^Q\XYUY%(>5.@S#"L5\6&FSX<-R5^!\6&=&XR_8;#0>Y;O) M#%"-2""2B!0BC<@@L@QQGRGH?7QVYL4R\L@]'\S627$4OYRU5E%TUH@$(HE( M(=*(#"++$`^#NPSWF'I_U693'R[DZ0Q].0-4(Q*()"*%2",RB"Q#W.=2%)Q) M=Q0#,X^*^\E2LB:K-/5MQ8@$6DE$"I%&9!!9AG@8:&_H,_7.O%@!'K%5#ZB> M`1*()"*%2",RB"Q#W.=20YR9>A0.LZ`2*,6S55\>CR>K.,\U(H%((E*(-"*# MR#+$PC`OM<3I,#3F?.H#RJ<>48U(()*(%"*-R""R#'&?NY3*18_LYZA5`LKE M(Z(:D4`D$2E$&I%!9!GB[I>*Z,R4HQ":>Y1N999`:B`"B`2B@&@@!HC-"7>U M2V7U?F0_1\T54!X!;Y1O!MF]=B/%ZE#KS"/[9!5W#(E((=*(#"(;4#-T'JQ2 M^V5W59>_WS!'21@0)4V[3U:+4J8&H]/Q\VW3S)MNT2X8%UPN]R9>7NY(K+:T#Y<_V`\N?ZB`0BB4@A MTH@,(LL0]]D)O]QGETSN+>(SFXVK5EQ?/&+G2N-A>:XT#U:T0;=)ANNOPZBZ M+6XO16@JG!S.BH>',O9$Z_UH3RH:G1J.[C*"X1@^G%%QUVEC(T>&PR>EG]R= MH]P-B-94Z_N\O,\)-A3KU@9GPC>=5J4(M<)AV*CT4[KRH^VI"_K4K4U4*41?TJ5N;%''6YVUQU;+'NF2A7O2[ M)6C,^98=4'ZY2NBXSW4T&K>7;X%(1I1>X0&7C:T^4B MK4-3]&.(N`(%(AE1GK`7M*YCO=2Z0>0^).O<\6/W\?(?AO4?^WQ=[[ZME^N7 ME_W5X_:'^^@K'8=]^MAB_T7:A]GBSAV6D!M0KA/JA9QX=);,)C:`)0CF"V91*FL^O0,F,2IK-&$KF5-+< M()0E8VJ-SG`[1C"FUNB(KZN$6J,?!W25D*?TWGQ'R83J^%N4<@03JD-O_'34 M&5%TZ+>('25CF@42UETE-`NT[+M*1E32I&,Y@O&82IH=$DIH%GRBER4CJD._ MI^_H9T1UZ/K754*QIOO@KA**-?W^N*N$XN:/F6`$%#?Z=6I'G8KJT%=?NDJH M#GWOI*N$8DU?!>DH&5&L:9ON*J%8^[T9QD:QIB\L=-2IJ`Y]@JRKA.K05[FZ M2BC6].VJKA**-7W.J:N$8NT%9SFVBF)-WP'JJ$-5.F?'+:LN>PIS9Y0IR)TQ MIA!W1KBB"-.GZ'!$]7QRY^[OL81NUN_<_3B6+.?3.W>_BR5TRTL#[BJA;W-_ M[HX\#:RCI0=7.?]G< M_^,0KOU?M@?Z(GDC`Y[I"_1K^I8TO1(SN/JZW1[B/UP'[3?M/_U/`````/__ M`P!02P,$%``&``@````A`)[N?AJ,!P``UA\``!D```!X;"]W;W)K&ULK%G;;MM&$'TOT'\0^!Y1)'4E+`<1KP%:H"C2]IFF*(NP M)`HD'2=_WQGN?5:6Y=8O87QX=G;GS.SLB'OW^M5W=G-:.-YXXH^I4 M-MOZ]+AV_OJ6?EHZHZXO3MOBT)RJM?.SZIS/][_^W.;55LAT''@^M/)G/W6-0GAUD( MVUML-+M=759Q4SX?JU//C+35H>AA_=V^/G?"VK&\Q=RQ:)^>SY_*YG@&$P_U MH>Y_#D:=T;$,OSZ>FK9X.(#?/[QI40K;PQ^6^6-=MDW7[/HQF'/90FV?5^[* M!4OW=]L:/$#91VVU6SM?O##WYXY[?S<(]'==O73:_T?=OGG)VGK[6WVJ0&V( M$T;@H6F>D/IUBQ`,=JW1Z1"!/]K1MMH5SX?^S^8EK^K'?0_AGH%'Z%BX_1E7 M70F*@IFQ/T-+97.`!<"_HV.-J0&*%#_6C@\3U]M^OW:"^7BVF`0>T$G M-9IT1N5SUS?'?QC)XZ:8D8`;@:L;_@?'C*==WD$&RK86'P%`,U.>T971:.(;IQ MT1?W=VWS,H(M`X)WYP(WH!>",1%69D$&^K4X0X#1R!>TLG9`&PAA!\GY_3Z8 MK>[<[Y!0)>=L;(YG,B+!P.Q!LS$%$@JD%,@HD&N`"SY+QR$1/\!QM(*.BR5O M!*"4\(F7@B&&Q!1(*)!2(*-`K@&&E[!3="\O[U81122O'1Q826TAB(:F%9!:2ZXCA%6PJW2M,6G\VEEOYYK1%.Y#XNL?!?$(\9J0` MMK0FR\PD19(DHVHAB86D%I)92*XCA@BP:EV$ZZ%%\N"I6-^&(7H@+22VD,1" M4@O)+"37$<,'$%7W@56?,1;EZ^[@.-,=A@1J)T86$EM(8B&IA606DNN(X0Z4 M<=V=ZSX@V?2!(<,A/M2_B`(Q!1(*I!3(*)!K@+%X[-3^_TF`5DRO&`*]B=H_ MWG)*]@\GP=KD)ILN3$[,.?"0''\V-TF))(E$3Z5I@60248;H9#GC>/!0DVFE MP5`.SKT/4`ZMF,HQA'5U+"$XHJIOS!%CG3.B7"))0H+4,I192,X0(H$ZLPT) M/&@H/T"#P8PI`H=T%02DR2`@4XRF%MAR6#MI MJ&K]OBZ?-@VD%'`NE(<`>B?>4;&^!"!35492YMQA+% M$N93`2E;F0WE'/*&0FNZC3V(YO8%]Z#5E_ZQCL7PCT%38^5STH!$'F/YX+GT MC^[>6)&$>PF'`GV0HF=@HW[1-JFR*X]34MCYO3YWK4YOJ8,>C MJ8--P73VWNW#VB9#-`;Y4*G4TN>D5$8>9UT+;:Q(2CI,,;'UTL1\8U,BFY1?!@6^K$,1B(HL@)20U)58 MD`(Y+K&A5$#*>J:@UZWGBF3M+6S.-(X+)>[,'C1`=&`11UI*'U(7(8R35 MP<46DG`$-A@FBITG8$+.0%7-+'.YCIB1QSY/$^*-R+.N$'05&;WQ&&1$7D*O MKS$6X_3(\W$*2@5+C_P-UG-CG.DPMFRW.XQL$F(&F>?/@OP>\]';)](^G/("/R"=E^ M0A*.D,#33@M95P)OFN@8]4^5E%U M.'2CLGG&BSSH+._O),QN&=-EB-\)8).3%]DRQ*\%]@NXE_PR+)4,V,!]Y27^ MQH=[S`MV-D$(]P$7[$_!_I!J=()I"-_.[0&;60C?HR_@\Q`^[%[`ER%^>;%? M1,LPNO@B7H;P&=(>$*]"^!)W`?#-,+DKW8-;U7/Q6/U>M(_U MJ1L=JAT$B_W":=F]+/^YP_/WH>GA/G5(Y3W&PO=V]R M:W-H965T:%^6G4/5Z:[35=U%^_&WK]59^U(T;5E? MMKJY6.I:<I_?PX_N;K6=MGED)WK2['5OQ6M_MO3K[\\?M3-6WLJ MBDX#ADN[U4]==_4,H\U/196UB_I:7.#-L6ZJK(,_FU>CO39%=NB=JK-A+9=K MH\K*BTX9O.8>COIX+//"K_/WJKATE*0ISED'\V]/Y;7E;%5^#UV5-6_OUT]Y M75V!XJ4\E]VWGE37JMQ+7B]UD[V<(>ZOII/EG+O_`]%79=[4;7WL%D!GT(GB MF#?&Q@"FI\=#"1$0V;6F.&[U9]-+S0?=>'KL!?JG+#[:T?^U]E1_1$UY^+V\ M%*`VK!-9@9>Z?B.FR8%`X&P@[[!?@3\;[5`XHS96OV7V M2[U'B(^0`"$A0B*$Q`A)$)*.$2ETV'JDT$E]6*N%V(#NKA!"!$4VEL5>N8HL MU,B&G6BDG6*T%T8B.Q`2("1$2(20&"$)0M(Q(BD%D4E*S2<)L>[EX$'L*#). M"83X"`D0$B(D0DB,D`0AZ1B1`H75D0*E6^:"G&7S,1-'.6:*V,/>L$>(CY`` M(2%"(H3$"$D0DHX1*68X$Z68YP,EUG*@%%F+/7"O`KX*!"H0JD"D`K$*)"J0 MC@`I/M(H_X1CD-#(@5/$`F%%19NN(Y?]GAG!Y(21HYR>/K.!A["QE@I1((QX M586"FB.10`8B=;!8\`PVUE+9PQ-AQ*E300V()"\T!A/R]B73GIAK106MP)C8:4F MNS]E9&Z4EBQ@5K;9)Y*SE$<*.0DT$C='BKC1W'3B*2,TG42>SL:6IY-RDAO3 MD1>#M'T_L!BT2Y06@T+0&HC8+6LC3VEO4J/Q3J@N13HTHZTB:R!_0D9@KA4PA.:EM])7$K.:RR#>9 MD2U*)F"0(RT3%EP)AE(.]>QR_L&:2+K\O_PC+,IF0"%Y,S"5O7!O,JOQ M02^@(6QT@`3,\>9YQDC&2:NN3(0'CP=H9O!D?O"4D]P87-:?M/3CO%3U_UQ? M0=C)WG+<5M$O`UAG7CT[N-#M\V[(J/T`#=&IJOC8(A<1@]SIWK1RV5Z^5<5S6NQ+\[G5LOK=W)Q;&[@X!,PO=7>.1Y\[H,> M*K[RX.MX`E][\`6)\=CUX&-A`M]XT"AC/'4]:)7'FE0\1OH4>$"?NH- MW,P_]Q*K,9`;^PFFG>7!-1@>86=[<$F$\6?'>P:Q\8N=Z^TF@W`]^$K!]K[K MP>?;!+[QX!L%XZ'KP9<*QB/7@^\5P`T1,?P2<,U>BS^RYK6\M-JY.,*"+_NO MKX;^ED#_Z%BEO-0=_`;0%\T)?O,IX"9V26Z\CG7=\3_(`.)7I*?_````__\# M`%!+`P04``8`"````"$`2J@4/ML'``"[(0``&0```'AL+W=O'$-+KEU)^GIW=>>SLX,W=Q^^'_>!;V;15?5QZ_G#L#E]_?7],.--VB[XK@I]O6Q7'H_RM;[>/_[;W;JMU&=?KYT-Y[(22IMP7':R_W56G5FD[K*]1=RB:I^?3AW5].(&* MAVI?=3]ZI=[@L%Y\?CS63?&P![N_^Y-BK73W7YCZ0[5NZK;>=D-0-Q(+Y3;? MCFY'H.G^;E.!!>CV05-NE]XG?Y$'-][H_JYWT#]5^=):_Q^TN_HE:ZK-E^I8 M@K,1&IWT$_FP&FW);/.^[O^J7O*P>=QV$>PH6H6&+ MS8^X;-?@45`S#*:H:5WO80'P[^!086J`1XKO2R^`B:M-MUMZX6PXG8]#'\0' M#V7;I16J]`;KY[:K#_\*(5^J$DI"J00^E9+A))C.;WHE%P9.Y$#XU`/G_O@V MG,/D%\;!TW[5\"G'W5Z4GTEY^)3R,.,%_7,I#Y]Z75<9!-NJ7QA\JH&6._F, M(Q&./KIQT17W=TW],H`M`PYO3P5N0'\!RE18A08=Z-?B#`%&)9]0R](#WT`( M6TC.;_?!-+@;?8.$6DN9%9?QJ42D)#![4&WL@L0%J0LR%^06&('-VG!(Q%]@ M.&I!P]625PI8GG"L5!)J2.R"Q`6I"S(7Y!8@5L).L:T\OUM5%%%XZ4&N6U$, MZ>I70B:8:XLC1F)&$D921C)&93?N(5/24&R:*G)G.ZS6`E!"+10,)U1J<1(J>V8*F3.E,P@H\N= M,)="/IEP-M834A=B'\#R^=TUR!?M!)PF:ODKB<"%"D4*&8MBAAG"D8(C:YL?T6G0CPA MFQ<[*^Q^1C:X$D%5M?;,K>L)+64\P71E/D.Y1'Y?>JG9V'%89I\Q#WZ7:?M$ M?T+L$VA"5CYSNL7(%U(!.%#;Y^[CV`@I\Q*)0GM<,'/*4JH&@N%:>S!VO),(L!:'&>787>-L98Q;A*C`JK; M*;DICC-3<_^\/75N3TV]@SV0E4=X,DVF[]T^HI&"291E*U^@`$XLL_294RXC M)74IM+$14MH3B2"]\*>J/W&BD:HA=F*YXUYX;(;:WX`2P#<;L M"BV<.I"A.=#O^546L2,))+`!L-$X7D"*G1ZNE[-F+K<)C3R MV/E='WG1)Y+("T0BK]'K:XSA:$`GA';D&4J5E!WY*[3G9!PQ&#?V]0;WTC3$ M$M'S9VZ:O_Y\C:04G#\ZR!PE$CFGC5M&U4"[*/#31DF9&7."J!>@=KS#"RCM M>$$@FNA.-8OP]*6)SD@B"3U)YJ9_[-V9HI3.]S.VNQ/E]D34R<311B=5`@Q*.4HXRCG*"J)W8E#EV^N\] M'P-4X@1>(!+XN=M]R7&F!8T9221Q`N]V6BAEW,M:"*8VEP1+OQGWVKF'D]M. MNGSN]=*.-U`!5#%3GR(I!<@LP*W0L1*RJA]'J4)&>V;0Z]IS(^2>>Y#2Q."? M.O=Z)8X?9#](-L/,/?CD0-B;IBC*@08E4HH6Q;E36U*EZXW\8.IS-;"?D6X9 MIZ5\(QMX[X@O,]QLT.CU>,5JG)T-QDN4([ MWN2:%!:.$#>SXN[N4#:/953N]^U@73_CK2MTEO=W&HLKX=5\`:]WP;U+.X47<(H57!OP)O(];X/L%_@2NG3_UQKESP'5TO[5='L`U]1D]JW`!USUG M]$]`_[G%KB8+N#7A`U;3!=Q$G.&S!;RO/\/!M-59TR)X$IU]`J\Z%_@BDVN# MUWSPY)SA\-(+GIPS/?9#>-(;/]+>@JOS4_%8_E$TC]6Q'>S++019_#)JQ.6[ M_)DD\_ZA[N#2O-\"._@CB1)N3\=XQ;*MZTY]@>6.])]=W/\'``#__P,`4$L# M!!0`!@`(````(0"HF2+H-A$``,5;```9````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`!U^WHOYV?.%&P][V5AZ(IB:!V@"$"Y?A,W= M.74R&N('FKS^_+RX\CY=_DD3SH/2K%'C*#:L$+.+L`U<$+H@V"Q@6M"[H!N*3PZ!C12/C_B)&P$3'BUETS,$&;VR';L(*K M!"X(71"Y('9!XH+4!9D+ZV&E_?U"[&L/3Y;B8IV#"19F!O'!D@` M)`02`8F!)$!2(!F0'$@!I`12`:F!-$!:(-V06#&@=9T5@^,-+]1VPTMR;>X) M+@A<$+H@V"Q@6M"[H!L-J9EJU6.P_Z^MN/ MW<,?Z[W<>(ZT_X+6JG(%*TSLYI=DT/P,S'UA>6,OF`(I$;O.P;UC88M"+>)I M+@(2`TF`I$`R(#F0`D@)I`)2`VF`M$`Z2?HFM")&&X61B/%6_<.[#F%CQTR2 M.0W)0?LO[?;?*!%U)RV"0"H-_=`:[_;*-@JU2`=2DD6?:NG[5:R),7(/EF@? MH_%NK^V#I5K$!\NT-9-<$V/D'JS0/D;CW3K]N-0BMJZT-9-:$V/D'JS1/D:S M6MD7UFH-.W>*]*MAJ]^(5,1(Q^EO:Q\?ZKV+W6\4HH[#)[%A9-;D`2.9_Q([ MU!!1Q,A4C!$EC(Q7BBAC9+QR1`4CXU4BJA@9KQI1P\B>PFZ=F!D5MU?'J+>W MHR8VML,DP\A$3%,FS\0B:>0,:X7F%/[!<'0ZTH955%^KW!X9&!&?>8@H0A0; M-.V>&!&[IX@R1+E!T^Z%$;%[B:A"5!LT[=X8$;NWB#H+V6$6V^43PBQWU[09 MX\.M1?*/(D^["1T_;S6SN]Y&B893/`99&IG1'.I:?+`(2*R).;SKG&@-^Z1` M,B"Y)M/.A=:P)T15[M2MJ*K-NS5X5Y#[ M4ZKC@W=$Y*V9SF8B

TM8@4)=4]S0QVSZ-@9)4;$C9LBRA#E M!DV?0F%$[%XBJA#5!DV[-V,B:,V659.MV;%BHC7M[B12!2=T)YE9L+J31/8D MX2RQ-R*A3UW@^"3!&F[;4-=B$@&)-9ENV$1KV"=59+[LN^3*66YEHGBR(^;: M;EI3:`T?L@12`:DUF79NM(:=6T4F+J83Q6,78_<#D;DXH1\(N;-DD\A>$ZS< MM3[UG'XN.#:(`R/B:PP118AB@T:ON-\!)$;$[BFB#%%NT+1[843L7B*J$-4& M3;LW1L3N+:+.0G:817+DA#`+N1-FB89]RELY&[&->/;V[G!G#5])J&LQB8#$ MFDPW4J(U[),"R8#DFDP[%UK#SJ4B:NQ=7SD37R7*QP9?WQ5K[3>M:;2&C]F^ M<\QNZIAV3Q#9FQ-Z@DSV4,_BTUB+YZ04Y&$R&%&`*$04(8H1)8A21!FB'%&! MJ$14(:H1-8A:1)V%[%B(O,PP%H.,V3M[,YG1L<(BT3`_+!XD4Z0&*$`4(HH0 MQ8@21"FB#%&.J$!4(JH0U8@:1"VBSD)V6$3>8QB6=V(ATR16+"0R^YZ-YY(` M2`@D`A(#28"D0#(@.9`"2`FD`E(#:8"T0+HAL9I>K"*LIA^,B(\GEGH7^_:E MT"`BFDS/P8'2V'GDE9,1#(V*Y\@(48PH090BRA#EB`I$):(*48VH0=0BZA3J MF]0.(BWR1H)X&E4[%X9=T:U0<;+/6!C MK(P(TLQ&Q.8=(TQ94NY@K"N=F&CN79R.)#-3PT2S4@W6-0$CL_H)$46,3$(W M1I0P,EXIHHR1\(JH0U09-NS=&Q.XMHLY"]CPO$C<22`6DUF3:N=$:=FZ!=$-B M1U5D:DZ(JDSL6(-7Y7JLP0N)9K&HHK"*N?_(X!T106HT9"N5&EUXMT[Z*6+% M1&I4/B)FT;$S2HR(&S=%E"'*#9J^WL*(V+U$5"&J#9IV;\9$T)HMJR9;LV/% M1&O:W4FD>T[H3C([9'4GB>Q)PLFW;,2*\-U)@C7.YEC'DLA>[B[B68E MFNAX?1@"K>$K"8%$0&)-IALIT1IV3H%D0')-IIT+K6'G4A$U]JX7SD/62I2/ M#3Z9:-9^TYI&:_B8[3O'[*:.:?<$D?$:3OPBE3._NJ`[^HE_U#*7N3.Z)YBK M6+@9][526>^+SV=PGY!>I.*K#4Q%1B&B"%&,*$&4(LH0Y8@*1"6B"E&-J$'4 M(NHL9`63DAUV,(\/ZUYN+_45HIF#6WF#*$`4(HH0Q8@21"FB#%&.J$!4(JH0 MU8@:1"VBSD)V+$3BRAU8WM4'WBE?B)I.6"0:/"+8*-4`!8A"1!&B&%&"*$64 M(F>(R.S)<*&[D,A,31L@`9`02`0D!I(` M28%D0V)?JIO?D5GZDR?V!29^%+*6E+"=V["*EG&3][Z`1<,;Y'SFK!=#H^)Y M*6)DIJK8H.D#)BRR#^@L75*CX@-FC#"3MA"YCXFQ_O'G(;V+,^YE4H7:F<]B MHU2#&3I@)%X*_?/S?.8Y%Q,:`=M$C(:MIPYF4,(J[>S$)34"=LX8C3232!,, MF^F=L2>S"M;8D\A*.,YGSI.>S4*ICF4(@C$1[+)#I:+Y1#0MK.LB=IG88\N, M!8N.G4\R)H+S25DE=_W>;.9D@#,63)R0/4&(G?8P'F*"N)Z=F+872SGW=B71 M<',PGSEO<6U4O:.;`ZWAWA4JHA;:<^>]R$@43\XUL;:;UB1:PX=,S2%-M3DV M_/#(\YE)@MM-+K:TPR9_9PC(';`U!"2B69]/<+/0R)P@)-A9M-#U0D01(^,> M&S3MGK#(N*>(,D:]N]TN8HL+UAE,&'#UUCN[N.C-VF3BZ'8&QC:!: MK_;WL'_M?U+3OO<'D;0>A1"HS9SI4QNE$DN7R=$:L&BI@Q(BBA@9]]B@:?>$ M1<8]M9#5.,O3-E:]O.^'Y@065\Z]^90:+#0VB`*$(6((D0Q MH@11BBA#E",J$)6(*D0UH@91BZBSD!T+=\\UF-S?"0MNOY82T5CE\;!!%"`* M$46(8D0)HA11ABA'5"`J$56(:D0-HA919R$[+'1;.&6("+DS1"0:[$Z6+@F` MA$`B(#&0!$@*)!L2^U+'-V@G;X67B-EIG]8CW$]NO?K6R#N M>XV*>WO$R&S38D0)(]O>V1BF1L7V&2/*6R62C5<(F(OTR(^\U#54TM6S]F616Q+`]GT2\])T,>L&BQ9$:7' M#Y5QC:E#V4/XM)W3$G=."@WZU`91@"A$%"&*$26(4D09HAQ1@:A$5"&J$36( M6D2=A>Q8B`W+"5U<[F^L65,BVJ!PO]S0YQK%0!B@`%&(*$(4(TH0I8@R1#FB M`E&)J$)4(VH0M8C$MRQ-X\A8R&]3RL_3/6]?OV\WVZ>GP]G#_I?X[N3U+66L M-%8?Q5S._"_D1$WNE-!>A+Z7V7^'`4H\*NF'.93,J:3?=D')#97T,R.4W%+) MZ!E<^UV_CG!K>.1%?YLQ>=&?!V#)E_G*_R(7B*X;E8CG9UAGO:`6H*D[AB[0ZEM##"5\\>A@K MH>L9K4//)7R17<3L82>LW<%^\H8PF];>Z+5Y6QA%XQ]UN93'.Z/[W' M3"5C==949SU:LJ&2S6A)0"7B56\\`WK]WQ=O?&-)3"7BQ6\LH5?_??&R-Y94 M*U]\#P0+ZI4OO@J"!F&?I@B-^.UNAH9AHMH#]OH28;.TAPZ[>C`WKE MKT>M-BM??*@%3S=8^>+;+%@0K7SQA18LB%>^^$X+%B0K7WR:!0NRE2\^T((% M^6?]]^WY?WK]]W+X>QI^XUN=O*1Q:O\#+-Z M?J&RE5_W;_3Y9%I?T\=:Z7/96_H*#7WD]OSLVW[_QO\1!]`?X/[\?P(```#_ M_P,`4$L#!!0`!@`(````(0`UJZ(:P`8``,$;```9````>&PO=V]R:W-H965T MWOWW'6-LL(>P>Z=[638?QE][QF-[@/7G;]?+Y&M65GEQVVADJFN3 M[)86A_QVVFC_?/$_V=JDJI/;(;D4MVRC?<\J[?/V]]_6;T7Y4IVSK)Z`PJW: M:.>ZOCNS696>LVM238M[=H,[QZ*\)C7\+$^SZEYFR:%I=+W,#%U?S*Y)?M.8 M@E-^1*,X'O,TDAO%7Y_Q><;5K^A&Y:U*^O-X_I<7U#A+/ M^26OOS>BVN2:.M'I5I3)\P7\_D:L).7:S0\D?\W3LJB*8ST%N1D;*/9Y-5O- M0&F[/N3@`0W[I,R.&^V).#%9:;/MN@G0OWGV5O7^GU3GXBTH\\,?^2V#:,,\ MT1EX+HH7:AH=*(+&,]3:;V;@KW)RR([)ZZ7^NW@+L_QTKF&ZY^`1=S M*H6(@LS4F%.EM+C``.#OY)K3U("()-^:ZUM^J,\;S5Q,YTO=)&`^>VX6)JS^?6PEZ.#WO1-ER*AN1C#6'1-3W"E?L[&I]5:P_7 MUIY`@HRX1&^SZ:2)U$[5Z-AF+!^:]'*3.MFNR^)M`FL69KRZ)W0'(`Z5Y8G% M>A>I]BC3(,6HRA.5V6C@`"11!SKY#2:6NSPS9$MMAS"YJ_5-95 M@:<"7P6!"D(51"J(>V`&81&Q@3S_%;&A,C0VW*L=!UVP#"40W((W<57@JD`(!"U<*Q/"NPW.!6F\T6%LB%PRRE!W<,1MC*8*R1\1%Q$/$ M1R1`)$0D0B3N$\EUV&Y^P'5J#2NI[[LY7RB^,R,3MI=>@%:RT5X8B11`Q$/$ M1R1`)$0D0B3N$RDRG#66?&3&[#6"/B(N(AXB/2(!(B$B$2-PGDL]PT$D^CSM* MK65'&5ET:UH%K@H\%?@J"%00JB!20=P#DG^T&/X%9QV5D1UGQ(#`BA5-;$M9 MT:T1#$X86<*(KRI?2',2"-()J9V%0J>S,73ET(Z$$9>. MA300*;QP^@^$MUDR]3E/7W8%.`5G[4!:F5`RL$*"BLC!902"RT>P;TEW>+@M MF3>5AZ$3Q0M/W.<:/M(($`E%*UK/@*HR$9&XSU7COH84&UI:2<$9"`)4T3P* MC;D'%EFL2F<%$^UGH_60AZU\C`*,0HPBC&()R3[3NJJ_WM[QF95A M<'CR<.X(0P8XU:T'0U<6%K<"8V&E)KL[9$162MWE<2N#)9)MFW)?/C>`>N%A M7P$W&AM0.&2$!A1Q*S:@I6TJ=4+,#1X,2)X06M_]P(2P&P:J MXIE1?S?$T\%M^%Q[A!'#:D*_TI6JR:?W1:>J7M"V'NLS%#:\SZ@EEM[T28BE MK/#X4:=R6&GQV`]KKU;X^,9'6`DJ19LA)?V5G-VW#8VQ;',[(^Z\QQ'/=0OE M>ML]7$8"WQJ-]1[RKKJ-*N*(]4[FMN)6S`T>]"[/`*U7^S/PSD[#RELIU&W% MV]]=!7KLODM:(U-L6AY&/D>=>M"AQ^HA-^K4(XQBCAIU.2ZTO.W'Y>[A+#Y[NE'8%Z1Q$^YO7&K4K<+$PE33PJ<%(]JF]AA_I-9)[)?I\ MH10,\:-NY?#22GHLO%^*^Z.*IW_84QGEL&=(.NP%>AP/E[1&W<1X&/D<]=/Q M`^HA;]>I1QC%'`VD(RW,^_%Z9YFR.AZF@N]9.\)0__D1(Q[3BEAU M?P'UW#N^LT):\ITABQT8GU#1(6YWR\,PNB.-C8J]7V523=+B ME;X[AR-TNQ:8O=C?60Z\#8$$5/G<@9<'`WSAP`/V`"=+^$+0/+*H2L2&._9` MF]!VX/D+:X4K!YX],(]!:(COB>[0FA^W@+(?^AZZ`Q\TGIH5C$8+#0:4=H8# MKP]Q#SO3@9=KF#]9SA/[8*)V8#N[02=L!Q[\L)!K._!$/,!7#CSV8>[;#CS\ M81[8#CP"`I^)`<$'E'MRROY,RE-^JR:7[`A)HCGEVP("U@)'M;';_OC-VH)!;TY<( MAO$Y<\[8XRSO7^N*O'"EA6P2&G@32GB3RDPT14)__GBZN:-$&]9DK)(-3^@; MU_1^]?[=MXBRS MB^K*#R>3N5\ST5"'$*MK,&2>BY0_RG1;\\8X$,4K9J!^78I6=VAU>@U,ZVE?DN=Y^X*$H#[9Z!(A069V^/7*?@ M*,!XX0R14EE!`?!+:H%;`QQAKPD-@5ADIDQH-/=FMY,H@'2RX=H\"82D)-UJ M(^O?+BFP13DL6]HC,VRU5')'H-^0K5N&NR>(`;BKR2'T59XK$JI#D#6B)'1! M"?!K)HF^A\:3$XHV-P7'T6+'M46!W4(HZZ/]I?(VMXA MA_%IO':7B]]_@>'>LH)_9:H0C285SP%S8K>;#>S&R!7]@Q$L#8]T^EG"- M2VFZ%[R`^C\&JS\```#__P,`4$L#!!0`!@`(````(0!Q!CVROP(` M`+$'```9````>&PO=V]R:W-H965T[Q@F#)JOH"^#+\3GW7%\N MZYMG6:,GKHU038:C(,2(-TSEHBDS_.OG_=4U1L;2)J>U:GB&7[C!-YN/']8' MI1]-Q;E%P-"8#%?6MBDAAE5<4A.HEC?PIE!:4@M+71+3:D[S;I.L21R&"R*I M:+!G2/44#E44@O$[Q?:2-]:3:%Y3"_F;2K3FQ";9%#I)]>.^O6)*MD"Q$[6P M+QTI1I*E#V6C--W5X/LYFE%VXNX69_12,*V,*FP`=,0G>NYY158$F#;K7(`# M5W:D>9'A;93>1B$FFW57H-^"'\S@&9E*'3YKD7\5#8=JPSFY$]@I]>B@#[D+ MP69RMON^.X'O&N6\H/O:_E"'+UR4E87CGH,C9RS-7^ZX85!1H`GBN6-BJH8$ MX(JD<*T!%:'/W?T@`1SMN[+UPG!BQO;%*_O&HZ,CE6>(C M"]Q/+(M@O@R3"23$9]09O*.6;M9:'1!T#4B:EKH>C%(@ONP(K#CLUH$SO,(( M@0!T5X9U*8K.[!3=K5UJ=SZP%`FOBR3 MO$?&@3,,1](GGT3_TO?*'K/H&F;H9_8>(0>&DH^57I?R"`*K@W3^8Q.8IE?3 M@3OUOIP^S?\8I@(?;0?S-O8?2FOX[-TZP&ULK)O;;B))$H;O5]IW0-R/H:HX MEFR/&NJL76FUFMV]QKALHP;*`KK=_?8367F,_`L,O7,S3']$1F;\&9D9E2[N M?_^QV_:^UX?CIMD_](.[8;]7[]?-\V;_^M#_SQ_9;[-^[WA:[9]7VV9?/_1_ MUL?^[X]__]O]1W/X>GRKZU.//.R/#_VWT^D]'@R.Z[=ZMSK>->_UGKYY:0Z[ MU8G^>7@='-\/]>JY;;3;#L+A<#+8K3;[OO00'Z[QT;R\;-9UTJR_[>K]23HY MU-O5B<9_?-N\'[6WW?H:=[O5X>NW]]_6S>Z=7#QMMIO3S]9IO[=;Q^7KOCFL MGK84]X]@M%IKW^T_P/UNLSXTQ^;E=$?N!G*@&/-\,!^0I\?[YPU%(&3O'>J7 MA_Z7(*Y&P_[@\;X5Z+^;^N/H_'_O^-9\Y(?-\S\V^YK4IGD2,_#4-%^%:?DL M$#4>0.NLG8%_'7K/]O;R>:[C%%)`*+GW\F]7%-BI*;NW`L M/*V;+0V`_MO;;41JD"*K'^WGQ^;Y]/;0C\*[<#8.QA.R[SW5QU.V$3[[O?6W MXZG9_4]:!%EA/5DCY5R[F-]T*[J6I'GV:H5NT+ M#6F]MD.E3]/PJACGJB%]WAAC0,DH=I#)>D[;GLI;257CY(MP\]"D0RL&#T@>5`P8DB]&&ELQ?H8UP([3142TT ML&*%GA#:0C=)?)#Z(/-![H/"!Z4/*@S!>#E18\T`E MX9,<#KU)-D9FDH&D0#(@.9`"2`FD<@F+G<[Q&V(7UCQV2=Q)!I(`28%D0'(@ M!9`22.42%JBH>%BDLOQIE_GE"6];\J@5BNQ)OT24($H198AR1`6B$E'%$`]? M5#[7)WD@"R4ZWG2Z+A2:&+($D@!)@61`JJAMW%"=F3Z];=9? M%PUMQA1@Q[1'5-"J,E=62$P!B5P%-+';^\BK?Y)`VHA','L&A%X]G%HK+7B& M*$=4("H150JU0^=BB7+H_Q=+%E5,+%5GL:C]XC>01G0$&6E0/VDSFK;/&N$P M&/.=-55.R,!*I_UJDE_14V$=B:<:ZFG$>RJM@?9;&;]$N+"BL'*%[<@VR@F3 M;K(.8PI*%-+&9=2)PHB/:1DH*\IG8X4:&B,]\-2VTRA#E%MTWGMAC;2K$E'% M$)=*E&8W2"4K.2:51!2ET6#FU>)+LA>'U^5<0YM@[B5MJAR%;F]1Z.5*)JS, M8,*A5_/E5XRFZ+"!T93=H_'62'5V-'PB1"WH3L2O[9RRHJ0N=3HL`HE8*@=%2+21*[%J9U&FK:SW MW*+SW@MM9%V5B"J-6N]<%U'+NKJ()(V&;2%WP_$N*V(FET1N%LW\9_5`VM@2 M(`&2*O+9_D">3!ZZ2="6'SFX+8"4W1UY]43U?7O]B2A%E"'*$16(2D050RP70MK%;HE9F'LQ2R2Z,*D7A?YB:OMYZ-.' MWD<31"FB#%&.J$!4(JH8XC*(PMU=$F*C&8UOW&A"6?Z[*T4A=Z.)0J]`6"HC M9Z:"/KO414:=2QO5`2,%U^J>(2 M1XV_`B7B*]"OB9:J(:T!NP)50[>2@:HS50UYO1-Y#[69=D_S9)(0CSIM90=1 M6&0;PB#*[D%XY7JE?9T;!,]3\0#@YJD_'W\T[^?N#IRG.?&P[T^(1"Q_#;)1 M^FLT4:ZBD9FB%%&FD9N_5W@O=#OKO414:=21O_X3PR?K&A\-0E7/VZ?W):($ M48HH0Y0C*A"5B"J&>(Z(6MC-D4]BEJ4SV\M4-4VAFW411?Z3/5VJBB2B>V6[ M.`&E:)4ARA$5B$I$%4-` M:B4V8KMCP"6RM=(+*D.4(RH0E8@JA=JA<[&Z*N7@UDJ9CD802R*WB`UF_K61 M:G=9/^GH_"6R(AN_6LS<$#L)_DP5UM&92V1KH/U6QB\1+JRH<-W]YO(F M0T4N*"@1]:![6RHK]^D348HH0Y0C*A"5B"J&>,Q^2?Q)S%C[4JTD9/!J7TB; MCD+7G\U$N[*U::I1V#YTC>9CO^K5!F[!Z3O.M9%;9OM&A372DU=J)'N/)D/_ MIE<;G.F=2RU*Q!O22U:4[ADF7FTAJ4E*NRU%WI"6RNCR`I6.[+:8JE94OK?O MF'E.,_92C:]2E> M-Q!)?BF!$FUD'T]3A3ZY++<-[<2BR%<,H=">[`HJ%:+C1,QLX+\J4>DF5Z6P MJ(C=%/ZU*9[67$,I)&I(-)?U^E5-F,W&CPKQ/"ZJR/_(I^"F-C MTUF%(*^'@F@^];:JZERO/*-O*_0C+/058H>0M!(GW]FP$]W.35_5SJ),6]DC M+K?HO/="&UE7):)*(WSVI;<__HK4PP>#UK%W?LW]^T%M9-=5@BC52!]6_E]% M,VW@9J>?PKDVLGT5B$J-9%_!=#KVGF@K;7&F,Y9U]+K^976ONXEIW?#]52$W M&RTZGR^)-K)W)2FB3",G&RTZ[[W01M9[R9`41_X"0;[6O:L/K_6RWFZ/O77S M3?RZ@.XL'N\-EC]]6(QC>O61]@2?3V)Z]:^#3V-Z4ZZ#SV)ZBZR#SV-ZZ:J# M!\-8O(^$WR11&*=2?6],5#S'9>EG0 MCT':3/9Y&--KT>AG(3KHX%]&\1>:HHX&(_JU20>G5X%B\7(.MDB"*!;OL>`W M]%(*M>GZ9AD.8_$'(6Q#?Q.B2+J^2:*`!.X.GO*!\@>]+4+*"'E'`X)13M!E M25<;R@JZ1Z!O!J81_>#E??5:_W-U>-WLC[UM_4(I*_]N>Y`_F5%_Q%57K$_- MB7[ITMZVOM%/FVKZE<#PCBJTEZ8YZ7^(#LR/I1[_!```__\#`%!+`P04``8` M"````"$`_%,4,F,$```L$0``&0```'AL+W=OF>D66FUVLLS#4Z"&C#"I-/]]U-E M$\"&-.0E"D6Y3IVJ\HF=[;?W(C?>:,TS5D8F6:U-@Y8)2[/R&)G__O/\]<$T M>!.7:9RSDD;F!^7FM]UO7[875K_R$Z6-`1%*'IFGIJE"R^+)B18Q7[&*EO#F MP.HB;N"Q/EJ\JFFT;&20FN9Q M`_GS4U;Q:[0B61*NB.O7<_4U844%(5ZR/&L^1%#3*)+PQ[%D=?R2`^]WXL;) M-;9X&(4OLJ1FG!V:%82S9*)CSAMK8T&DW3;-@`&6W:CI(3+W)'QT;-/:;46! M_LOHA0^^&_S$+G_46?HS*RE4&_J$'7AA[!5=?Z1H@L76:/6SZ,!?M9'20WS. MF[_9Y3O-CJ<&VNT!(R06IA]/E"=040BSLCV,E+`<$H!/H\AP-*`B\7MDV@"< MI17C])`0`D_G`DF@[QZ=(W-C&@##H8!O.\?UMM8;D$Y:GT?I`Y^=#^D\+`#M MD`%M.3(Z(S)6!5-YE(8AC#T-X]P#@\Z1"=7LDW?]+JY$ECZ^J.J0CWL/$#I# MR8=(S@BI=0*J?3J^TZ6C5!,B+:\F.@OTKIS2,B;EJV%Q9-WU9@7FSR<%UZD( MK06J-R#C3I,)QJBVCYMB!A77C:H:=!BR?ZV34E7OQO"@]"[>'>BLC1DA(%E#W,];*+Q5L-8T)D1PUP\*A8P\LH"0 M6*B!M`JB4KHQ*01U8``\0ZE5#:FN0D=$@,B$5RH46I- M*J5>.96=3.X2$N$MT/I]Y;@/VLQ?O=2A[Y5-30#%8,!\IJ;HK=&5IHF:3LB) MO0&^,Q!C-2%3#.N3[ZV[ MR^EJ/9=:B*\-;I28":*B@HPV%.BJ#X8Y-Q)VQANA#Y>MSMK=5O?BLJK;W7`O".GV(-S# MT01^T_07!%:`3D^\L0F\"2;?/(1[>5>VNG!P5ZWB(_TSKH]9R8V<'B#SM3@$ MUO*V*Q\:5D$;X,;*&KBEBJ\G^%>"PK5.5/C`6'-]@*2L[G^.W2\```#__P,` M4$L#!!0`!@`(````(0`>JX(<,P$``$`"```1``@!9&]C4')O<',O8V]R92YX M;6P@H@0!**```0`````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````````"YMVFS)"FX'*GAP(3A3?8G+7!9LTY$:[_7NSKJL3?1+R$LZY M7\X]*1<[TR2?X%&WMB)%EI,$K&R5MG5%GM;+=$X2#,(JT;06*K(')`M^>5%* MQV3KX<&W#GS0@$DD6632560;@F.4HMR"$9A%AXWBIO5&A'CU-75"OHL:Z"3/ MKZF!()0(@AZ`J1N)9$`J.2+=AV]Z@)(4&C!@`](B*^BW-X`W^.=`KYPYC0Y[ M%W<:XIZSE3R*HWN'>C1V79=UTSY&S%_0E]7]8[]JJNVA*PF$'_II!(95K'*C M0=WL^>[--PGBMJ2_M5+)/AV3'D0`E<3WV#'=27F>WMZMEX1/\N(JS>.9KXLY MF^1L-GLMZ`+S/_?//^1<```#__P,`4$L#!!0`!@`(```` M(0!D4<_'E@```*H````0````>&PO8V%L8T-H86EN+GAM;#R.P0H"(11%]T'_ M(&_?.#.+B%`'"OJ"^@!Q7J.@3_%)U-]GFS87#A?.O6IYIRA>6#EDTC`-(P@D ME]=`FX;'_78X@>!F:;4Q$VKX(,-B]COE;'17;P.);B#6X%LK9RG9>4R6AUR0 M>O/,-=G6L6Z22T6[LD=L*`3$#``!`"P``$``(`61O8U!R;W!S+V%P M<"YX;6P@H@0!**```0`````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````````````"< M5MMNXC`0?5]I_P'EO0TM:+6J0BHNK5JI75!#VT?+.!-BD=B1[;#0K]])`FEH M35;PYMAS.3-G9C+>[29-.FM0FDLQ<*XNNTX'!),A%\N!\SJ_O_CM=+2A(J2) M%#!PMJ"=6__G#V^F9`;*<-`=-"'TP(F-R6Y<5[,84JHO\5G@2R152@U^JJ4K MHX@SF$B6IR",>]WM_G)A8T"$$%YDM4&GLGBS-N<:#24K\.FW^39#P+XWS+*$ M,VHP2O^9,R6UC$SG;L,@\=SFHX?H`F"YXF;K=SVW^>D%C"8P1L-^1!,-GOMY MX3T`+9(VHUQIWUN;FS4P(U5'\P],V[7365`-!9R!LZ:*4V$05B%6?93G)--& M^>]2K70,8+3GHD!U61Z;LLTS[_O]7BF!IT/)PD*%!!\.,Q8)U@:Y$P;S11Y%Q3:73>1U#&.)1`L-(<&3E@D/J<&/$4VH M8)C-6K#(2^6E7>7J%)W`H+?T)#<[E7/<7)\!K:)PQW>=@JE:4L$_RMHMDSW* M-1>@#ZJCE@[R-*5J2V1$`KX4'!L.2XT,&9.Y,%90]UBRY(TF.9!GH#I7F"5Q M6'RU>;2CV(6E4><5"F0.9T?%KG,\R\,P/"W+0ZV_#/>ZOXX14_@PIWEY`8:U9.7RF)=J8EA5VNFW3SLK M_?6`LKHI9@"I@I6")HT_BB"38[.[93H0JY?V\6`/IKW.SM'I6;&U^^E;=9J# MZ'OVK"KM+6`/IUW''D[[/#MHM8-5Y`RY>*BF,C&.*OXYP+_/]H=@5WZJ%V+_J7W9[75P#&W>>^[GZ^O\` M``#__P,`4$L!`BT`%``&``@````A`(3FT(<(`@``@AL``!,````````````` M`````````%M#;VYT96YT7U1Y<&5S72YX;6Q02P$"+0`4``8`"````"$`M54P M(_4```!,`@``"P````````````````!!!```7W)E;',O+G)E;'-02P$"+0`4 M``8`"````"$`"GHX!#,"``"I&@``&@````````````````!G!P``>&PO7W)E M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$`-@02AN8#``"\ M#0``#P````````````````#:"@``>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``& M``@````A`#NG`VHW!0``210``!@`````````````````[0X``'AL+W=O&UL4$L! M`BT`%``&``@````A`*ESHVT2`P``2`D``!D`````````````````DQ<``'AL M+W=O&PO=V]R:W-H965T``!X;"]W;W)K&UL4$L!`BT`%``&``@````A M`+RWY8SA`@``NP<``!D`````````````````TR$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(]7L%6=`@``.`<` M`!D`````````````````."L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#@-\=,M M!0``?A0``!D`````````````````W#$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,*#"!7-!0``*Q@``!@````` M````````````SSX``'AL+W=O&PO&PO&UL4$L!`BT`%``&``@````A`/9. MKO48`P``9`D``!D`````````````````AY0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&WL%44``P``N`@``!D` M````````````````Y9X``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&!WF'HN"P``;C8``!D````````````````` MNZH``'AL+W=O&PO=V]R:W-H965TC`<``"PA```9```````` M`````````!O```!X;"]W;W)K&UL4$L!`BT`%``& M``@````A`&+F`8X(!P``_AT``!D`````````````````WL<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*^;\>&J!0``9A<``!@````````````````` M9?```'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`(0'5_@Z`P``F0H``!D`````````````````-_X``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*B9(N@V$0``Q5L``!D````````` M````````.2P!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`'$&/;*_`@``L0<``!D`````````````````P$&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`!ZK@APS`0``0`(``!$`````````````````=UH!`&1O8U!R;W!S+V-O&UL4$L!`BT`%``&``@````A`&11S\>6````J@```!`````````````````` MX5P!`'AL+V-A;&-#:&%I;BYX;6Q02P$"+0`4``8`"````"$`00+>`3$#``!` M"P``$`````````````````"E70$`9&]C4')O<',O87!P+GAM;%!+!08````` ..-0`U`%P.```,8@$````` ` end XML 22 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Warranty Obligations - Summary of Allowance for Warranty Obligations (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Mar. 31, 2015
Guarantees [Abstract]    
Beginning balance $ 93us-gaap_ProductWarrantyAccrual $ 40us-gaap_ProductWarrantyAccrual
Provision for estimated claims 5impr_ProductWarrantyAccrualProvisionForClaims  
Adjustment to estimate (51)us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease  
Settlement of claims (7)us-gaap_ProductWarrantyAccrualPayments  
Ending balance $ 40us-gaap_ProductWarrantyAccrual $ 40us-gaap_ProductWarrantyAccrual

XML 23 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 24 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock Award Plans and Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Estimated Weighted-Average Assumptions Used in Calculation of Fair Value of Options Granted and Rights to Acquire Stock Under ESPP

Weighted average assumptions used to apply this model were as follows:

 

     Three Months ended March 31,  
     2015     2014  

Risk-free interest rate(1)

     1.77     1.87

Expected life (years)(2)

     6.02        6.04   

Expected dividend yield(3)

     —       —  

Expected volatility of underlying stock(4)

     47     54

 

The assumptions used to estimate the fair value of the rights to acquire stock under the ESPP during the offering beginning on March 1, 2015 were as follows:

 

Risk-free interest rate(1)

  0.07

Expected life (years)(2)

  0.50   

Expected dividend yield(3)

  —  

Expected volatility of underlying stock(4)

  55

 

(1) Risk-free interest rate—the yield on zero-coupon U.S. Treasury securities with maturities similar to the expected term of the award being valued is used as the risk-free interest rate.
(2) Expected term—the expected term for stock options granted based on a review of the period that the Company’s stock option awards are expected to be outstanding and is calculated using the simplified method, which represents the average of the contractual term of the options and the weighted-average vesting period of the options. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate the expected term.
(3) Expected dividend yield—the expected dividend yield was not considered in the option pricing formula since the Company has not declared dividends and does not expect to pay dividends in the foreseeable future.
(4) Expected volatility—the Company is responsible for estimating volatility. The Company has limited trading history as a public company and does not have relevant historical data to develop its volatility assumptions. Therefore, the Company used a weighted average of its volatility and analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March 31, 2015. The Company analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March 31, 2014.
Schedule of Stock-Based Compensation Expense

Stock-based compensation included in costs and operating expenses related to the awards of stock options and the employee stock purchase plan are as follows:

 

     Three Months ended March 31,  

(in thousands)

   2015      2014  

Cost of maintenance and professional services

   $ 60       $ 23   

Research and development

     223         92   

Sales and marketing

     216         89   

General and administrative

     202         94   
  

 

 

    

 

 

 

Total

$ 701    $ 298   
  

 

 

    

 

 

 

XML 25 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
Computation of Net Loss Per Share - Summary of Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share (Detail)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted net loss per share 4,986us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 17,753us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted net loss per share 4,951us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_StockOptionMember
3,605us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_StockOptionMember
Common Stock Subject to Repurchase [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted net loss per share 35us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_EquityUnitPurchaseAgreementsMember
57us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_EquityUnitPurchaseAgreementsMember
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted net loss per share   120us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_WarrantMember
Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted net loss per share   13,971us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_ConvertiblePreferredStockMember
XML 26 R37.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock Award Plans and Stock Based Compensation - Additional Information (Detail) (USD $)
1 Months Ended 3 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended
May 31, 2014
Mar. 31, 2015
Dec. 31, 2014
Feb. 27, 2015
Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options expiration period   10 years      
Stock options vesting period   4 years      
Employee stock purchase plan fair market value of the common stock 85.00%us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent        
Share based compensation unvested stock options   35,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber 40,202us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber    
Share based compensation stock options repurchase   $ 162,400impr_StockRepurchasedAndRetiredDuringPeriodStockOptionsValue $ 184,000impr_StockRepurchasedAndRetiredDuringPeriodStockOptionsValue    
2014 Stock Option and Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares granted   1,446,050us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
/ us-gaap_AwardTypeAxis
= impr_StockOptionAndIncentivePlanMember
     
Weighted average price   $ 13.55us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= impr_StockOptionAndIncentivePlanMember
     
Common stock, capital shares reserved for future instance   2,122,083us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
/ us-gaap_AwardTypeAxis
= impr_StockOptionAndIncentivePlanMember
     
Employee Stock Purchase Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common stock, capital shares reserved for future instance   627,033us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
/ us-gaap_AwardTypeAxis
= impr_EmployeeStockPurchasePlanMember
     
Common stock, issued       58,793us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_AwardTypeAxis
= impr_EmployeeStockPurchasePlanMember
 
Common stock, purchase price       $ 11.64us-gaap_SharePrice
/ us-gaap_AwardTypeAxis
= impr_EmployeeStockPurchasePlanMember
 
Employee Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock option associated with early exercise vested   5,202us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember
    5,626us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember
XML 27 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2015
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of significant accounting policies

The Company has not made any significant changes in the application of its significant accounting policies as described in Note 2 of its audited consolidated financial statements for the year ended December 31, 2014 included in its 2014 Annual Report on Form 10-K filed with the SEC on March 11, 2015. See Note 2 in the 2014 Annual Report on Form 10-K for information about these critical accounting policies as well as a description of the “Summary of significant accounting policies.”

Recent accounting guidance

Accounting standards or updates not yet effective

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers” (Topic 606) (ASU 2014-09). ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. On April 1, 2015, the FASB voted to propose a delay in the effective date of this ASU for reporting periods beginning after December 15, 2017, with early adoption permitted as of the original effective date of periods beginning after December 15, 2016. This new guidance is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017; unless the early adoption provision is elected. .Entities have the option of using either a full retrospective or a modified approach to adopt the guidance. This update could impact the timing and amounts of revenue recognized. The Company is currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of operations upon adoption.

EXCEL 28 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S M-V1A-V4Q,#'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D]R9V%N:7IA=&EO;E]A;F1?0G5S:6YE#I7 M;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C8W)U961?17AP96YS97-?86YD7T]T:&5R7T-U M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O&5S M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=OF%T:6]N7V%N9%]"=7-I;F5S#I%>&-E;%=O#I%>&-E;%=O M'!E;G-E#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E=A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D%C8W5M=6QA=&5D7T]T:&5R7T-O;7!R96AE;G-I=C$\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]R9V%N:7IA=&EO;E]A M;F1?0G5S:6YE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9A:7)?5F%L=65?365A#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9A:7)?5F%L=65?365A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C8W)U961?17AP96YS97-?86YD7T]T:&5R7T-U M#I7;W)K5]/8FQI9V%T:6]N#I7 M;W)K#I7;W)K#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-T;V-K7T%W87)D7U!L86YS M7V%N9%]3=&]C:U]"83,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O&5S M7T%D9&ET:6]N86Q?26YF;W)M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I!8W1I M=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6UB;VP\+W1D M/@T*("`@("`@("`\=&0@8VQA2!296=I M2!#96YT3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^,#`P,3,R.#`Q-3QS<&%N/CPO'0^+2TQ,BTS,3QS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^)FYB M'0^)FYBF5D(&%T($UA M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%? M8F4Y,U]F,F4S-V1A-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@ M8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S M'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA&-E<'0@4VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!C M;VUM;VX@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&5R8VES92!O9B!C;VUM;VX@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F M,F4S-V1A-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R M,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAAF%T:6]N(&5X<&5N M'!E;G-E'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&-H86YG92!R871E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A"<^#0H@/&(^,2X@3W)G86YI>F%T:6]N(&%N9"!B=7-I;F5S#L@+7=E8FMI="UT M97AT+7-T6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@ M26UP2!A;F0-"B!P2!H;W-P M:71A;',@86YD(&]T:&5R(&AE86QT:&-A2!E;F%B;&EN9R!F87-T+"!S96-U2!A;F0@"<^#0H@5&AE($-O;7!A;GD@=V%S(&EN M8V]R<&]R871E9"!I;B!T:&4@4W1A=&4@;V8@1&5L87=A#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z M(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/ M4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T&-H M86YG92`H)B-X,C`Q0SM.65-%)B-X,C`Q1#LI('5N9&5R('1H92!T:6-K97(@ M#(P,40[/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO'0M#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2 M;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@-G!T.R!,151415(M4U!! M0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M M0T*(&%C8V5P=&5D(&EN('1H92!5;FET960@ M4W1A=&5S(&]F($%M97)I8V$@*"8C>#(P,4,[52Y3+B!'04%0)B-X,C`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`Q1#LI+"!A;F0@;VX@82!B87-I2!A2!F;W(@=&AE(&9A:7(@<')E2!B92!E M>'!E8W1E9"!F;W(@=&AE('EE87(@96YD:6YG#0H@1&5C96UB97(F(WA!,#LS M,2P@,C`Q-2P@9F]R(&%N>2!O=&AE6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO$$P.S$Q+"`R,#$U+CPO<#X-"B`\<"!S='EL93TS1"=- M05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[(%1%6%0M M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T2!A;F0@:71S('=H;VQL>2!O=VYE9"!S=6)S:61I M87)I97,L#0H@26UP#L@0T],3U(Z(')G8B@P+#`L M,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@ M34%21TE.+51/4#H@,3AP=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T3PO8CX\+W`^#0H@/'`@#L@+7=E8FMI="UT97AT+7-T2X@5&AE($-O;7!A;GD@=')A;G-L871E&-H86YG92!R M871E#L@0T],3U(Z(')G8B@P+#`L,"D[($9/ M3E0Z(#%P>"`G5&EM97,@3F5W(%)O;6%N)SL@5TE$3U=3.B`Q.R!-05)'24XM M5$]0.B`Q,G!X.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5. M5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.SPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=( M251%+5-004-%.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$ M+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@ M)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,'!T M.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M M=V5B:VET+71E>'0M2P@86YD(&%R92!T:'5S('1R86YS;&%T960@=&\@52Y3 M+B!D;VQL87)S(&%T('1H92!R871E(&]F#0H@97AC:&%N9V4@:6X@969F96-T M(&%T('1H92!E;F0@;V8@96%C:"!M;VYT:"X@1V%I;G,@*&QO"<^#0H@/&(^*&4I(%-U M8G-E<75E;G0@979E;G0\+V(^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^ M#0H@3VX@07!R:6PF(WA!,#LS,"P@,C`Q-2P@=&AE($-O;7!A;GD@86YN;W5N M8V5D('1H92!A8W%U:7-I=&EO;B!O9B!(5`T*(%-Y2!P86ED#0H@87!P2`D,3DN,2!M:6QL:6]N(&EN(&-A2!U7-T96TF(W@R,#$Y.W,@=V]R:VEN M9R!C87!I=&%L(&%S(&]F#0H@=&AE(&-L;W-I;F<@9&%T92X@061D:71I;VYA M;&QY+"!4:&4@0V]M<&%N>2!W:6QL('!A>2!U<"!T;R`D,2XY#0H@;6EL;&EO M;B!I;B!R971E;G1I;VXM8F%S960@<&%Y;65N=',@='=O('EE87)S(&9R;VT@ M8VQO65A2!I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!O9B!3:6=N:69I8V%N="!! M8V-O=6YT:6YG(%!O;&EC:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\9&EV/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@ M5TA)5$4M4U!!0T4Z(&YO#L@+7=E8FMI M="UT97AT+7-T2!H87,@ M;F]T(&UA9&4@86YY('-I9VYI9FEC86YT(&-H86YG97,@:6X@=&AE(&%P<&QI M8V%T:6]N#0H@;V8@:71S('-I9VYI9FEC86YT(&%C8V]U;G1I;F<@<&]L:6-I M97,@87,@9&5S8W)I8F5D(&EN($YO=&4@,B!O9@T*(&ET$$P.S,Q+"`R,#$T(&EN8VQU9&5D(&EN(&ET M#L@0T],3U(Z(')G8B@P+#`L,"D[($9/ M3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE. M+51/4#H@,3AP=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T#L@+7=E8FMI="UT97AT+7-T#L@0T],3U(Z M(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=) M1$]74SH@,3L@34%21TE.+51/4#H@-G!T.R!,151415(M4U!!0TE.1SH@;F]R M;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M2`R,#$T+"!T:&4@1FEN86YC:6%L($%C8V]U M;G1I;F<@4W1A;F1A#(P,4,[1D%30B8C>#(P,40[ M*2!I$$P.S(P,30M,#DL("8C>#(P,4,[4F5V96YU M90T*(&9R;VT@0V]N=')A8W1S('=I=&@@0W5S=&]M97)S)B-X,C`Q1#L@*%1O M<&EC(#8P-BD@*$%352`R,#$T+3`Y*2X@05-5#0H@,C`Q-"TP.2!O=71L:6YE M$$P.S$U+"`R,#$W+"!W:71H(&5A$$P.S$U+"`R,#$W.PT*('5N;&5S2!E=F%L=6%T:6YG#0H@=&AE(&5F9F5C="!T:&%T M(&EM<&QE;65N=&%T:6]N(&]F('1H:7,@=7!D871E('=I;&P@:&%V92!O;B!I M=',-"B!C;VYS;VQI9&%T960@9FEN86YC:6%L('!O'1087)T7S4T M,C,Q9&(R7S(V,S)?-#@W,5]B93DS7V8R93,W9&$W93$P-PT*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F M,F4S-V1A-V4Q,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"<^#0H@/&(^,RXF(WA! M,#M&86ER('9A;'5E(&UE87-U#L@+7=E8FMI="UT97AT+7-T2`H86X@97AI M="!P6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO'0M3PO M8CX\+W`^#0H@/'`@#L@+7=E M8FMI="UT97AT+7-T2!T;R!M87AI;6EZ92!T:&4@=7-E(&]F(&]BF%T:6]N#0H@=VET:&EN('1H92!F86ER('9A;'5E(&AI M97)A2!I#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P M<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@ M,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T$$P.V%P<&QI97,@=&\@87-S971S(&]R#0H@;&EA8FEL:71I M97,@9F]R('=H:6-H('1H97)E(&%R92!Q=6]T960@<')I8V5S(&EN(&%C=&EV M92!M87)K971S(&9O<@T*(&ED96YT:6-A;"!A6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA) M5$4M4U!!0T4Z(&YO'0M6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@)B-X03`[/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@ M/&D^3&5V96P@,SPO:3XF(WA!,#MA<'!L:65S('1O(&%S#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z M(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/ M4#H@-G!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@ M,'!X.R`M=V5B:VET+71E>'0M"<^#0H@5&AE(&9O;&QO=VEN9R!T86)L92!S971S(&9O6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M M4U!!0T4Z(&YO"<^#0H@)B-X03`[/"]P/@T*(#QT M86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)SL@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@ M5$585"U44D%.4T9/4DTZ(&YO;F4[(%=/4D0M4U!!0TE.1SH@,'!X.R!7241/ M5U,Z(#$[($Q%5%1%4BU34$%#24Y'.B!N;W)M86P[(%1%6%0M24Y$14Y4.B`P M<'@[("UW96)K:70M=&5X="US=')O:V4M=VED=&@Z(#!P>"<@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#DR)2!A;&EG;CTS1&-E M;G1E$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P="!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/DQE=F5L M)B-X03`[,CPO8CX\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T2!M87)K970@9G5N9',\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,P+#$X-SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CDW/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XY-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#XV-3,\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$#L@ M0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$R<'0@)U1I;65S($YE=R!2;VUA M;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,'!T.R!,151415(M4U!!0TE. M1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.SPO<#X-"B`\=&%B;&4@#L@5TE$3U=3.B`Q.R!,1514 M15(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET M+71E>'0M$$P.S,Q+"`R M,#$T/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4 M+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M4TE: M13H@.'!T.R!&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B<[($)/4D1% M4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED.R!724142#H@-#@N-G!T M)SX-"B`\8CXH:6X@=&AO=7-A;F1S*3PO8CX\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R M/@T*(#QT$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/CDW/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/"]T$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C8S,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XV,S(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M M4U!!0T4Z(&YO'0M#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z M(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/ M4#H@-G!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@ M,'!X.R`M=V5B:VET+71E>'0M"<^#0H@/&(^*&0I($QE=F5L(#,@9F%I6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@ M5TA)5$4M4U!!0T4Z(&YO"<^#0H@5&AE(&-O;G1I M;F=E;G0@;&EA8FEL:71Y(&%S2X\+W`^#0H@/'`@"<^#0H@5&AE M($-O;7!A;GD@#L@0T],3U(Z(')G8B@P M+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@ M,3L@34%21TE.+51/4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@5TA)5$4M4U!!0T4Z(&YO"<^ M#0H@)B-X03`[/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@5&AE(&9O M;&QO=VEN9R!T86)L92!P28C>#(P,3D[6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@ M5TA)5$4M4U!!0T4Z(&YO"<^#0H@)B-X03`[/"]P M/@T*(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)SL@0D]21$52+4-/3$Q!4%-%.B!C;VQL M87!S93L@5$585"U44D%.4T9/4DTZ(&YO;F4[(%=/4D0M4U!!0TE.1SH@,'!X M.R!7241/5U,Z(#$[($Q%5%1%4BU34$%#24Y'.B!N;W)M86P[(%1%6%0M24Y$ M14Y4.B`P<'@[("UW96)K:70M=&5X="US=')O:V4M=VED=&@Z(#!P>"<@8V5L M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P M="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$ M8V5N=&5R/CQB/D1E8V5M8F5R)B-X03`[,S$L/"]B/CQB$$P.SPO=&0^ M#0H@/"]T$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L,#`X/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/B@S-S8\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@ M,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU4 M3U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO'0M3H\+W`^#0H@/'`@#L@+7=E M8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4+49!34E,63H@ M)U1I;65S($YE=R!2;VUA;B<[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P#L@5TE$ M3U=3.B`Q.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@ M,'!X.R`M=V5B:VET+71E>'0M$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P="!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/DUA$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P M+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$W/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XE)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XQ-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)28C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA) M5$4M4U!!0T4Z(&YO'0M6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@5&AE(&-A'!E;G-E7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'!E;G-E'0^/&1I=CX-"B`\<"!S='EL93TS M1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[(%1% M6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z M(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=) M1$]74SH@,3L@34%21TE.+51/4#H@,3AP=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@-G!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L M.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M#L@ M0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$R<'0@)U1I;65S($YE=R!2;VUA M;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,'!T.R!,151415(M4U!!0TE. M1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.SPO<#X-"B`\=&%B;&4@#L@5TE$3U=3.B`Q.R!,1514 M15(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET M+71E>'0M7)O;&P@86YD(')E;&%T960\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`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`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO M=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R M9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R M9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/"]T M$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ("=4:6UE#L@+7=E8FMI="UT97AT+7-T&5S+"!S86QE M&5S+"!V86QU92!A9&1E9"!T87AE'1087)T7S4T,C,Q9&(R7S(V,S)?-#@W,5]B M93DS7V8R93,W9&$W93$P-PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]# M.B\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA"<^#0H@ M/&(^-2X@5V%R6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@5&AE($-O;7!A;GD@;6%I;G1A:6YS(&%N(&%L;&]W M86YC92!F;W(@=V%R2!B92!I M;F-U2X@1F%C=&]R2!U;F1E2P@ M:&ES=&]R:6-A;"!A;F0-"B!A;G1I8VEP871E9"!R871E2!C;&%I;7,@;VX@=&AO6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P=#L@5TA)5$4M4U!!0T4Z(&YO#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z M(#$R<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/ M4#H@,'!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@ M,'!X.R`M=V5B:VET+71E>'0M$$P M.SPO<#X-"B`\=&%B;&4@#L@5TE$3U=3.B`Q.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4 M+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M4TE:13H@,7!T)SX-"B`\=&0^/"]T9#X- M"B`\=&0@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C M>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/B@U,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T9/ M3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]4 M5$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)- M.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[ M($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%2 M1TE.+51/4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA#L@+7=E8FMI="UT97AT+7-T#L@0T],3U(Z(')G8B@P+#`L M,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@ M34%21TE.+51/4#H@-G!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4 M+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M#L@0T], M3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[ M(%=)1$]74SH@,3L@34%21TE.+51/4#H@-G!T.R!,151415(M4U!!0TE.1SH@ M;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M#(P,4,[4F5V;VQV:6YG($-R961I="!&86-I M;&ET>28C>#(P,40[*2X@26X@1F5B2!M;V1I9FEE9"!T:&4@2`R,#$U+"!T:&4@0V]M<&%N>2!A;65N9&5D(&ET2!T:')O M=6=H($%P2!T:')O=6=H($%P6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!! M0T4Z(&YO'0M7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/&1I=CX-"B`\<"!S='EL93TS1"=-05)' M24XM0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[(%1%6%0M5%)! M3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G8B@P M+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@ M,3L@34%21TE.+51/4#H@,'!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!4 M15A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I M;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@-G!T.R!, M151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B M:VET+71E>'0M6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@3VX@2F%N=6%R>28C>$$P.S$V+"`R,#$U+"!T:&4@0V]M<&%N M>2!A;65N9&5D(&ET2`R,2PP,#`@;V8@861D:71I;VYA M;"!S<75A&EM871E M;'D@.3,L,#`P#0H@86YD(&5X=&5N9&5D('1H92!T97)M('1H2`D-RXY(&UI;&QI;VX@86YD('1H92!L86YD;&]R9"!H M87,@86=R965D#0H@=&\@8V]N=')I8G5T92!A<'!R;WAI;6%T96QY("0W,S4L M,#`P('1O=V%R9',@;&5A#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2 M;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3AP=#L@3$545$52+5-0 M04-)3D#L@+7=E8FMI="UT97AT M+7-T#L@+7=E8FMI M="UT97AT+7-T2!I#L@0T],3U(Z(')G8B@P+#`L,"D[($9/ M3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE. M+51/4#H@,3AP=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T#L@+7=E8FMI="UT97AT+7-T28C>#(P,3D[2!I=',-"B!S=&]C:VAO;&1E#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I M;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@ M3$545$52+5-004-)3D#L@+7=E M8FMI="UT97AT+7-T$$P.S,Q+"`R,#$U(&%N9"!$96-E;6)E$$P.S,Q+"`R,#$T+"!T:&4@ M0V]M<&%N>0T*(&AA9"!N;W0@97AP97)I96YC960@86YY(&UA=&5R:6%L(&QO M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-#(S M,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#<-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAA2!;06)S=')A8W1=/"]S=')O;F<^ M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]- M.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N M;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[($9/ M3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE. M+51/4#H@,'!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5. M5#H@,'!X.R`M=V5B:VET+71E>'0M#L@+7=E8FMI M="UT97AT+7-T"!E9F9E8W0@:7,@;F]T(&UA=&5R:6%L#0H@=&\@=&AE(&-O;G-O;&ED871E M9"!F:6YA;F-I86P@#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XH,30U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#QT M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C$T-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1&-E;G1E$$P.VEN8V]M928C>$$P M.RAE>'!E;G-E*3PO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP M+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP M+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@,7!X)SX- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/B@Q,3PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P M+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P M+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ("=4:6UE$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@T-3PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G M8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G M8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@ M/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.S,Q+"`R,#$U/"]B/CPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XH,30U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/"]D:78^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-#(S,61B,E\R M-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAA#L@+7=E8FMI="UT97AT M+7-T$$P.U-T;V-K(&%W87)D M('!L86YS(&%N9"!S=&]C:R!B87-E9"!C;VUP96YS871I;VX\+V(^/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z M(&YO2!I;F-E;G1I M=F4@<&QA;CPO8CX\+W`^#0H@/'`@#L@+7=E8FMI="UT97AT+7-T#(P,4,[,C`Q-"!0;&%N)B-X M,C`Q1#LI+"!W87,@861O<'1E9"!B>2!T:&4@0V]M<&%N>28C>#(P,3D[#(P,4,[,C`P,@T*(%!L86XF(W@R,#%$.RD@87,@=&AE($-O;7!A;GDF(W@R M,#$Y.W,@8F]A65E M2!P97)S;VYS("AI;F-L=61I M;F<@8V]N#L@0T],3U(Z(')G8B@P+#`L,"D[ M($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%2 M1TE.+51/4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T&5R8VES86)L92!B=70@ M6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P=#L@5TA)5$4M4U!!0T4Z(&YO#L@0T],3U(Z M(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=) M1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T$$P.S,Q+"`R,#$U+"!T:&5R92!W M97)E(#(L,3(R+#`X,R!S:&%R97,@879A:6QA8FQE(&9O<@T*(&9U='5R92!G M#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@,3AP=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T#L@ M+7=E8FMI="UT97AT+7-T7)O;&P@9&5D=6-T:6]N2!O`T*(&UO;G1H$$P.V]F#0H@96%C:"!Y96%R+CPO<#X-"B`\<"!S='EL M93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[ M(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T], M3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[ M(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T2!I#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@,3AP=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T#L@+7=E8FMI="UT97AT+7-T2!I2!E>&5C=71I=F5S#0H@86YD(&UE;6)E2!T:6UE+B!4:&4@0V]M<&%N>2!M87D@86QS;R!I;F-L M=61E(&%N(&5A&5R8VES92!P M6UE;G0@;W(@;W1H97(- M"B!R96QA=&EO;G-H:7`N/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO&5R8VES960@=V5R90T*('-U M8FIE8W0@=&\@2X@5&AE"<^#0H@1'5R:6YG('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@F M(WA!,#LS,2P@,C`Q-2!A;F0@,C`Q-"P@-2PR,#(-"B!A;F0@-2PV,C8@6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO#L@0T],3U(Z(')G8B@P+#`L,"D[($9/ M3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE. M+51/4#H@-G!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5. M5#H@,'!X.R`M=V5B:VET+71E>'0MF5S('1H92!";&%C:RU38VAO;&5S(&]P=&EO;BUP M65E#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S M($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@3$54 M5$52+5-004-)3D#L@+7=E8FMI M="UT97AT+7-T#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ("=4:6UE#L@+7=E8FMI="UT97AT+7-T$$P.TUO;G1H$$P.V5N9&5D)B-X03`[36%R M8V@F(WA!,#LS,2P\+V(^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M4TE:13H@,7!T)SX-"B`\=&0^/"]T9#X-"B`\=&0@ M8V]L$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$'!E8W1E9"!L:69E("AY96%R$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XV+C`R/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C8N,#0\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T M'!E8W1E9"!D:79I9&5N M9"!Y:65L9"@S*3PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C M>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XE)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XF M(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)28C>$$P.SPO=&0^#0H@/"]T'!E8W1E9"!V;VQA=&EL:71Y(&]F('5N9&5R;'EI;F<@$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT-SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)28C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#%P>"`G5&EM97,@ M3F5W(%)O;6%N)SL@5TE$3U=3.B`Q.R!-05)'24XM5$]0.B`Q,G!X.R!,1514 M15(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET M+71E>'0M$$P.SPO<#X-"B`\<"!S M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@ M0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA M;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,'!T.R!,151415(M4U!!0TE. M1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M#L@ M+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ("=4:6UE#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C`N-3`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T'!E8W1E9"!D:79I9&5N9"!Y M:65L9"@S*3PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C>#(P,30[)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XE)B-X03`[/"]T9#X-"B`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`R,#$U+B!4:&4@0V]M<&%N>2!A;F%L>7IE9"!T:&4-"B!V;VQA=&EL M:71Y(&]F('-E=F5R86P@<'5B;&EC('!E97(@8V]M<&%N:65S('1O('-U<'!O M#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@,3AP=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T2!O9B!S:&%R92UB87-E9"!C;VUP M96YS871I;VX@97AP96YS93PO8CX\+W`^#0H@/'`@#L@+7=E8FMI="UT97AT+7-T2!UF4-"B!E>'!E;G-E(&9O'!E;G-E(&%S6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)SL@ M0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@5$585"U44D%.4T9/4DTZ(&YO M;F4[(%=/4D0M4U!!0TE.1SH@,'!X.R!7241/5U,Z(#$[($Q%5%1%4BU34$%# M24Y'.B!N;W)M86P[(%1%6%0M24Y$14Y4.B`P<'@[("UW96)K:70M=&5X="US M=')O:V4M=VED=&@Z(#!P>"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,"!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4 M+49!34E,63H@)U1I;65S($YE=R!2;VUA;B$$P M.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G M8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.TUA6QE M/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4+49!34E,63H@)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4+49!34E,63H@ M)U1I;65S($YE=R!2;VUA;B<[($)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@ M,7!T('-O;&ED.R!724142#H@-#@N-G!T)SX-"B`\8CXH:6X@=&AO=7-A;F1S M*3PO8CX\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G M8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C(S/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CDR M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF M(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C(Q-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#XX.3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/CDT/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE M/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M&5S/&)R/CPO"!$:7-C;&]S=7)E(%M!8G-T M&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\9&EV/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA) M5$4M4U!!0T4Z(&YO'0M6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@5V4@ M;W!E"!J=7)I2!B92!S=6)J96-T('1O(%4N4RX@:6YC;VUE('1A>"X@5&\- M"B!D871E+"!W92!H879E(&EN8W5R"!A"!P2!R871E"!E>'!E;G-E('1O(&1A=&4- M"B!P#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P M<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@ M,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T$$P.S,Q+"`R,#$T+"!T:&4@0V]M<&%N>28C>#(P,3D[&EM871E;'D@)#(W+C4@;6EL;&EO;BX-"B!4:&4@0V]M<&%N M>2!I2!M86EN=&%I;G,@82`Q,#`E('9A;'5A=&EO;@T*(&%L;&]W86YC92!T M;R!R961U8V4@=&AE(&-A`T*(&%S2!W:6QL M(&-O;G1I;G5E('1O(&UA:6YT86EN(&$@9G5L;`T*('9A;'5A=&EO;B!A;&QO M=V%N8V4@9F]R('1H;W-E('1A>"!A6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M M4U!!0T4Z(&YO'0M3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S M-V1A-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D M8C)?,C8S,E\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/&1I=CX- M"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-% M.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE M=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3AP=#L@3$545$52 M+5-004-)3D#L@+7=E8FMI="UT M97AT+7-T#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@-G!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L M.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M2!T:&4@=V5I9VAT960@879E28C>#(P,3D["<^#0H@5&AE(&-O;7!O;F5N=',@;V8@;F5T(&QO#L@0T],3U(Z(')G8B@P+#`L M,"D[($9/3E0Z(#$R<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@ M34%21TE.+51/4#H@,'!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4 M+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.SPO<#X-"B`\=&%B;&4@#L@5TE$3U=3.B`Q.R!,151415(M4U!!0TE.1SH@;F]R M;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.TUO;G1H$$P.T5N9&5D)B-X M03`[36%R8V@F(WA!,#LS,2P\+V(^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B M;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@ M/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C M>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/B@Q+#(S.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE M6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R M9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R M9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!T)SX-"B`\=&0^/"]T9#X-"B`\=&0@8V]L$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,L M-C(W/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/ M3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@&-L=61E9"!F#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$R<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@,'!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L M.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.SPO<#X-"B`\=&%B;&4@#L@5TE$3U=3.B`Q.R!,151415(M4U!!0TE. M1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.TUO;G1H$$P.T5N M9&5D)B-X03`[36%R8V@F(WA!,#LS,2P\+V(^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/"]T6QE M/3-$)T9/3E0M4TE:13H@,7!T)SX-"B`\=&0^/"]T9#X-"B`\=&0@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE M6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-#(S,61B M,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#<-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAA'0@0FQO8VL@6T%B'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$#L@+7=E8FMI="UT97AT M+7-T2!M86EN=&%I;G,-"B!S=6)S=&%N=&EA M;&QY(&%L;"!O9B!I=',@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT2!M87)K970@:6YS M=')U;65N=',N(%1O#0H@;6%N86=E(&%C8V]U;G1S(')E8V5I=F%B;&4@8W)E M9&ET(')I0T*(&5V86QU871E M6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P M<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@ M,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I M;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@ M3$545$52+5-004-)3D#L@+7=E M8FMI="UT97AT+7-T2!D M;V5S(&YO="!H879E(&%N>2!O9F8M8F%L86YC92!S:&5E="!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2 M;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@-G!T.R!,151415(M4U!! M0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M M7-T96US+"!T:&4@;6%R:V5T(&QE861I;F<@<')O=FED97(@;V8@<&%L M;2UV96EN(&)A2!S=7!P;W)T#(P,3D[2!S;VQU=&EO;G,@=&AA="!I;F-R96%S92!P2P@96YA8FQE('!A=&EE;G0@96YG86=E;65N="P@86YD(&EM<')O=F4@ M<&%T:65N=`T*('-A9F5T>2X@56YD97(@=&AE('1E&EM871E;'D@)#$Y M+C$@;6EL;&EO;B!I;B!C87-H(&%T(&-L;W-I;F2!S:&]R=&9A;&P@:6X@2%0@4WES M=&5M)B-X,C`Q.3MS('=O2P@5&AE($-O;7!A;GD@=VEL;"!P87D@ M=7`@=&\@)#$N.0T*(&UI;&QI;VX@:6X@6UE M;G1S('1W;R!Y96%R&-E6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO'0M#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2 M;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@-G!T.R!,151415(M4U!! M0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M M0T*(&%C8V5P=&5D(&EN('1H92!5;FET960@ M4W1A=&5S(&]F($%M97)I8V$@*"8C>#(P,4,[52Y3+B!'04%0)B-X,C`Q1#LI M+@T*(%1H92!#;VUP86YY(&ES('-U8FIE8W0@=&\@82!N=6UB97(@;V8@2!I;F1I=FED=6%L6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M M4U!!0T4Z(&YO'0M$$P.VUO;G1H"<^#0H@ M5&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N M=',@:6YC;'5D92!T:&4-"B!A8V-O=6YT2!A;F0@ M:71S('=H;VQL>2!O=VYE9"!S=6)S:61I87)I97,L#0H@26UP2!B86QA M;F-E6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO M'0M M#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@ M)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@-G!T M.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M M=V5B:VET+71E>'0M#(P,40[*2P@86YD(&]N(&$@8F%S M:7,@2!C;VYS:7-T96YT('=I=&@-"B!T:&4@875D:71E M9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@;V8@=&AE($-O M;7!A;GD@87,@;V8-"B!A;F0@9F]R('1H92!F:7-C86P@>65A$$P.S,Q+"`R,#$T+B!!8V-O2P-"B!T:&5Y(&1O M(&YO="!I;F-L=61E(&%L;"!O9B!T:&4@:6YF;W)M871I;VX@86YD(&9O;W1N M;W1E0T*(&]T:&5R(&9U='5R92!Y96%R+CPO M<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-0 M04-%.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-) M3D#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S M($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@3$54 M5$52+5-004-)3D#L@+7=E8FMI M="UT97AT+7-T2!5+E,N($=!05`N M(%1H90T*(&%C8V]M<&%N>6EN9R!C;VYD96YS960@8V]N$$P.S$Q+"`R M,#$U+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=( M251%+5-004-%.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$ M+5-004-)3D#L@0T],3U(Z(')G8B@P+#`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`^#0H@/'`@#L@+7=E M8FMI="UT97AT+7-T#(P,40[("A4;W!I8R`V,#8I("A!4U4@,C`Q-"TP.2DN($%3 M50T*(#(P,30M,#D@;W5T;&EN97,@82!S:6YG;&4@8V]M<')E:&5N$$P.S$L(#(P,34L('1H92!&05-"('9O M=&5D#0H@=&\@<')O<&]S92!A(&1E;&%Y(&EN('1H92!E9F9E8W1I=F4@9&%T M92!O9B!T:&ES($%352!F;W(@2!A M9&]P=&EO;@T*('!E$$P.S$U+"`R,#$V+B!4:&ES(&YE=R!G=6ED86YC92!IF5D+B!4:&4@0V]M<&%N>2!I3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y M,U]F,F4S-V1A-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAA M6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@ M)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)SL@0D]21$52+4-/3$Q! M4%-%.B!C;VQL87!S93L@5$585"U44D%.4T9/4DTZ(&YO;F4[(%=/4D0M4U!! M0TE.1SH@,'!X.R!7241/5U,Z(#$[($Q%5%1%4BU34$%#24Y'.B!N;W)M86P[ M(%1%6%0M24Y$14Y4.B`P<'@[("UW96)K:70M=&5X="US=')O:V4M=VED=&@Z M(#!P>"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS M1#DR)2!A;&EG;CTS1&-E;G1E$$P.TUA$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P M="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$ M8V5N=&5R/CQB/DQE=F5L)B-X03`[,CPO8CX\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4 M:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/"]T2!M87)K970@ M9G5N9',\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ("=4:6UE#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$R<'0@ M)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,'!T M.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M M=V5B:VET+71E>'0M$$P.SPO<#X- M"B`\=&%B;&4@#L@ M5TE$3U=3.B`Q.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5. M5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.S,Q+"`R,#$T/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M M4TE:13H@.'!T.R!&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;B<[($)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED M.R!724142#H@-#@N-G!T)SX-"B`\8CXH:6X@=&AO=7-A;F1S*3PO8CX\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@ M,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P M.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G M8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@ M/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE M$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CDW/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF M(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C8S,CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XV,S(\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^ M#0H@/"]T'0^/&1I=CX- M"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-% M.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE M=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@3$545$52 M+5-004-)3D#L@+7=E8FMI="UT M97AT+7-T#L@+7=E8FMI="UT97AT M+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE#L@+7=E M8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@ M.'!T.R!&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)T9/3E0M4TE:13H@.'!T.R!&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA M;B<[($)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED.R!72414 M2#H@-#@N-G!T)SX-"B`\8CXH:6X@=&AO=7-A;F1S*3PO8CX\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L M,#`X/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE'!E;G-E$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(Q M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@S-S8\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G M8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G M8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1% M4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/"]T3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM M0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[(%1%6%0M5%)!3E-& M3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L M,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@ M34%21TE.+51/4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS M1"=&3TY4+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ("=4:6UE#L@+7=E8FMI="UT M97AT+7-T$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ-SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)28C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M#L@ M0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#%P>"`G5&EM97,@3F5W(%)O;6%N M)SL@5TE$3U=3.B`Q.R!-05)'24XM5$]0.B`Q.'!X.R!,151415(M4U!!0TE. M1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.SPO<#X-"B`\+V1I=CX\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'!E;G-E6%B;&5S(&%N9"!! M8V-R=6%L'!E;G-E'0^/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]4 M5$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)- M.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[ M($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%2 M1TE.+51/4#H@-G!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E. M1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$R<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@,'!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L M.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.SPO<#X-"B`\=&%B;&4@#L@5TE$3U=3.B`Q.R!,151415(M4U!!0TE. M1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M7)O;&P@86YD(')E;&%T960\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`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`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/"]T M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ("=4:6UE#L@+7=E8FMI="UT97AT+7-T&5S+"!S86QE&5S+"!V86QU92!A9&1E9"!T87AE'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2!O9B!!;&QO=V%N8V4@9F]R(%=A6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M M4U!!0T4Z(&YO'0M#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$R<'0@)U1I;65S M($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,'!T.R!,1514 M15(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET M+71E>'0M$$P.SPO<#X-"B`\=&%B M;&4@#L@5TE$3U=3 M.B`Q.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X M.R`M=V5B:VET+71E>'0M$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@8V]L6QE M/3-$)T9/3E0M4TE:13H@,7!T)SX-"B`\=&0^/"]T9#X-"B`\=&0@8V]L$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@U M,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M*28C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G M8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G M8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@ M/"]T86)L93X-"B`\8G(@8VQA3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A M-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)? M,C8S,E\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\'0^/&1I=CX-"B`\<"!S='EL M93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[ M(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T], M3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[ M(%=)1$]74SH@,3L@34%21TE.+51/4#H@-G!T.R!,151415(M4U!!0TE.1SH@ M;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M&5S+"!A#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z M(#$R<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/ M4#H@,'!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@ M,'!X.R`M=V5B:VET+71E>'0M$$P M.SPO<#X-"B`\=&%B;&4@#L@5TE$3U=3.B`Q.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4 M+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M3QB$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R M9V(H,"PP+#`I(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M8V5N=&5R/@T*(#QB/D%F9F5C=&5D)B-X03`[;&EN928C>$$P.VET96TF(WA! M,#MI;B8C>$$P.W1H93QB$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/B@Q-#4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,3`P/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE M6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C0U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/B@S-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1C96YT97(^#0H@3W1H97(F(WA!,#MI;F-O;64F(WA!,#LH97AP96YS92D\ M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#PO='(^#0H@/"]T86)L93X-"B`-"B`-"B`\+V1I=CX\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^ M/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251% M+5-004-%.B!N;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-0 M04-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I M;65S($YE=R!2;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@ M3$545$52+5-004-)3D#L@+7=E M8FMI="UT97AT+7-T#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ("=4:6UE#L@+7=E8FMI="UT97AT+7-T$$P.TUO;G1H$$P.V5N9&5D)B-X03`[ M36%R8V@F(WA!,#LS,2P\+V(^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M4TE:13H@,7!T)SX-"B`\=&0^/"]T9#X-"B`\ M=&0@8V]L$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$'!E8W1E9"!L:69E("AY96%R$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XV+C`R/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/C8N,#0\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@ M/"]T'!E8W1E9"!D:79I M9&5N9"!Y:65L9"@S*3PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/B8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XE)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XF(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)28C>$$P.SPO=&0^#0H@/"]T'!E8W1E9"!V;VQA=&EL:71Y(&]F('5N9&5R;'EI;F<@$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT-SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)28C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#%P>"`G5&EM M97,@3F5W(%)O;6%N)SL@5TE$3U=3.B`Q.R!-05)'24XM5$]0.B`Q,G!X.R!, M151415(M4U!!0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B M:VET+71E>'0M$$P.SPO<#X-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N M;W)M86P[(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T],3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2 M;VUA;B<[(%=)1$]74SH@,3L@34%21TE.+51/4#H@,'!T.R!,151415(M4U!! M0TE.1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M M#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ("=4:6UE#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C`N-3`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T M'!E8W1E9"!D:79I9&5N M9"!Y:65L9"@S*3PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B8C>#(P,30[)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XE)B-X03`[/"]T9#X-"B`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`R,#$U+B!4:&4@0V]M<&%N>2!A;F%L>7IE9"!T:&4-"B!V;VQA M=&EL:71Y(&]F('-E=F5R86P@<'5B;&EC('!E97(@8V]M<&%N:65S('1O('-U M<'!O'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO'0M6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!! M0T4Z(&YO"<^#0H@)B-X03`[/"]P/@T*(#QT86)L M92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)SL@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@5$58 M5"U44D%.4T9/4DTZ(&YO;F4[(%=/4D0M4U!!0TE.1SH@,'!X.R!7241/5U,Z M(#$[($Q%5%1%4BU34$%#24Y'.B!N;W)M86P[(%1%6%0M24Y$14Y4.B`P<'@[ M("UW96)K:70M=&5X="US=')O:V4M=VED=&@Z(#!P>"<@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#6QE/3-$)T9/3E0M M4TE:13H@.'!T.R!&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B M;W1T;VT@8V]L$$P.TUA6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4+49!34E, M63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M4TE:13H@.'!T M.R!&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B<[($)/4D1%4BU"3U14 M3TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED.R!724142#H@-#@N-G!T)SX-"B`\ M8CXH:6X@=&AO=7-A;F1S*3PO8CX\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI9VX],T1B M;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!T('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C(S/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@ M/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/CDR/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(Q-CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XX.3PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\ M+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/CDT/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z M(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/"]T'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2!O9B!#;VUP;VYE;G1S(&]F($YE="!,;W-S('!E'0^/&1I=CX-"B`\<"!S='EL M93TS1"=-05)'24XM0D]45$]-.B`P<'0[(%=(251%+5-004-%.B!N;W)M86P[ M(%1%6%0M5%)!3E-&3U)-.B!N;VYE.R!73U)$+5-004-)3D#L@0T], M3U(Z(')G8B@P+#`L,"D[($9/3E0Z(#$P<'0@)U1I;65S($YE=R!2;VUA;B<[ M(%=)1$]74SH@,3L@34%21TE.+51/4#H@,3)P=#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-T6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P=#L@5TA)5$4M4U!!0T4Z(&YO"<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)SL@0D]2 M1$52+4-/3$Q!4%-%.B!C;VQL87!S93L@5$585"U44D%.4T9/4DTZ(&YO;F4[ M(%=/4D0M4U!!0TE.1SH@,'!X.R!7241/5U,Z(#$[($Q%5%1%4BU34$%#24Y' M.B!N;W)M86P[(%1%6%0M24Y$14Y4.B`P<'@[("UW96)K:70M=&5X="US=')O M:V4M=VED=&@Z(#!P>"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!W:61T:#TS1#$$P.S,Q+#PO8CX\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@V+#8Y.3PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.S@L,S`U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT M"<^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ("=4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C(S+#@V.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS M+#8R-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G M8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G M8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M4TE: M13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L M,"D@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1% M4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T&-L=61E9"!F#L@0T],3U(Z(')G M8B@P+#`L,"D[($9/3E0Z(#$R<'0@)U1I;65S($YE=R!2;VUA;B<[(%=)1$]7 M4SH@,3L@34%21TE.+51/4#H@,'!T.R!,151415(M4U!!0TE.1SH@;F]R;6%L M.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.SPO<#X-"B`\=&%B;&4@#L@5TE$3U=3.B`Q.R!,151415(M4U!!0TE. M1SH@;F]R;6%L.R!415A4+4E.1$5.5#H@,'!X.R`M=V5B:VET+71E>'0M$$P.TUO;G1H$$P.T5N M9&5D)B-X03`[36%R8V@F(WA!,#LS,2P\+V(^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/"]T6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ("=4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M("=4:6UE$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT+#DU,3PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS+#8P-3PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XS-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XU-SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X M03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XQ,C`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C M>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/C$S+#DW,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT M"<^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C0L.3@V/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$W+#6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L M,"D@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP M+#`I(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\ M+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@=&5R;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,3(@;6]N M=&AS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7-T96US(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\F%T:6]N(&%N9"!.871U'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^,B!Y96%R65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!-87)K M970@1G5N9',@6TUE;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!-87)K M970@1G5N9',@6TUE;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-#(S M,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#<-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A M-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)? M,C8S,E\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'!E;G-E'!E;G-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#<-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^4')I;64@'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'1E;F1E9"!M M871U2!D871E(&9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!M871U2!D871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A M-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)? M,C8S,E\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-#(S,61B,E\R M-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#<-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAA2!3:&%R M92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A65A6EE;&0\+W1D/@T*("`@("`@("`\=&0@ M8VQA6EN9R!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S65A6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'!E8W1E9"!V;VQA=&EL:71Y(&]F('5N9&5R;'EI;F<@7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6UE;G0@07=A'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#

'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!3:&%R M92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q M,#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S M,E\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&5S("T@061D:71I;VYA;"!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S65A"!A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#<- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S,E\T M.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!O9B!#;VUP M;VYE;G1S(&]F($YE="!,;W-S('!E'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\U-#(S,61B,E\R-C,R7S0X-S%?8F4Y,U]F,F4S-V1A-V4Q,#<-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-30R,S%D8C)?,C8S,E\T.#'0O:'1M;#L@8VAA2!O9B!#;VUM;VX@4W1O M8VL@17%U:79A;&5N=',@17AC;'5D960@9G)O;2!#;VUP=71A=&EO;B!O9B!$ M:6QU=&5D($YE="!,;W-S('!E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-L=61E9"!F&-L=61E9"!F'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-L=61E9"!F'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$&-L=61E9"!F'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&-L=61E M9"!F'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC XML 29 R43.htm IDEA: XBRL DOCUMENT v2.4.1.9
Concentration of Risk and Off-Balance Sheet Risk - Additional Information (Detail)
3 Months Ended 12 Months Ended
Mar. 31, 2015
Customer
Mar. 31, 2014
Customer
Dec. 31, 2014
Customer
Revenues [Member]      
Concentration Risk [Line Items]      
Number of customers or resellers accounted for 10% or more of revenues or accounts receivable 0impr_ConcentrationRiskNumberOfCustomers
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
0impr_ConcentrationRiskNumberOfCustomers
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
 
Accounts Receivable [Member]      
Concentration Risk [Line Items]      
Number of customers or resellers accounted for 10% or more of revenues or accounts receivable 0impr_ConcentrationRiskNumberOfCustomers
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
  0impr_ConcentrationRiskNumberOfCustomers
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember

XML 30 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurements - Additional Information (Detail) (USD $)
Mar. 31, 2015
Dec. 31, 2014
Fair Value, Measurements, Non-recurring [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Fair value measurements on a non-recurring basis $ 0us-gaap_FairValueNetAssetLiability
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsNonrecurringMember
$ 0us-gaap_FairValueNetAssetLiability
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsNonrecurringMember
Validus Medical Systems [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Contingent liability $ 9,800,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= impr_ValidusMember
 
XML 31 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Fair Value Measurements on a Recurring Basis [Member]      
Liabilities      
Contingent consideration $ 653us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
$ 632us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
 
Money Market Funds [Member] | Fair Value Measurements on a Recurring Basis [Member]      
Assets      
Cash equivalents fair value on a recurring 30,187us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByAssetClassAxis
= us-gaap_MoneyMarketFundsMember
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
33,184us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByAssetClassAxis
= us-gaap_MoneyMarketFundsMember
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
 
Certificates of Deposit [Member] | Fair Value Measurements on a Recurring Basis [Member]      
Assets      
Cash equivalents fair value on a recurring 97us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByAssetClassAxis
= us-gaap_CertificatesOfDepositMember
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
97us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByAssetClassAxis
= us-gaap_CertificatesOfDepositMember
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
 
Level 1 [Member] | Money Market Funds [Member] | Fair Value Measurements on a Recurring Basis [Member]      
Assets      
Cash equivalents fair value on a recurring 30,187us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByAssetClassAxis
= us-gaap_MoneyMarketFundsMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
33,184us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByAssetClassAxis
= us-gaap_MoneyMarketFundsMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
 
Level 2 [Member] | Certificates of Deposit [Member] | Fair Value Measurements on a Recurring Basis [Member]      
Assets      
Cash equivalents fair value on a recurring 97us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByAssetClassAxis
= us-gaap_CertificatesOfDepositMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
97us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByAssetClassAxis
= us-gaap_CertificatesOfDepositMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
 
Level 3 [Member]      
Liabilities      
Contingent consideration 653us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
632us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
1,008us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
Level 3 [Member] | Fair Value Measurements on a Recurring Basis [Member]      
Liabilities      
Contingent consideration $ 653us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
$ 632us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
 
XML 32 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurements - Reconciliation of Contingent Liability Measured at Fair Value (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Business Acquisition, Contingent Consideration [Line Items]      
Revaluation recognized in general and administrative expenses in the corresponding statements of operations $ (21)us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 $ (45)us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1  
Level 3 [Member]      
Business Acquisition, Contingent Consideration [Line Items]      
Beginning balance 632us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
1,008us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
1,008us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
Revaluation recognized in general and administrative expenses in the corresponding statements of operations 21us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
  (376)us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
Ending balance $ 653us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
  $ 632us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
XML 33 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurements - Significant Unobservable Inputs Used in Valuation of Contingent Liability (Detail) (Level 3 [Member])
3 Months Ended 12 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Level 3 [Member]
   
Fair Value Inputs, Assets, Quantitative Information [Line Items]    
Discount Rate 17.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
17.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
XML 34 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9
Organization and Business
3 Months Ended
Mar. 31, 2015
Accounting Policies [Abstract]  
Organization and Business

1. Organization and business

(a) Description of business

Imprivata, Inc. (the “Company”) is a leading provider of healthcare IT security solutions that provide authentication management, fast access to patient information, and secure communications technologies to the healthcare industry. The Company’s flagship product Imprivata OneSign, is an integrated enterprise single sign-on, authentication management and workflow automation platform that addresses multiple security and productivity challenges faced by hospitals and other healthcare organizations. By enabling fast, secure access to healthcare information technology systems, the Company believes that its solutions save clinicians significant time to focus on patient care, increase their productivity and satisfaction, and help healthcare organizations comply with privacy and security regulations.

The Company was incorporated in the State of Delaware in May 2001.

On June 30, 2014, the Company completed its initial public offering (“IPO”) and is listed on the New York Stock Exchange (“NYSE”) under the ticker symbol “IMPR.”

(b) Basis of presentation and principles of consolidation

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company is subject to a number of risks. Principal among these risks are dependence on key individuals, competition from substitute products and larger companies, the successful development and marketing of its products, and recruitment of key personnel.

Management believes the Company has sufficient cash and availability under its letter of credit to sustain operations through at least the next 12 months.

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited. All intercompany balances and transactions have been eliminated in consolidation.

(c) Use of estimates

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP applicable to interim periods, under the rules and regulations of the United States Securities and Exchange Commission (“SEC”), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended December 31, 2014. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for the fair presentation of interim information have been included. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015, for any other interim period or for any other future year.

The consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements at that date, but does not include all of the disclosures required by U.S. GAAP. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s 2014 Annual Report on Form 10-K filed with the SEC on March 11, 2015.

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited, as well as two branch offices. All intercompany balances and transactions have been eliminated in consolidation. In the first quarter of 2014, the Company completed the closure of its UK branch office. In the first quarter of 2015, the Company closed its Netherlands branch office.

(d) Foreign currency

The foreign subsidiaries and branches use the local currency as the functional currency. The Company translates the assets and liabilities of its foreign operations into U.S. dollars based on the rates of exchange in effect as of the balance sheet date. Revenues and expenses are translated into U.S. dollars using average exchange rates for each period. The resulting adjustments from the translation process are included in accumulated other comprehensive (loss) income in the accompanying consolidated balance sheets.

 

Certain transactions of the Company are settled in foreign currency, and are thus translated to U.S. dollars at the rate of exchange in effect at the end of each month. Gains (losses) resulting from the translation are included in foreign exchange gains (losses) in the accompanying consolidated statements of operations.

(e) Subsequent event

On April 30, 2015, the Company announced the acquisition of HT Systems, the market leading provider of palm-vein based biometric patient identification systems, to enter into the emerging patient identification market. The acquisition of HT Systems and its PatientSecure biometric patient identification technology supports Imprivata’s long-term vision to be the leading provider of healthcare IT security solutions that increase provider productivity, enable patient engagement, and improve patient safety. Under the terms of the transaction, the Company paid approximately $19.1 million in cash at closing, of which $2 million was deposited into an escrow fund to secure certain obligations of the selling members of HT Systems to indemnify us and to pay us the amount of any shortfall in HT System’s working capital as of the closing date. Additionally, The Company will pay up to $1.9 million in retention-based payments two years from closing plus up to $5.0 million based on achieving certain sales targets over the two-year period following the transaction. The Company is required to allocate the purchase price to the estimated fair value of the tangible and identifiable intangible assets acquired and liabilities assumed. The excess of the purchase price over those fair values is recorded as goodwill. The Company is in the process of finalizing the valuation of the assets acquired and liabilities assumed.

XML 35 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Payables and Accruals [Abstract]    
Accrued payroll and related $ 2,883us-gaap_AccruedSalariesCurrent $ 7,839us-gaap_AccruedSalariesCurrent
Accrued taxes 906us-gaap_AccruedIncomeTaxesCurrent 1,144us-gaap_AccruedIncomeTaxesCurrent
Other accrued expenses 2,843us-gaap_OtherAccruedLiabilitiesCurrent 1,582us-gaap_OtherAccruedLiabilitiesCurrent
Total $ 6,632us-gaap_AccruedLiabilitiesCurrent $ 10,565us-gaap_AccruedLiabilitiesCurrent
XML 36 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Income Taxes - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Income Tax Disclosure [Abstract]    
U.S. federal tax provisions $ 0us-gaap_CurrentFederalTaxExpenseBenefit  
Valuation allowance related to income taxes   27,500,000us-gaap_DeferredTaxAssetsValuationAllowance
Cumulative loss position in United States   3 years
Deferred tax assets, valuation allowance percentage   100.00%impr_DeferredTaxAssetsValuationAllowancePercentage
Deferred tax assets   0us-gaap_DeferredTaxAssetsNet
Liability for uncertain tax positions $ 0impr_LiabilityForUncertainTaxPositions $ 0impr_LiabilityForUncertainTaxPositions
XML 37 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 75,377us-gaap_CashAndCashEquivalentsAtCarryingValue $ 78,524us-gaap_CashAndCashEquivalentsAtCarryingValue
Accounts receivable, net of allowances 19,073us-gaap_AccountsReceivableNetCurrent 25,335us-gaap_AccountsReceivableNetCurrent
Prepaid expenses and other current assets 4,693us-gaap_PrepaidExpenseAndOtherAssetsCurrent 3,516us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 99,143us-gaap_AssetsCurrent 107,375us-gaap_AssetsCurrent
Property and equipment, net 7,286us-gaap_PropertyPlantAndEquipmentNet 7,640us-gaap_PropertyPlantAndEquipmentNet
Goodwill 1,560us-gaap_Goodwill 1,560us-gaap_Goodwill
Intangible assets, net 1,407us-gaap_IntangibleAssetsNetExcludingGoodwill 1,499us-gaap_IntangibleAssetsNetExcludingGoodwill
Other assets 98us-gaap_OtherAssetsNoncurrent 105us-gaap_OtherAssetsNoncurrent
Total assets 109,494us-gaap_Assets 118,179us-gaap_Assets
Current liabilities:    
Accounts payable 2,929us-gaap_AccountsPayableCurrent 2,498us-gaap_AccountsPayableCurrent
Accrued expenses and other current liabilities 6,632us-gaap_AccruedLiabilitiesCurrent 10,565us-gaap_AccruedLiabilitiesCurrent
Current portion of capital lease obligations and long-term debt 571us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent 625us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent
Current portion of other long-term liabilities 196us-gaap_OtherLiabilitiesCurrent 288us-gaap_OtherLiabilitiesCurrent
Current portion of deferred revenue 33,102us-gaap_DeferredRevenueCurrent 33,120us-gaap_DeferredRevenueCurrent
Current portion of contingent purchase price liability 236us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent 152us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent
Total current liabilities 43,666us-gaap_LiabilitiesCurrent 47,248us-gaap_LiabilitiesCurrent
Deferred revenue, net of current portion 4,004us-gaap_DeferredRevenueNoncurrent 4,021us-gaap_DeferredRevenueNoncurrent
Capital lease obligations, long-term debt and royalty obligations, net of current portion 490us-gaap_LongTermDebtAndCapitalLeaseObligations 619us-gaap_LongTermDebtAndCapitalLeaseObligations
Other long-term liabilities, net of current portion 1,634us-gaap_OtherLiabilitiesNoncurrent 1,535us-gaap_OtherLiabilitiesNoncurrent
Contingent purchase price liability, net of current portion 417us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent 480us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent
Total liabilities 50,211us-gaap_Liabilities 53,903us-gaap_Liabilities
Commitments and contingencies (Note 7)      
Stockholders' equity:    
Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized; none issued at March 31, 2015 and December 31, 2014      
Common stock, $0.001 par value, 250,000,000 shares authorized at March 31, 2015 and December 31, 2014; 23,979,778 and 23,742,467 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively 24us-gaap_CommonStockValue 24us-gaap_CommonStockValue
Additional paid-in capital 173,654us-gaap_AdditionalPaidInCapitalCommonStock 171,903us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated other comprehensive loss (145)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax (100)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Accumulated deficit (114,250)us-gaap_RetainedEarningsAccumulatedDeficit (107,551)us-gaap_RetainedEarningsAccumulatedDeficit
Total stockholders' equity 59,283us-gaap_StockholdersEquity 64,276us-gaap_StockholdersEquity
Total liabilities and stockholders' equity $ 109,494us-gaap_LiabilitiesAndStockholdersEquity $ 118,179us-gaap_LiabilitiesAndStockholdersEquity
XML 38 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Stockholders Equity (USD $)
In Thousands, except Share data
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2014 $ 64,276us-gaap_StockholdersEquity $ 24us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
$ 171,903us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
$ (100)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
$ (107,551)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
Beginning balance, Shares at Dec. 31, 2014   23,742,000us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
     
Exercise of common stock options 367us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised   367us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
   
Exercise of common stock options, Shares   178,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
     
Stock-based compensation expense 701us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue   701us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
   
Employee stock purchase plan 684us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan 1us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
683us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
   
Employee stock purchase plan, Share   59,000us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
     
Common stock grants (1)us-gaap_StockIssuedDuringPeriodValueNewIssues (1)us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
     
Common stock grants, Shares   1,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
     
Net loss (6,699)us-gaap_NetIncomeLoss       (6,699)us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
Other comprehensive income (loss) (45)us-gaap_OtherComprehensiveIncomeLossBeforeTax     (45)us-gaap_OtherComprehensiveIncomeLossBeforeTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
 
Ending balance at Mar. 31, 2015 $ 59,283us-gaap_StockholdersEquity $ 24us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
$ 173,654us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
$ (145)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
$ (114,250)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
Ending balance, Shares at Mar. 31, 2015   23,980,000us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
     
XML 39 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Commitments and Contingencies - Additional Information (Detail) (USD $)
0 Months Ended
Jan. 16, 2015
Jan. 16, 2015
Leases Disclosure [Line Items]    
Additional rent expense $ 7,900,000us-gaap_OperatingLeasesRentExpenseContingentRentals  
Landlord contribution for leasehold improvement $ 735,000us-gaap_LeaseholdImprovementsGross $ 735,000us-gaap_LeaseholdImprovementsGross
Lease agreement amendment Jan. 16, 2015  
Massachusetts [Member]    
Leases Disclosure [Line Items]    
Operating lease office space square feet 21,000impr_AdditionalOfficeSpaceUnderLeaseArrangement
/ us-gaap_StatementGeographicalAxis
= stpr_MA
21,000impr_AdditionalOfficeSpaceUnderLeaseArrangement
/ us-gaap_StatementGeographicalAxis
= stpr_MA
Operating lease office space square feet 93,000impr_NumberOfSquareFeetOfLeasedOffice
/ us-gaap_StatementGeographicalAxis
= stpr_MA
93,000impr_NumberOfSquareFeetOfLeasedOffice
/ us-gaap_StatementGeographicalAxis
= stpr_MA
XML 40 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Accrued Expenses and Other Current Liabilities (Tables)
3 Months Ended
Mar. 31, 2015
Payables and Accruals [Abstract]  
Summary of Accrued Expenses and Other Current Liabilities

The following table presents the details of the Company’s accrued expenses and other current liabilities:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Accrued payroll and related

   $ 2,883       $ 7,839   

Accrued taxes (1)

     906         1,144   

Other accrued expenses

     2,843         1,582   
  

 

 

    

 

 

 
$ 6,632    $ 10,565   
  

 

 

    

 

 

 

 

(1) Accrued taxes consist of accruals for foreign and state taxes, sales and use taxes, value added taxes due in foreign jurisdictions and franchise taxes.
XML 41 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9
Accumulated Other Comprehensive Loss - Schedule of Changes in Accumulated Other Comprehensive Loss Before Taxes (Detail) (Accumulated Translation Adjustment [Member], USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Accumulated Translation Adjustment [Member]
   
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Beginning balance $ (100)us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
$ (145)us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
Other comprehensive loss (11)us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
(100)us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
Amounts reclassified from accumulated other comprehensive income:    
Other income (expense) (34)us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
145us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
Net current-period other comprehensive loss (45)us-gaap_OtherComprehensiveIncomeLossNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
45us-gaap_OtherComprehensiveIncomeLossNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
Ending balance $ (145)us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
$ (100)us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedTranslationAdjustmentMember
XML 42 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
Accumulated Other Comprehensive Loss (Tables)
3 Months Ended
Mar. 31, 2015
Equity [Abstract]  
Schedule of Changes in Accumulated Other Comprehensive Loss Before Taxes

The following table presents the changes in accumulated other comprehensive loss before taxes, as the tax effect is not material to the consolidated financial statements:

 

(in thousands)

   Foreign
Currency
Translation
Adjustments
     Affected line item in the
statement where net
income is presented

Balance at January 1, 2014

     (145   

Other comprehensive loss

     (100   

Amounts reclassified from accumulated other comprehensive income: Closure of foreign branch

     145       Other income (expense)
  

 

 

    

Net current-period other comprehensive loss

  45   
  

 

 

    

Balance at December 31, 2014

  (100

Other comprehensive loss

  (11

Amounts reclassified from accumulated other comprehensive income:

Closure of foreign branch

  (34 Other income (expense)
  

 

 

    

Net current-period other comprehensive loss

  (45
  

 

 

    

Balance at March 31, 2015

$ (145
  

 

 

    
XML 43 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 44 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash flows from operating activities:    
Net loss $ (6,699)us-gaap_NetIncomeLoss $ (7,067)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 780us-gaap_DepreciationAndAmortization 695us-gaap_DepreciationAndAmortization
Stock-based compensation 701us-gaap_ShareBasedCompensation 298us-gaap_ShareBasedCompensation
Loss on disposal of fixed assets 14us-gaap_GainLossOnDispositionOfAssets1 12us-gaap_GainLossOnDispositionOfAssets1
Change in value of contingent purchase price liability 21us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 45us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Changes in operating assets and liabilities:    
Accounts receivable 6,262us-gaap_IncreaseDecreaseInAccountsReceivable 6,264us-gaap_IncreaseDecreaseInAccountsReceivable
Prepaid expenses and other current assets (857)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (330)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Deferred revenue (35)us-gaap_IncreaseDecreaseInDeferredRevenue (410)us-gaap_IncreaseDecreaseInDeferredRevenue
Accounts payable 412us-gaap_IncreaseDecreaseInAccountsPayable (1,783)us-gaap_IncreaseDecreaseInAccountsPayable
Accrued expenses and other current liabilities (4,145)us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities (3,367)us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
Other liabilities 5us-gaap_IncreaseDecreaseInOtherOperatingLiabilities (62)us-gaap_IncreaseDecreaseInOtherOperatingLiabilities
Net cash used in operating activities (3,541)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (5,705)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:    
Purchases of property and equipment (371)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (655)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Net cash used in investing activities (371)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (655)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:    
Deferred offering costs   (1,154)us-gaap_PaymentOfFinancingAndStockIssuanceCosts
Repayments for capital lease obligations, long-term debt and other (180)us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities (220)us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities
Proceeds from employee stock purchase plan 684us-gaap_ProceedsFromStockPlans  
Proceeds from exercise of stock options 330us-gaap_ProceedsFromStockOptionsExercised 294us-gaap_ProceedsFromStockOptionsExercised
Net cash provided by (used in) financing activities 834us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (1,080)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Effect of exchange rates on cash and cash equivalents (69)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents 84us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Net decrease in cash and cash equivalents (3,147)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (7,356)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of period 78,524us-gaap_CashAndCashEquivalentsAtCarryingValue 13,284us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents, end of period 75,377us-gaap_CashAndCashEquivalentsAtCarryingValue 5,928us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosures of non-cash investing and financing activities:    
Equipment purchases under capital leases   507us-gaap_CapitalLeaseObligationsIncurred
Property and equipment purchases included in accounts payable and accrued expenses 99us-gaap_CapitalExpendituresIncurredButNotYetPaid 19us-gaap_CapitalExpendituresIncurredButNotYetPaid
Accretion of preferred stock   $ 1,238us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment
XML 45 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
Mar. 31, 2015
Dec. 31, 2014
Statement of Financial Position [Abstract]    
Undesignated preferred stock, par value $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare
Undesignated preferred stock, authorized 20,000,000us-gaap_PreferredStockSharesAuthorized 20,000,000us-gaap_PreferredStockSharesAuthorized
Undesignated preferred stock, issued 0us-gaap_PreferredStockSharesIssued 0us-gaap_PreferredStockSharesIssued
Common stock, par value $ 0.001us-gaap_CommonStockParOrStatedValuePerShare $ 0.001us-gaap_CommonStockParOrStatedValuePerShare
Common stock, authorized 250,000,000us-gaap_CommonStockSharesAuthorized 250,000,000us-gaap_CommonStockSharesAuthorized
Common stock, issued 23,979,778us-gaap_CommonStockSharesIssued 23,742,467us-gaap_CommonStockSharesIssued
Common stock, outstanding 23,979,778us-gaap_CommonStockSharesOutstanding 23,742,467us-gaap_CommonStockSharesOutstanding
XML 46 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
Income Taxes
3 Months Ended
Mar. 31, 2015
Income Tax Disclosure [Abstract]  
Income Taxes

10. Income taxes

We operate in several tax jurisdictions and are subject to taxes in each country or jurisdiction in which we conduct business. Earnings from our activities outside of the United States are subject to local country income tax and may be subject to U.S. income tax. To date, we have incurred cumulative net losses and maintain a full valuation allowance on our net deferred tax assets. Therefore, we have not recorded any U.S. federal tax provisions and our effective tax rate differs from statutory rates. Our tax expense to date primarily relates to foreign income taxes, mainly from our international operations, and to a lesser extent state income tax provisions.

As of December 31, 2014, the Company’s valuation allowance related to income taxes was approximately $27.5 million. The Company is in a three year cumulative loss position in the United States. As a result, the Company maintains a 100% valuation allowance to reduce the carrying value of the related deferred tax assets to zero. The Company will continue to maintain a full valuation allowance for those tax assets until sustainable future levels of profitability are evident.

As of March 31, 2015 and December 31, 2014, the Company had no uncertain positions or unrecorded liabilities for uncertain tax positions.

XML 47 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9
Document and Entity Information
3 Months Ended
Mar. 31, 2015
May 01, 2015
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2015  
Document Fiscal Year Focus 2015  
Document Fiscal Period Focus Q1  
Trading Symbol IMPR  
Entity Registrant Name Imprivata Inc  
Entity Central Index Key 0001328015  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   24,082,957dei_EntityCommonStockSharesOutstanding
XML 48 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
Computation of Net Loss Per Share
3 Months Ended
Mar. 31, 2015
Earnings Per Share [Abstract]  
Computation of Net Loss Per Share

11. Computation of net loss per share

The Company calculates basic and diluted net loss per common share by dividing the net loss adjusted for the accretion on the redeemable convertible preferred stock by the weighted average number of common shares outstanding during the period. The Company has excluded all potentially dilutive shares, which include redeemable convertible preferred stock, warrant for common stock, common stock subject to repurchase and outstanding common stock options, from the weighted average number of common shares outstanding as their inclusion in the computation for all periods would be anti-dilutive due to net losses. The Company’s redeemable convertible preferred stock are participating securities as defined under the authoritative guidance, but are excluded from the earnings per share calculation as they do not have an obligation to share or fund in the Company’s net losses.

The components of net loss per share are as follows:

 

     Three Months Ended March 31,  

(in thousands, except per share data)

   2015      2014  

Numerator:

     

Net loss

   $ (6,699    $ (7,067

Accretion of preferred stock

     —           (1,238
  

 

 

    

 

 

 

Net loss attributable to common stockholders

  (6,699   (8,305
  

 

 

    

 

 

 

Denominator:

Weighted average common shares outstanding used in computing basic and diluted net loss per common share

  23,868      3,627   
  

 

 

    

 

 

 

Net loss per share, basic and diluted

$ (0.28 $ (2.29
  

 

 

    

 

 

 

The following common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders because they had an antidilutive impact:

 

     Three Months Ended March 31,  

(in thousands)

   2015      2014  

Options to purchase common stock

     4,951         3,605   

Common stock subject to repurchase

     35         57   

Warrants

     —           120   

Convertible preferred stock

     —           13,971   
  

 

 

    

 

 

 

Total

  4,986      17,753   
  

 

 

    

 

 

XML 49 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Revenue    
Product $ 12,913us-gaap_SalesRevenueGoodsNet $ 9,274us-gaap_SalesRevenueGoodsNet
Maintenance and services 12,723us-gaap_SalesRevenueServicesNet 10,166us-gaap_SalesRevenueServicesNet
Total revenue 25,636us-gaap_SalesRevenueNet 19,440us-gaap_SalesRevenueNet
Cost of revenue    
Product 3,423us-gaap_CostOfGoodsSold 2,160us-gaap_CostOfGoodsSold
Maintenance and services 4,927us-gaap_CostOfServices 4,193us-gaap_CostOfServices
Total cost of revenue 8,350us-gaap_CostOfGoodsAndServicesSold 6,353us-gaap_CostOfGoodsAndServicesSold
Gross profit 17,286us-gaap_GrossProfit 13,087us-gaap_GrossProfit
Operating expenses    
Research and development 6,872us-gaap_ResearchAndDevelopmentExpense 6,536us-gaap_ResearchAndDevelopmentExpense
Sales and marketing 12,018us-gaap_SellingAndMarketingExpense 10,419us-gaap_SellingAndMarketingExpense
General and administrative 4,580us-gaap_GeneralAndAdministrativeExpense 3,013us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 23,470us-gaap_OperatingExpenses 19,968us-gaap_OperatingExpenses
Loss from operations (6,184)us-gaap_OperatingIncomeLoss (6,881)us-gaap_OperatingIncomeLoss
Other income (expense)    
Foreign currency exchange loss (462)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax (131)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax
Interest and other income (expense), net (16)impr_InterestAndOtherIncomeExpense (29)impr_InterestAndOtherIncomeExpense
Loss before income taxes (6,662)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (7,041)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income taxes 37us-gaap_IncomeTaxExpenseBenefit 26us-gaap_IncomeTaxExpenseBenefit
Net loss (6,699)us-gaap_NetIncomeLoss (7,067)us-gaap_NetIncomeLoss
Accretion of redeemable convertible preferred stock   (1,238)us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment
Net loss attributable to common stockholders $ (6,699)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (8,305)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Net loss per share attributable to common stockholders    
Basic and diluted $ (0.28)us-gaap_EarningsPerShareBasicAndDiluted $ (2.29)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders    
Basic and diluted 23,868us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 3,627us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted
XML 50 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
Warranty Obligations
3 Months Ended
Mar. 31, 2015
Guarantees [Abstract]  
Warranty Obligations

5. Warranty obligations

The Company maintains an allowance for warranty obligations that may be incurred under its limited warranty. Factors that affect the Company’s allowance for warranty obligations include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and the cost per claim to satisfy the Company’s warranty obligation.

The following table presents the details of the Company’s allowance for warranty obligations:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Beginning balance

   $ 40       $ 93   

Provision for estimated claims

     —           5   

Adjustment to estimate

     —           (51

Settlement of claims

     —           (7
  

 

 

    

 

 

 

Ending balance

$ 40    $ 40   
  

 

 

    

 

 

 

The warranty obligations are included in accrued expenses and other current liabilities in the consolidated balance sheets presented.

ZIP 51 0001193125-15-179221-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-15-179221-xbrl.zip M4$L#!!0````(`'!RJ$;"S0D^D(8``)G0!0`1`!P`:6UPA9I%B7QIQ-\JIV,1!PFDRA^^'0RSU"0A5%T M,LKR()X$TR06GTY>17;RC\__^B\__1M"H^OKD9O$L9A.Q>OH]U!,11KD8G01 MRQFA@(?A?";B_+]&=T$F)J,D'OWN7'\9D5,\&CWF^=/YV=GW[]]/TW2R_)C3 M,)F=C1!:?L5OQ>K.1R/CE)!35GITG'O/1?X3_"8-A),R@H^O3Z],2L'\?W21Q!J-G M3T'\.K*GT]&UG)6-KD4FTF/LTTD)GOSU:9(^G,%7T+-H M09V38N2Y?#I=,WX:Q7]*\KV-E[^HC/].U6AL6=:9>KH<&F4)(YBO6TPQXNVS MLZCMDV$H/OO]ER\WX:.8!:B.`$[*0Q`\OM+R57(UD[RZN`4-]+/B865HU#K4*(9&RZ%97@)0`2R?R&7@ZC)" M.-QY^MH^9_%03J.U:?,T!19>-6_QM`6V>`D?VR?))RT3XB`*L_89ZE$+IBA^ M%EG>/J=XUH(HB\(5A(O"EN^(Q0.P_F3ED;?.TF0JSA;#WF;-9^TS)GEZ)D_* M&8P0:12^30#IL'E.$J/:O'F>KED:/#T!.3(:*4DR/<\4OUV+^Y%BZW/YJ9]. M,N"&J60^];L@#26B;@)$S7A,Q?VG$\E2:,DQIR_99`?YTEUTG16P%@+A_"I- M)O,P_V>0ID&%$PHO@6=-8^C8LY"FMW^>N.>C"8BC&;!%,XHHB>C"(Y$-+GEIJG! M!]Z:EC?V/>8@;>P1Q#R=(]LB!N(V8802A]&Q>RO%'GS^9XO"%_]TMG[Q58#C M('NTXXG\R_MK'CT'4U"#F9V/8=(KJ-??@NE<](G7\WQSS'1DV@[@M703V;KA M(<\V.?5=72>N7N`EQLEG3(G)*I@[X:F2P)EG()BS#/3F710KM3P&O#`8IL*_ MLF@BS07X]9!0P\UE< M@$TV$U^2+'/$?9**;\$+WIE4W&`:5J0B%MZ)5-2R?-O7-80]=XS@G'C(='T? MN;[GNYPQ#"?J%DM2X9//"#.]0JJMD=88*YG-DO@F3\(_;QZ#5&07638'TW([ M@>TYFK$>";L:$A9AL$3HD./S+/T1G&E/K>K:30R6=" M.2/,X"4>:E_Z!GR7\US9WW"6A@62:9U`EM:_`:D]SQ^3-/J_P>VF"4#E(=:J M(G'U^E<"O0K2R_0FEX=?2[I<`_.2S=@H,W0I^%::Z MQA?W`JS/R8^PX0PVO+'?ZQ%4T:JGCO1YI7@#V:9DORT-A@
%0=Y@4X@^W`FZL?QV7[N(@;@#XDD7G M<03^.LA3L3./DH8S_T.P'ECDC!-69;Y-?*=<>S$IO!(XK\<`2&S=Y&/?1&-J M,,EMX+F[W$:^[?FZXQJV#A]#I*N%,6-U5ZM]^;7]2^*';R*=N>(N5S[^4Y0' MTR\"]/'EW31Z4+R9#6]/"6`VL%7=T4Y85MKG!^"Z?2"E4G&P5=Y'2^Q%/HUR M931)*BQ#$2$<]`'*%*(W9$K'*,%7D5_>P\D>WI8Q(F,?-=6W):H&2638/P,3 M.;B;BN&*6BH/JV76D;L1"U0H5$8#1`LHVJ;N:Y7 M=?YF++7-G4PB*9J"Z540@<1>"*X2EP\0N]0Y'`1P-3R^&4JKDKT)ID%Z%!.B MHX8%TXZ;U&K3L+6UM^+[(:PD)F/;NM&(V+8#J,4\Y-8^)M.)2+/"=1\>0`8` M#4:X40'87/EZ!W/0'@CH':S3Z@ZN!M`"=`CGM2-+*JPF:6+M>&2[68O#95<= M3C/1=S"`VZGQ3BV8^4.PLRZ]'A-S:Y5;UPKDP_>4PST1IN2(*D/LCN\`=_8? MH4&G._OW(/36=_:U.,UP-YF??*84D_:P6G7U*SE\>+`(Z&:=UJW)TI(_S+:# MUMO@2*CHU,$7`ILH[KO MR]4VY.^32//7JRE(,,`OL3_)$,]7,<#S;,#.&4TAO!)!(Q;^!,ZC]R+O"P4, M+:PZ=5TP6+D,\HOJV*A!W@BDYBVJ1\,#A[564ZM8[H;;J@,>4.T#MU.TG<LDT#_C!< MQ[)T;'*B%7%$0-9M^5V,.#^(4F7RN%$63I-LOFM62RF/%OYFYJW*IS4LF2P* MO^;%SYS(GYE&R&['P*'$Y6,7T;&#$>,8Z,,H1^,QU9C%/1<<.9EGJWC9XAT, MOQ;\QR(;)P"B3#:N]TDV*K5:X1QV2M_>2+G#IW"WT/"P*=S+^(!!/QPE&0BM M^CM?0#NJ#,&]$^\+3+^\'X/YM>LEGZ(",S2@@HDUT]I-A',#4P>D#C(U@P(9 M-`K"W-#A1&'?'P-%/,=\.T*5*,7[^OL6/L>3T>Q'DM''D\ELKS+Y;0#8L1Z8[#['4U'ID\)#.?^P,XL8S?JA*A M*LKU=4$'V-(ZROUOJ:IUJ\6ICW!V.37H;L9S5Z#TMCWK9Q/80Q7_SUQR$@2]DQJ.:.+F\OX^V M+F=88)6[3^$_I;Q-:I0%VU_W^<8JIRZPR4*N+8K".Z$I`7_/CBL>W3P%H?@U M!K91$TIE40,G@91W^)T$W7&UJ+2K=)#6*`2^3X6[VX=(LA[C,TCA& MF%HV6+*:A6R'8@1NCJ%[\(PZWAL%,#XU6$VS*3"KW5L_",LY%DZ2ILEW4(+C M`"BVO0[0-4:U@@R8QO0C"5NM:%8*M@EV2*EX7PS!5/,FQ\+93J M^98LW0@[!'5$6))J(Z-P#]PG.WOYJZW5-UW:IA"2.X_.QCQ&E MA$CYZH!\Q0[2-%"CQ,">:3CR%D3"U95%:1)+YS^==4/10]*';!=SR"8D:L\) M/_FL6Z1:0[!#WL=^ND7H#+`((MN$1M!]M`MXM"[ M.;AN$4W`!RQ:Q\/K%G'H#?_;=HO8E7!=NT6H8'#->_P[=8OHF_$&UBWBT'QW MS&X1:[=V'YDP6'6+``M[;2'/VFX1'^V7T`/&HE^"5HV;]M8O80/`/=0VXX/T M2^CC\,E^"=0PJL>OKWX)'P'8J71,!6\LK8KNF.T2^N`U@,RL6L"A_W8)/2`] M8KN$/D1*[^T2>MBRHEW";JTB#]@NH0])*Q.U+=*H*^^_74(?VZS:)!>O9.7]T2^CBQ MK(C";G?3O[=N"7W81/(:QJ!LK9/52[>$'CA2)N.8C#:Q#J!;0A_/;@E]L+.JK;&8Q58Y=4/JEM#'B9"A>EIU`@?5+>$C-.C:+0'+NM5C=4OH M8Y.+Y&NMJJ4/VRVA#\TE=;-&,%[%R\?KEM`'>MDM`?./)1N"3W@DMT2B%EO'7"\;@E]6"/`P4;CS3I]=$OH0^EHK:96 M6[>$/785Z".T*N^D--YPZX_75:`'T*JK@%85J\?I*M`#6.ODL]72HOYP305Z MP`2.CV7AFNO;5T^!SOAV[BFP+*K;IJ=`)6_=`3,_?-R#F;O\H(U)UM:86"[U MD489[)LVUI#ERXQ90ESJ@./BVN\9(J269;_\DGXJ2!<@A],5L^*&/L.E?O>VFQ4:--7FXUZ M?YKAM-EH)\=AU3([B%K>UY5??UTV5"\:F;30R+0Z>*N"%JR';;-!59L-UIYN M=.@^&TVTA^NSH?H0R+MM0JU:_^A#-]K8#'/_FUIDW?3=::,%Z6$[;5!55,U: M,\:.W6JCA1B';;6AJVT_P,O$>U5W1*BYOUSY"]A^=V)A+?J M5-)"E&ZM2M3+FZP:1;8`5(J95F?9#ZE096DV_#$1$Q>.XJ[H=T.FJ@^QCC1P M*8U%I'3S&EOD8U$LY1H^PF?*2\GMMWE3 MQX[]NM!JU\$-L6A-=FZ/M)[Z_%QK^$H#'#=RRT]9W[$6Q2YL)U:R)J]-A M((TA6DE_686@=K-<%%AFWQ+55B$52RDBMFU)M`EO;PTEU*G`5KUKTR:D)0FP M''H97XL<_@$BLUR-^F,2A:B+W8(FG5"V$L0.'R/Q++N4%/=.-^!M9]^"]&&; MI(L!487*)*MVJJR!VB1-(67Z/C`[PP:=#V$UY",P?ZF<60#J M@PM"I'WI(F8:#-F4:,BT?0T,$>+9!EM<.)^:>LW7/`CJ+GFU5V#AO$29-'G` MZD^EU>.*XN\MB&;HO;RB3(7V4:WUY]:X.I%E:P'3'PUDY\`N%&@*F''A\H&' M)WV[95Y#P:>[(]WI-3*RC/B*+B7&NH65!>2*K4Z>HPS&^TDZG@;1;)"[A@N% MN!21'9&4P"O.OA9/"ZZ?V/$$-`K86U5[7(Y:].W8,MEV6UJT.%Y=VIG\$68DVC5<0R0&%')U.D^_R0F\A$X.'?5"DK@U:G:UN?"#-Q],W4FP%9,6] MRT7\-,\S>3TC9?'O./E$\ M1?FN!3D?HDY+KN;>BN@;].PI;LH6-BUK>4G45K7TFV.KUR*V9MNF83O\EI5S>#?#J1XOF6X?9(_*\)J(B?/Z:R;[V+R%@>T0C-*B ML%?)P3G\;O%PJWQFJY\6H*2XN-5Y[>UV'X.YIYY[;VH=+)OYK##DY+5!*'M5 M1')A8/=M9:VLHNIF9]TG&+L,C#-F4##.QB90TW(-9,CXL&F-&:6T<#>UT[TT MV>L*?D\1D75?)\NVM[!I:D3>C9#2VS/^P+J[A[C'1FP'/*]2I/BI`.F:BU1D M6UK77<]K,Q+7D'F$C[&>0'@_BK;^__(I2/@5\ M6Q2"G^=&TWF^37_$523LE!:"?>SXV-*0S310P;J4H38?(]^@S+$=W3,M7W*] M`<:TS"`M<_YNP*K$63;I6;:/W#L5-G?);(K"KD21BH6<$NN=)!O@]*`V?DMD MU$BZ(0-3'*JAJ%Y_P<%AX==R64"/3^1&@"UX(T)Y30GJO:BT$Q-I/LJ%S'.U MCLO[^EX6[E]/?*F9V-7!CT7,Y>#CNBY'IC6RXC7AF/-:-N)> M<+;>W5[>^^`VQZ&TCQ;M/9;9X>,DVR8VW)_U)]]LC&M93QWAU"K9Y=4MV(OW MVR2\?QQG1V$DZTJI5LM7+BVY)GKDA=.B7X6L,-WNM>J]@9*--65.;\7>;%GZ M:G##Q*4JGUFM44IMV?5BY^J-S46\J&]?AD=;Z]P'R(^6[*!2!;X;M@9]%L&4 M0KXU7;;"U2\U9/5>P"E.4C!1@O3U(A@A+L)$X>LW,$>R()3D^SF( MXDH&Z!!!J[?(T2KF+2`U"N'JX;/M(]9[P"['68:!/$)=Q#BE\A*-(]NQ[#$? MNX[G+2Q,9%BD:@RM@5!3[PM27,9NE#TM[ELO[PMALWMPX'"25)<[7>U$M1Y# M/8S\M,P_NF]O7?=N.PX0O>SV3DA5D6P#:4-NXLJ&.0,DA>1Y0]?;+-P.@!K1 MWW?!:#\'T52V8/F6E%)I%M4"RK4=H`24;3B129OAWFUPK2'*$"%KRAPP^&K( MFZS)9MN=`1YT:?48Q&`;K,]Z430UVF_D?XUR?\0N6P\/D#L5%ODI#>@;T13"UC? MWXL0[$?O)51I(3+,>!FW%X8/D`XR9FU6N64;1)O42*T5Z@`)(+OI(>4XK]4A M-2`K_-]%8&*(-@%6,2;+,-N]W^7*ZSY!)H(TE!OO`O!IHBS$Q=@A@M14+;Y1 M\P+6@*A9`D)%.6#D+T'ZIR@19HA@U7N164V*K88P\,3`WCC>:"2M'24-4-XH M7-ZKB+6\;%@8;C?@=`SPK''@*ZK7(RFK`'1I#%/D6^U>4-&?AI1Q%4YUHV8L M=`?5MN]+<@UPKR5_8*MMKY>+;@NU@SV\D#..B,4P[\3DW1\QZIJ^;?&;[)KE MJRW*+U*"X]!\V<4`#S26`1'Z_^P]:V_C.)+?#^C_0&1G!MV`E;$L6;8[UPOX MN9M%I].7>+?O[LM!MNA8V[*ET2.)Y]=?%4F]_(KC6'Z%F`$ZMB6R6*PWBU6: M,5]S=NLUYI'5IQ//]4U_QLM'X.,4Y6#?O:,6YVJ;PF$$9^J'])_MXA+0/1K#1R"O_ M-0O8*!$V31DXM438"FN85IXK[/.V96Z$LFO6+/D4488-/Y3YV/K;5KEPUW)( MJ<5.;+/7N;K/U!_:P7'&D;#YTUPU^A?7,7?8!FK7-QWD/VMB3^V`Y:<_TB/V MOGA!P+R9],(R-@VZ"V5[A%O-"R75YKJVO;B23?('))_X\5=ZS7 M>(T\HU9(;JDJ*L.K6F.NSUT!Z:5'@TWCA1)26V?JXM1XW[WV7E"IZ?JK:U1N MA$I-U+-6YY(_SA>7=;6";;H+P*4NJOMJQERZ1`'(W/IR4US@``0SM7*73+95 MIVG5.+R%7MFB.KW1[?7*U9:B&^V>HI?UIM(P>JI2[K4Z,+'6Z;4,?O<(AC=V M<,%K#0X*M+403[I:;;`*NZJF;:6,J^UVSVB6@?(JM296P&@JK4Y#P\S,=J>J M&:I1K23:9LZKV,3Z*F[%(*R+6W&L$1J58UFQOFD1M"U7K`EA,Y>@><`55]5& M72^0JG6AJNJ-C5>\\QOH"TN/+Z!7&FJ6O'=Z`3TN&;_5!71,R;-9,!7/F9)3 MMB$HH+3`?A\6WW+$57U29VD=*45M-0E79%K]0[ MM6JK5]-XK;+?G/#*LA]_>PBO`&[\Y)$@G#GTR\5-\^YOU]^4UFV_?WOSF92] M\(K\^/MUOZODW_WOOM*_:WZ[[]W>W>#W4PJ/WMYUV)/7 MW_Z&;S]?D?;MU]N[S\1_&'PLE^"_3U>D=_NM_YFH,#CYS?3(4#`#EB0Y^ MVJ&".%:"T'=_4N7)ML(Q^_TB@X4!_EV[))G](^:4!["2'<0'?V=/LK^\4\6B M42@6/YJ?2.)L$X>=E+II=I9$XAHDWD[)/\QI9/JSW\R)=_67YV;Y2C5*!'F_ M1,"M1P+US.F,F+R$,;&!4#F.S;BZ,8PSL/&#A$`6Q/ MR5?Z#-L3NM,2N3&#P!R.HX"&\$KH\O%@%-/S?/<9Y&E(G1FIJ"401\0=$=.R M6'*^Z9``QZ0PGXL5K"Y)'T!DH`E`;!&,L1CP(3PU_PZ?S<)Y\_,U-)P/P0`^ M!*SQ];)AJ#^!/WPW>AB3#AU2%,F`HXHJ`$CA\SD85,1Q[&!NDE]JEPTRL1T' M53).A.,[\(?C^A89FP%'JP5C`(#LK1@M^=!*5`WF8(D@$&&%#'IH^PC`D60@!2?P2B)DC/O@V,8UJ/("DHH2S! MDL"K*$\&(OD(WG?3HR\0-B-^XH;<#7ZUI/4-:'WXB5R#2)M,TZ)9DN+78*X9 M$"`YL,ZPM$8$F/-!]COF$^H2^">G'H7V!+79N`H(%BKF2`9+9`1#86R<*\98 M[+=FY*OY!#/PU83'^+CK4$DWA#QF3ND/< MHE,RF!%4L[`84,\XED_Y38!@;'ODR0['^'Y\J8[/P1<(8X@E7F9E2AZ!B6D1 M\+&&B2OWP`\1G1F,XU-V62N'-I!`*>;PA_A5&!,6AQ>4>8E7&S'R-+8!02OW MT>-55O'A$182Q:ELWU*XL/-,K,<=E!AFO9F/8@VWQB?@O@$(IO]3;$,*40R$ M&!DDIJ,I+FA"`,P`]7.R\^LF\%W>NJFPPA"8P0,FA)+ MKJ!5-Z8^A2&?X!_BIH5_1[`=>`A=)Q2P2S] M(V)JNX2?>)`ZE3\CT_;)(ZO\RUD[[TV![H=1IO0!OL$>[,FR8V!\WA$SX`ND ML#QX.1A3*T_7_'_VE0@/Y)MM;A[36.P04F#@HZQU=>R>HG0;E0X>$U>4>JVJ M*^5N"T:K-UMZ19>!CQ=M$>.2X$9)\V,39+7,*=`O[QT[,H=,74C,;>BJ,(\: MA-*CZSRR=H)Y/'+I;)(!XMB+?*QG!'+0Q2@`^>J:W%@3AWHSDC1T(A83=@NQ M$ZV,.J?<(!^YJ9/:$^VKNP0(T0BX%V]F\E#GZM,E&(ND1P<^#ISJK]1L(A/7 M`A$O0A,+*TM,)R[24=F!#L%BZ-SDN05CD4-8RQ-S[>=9,K,QWE=/HI\5*@;SYN9E5M<*^8UA-TF M+E[@I`/7]]TG%F*T)SBJ[TY@C%_4\F4YB>C`#+\`T.D7['`2S#T;S$$;/&4T M_T7Z%[-@XTO7PE`,2!`-_HT:'Z,_PB!/?=VA"[:Y.66+1-L7H.$F1=;^G<`[ M[#U,LIM$$^+@Q2YF0#DVO`4H`=L[4W,0G?-X<0&"YT=H2XB"/L(N^`%&-[D/ M@;A"\@\W\C'8Y45"M\,(N$0@1R0;SXD"4KZL57^])/?1`*<);;39"8XA'`:3 MUUSBGS+4C=Z5YU#K`:TR#"@Z:%>`R2_MXF5V2U1US>%UR$JPP13>0G4WCWF?!"G*RQ&(M M6-@('KL`F'-TF3L>@%86;B@J",]E?*8<' MN@2P[!?F$Z>?L_K73UK*L/UP.!L MA=C*!\_.6!PKPVRX"(8IAE`(0E_),',$)0P93((`K9>`D! M"*L*WZ%"%Z3R).$3%D5EJ,)0"0N4\/,$-$_3:`6NG;^()P81L^A61_LR6#IM M<56,J=$71`CKF'+#;5'@L[V$C1FYV&TH^'P<>*P<50PD,<46D!,RUA,(0MB5 M^^O_[7)"X(M1>LV;ZZ__\WG]!F!&M!?05V`S@Y*=80`< M&L<)/!,ORK'V7_C9P\-S\9D]^^6B9OQZ`?+-?IA^N_7R[]>)$9':.6?>10##]PP="?)G/KJ5W;U_<&F_CV/)W\)B=5?0V$7 M:Y?%8,@3^0N(F'MC_;L"=D'CL?Q(N9ZHP.V!Z]C6Q0+"@0^`_.`+8YZ^YLW; M_A@`.!P9]\T_MRP?_-/NR]=>9$ M.*W;."9]^G]'R5V]-*I>N'B6S?2X&P5@-H'5!=8#A9=3-629H?EIC?=Q?!19 M64:1R7K1H=TM29W$FO6]L]'K5"VHI0=8C0MZZ2_M=K?;ZZW@K-!]D8U>J^2% MH?*UVT,3AT[F]+$"7\53?HLFF#KC^HOVV$Z)8MF[AWKNJ&'>/2$>ANRT]60G MW(.]$]TO&UE?XB-+VV"O?31*1J.QT;M+-.2G`J7M#M=8*Y6-6B%K/%_INI[, MFVE@;30?*]DKZ2_;L;>-L$@_N2--O2A0]\I)KX1\D:744D6K'XRE\K'YPVG- M>>83IB$+I.3LPF=A%R[!_6LYI>@Y"S:B)1;/RAIZP0A/3F9"?J6#!?O8'8_T M*$'D]VZG-O8E[_9N)NUK8?625JY*0?X.19#$XKX$>3Z8!^L8LX/2+Q?UU02> M/I+&CO3=/'Z^3LMZ;=2A4W>"U9RW#@K)YV2P)T-0/^;S'59GA$0!RT45&0T\ MWRRPAQ_^8[.LEZ,VCBI:J6YL[0SN)6KYQA5J):.R=0!ILP5*:^FX];S$XG&Z MO:=A>GQ;R!HJ+28]%BKDMXV=ER\KQ<3Y#K.K:?]&@E^)GA,4_IO[.8WC+`WG?6*,\&G4^;)C33^XU?%LXF`8L<]6'^CL%2 M[T"DGBZ-JW[(5TX@`SHT(WZC:\8NQ[$K?FG]3BR>8PY#F;DJ,U.[,=8X*J/$`YBBB&J#&.AF9R M23!KW1;+T07$=?52HZIN&PXXU=PMK61L?^*_NV#V*1S_K&>']HM7:$^.(;2" M">/X5EP]@G.=<]05/_C=\_TFPLMLX(/PD%HIGQH3'2/+M%?7'Y!<]`ZX2"LU M:@5;HV=X2G56Y^,2BS++8/M\M#YV?MA.5>S/X:X;!Q'L^Q+BM5*MJDDA_KZ/ MR"4>-YGTA42"Q6J**PLEYNLI]DS;_Q<6\\XT(;ZA)E9@M&ZG=UBW"\NSMBK&I5PVMH[:4KE&I*WJWTU5:K4Y5 MZ1AZN57M:4V]W3N/4HQ[R*S@)_"B(PLO>9S=O+CJ:M)>#,O()\T'R$20!!9[ MS12`Q^8K#]G:\R3*T,@'K(^\#KTJ/] MP\HJIRU=$.Y,XQ=1S#F(G#!9T1C;@?+:QBGH,G]#YF\<(G]C34;$JB2*^N'R M-PJ?6A[_QP"<]_'_\C22@4]^%Z"\Q_R`I<6W%_$BBUSM)&+)`NQ_I=C/L^"[<>=R.K(^N'67,;/1O@;[_$]N88OV:,P@-RUL M`!&P7M*/-&Y)*CJ?<6?`Q[Y4+K^6N_I MAM(T>FVE7>\VRM6ZIM9Z'7F2\JJ3%-:<;N3ZX9KVT**%'?A:F<,4&UO?LB9% M>"EUQ<$*'H^@Y\8I@Y4_P$.0P8SWZF-=*<5Y2>:ML0T^F3\"7YL/N3%7EH]SX.[;XR4T/=+?&Y6`GZEGC6KI^3,$N8S^9L^H6;>V8PSI;V MDCW'),SO">;S5>GKX[RVPEF:UTO$PFLY5D MMM+J]JZ459ZU6JK6:MK\(\N*Y*MS/GZ MP3JP8]FP1Y#R#Q1+C<4;1B+88>RM;'J>,R/AV`[(Q+6P:ACU\4EXGU7?.8?S#%F%L.7B_IJR9L^DJY- MW\WC[S7F=F<'/Y41""IB(V70("3@E-./ZJ?]>^5O=)W4R]K6@=E?BP9W-PO< M_C[^V@6>2_CIA68!SQX=HDOBV"-*/LZHZ0>?/E9.C]"-R_*AXR+[6^G)G>F> MAMQ/F,&R'VT+;%$RLZEC?=1.CQW$^VC&;`W'R>J$@RS^G>F+1]Z9[__T[ ML2+6B0,_NZ,1Y6TYDI:B+K9,G(LQ\=N,U3CJ+F/N,N;^AIB[47];S!VOP&\: M@#JF&]5GZ1[L.BRT)\5?OBS+",FQ1$CVMN?5LHP1G$*,0+K$9R,@"G*)]^4? M5H_+/Y16M+2BDTR.\J\;VLU9D1"_KJZ,-I6D3M[?_XE?";"/Q8M M01@!;4$V9C0O<-']9%H".T3^27U7&;J1!W__\_+^DO1]EA\X(P%F![*,01@- M>T42<('%-R2P)[9C^N@3T!D-XU+==&&!LAJL;JF9'Y30:L"ZJZ?P8QQE0XD9A$)J\?3G\@Z0[ M-)UA!&H5GHJ".)0#O."!-6[#EQ,:CEVKQ'NS(A-2#VB:U:MB'"$2+06#8!JL M;P[#R'1RC!.OF/=\Q6^>1*JF$H_PB"$IF%^L./_B)0MDB<7#",!PP7)(89E# M$WXF=D@L%YZ:NB$9PR0DB$8C>V@#Z##`V`:D^3:L/L8;?:;^T(87+3,T40IX MOHL&*-L4,W"GC!U9RUF"L@5%".M7.Q]-R^VZ9/MC8GMM)VP?.R8P`%,ZJW42 M7>[+D">3TV5\(06UR%0PAB!'#X@3V0&DQ@3X$PA].J19$0!$S0>QZ!#T%D5P MXFD8HZ7DS\%@-&W.,@_%K9)=Y&B*=`=CC")0B5)='17=ZCNAV]1]6J>T8O(" M,0=DX2&%XL:B]A)B#LDR'2LGFI$H/V!3[XG-)*!O,EW#I>T,3223>-'`L8>P MK?R-'*6BH&9*QJ&/H!NS8CH6RQ96-G,]D.]!UB','')<\G,/GR)AEW(\PPVU M1/EDU5=^/#SW`,#,J>G,_L25P"!Y]S.@^*X3+\>CU!=K0FN2:=P@\CS7YXI[ MX1`&F`^GC/4O^P&1C`^'F,0+`TQ8]BYA2;OSYRBB+&0UC_\LP&BBO@KD+,"( M@%>#G`-X\>@GKF3Y>N&R[FK0+N[O\+M!%K4_=]QAA(/T9Q[=U:V>5J?6J50K M;:73K585O6T82J.I-Y2F4:^VZ]5.M]E0^:T>'/0_?Y^'(X6N.PUA+Z^G0]>' MC6)KN@_!\&B[$1A>LV_F9&=`-XU:MUTVFDI;:W45O5O7E*;:+"O-2K7;,MJJ M4:_U.-`=ZJ#123G@&X`XOYX[^@!\CL;P+A=0:;5ZM79/532M4E'T:JVE-%IJ M2RF7:UJU8JC=NM&"!>@P7%F]^.OU!%3N(PH9@#V[E#QT*>Q]+MSN9Y.!ZQP" M:$#]]BD.W:[:AK M^GB,&WRG/F.RG5]WZ^K=MMIL-I1>HP&,4==UI=%0.[!N3:OU:CU#K1CRNMO: MPWU^?(Y*%B0YB%_A#&9JL_&3=BHVF8Q@EX6`'Z:;S6JN(&7`$U,:$L<-`G3% M2(`;3\PP].U!Q&T\4!1\+E1Q.-O8=<#8"1+7"T9'2P#5)_R?DAP!9PV<0WG4 M+X.4A[A>5WO]4;]QN-MUA4\M[V;M^G)=]YPOU\D2[L41WM%="CR&-1_@>N`Y MYE,('YA%_R(02.`HYTS%8MFCB#3R4J.J;GN4?JH56K224=XZ?^!0"4?'R`[M MK)<41(-_B\BX3V/N.#F&T`HFC.-;<5760BR$.7Z8/L:Y]EL(\85MVF*$18)) M/>R=)^B=*@^IE9-+8#U&EFF[TT>L78PQ&L^G(^KC:>[^+2O)18?A(JW4J!5L MC6Y4V.1Y!7?LN?CB/!,*'Y$%3G,.XK-P$)=LPFM9IN@Y"_:F)1;/W.9:7Y\V M[51VK(GKX'#7C8,(]GT)\5JIMM]^S66S1_FS_:1'*\;/#(]O M2.7957["?())SW:HWS9#^H!9:`=(U=`O_OK-G2KF<$@=K#\.+@*#*9MGD@,R MG\&15#^^GL+J@TSIX_^*\(`=$?((/V*R*,--,=6)=:VJ:XU.4U'+_\_>E?6V MC2SK]P#Y#T0P#S$@"J)6Z@S.`-0V-V=F$B-.[L$\7=!BR^*$(C5<[&A^_:VE MFXLVVXIH6S*!@X-Q1#:[JZMKZZKZ1MB=>#S2!^UQ"_[/:+5,HVT..\,J76-/ MNH8;Y?(U^%Z_D$T?P6$F%!P_UA(_N(Y$>$M/N;3O;]^D>7B4CZC2VO+9][+5 MO2=99%4E6QPEV>*PZ\S7FVNQ)WMA5\*#83QC*^/2OUUE6SSN`GA[\D0.P_GU MM,H=B:E87(OP'FI4]^5'">B.W&B*JDIW@<9Y]U@K:7GGU&/-?.(> M:YO^W`]Z*T77YZ.($6SZDHLQG<'J*UC`'_Q/2X)Q\F^L*0Q&@S/04P+_)G_$ MK)=#/9_$=_DE-PK:3:/W?U^O1N^PU,X%.D;_?J>WMF"WC"?FL-W136L`WE&_ M8^I6ISO6QY;9:TU&G4YSU`'OR`!?4`='RH!/9S3[L66NY?NC+TPUQ>@M"S_B MVA>\VKT16%,R6&6/Y&MFQM^7+H]XR46X1_(;)]U6UVH`/8S)>(+U+WV]/VX8 M>K,W&)J&V1\Q9VV]W6UA39$)W-8?=?6N,31:9G_8;K5:0-/FNU\: M]3RCE;[X(_'BOL]]$>'".!IS/HR0!C!G]\_>Z`C<>>_2BB2TIF2/1#`$RDGX M,TQ$'O[*\IU/X/Z'N7]"(\8+$!1KF(0AEI$=.Q;4ZS=[$\/LZ-V^.=3;#7.@ M]UN&H3=:$ZO?Z(^-4;-W'K$@LY00A#+NVW5-[BB5:?O8V``K3P/<46W*NY>& M?J8':E";%4]TW/$V/;T M(=T5Y]I3`E5VB*WT3U?E,`7%3%K[=7,5K_;SQ/)M]S7HG4 MC':%YU5.;2FYQ.O>\LD="E`L[9-3+#]^+#IFR8!^9YCS>E8I]Q457V;APGY1 M_^!]+-="[=:ZK>C'KFH*$/S'9#;QN#(=:M]/7VJ#?IC8UQR^RUSR)AH;I8K_3%J]87 MU<7Z<3]=7:RK"507Z]7%>G6Q?K"4.,L[D.IBO;I8KR[6O>IBO;I8/X6C=!I* MI;I8/^5C45VLO_(KX8J*U<5Z=;%>7:P?XWB=V85P1%!K6O,'J]DAI8 M;%M^D=I?(]BR,0-?B\/[R:PMOS&$90_'7;W?'YIZ>P0#F#VCKQN3?M.RQCW# MZ)]))\URNR>\GUYHL$,H*X3:(SI_VV_D3HITI>5Q@%3E[`Q,Y4A\.W$(K!U8 MV\$P$_T7.734IW;F^B`27=M[^X:%[H)R/A"I7;L6PL:U_K5W7M5\NZA)?MY=)SIPI!UL43YRX08]8-'!#7"7R=H<3#1$GS4-RD M0./!#,;`G[_Z-%T"E8ZTK$TPO3'^/IVC(""<)S>*7$*I?9_EH0Q_OAH/LS]' M/U_4.`D%)J]=VZ!Y$!4*%NK'L&9OI=01IJ;@DN0DY7P@XEUOO66T?&3L?`.]`8]LY;U7@V*[`Q@3-B("IU2@8%ZZGO MNEF;+?G-((9'@5PA8@2'A--^OI1ZK[+6EUYJ?\>C,>E81QZEK:40L^'R5>G"+8$RG7,>QW(-AW-`1% M1HJK^;G>BB8!Q@1U-U/D5Q^)YW8,)%K!="B<.R5^D4M2&\^DV+GWG1J]@5S$ M*5/%,Z3!;_)W&(6?F"4QJ&+Z0/VTI6%Y"-J%(WQM>R2]HKD0L09[MOLD`GM% MQ%TP#C`K;'H&KIW*AZTB`88E?L!/UK3K),81`B#&CC/LI&F6V:DMG-DZ+N3M MFZ)DOT^>YV<4S8/$@S%QD%#8),OAK;\2GVQC%N;Q.K&V+\Y'B<(B!GE0$%PX MG%77SUI7;TL/9*):O@\6O_99+(,0Z0(?G\`F9^0'*^LW^+(GG&Q6(-+QP;7# M:LAC4W'^#LY_N.[/;[!D4*4(I3>SH>=`U[@(/C\/4(L&=[C[J%E=QP5Q"0X: M#/!AL81S8\=V7HT/@Q#V/M-8V4-DI?OTB^W5X,]IO295Z>Y/K7(#?/U-^]U= MX(IKJ(CO!.HIS$N-[P+MFEP_6,?,!9D.>A9^)`DKSY22#6QHQ/!T9$O/$14- MJE%4-<*#+_A$/CY$DISP8*HX9VX(#N[?B1W"\$@Y9/V:U$**@DH'.WSP6`#@ MP[A66$EAOL6A893BX)U:87-P,,%$^RCPD'J8RR9'Q$/'8VX&J3;P6Z?5&^J3;JL]L`:=L=F?8/_$[KM?FBVS:Q:Z M=1ZVL@R58A1,$SQ,W)UR#$_\B-N]MK+!J#=J=II#?33NH&O=!2_3:O=UJVMV MAF9G-+;Z!G>&Q$'T1DMO&8Q#L75:>S+YDT5">4YT6XV\%8HY2!%J[@K<*WX/ MHI*2^=OFL&$V.K"RT<#2VX-A7Q^,QPV]U^Z:HW&K:_:&G;/PGY\GF9]]J$AZ M=&J;V::$]Z?YK=9`EJ`=A#$U%7JS>1CX2Q.S&2+LNFS MJL_`2Q$8.Q+QVA,NF4RH**4JEOGC.^C\6C,CT]T9R$B-'6O_L7WP=E8YS[^V MK2;CE#(GWQOM@U-E+IXX7_()>/-Y.'$_<"OGZ&[:PB?(:XV#H>#/D-=>BAS< MSWW6@L-NH9AZ=A2Y,U>%GS<\MC4>947S+[0!LIB2RHC@$-#)L?`/2,OG2#/? M;GB00,D;%+A/N0H960:P)<'F#-,>SRJ3^30%X4L4>Q]%K#I%Z.K:\ZAZ^(D$ MUC/)JU*YJY(PE80Y35/K\2[G[K2`'W4ZS]3H?T%<]Q+UVG&=R2?C(>.5LM!+ M$5PE^8AI.'+S\JW&5$5XY_@4I M];3W.J7R625K*EES"M;.X]W['64?1)3R??L#&RP\]9UQ)5O.MKO`TTN7PPJI M'Y^!O#.=F7WESV(:W/CN/\+YX#]]6O/8'#0FK7Y#;YA#0V_W6QW=,JVQ/FBU M6]W&R#"L@7$6:#O8K'T@I40_#.\OTQ`<\`,M"4H$RH3M".9;%VE M,E>IS,_2S[Q]0"ISXQE3F4O_]M.F/I>L;(^20MR]+QGV"]9&9S/Y@XJDL[^I M6CKW\]96XD_:'[O*73^#W/77V'&^ZB9?2NCAI80Y]P[!F0;/D9SY`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`:11=WD^9PR- ML.W0\S,"LR!G?!`)]J"N_0HSC?B(B.CB[9O/GQ)/ZJ,PPDUAR'L/ M7!$\`][/)-U#.E(?;*\4S1ZVE[_8WT=I\_VC6S:-9F-DMHVVWC";8+--VI9N MC9H#W3`&HU&CT[-&9'!6ELT]EHW1P/;G),U3-/+*JME!M?\*>:!('D3BEJY6 ML%7S)AH:2:7D^B\4&9@032AJ+HHE$AG4^3]<(?!(_ET<]V[NP@-WY)LY";Q^ MC08!Z.NZ-K9#'\Y\JMB#!)&N8_=6FCE)C.`O2D`6T7Z*$T(#B:TN.1$W90)Y M54IX*[D5D*#,G@*S`P=A'`Z8+`'&P,\H.QQ-VA%H,OA@$+'\D@.[!&BAV6#> M>=C-^M;V$BD0,=6;S`6$IH&UX;N.F`D:DZ9&%AZ9/"&US<9OPQCT=>R2'0I$ M^(&G43/0E&?"2;<)#)];-TKW"#_!4IT+]_$1VEW'A7\%?4!$1IF:Q`'0B.RO MNO8)7J/^W&S1(7&0###`,G07!&@C<^$C_$V)=3=WS&I$!WA.;>-;"<.C(!IR MDIO5%PQD:QYP@8`Y?R=,)<;QRX:E":@%5L@=6PZP1<;#[@8TM=T(*RF7HF&> M\FFNY"&_O=H=N`;V$G;C.Z$[P$;_U.S5.]K"]3Q$LY`NDC)A7.X7+U&4"-,H M=X*H2SQ0RU42@KVCPO&NX]IL:7$4$2O4B;/Y,X"/M=,,(_(@R*+MH=K)B4O@N>$#[R,`'`^$Y!)'+'7@-) MY7H@DR)\GRH<&*0)A1GF.M'N8KJ?&[/OQ\:AN`6AZ,?5B=AY(G9"=?G[\-0* M;$9"V('YP"Y-I=6N>#9"-9?XJ6S.N^8S^DF^(65P^EYQR][N*6W;9W,6K=-/ MX8WMN_\0PPWS$#-@XE[FL-$^S28*4N$JM:I+M&B'UJ#;[8Q-O3/L]_1VJS'0 MS4ZOJ[?&C<9P.)X,>HU^9=$^P*(%!9W;8HXX20NJLFX?%.VT+^#41]/074J0 MP(J`#R%@"I;%^%K:>Q2/F14Q_'G#L!C]?(&Z'PT[&TO7V'YS*/`&5)\+VXOG M4]1A'[Z`OT$X7RM,DDA8K!(4GGQ'LQ/X'FC(J=+M>5C)F1W%&#?`L!\HX24\ M@R9D#O*1S4SZB."XWR+QY6#PCIC._<`+;EPV:G%IN>FYX*D`758*36^K"37S M[)MH[BYQQN389.ABGWQQ!39RC:CA2V/X)B1C@^H\X$&P!3`PBG6-\*A.,RXL M.;=@&0.^"\)O,S`I\,%`(ELNP83!13/Q;,<)!3DG"PS5+'%T16<>0TX6?:P5 MHOMXGB"`GYD]92A!L%*68'!XTJ>@SBH9:7`G<^((#+7!"I8$U@O%A6!;:I+H MN>TIO)Z'Y4RW`;A@%8%2BHJVWK7P7+"$)&>X%`+.V"5"+VD*'W9!J^'?0$=W M!M0#@L7N0K"W@C=K2"=F$60%&_TLL&]#87/$GF!$UF0+#D/\8>=0'YJ-AE$1>`N!/_G:?Y(\=N7`D_CC\G,]_^*)[4#6?($P@U:N!E M3G06(ZBPY=8"SO'4+AZ]%$NXR`9PH)"%M"*BA"R068)"(E<]5BR>4;?I:L":Q)N?AHE+]\[X M`$P.;2<11H'O"Z_2+5N8_H_,7,W9;1G'($AVE"">+-GJ4SN:2YO4OK5=3X6X M6,[CCH`&DKBU8*HY+C&:C);EXLF4V!`&R+T+F:4%6C*SQ\-$5:3F M_%LV&3>MCMPIQS=2ZQ^$QL*EM@;P6L$>N1H/"Y8(*VB4#)C%1@[_:_$S?D-+15ME,T*^6P;5U2B@@? M+,&5HPCH6C@-OY]+M-/>2R)*\XB9&&VB)`QE,E_V]`63'+@!".$+-+E0Y*;$ MLBF\DO,MZ/.*G_+KS7A4Y1'5M4]I:S:^#(S4P*SWA>!TI4ANQ,ZKGY`OU-7\ M7#*0T=Z<\JUD>B7('Z&`D\P:P(OQ*?&+7)+:>";%SKWOU.@-Y"(.HQ7/$-XB MR=_1IZ8G^`*0/G#JBJ1,0R4[PL5,U;UP+&2`(G>1-P#F@()`R,N'K2*!TZPTYZK9:=VL*957'E@WW$:!XD'HQ)#I6P93M#_R^98>X-0!.1+5\']PU[;,`@PWI`A^?8#C::.B_ MP00_U[)U`]D:-W%\AT M>XQ!8N,C,N(?8\*KR$K!B%\SX96^G+DA.)-_)W8H_=`T4IK=">5BI73>,L`, M7"NLI##?XM`P2G'PSEH8%@:3,=B/`L^FAUW=Y(@9JW+27%7V0I>7&A7H*?`S\*8#\KMN%+P^W,`++"TO8TD M@#7KT_;]`%-9'8(RIA6!I8-8C6:AL$=&I4D^&6"FPIH M.V+AN[,5&&VJ)&5ITU_R6HN::>"+N,IH#OL\L\G9S$8J[C7FYY%>C/KCT8$4)9J[A<)UZ(QU,FW(@VY MW@4ZA3]E#)/Q+%R^W\_S2'T]6R`7OL9-]=!SB/D@9$@9<.J$RL=4%T0.AY#S ME1LX!JA9%QF4.)XK,=0OTFO8BIC<)ON!3R1+(2TQ$%[HVTM&7YM5I(( M`24Q9#.*>&VJ3"O2;H+`P4W<(("T`*0%SRFQ&+GQW'\4_;+2$3F'+0O(3__M MFW0!#ZB'/7:I0+$0X9*ESW_M$)@@7I586C#NCPUK8@WUEM49Z^WN>**;XTE; M[W<:EMEO]@9#D/F$0Q=2/+VH)EQ)@,CO/!N4B$ M34\EY*C!:MK(G2;]3[O5J]\W#EI6=NI-4VNU!3D.S0%85GM5SX%EU*SRK"@[I-<(A;8?5N@ZY3R1,Y37B)6W-_=BD2X6I=+XM MI/?#!PS$C>MCRQEUN56N'#A>,^;V:\%-ZE>X24=HE7ZI^N;PC7,:2&-?[$F9 M_IZM.F"$3:;)C&V4[F5-]:2@-@Z&?W_MX$O[#Y:59FC\/WO7^MNXD>2_!_#_ M0`RRP!@0M7Q+2G8#4*_;AL-J1K"O+(LRF;;>C= MK)K.FRV:$X,..2N(HH:+#=#3]J?T$656O>Z(?I;'\=,FZ@R5]IGA%#5\/`C> M4W,Q31?3*\,35N0UQ!FKIF"$E00''J-0"^@245;KDT3Q0EO<@6\6-O5\8%,] M$*J$X\KKFU^Q^/H>*,-22ZX=>D,_R*#S.OS6SJ*C!IW.>&CWY:YBJ+)A:ZK< MZVLZ_#505,M0S*$U/H_HJ#UF&$]G0(=(E\PKOE.,2H+S2%+J)"*TH@E^:((? MWB+XH?M$,,&Z``3C[6(?]M[U84,?]FQ+[>2VW%IU6R[ZH.OOKUA`HQS)KU1) MH_P\PI(:E9]7QAP<]"+]+&-75,UL6^9ST2LM"D^'E\MM"*P;YYR"6MYCS,K; MQ*.'!PH=O2S??1:EF]WD;O MOO1:YGAH[+04Z^VNGDY3NSX3^>"Z,Y:DO3 MNV^VI$[L8N"L[B$;+A[G;>Y1&N&YL]1)T]B_S=*\?BP"\&!=!]PO[J/`8_&6 M%M.A]-W!S:1#$58VT&WIRM:!HHU*/V%EU'#Q.%7ZL9P%GE;R0Q9&5#QS:U]+ M\USC0ZD(U+\H=PWKFXBZB;FU@&YN#@2>.CPJ+$ORBJW369;R.+&$*DEA9(#' M;];K=[;5QH[:YM#T5M?:^HQU$&?@*RG46Y:VM5_FW8:9G=6FV7"Q,3UV<+XL M;D%;?`.HJO^]*OEM7=)*6]N/^^QMR-':VGY.QV>HO\\LO+7AXT'"A&^I(E:2 M_/.#/9L%3.8@!U1>6`[98^"'[`,O:T&O+\6M;AF'NA#,*IYG'M:&8F'""P9B M*"RO)MJ?EX]<\5*4]J,3>_3/'XPPA*ZH5J2ZJPC7L:5;MF)V974\&LO&P.K) MO9&BRE3Y3^WVAMK0O%%OU`\_71G_5^''#DE98))?`$_;!2CG%6S[KL^2G0?X M&K9MF9WA4!XHNBT;8[TKVP/%D+MZQ]1'(U73Q\/S"/#=;_E#K2U=9],I0H]$ MDQIX>!595;#OT19%1)`EA$6:.HB)A(5S*XSEVJL(TA<(%N&\J#;M$_A1U;P$[&D9 M_RA'/X)VML`_DJX9R\GA'+KX[HE.1!=17,>,NXVRM`#;=1&LARHUKN:D@-:1 M','36:7X+(IW<0D^^''SM=+@;V^J@KXPE]5Y>)?Y7I'UV.B;]?SS\>]RMY7( M00C[=(*P>MG,HSJDJ(CF<&+D^`_^`V>KW[!U)5L_H6J:ER!74E$&6JHP^KI@ M=#^"_UTLH'6.[>M^=?U?2GZ28`:7??T[*+=VJ?>P'UGIM6I:1N#N7`CXFP&8 M3+&#,-^D1`=9`M8[7AU7>I`^?HUFOBM9BG4I?<1N1,N7;>Q4Z%#XC'YDM)I1 MW6%I](`M0.1,(X\%O&12F/)TLC1"CS-N+6%UF>(S,1^JY,1^4@"%N/4!N_F` M1:G<)$,,<0;*%CI+TB*#+6\+"XF#;B4MG*N"EMAX.+*0'WK09CR7DQES40D7 MS[57(#NH56`'G!KI(4KS&NRS.)IA15Y4_H$SSW?E8K%0K7J^&?@)S1\G&SD"XI&VI/8=%9LYH5))S">(44>:9`'2!VH`98BCG^+W(/X@4#@%".7@$,0G%I*$5GO+B\./2UP!Q>$_*^\['ZE1GY9=9H]\%KX M-+6E6`KT"X3\W^@R9L/&&J.X!/8H=_^A\UW=5K4^OUQ9S!695W7--DP M.WVYUU?[LJ)T=%.SU%'7ZL-IT5"PO0\_P;^JKG6AO7_\?>W8ZJ??,B'V\Z1Z MLO[""*EI`'HN63I8[_Y8;/<[74,=#&1SV`%"C5Y'[MK&6!YKPY'1[<"IN-\[ MBV/Q?O(U6`P/;8W`<05K\"09F@7;$E4DB,"52(A"&C-WGF-@E MQ00[D(AR#J6>H7@.M!59T0&C!<4!D#AS] MT@*+G2>N83W*K!!/CZX9Z30JLENF4>3XAF^%Z_<9BUT\HLODV M2Q$E]]]DFH*M+-$5*?X)ZU4`2+4(]PS,H!9B2B49IT?(Y`._5Y`2<5N3CQ'. M>?Z#[^%1A,;2"-8*P1IF<0$]AJGL',XSX<[<13^KKJY`.81&B+WPN-HR#*NE MF$HAJ7A&SD'`JO'K.)^.]"B"UBZJ<+\D&05DV$3Z7M7;9@-MOVKR8($^-4.@ M(A[Q'ZVE:EI+Z>IY-*#SX/@!+3Y^8)]D*:(!TC36-A:QCYPZ\_<,GWH+]JC8 M^(1TE\!WC5FZ"[-TE8$H+,L2@[1N'N:V([99S`[?1J_RV4'97O2^CJZOKFIV M7%L:((0)BS8$-ZV3I?11SK,*9 M,X^C(`![CP!'!;+SO4^HAK&$MM*M4)JEV>9Q9>V@OV;"XM)KAI"CN;\+78'Y MR&A?+$:.%XNSF#WX498$;'S&)860]XLFF_H#A(CJ4*CKQ@X>8M@CZ?` MXHK&)U+`OL,[KSP.F3M(`P=LCUMTJN&@/6=>."SK=$D$]^:(S0!L5-C+H8.N M^;?\!8*1%,"Y#Q5\R]IN@P/A'4_\>*GG>+,A%<[:%D==96@Z^0A/"TH6C"7@ MP<+H2\Z@US?QOT$38GOEIY<[M):6;S-1,R39RK!`%5?6'Z,O7S\-[%]D^Y=/ M/__V@Y3'$R8K^;>QKSQZSVSB# M15&YR.FL@H\6USYFM]7I%7LWL7C9E%J$6D6[26U;1C,'V]M-%DR+HK_4:L(= MX-2YOF>#R06#B2YE"FL?0R*J1]S&9MHP6(AT1%)CGN3:2'H)07VM!\B!7[_W9J2N. M`ZMKDN/U\68MV!C3"''D:=?4S9:B*/2.H;0T1:L(22DW"YZV7%QP1ZC+2UT: MT-MZ!P)ZATZWRB9L:2V#=PIO?Z]V#1Q#"Z]*Q<5 M?'D;W)'Z1.'>E3)/J.#:G)2'W-SB;FV[@#42^'^)^[A^X+A_RM?N?12@1B99 MEE&/XEKA865D=.2(8>7IOSCV+RP#O+@2*BR_EA(JE%04&4>."]HMSNV,NA&? MFS\QHV?`R,(C/VPF?S*T76"99=/2S0V:$P.V3WT-[47C+26G5WF7>XTPE'W. MHY#X=-,9C"Y%FRKA397P-X1(?Z+N]KI2W0U$>E,GO&8]/%,GG)USG?!3F,"C M*ZO]=I0VX.[OM33$%S_Y4Y[@D93"\S%`*`93^Z-ZN1RS?>3%5M5V9^LJ.7_; M]W!W0V!W/P2>2[VL9Q`2O\TH\T,*_`F3/E+$V^5'[?0$W6HKVK9R<+AQ[XA2 M8[^4OE>]7RP&"I@$6U2:^RSP/NJGMQQ*M_1NBXZ?Q)[P)L2_L_WB(<+;N@"O M1.C:R&-Q,.?ITY'[YT?C]):,<=Z&DKGUIO$"L7\!0NFW_7DF9]^V=?I^.ZAG M\J1[=@L=:.-7VDKC(3D6#\G!YMQ4 M&A_!*?@(FB/QV2B(/1V)#W4^W!J_9S_GP\:*;JSH(I)#^=N&=G-5)53PXG-Q M#]@D!R&\?%+%2:5#<)3#+[2\61[(;45S\ M[^WKMO0U9DZ286X@<[.80I@O>/$O"8[`XALI\:=^X,1Y@#[+E0Z&UN?'8EY? MYY;Q+#TZ,7N8FD>G:E&&(UYMQ+9?O'(;X=R?<&JO$X754,+:_[%]DT531>2B? M.9%<)W!%QBVO/8>])%BUC0?F3UEZ7Z2BXB)D,Y!IGO.#*T($6A;)L+RF(N7/ M5A9.$2M+8;'X35Z20J14JT>^%GR4\F+1&%1 MJC"79%@^QF=4TN/>!Z;%5&]7\*V(6?>W\FRSP\FT`!M.NOW)+;Z+$,5JU`N,5D&OH^I4+58&$7U M2!Z1CN6B87UB%527U;)V\_+='N;1Q)1MDW?#$VT*\>?#()EVYI6'1!X/=`$K MFJ'<7>39IHW<'I/<&CN1V_+X]-2F52GQB3D[**$B%3E7;WWO$#`6[GNG.#;5B\ZEN7_7V+GC:DQ,ZP?PO4=VC?OS,DS0$ M.3/&X>N@&UZ,^()*"%,5^'35)8RH3)_OO_1#7N:>TK4NOMLH8:O._^J`T41] MT9"K`[[X;HLAUP:\?/63ITN^7+FOO/#V&4-#6--=AAI_3!IRM-OG"56 MV)2@ME`_R%B!O$#'1I8*$Y-R*+^/JBK*[>X$7D1?C.>T)W6,!PU7+H0H)@A7^1+5(7CX: MJQ?QB4DN1*(\ORI M24UNV0LF<-6]S!/782_JN5!/3TT:P0$PG"@M3EU\`8II/HY:&O.XFC"DH179T]8_."[ M`NWPD%'@6Z(06WL.ESD:0C5]OX2^CYB/+RQA:#]P]R!W^6$]LX.+^VNC/K1] MR\/QD=S;]T7KIV`5Q82=8CAB'AZRT&UWMMRZ/9.;3D2_*;@-V0$6S?:='JZ_/C(_/A+7/NO1/>,3ED MCQA_\$'Z>R'J2_#%K\3SK8,#CYP8D[:3*Q;G[_BN'7I#/\A2NDW?#OPW"WW^ MDI]$AJ9V;GZ_'M[,6'S#BZ)_P`!&?^H$"3G%%Z""U;':'ZL]1;8-92`;IMF5 M;;LSD,>6;O3MOCGJ]L8WZHUF?/A)5MI:M^3-,^34:1\[?OP'AO.7'-T][''/ MMC5%&>BRI?1MH,7NR%U+&\O&J#\&PD8#71F?!>SQG@.@]`KN\;@L73"E+`^. MVT#+I0EZ6LW("L_\!%;?A%!@1?H*^\;UCX`6H+BE1X*-YR7[&9RX,60)@YTP MN"5)&(%,S!R?!\S$3IA,".PSAPR82Q\1BN.;G_)&+TL4,_@<(GY8@$U,\=[# M\3#PT[EC49;D>%MYC&'16=DRA4TC3EE,R8"\>X?PPF#`Z2-C8=Y*!48MQP># M=RM20SBFIQY4M>?80^>R*C[W/HO12S]OUMMS-5A<%S$W,-#L+O,]NM-#L9ZL MU%]E*7C"#42,&I!U@E#^YD_]OW@B0,;QC*);O`ND."D_G&4BL`T]9/F3%]_E MSV;A\M./][A&J'-*."A&Q".+*6'(B7'-(W;U;>`G]SBPZM`+.2A3F0CJ#N]M M."2*'WILA@$B8=J"$?];H&@S2D5`?)`LCH%!7IZ!),8FRM64Z[0V/%L"U06L M]$%_^"'P/Z,KHEINE`MK^@[!$!T!+(RQEGGBPRH*0"5R(CBP#I(1/6(67XV: M&45B(CH09@[>A?[$=S%@780,KIY6SE#\[>*[5?T>793@<85V(AM\_/L7F@E^ M]/;K)C@6]Q?![+1;(+3DQ7C,/EDV\= MB0!B0UE-*1FA:+O:\JEO'8>8-&V'DR9T!,?,=7*#Y:T7KKC8D6 M#]6&5L:1=]4HZS6)Z0E78]P=KQZ`V5R-^>6S9*C%FWJ MY)[@^H"U5`D`=@#0Z#[H?\IH%N&+0/Z\V(.D288IQR7<8$I9.#GV%<&H?Z,D M^J0R;:7A7ZF24#?6R!'!10'337F"S^(&R"UO]./!Y.-RS#.O^9*N^!/J0ZS9 MZA[C,)M%J03$"X]N\U>+I%*$"L7#'OI,D5,3L.AQ*`0V5;*JR7&N2?HZK:0O+$[ZFJ0OZXE*I6]6W+3I^OBJR;ZS1#?5>"[3 M#7WD?I6?-A].E.3"%<_&YQK(ES5[;DSX3D1LBOK MYYW3K[\W^LOHOX+HVYA'Q527O>O$,1:#753;AU:U)QJ!^73T/?>U[%>#OB;` M;]?/-6-NQOQ.$FL&"\Z\95_%Z<]D,^9FS(=;Y<>RI3^=5/$KNN=KSOF#+_PM M\Q-TI:5NCTG[9BETS>H[R)B/6*C.Q:!X6K$,6)S213A>Y443R6/0A/\&E1M. M4'A?G6?;J,5FEL[8I'GZ*/-+>:7;:)MFS.]HS._$LE@3O],L]G,=\RLW6LM\ M=\6W]D[R,5;J;P*;FL"FM9+^#D)\WF?736#39H%-V`/=@*])EI<<1$0;,I=- M;UDE["F':Z'Q'O(*O8E6:J*5CG>1-=%*3;32>OJ;:*6W]P,VT4K-F-_=F,_% M!=A$*S5C;L;<1"N=3;22WE*[>RY_?8J2W(SYR(7J7`R*)EKI6.^JFFBE9I;. MV:1IHI6:,3=C?K>611.M],[&_-K0'?W=X4+MG>1CC%8ZUIIZ[O,U]:@.%I`L M-Y7T7EBP+&;2(_X31FN*0RHEY/8L M]=ZE)`J)KIN81K2?J<57J:M85E)TDB1R?2S_2]7Q>*U3]S^9G_A490BLDU!YR)0%`7/3S,%RC-&,Q>G\U!?)WNHLBD**P%M9 MK(ED32';55(`C<#<,<>]AWD*"/4@N6>\\C.K@P7,H&6J<9VW.8E`#SH)KQ\M MIA;[CJ/L[GZ]OK-$K4]",4FD2E7&B[R0)Q9Z+.MP>O"-*-CK^9,)*&D<)B\B MBB*22Q4*)8T%'J;A/[`XR1(!5P!"S<4IK]Q)6AG>]1/Z)'I(_2G?-`G'=(IE M0NNT+M0";0J`KA-,$)O?E<8^?3RO/,ANQ MZO"Y.6=Y%=MG=WX8S91S0"5X9;$FIVE*4(X`E/_UKR2\58QRM M<+#B_^)V.'>;!=PUX2&`))A,_*B*A]\P(7<*'9P9X7NQ9!;Q`_(ZT_S@Z^BU M%U*:>FKKZ;44?]0[UK8T7[YV.=4=\F]W=;NX%-<`Q:,?A&_U*SB_)W#ZK?O< MLUW4U%V&[`#:ISM.SU:Q7UF M?#RKV*`]W;/YR?K;!#P&K+L%*.&#LZ3T\IYT7BO=W(4&XH(%^F+DQ[> M<_U:_Y.Z=7K9W_8]V",F[ZQLUSU'^+)+Z3,8F[$T\4,G=#%.SP_AO:R)[MTH MNE>4JA*A.TD>,E>:];4HG5J<)QX`$*"=<-#Q7F$).OYCB;WM1M-9["<W%2TIPGF'%C">GO'`.D:1 M2?GK,V?.WZ5+#]>-,U:^7T6EOZC&$55B1N&KY#Z*D9'Q5((GLYAR)I8#]_[N M^0_X\1]_SQ+YSG%F/V`]QC^P/=3@043!M5]A/OI!Y/[Y$[PF_2-_%*3`YF.& MF;B*HS#"6$42X"M@O3OG_Q9OT\D*/GQADW]^8%%PO[Y^'KW[!U)5L_A=*O MSIQ,\!9I\'&Q,U88?5TPNA_!_^"]CV5\YN#'L7W=+S\/?[R4_"1!]6E?_R[] M%K5+\P7[D95>2ZJ^_H6':J->C:,I9C;#3*/9PCXH0=MQG,YF3$7?6S%)4``;*4!3+S8MXO%PO,9R"?G)S1_G.P9;&Q\,$",'X$D MW!:1,LX$=KP5:1@X!AA)I\7YPIP8MG''BRB4`0)TA+#$ M1_IXZ!ZP5GQ]^0(.X4K,PH`EW)5:YQ3.&<\=H:%S@ZLMM4>YO-X[#Y3A`(V( M-X!;/#2;^63N.M(D"Y`^4`,H0SSI`+\'\0>!PBE``\=Q[[F84-\TEE+2B)-< MRX+(9P$8?=,9B'TEFT5(?&X>PC`6A/PO''DUF0B:%.L!*,[C46AJ2['DZ1G0 M64!F3L5M7`[HT0?ZB!'(IG0I8KPT^,F`I/ASRL/`4/'%*/)L1O*93T#=@./_ MK3;C7FJ;U2V[:_>>>5G`/D_@52]STW^!O>V$Z3RO#S+_BA;JSBT[:ZPK0QWL MN=ZX,Y8-%11GSQX/Y?[(UD;XR\`>GH=EM[<4I"=O1CR6.GY0J+@U"0X.MD`* M"C7NHYAZ*;H-_#LNE\UU2).S<"KW(\F:Z'N5GM?60MO>X_SYDPY MWAN=NFA"'_<,G>___-!=K[_*1TKZC=T\_EXOH4XVA<)0MKV@.;$,BMY!@>'. M-7WBJCB6D_

EVP)/

&:JMFAA66A*8QNU^[Z&>E()$^:I+:-C MV4">7EBV]^\L2=%K@JZH?&$U"^K\%]1'<^NDJUP-# MU_4;]4;_\)/2-CH5YNV?_`5^9[<)^T\&S8P>]AX/V]?M44_K=N2>-;1EHS_H MR_W^:"P/C8'6Z?44T[#4\XB:V']0?CEQ$L8+<>6(_YTI1KREX=6 M.2$//_)6%=S^KZ_H,)@G*9LF_#51?#9@#AF&%'3FL9@B[YQ@*C\P/Q1UFF_] M:,K2V'>AC1FL1IPW>#84\&G815(T'4ETB8CQ<[SP,2S]^(ZZX*]"(PLO\Z'P M0+&E<>>CIO@M'NEUQ1NZQF+YK!S=NK&ES+T/P4*_P]*^,XSFPT8^8`:SR22-#`PCN':TV>H>!/\4U686+B3%@Z;TN_ MAS@6"LJ#81=A1RFHW<2ABM1U.<%$"7B]DN$0S*7OU5Y;S:NL8Y0HS]M()RY^#5AZ=)$_2X`76(ZKBGKAQ]$AHG?Z,8K_Q#Y=9^:G6/ZJ,AY!-T6CMB7;\T@DH3V8JFI`(P4BTCAF.*+OU78/ M6J@P,F8I2F,4RGPQS?C&!Z-^C*0YZ"1"Y8F3H"!S$Y\AR`>(">Q8`IT(F,G(DJU&KA6EY&E,,T86D#&AY_^5_W' MWY\<4MV.LT$8/!_UY0.[Y@H4F#7ZAJ'8S!O#ZL!IR7@D\.?)R(DQW""!]LB> MM/G"?[5EG&!C2=4VEO4E)BA==6AJ8[``AQT5_AEVY.YHH,FJJEB&97?4WM#@ M3#!Z70OZ+.=S)V36.3>HYC9\"K$Z_6]1NON0X7'/4)0.3+UE]L:R,=(5N3\8 MP]3W]6['Z`_A_[VS,'[W$[2:V[[=-F;99-,L(#U).8H+^2FP"S2)J:\*OZ[@ M?SB+S+[X;@6[P;Y#(`EHZQMFCCJ\&?B4YR/X/,L,-[?8=P*^(RZEOY8I!V5- MS":$NPGA?H,0;LO<(H1;?\,0[A?WW81DUYTJYQJ2/0;%##\*#V_NOQU0"ID[ M7_CZ*QYG@@)JM?)+&6*TN+F>;OSV,M>J$F'3UL6\<@#H`B\_^>5I&#^%Y=^P ML2UPK]C/I$>",PQ9NO"$3Z8G;I1B*X:.G^#S>[V$+6:G+TIE.*GTWTZ8.?&\ MY+\`;SS4(MY'@(IJ;!TJ^62(RAY(/8!LOHTD/AT[]OFIH\=IR9JR]17[&C!9R)^BWI"=&?+,]+)"[IT8EN04;[1_(`V`"^;DV,H`E72+>S_[OW)B?`K MM.5;A#"N-CQ(H50-"IRG\O-'45GI:BO`8U=YOK*@&(XO[ MF"==@/L*T'NMPGHC?;57Z6HT3*-A3M/4>OF1YV]REFC:QI=R&Q,X:M/5%1_F,587)JL!DJ2!'5!OVP?UU]$O/M) M9&AJY^;WZ^$S8>_CL6XJZDB5AZ.!(AM]Q92[8UV3AWJG,U158ZCW.S>FHE@W MJO+A)[46][X1,77Z?X[!%+J*HXF_@[C^S:E4QVI_K/84V3:4@6R89E>V[GJ`VJ!%35: M-R*GSH%/(EUQR/C_/X57'&%IR"8,SC'>B)_S[="CUFV>]W1`EG3AL-<=&,`( MNZ_)1@\GW[1&\LCN=O3QT#2UH0F3W_OP4]?LU-BQ'6U+_!$,Y&D["`"0@6;[ M7(`*<,;RY[YB8L'H6QH[4>SYH1///V%6XV]12%`B$64^?D(W"TN.<06IH/!D MR[*T13[NBP>;;X:CZ2R(YHS1,UXO`Q<7NJ"7*P8>YTX$1J? MQ\)_+7-Y?W;\\,WVJDV)MG"C6E`I+R#I^3Q(EGZ>')IV?*YG6?)(TX>RT=%U MN=\S.[+=[]F#SF#8'XU$Y109QE"?[R=(6+"-!2L^AT,_R=%M/D_X-J4>X1YL M`KEJG=BG::C3^X7E*?.?)[]$X=U7%D^'[#:%_7G`$_?+9-HCI%[#\U!7J9'_ M$I+JS!!E.N@.^/X-L9Y6H<'RMPS>N=^N%P5?"G07X]0T,E>UI;MY6=I6:B+4&:MP?(H2I!EILZ#$26A?IZ,OO&B#%C"[S,L MV.2>+)WD?E3!`S\^/FAT,*LSXB4D/;>7Y0XGL5B/D`/HS)=U\YE];(&.-6?P M48ZM?GQZ%+VFFFYTE-4G\'SDB^>2A.%-*\S[$`@/(K)2Q;/'2*2"SJ>.MG`2 M>8*(A6V15VB#)W^E>GTE8XZ16+K.4.C@5=D:UY)0)[6/:+HL26"/N/5#TO?< MOWD'S(&_$JS@MUC=-!F00@"SCB)7/T_6O%*4DCW&LSJ98_,;H?7]*O* M^M,$K-7B1ZJZ07WIQL+Y>6'4=9*&#`Z-KN^(`R%L;W'J_\5K@!Z?-(-9VUEP M/3]!P)(O$17X%:]7[/7GOR<,M/>85[D#(XI7+@817W7U>X3,T'3#FON"O?QV5"Y<96%J7>10_\.;WU)M*$6P0NEY?4\_2 M\0S9>-5QC`*@JSU.UU+&9]'A>U]P\O<7DHTBP1D M4IE'JL4_BWVPZV8(ED!(#VYU9I](D#DI#N^M[+;CNAP>@:`GHM##U>,]7P5; MNGY2T]^ND]?<[(45B=J3N^#P=S:`*>8#,.-4(5 MN'\/"7CD&ONB*;>G+/9=1_I80GT,?OR]?=V6?K;MJ_++X8^7;4%6!?,AR6[_ MC16_$?%""C,LDH*-QG[R9]*6KOB8$"ED&G$("$*7H)\E1(#Q&-Z/,20().Y/ M-D?8$K"'O0PT6HO2/5G*P6VPE`&\"SV"W9QF*09&93'R7,'LX9@YAEC@\HF*@I6-,!PYEI"P>7-5.5#Y$M@F_6'&"%GQTV]C*TUW-*PW\_C_2 M+_X4]6!;L@/4#!S\4(Q90+X*T*0RGH&K9:Z40;BG>+E#BG5Q7WP*JV9+JZEB MJK)B"U)>-MD(FG96_L!RDR(,7OH"RCNN![57OP7Y# MM)99TAWH>E_MFW)?Z\"98F0H&$_3E36],[3'VMB&!T2>F*49A6F])6$5UF#T MZ^?)-5>#S"N]1:63Z1?2FY\G`]*:O\)A?)I-=R4+7;VGFV9'E[5NUY:-@3V6 M;:6GRY8^,'5K-!QUN@HWO:]4[5=!]K:#KM`-"P2+JXCWOH`1@<>3R42DVMBH&%TT*;F\^&%6P@X+1[./V.BFL-_H#FF"5V#3\NK`) MXB)AB*C^<61,_+;?):+[4^_)!HQ;,`F0+0"MAW;)XC M=4ZS%$X1!*J8\(X)7U$`2B:2YR`A@0]->FAU9SDLXOV,7RO*G_#GZ<1KZ06\\@^XO<%!\B$$PIC$C^!2'CH]=85 M'J')Q.JB:-9"APCL[,/1==[,T.YF*%^:ZO!D.3LKX0;#-5&YXQ[]7?2C+WOOZ@1V;TFC5'3HKU$XPO$?PK7Z#K MY_O9,]XKC-7C`?N\436K"T>[;ZK642S=V`OX)QX8\92T$#:]!_3/(V%E5]4T MJ^F3EV_)A.II]">#%!.<:',+[_%2SJ*7H7IIHK'1ZW:$\[JF&;-B=H=SOCN&CV>F/C)[=ZQDC$9_55CN5).KUA)Q2 ME/,3W-O\OG"@#4>::1NR:9H@90,#CO;ZR)#'XY[>&]GDUN`^#?D8PIY7Y[!5 M.NC/RT=$YJS]Z,1>[ED!4Y]YO]&]Q><)/;KMM?0-JDA=U3G[M=Z3ZWN5^(ZL MT7BLF'W9L`9C&9T)C2S0H@-3[@\U4^[J^EA3 MA]V^K75O5*%%5<.P%//9`(A7,>*%G$Y>U,._&)8+9)[]`.OHCN7A55>$][[S M&:AHF9L9BV^69T1[Q7R@&U5OF^8+9F-WS-K1>BAV&AM![?.8MQGA3@[QUA.L MSM?MGV)N#,W4:];:XOZY8B8Z_9YFC4Q9[4`/(/B:W#-46^X.U9ZI&?IXT!/9 MH4K[^:"@'3)C1QK_J>[0-_V*;7>!Z=LQ%N3[ROIU!VK]64+W*,QXH!G#D2L/ M'SJ,,&_-W&$ MYOY(-CO;'3HV(CGW$FB+U1O>CF3#,CL=8W\DZ\(.M91CH=A4>UUCCW)-_@L- M4VJM%Y.,]:`^%5L9`4VV;KUI,&(9V9>"$UJVF&6TP^J<(IIB2 MZUG,'.]S^(<3^^C/1H6W.YI?L`%OS@^=[\$=[0LR!+)*7=,?]6,N$%Y&RZ#MZ>;.6E MPO^B)3X*_[^]J^U-'`?"?V75[RQ)G!"HV$H!RNWJMGNG[:WV8]6"VT9J"9L` M+?_^_$)"`DD)$`<;CU2U-'%,9I[QVWCF\5B"!N[$,MH-9)1NX/3=ZR-5IN*V M;,-\9T[I5L$JOB*&*KLJDN4JV-K2DG><=ENHY`Y/C]Z'P*V`P)6[Y0KI;2O0 MAFO8EK7OID1913!>:2>KA`,EW4-=QQ+_UZ<=QKY27CL%AP!\^$R5^:+U*<:F M)P>TRVNF1#:IR*,B/E!,];V+6LG_8^ZJF`.URDNE`+B2621)QL M'=6I,%&=4@W*JIY\75+VTIKU>G(VTX\FID=RI*=5Z5@=\R!5HDYGZ`T=HV%> M#\A*Q#"N&^W!<-@8#*^'`]>V31<-[]QX>-AGVIU/G[Y[HOXS.7%XE#['0AD] ML>1G<\_52;'0FZR'V7(TUL9;'\A<]$4KWB!NL(KIDQ)C94DP*E5"448(W6V) MPQCZ243HX1JC,Q2J,:*P=*<75[TKU*#C]BP#6=<-9%MNP^Z;O89G#!!17]\S M/*_=\GIKNJB2TM0MNF.U+5&BHT-$7XG$OO`(D5AEI#K,LM-6_U'-CNF51Q^' MGZ+1,W[%7RZ>9[/I9;/Y]O;V.<*CST_!HMG_]C=YY4?LIMZ=>IN9^XU[LDSR0^I( MKB8%\62<*H8:R*15CU.%NLU4Y=WF"K^JP&1-4W$P-TY6TPS)S+`D)9*W<:<+>DP%4SH7'2K3<;#62[KN::XLA6#TKCFKS9RDH"F.;-].91Q++``U@S:S`RTEM-EXA,UVN0A>%J1%9@MIAF$F M4$I*#'G32AKI]X#[9#B8G**$+DG2ASYHB>$JO$]1##DK]PWE`,"4&D*WOC03 ME:H>AJ7.F]$54AI;K2ZD.VB2-0,UDV,@):@LP>"_Y12G>M?"O6\MT5NE`BJ# M7FHSGK3";\Q32QJ@MOBM,I95P"^^G&F`'$J]H,OF^DL)79*4U5LF'[^2.NE\ M9OF=SF:RF&X0,;`22#-4,Q0A4J)Z))5(;YE?P<:FF+;-.D.WHZ\!<-4XAY6K]&%B'<`M34C@VA`,?9N5T.2;M.),%S>BX8@N=4?0S!D+AZI+<)NN1I; M1#^8+'`X\Q]>\+\A?L1AB,>B0W5E,P>Y/'X2:`>U'*8>TX)4KKILGP,(&]?G!JNC@)%`])A^Z'2FUXY0;NAU1VC'Y3J:-#-[5F\AE/0)"#N_Z M.S3?H2/Q;D%\JH4WXD0BV9V"K[/;942&AEW+E?(CS?PAPG_F=*A9D%_;KK.- M`F)WPCF!XU;#<$N#Q8N+`,\V6;&,L M"X@Q6R64PXL)4,Y6>B@;4YV.U>E(.NO^>$PE\VM_/*_8`4B/:+TGI=/!2?$U MD5C`TE9!M("R0@&0@(A"3F"`7D)J=(`T0A'`G);+]CAL0]9^+N4\O<'W]`!C M6L$P9&O*T;+`9#LZ1&3=+)W/&(_@DEX9J"U:&"DZSIM5[EF MYT41GO4IL6H6NAO2<2YY!/IP/AE7YIV$%I]O/`8Z(^/ITP`,QM.+HW\>!W@: M1/ZN]1U8T*$6I*$'6PUDP$$L*R9`-B$5*IDP#^5&06%A'S`D5F!.^IJ/6EA9 MB![R!ZNI0QO^P69D0B\DU++)7[L-2[U3F;<%YEV]>9\\@J).F65)JDC);(O' MV3$DD]F)8U'%R0Q!IFI$!F:M@@?\G<`J=/2\@87D6`B$A.Z/"8_T%(<)B_2\ M8ZT5,8H+NXU:6!!!UJ0AMYC)9"!:#1HZ*+,25_S40LKB$:#:+2S[(4@ M&@VBT<[-O&7:8A0N,X(MQNHL%-6'%DP#%<%*IM[D`)GG$Y\+[$>!;9GNW:_; M02+2*^__KU;W+LF];C.^R"NCSV_4%%'V]6BK$GZYQ/.I-[DC+WZW4=_87Q`= MK>6GS_V8OQ*[FP5K>R[S]EPW^<^S:@=X$KSZDZ**\R1:U[G]<+>9>O=\U?UY MG&TI;CX++^F-$JKKD>Z0V-JV\EG@5GRW1$53K$GJQQ+-]T@T'1)_Y+Q'? M+:B(]P3DP_]02P,$%`````@`<'*H1JE]?(&2$```.]@``!4`'`!I;7!R+3(P M,34P,S,Q7V-A;"YX;6Q55`D``S3^3%4T_DQ5=7@+``$$)0X```0Y`0``[5UM M;^,V$OY>H/]!EP*'.^`<)YO=MAOLMG`VR<)`=FW8V6YQ7PI%HAW>RJ1+2DE\ MO_Z&U*MM4:)CR11S!8JVD?GR/,.WF>&0?/?KTR)P'A#CF)+W1Z?')T<.(A[U M,9F_/_HR[0VF'X;#HU]_^?Z[=W_K]9S)Q+FDA*`@0"OG=P\%B+DAFEUO\7`SIT?CU^].GY=^&5"(^*?.S\7/GU@**[8!TCGSJN3 MTS>]$_CGI]N3L_,W/Y^?G?R[F)HN5PS/[T/G']X_(3&DA!QGSN1X'"0]=XJUE%(6593U]^_9M M7_X:I^;XG,M2;J@GI:0!T%&F$'_UTF0]\:EW^JIW=GK\Q/VC7T2%[Q@-T`3- M'(GA/%PMT?LCCA?+`!TEW^X9FKT_@D],2/[-R5F<_X=+ZD4+1("J?T5"'*Z& M9$;90J(^H)#AIV/DSUW6HP2*1K(;A4F?[(L<_585/$A<#G',XS\9S/0+/Z07,8N0\]ODAWJ".]1 MB#TW:)[=$":[!1H$(6($.L,#:H+.=J&-XQZ!2)B8E1BZ1X1#'7&E37WU\'])$/B8\9\L(F.&T7NC?N M2\R]@/*(H1&;NP3_5\Z3(*J+B`,>S@>^+\>I&S0R.3^ON@9I7KN8_>8&$?J$ M7/&WD"P?<([@W\2_P>X=#@`!XLGO_B#,LHS(!'D18Z`R7;@<\P;$T"B$UBR/9>$ M7PB]$]JQ>Q?`7+J,0OX%+(`A$7G4H-N2U_[`&A3=P/-8A/RKIR4L-8AGRP^, MV$*5,+2GT6+ALM5HIIVC`?FUB:Y!(7YU&8/67(WN`CR7[58`%,!:*,RD:\I* MTC4@I'UJ;U`(E^@N;&ON59?=(`%0N18XC*=UXF?CSH/.TA:OG:ML=N1'"^$< M024:YPWE7)CY?A0@F(/N78`%"EUMG@L$6-&M^]34\&\78H/BG(;4^S9X=)D_ M#EPBFE-^N1"^)H$!`,1J9$M=:;_Z#0@B;[LK'N*%:+"O2/BR0$UX0,R=(]`P MH\523E3QLEAPYX&1GFF8LU&&!4)9"^$+"RKJ;C\0&% M;8ZCT08M_SU9DXV(OQI1@\**374YN[0UTFNK:'9-!*TTZ8V?42@FT#%BTF^1 M*1DB$25B$=M*T\P:N1\$`^)80-\3/4[X=![<0."Z>O*"R$?^-:.+M6(N<1#! MB#8GN`;`-BIBT%9)R)(*)YA_$TK\;';A!D*1G=XC%,JOK>ED>P%HQDGWF88( MYO;,$9WYUWC1)050.0VPG_JGQ@QQL:F0+![;F7.6M^@IO`B@U9\ML0-"M$VF M8RC`V\<"-@"U;1D7O!Z@HM-(FCII[6WV1LV*V^:?J7)Y([1*N[H^HVQOA;NK MC<&A4VO;S),^QL?N2E28^*,*CJ?4)57X5%A\8C]5FQVC88!VR;.UKM<*S+9E M.V;4C[PP=0P>1CO0J-0\[];ZB7;5;CR:1E)=O*=V`7-8D!FD1\44<]T[.4V"T7](/O^Q82XF]E]:4^#>H>#]44WBOD'<$^0A+,.6/J-0#WUI%D,< M-FSS6@**](;0J^,;XO50;,V`C$&J&0-K:4R@3&.OH17O,$GW/Y+02+$3@GW$DJ4DB9.L MIK1'@9;P_PRJ0],B*)1I0@KB<('PI!SJ5L]?(:897/ M3)4$-I.9P'J)9@C:WY^@!T2B&LU%D;@#N&O'ACJ]"?0?*?4?<1`HP&8_F\`V M%)K_'(M=#[E*@-(0QX_`F*K!K975!*>U,/92Z-NAY,80IO%O:P?)ZF&79S/, MI7H^Z8@.?D/)_!:QA0Q+%RN*U"]OD,O16FA_.0>]S-WE5=-$.Y5A@J4T>)+Y MIFX5*$]K#+7V0%&E[@)R/:&79S"!?\P25:!602M+:0CQ$BS?)+PYC3S0L?-T M(A2L1[RVF%;%8+85G#S0&)96*+"8X3%#H@KGEI_[M@@\&E$WL8143 MC8PF^&CK'%5:1L$%/&#KT%WFI07"_Z[Y?[>O`$E2]+D(;!:E]7"(%FG^&:.+ M+5]+6AE5N3DF?7@)IAJF.H*K*'J%\VZ+%5. MWLX93T-YV0SKR==N.WMY-655-$T^MNWLY16L=_24YY*P2%77DX32+YUSMDA5 MU^.LV@//*=NIHE=0WB?\)A>+16XTO?6M=&\@7^`L&NUZ?+3TW^.XZ+3(?+KMUYW!._VM=9&0OJ`-(TT%5@DT2V0"YS5E,/))K/UXJUOF M$NYZ8D!\A"ED[09"!8E=2C`2C(@(Z'H!=-^!O\`$.*MDEJ<.FRN-*EIS'IPNX`T53WU$!=3&T&.Y/H,'?63R[ZAPOR@`J_. M8`+_+5HL*0.E(WD\Q_,8$BK*+9T@'\7W*DL_U<#_3\3E53P*8L\IR:C?HM[P M7/?;;9AY5H8V/H=S;C!:&>!88J&L[:]N3I)61@G5D*QJ=D5P9Z_;A`]@U:WM MT96I75;NSQU8<#OYOBY>J[\*IR&-^\ZNP66U5(F-ILAK5+_I4,SDQ- MJPN):*LVP^[,VJZJ8P38-$ON2+FU3F;[C"LO1EZ+6LQ>.E9-P^9!BP/-UP%] MY$/B8X:\T,3ZH!_(/A!/=,R36YCE\[)#,EB(\SW%5[G+8]]/%?/8H6KOSMV, M8P2CR8>.R,3AF$L4_U>U%.]2A)E;!&%P>?%+]\(.6U`6)J^Q*2A5Y3#!X&HV M@Y$WFET]>;)736!XCDBYX!64=BK"2%A?XIP?D4O,ETDT\V@6'ZA7#-BP''0+[9`X9#S2#R$(Q_`4N#7S6WH9DL/(5]&!TA((^EK MX%=/B'F8(]61K/I\G6`C[AI4-DMY8C-AWLODQ;31K/QNARGR(E:U\.]4A)%@ MW^QUN.+[<:I`W_+$9IV'SW`P;#A0]YKRK8R8:TEHVOJ"E5%=+0E-6]FT\E:L M?86VFV?*RBNTFC%"UBX@T56,%*&"'8\A:%Y@NZWTUD8<-MW-%'J=K9&(;8MG M6XFW\N['9HSDE[:)W;Q4*K>5K+SSN'D9JNCTOQ8$_.U>R/>1T ML/U_*X\;-B]OO5T_.X_Q'4):>KLSBH#HO^2WO1]KY:F(0X[+++;`RI,4AY#4 M#KOB5A[).)@,R_?5][LMV5"<(VA=7D!YQ-"(S5V2:._0*U*%([]-=$AFE,6- M8#0T,X=\[6(F#\Y]@L:!OZ7.$Z\MP*#0.,GO_B#,LHS(1#A,&+2B.+C'.TW) MMC8`T5+B@?#=6)W/]SS,B MCYIO1\@EDWUZ2"L+OXXOO2X,F:F8<-D*3#'='";"HA-PA5/HU0]%JM.;V-JL M>(2@"GU''DA-T$S=P&6ZT#<3FWM(=T?1UV0R^U!7'9>2AR^V6LU*E^9SF)?- M%5;Z*GQ.DK\3,'QQ+-*'89=^1J`<#Q/O7OD1P$"I4TZ2[GT*%3GR4[DF5%Z MJHX7QM!`_TXNP??B3K[/0=7:(KMVCK?FX+165C/1?.LB%MNR&J]9)'-X'+%2 MU]#-UF'V8HH=NH#NZ=SZX6.EJO!<437<(Q5*AJZ[W_AB(F,D!H\N\V4<21JR MM+6[V^4%49=#OBY>\1`O1'-_E>V%_,$#8NYH&JX+QT^5.*@08 MA4E/@@E*S%,PF\A8BDRO%XDHB4/B-M)81B.]2*X0*7KUY`41`(EO7RP4]>9HEV>GV M'#/J1UZ8^@+MF:+K@7=:[L+%:8^P*QR>5I'8NK@,$ML.N]O=/`^IF14MP0F2 M3A-YL"F/"D].0G5^^=Z35:=;++.*[1G8Z8N^J0%H+=Y.=XPU>Y:KS=F=^LV[ MOD!Z!\,$_O@?4$L#!!0````(`'!RJ$;G\QR\^AD``/V8`0`5`!P`:6UP&UL550)``,T_DQ5-/Y,575X"P`!!"4.```$.0$``.U= MZX_CN)'_'B#_@Z\#''+`]7LGV1WL)'"_)@UTMQV[9W?OO@S8$FTKHX>7E-SM M_/4A*5D/2Z0HF3(I3P.+V1F9CZKBJ^I7Q>+/?W_SW,$*(NP$_J>C\Y.SHP'T MK`X?\.Z)_V@'SZ[6KR,+@X.1\,%F&X_'AZ M^OKZ>H*0O6GQQ`J\T\'Q\::W7V*Z/@[^7[RANVCO]$.?T:!"R=P-F`4?PS72_CI"#O>TH5'R;<% M@K-/1^03HN/TX>PRKO^GF\"*/.@3P=BW?NB$ZWM_%B"/47TTH.U^F=RGY#L> M#)'S=@+M.4#'@4^:AFS2A[(S>G#HAA#Y M9#*LH`IVRHTJIWM$1(+H'H;@`OJ8]!%WJH)\;MO*N9@NR.@N`M]]V$+1"%3R5&]V9[AL'6VZ`(P1':`Y\Y]]L MGR2BNHHPH0?CH6VS=0I<)9MSN^X4LGD''/0+<"/X"`']-Y4L'F(,R9^^_>"` M%\K,?7)D6\`/O_C!"]6EP8M+]M)E M%.(OQ%ZX]VD=/M%=R6MWPA2*;FA9*(+V[=N2'#40I\!]!Z M-).NH4!^75*G4(B_`H3(:*Y'+ZXS9^.6(\@E9R$UJNX"5%%.@9!VZ5VA$&[@ M2]C5WLMO6R$#1.7RG##>UGT[77<6F2Q=\=6X2[4K/_(BE^AM%1KG0X`Q!07L MR(5D#UH`0A91Z&KK7$%"*WP&;ZJ6?[+0\>C`_8KI,@741-6$($Y)!IFY"W91A4?B]?` MM>C0LH,QTS!GH[C09[J]D=J^'2-HS\'0(D950M(7GUA9M]/Q>(_"UL>CU@&M M_CTYD[6(7TR10F'%ICK;7;I:Z;5=J#T3B5::S,8G&-(-=`P1PRU2)8,6"GQZ MB)7*J#DC=R-!@S@\,O?HC*.8S@JXE*[;-\N-;&C?H<`K-'/CN!%9T?H$IX!8 MI2(FVJH?HJ3#B8._425^-KL"+E5DIPL(0_:U,YUL)P+4@'1/00C)WIX"T2F^ MAO.0%"$5!ZYC;_"I,8*8.A62PZ-<.>/R&;Z%5RX9]=82VR.)?9/IF#1@[6(! M:R"U:QGG4`^BH@<1,W4VO77VF<)=72P.F5Z[ MYCR98W@,UK3#!(_*`4\;2"KW*7?XQ#A5EQ-#,8']DF=G4Z\3,KN6[1@%=F2% M&V!P/]J!1*?Z^>YLGDAWW;4,**2ZGP'G]=0UAP)P=3^,-R1@#_+8#BF@A3N6 M@+A+W3QWMLXE.^Y\E6>A#+,\\C6!#"&_#C!1D*D)S[`Q\W@+DDPT]1<&Z9)3?ES8N.YOI=3UV?V;D`$#, MQ__VI42TIR:1%$"6K+`X(=:;X&T:6_V!R1"X[M$@:3C/;UK+\<-3V_%.DS*G MM$*'])"NZ%D;^,?U3'=RE;LXQ<%B`RM()@2OF2%A'#Q?_BG",Q3P''/+81'O9 M#A*90#+GR-X"IQ"M'`L2M=0);!KT/(_G?Q)V-`"Q-MQA*P%T5)8R*V(J1:M&H<"KLSDV/01CX(?P+;QU60N?CC"K6]TM0(T1WY4DZEJ(^LEDD1-8"(*4%6K+%0,N,<*5#H M1J^OIP,2K:**[VCDE6Y&>3EDFG[YNHE1M`*T#.*`Y$=BV2[()/@_"%`K,A"<6)1D[]L2YA\JB*(K;]K>ID3K9^`M^UKE*VE1N*8 M;)&O-W!)@QN3FQ[/0<4@5PI;NK(26O\13M>8GD6580>5193T^Q31MD:S*P1\ M:U%R>E274=+SUD;X!$)V.V55KM75;^FQK:>N!VIW5BH]VBUK.N5=C6>3M:@FAF.?@ M:Z6CI:,JIS(=H!NPM=BD[2F3W82[39JF%K+)/L7=)-'^%#'9U;B;3,J6JLF. MQ=:\RNO$)OL*=]P(Y($;D_V%NPFAWKHSV5&HBG>A]6VRXU")`.H@$I/]B$H% M(#<-=#D=:WUPC6'$@EN.9YMK-QJZY9MK825\7Y@>_BG&5&J&V!C+4,:C7H?! M"'@MF_URRKQF-Z[21]UTW.AGI%:D_!V^X!`!:QO;EJ^GT\U['7@OCK])[YV\ M_$43?1.;*;:@#1+#`%QM@1!#1T^J4G[(K/`5ZM6766E4>(:G?6W;OL6G>G M*8>$&G9*FGDG0LMZZ:^D1%?J5?:@54+YV2UP#/++:Z8^_>L_'')\(VNQ?H`K MZ,JQ(JJLF:^<]GF'F%9MK>68XM;4RE'\C"L3[[GPO!?5,(6#B\8<7!C&P65C M#BY-X*!J;LNI`(*:IG"$R]M18][X;7P77.K6S+;>_XXU`;FE)JJJ@Z<`OL'P+O)M<38P3F%]@)PTNE/(D"$/*9CL>=J7%9D7'6^V MF.RAUB$G(:ZCW9_-37+0D4F=EXQ26_0`XZKV.!02FZ?)?M<]2DKV\#??0=LA M)%2YRFL0">U./P,%M@U`:?<"&R@C/AR42.O2!)^Y*$54+>*H_M"L4EVT+T"Y M$`,CI&5$@JKFTTL"$JZ4GAQ(89)`Y"90E_(P;8K(2:0.7*\31PE[U"^"!FIC M/8A:.QU*V);)T;H[H9&5HJAR9IA\>Z-3"5R4)6#>K8U.)7!9EH!Y=S3:X;I5 M89N-8K&:1G(;&?WWGL*E5]QH\@+I2$GS'F6Y:Z1%[KW0SRB(EH34\G.CUR!. M?ED"S;AA&"V;U1QU4D6V5!B4J.I[),U[#,3>.3(I$N`I\%'[8("*VEHY>X(A M`XKJC@)!!24).4C;CAT)TFH5"_0I=<86:_J=S7(8W(%ESMA_NA`CT+1Z9_F. M.A/'Q2'0/;X'MW<70JW8JGL%4RF4R8[@A29$J[DG4D*';W(5MT^.ZH:L-_&N M&G$C6=+]=8#.#*ILEJ;PMHE8;M'G/9IEAT"Z[U=<[#8$[.6> M6&)4JDU+9L.00X0`^`_T MBN!!7>8ZO*M/4VL![AONX>&&B[3IUYCZ[9.>' MI5AN_(4<6/?LM4F^9:O#C/U.%/$X]/Z?$:"IKLD(T%?ETEBQ.@.]75NFZ*VDV_YG[#ID=9+^_]]LY:T:R`#RV++'7[]HV^]`YIZM_XW>`(H9Q&[4`\ MC3P/H/5H)EW#B-=J?P44C@C7HQ?7F<=/D&20Z+0WRAB&X:-QM/V(!(8B9\G\#L84*#W_4'D`WT0V3#J\YJ\EEAKOK57R(A9::_H MQX&D4.CV+/8E5EID3N9YK-FJM>>+Y*+H4KI,,>P?$8!YJ+W_`I*DA2Q]G$VY*7#-B]L[]1"L]S8TB_?7T<;A&T^:I$`D\1W2=& ML^GO$4#P#L)P-&/,VO%LKA)&;1TEE(V6[**#/X^7T1Q!-A6''MMN*GSJLK5T MK,(B67A"M^DX*BJ[DT`_`I>W+)NTH`7,CC&MSS"8([!<.!9PQ6`VMWROJ=<4 M5)-F_LE3)'+B<,OO"Y25.PO2_&^[^VSA6Q7#Q;2=^\3<12IY(7^-F]'A]8O224/86G= MC,&\BB(>&S6AF<=GHKMB-\Z28O\KP@P3%<832E;6P1=]8CM<4W$'/J%$:%E7 ME]6"V=0N_`FTZ-.`\2O/+&_'9C_@@3B[-&F:#)ZHX=&.U[2JGE#CHHCOB#H@ ML34D`3YC2(YUNVZ@U?;1>REMOZ'5I;32OK3B<%O;&);!XBKK[#M(LJU.47A5 MO-%9?8`8G@9AYE5:D\$NE:+9[80V&253*:6.=G+MT)MT.%`;TZ$2I:K>U/7C M'/7S2*B!IT%I%[V247RV9==(,#OJGQ?`CUNY>2MR]+9TX470\.4324])^K^9>G4M,0<.] MDDY_NW\ZJQN:NKZ2.M@E<)ES;I*\)#!VT):>,&!P_HLFC MN$53>H-&*Q&S@A.EDPU!!)$1!5\&H5Y:]=*MSH"W4& M;?7C@#O+]H"#-3J2O3H`IP\^UPZ%J`R'[4-XC&%R%.%#?8BCT21.E>:5]G@; M;6)NX>?L0PB%8>>-!#BG/\I"FU3;FM%]2('6X40L[5V:LJ29>T2H\XYJ3[R[ M=R'O!KTT38W5?WEUZ_3*Y-EC\V0'-T)Q1HJ!RDQ6/39!5,BJ-HPJDU2/K8L= M)241`I>)2S&S\):"[/LWUO._YN-5S[R4Z M_`4[N=]?_N^O_W?7?[9G\ MG8<$=*2"OP<(=&@FOH<+=&KU'$28P'Z19`OD$:XRFX",(I^NZJZ(>KHA%<9!#=AH&&6BX'29Q,>3VY9@/5 M#N'(P7XJF3;B*H^$8B]U]*4:.E=[[`.J(DWL`5N4]DKG<04;R>V.,K@E2*^I_X749A$I_W!$.: MR',,$1N":>1Y`*W9[9,D,V:I3*^8V%RAH='\*W(2$H9NWRPW(H30C*F%9FX< M-Z)AU57L[CD0T0\=FU)#3JXIM"(RYQW()_P6()\<["G)0R^(N+E\U+2MY766 MW2B_6EL%A8"VVLU5N^4L&1=IEMR,P%CYSS(I5IVJ MD01O>MTY_[4AY M1VS6&A7:,]BTT[$L>C+A";2@LZ)C7/>.<75Q3;9_)FTJU2OH6PL/H&]")*.VV@'Q MH@^5V2)KG1(F@%1KJQG!2QW2*:B@)*ZNU/XFU\MUA,/`@VB;,-E:1DA7A/9P M"FM!;6CDQ`2NH!_!)RC&0ZK+ZE.)9/>:@H)?S6\?E/PV[/*/1?VJO1SP);L% M;^F]-9+2CL'(H5==,&\V!%5_2@EY/7QP2$Y`T@>L=B!'V@(4G[#B%;"]:GIA MCCT%(<3/P9U#PU8=X*8A;'B$YL!W_LWX(\SBP'7L.$3)MXFACTF936JJ*;QFB7_3$Y)@U8Q"`WDMFI,_?9,\=^F!S9-*ED0K'9XY3>&\UD MWF>*V:YBYB39*'-CL*9$DG^28\Q^<,`+O9KKL`AHEL`U]RF'Z<2O8IL]-&I9 M-'@LQRBP(RM,@.AU7S;E>K(-EOD-?`G[(F@:UNF$\9KP;7+^T0.!*#&%^6X\ M"TL$%U2G6R51P[1POXDV>7JG\R(.;=Y$F$^@2U.:THM0N!2V;OA1O2-/!H]6 M&D;?E^5<&UL550)``,T M_DQ5-/Y,575X"P`!!"4.```$.0$``-U]?7/<.)/?_ZG*=T`V;]ZJL3W#>=_< M_[3WW[Y=O_VXO[J\^=? M_N<__L?_\`__Z>U;='>'/@2^C[=;_(K^986W.'1CC![_O7__X\>/=V&X3JF]6P6[]^CM MVW2DOW.>?D.S=X[S;E+XRUUP\->_H47A5UD_/,7JS^I4\3)XD;XS1W;N[=P7Q_ANZ#_R(/+W; MN_XKNMANT1U]*T)W.,+A"UZ_2XAN$W$14:8?_>V7@H0_'\/MNR!\>D^&&;]/ M'_SE/_X'Q!_^[6?DE5[X,4X?'[W_ER_7]ZMGO'/?>GX4N_ZJ]"(E5O?J:+E< MOF=_Y4]'WF\1HW(=K)B6%!A$PB?HO]ZFC[VEOWH[(,8#[_%KWO\MU\B;[??XE^2WSV'>%//Q38,W]/WW_OXB7S+-1UA24<8 MS>@(_SGY-;.S7Q!]\MO=9Z%`RQ(M_M)[8TP^$!/&K3@MO)FPNZ7_H+`J,8Q_ MQMA?XW7*,J4A^;IL"&88C"@E&ZQ*!+?41(*P5@6,UL:-'AG!0_3VR77WA/!H M\AYOXRC]#<72Y.UPE-C$?TY^_OE"0(<10,L%707]_$SS@L_.J#%ZVV070(\=4A#+$?/Q"/<4F8 M_%-N#%T-8AZG'7&N;/KCV:B,[0@E'`Q0P@,JC#A`KK]&C(_BKU'.R0`EO*#O ME!O$V(%U#2`Z3=T)T^#'GWOL1T1/N?92+16&ML"]=(S.&I?4Y<>PP(TE?*D9 M8/HPG%M).%`UY86SG#LB]Y#0L@+:K>1R2G+M.26+0'AD6Q(P%<6'!,4=7F'O MA7+T!>\><=CP\2J/`P#CF`=E+S\E5G0$C9P6^LZI`4]\IPGGM!'.-%9$)E>' MEEIUV(&7KSA6FTIJ7P'%3EX ME*&)K3B^83^O7011= MXDT0T@E^)/[`FG3,HDJ/.67#G(R'PPQPZ1CI+GAQE#1L?4,'^G6`'ME8-(KM M!9![''K!^J._;@!EGVJ94+40%NB!XR,Q=P*B'F6]C]TP!I1V2J6]Q$^>[S<( M;-`GM8/VD;MJH36+/=FUY^//,=Y%IYE)3L8^/Y;QIKPE.EJ.)BW<&/I.AT)L M++C=X!Y5XG2O$LO07X%#"_"7E6LQ]K_B^&9#G-1IMI11L0_Y*6L:9X6S>:OX MY2O?X.TK?ND*]^T44H%]LL%04LB6D#\#@!_;?`M\EY1H,;P?Z%;]:?;"2=@' M;,:7\MRUF,Z<5M,Y&\;NF;R%)MK,XF)-6(;ODM&W`'>N3TN1W91MH?B^79C6 M2UF8+6:S92M`0V=J]*&'-G"V(ZE#S]0UP0R?]I%R^!"Z?K1EUUDNUO]ZB.(= M]F-5&,M>AL&PA".-G*/EJ`K@`F64D[8'M9U)7H%L"\D!<*I@R`*0-FE.#Z$> M`3O%W70X3E!'?_/'Q7KMT1'<[,*[ZGF7 M[ML=XVX=$#T1NDP]I[&F:(;3\7PY'?TQ9F:8$4><.F+D$:./V`"H,$(O(*SS M/+U*/K)%.MZZ\_^E;OW8G=+(IE=X-_'DGM/S2^:#`P:N=$YU78JR*14 MD>>CA.X`<4^HOB4BKSA=T,E?V4A+$[^:@BQ"G3P:E[X# MCS7-"'0\&P]K8?8VAQETS-V=H,?@TA$4&&62R+I1/S#82B/[Z"$0L'C_3,(* M5FB#+MG)>IT%O7?XKX,7>3&^Q^$+F:YO60K#'5X%3SZC\G=W>Q!N9?<]K%&$ M]RN+>@['?#A+G43&$HH#))N:&6=O>1F5(F\#E'&'$O80YP\5&(1R-39IG'DK M-D,F:EP5!DR3?&%=E1F,E[V=@4\$[C`I5_[*8Y=K"L<1P94;/=^&P8NWQNO+ MUV\1O5V0+=TN5K'WPF]4-Q0HZ6,H*,?8$?\ZIV:36F>8,<+._\M[[.3/E!^4 M,H0>7]$;RA-QF;^B?/&=\P5?7@5O<4O+Q?8X][0_+#L1,DO_KC@G"]IIQ_ MVKI/1T99_;L!=U,95+VNT#0+F-+W$25@%LDG\N^H\=\W@H2F0DJA*]:!HAS M`#3QFE>>4U%>E"L/EY2W*BN/O4#^ELW&9!I!$>4#=+;M$HREZ;6S;W.&/NKR MM9[`Q4]/>&&@QQ'/QY_)Q-!([UG,Y5[N.Z4'M5JP14-55Z:DH3/Q3"H0[-!? M-7Z6,_1BUTUWG+HB?S[^Z5K[`M!BNIAT&G+9<%L*1(E2?]6U$L_$RU4@VJ%+ MNX:_CU4KP%=WAS\$.]<[3OI2?@W M05Q8#%?-M!F;1XH"P5P4X5@XX_,_FL0/&U%YC3Z?+\<)2MB+0)5[6C"=E^E! MKI!U8Q9=,H*2W>:BP5EGTZ%=^2'CUJI]AC.>S19%JX4_T3I!#D>./K,F+#T` MJ@H)9](-%:5*SQ@W:.VJGHN14[3GGJM&J;GC5D(4O'):%\X6[RPK#E41&-RP ME5SV\;-0AJ[?'67IC&H-WA)/?I),8F9XL#JUC(>I2M9^CZB!&#/K=J+X2B+8Q5U\6I+Q?3=6WT6%4UJ/)R. M)D-^!Y<-@FXVJ#@,(N.@TD"\3]WK.[-W[TIX+93'B:Z>Z8^??9['?K,1BL=;W+R*&F*8&AW` M[_0LDC(HI_/YL:\JL"8!99$]\AACD%ZIY"S2-:;HU4'65NL5ULE9]0WX05.F MQA=V%,!7ZJD6]T03S[3J%EG+KW#6HZMC+2ZY%GW\1(OPG9T>1ZQERAVF"N26 M&O*K^__&K_R2@<@(O.F1N]YYOD>W[UE^7=8/C3P6/V.B^I!H;A_P]BM13/3! M+QB3SY+<'"8]O9--,4!+8?E\GMOWJDBS%YE?4:!L2F_;M!7J/*DOH,UFB5YCVFIX2)ME!)'CX>8H#]&K\38Z0`P^.]' M?`;UVY!NL,6O;)N.%N3<[XJPIUMTR95WST?N:D5WDR+:T)QVXN)[>TF3\W13 M#](#Z)I^$>Q:2@;$->N1XT]R#[M$'VQVS;N5\-*/C@SF5WI++# MNEX-?U5VP*I:LL<-U]P-T[*!NO?!W7$-4^JE/1;C6:-+KKWX:!,T3]9`#L\" M*M&&RIUD>9`E#,U2(+$%,6W[\"HQ[&;,BM1G#VYY@P<2VX4TW/N`^7^U;$1` M`AR]]7PIF^_,60X;`9PT94D'06_287Z%*7C1GR98/0S:M&&=O(Y8P[6SF7?E MAMX,98D.0=",P]C;>(0^CFXV'_`^B#QYBV39&R:Q*F9#XVIQ6N:W2(T&MPD] MX&YLG,(DD,1O* MKMU9.NF>>TZ-SW5%>D`PZDI`IT[`59$>>O,UB#&:UT[;QL#4;(DE,#6HQS(P M*9>]T:-A!^!.*`[C#)VE`@1MJHS3HR)JH=I2$1;@5JV\CKX^K<6VJ'I)2R*V MH5NW/(4S(S]-=>$-5JO#A"Z:$6X]EFLKE^"V;P0.`<^8H,,LB[9?!R4#H0V08CX M4"@="P[:/:K$*:@DXBI)#\,CKI*PJ)(-5XGG1[%()2:1WPH0Q^#7URXP_N7; M1I7G8/"KNWTR<9PJ/J'WA4X3Q]$2!P`WDHV?6LF![?[6#6_">WJS=GDH#+KI`..H6[$KIFQ]FYR.FD)KIH, M58`TJ7Z`L<>GQ8M#_!R$]'9Z\]>NO`&#M6,V=%QX;<281(HY17!0 M2P>&GQHCE(+H6"?`2))FUA\_!H,8O\8NOV]+>3_X&< M\6`Y7P[F\P5[@OQS/G$&D]D\)'>SV(7[&?D3T]ME?!3O\%<A]WB(V=W).*!;'KW=*6_,WNQ*!;.J"K9$=&`0 M-=GE$9ZDJK`%6D&L-.K9SF>-2$,LJ8];5:KP^ZP M9?NB-_$SF;?*>KBV$&YUMMJ$N8J:8(!'Y/5C7M;ASHO^O,3^ZGGGAG]*>T')>-/;8\@5>@22B-%%&%+AO1+?2.B=):PYQ:D9:1IR"GNQ`W&O&FJ1W M1.-KH(@K\Z)L@W1;6P5Q@%TENI55`6_@;294#52.MAHM68&VZX;^$I(7(!&6 M<:%C;U,AMN`[0G0EH0A1MC1W:#9`*8[*6NFD76)EC*\'NCMTL[DZ1#$)3,-C M:*B^9;H=8C-+BJ8TF4R'W/ZPQ)4Z6-@3,")OM>MBUH"*O8$I0>4/#KJ5E M'B(1C57P2ZC0]!N:,;G=TG\DQ;Z2Y,G1\+_2/^^"D#5+"/$+]@^8O9)5!0OQ M"GLO=',+K-&A.I2SQH:*VK5BKGZ@RE6=/_C#D',TXT#CH"U/6JG.7HR6+5-S M"\&$T[)8,+`9N61FTMDX5T3W,W%$![CPUS>;S26O8'__C'%,?]M\!^AD*62/OYD@%1,B)B0_(_F;PPI#;I]ZFAJ@^R2T,:T4*? M:JKQ:"0R8-IPN:+>5A5E1V30SK74APPM5`P42[S0B@C$7]\2LIB65U2YD2%_ MRVQT(6-%8YMW-L\@GE)$&4E++F]T**MSBJP&8Q`5\SP*1AJ5!(.T*+[9_!X$ M:WHI\QZ'+]X*1_?!5IP[*WS!*+Y$7*@725SDJ4X12WM@Y-ATD!)$E")4RD,W M$K*,AP7TZ0 M)*T;OSZL:G.7``Q>P;9X)%9\LT$%6OW&2Y(E80RJ.M75R0X'A]2M2#]7]I!Q`*0CJX<_X]&L;/DI"4A[;R<&,_3C22&2 MB&/6XH]-IVKJ);%!;#S$:R_^Y*Y8XR]9IEKU09.V7AE=V2-.)[.T+#4C@E(J ML`EH)PKDZ`EDS.Z%YE2R_7KAX>U?GAU=]R@8!C3S@A?SX5B``MC$YY.%JD>" M#?G-$M,2HZ%U'K-HD<]O77@OF-ZPN*7UH\ERB1=GKUVTR9XWOMR7,*-H)>/Y M<#E;)FO^C!R[;H)2@DE7`L/+_LYD&T')UK#\[TQ`YTA`>C4/[5,!/1]]\[V8 MG031.NEPRWX%J.5K_R;M@,R&O.OK)TQ;PFX?W)\?>3_,2^SCC2?<"FAXR^0< M*6=%9X\X3:A,6@,G).D=6)0016\2LCWU+FF<.[L4EF'LV[O[=VB32!H32?=A M\.+1_378U92:698F507=M$=8A%?OGH*7]VOL<7"1'XXQ17Z5<>%%*W?[?[`; M?O37'XB/.OJ@TD<-H$`XVEBI.@@Q*RJ3=!%X(Y^H*9FCOD M9E:<,B2*@,='4\T$T=-@"&E3['XV$4`$O"!")[)E*+$'#]+R!C*AH1#QV2>P M9)L&EV[D1??[$+OK&__O;NC1+/X[,J.-)-]0Z77#F%'A2:,GS&)<`%%.>X`8 M=<3)TRZBZ0#HSGA%BG#H,0C#X`?Y*1H@>E9$9(E1"!2TM;7F8V0J MZZV3;<3RB%F;UE*'94$,I_^^Z6U&'>94LU>FL_%BRK<=CY!8;&)<[B_?=RPH MW(OL3P%UK@A.`?(-R_ZTX'2I!2-[F6WPGNUM:BL2/IKXXL:'D!Z_5'=G%%X` MBQB*7*@7Y M2F"V$3Q)DCQO1);-5P.3!8W!H)+?Z4QRFI-3&.''KWW8*.[J.%">"B;.>)D" M+;F=FU`:H(06%*Q.EZMT!+@/PK18P#H5U8),>[FYE6$CU(@%./E*1-6!2N%Y M.+3D3"@;UF@YFXH`DY.S`C-MI7-*TH6I=#XO*;\JX\DB[%1-4`*?(^5`(NC! M_7D113B.ON(F\)0>!0H3E9G%#6JH#N,?%R+A?;;?`#KGWP MZ;*6`42SLEQ&R`:LU!E;'4PJTEN!D,Q(,AM1_8@U;T+BI\J.CH\>2^!D+XY. ME9G!*A?/3:F0*8IW*8@#LC1BS1D(YF"ODVE8KA1]`IUU=$+8.-@M#FG)*??I M&&!D+_IA+`W)8AF M^0%K0G;LH_92+1@Z(6R!]\(1H:XF82*&?8A7'N?+7U_LZ"KEW^I\A,H;1B,$ M(1OJUP*6PVPS)Z MPOQ2`6QHT&BBY9!`KAT0E&4YAC<;VE*)J)37YN6!&+TI'[$VGX]NA->W[BN= MJ*.FC/'3B)K$ZDF<*I\%C',XYYFU9*5<'!(E8R(V:-($]RT;%Z4#PR>L&]27 MT[N^C/F)3D!6KOW&_/L3J=KH;^I95;\9DL?V)P((/OW?I,J8 MS^%%;2]^N"%1!'DKJ3_*?LL&*:GQ+!R+'$^M/(M$W=WL:22[`B12^NC'7OSZ MV=\$X8Y'3[)L9Y7WC.]@*#"EFM8Z'I+Y,=FX2,BRPO*<,"I0ALMI[ES7*\(T'NA]=34TY$^" M8"$;7J.ZP&A8CP167L`*'+24JA8%'/V_D#(2KX+^[-AZZ9C M*E_T7RYFQX$-?1_.DO6Y=Y2X-VFU1:,X-M9,/HB]Q(]NZ--KY00Q;#^BX4Q" M^+C!W3\1#^KE9Z=I_EU*BCHYOG,'?C;0C71.*^E,;;@U&5UQ)TVJ#QL00VL7 MK,CZ^X.W/<18U"^GZ2U`_!RQHK'5FY:EKAH:K]6Q8EN^"5T[X'22L`Q5N6#K M'@5[P>%C8%"T$>]&C>.D-"GYD!'_D(\J\D)Y#@'X9`ZD3DT6^A'-B5CTMCU^ M17LB&TX7QUU827X^79'`B9]AW;[0YRU4J;HXP7) M4WEM0I;T&%JN%1#T;#9X%=]L/OY MAXL^M0X)DQC3X$N]T^EXEE1=Y>2I0:8#L+)WM`X>)L M")PJ@E;"BZ@F5JDFV`]8K@ECD&UA\R44Z^H3!-B[_39XQ9@E^-SLJ?.4MC07 M/V\2LB(FU'=;9DXZ+2:TDA0G3@VX@7E'\CGMY#.&KR;3*X%)JI).)]UJC\PGIBG_Q-$GL%U17`9NMO/_AK__%_XM>9@K/XY M0V>*M8.K[S6.1NG1"T_"2P@A1@D14N;/&3N0R-&5R,39H]2E[F81E:2SKX)P'X1LH?(E\&.ZY4$S&6\VI3_5!KUZ M%(POL;384PW19^/):)BLN-)K#@4RB`W!;D&P--:;3?GOAA=@/:I@9)4*&I9G M/>J!UTYE(KNIR,&&U062BFQFG=8*Y/FR35]OIF;>TLBLJ^M5<"!!]NM7=U>7 M'JKREM&96'6\=@RALB.1U0.)PBCJ,GCCD,U)M1V>AK M!`9PD*M!DBWLZ6MW?H*IY&-'+R%J]-.R`F%".TY=RS.R5 MG.9*\DV3$U0-%RM\\[TX/9B_>`HQ9LS),\R:7S0>1_Y7F@L8!66CN4P58D9.F;+75:*118]V$)A$1 MYL<'O`\B+T[JDCT$EX?(\W$47:P(*^0/HDE>^67CX8C+5_;ZU=:-(ND&0V_#&8PN^I)!8X*>)LZ"D4",!O`. MAQU*<7248BH\Z1MBQ:"FU\]POO[IFOC;SS'>B:ZY=3W*V7FCC'6-3$%E9M!WR@YB_)RU.VNI50=&J^?E M#RN0[MX-EC_?^7J_!_K[7@V=CW!V7H^QK=ZY?CH<]N;Q&"MG[>Q:*+,O1R=6 MYGGYN!)PN_=O^1<#]6V7[I8V\+I_QCC^/0P.>\+^)\\GO_/<+4N%HIM05RZ[ M/QHIAW)MR4)XL9:\*H<5VK+JN9%3$AD7IN`.4C8RRH5$ZMDVQF1&M57Q4 M+UHS[I=.!%VM,SKE>\!ZH,)Z]^*GU^Q:CI\'\1E'3&B4&4B=06FGA-(`1_1) M,E5W?X0RF<>;P,3J@52G!F"$U(%;:6$A>Q4&-T)^-,QM7K,4>'P53`Z6A/>= M25Z9$UM)#H#!1B,6P%&N-V!D9C_^DX=#HI?GUVO\0M2K-)')7H9!IX0CC9SA M\:**SXR@+9-=9Z)6`*DB*@#^%$Q5@,`F50%C,%F!LPX@(?[K@/W5JQH`A6_" MH$_$CLX$D5P[*)!"&2U;H->-G$X;.0%PUV2>`M!)E02*N+SG8U-G9^DK$!BK MX4.]9R^X MT#14^2A#BQ8$_G085#;7\7)9Q24?*3TI'*#B:.4NL_:<4_2GG6,P=Z8=XZAO M`Y=:;Z"M;-N]A-(FJS(=2[V#;O+`Z!3/8,5F;#]*:>\0+-JGU05%6S]@R0XN MYY1&,;3BRUVU"1]&ZJ[`TXV!394$\/'@]KDJY3W#"2:`1\$[4S.1ET5&0"0D^= MZ4G04U&$+>AQM-'CV($>1\^J9LOAI.94L(P>QT+TM)*S@!ZY3)#HL9VH&>LW9UF49/S4D;/V$+TM)*S@!ZY3)#H&>NA9VP9>CSWT=MZL8>E MZS/EPXB65`%1J,FJ3O0T%2ZN"J,V;@<@>PX^3*B,@?[>>_*]C;>B532K5TTB M]"UBU0F85K.VE50[AIK,H[3Y$J!>I\!QV_LRJJZHRZ$@ M_%.'_&L$K;.*TRIYJVYNA5GDTL"TS/S8,/;T!BMLJ21L>M4T%F:4TB$7B1ORS9AE^++IE0N_ELU M^4'!*[;J1M@*%&@-8._:H_7X56BHWK4W5*<)IW5K`7 MI@);;L1HG?Y``?H5QRQ'*]MQ:+*&Z@L08*QPH9RF-QTO:O:Y"#V>HX?>9"1_ M!<;=B3+F:'MA:-M5T.:7IL1'BC@K@":TR5IXU:L)!%1!B+TG_XHHE"YR'T+7 MC]P5W8#ZG43/UT$47>(->>;!_2GZ]AH43,).G2UE&QT[DW3SAU-'*7E4H(_H M``239(A?!^B1C8+(,$#0[$L/3E$/JU0/^.?JF;R,T990!D6FOF&7H*JI-KNP M2[N%L']NV5YR=!ML/?)`TUE4:WI6X+J!2?427N/)K!GE$6O76QP/\0'1]^2_ M\*=&9E15ZPCLA+XB+M0<@8H2(=Q"ZJ!N_`]>Q+H($.YN-OQ:PTA@*PTO&02X MG!/E.6HRFB9ISX7IF,:0!:KT!)/3[1:@2RZECY]H\P891#L5=L(2T`@U*N:: MT7.W5,:-]Y.>Q@HE-05,->SAK0TE>7CSSWV M(]%=G*:W3(),SHJRX2TFBZ2M1$*1S8IEFB@A"C,)=BJI#70"+SY^GL0 MK']X6^''3O]L$EG)F.I;C%D'UO15(&2T8MQI8MR8A1^90LF(BZ*!V&E(HL7; M,-AXHN)>Q2=,6FL^K/)W'RW2_4;V-N*O]V.T0>QNI4;;EO]9SO]>R+\QVZV: M1\E\CX0$L>"#&[I^C!NKU-4\:-*>*Z.K)RG-%VD0DQ$!KT)WJCR.ECS&[%UH M3"6SKY>]DS:V_Q3?OT:T<$YMV%[[B.F6M$?C*W[WY6PZGT]XX]E_>D`)"<1I MF.TM>Y(`HR,!8%8-I\OA:,C1-_QDEI\U>JV3%F+"^>RO@AVFNVR?"//\1L?! M\Y]N]CCD.]O\J(L_]^#^Q-''G\1+!.':\]WPE97%^DJ40=XDBB'\/7TFSH28 MAVCFZG-$@U-@CV(HAUC.?)ED9_%1THUN:HBFRH)P:/IDL!9E)ZH"T+.I.Q'CP*,@(AJ,X,)2BJ*,8B)$GO\3 M[J6UA3-IQ!/H9;T.Y6S"E`4W])1,4@%7P#?PLK@S+_:N%,_5OV$<5;5LZ`0_ MBQ*F"+E"@P)+@KL.9'3:RF@635(SK&))K!A+D-242RQ]!19++=)<)Z.Y%$S@ MJ;[=B7F$)QMV-.2&UP`>^'SE-0@WHIEHGLA4Q8LFNG]"\:N%1(SP0,D+L1O@#YO_][%^L6+7PZ-9]E;2P M:'[/+%KDS*BGF$Y'TPPWC!9ZDU+]E=8/3`FCA#(8A+H4F'?@3B7;BR4S""@U MJSR"EH)2[`+9'5YA[Z45S@JO6@&UG!_U.Q/3R5@-;3EQJ&LB/0@^*<$NE(H( MC[RJJ:J![T@]=N#O`][@,,3K._R"_8,Z^([?`T7>$3,:N:R3N11V*6&44+9E MDCM)8-[2)94L%$L&!S6!5 MY"^':0%+`?ZR$5`RA`U[A;UH@8'RBI4KB*CD028YORK)KIAL\TJNO]D%V"8+ MER-7JD)+(!P_X_`HC*;78U:K\$#BI?S#J-N-,D58D*NRJ;-M,9.CG@Y966#R M2U9\V&)=;6O\0#^*2I>D3&S,]TJX-PB8FGB1@[CH&RQS#;K(:?`56FJVR'ED M3JZULZBE`.\)BN.=AT9BR:2@1`X6P"H<:.J75&U8R6X\E\RF]GIO0*;C^YLI-, M"._,7M?L4+Y12;Z+;&9/DA-`*B]U+:,C_X9ODH_X*YAS4,=<=O>S63T0,_$U MC1:>@^WZ,^$Q>.%UEUE-!('?E[Q@<-856=KX)R`(XD]S+QX&<;)O-L3C%-F@)#$]-93R.'C*- M&_UR%\XT;8G."8"?#YTBAZ,LAU&KEY;KJ)&WD["1T\U39Z\]'[-+NG43O/AA MT^&BD!-%2YB.)HM9$BHFEE#,[:;D^(7X?LQ;&"9V)-<(2"YY?-B1<$X[X8Q$ MA(UPRJ)!N3)ZP?9#3=J?Y$%H3#]H9+A-)^/E?"C$,R,%#.46XHA@W*,X>@AN M(9,(O6*90(#[<)QWV"`_2*C9>,`)=(#9YFANDB7"]W[RV%1UIC7[K$K,`R5O MR\EBP\FA#2>#!1XN_/5]'*S^I"LZXH<^_G40-_IJ?`W&WFMY46^R,QL/*R!@ MVU^<$#@>.A"O'B1,R*A`^K\C+!09`#U2TQ1`2JPL&W'6M&6A^KI%N-/>'I@N MYB,9_N"W/7J1V*F3^-S`*-T]T5$;,#AYUR$%&*8/P@`N&5T]-<-95*$U2-IL M`947/%6CXQ=``=%B2WI67?ADP+!IQCE)0G[Q MHHH2T`L6S58GAXM-\T;6:%:Y])'BRS!PDG"D4=QDL:B!5J&UMT75D?J0_3BP MLP1K"J8JP%V39KK9-T\[-'\*PF]$KC!V/?_!_7F;]**K/QMK?,GX?GH31XJV M-!XNG?$LV5M/:2)"%&546;67C*[A??9NQ1S!BMFP_]ZMK$Y95IH0YFL9O;E5;&8[]$KZ0AFLO;QS>8JQ&MA):C2(T8GWGQON: M0+0-!6`D"]A2+S,QFLT;@)PEMM,Q4&$0>W#KO#[I2X5T@"&'LBOG367:.&Z3(9P^JXMQL]I$6&^97^ M;+9$6V]'-'(>T6^3L3=!6*I)6Q!=ETK=_#PP5G6R=>FIW4(>Q\+D(7/6^_)K3M/T7S9)*J4.-(H M5^+,CS=0*6F6?Y568F3448$\$-YZ$)UO\R1RLJNH*,AI#=`VT\HZU4H8O+I; M`LW21_%^Y"B?,1^ MHN@>%=!-?_?'EXLC6TA_:P"!R5#JK2H7Z5']EXO[^XNK?_IV__'AX=XL5EHQ MS:S_BQM%[NKY$.$XANU:?_3EJ9D6Q8*88KX$/B:KP/!/''\Z^.N(:T?@IP0/ M&YPTZCE0S]/*EEF,$.*4$",EM8S^YX`N)'-:2&;*DBQ)9J`0,A7'%^Y MT?-M&+QX:[R^?/T6X?5G_Y/GN_[*\Y\N5K'WPO-4:SJT"[[VB40-(NXT3I6# ME?EHE.Q,TL)[=$24#HD>7]$;.BKR_%]1-C#*1R;A6S8VR@>'N>=@4F&S5&$K MJK!]46&'5&&;3&%N-C*D(^@&3T6'T8'&S\^Q-*2;=T3\;!R-;LKV;#F>3KMV M..!I[1`Z3/:5B/XVV^!'A"C::YT.Z.63;L'6G?-/2Q?2B,*<4WB01#?F_5$56!S2:"%)P*3HZ/C]7 MTBZ@T25^-JY%_P[:=+GLVL78&M#TJL/:@*;.Z=@8T+0$6W?>Q]:`)FO0TF5` MHTH4WNLHSS%;3)2\3=[DZ+SV:WI1V*PVH"FT1;0YH-%$D()+T='Q^;F2 M=@&-+O&S<2UM=A=F7;L86P.:7G58&]#4.1T;`YJ68.O.^]@0T/#N%=?B/A'E M9\SZA'Q@]?SKR7R>0SOII?*&DO@57<2\:P)KCQH'Z-:%2\PY0;IL[V+;6UL+ MAS)NX->H6J\1^!^TA(<(Q>O+C>EIKO0W`5[':!7ZR!=^E&WDKE@RE0 M@<)Y,VLZUC83>H)T&.H&^$"H.-(`L;$L<`U=*Z3D/)![Y!%77!7%FI$6.)BN M=3#K0@<@;DH=_T)'IJC,,W!US:N@5M3L=7W:FXY+9R(.AM1+)/(FLH/:!DKU@SL-MAZJU?^OP_X9WQ) MV/A3:#&:9(PB7H\W#3.>9KNF/U`^!BH/,D!\`/0]^2\=";&AP/#=IT88L._P MBO6)SI7R=/#6+AD&%NCMK+V,\!;*`X$VT8<;/>NL3FA$[QCY M@?^6J<^W#!=LR^!6TNYG91,)2'0(PYO-I:YTH^H_AG3!5&/&5"T MK/U33@+=;%!*Q&RQT]-$&!D405[(]#0YG((1Q1VKF9:$KE9, MU.KV7#N!*^JKFXD]?')][]_8?'GAK[^Z\2'$-YO+0^3Y.(JN!27P]=XU/LDK M,J8Z)RPGR_$DF>H+I!&AC3AQ=G*0D.^_3+YXTN]%\)$U@C<$`;U([U2D=W/I M`PWIS40(FGC.XP0=Y9EP/775Q-7?L\SEZ!3A'L^7H_E"P]WT6'&\K:=I(:^Z MEX&HL-Z3T%7GHB^T#7ZE4GU=3U\@JX\"_(;G@_6M`/>"6V3*Y8N&%;>>IX-G6$5[VSEDH_,IMGBV'2RS49'^?#P>_'F ME5?Q&STIS]C2J4LPEA95G7V;L_-1>3?PIASOSH6L MD+D>.HT<5JGU*ZXT:CA;-R7!8V<>2Z1[$.<5/^/P8K4*#WB=]A^G=_>E;3`: M7C+I6*2T*4#I^UCB"CAC0V.H?+4K`880&*"<%"9>3I"JBA!&"QX;`I*J0J!,< M#`E7P6X?XF?B7[P7G.<]7.)-$.([O-H2]7H;;\63./BO']R?LB_;EJ1I7+7D M4_UN_S!MT,0-M31>.=EG@!X9>509-OL+&1D0K49T50#UJJ0KZ-(L72"EX@=. M4:F=[N(4OV"=`]"Q7FM#Z/H1O8;*EL'L7UN^*%[_ZR&*Z=KW%!2?,IHEN#]!!/5Y;K%0]Q0) M0RCE"!588ALZ!:90SI7=+L:8EIE32E6X2E48%U3F9D-8&UUT`&)5;W;JA['- M_WVEM][:.;/L54L\4\J/^JSL.%-E-_.5WV#MS5LTWCGH7/*\^#1?8K_=X]`+ MUB@XL[7%L0FK0KFD-5MQ>8T743"OH%=@"N>K;9A&FPI+&ZF4XSM#&ZACD*`KP?Q)U3^#WB#21C&ZASBD`J_$DEJ$(`Z MUGL$1F5%=7)?,QF0[[?<^!>K9P^_D&&OECU9\`!31$5#,AC!IZ92^_!. M=S@F_R*`OZ1Z3OY86\5"[45@GU3/E8Y)CD3N*$Q))R:96BBL(^I"8($/RD@C M1ANEQ.&]3Q="BQQ/]IG?EC^S+?Y%#EB1:Y%HK$NO$K4-=QI>!/(J3="1IQ7$4/ZEEH4@C#FO\1&[ MH=%#<+'ZZ^"%.+TUCZ/?0W$IZL;7S.]_"GE1/VU>SL='2(L#E!!%.=4!8G3! MSAHZE+:"-C(=TZY7%FQQ-IIDS=ZF7"M6X.LVI">,\>LM^3SQA;_^2'Z[WXES M530(0&).R)5&;^CQ\3Q70%]*?X#8"`-V#)$-`GSVT+T:V/'#+>'XF59VI0

L_^YN#_@6A_?/;GA< M<5+S99.85>)(V5"'RWFZMDT)\W-!`E$W1$'(BQ6M$2-/M],0&P!HVNQ!>#9Y M?O/7./*>?";J/M-$Q#6Q)YIXH2.``E7+CDL@5=<:/$`9+]'%(7X.0N_?\%K) M$BHO@0'RF!/UOCSCR40`1$X3Y41M`-]I@BJ`SI6*"X,ZD7&*T5:K)EM01C,& MM!"6O`",+LZ%AI=?#.7(X@3M054;`140Y0G%A$13V0B;D%10#3R*V/RI]%WY MDV"X8<.K7T<=3453$2,TL`@P+2130,I_&;X;#D=YW#=`SG`P'++_CR+N-/+Y MZ7_05NHX@1=R8_2%0.(9C4?TM=&4K?4^X!5FW6F3WT[L@6')BL7XRS4-!#RZ MLY4FRJZL@)Y=)M5>+I7_S`DQA@'ZD53G>%$#"Q&RQ(PM9"K#D&[_39X MQ3B!SSXY.$![0L\J$)6L3HJ<7#%`<%D?5O$_NV'H^O%KA3H/G;# MN&^1IE2D2_SD^7Z#5`:Q+H',$=9%\MN#=4%*G>)+X-C73+ZBBZ/LCJW`!PQZ M2C+3.&[O4E3F%.YQ'&]Q>LEQM76]'734J6"+S6""SRNK9RO$^*<7)=?K2_67 M]#ZYA`X\],3,Z?CX>2,:\W$&*!T)O4G'JJW#8"3"[5,G22OGM"8G31'"A.Q. MT$4>&+?-YJX`Y0;5=9-8+A@Z>/$BLH#]%(17S#<>?72]=XTGFBLRIFB!D_'" MF25M5E-4_DA1Z7+B-$V+4V=WJ/B$8CKSO!>QI M+K@+'S;U.6O`F*$53F=.CJYBKGDY MU9R5$P;#54=B.D4QRQGEK)HB,+`:[?`(4G*M0(#IN*$1W=8F4^QA=]C2J$%4 MIC@YG^67U9OZDW0[AD&X=LJXQME)VB3@>'Q^AE+@`(F+BF?I$$E]B/ZZCZAO MBT'J\%?T.MWK_.S=5$,]RG[&.E>WI5UU=3)UG'[=%W@930L47+@/ M&Z$PXX?HE"G9+2BYKKL*=X&@?15ZA71O'A"\*N@=3HL*W&RN`__I`8>[#_B1 M!I17[MZ+W>T]7AU"5IY;:+X:)(SZ+76^U*^ICA>CU!UE)>J"#;K.*K33(0:% M?R=CH6MV3%%8Q?.[O.F?]#4Y4AC;(TX$WS*]!$6]Y.7NUV3\/$D5 MUK_H`Z7L-C2U"^,-(DPS\0E3'_`+W@9L09FDU`K-1O:.4;Q+&-'8)TC+SJ3T MDML(&<4T91PJ6.A,2JL'^`3WT(WW4 M=-:^@`]%DYF.EHO)F"?I\ZX*A!3*:/4[W=3AOCN91B`RR1/N.Q',R05SE04S MDEW?`)\LF5ZF!H@9DO&31,*_!\$Z$N?PUCYJ<#ZL&U^C*M=P5L1%0F>`&"7` M5-W3I7(*>?Z0,YO,E(H3FE!B:/M7,WU`J]E\4=I:Z-'&@]C=JMJXM@PS M*L,#'0*%\!L+`GL1V;=%IBW=3JA_%L[,]9;5-^@`\&<\@:A M!=L#4M.28,&B8.<>AR_>"BO&.\6G@5!18$$]EVP^']?B(B5F2>#36C8&C2]T M48Q]UF"<+@NBA)HM"*DQ-1%&CA4!@I+5,UX?MOAF<[%:L?SF6_?5?=S2"I'L M\B]>7WON(]W?\VCC.O*7IHNV)Y$TB;<3^-1('U\D^?GI<#0=-AT0)2,R2T[& M1(5!T7B<-T'O:$#_VJG=^E;9\ZQ MSJZ>R5O$L7A^H_KHV.@RNQIED;]I#S6ARVGY(8"]#K^D=8=7P9-/:^E_]KOT M/B=1A_%"I["L@ZRZ,">Y,9H"BP4KAJBE`E^S;?`!GTI2V;->A@FC@O> M6QG7:,5I&=`H@(_K$,@"5]?5ESMOCZ<>D'4UT%EZ/NT`8^2,IWU[/ZO"-A`% M'V]AD3%V1&F\RP2M0_7B;MD];ZF"/U"^R=_HJ19;=^YEK7+/SQDJQGY=?D%8 MIWB9])YGC:TCCUWFOWPM_.LJ\&F2$#$-\E/DK7'(I%*+_TZC#N+^3F)99U=Y M6?5YZ=BH.#AZ?"W^>X!R!E")`UL"/8,:K$1X_6G0O"_K!)KU#NST3P3KM8X] MZJ4;>2MZE9E/3YH;:'K40+R2%HL:&>O3<=4+58.H`6+C\?OO201@7US5HXYJ M@J=]X*=UA&P-AEJAI-YAZ.L6UD%\ M0B(8E4=WW[V+,4"<20>,:VS$.#6!#N4@[;+,F6"^I9ADD/*!R+2<<<+\D(T) M",95RF]Z-ZC.C0N:KE&D'6ZJ0ZS6.Z^N/@ZL2SLJQYZ*\*KIM13)@#@F-=Z4 MI^[E=%RSK5[I1Y`-8Z%?Z4,CE62F[3;XP5(7:8D_VWH7M`5`O2O0T"10;H7D/QP80)Q+BP98?&J!ZKJ0.]ZM&\7^H(JO4.JXM/98LG*W)7[#A. M8S,N5A0==OQWFE%-)X,`^[3VG&LL':8U$9$09X/D>"AA9(`R5E"!%PO#)O-* MK7BYCUG7M7_&WM,S^>'MQ0L.W2=?7;G;%#K\FUSDB1\;Q$_B)\KR M[SAX"MW]L[=RMQ^"G>L=EYMH?MZD]Q(QH9Y4.$[;PQ6)H.^<#)3_Z$8L1TLL M8XAL,K02N*2:@,')EM!\*M:MD)&C%03()BI73N(OF3]PR:Q4LN!>H^O>7:8*5A@`D&D`[$X M/%C*/1=KU;=8)%1]#/H7;"25#&$++A-(053R`&)]V(/^PLZ!:..`_<_?,>OB MSEL?C;0LH.40X)ZF'=_JB03+28-_*FZ`2?>_!LDV6,))TA_-)O=F0I>YZT!! MLD!^212R%RH$UFV73]9\7\- M?&H+>/WU(*LY9&S\&3RSL*\?U3-OF.EGG>KGU<-;>"]H`N:=A'-:W^:LPCB99+3GL73_ MKY\!SR'0:Y1"`Z7CH3D'27D[LVBP8U67'>+6VV#TYA6[853;.-/ZH%`9OYU$ MB6K?XM]-V/CW@*9ET21QTX'CTHO^\N7 M7$?!!AUHPN'VE1Z[L/U"<`]JQ@'T'E+6?*^S]ZFTD]BG$.///L$`CF)3'K5V MW'/UIW7"J)?-F`_[7XI3#A%E$:4\_GMQIJ?K/FL0^'9#%>2E"@H%"CI+URG# M>6^.4_AMSLIM7GL^_ASC7=2U.>>$S\'Q9=QJ7,-8.AUY-O2=#H_8^%"YZ(85 MYYA1G/7>K`*_3MQ5^:.$X&%Y)OD'J'4JW4]U#D<9Z%9P:_]O93?EUUDAG1L MH`JNY+P@-XJ"E<$W7#[BO!/'*Z\"".>>P;N\WH"<"=G'4T?YZR\ MWBTQ^F?RR]O06^&;#:\`S0R&./,5>:IKTVX>\!P\8*,4.C"==.8'4[80X^NX MI/<`)TH(+\3.F*=%4 MFW:<:?0*]TX\I=J'LW+I*RRAP^OH$/XN_/4M,9:O[@[+JS/T,91-B]\6_.L` M-CGH3>YX)%M*L#4AP#7B:&G$FM7J":#26JZVU?]Y>:+:Q7=:6"BI*_0QB>N9 M!^[@GL&PZO"$FM0 M6)=9`48Y5BPPY>CF$$>QZZ\]_TGV=4K/F3;LXN`Z.8=%^R:S7H%*+W;.;P1^ M]->-MMY>H`D+Y-F+Z-'=THK;@SZWK+E,][$;QCU*-:527>(GS_<5!3.*XCJ0 M5,!H'3R7!4VJ,K=,+Z3BE!0:X[Z1Q=Z8SA2L7\2G!J5`HHBHK5 M95405'D>`CW'3*BO>LC_JZMX;`-H3A.JIMZQ/5@1&5DM3FKU`(J1ZZ9L\.J# M$*BXUDTZ)FN'97H/)25B0];UB0(Y>@(91T/%G&IA<`V?K9RR@[_LISM[LCBWQJS`8$_*CWJ1J/!O78"TCC%+* M-F&N([&KV-,6&P"#C>8KP*)<:<"8_.RO@AW-5:#+M!`_8S_R7G#R6V5X*E&! M0:H*:SK66SM!%DDC3MLFV':O@YK94U\'`!C6,7MP6Z1\G]/RSQ;A-VN)*\BMH7D`(AM-F,!3AL4!XI. M:;/<\D,0>--KMSJ9CRN1+&S'V1/D.-Y*L:#C:ZW1U!H]<._5"N"$WZ?RH%$K M/QY=V9&.)^,T0:3.=U[$<>@]'F+6EC0.T*T;]G431BUQY$1):S)'0#-&3A2G M/F6D'Q<5Q.ZV3UEF5)8'.@I/8\M,$3-BL/Y*Y`;*/JM6`7;XK<9`V8[H^-3` M<#Z;C,;:_LR"X+@;P9VJX!P]O]D%'WF\:V&02UCZ'$4'O/YP"+-V3SSC+;T3 MR6_HI7?WR-<2GS2VHV8:B/HLZL2EBP)*$1\*\;&RZQAIRFIVZY0_G%_7I6," M`K9O!=5D=GML2+`^E4;,HO&F<6(9X"ZMO4>H^+N62K7.&7[%/]B?6OF^_&5; M7%W&D8X)+]4]&Z'/G[#1C;44ON*U>$FHR(I$=BW;549I65/6@9+]\2:MBZ8IGP4KIE:B/0.-)?4-4^NRP:;4M&/M'.8 M]2Y`BA1E=R!6IT6N@=7\%887>E;40`O>0<@95-^G&@Z'S9,[&TR^:K'*!W2I MG,;8W4+HJR%!`?T*BK3-`;2,UX_>M03@V@'K8C3-RBDV`[JO8'W)I?;Q$ZTO MV!;`;86?",)U6X':)DJO49!M0.P@1I?0L02@I\699((9*8.5/Y*,E87A=@7? M7>E$*?:V%<^GAMP-2M3#N;?;AQ2]T^$XP2[]S1\%\A?^^K-/B_!Y+VQ6_X*+ MSH7`C+W[5STD$D]B8:NP,(#SEFM5Q$_ M9WIZ+PZNLTTT+5UX3\P*!C<=R<.@DD89-)\@7>L6*PB#PJ31NBIS;$4;W\VP>A&[XFET!6JQ#35=E#<(?7F']J8?#-E1!LT)Z8+P[IWA#;!(%*\^C?(":0HC^`?_G1HB(_D1SC';L62%SK M"PYCC_ZLH!93[OP$?UAT]&V5V\DA`/GTNYO-/:%+9A:\OMGCD&TZ1K=A\.*M M\?KR]1K',6T->D64[L5?/-_;'79U6Z6M:9D^!FC+J*)-SVCUHN0TG@[%>G&G M@Z$@&XW8,A^.YJYOV8`L5X0-B79\S'=FCP+,J&;4B6H`3@/,J(=?V*&5(MT7 MUR/C>UL6'Q"ZM4(;V?0_U5-DN_XGZ1`F[DUV=QJN[%>?,QJS'@VNL7)R,D2F M&Y#@]^]/%,?1$L=[N/\.K=4_#R?HT];O+DAV-+)[_ZXR%T M:1&6^]?=8W#\5:I_-V#9E4%536"V)#\F%LW?1YR`65,^D7]'C?^^;5=H&M1F MZT6$\-'?(GRS^1C%WHXL:$3;WDG(INND;<3A9D9*7GK0^1.(NY_(#II5-I=,6//%TZR^60KX>2 M]X&RD$_@?F2,>_D*Y`01G*((7TAD3?N9W+]&M!T"?.)PK>%GBX:JV!"SS#^[ M],*Y//&G_(S!.:8TL'I&S&227+A+W@?.[SE!"J<@!:Q!2^VE.(M4I04QZW)+ MXZ\'R@U9HM.$Q$+[R$LW\E87_OJ#MSW$PKMP+8F9!$HK#C4B&B?)=JUT+^=# ML;K(K"Y!L??K`+$!V:6.9$@@!!I0#X-J+N^Z1WD5JF@9,8CZYNSIQ4!N#D$^ M&#K0/&#/9ZG`AY@7$SW2%_)QC+9!%*$]L:HB*5"G=Y(W*7G']M_%-C=:;,/; ML(VH3<82UUG'FPY&)JV<9O+1P3DKA9^%^(Q']FI`D_R;_(C_02RCD'_\? M4$L#!!0````(`'!RJ$9_.'<3"BT``(8O`P`5`!P`:6UP&UL550)``,T_DQ5-/Y,575X"P`!!"4.```$.0$``.U=ZV_C.)+_?L#^ M#[X^X![`=:<[F=G;:.LTYZ9O>^-!2)MGDM2QY2R6%6L*O[\7Z_S<+`$",,X^N7-AW?OWPQ`Y,G7W_ M_OT=0L%ZS'=^/#\;O'V[GN_7C+*/@S^_.S]_]T/I+^,XC8*/@[^4?KI"()LX M(#1]')R___#CV_?D?__Q_/[BXX]_^7CQ_G_+K>/%"L'I+!G\J_]OI#%I27I< M#,;OQN]*3/[SX"F.,&D]7WC1:C`,P\&8]L*#,6$5+4'P+A\TS-D=$$@C_,N; M$H>O+RA\%Z/I&9GFXFS=\,V?_F&0-?[XBF&EP_>+=?,/9W_[?/_DS\#<>PLC MG'B17^E(!ZOK^N&GGWXZ8W_-6F/X$;-1[F.?H:1`X(#;@O[7VW6SM_2GMQ_. MWUY\>/>*@S?_22?\&<4A&(/)@-'P,5DMP"]O,)PO0O`F_VV&P.27-^0G1)'_ M\?U%UO^?KF,_G=-5%`4W40*3U5TTB=&<4?UF0,?],K[;D`_G($'P]1T(IAYZ M&T=D:,"649(ORC/:XTPXZ%E;DL>DY]9N3KSN(P('+^YO>4;,MA%'3)FMZ$ MQOF]\O#L-HR_X[LH@`CXB0F>=@=M3?Z*[S:$V80NJ'OHQ0$-Z\+AD1OJ]$X[V.,J9D?I"$@,FCF$;*( M0B?M#9>S6U_;LET2"<3TGL?QM^]U#P&'H1_9SLETOJ:Z(T$`(R-;*C MI=1N?@M`%-_N!B=P3C_8;X#ZLHB:L`3(FP*B8:;S!1-4V;%XY84^_;3L8"PT MS,DH:_2)BC?2.PHRG]AS//2)4963]"4B5M;-T^/C'L&VQZ/5#UK_]_Q,M@*_ MF"*#8&6F.I,N7>UTZ11FST2BE>:K\0$D5(`^`L3\%ALE@S:*(WJ([;0Q_3`-0'"+XGEEF&L8IF1'VP/.`+%&(2;::I2@ M?,(QQ-^H$C^97'HA562?9@`D[-?.=+)6!)AQTCW$"2"R?>.(WOC7<-DE14C% M<0B#M7^J?-]5\F(7G0LNG\%K&B8/I(!_#86L`52N\:XY/4@ M*GJ<,E-G/7N7JU%QXJ[YWZARQ4?HE&WQ?%:Y?:;NKBXVA\JL77.>KS'\Z*WH MA+D_JN1X6KND2C^5#I_,3]7EPC!,X&'AV=G2ZX3,KK%]1'&0^LG:,;@?[4!A M4OM\=[9.E*?N&@/J4MW/!^?-U#6'`N?J?AC7)&`/>&R'%-#&'2,@GM(VSYWM M<\6).]_E12C#I.SY&@/F(;^*,5&0J0G/?&/D\&*].I4&+2GJ.6*=+2@S='6- MWL8WN1\)*YRN:UYO/!01@;[Q@G7)*'\N:UQVMM)E,W9_9I0<@)CO_]N7$M&< MFARI1!0">D>_W`_T7^B%_>/O^0Q[<_4_DIZ]#,G5`I[\-O>EZN-![`>$O M;W;_?M8Y/;DQ=TL^B!?^'7CH)@JNR>>L(8W;5(_*W25.?_FZ_BS#FL\R?,%D M3=&(SPI1ZOVZQW%-1H8.D08P#F[);[@&2'[;?=-)OZ(:E47+_=&8(<-?D/7M M]D??,QE60!;[<_?49*O^BHG=\(Y(Q]?_`:L:LNK;[8V^XNJ.G9-XE"8T(X=F M2_&)%77:%^6W,`3HBJRL:8SXN%9;[8NV,9A"*N*BY,&;UZW%VF;=4_>,//J- MGE;SESBL(:OZ]PT]Y;-_B*JT>*YS=JRIB&MV]R!&`4`L^>_#^_=O!H2!"2"G9'"?\])>KYF57931P-"B<8CR;/WBN?)ZU1 MK'"ZB>Q^]"#+R5G`Q`M+0I+'G+RC%7Y8JCZ/YNR/]NCB7$5P&MFC4[)7*VVL M4ZD$ZG9;&U2O:VJ0/?("HW5<>Y[R3B/<80!0?N[G^>_B#]%BP`/A_R&.?-,0 ME,:T@0(M&D-CY,C_E=*0ALF5A]"*T)T7L*CE5JVO%:[X`8`\7@0];'&0GUS" M3[#=S`:MU[E5,@9+$*42S9;3N`=T2WTDERK/=2TM M4;SPX+ITVCI?4<7WH=+3#D?Q`J!D1:O$L$L1:+7:>JR*YKK'RTZQ M_YC>;$I\HJ[&&*H#(Q:-KL88JN-3N`=)J%*$Z3AP3P=6005TI MW#8X,*86X0$@P7%.E`%1O.[8X'7NLAA6P$L<_%'`Y+*$5H!)R8(KT')93JLL M*AXN3<1T_X63KBN[#)7(]>IJ*+,)W`17>ZY&-AM9;HJ>PWM3$[( M1H&>\]JQACVZG411V!!N93\V1HF7[E``Y;S1H`"49@1%`9[SIH,">-P0AP(F MYZT#!9AXT;$;E"ZV8=<36:.J7KBI MXC?%25W%+1!T4]G74^]K8]$*C=Y-757?Y*XFNA3XN*FBZN&CDA);(.:F7JJ) MF&ZZ=`&?F_JJ'GPJ<8^%AN^F[MK6^55&J(E.JJ-Q];QRQR,#>P82Z!.2[692 M$EI&B)$=L+.F>/,OFY:?7,GM:3DW-*L9,TR3&5DD?Q3?D\_)3H]><'"'<:I. M?=ZZ%Y3S:[\J=;&?(:&Y*10[V^=+<6M(.O6%#^$&$71P.M/@@"QHU3WG>H"\ M&?QV][;K@?,F<5O+$M<#[)MBIJ0QNAYU;P`\T2YU,R+?&&B[6]157Z$AP.K+ M9G8>&=L'XSMS:0U#0CB].%MN-/=UL#'7-P0XX:T98IS2^A)5IX?5M[5*\_LY#<32,;=&X_G7;I8>B3 M!7H-PS3AVFVR7CWD1+)R5'O;X.PV1@!.H^Q2W%\](R_"A!8BH3]Y,*)7`I=@ M0MKP2ZCJC&"E)!B(`/)"@OE\3A2M;+"B>(@/F(X@FWRD*Y MA9T29^N+I%NBT62Q*BE9^J-%'J>2KX7-2YD`W[P29(EN0A0=M+HCQR_+#2`] MR8E.Z)O>1>0(!YC'<9^RQYIB336'L:FQU[H1ZRZZ+=S,=A'>3B$D\,&X7DFO"4IE7T^[$GK]%^`Z^"AZEEROHZXK[#)W6B5Y4%H:?4]1@_+:Q$OBS78_NT@)*&+KA>[5(+ MK9HKNG9E+?NO2.C=.Y7!THK[<;U"HSZ,*F$&KA=?;+[X.@T3[WFI5Q_"F#,P)3FH'T?#3+3R6^JET9G?XO4%XH M1\6\J`VA<+V`CBXRE?`'UVOEZ(*S!4J3JY#^[Z6F%_6J?B-1D,/^*J[V(1F- M5W%I@VB>D_;#7WX0YZ15QK":H;;#2U$YJC:<0]3#>N1R;^.K1:6Z^!8\V6CL MO\),FFP4+EDF3U>S]0VY]<)[!$1X!.1W1&L;7X/L_U6B==L-;+G\2)X:2TOY M[W"A7HE$:13K6K>1%;!S']?%CG0]$*R;SR$\B-J%D/5?@6NXIU7\&^X7/VF* MF(EUO+\R*7W0?IDQ4*T;&7&+D.ZJQ'\6J\3ET?]ED%>:M'#`*A18_0RH=<0Y M6M7[VU`?.`5WQ1P)^]CA8GWPXN>80QY;3R]DNS+!0.!G>V0,R,+",%F[3;(= M/@9^/(W@QK?)!:+C:2W7?!2N@MUV5@HX,+E`H8TC\AVNX[D'(P[%]6U/1FH3 M4ZN-R6G7@-RN^"Q@M(8&'KY"W0\5]K')! M5#_`+M-EI!<-+3LOY$7(^2X+05^K7#W32ST9^5DC.W3N5G+GT+K3\,#HM295 M""%9=`5`5GHS1?Z,:(F/H1?Q-VVST7K'^0/XSO[4 MB-&B<^_X8G\<,4,=W[P"Y$/,3?QM,%"/^&7F"7?)Z;$L&:MO7#=!F$#_?J%5^EJK)U>LBT\<2#R5.X",J'-[@&M4U>/1UHZ.Y M4VT"G-`@.IK7)(3(=7]IY7IR:ONM+3!A74]8-;"]11ZL5AFL!Y%&WG[UE5P) MS1):JQDS#L.UXS=TO9R1&EK<++9CM@04KZU=S^)M:C9]/6^9:IM9!C>1&_*H MYGZZ75KMH<&CG]"J+P7-[#L`9<^1--> M>7AV&\;?\1V1,PB4-E<>,?LC+2HG3"(C(PS8$%;B9,OF++5%(Q^&H**A/,>4 MQ$<4+R'![7+UA=BU=]&FO,O03^"2V*_2@NZ=3&7C1NXRQ61=8$Q$P@N,V#++ MBF9,"6_DWS`A'N5;%7GD5\;SU8S^ZUTTG,ZA]P)#LNP_<&#C%Y".,U* MJZP)%+/$[66'$TP+J]'_HV?CT@O9L9A<>0BMR*(2!5^K]762*TO13/6TU>?$ M:+''&<(&C]>`G/D^]/+D/B+D4`+_8/_)84G4PTI$_&1"E(?1Y.;59Y)Z3#2$ M450//"]07F<(*P_FY:7,1M$UQ(O\!=W19(@Q2##ON)-TLO2T6F7)DU/5]^FQ MBA^]E2!X5-ZO7]P0'0V0!=.$H5+7?O!TG5LA>44198:V^_6#FXU&G*L'\G<) M50?H"7_4&;BU.:B4]GV4$DLR5U(A-YJOS8@]0F#SE1IS7#M"/SA\1&!!=/'U M!EN7W\IS43/YKLRLTF"6'ZJ"'AT.S]:$[>(]PJ7&)M5\?JH,>'@[-UH?NX*><9"Z5<>03@(L- M%P4;XZ(.IE=!A0'3A1L0B+(+X`^S\/[.JJ]+7)&(]W\WU.( M`-DB9-TG*QHN1`MM4Y?"0O`ZI,8`5OA#L0]`P.I>Z^32R/OU@AM16B*GL9W< M_D6^3$:3^SB:/@,TOP8O"7-;90&5P$^1R/S1&L):9OWE=D@H+U6KOK'E7._- M5:=ZBO=NER-^[-;"'7Z7M[OE2`"A_]WU4GK[`IDG0EQ_FG5?^,JN)YIECAQ2 ML.^^D-Y;`(7K*2OZ-P-;#Y`HW/PT2TD10Y.UQ_,VR.B@K1_1ZLI=0=NV]B/=O69^O]@@MD[_YIS3^G>JEE% M)P<$L@&`+]P M\RI9)9K%G)BL.ZA.N)JT2`IH->D@F/_54LSZ.W4)6CUA/OAE04V"5ZE.-AY`P?*X14'4SM-U/7/`KZN M_1W6BCY=0^R',2;VR`A-O2@/;R68K*/9BF+`=]$D1O,L/--B?2+F^\["&',W M.!"^M"CO9[/:4IDJ_NMNO-9ZE,/Y`E%Z?GQ_D5-#?_EZ0W2F9$4=@XC:5G3P MST2/HA+F[\!#V2O&FS]M4=ADA.9X8^"_F\;+LP#`#&KR+]L(DY_J"&)BXHJ& MN*#5@S??KI6@VLL,XI@(M^_7@(7CC@%[HN,YKOG(M6`K=S9"ZW\G3RM,Q6+M MVY2U38S,^Y#2L4:32T1$\VPG1::^C9&9MP3A@T>]-622'.%[SG.&>GWW06G= MDW_J_:R\\EHBC(8_QR$,UE0^EH["3>B/%VZ.?UD"CYFQC7RW_"(WLQ5&Y#B: M0;"D5P$`T>=GGH@^1SX"FH)M7G1[=T'M&!"M@P+%DC;6=](*A'(ZFJ01-P53 MTM$PC=H0\OOT(G]V+3@`_H3X"=O2;E8R`=,7#'Y/"5TW2_(/X0/,]6U[0/4S MF4_T-C"G=4\H%VKO_/9&]B2-:AQ-GE*`T+9^,]2!*J9%P1PP\FGV$$ MY^F\;J\V'LNF]:QL55$3NEXA=+UXO<14JTL!$Z#I:@GR1JHSQ4[97G,UX[8Q MFTEH)/W8GFZO-I[0"4 MVZ.N9J*:PDWH:W`U"]4(>#)GDJMYID;!4UM^CJ67:CN^*\5F>'X39]\]:@47 MU_)=PW645NP.7)J;>I^/2=GQF!B]QE%%^%B>>!.[?B72SG4OE+*;68#3KE^S M:T])#Z)_;CV(6-C89^#1_\ZV(BOJ0_9:J7!%_O=@F&RZ4#6.IC(0382H<=#. MBV^,U`U)!6.RY]ND_?K]%MNF+I@DWPAU1T.$$DO$! M'DURGX7PKE'4P\C-%ZWE<1>1-9[2K;X!JA)"RMD[^OUM8+XA*=OB:[FU+:R^ M1#&1_HB5A;N+%FFRSI;-ZGY>KECWJ]##6'A1V=ETAXO=CB';"63%+(>+5%VD M5A[*_4 MF.+VM,H16_V8P?M!>,:*>O2%@W-M#LY[QL&%-@<7?>"@;FVK*0""GGWA".^* M(VW>^&/TALO-":FV!$5=;?!4LKKU#5O%SC;X^AQ'8/790]]`K8'K]+5K$[NSC*-1A=MU-VC7-G#YP_!VM:N!/S8P%OJ17`T3 MZM@I42F;)I?LKD8F[!%E5;W&U1"&#GU'M2>EQ'7A;.S#_G'>=G`Y&R>Q?VCY M7JHUR.W3D$\&O-%R?E>B[F:T^N(@)1Y^V4H[CA# MCP8[N4=8N@)W')*N9B:T&PE@-TZLA6BA@3=3T%'1GEJ!#NLCIDPBY]"9UP,.3E M(8Y0\WB0FMY6.7L`"?,'R42_H(.1,'(R-@Q207'(:H.^U?$1ESK:8L[UF^Q3 MH:-F/K5VRDJMQ5FSO8_&V6$0SY:F:`._R!*@E_APH);KEEKYX,=PX:.%F-8% MYA&(RJ;H-14)1W45>;K::8J=P'KC[&;!.CX:U`Q$6RI/S6R(G[*O$H$I+29\^B)8";C=5W MKI4"-97'Z0&W5*!0.VQ,;"0UOBH]>L#!R=.EX^DZ-,NKP>8\&M/@9&,9`K+) M<2=8I%69>C2)>;K'Y\FJZAQ-O85]1.%5!^Y5Z8'].?1]E(+@YG4!(@SHLQ*C M9`;058I0R:"$`#^E\[F'5J.)<@\K+TYDQ-'G5>?@V7L%.*>+HW[QV]M0*'-J M2A@J45_3WB+U3U[H(572MQO;H)LM7UWH)9UL\/'HK>A)0G56$RF91'"]S$2SA25&JDEV7IQXX0'I4K]Y M-#XB68U>0CAE$Y:TIC",O]/@]-L8U;2SH2M]2CU*!I`F1]4=;?>,#I5L[++1+RHL'@34XV'3J$1\(@%>(Z=T9.1,1,27!-BM?1^@XIT+,-3M50S0;/`FB':O9`-Z87B+TIIG9% MD(;)K>>S8!E!D$=-0RLOE5;($-XGUS:U07/UQI@54WXBZ\T+1M&O'H+4OJ07 M:[R<.N7N]GG[3-\\IV#S8R\$'?I%_Y@&]1/)HO99ZGOVD".FWS7D*>]K1).G MCTS1-.%D%@=WT1+@)*LR&057,4YV?Q=$US4=RLZ;:1$833+1Q/D(E2:V:5R+ MS]R-=1DC%'\G^N"5MR!_X>9[:@W1%Q[OB!9#U``6Y7`-L(\@TQTT6.2-T!<. M[R4ACN(^?>'BL_<*Y^F\S5KD#M$7'D5AF?SV-J@?@V4<+BF&581%X8OB/E:2 M6-,7S$J$)#=+>O2)J*]OVP.JG\E\`A6>U[HGE`N5>7Y[F[8OWWJJO(I7:[.X M'HLHLM3*Z$CDAZOOV9E0@JN/UG$/$==7FI*F4\9*9+2Z'BFA#9:>->"Z.]T( M?'P%UG6G>LNM*O*=N5[]V,C*XYJXKC_.:_",*#D&77\>RS1J:^>CJR_(&]FK M^WQLJ#_P<%,_ZFPLYRL2:R'$]0(X__*L%DR23>E^KI#$6R194L?BMY!ZI@0X M[3@M.G\9O@?Q#%?Q?`Y+CHN\!(5BX$*!&S.`SN"+'Q,DOJ^X1BS+VWX7>P1K\LE'JKD9%+Y6S, M8FGNZ%SE1 M;A&T_M4(`@\IE8:CR=/O*9&ZMP`DHPEC-LAV71T8TCY&*!LM6+6E:)IM]RD" M;,L,YTPLUD2OJ/:RDK17(0N/Z6&49:06Y9#HCU[($Q\Z(UBY+`)3"O0G$$^1 MMYA!WPO%ET7<]E:H7[__4:9'=$W';6]5U:Z5Z9N`:XZT,>AO29&:[>IM@N9R4E&47+TZD&OQ%4\`_Y1W MML2/&D*R)7<$CC>9_DIAVAADKE\J2?7ARK;B0[<_W;('3K:A[Z?S-*3I8%F- MH9CL*C`C^B-<@GMR9!7%B[/G"/!=).US"28QRNI?6*I0Q*M(2SS^$SL$!QF,C3XOS2+UA.&$"MVML%7%I-( MX8XC0HG0T5+?UEKE*N'&'P,_]#!FQ<2S@NYK><#SBK49LF\8/%!#L!FOFZYV ML@NJ$-\254)!-.0!BH\L/5CVHYMNIG+JF-V2XQA%>=L;1^K7(PF M&=+L$G8'?\E7U1W%I@'15)/:*M2EJWL>QTMJ)L!M=QB[ZJ`TB7!'`M]5KV<; MNZ36R5=_8CCKZ#.%G_[2=]\Y*+2W..`)#4Y7+P_WHNQV)F2;WI,<4BFHO7T9 M-4NWG2-=I^*JXW"W4I8;9'CT_`%6+?NQC"-'U+L:)-/20FVP`O<>==2#FZ&G M)/:_#;][*'@,B59`L&6_7-*8#PH3P2A7%'I24N)3ZGEH%8N/^:+,%Z!;%.-V%X7WN/PVYLIDE8>_C%% M_HP@1;=Y+5%*7:RX*#=WT^QS[XJF(I`/7ZZ*-OF2R(2!X*[0W/A6T)'1S".9 M_>-7P.KS9MH<[X;=KA[7<#LV>IL<8C0,S+^0:T]62B'@8$/"H]\Q7^B%:#Q7?Y)16EM M7*[U;[(,?,!]QJS#"7NY2[F: M4&%[1TX@>+-!O-B.U8,DG)[KJ+J"2"2XGU*.]D MCK8Q6.13 MSGOZ#40.)->C1BU]"I,6K^O1I=U\H@87T:YFY/?T;%;P.#J?T]W-%VGJC7&] MOG"'&V!'5KM9@KAGFHW^-;6K[Z)T\X':>1WW5\[5!:R[O?4LOL61FKTM[NVJ M.T%\-U#@?*2FK0FCVS9 M[D.B=L\S0?R%=+Z+KKS03[.MDIR"SO=Y\ M*)AOIY`SZUNEWCUQ"D#KS8?9MM2//O!LOW=9G4>='>1%2_W?\S?`C+R)2FV2 MT>0S^7B$4QH)R'>P\YJ>+C[LU9[Y!"*`O)`LI6$PAQ&DI-!;^7R)".O0J/6U MP556G&M3`NP^SFK5":[B1#UZQ('0RR3N8Z=$/`;D1)F1)7(-EB",%Y0PE;6E MTM-,5J@7`BI)/WOH&Z!Y%H(\54[3T\7@85P,:CEG>T1WSUST)[_H+8-USMV74?F#),6JJ$ZWXJO<7%56U<]QII+RY%*\AYETZ7ES;" M8^1T'W:Z#[/NL#3H2V[IF%P"]!(?E&LRV]WL55<#-;]YOL:L''O^D.QCC-D\ MM55`Y>VMU/?.7D&X!0$];@A:^0%S22Y%66]K/A/\^5,'W'`&"3T!0R> M5[2N:2]HIEW,?I"$$()T1/)?&N)L>U54>QD7P46HERI]R`33,=ACRKC MI21*CL,:E6*F<'0?AT&JAI3F$>"Z3=IV8S*]Q/7:-#KK2^&PVU_AF!Y8+M1L M2Y,\Q92L%B:?`&)VW5,ZGWMHE5TZ9,]L[;2QD5QZXZ$(1M,-#1(%BMO:ZJ=OR:.&N4/=-7X/(-3KEFMG'A_0`=E=K4T57=-VP M;GK2%T;-Z]^F!)" MZ)/NE6%R+'O@^!A&"0PH-7`)GH"?DJ\!`9_P':5G'J=O4!7Y/'B-+92R(C, M3E/I-P'3[,@6NUS%?:SXWVA!@#%8@B@%#T#LV:IO:U-U4)68%?6YGF/7+?XF M4/$/4]?M?-7C:\N(E2#LNJ4E/RA+56[D1YCKODKQR2=>6MO+T7DKL058ENPW M.S@IJ25"N/;N%K)FZ#[$"<#/\2VD=;:@%VXJT>`1FGH1_(--30#"<0B#["M& MP6.)K-&DIG-A/S\3*B^)]O;-HBE,'Q0FY/MR[530P89J:OP;U'-M?!JKSG?I M-R]O??,([^_(/@*AL?Z$QR4\.#X/&L2+1Y,RC@36"LQLXA5OOS<=Q8;HNXT1 M@-,H*\%!B$%>A`F2A#IZM+/_S%[`Q6*>VX]G)VGS>VDU(;+W4J*BL%V2D:?& MM/8P5OPOZ0L&OZ>$J)NE+H-J?6UP]0677G3F>4FW&AW.L:GXS5PW7]5`:RR\ M77?(Z:VY[1WEN@-.#YT6YZ7SX3A:0.H?O4?PV@Y?XW\BBPY.H.]%R2[.)^._ MC5ZDABQ',5+K?#C;4A6-HS:_-R^Q%::TW3U81Y!D%PJ[6+%$A:"J,]&/7:?R M12IZA9C[TW;C8UBD2)VL_`HY\H&$5C&LN)\D()^$L4$[LBL)"BTZEH+SY:8Q\,@.H]%,IICZKJ]X'[X`I#H0>!5.3V#A*<](I MI8Q\+Y3IDJ(>-B6$`B=UD9^F%LA16TIFP;1G6G6T&^Q4Y=CZ)CF!E<^BJ0DW M&/*`)$([Z(YZ_S^B.$C]),\#7_4D//!3ZE%R@-0]4M/0REDL1Y$CA.0=;>Y# M_GNW4-T\%*)Y-"H.T_]MJ(_,46_*:_"2].2X MJY(BV8>**R'4(7P?NPL,?+5EYHXO![U)J*5>6&269(L:(Y>_H/(KUB) M5O>6$H62+::<5]VMCV MOA;3Q%WCXF[V"LS*2N)6&UFM"%9+[];VDGR=TX82P&//'&RU%&UY2[/'6D'F MJ*[!ECX#H.\P;3!JOS=E:\R.>L\6:D'VOB8!*TM+!PS'JQ@G>/VD!P@>O17K M9=>N5"7YI4RRS/YL-Z@5.[7EIVL)!&=4JW:OD951L8_;8GP2+LW1LZEBJ<1_`,$=Y%)O:35Z':1V5G`P^\>"DH5SDMOQV.<9B_DZ0)D9!*W M1+/I+^!Z7&B77Z"E=-A?L&@/#\D,EF?OM2>NY1IZ)`>;J(<-V2Q$5)F%?LA- MA:]1WI)BUH]:&=VI76YSDQWTPV%<(-6([\?&TGG_0<#Q:4O5X6+1TWO`&\O< MLPSJAI>IB>SB)7E_6-/8TAOM4(188[1<-XSLO`1TLG[R.\-2+5S,?^ZDM7&D M\K"#YOQ5.=)Z.!LB=#.[Y)S<;6=SQW*IKB]VKOM9+>MT/Y]17J@7AOS'_P-0 M2P,$%`````@`<'*H1KI#=I5_#@``.XL``!$`'`!I;7!R+3(P,34P,S,Q+GAS M9%54"0`#-/Y,533^3%5U>`L``00E#@``!#D!``#M75MOV[@2?E]@_P./'PZZ MP-J.D[;;!LDNG-NN@:0.['1WSWE9T!)M$Y4HEZ22^/SZ,Z0NIBZF)=MI7$!` MD5K2S'"&\Y$=SNCR\'@]9O MO_[XP]F_VFTT&J&K@#'B>62)_G:(1SB6!#W@YX`%_A*-G3GQ\<]H@@5Q4<#0 MWQ>C6W3'/W7I`X62TYG M.#\!,5`"QPD:=48=PZI_HW'`!%#["\R6J.]Y:*2X!!H10?@C<3NQ4*&-15"# M3)RW#/N>3CH!GW6AB%[W[[O;J%):/_Z`(MK3YPGW:(9#W4EX3KJ4"8F90PP6 MC[(O%@[U6-6Y64B!)5:K]_'CQZY^:E"'HCW#>)'23[&8:.KX`133>]L^ZK5/ M>EDNN5P04X,\S;`0/-B(:%\N?128:1@9M"O[PB M7,F[JLPN$+6!BG#JF*R;^0H\BL:5*9M9Y^^ZT4.#V@&$2K[,D@OB=&;!8S=^ MJ(PZ*=2'$W(.S6X=:_RTO"Y=0LO9X$$Y!WEVYN4LZLD:C[%'(F0Y5_2LW#*& MJ2/*V?0CQ=4K<`GJE//`@S4Y'DDYC,B/V&?B`5V2$TH0J_G$R9O M`NY?D2D./:B7KR'VZ)02MX6P!!F34)(,08L4#J_DM?JSN+!673 M(+Z$&ZJ1GO+`(P^`3Z1^?!X--FLKX^ZXJSBZ5X$3*GTQJ>MZP4J3:)/BZ94D:UWKVC'FJCA-W\":)0)`L9PLZZ>0EYX2&,&T/VJ_[M M8,\)/VL,:FMX#:.+'=TDL-B(J%;,5U0X7B!"3A[( ML[SPH'D9B/B&A=KQ]5%-M%(NN##+US.OBU!`Q35CPDY0&M,9@P#;P4SV'9V^ MH6QV#[YU*'#4`DA%45:W]X[R;A^'OH_Y4@\%JP+0J@24%-'@8`< M2%:57]/]=@EVK_?R7E?"D):&[@A6-W49C8MW<''<9,0]7N*)1^"2A\2]I7A" M/5"9B"2R,VZMG'*I\[.R'B;V7*0=1,=Y$,7%H>OGA8I,A!XU='$H%HV,QZXH2/_PIQ#[[S<-L:H(,:.@9,\!A)1:#CQZ*Q)#^SLZ2LRD=NZ=QVO MW:=O\SY58AH?[N!#F+K[5$8]-',AF%=Q%&%.IO>MY]J:(NT>?Y?WN"%==^(9 M^0T4=H-"/HNCB&L[WR[$[N[W)0-WZ"LGD72\;C*!>^W$T]H>3E750KUJ"T=$ M5_IE(&`ZIS)_%VJ)"T1OFJMF9[]C&7;,_%*8)ZH\(>H_8>ZB>P^SJ*.([NH2 MD*E$@YX=T!.U\`?\O.U@815@]_N'O-\C66IQ5C,2[.35:\P9C*GBGG#=+.NY M=#VWW9^%-)]JI6%4MRKG\XE(W=TC$(RTY,;).PWWS('_X_>D(RJ^J!GX=!J_ M$]>OQ-7=[5;@7)<2`QFBE)047*C*?YTVLZ\Y->/&MP MTL+MB"LD)=>^@4!O$I'-\I$72T(_J`QB-H&<-\F75T#1)6%V8%12'.6I:X;]W^+I%<-YU<497=] M(=]9)0'60.$`,F$UD+*?DNQ`*F12ZV7%&DB]:"*E!E@VR;##H)`G-%)*;- M]H=:_D_GF>:4L"\$T2]!C:@]?N[V9A[:5`#Q@D?CK&>Z&D(F;7)9TBE4@L:6HNW8J;JZ$YYDRX_V`"4:I#W.6F M+BA2!BEM$&4HU6+M`,-I98X\$E^R*#L< M=TW]9C9#U$T;-ZBLC\HD`VLD8%>@\+S@2;UBO@EX"5T>=;N(LJ.J6MXXBYVD M0`3AV9H\7K">V^+B2*E:`FY-ZK$RTKF2OYMC:_W>6%E*YU M+72#A7V')=Y5!55\]DV(-5O<_0K'OV&!SH=?4>_WC'? M[E3JO7839H=7(4]=\^U4T[>]!FQ67;K M*6R'?R'-7AO^9C^;VH82X]JQ=<@P+\U;&!8J;C-)K[Z<%!''=FHUXL^!R@#% MML:*:6N1,K=I=M^FV94_C^?]NS<2NW@KI-\6O]:P"Z0U6;N$+%:F`=PV@$LW MVU2'1J%=/SF92F9M-6JY`SU8K6(I0'1RX'(AT%#==#J&VR/V-.KE)X=+W2) M>\,#/R/FBGHA!!)[@ML>2K8#LY"8KP],T#$>Y@PM4:(FFH*>>:FQJ@V0]P9D M8T/8<+I^\UG%--Y.TNR`*^3LZVYF:P92N*W^J/,`1F2*]*?^3]47[L];@OH+ M#WJ;Z![FCN*W'Q+07?``FI]Z5=9-Q"8""MS94PDT"G/U%VN52)AS,CUOJ?,` MVLDWUO\!CLZS[R4DDDI5BCE-4X+$SPA[7JM[N)9GW5C!<&`H,?PJ%?.=V.WA M"?$JF@RT)2;?*@G?B;7Y9E[!:&`I,=KA)*EWA2I++:*UGUJZ/TV))*M6)R?HH85;5\5-72>[^+)MMIL9T* MI8>J5$5%PJ`*?5<;"/F#;7;`@;I3%P:;SH>QJE/&EURT5T*V4*3DM)EJFIB, MZ=5.E9([PJ:2&@F/^K%3X?G#<"J5GC+I7SN57SQ6IY(&!EO\>R=Z:8D^'/NITLE,(B6C@/FBF:-@'&8QZGEKZ>=Z27"V;%B$P4QDJ'7[G0;@X M;T7<%,27VZGW.@RG9K`3K059?;M"?S%BF?NZBK9W&^;8;GUPV*E,[M>RWPUY M/!'>0P5DYK-JP@I#]X3PX?0R%#*`(508!ERZ M4@[/X4(.IW=8^4;M9B1W1/DP8^X:BHPI;N`#19D=D6HO;4:T8"5>.9,<0W2O MBS-ML9*96$VT>SW/J"6"`^C;N#ZS+'VY?8DY7U(VTQ?]6"?#Q'ILILEP#PA> MS8579$H@*G,?\'.T6RU=LI\N>P5'J9:'9R1C<"V^U4BSB.Z^HH?C\^CZ)2?; ME7FV$OD!>?3:7WC!DD3OMN]#[LQAV%=OEPM]S$;*0^IKDLIW`@XQFI9[%S`Y M![_\AV`>G9J5/C*MK,EHNG*F*#3UZ^$U.L7GCLAYX`YT\+Y:+2MD\7X1PEM+ M."14"X<'3U=DH4:/^",0#T&Z#UPMNHF&%=/NZCRFI7[`B,1\N5T\'#V:1%$) M5`*9T/U$R7_(\5+`4U%HQX4GA]1N!Q#`0&PNDWU`T0*'S'H<;<0&NIT=M#(J MYR$'1K$]N4C/L(Q/E]P"T)229OANH3F@YI;74G_OPF)%_/P;6^#*T_E2!13A M1-?A&EN2S88W`?\,+N<2V@/$+4D@FO'.9MH7ZRKV",1D2G@!DWUG3DP+BX]V MG2SN,Q60:#?^&F).;F!.-YQJK+E1-J/$D/6D!Y+>B$_:9+,H`3/C1#_MPQ^7 MN% M38]JUTT2XL"+Y2V14K_TT`L``00E#@``!#D! M``!02P$"'@,4````"`!P&UL550%``,T_DQ5=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`<'*H1N?S'+SZ&0``_9@!`!4`&````````0```*2! MO)<``&EM<'(M,C`Q-3`S,S%?9&5F+GAM;%54!0`#-/Y,575X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`'!RJ$8OY$W0/%,``.R5!``5`!@```````$```"D M@06R``!I;7!R+3(P,34P,S,Q7VQA8BYX;6Q55`4``S3^3%5U>`L``00E#@`` M!#D!``!02P$"'@,4````"`!P&UL550%``,T_DQ5=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`<'*H1KI#=I5_#@``.XL``!$`&````````0`` M`*2!Z3(!`&EM<'(M,C`Q-3`S,S$N>'-D550%``,T_DQ5=7@+``$$)0X```0Y 9`0``4$L%!@`````&``8`&@(``+-!`0`````` ` end XML 52 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
Accrued Expenses and Other Current Liabilities
3 Months Ended
Mar. 31, 2015
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

4. Accrued expenses and other current liabilities

The following table presents the details of the Company’s accrued expenses and other current liabilities:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Accrued payroll and related

   $ 2,883       $ 7,839   

Accrued taxes (1)

     906         1,144   

Other accrued expenses

     2,843         1,582   
  

 

 

    

 

 

 
$ 6,632    $ 10,565   
  

 

 

    

 

 

 

 

(1) Accrued taxes consist of accruals for foreign and state taxes, sales and use taxes, value added taxes due in foreign jurisdictions and franchise taxes.

XML 53 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Warranty Obligations (Tables)
3 Months Ended
Mar. 31, 2015
Guarantees [Abstract]  
Summary of Allowance for Warranty Obligations

The following table presents the details of the Company’s allowance for warranty obligations:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Beginning balance

   $ 40       $ 93   

Provision for estimated claims

     —           5   

Adjustment to estimate

     —           (51

Settlement of claims

     —           (7
  

 

 

    

 

 

 

Ending balance

$ 40    $ 40   
  

 

 

    

 

 

 

XML 54 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Concentration of Risk and Off-Balance Sheet Risk
3 Months Ended
Mar. 31, 2015
Text Block [Abstract]  
Concentration of Risk and Off-Balance Sheet Risk

12. Concentration of risk and off-balance sheet risk

Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains substantially all of its cash and cash equivalents in institutional money market mutual funds. The fund provides daily liquidity and invests in a portfolio of short-term money market instruments. To manage accounts receivable credit risk, the Company continuously evaluates the creditworthiness of its customers and reseller and maintains allowances for potential credit losses.

No customers or resellers accounted for 10% or more of revenues for the three months ended March 31, 2015 and 2014, respectively.

No customers or resellers accounted for 10% or more of accounts receivable at March 31, 2015 and December 31, 2014, respectively.

The Company does not have any off-balance sheet arrangements and did not have any such arrangements during the three months ended March 31, 2015 and the year ended December 31, 2014.

XML 55 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
Accumulated Other Comprehensive Loss
3 Months Ended
Mar. 31, 2015
Equity [Abstract]  
Accumulated Other Comprehensive Loss

8. Accumulated other comprehensive loss

The following table presents the changes in accumulated other comprehensive loss before taxes, as the tax effect is not material to the consolidated financial statements:

 

(in thousands)

   Foreign
Currency
Translation
Adjustments
     Affected line item in the
statement where net
income is presented

Balance at January 1, 2014

     (145   

Other comprehensive loss

     (100   

Amounts reclassified from accumulated other comprehensive income: Closure of foreign branch

     145       Other income (expense)
  

 

 

    

Net current-period other comprehensive loss

  45   
  

 

 

    

Balance at December 31, 2014

  (100

Other comprehensive loss

  (11

Amounts reclassified from accumulated other comprehensive income:

Closure of foreign branch

  (34 Other income (expense)
  

 

 

    

Net current-period other comprehensive loss

  (45
  

 

 

    

Balance at March 31, 2015

$ (145
  

 

 

    
XML 56 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
Debt
3 Months Ended
Mar. 31, 2015
Debt Disclosure [Abstract]  
Debt

6. Debt

Bank credit facility

The Company has a revolving credit facility with a bank pursuant to a Loan and Security Agreement dated January 30, 2009 (the “Revolving Credit Facility”). In February 2014, the Company modified the revolving credit agreement that had expired in October 2013 and extended the maturity date to February 2015. In February 2015, the Company amended its revolving credit facility to extend the maturity through April 2015. In April 2015, the Company further amended its revolving credit facility to extend the maturity through April 2016 and increase the borrowing limit from $10.0 million to $15.0 million based primarily on accounts receivable, and is subject to certain financial covenants requiring the Company to maintain minimum levels of liquidity. Outstanding borrowings accrue interest at the Wall Street Journal published prime rate plus 0.75%. Substantially all of the assets of the Company are pledged as collateral.

At March 31, 2015 and December 31, 2014, there was no outstanding balance under the revolving credit facility.

XML 57 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Commitments and Contingencies
3 Months Ended
Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

7. Commitments and contingencies

(a) Operating lease obligations

On January 16, 2015, the Company amended its lease agreement for its corporate headquarters in Lexington, Massachusetts to lease approximately 21,000 of additional square footage. The amendment increased the total square footage leased to approximately 93,000 and extended the term through December 2021. The additional rent expense is approximately $7.9 million and the landlord has agreed to contribute approximately $735,000 towards leasehold improvements.

(b) Litigation

The Company is not presently a party to any litigation that it believes might have a material adverse effect on its business operations or financial statements.

(c) Indemnifications

As permitted under Delaware law, the Company’s Certificate of Incorporation and By Laws provide that the Company indemnify its stockholders, officers, directors, and partners, and each person controlling the stock held for certain events or occurrences that happen by reason of the relationship with or position held at the Company. The Company’s agreements with customers generally require the Company to indemnify the customer against claims in which the Company’s products infringe third-party patents, copyrights, or trademarks, and indemnify against product liability matters.

As of March 31, 2015 and December 31, 2014, the Company had not experienced any material losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.

XML 58 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock Award Plans and Stock Based Compensation
3 Months Ended
Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Award Plans and Stock Based Compensation

9. Stock award plans and stock based compensation

(a) Equity incentive plan

In May 2014, the Company’s 2014 Stock Option and Incentive Plan (“2014 Plan”), was adopted by the Company’s board of directors and approved by its stockholders and became effective in June 2014. The 2014 Plan replaces the Amended and Restated 2002 Stock Option and Incentive Plan (“2002 Plan”) as the Company’s board of directors has determined not to make additional awards under the 2002 Plan. The 2014 Plan allows the compensation committee to make equity-based incentive awards to the Company’s officers, employees, directors and other key persons (including consultants).

Stock options expire no later than 10 years from the date of grant and generally vest over a period of four years. At the discretion of the Board of Directors, certain option grants may be immediately exercisable but subject to a right to repurchase, at cost, pursuant to the vesting schedule of the individual grant.

During the three months ended March 31, 2015, the Company granted 1,446,050 options to purchase common stock at a weighted average exercise price of $13.55.

At March 31, 2015, there were 2,122,083 shares available for future grant under the 2014 Plan.

(b) Employee stock purchase plan

In May 2014, the Company’s board of directors adopted and its stockholders approved the Employee Stock Purchase Plan (“ESPP”). Each employee who is a participant in the ESPP may purchase shares by authorizing payroll deductions of his or her base compensation during an offering period. Unless the participating employee has previously withdrawn from the offering, his or her accumulated payroll deductions will be used to purchase ordinary shares on the last business day of the offering period at a price equal to 85% of the fair market value of the common stock on the first business day or the last business day of the offering period, whichever is lower. All offering periods will be for six months and begin on March 1st and September 1st of each year.

At February 27, 2015, the Company issued 58,793 shares of common stock at a purchase price of $11.64.

At March 31, 2015, there were 627,033 shares available for future grant under the ESPP.

(c) Early exercise of stock options

The Company issues stock option agreements to Company executives and members of the Board of Directors, which may permit options to be exercised at any time. The Company may also include an early exercise provision for incentive stock option agreements at its discretion. The unvested shares of common stock exercised are subject to the Company’s right to repurchase at the original exercise price upon termination of employment or other relationship.

At March 31, 2015 and December 31, 2014, a total of 35,000 and 40,202 shares of unvested stock options exercised were subject to repurchase at an aggregate price of $162,400 and $184,000, respectively. These amounts are recorded as accrued and other current liabilities in the Company’s consolidated balance sheets and will be reclassified to equity as the Company’s repurchase right lapses.

During the three months ended March 31, 2015 and 2014, 5,202 and 5,626 stock options associated with the early exercise vested, respectively.

(d) Valuation of share-based compensation

The Company utilizes the Black-Scholes option-pricing model to estimate the fair value of stock options awarded to employees and rights to acquire stock under the ESPP, which requires several key assumptions to be made.

Weighted average assumptions used to apply this model were as follows:

 

     Three Months ended March 31,  
     2015     2014  

Risk-free interest rate(1)

     1.77     1.87

Expected life (years)(2)

     6.02        6.04   

Expected dividend yield(3)

     —       —  

Expected volatility of underlying stock(4)

     47     54

 

The assumptions used to estimate the fair value of the rights to acquire stock under the ESPP during the offering beginning on March 1, 2015 were as follows:

 

Risk-free interest rate(1)

  0.07

Expected life (years)(2)

  0.50   

Expected dividend yield(3)

  —  

Expected volatility of underlying stock(4)

  55

 

(1) Risk-free interest rate—the yield on zero-coupon U.S. Treasury securities with maturities similar to the expected term of the award being valued is used as the risk-free interest rate.
(2) Expected term—the expected term for stock options granted based on a review of the period that the Company’s stock option awards are expected to be outstanding and is calculated using the simplified method, which represents the average of the contractual term of the options and the weighted-average vesting period of the options. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate the expected term.
(3) Expected dividend yield—the expected dividend yield was not considered in the option pricing formula since the Company has not declared dividends and does not expect to pay dividends in the foreseeable future.
(4) Expected volatility—the Company is responsible for estimating volatility. The Company has limited trading history as a public company and does not have relevant historical data to develop its volatility assumptions. Therefore, the Company used a weighted average of its volatility and analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March 31, 2015. The Company analyzed the volatility of several public peer companies to support the assumptions used in its calculations for the three months ended March 31, 2014.

(e) Summary of share-based compensation expense

The Company uses the straight-line attribution method to recognize expense for stock-based awards such that the expense associated with awards is evenly recognized throughout the period.

Stock-based compensation included in costs and operating expenses related to the awards of stock options and the employee stock purchase plan are as follows:

 

     Three Months ended March 31,  

(in thousands)

   2015      2014  

Cost of maintenance and professional services

   $ 60       $ 23   

Research and development

     223         92   

Sales and marketing

     216         89   

General and administrative

     202         94   
  

 

 

    

 

 

 

Total

$ 701    $ 298   
  

 

 

    

 

 

 

XML 59 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
Debt - Additional Information (Detail) (Revolving Credit Facility [Member], USD $)
3 Months Ended 0 Months Ended
Mar. 31, 2015
Apr. 30, 2015
Dec. 31, 2014
Line of Credit Facility [Line Items]      
Credit facility maturity date Feb. 28, 2015    
Outstanding borrowings, interest rate 0.75%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1    
Outstanding borrowings, interest rate, description Prime rate plus 0.75%    
Extended maturity date for the debt instrument Apr. 30, 2015    
Maturity date for the debt instrument Feb. 28, 2015    
Outstanding revolving credit facility $ 0us-gaap_LineOfCredit   $ 0us-gaap_LineOfCredit
Subsequent Event [Member]
     
Line of Credit Facility [Line Items]      
Credit facility maturity date   Apr. 30, 2016  
Current borrowings on accounts receivable   10,000,000us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
 
Increase borrowing limit on accounts receivable   $ 15,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
 
XML 60 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2015
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table sets forth the Company’s assets and liabilities which are measured at fair value on a recurring basis by level within the fair value hierarchy:

 

     Fair value measurements at March 31, 2015  

(in thousands)

   Level 1      Level 2      Level 3      Total
carrying value
 

Assets

           

Cash equivalents:

           

Money market funds

   $ 30,187             $ 30,187   

Certificates of deposit

        97            97   

Liabilities

           

Contingent consideration

           653         653   

 

     Fair value measurements at December 31, 2014  

(in thousands)

   Level 1      Level 2      Level 3      Total
carrying value
 

Assets

           

Cash equivalents:

           

Money market funds

   $ 33,184             $ 33,184   

Certificates of deposit

        97            97   

Liabilities

           

Contingent consideration

           632         632   
Reconciliation of Contingent Liability Measured at Fair Value

The following table presents a reconciliation of the contingent liability measured at fair value using significant unobservable inputs, and the revaluation amount recorded in the Company’s consolidated statements of operations as a result of the change in fair value:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Beginning balance

   $ 632       $ 1,008   

Revaluation recognized in general and administrative expenses in the corresponding statements of operations

     21         (376
  

 

 

    

 

 

 

Ending balance

$ 653    $ 632   
  

 

 

    

 

 

Significant Unobservable Inputs Used in Valuation of Contingent Liability

This following table presents the significant unobservable inputs used in the valuation of the contingent liability:

 

     March 31,
2015
    December 31,
2014
 

Discount Rate

     17     17

 

XML 61 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Computation of Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2015
Earnings Per Share [Abstract]  
Summary of Components of Net Loss per Share

The components of net loss per share are as follows:

 

     Three Months Ended March 31,  

(in thousands, except per share data)

   2015      2014  

Numerator:

     

Net loss

   $ (6,699    $ (7,067

Accretion of preferred stock

     —           (1,238
  

 

 

    

 

 

 

Net loss attributable to common stockholders

  (6,699   ( 8,305
  

 

 

    

 

 

 

Denominator:

Weighted average common shares outstanding used in computing basic and diluted net loss per common share

  23,868      3,627   
  

 

 

    

 

 

 

Net loss per share, basic and diluted

$ (0.28 $ (2.29
  

 

 

    

 

 

 

Summary of Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share

The following common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders because they had an antidilutive impact:

 

     Three Months Ended March 31,  

(in thousands)

   2015      2014  

Options to purchase common stock

     4,951         3,605   

Common stock subject to repurchase

     35         57   

Warrants

     —           120   

Convertible preferred stock

     —           13,971   
  

 

 

    

 

 

 

Total

  4,986      17,753   
  

 

 

    

 

 

 
XML 62 R41.htm IDEA: XBRL DOCUMENT v2.4.1.9
Computation of Net Loss Per Share - Summary of Components of Net Loss per Share (Detail) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Numerator:    
Net loss $ (6,699)us-gaap_NetIncomeLoss $ (7,067)us-gaap_NetIncomeLoss
Accretion of preferred stock   (1,238)us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment
Net loss attributable to common stockholders $ (6,699)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (8,305)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Denominator:    
Weighted average common shares outstanding used in computing basic and diluted net loss per common share 23,868us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 3,627us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted
Net loss per share, basic and diluted $ (0.28)us-gaap_EarningsPerShareBasicAndDiluted $ (2.29)us-gaap_EarningsPerShareBasicAndDiluted
XML 63 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Comprehensive Loss (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Statement of Comprehensive Income [Abstract]    
Net loss $ (6,699)us-gaap_NetIncomeLoss $ (7,067)us-gaap_NetIncomeLoss
Other comprehensive loss:    
Foreign currency translation adjustments (45)us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax 144us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
Comprehensive loss $ (6,744)us-gaap_ComprehensiveIncomeNetOfTax $ (6,923)us-gaap_ComprehensiveIncomeNetOfTax
XML 64 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurements
3 Months Ended
Mar. 31, 2015
Fair Value Disclosures [Abstract]  
Fair Value Measurements

3. Fair value measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

(a) Fair value hierarchy

The accounting guidance for fair value measurement requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows:

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

(b) Assets and liabilities measured at fair value on a recurring basis

The Company’s cash equivalents primarily consist of money market funds recorded at cost, which approximates fair value measured based on quoted prices for assets traded in active markets. The contingent consideration liability is recorded at fair value determined using a probability weighted discounted cash flow model primarily based upon future revenue projections.

The following table sets forth the Company’s assets and liabilities which are measured at fair value on a recurring basis by level within the fair value hierarchy:

 

     Fair value measurements at March 31, 2015  

(in thousands)

   Level 1      Level 2      Level 3      Total
carrying value
 

Assets

           

Cash equivalents:

           

Money market funds

   $ 30,187             $ 30,187   

Certificates of deposit

        97            97   

Liabilities

           

Contingent consideration

           653         653   

 

     Fair value measurements at December 31, 2014  

(in thousands)

   Level 1      Level 2      Level 3      Total
carrying value
 

Assets

           

Cash equivalents:

           

Money market funds

   $ 33,184             $ 33,184   

Certificates of deposit

        97            97   

Liabilities

           

Contingent consideration

           632         632   

(c) Assets and liabilities measured on a non-recurring basis

There were no fair value measurements on a non-recurring basis as of March 31, 2015 and December 31, 2014.

(d) Level 3 fair value measurements

The contingent liability associated with the acquisition of Validus is based on an earn-out capped at $9.8 million, to be paid based on revenue generated using the purchased intellectual property.

The Company re-measures the fair value of the contingent liability at each balance sheet date based on the present value of forecasted revenues through December 31, 2016. The changes in the fair value are primarily due to the difference in actual revenue earned to date versus the initial projections and revisions to the timing and amount of forecasted future revenues.

The resulting forecasted revenues were then discounted using a rate that reflects the uncertainty surrounding the expected outcomes, which the Company believes is appropriate and representative of a market participant assumption.

 

The following table presents a reconciliation of the contingent liability measured at fair value using significant unobservable inputs, and the revaluation amount recorded in the Company’s consolidated statements of operations as a result of the change in fair value:

 

(in thousands)

   March 31,
2015
     December 31,
2014
 

Beginning balance

   $ 632       $ 1,008   

Revaluation recognized in general and administrative expenses in the corresponding statements of operations

     21         (376
  

 

 

    

 

 

 

Ending balance

$ 653    $ 632   
  

 

 

    

 

 

 

This following table presents the significant unobservable inputs used in the valuation of the contingent liability:

 

     March 31,
2015
    December 31,
2014
 

Discount Rate

     17     17

(e) Other financial instruments

The carrying amounts reflected in the consolidated balance sheets for cash and cash equivalents (which are comprised primarily of deposit accounts), accounts receivable, prepaid expenses, other current assets, accounts payable, and accrued expenses approximate fair value due to their short-term maturities.

XML 65 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Organization and Business - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended 0 Months Ended
Mar. 31, 2015
Branches
Apr. 30, 2015
Organization and Nature of Business [Line Items]    
Incorporated state Delaware  
Month and Year of incorporation 2001-05  
Cash availability, term 12 months  
Number of branches 2impr_NumberOfBranches  
Subsequent Event [Member] | HT Systems [Member]    
Organization and Nature of Business [Line Items]    
Amount paid in cash   $ 19.1us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= impr_HtSystemsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Deposited into an escrow fund   2.0impr_EscrowDepositRelatedToBusinessAcquisition
/ us-gaap_BusinessAcquisitionAxis
= impr_HtSystemsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Amount paid on retention-based payments   1.9impr_PaymentsOnRetentionBasedPayments
/ us-gaap_BusinessAcquisitionAxis
= impr_HtSystemsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Amount paid based on achieving certain sales target   $ 5.0impr_PaymentsOnAchievingCertainSalesTarget
/ us-gaap_BusinessAcquisitionAxis
= impr_HtSystemsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Payment period for retention-based payments   2 years
Payment period for payments based on achieving certain sales targets   2 years
XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 82 188 1 false 30 0 false 7 false false R1.htm 101 - Document - Document and Entity Information Sheet http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - Condensed Consolidated Balance Sheets Sheet http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets false false R3.htm 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 105 - Statement - Condensed Consolidated Statements of Operations Sheet http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative Condensed Consolidated Statements of Operations false false R5.htm 106 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://imetrix.edgar-online.com/taxonomy/role/StatementOfOtherComprehensiveIncome Condensed Consolidated Statements of Comprehensive Loss false false R6.htm 107 - Statement - Condensed Consolidated Statements of Stockholders Equity Sheet http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Condensed Consolidated Statements of Stockholders Equity false false R7.htm 108 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows false false R8.htm 109 - Disclosure - Organization and Business Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock Organization and Business false false R9.htm 110 - Disclosure - Summary of Significant Accounting Policies Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Summary of Significant Accounting Policies false false R10.htm 111 - Disclosure - Fair Value Measurements Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Measurements false false R11.htm 112 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock Accrued Expenses and Other Current Liabilities false false R12.htm 113 - Disclosure - Warranty Obligations Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsProductWarrantyDisclosureTextBlock Warranty Obligations false false R13.htm 114 - Disclosure - Debt Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Debt false false R14.htm 115 - Disclosure - Commitments and Contingencies Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies false false R15.htm 116 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlock Accumulated Other Comprehensive Loss false false R16.htm 117 - Disclosure - Stock Award Plans and Stock Based Compensation Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock Award Plans and Stock Based Compensation false false R17.htm 118 - Disclosure - Income Taxes Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes false false R18.htm 119 - Disclosure - Computation of Net Loss Per Share Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Computation of Net Loss Per Share false false R19.htm 120 - Disclosure - Concentration of Risk and Off-Balance Sheet Risk Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsConcentrationsRiskAndOffBalanceSheetRiskDisclosureTextBlock Concentration of Risk and Off-Balance Sheet Risk false false R20.htm 121 - Disclosure - Organization and Business (Policies) Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies Organization and Business (Policies) false false R21.htm 122 - Disclosure - Fair Value Measurements (Tables) Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value Measurements (Tables) false false R22.htm 123 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlockTables Accrued Expenses and Other Current Liabilities (Tables) false false R23.htm 124 - Disclosure - Warranty Obligations (Tables) Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsProductWarrantyDisclosureTextBlockTables Warranty Obligations (Tables) false false R24.htm 125 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlockTables Accumulated Other Comprehensive Loss (Tables) false false R25.htm 126 - Disclosure - Stock Award Plans and Stock Based Compensation (Tables) Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock Award Plans and Stock Based Compensation (Tables) false false R26.htm 127 - Disclosure - Computation of Net Loss Per Share (Tables) Sheet http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Computation of Net Loss Per Share (Tables) false false R27.htm 128 - Disclosure - Organization and Business - Additional Information (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureOrganizationAndBusinessAdditionalInformation Organization and Business - Additional Information (Detail) false false R28.htm 129 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) false false R29.htm 130 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformation Fair Value Measurements - Additional Information (Detail) false false R30.htm 131 - Disclosure - Fair Value Measurements - Reconciliation of Contingent Liability Measured at Fair Value (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfContingentLiabilityMeasuredAtFairValue Fair Value Measurements - Reconciliation of Contingent Liability Measured at Fair Value (Detail) false false R31.htm 132 - Disclosure - Fair Value Measurements - Significant Unobservable Inputs Used in Valuation of Contingent Liability (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSignificantUnobservableInputsUsedInValuationOfContingentLiability Fair Value Measurements - Significant Unobservable Inputs Used in Valuation of Contingent Liability (Detail) false false R32.htm 133 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesSummaryOfAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Detail) false false R33.htm 134 - Disclosure - Warranty Obligations - Summary of Allowance for Warranty Obligations (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureWarrantyObligationsSummaryOfAllowanceForWarrantyObligations Warranty Obligations - Summary of Allowance for Warranty Obligations (Detail) false false R34.htm 135 - Disclosure - Debt - Additional Information (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtAdditionalInformation Debt - Additional Information (Detail) false false R35.htm 136 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) false false R36.htm 137 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Changes in Accumulated Other Comprehensive Loss Before Taxes (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureAccumulatedOtherComprehensiveLossScheduleOfChangesInAccumulatedOtherComprehensiveLossBeforeTaxes Accumulated Other Comprehensive Loss - Schedule of Changes in Accumulated Other Comprehensive Loss Before Taxes (Detail) false false R37.htm 138 - Disclosure - Stock Award Plans and Stock Based Compensation - Additional Information (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockAwardPlansAndStockBasedCompensationAdditionalInformation Stock Award Plans and Stock Based Compensation - Additional Information (Detail) false false R38.htm 139 - Disclosure - Stock Award Plans and Stock Based Compensation - Schedule of Estimated Weighted-Average Assumptions Used in Calculation of Fair Value of Options Granted and Rights to Acquire Stock Under ESPP (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockAwardPlansAndStockBasedCompensationScheduleOfEstimatedWeightedAverageAssumptionsUsedInCalculationOfFairValueOfOptionsGrantedAndRightsToAcquireStockUnderESPP Stock Award Plans and Stock Based Compensation - Schedule of Estimated Weighted-Average Assumptions Used in Calculation of Fair Value of Options Granted and Rights to Acquire Stock Under ESPP (Detail) false false R39.htm 140 - Disclosure - Stock Award Plans and Stock Based Compensation - Schedule of Stock-Based Compensation Expense (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockAwardPlansAndStockBasedCompensationScheduleOfStockBasedCompensationExpense Stock Award Plans and Stock Based Compensation - Schedule of Stock-Based Compensation Expense (Detail) false false R40.htm 141 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation Income Taxes - Additional Information (Detail) false false R41.htm 142 - Disclosure - Computation of Net Loss Per Share - Summary of Components of Net Loss per Share (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureComputationOfNetLossPerShareSummaryOfComponentsOfNetLossPerShare Computation of Net Loss Per Share - Summary of Components of Net Loss per Share (Detail) false false R42.htm 143 - Disclosure - Computation of Net Loss Per Share - Summary of Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureComputationOfNetLossPerShareSummaryOfCommonStockEquivalentsExcludedFromComputationOfDilutedNetLossPerShare Computation of Net Loss Per Share - Summary of Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share (Detail) false false R43.htm 144 - Disclosure - Concentration of Risk and Off-Balance Sheet Risk - Additional Information (Detail) Sheet http://imetrix.edgar-online.com/taxonomy/role/DisclosureConcentrationOfRiskAndOffBalanceSheetRiskAdditionalInformation Concentration of Risk and Off-Balance Sheet Risk - Additional Information (Detail) false false All Reports Book All Reports Element us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans had a mix of decimals attribute values: -3 0. 'Shares' elements on report '107 - Statement - Condensed Consolidated Statements of Stockholders Equity' had a mix of different decimal attribute values. 'Monetary' elements on report '136 - Disclosure - Commitments and Contingencies - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2014' Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 105 - Statement - Condensed Consolidated Statements of Operations Process Flow-Through: 106 - Statement - Condensed Consolidated Statements of Comprehensive Loss Process Flow-Through: 108 - Statement - Condensed Consolidated Statements of Cash Flows impr-20150331.xml impr-20150331.xsd impr-20150331_cal.xml impr-20150331_def.xml impr-20150331_lab.xml impr-20150331_pre.xml true true XML 67 R38.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock Award Plans and Stock Based Compensation - Schedule of Estimated Weighted-Average Assumptions Used in Calculation of Fair Value of Options Granted and Rights to Acquire Stock Under ESPP (Detail)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Risk-free interest rate 1.77%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate 1.87%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
Expected life (years) 6 years 7 days 6 years 15 days
Expected dividend yield 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Expected volatility of underlying stock 47.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate 54.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Employee Stock Purchase Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Risk-free interest rate 0.07%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
/ us-gaap_AwardTypeAxis
= impr_EmployeeStockPurchasePlanMember
 
Expected life (years) 6 months  
Expected dividend yield 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
/ us-gaap_AwardTypeAxis
= impr_EmployeeStockPurchasePlanMember
 
Expected volatility of underlying stock 55.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
/ us-gaap_AwardTypeAxis
= impr_EmployeeStockPurchasePlanMember
 
XML 68 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Organization and Business (Policies)
3 Months Ended
Mar. 31, 2015
Accounting Policies [Abstract]  
Subsequent event

(e) Subsequent event

On April 30, 2015, the Company announced the acquisition of HT Systems, the market leading provider of palm-vein based biometric patient identification systems, to enter into the emerging patient identification market. The acquisition of HT Systems and its PatientSecure biometric patient identification technology supports Imprivata’s long-term vision to be the leading provider of healthcare IT security solutions that increase provider productivity, enable patient engagement, and improve patient safety. Under the terms of the transaction, the Company paid approximately $19.1 million in cash at closing, of which $2 million was deposited into an escrow fund to secure certain obligations of the selling members of HT Systems to indemnify us and to pay us the amount of any shortfall in HT System’s working capital as of the closing date. Additionally, The Company will pay up to $1.9 million in retention-based payments two years from closing plus up to $5.0 million based on achieving certain sales targets over the two-year period following the transaction. The Company is required to allocate the purchase price to the estimated fair value of the tangible and identifiable intangible assets acquired and liabilities assumed. The excess of the purchase price over those fair values is recorded as goodwill. The Company is in the process of finalizing the valuation of the assets acquired and liabilities assumed.

Basis of presentation and principles of consolidation

(b) Basis of presentation and principles of consolidation

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company is subject to a number of risks. Principal among these risks are dependence on key individuals, competition from substitute products and larger companies, the successful development and marketing of its products, and recruitment of key personnel.

Management believes the Company has sufficient cash and availability under its letter of credit to sustain operations through at least the next 12 months.

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited. All intercompany balances and transactions have been eliminated in consolidation.

Use of estimates

(c) Use of estimates

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP applicable to interim periods, under the rules and regulations of the United States Securities and Exchange Commission (“SEC”), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended December 31, 2014. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for the fair presentation of interim information have been included. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015, for any other interim period or for any other future year.

The consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements at that date, but does not include all of the disclosures required by U.S. GAAP. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s 2014 Annual Report on Form 10-K filed with the SEC on March 11, 2015.

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Imprivata Securities Corporation and Imprivata International, Inc., and its wholly owned subsidiary Imprivata UK Limited, as well as two branch offices. All intercompany balances and transactions have been eliminated in consolidation. In the first quarter of 2014, the Company completed the closure of its UK branch office. In the first quarter of 2015, the Company closed its Netherlands branch office.

Foreign currency

(d) Foreign currency

The foreign subsidiaries and branches use the local currency as the functional currency. The Company translates the assets and liabilities of its foreign operations into U.S. dollars based on the rates of exchange in effect as of the balance sheet date. Revenues and expenses are translated into U.S. dollars using average exchange rates for each period. The resulting adjustments from the translation process are included in accumulated other comprehensive (loss) income in the accompanying consolidated balance sheets.

 

Certain transactions of the Company are settled in foreign currency, and are thus translated to U.S. dollars at the rate of exchange in effect at the end of each month. Gains (losses) resulting from the translation are included in foreign exchange gains (losses) in the accompanying consolidated statements of operations.

Recent accounting guidance

Recent accounting guidance

Accounting standards or updates not yet effective

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers” (Topic 606) (ASU 2014-09). ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. On April 1, 2015, the FASB voted to propose a delay in the effective date of this ASU for reporting periods beginning after December 15, 2017, with early adoption permitted as of the original effective date of periods beginning after December 15, 2016. This new guidance is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017; unless the early adoption provision is elected. .Entities have the option of using either a full retrospective or a modified approach to adopt the guidance. This update could impact the timing and amounts of revenue recognized. The Company is currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of operations upon adoption.